data_2l3s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l3s _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.3 p90 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.088 0.47 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.62 166.06 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.428 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -115.49 131.54 56.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -102.23 92.68 4.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.724 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.575 ' CD1' ' H ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -103.27 22.63 13.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.942 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 143' ' ' ASP . 65.3 m-85 -119.45 2.46 11.26 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.6 p30 55.39 138.76 0.0 OUTLIER 'General case' 0 C--O 1.21 -0.992 0 O-C-N 124.365 1.041 . . . . 0.0 110.422 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 6.7 t80 -127.99 -41.54 1.62 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.844 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 144' ' ' PHE . 39.3 t-20 36.21 59.22 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.478 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.02 -141.28 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.571 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.2 OUTLIER 166.8 88.28 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.413 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 3.6 m-20 171.97 -178.42 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.211 0.529 . . . . 0.0 110.33 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 149' ' ' ASP . 60.9 t0 -91.0 -20.4 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.388 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.26 25.81 9.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.693 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.7 p-10 -141.33 156.63 45.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.4 tp -120.17 82.31 30.06 Favored Pre-proline 0 C--O 1.216 -0.695 0 CA-C-O 120.755 0.312 . . . . 0.0 110.999 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.42 136.79 74.09 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 121.456 1.437 . . . . 0.0 112.108 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.45 ' CZ ' ' CB ' ' A' ' 144' ' ' PHE . 10.6 p90 -152.09 165.14 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.524 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -175.86 102.93 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.795 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.577 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.5 tppp? 127.61 77.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.652 1.22 . . . . 0.0 110.959 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.71 49.73 0.02 OUTLIER Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 156' ' ' LYS . 28.7 t0 -72.91 144.87 47.19 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.922 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' A' ' 159' ' ' ILE . 10.7 tp -104.17 109.54 27.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.37 122.79 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.675 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -77.91 141.84 38.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.91 139.13 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.7 tpt85 -117.9 -43.36 2.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.276 0.56 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.32 129.08 11.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.684 ' NZ ' ' HE1' ' A' ' 171' ' ' TRP . 0.1 OUTLIER -119.48 77.53 19.48 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.145 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.03 -44.36 50.47 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.295 1.996 . . . . 0.0 111.732 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.49 177.02 4.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -96.57 -32.05 12.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.511 ' NE2' ' CZ ' ' A' ' 240' ' ' TYR . 85.2 mt-30 -77.17 -28.12 53.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.468 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.494 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 66.0 m95 -123.84 153.59 40.83 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.684 ' HE1' ' NZ ' ' A' ' 165' ' ' LYS . 17.4 m0 -143.65 136.7 27.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.4 108.03 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.44 168.32 9.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.957 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -126.63 138.36 53.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.894 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -68.09 174.56 3.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.302 0.572 . . . . 0.0 110.698 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ptm -79.88 -2.57 44.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.349 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -101.92 -28.25 12.51 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.6 48.69 0.45 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.57 132.56 49.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.671 -0.764 . . . . 0.0 109.568 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 125.86 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.322 0.582 . . . . 0.0 111.951 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.24 153.34 24.6 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.565 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 32.3 mtp -66.51 160.8 24.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.432 0.634 . . . . 0.0 110.817 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.3 pt -152.05 143.06 15.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.794 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -69.4 114.69 3.73 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.639 1.559 . . . . 0.0 110.013 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.551 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 27.0 t -49.98 -52.81 49.2 Favored Pre-proline 0 C--O 1.216 -0.673 0 O-C-N 121.927 -0.483 . . . . 0.0 111.69 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.6 Cg_endo -49.5 -24.71 9.48 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.147 1.898 . . . . 0.0 113.367 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.487 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.9 m-85 -74.54 3.72 7.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -134.86 162.29 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 39.3 mt-10 -81.28 -59.37 2.67 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.276 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 18.0 tptm . . . . . 0 C--N 1.345 0.393 0 O-C-N 124.515 1.134 . . . . 0.0 109.891 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.035 0.445 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -62.22 -165.29 0.44 Allowed Glycine 1 CA--C 1.447 -4.171 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.373 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.417 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.0 Cg_endo -46.78 98.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.767 0 N-CA-C 116.141 1.554 . . . . 0.0 116.141 0.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 10.3 m-30 -116.51 -132.09 0.32 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.511 ' CZ ' ' NE2' ' A' ' 169' ' ' GLN . 2.0 m-30 -136.34 115.88 12.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.67 0.748 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.681 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -106.85 140.81 39.09 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.943 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -103.91 97.71 7.66 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.74 127.21 23.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.142 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.48 22.91 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.99 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.283 0.564 . . . . 0.0 110.159 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.483 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.7 ttmt -146.76 -146.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.31 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.483 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 0.6 OUTLIER -155.97 -145.53 0.16 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.626 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 97.0 t -132.91 74.13 74.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.463 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 18.9 Cg_endo -91.65 169.93 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.036 2.491 . . . . 0.0 111.323 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.7 OUTLIER -127.12 127.34 44.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.792 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.07 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.856 0.722 . . . . 0.0 112.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.758 ' N ' ' O ' ' A' ' 250' ' ' ASN . 50.9 m-85 -91.76 -53.04 4.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 250' ' ' ASN . 42.1 t0 -41.24 -62.02 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.119 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.0 mttt -151.75 25.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.791 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.9 m 73.83 -18.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.589 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -43.95 108.69 0.12 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.633 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.67 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -47.48 159.85 0.13 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -108.21 119.01 38.25 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.091 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.433 HD13 ' HZ3' ' A' ' 246' ' ' LYS . 1.2 mt -141.67 -175.17 4.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.222 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.6 tt0 -144.94 152.08 39.64 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.37 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.0 t -59.75 115.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.84 6.67 24.49 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 8.1 mm-40 -97.53 -139.76 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.681 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 175.37 139.99 0.05 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.404 0.621 . . . . 0.0 109.366 179.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.598 ' N ' HD11 ' A' ' 264' ' ' LEU . 12.5 p -128.1 152.77 36.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -103.83 88.15 2.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.541 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.58 124.36 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.153 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.524 ' HG1' ' N ' ' A' ' 269' ' ' LYS . 0.6 OUTLIER -116.57 -53.56 2.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.232 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.524 ' N ' ' HG1' ' A' ' 268' ' ' THR . 0.1 OUTLIER -72.2 127.25 31.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.15 -178.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.411 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 0.8 OUTLIER -149.19 103.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.548 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.732 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -97.73 -88.53 0.3 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.492 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.732 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 38.1 mtm -67.07 178.73 1.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.4 p -98.95 16.63 21.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -130.54 -87.32 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.889 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -91.96 105.3 17.59 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.015 0.436 . . . . 0.0 110.935 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.543 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 4.6 p-90 -120.33 -164.95 1.13 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 269' ' ' LYS . 41.0 mt-10 -123.99 163.21 21.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.861 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.74 -158.21 7.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.909 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -170.32 131.19 0.95 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.0 OUTLIER -112.82 -92.86 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 283' ' ' LYS . 27.7 t-20 -101.4 54.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.95 3.81 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 281' ' ' ASN . 0.0 OUTLIER -61.41 90.4 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.774 -0.713 . . . . 0.0 110.144 -178.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 255' ' ' THR . 42.3 mtt85 -88.05 164.29 15.83 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 171.46 -157.46 27.95 Favored Glycine 0 C--O 1.213 -1.202 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.591 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -123.89 174.73 7.36 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.2 m-85 160.28 135.02 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.107 0 O-C-N 123.768 0.667 . . . . 0.0 111.731 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.53 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 23.7 Cg_exo -64.07 142.64 81.79 Favored 'Trans proline' 0 N--CA 1.507 2.297 0 C-N-CA 122.351 2.034 . . . . 0.0 112.25 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.23 2.63 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.277 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 66.2 p -68.68 2.78 2.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.955 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 7.6 p80 -137.31 39.84 2.47 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.61 161.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 121.992 -0.442 . . . . 0.0 109.977 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 294' ' ' LEU . 29.2 mtt180 -132.63 77.81 1.77 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.554 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 293' ' ' ARG . 84.3 mt -32.77 135.52 0.09 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.845 0.831 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.3 mp -84.34 -167.31 1.72 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.028 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -93.79 13.25 23.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.642 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 63.0 tt0 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.304 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.77 0.319 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.3 m -140.67 172.17 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.421 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -131.26 136.37 48.13 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.317 0.58 . . . . 0.0 111.017 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.53 172.22 0.71 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.475 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 78.8 mt -140.35 -45.17 0.41 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.627 ' CE2' ' NH2' ' A' ' 284' ' ' ARG . 95.1 m-85 -113.49 9.59 18.07 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.825 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.546 ' CG ' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 67.11 136.08 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.735 0.647 . . . . 0.0 109.337 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 9.1 t80 -112.64 -54.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.372 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.3 t30 49.99 55.14 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.523 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.488 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -65.94 -124.95 0.01 OUTLIER Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.565 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 176.66 -90.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 81.0 m-20 -22.94 139.24 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -57.08 -7.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.528 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 148' ' ' ASP . 6.5 pt-20 -97.88 7.22 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.565 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 12.9 p30 -133.29 157.61 45.04 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 9.2 tp -111.16 93.64 18.78 Favored Pre-proline 0 C--O 1.214 -0.814 0 CA-C-N 118.506 0.594 . . . . 0.0 111.095 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 95.5 Cg_endo -69.53 141.43 46.13 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 CA-C-N 120.567 1.238 . . . . 0.0 114.006 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 20.3 p90 -159.13 159.72 34.78 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.67 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER -126.97 96.76 4.72 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.839 ' O ' ' N ' ' A' ' 158' ' ' ASP . 59.0 pttt 27.39 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.611 1.194 . . . . 0.0 110.739 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 30.9 13.74 0.0 OUTLIER Glycine 0 CA--C 1.541 1.69 0 N-CA-C 113.948 0.339 . . . . 0.0 113.948 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.839 ' N ' ' O ' ' A' ' 156' ' ' LYS . 17.3 t0 -85.36 155.88 21.12 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 117.08 0.44 . . . . 0.0 110.324 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.3 mm -125.58 106.2 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.689 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.6 mt -121.63 133.71 54.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -97.84 139.73 33.27 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.4 mp -83.48 159.26 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.03 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -142.2 -43.73 0.33 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.283 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -136.52 113.58 10.54 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.54 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.428 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 14.3 pttm -112.71 74.07 1.6 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.77 -28.74 51.29 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.621 1.548 . . . . 0.0 111.881 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.9 162.69 18.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.667 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.85 -35.0 18.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.508 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 79.0 mt-30 -80.7 -22.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -124.75 153.87 41.76 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 11.2 m0 -145.83 138.16 25.51 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -86.06 106.89 17.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.08 6.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.761 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 30.3 tt0 -126.38 138.32 53.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.969 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.87 173.41 7.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.578 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.9 tpt -77.53 -0.94 28.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.21 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 79.9 m-20 -102.66 -29.67 11.39 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.536 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.96 47.92 0.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 9.8 mttp -128.66 135.88 49.88 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 114.105 -1.048 . . . . 0.0 108.982 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.35 123.34 50.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.412 0.625 . . . . 0.0 111.519 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -151.6 149.03 20.71 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.021 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 151.27 46.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 111.174 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.05 145.77 37.42 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -74.44 112.9 3.66 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.42 1.413 . . . . 0.0 109.438 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.501 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 51.7 t -48.62 -51.56 51.73 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -45.74 -31.38 7.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.077 1.852 . . . . 0.0 113.096 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.484 ' OH ' ' O ' ' A' ' 268' ' ' THR . 9.6 m-85 -69.4 -6.66 31.51 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.089 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.2 m -129.93 163.66 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 190' ' ' LYS . 1.1 pt-20 -117.4 -51.73 2.5 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.224 1.41 . . . . 0.0 110.003 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.37 0.129 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.484 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 136.72 -165.84 24.97 Favored Glycine 1 CA--C 1.448 -4.155 0 CA-C-O 121.72 0.622 . . . . 0.0 113.52 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 1.9 Cg_endo -47.41 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.535 3.918 0 N-CA-C 116.701 1.769 . . . . 0.0 116.701 1.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.568 ' CG ' ' OE1' ' A' ' 297' ' ' GLN . 11.6 m-30 -118.23 -134.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.31 129.5 19.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.248 0.931 . . . . 0.0 109.246 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -102.04 -162.34 0.92 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.464 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -157.34 92.84 1.27 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.19 129.37 27.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.741 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.5 18.31 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.214 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 178.06 101.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.374 0.607 . . . . 0.0 110.053 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -144.89 -142.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.489 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.0 ptt85 -153.77 -142.02 0.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.994 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 54.3 t -133.62 69.3 76.44 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 110.85 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.575 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 59.0 Cg_endo -91.2 177.0 2.08 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.838 2.359 . . . . 0.0 110.762 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.724 ' O ' ' N ' ' A' ' 252' ' ' TYR . 1.3 p-10 -144.26 139.01 28.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -36.51 -10.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.399 0.619 . . . . 0.0 112.305 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.724 ' N ' ' O ' ' A' ' 250' ' ' ASN . 6.6 m-85 -89.51 -50.27 6.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 250' ' ' ASN . 25.7 t0 -62.71 60.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.624 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.448 ' C ' ' HG1' ' A' ' 255' ' ' THR . 32.6 mtmt 82.53 15.78 0.4 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.167 0.917 . . . . 0.0 111.061 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.485 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.5 m 80.88 -17.93 0.53 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.675 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.02 109.15 0.11 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.624 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.16 156.06 0.6 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.521 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.04 122.14 46.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.12 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.407 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.5 mt -142.07 -178.81 5.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.886 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -143.44 149.93 38.3 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.936 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.73 114.78 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.428 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 107.29 7.82 32.0 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 57.8 mm-40 -93.53 -127.62 0.11 Allowed 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 165.97 139.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.031 0.919 . . . . 0.0 110.336 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.595 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.5 p -134.75 155.6 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.56 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.438 ' H ' HG22 ' A' ' 265' ' ' VAL . 0.2 OUTLIER -85.31 -158.5 0.38 Allowed 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.726 ' O ' ' N ' ' A' ' 269' ' ' LYS . 0.9 OUTLIER -142.65 -44.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.075 176.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.484 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER 35.14 -72.93 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -74.35 123.6 24.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.975 -177.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 162.31 36.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.827 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.661 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -156.46 -98.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.526 0.679 . . . . 0.0 110.359 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.661 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 34.8 mtm -55.16 152.89 7.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.601 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.9 p -71.58 15.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.539 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.71 -73.63 0.04 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.554 ' O ' ' ND2' ' A' ' 271' ' ' ASN . 13.4 mp0 -78.89 166.02 22.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.896 0.379 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.539 ' NE1' ' O ' ' A' ' 274' ' ' GLY . 1.5 p-90 177.81 179.49 0.3 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.617 0.723 . . . . 0.0 110.711 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 2.6 mt-10 -107.92 -178.53 3.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.607 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -157.72 -165.84 16.04 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.422 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -163.55 123.44 2.15 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.411 0.624 . . . . 0.0 112.269 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.8 OUTLIER -133.75 74.0 1.53 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.354 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER 83.99 37.08 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.644 0.735 . . . . 0.0 109.676 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 93.34 -36.07 3.87 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.032 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -64.61 86.16 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.355 0.598 . . . . 0.0 110.264 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.627 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 77.4 mtt180 -86.27 170.13 12.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.508 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 169.23 -151.12 16.81 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -130.18 176.77 7.82 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.0 OUTLIER 157.99 112.83 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 123.461 0.476 . . . . 0.0 110.026 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.4 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 39.8 Cg_exo -54.8 148.05 47.82 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.375 2.05 . . . . 0.0 112.906 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.552 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.4 OUTLIER -66.49 -2.63 4.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.804 0.335 . . . . 0.0 110.303 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.0 p -47.7 -5.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 289' ' ' PHE . 1.6 p80 -155.71 75.15 0.9 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.12 159.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -126.52 76.37 1.62 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.743 0.306 . . . . 0.0 110.318 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 48.3 mt -39.36 127.48 1.82 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.137 0.97 . . . . 0.0 112.019 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 -172.37 2.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.098 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -110.72 48.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.823 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.568 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 34.1 tp60 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.371 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 48.5 p90 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 120.667 0.27 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.39 165.02 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.533 ' NE ' ' OE2' ' A' ' 189' ' ' GLU . 12.7 ttp180 -122.62 136.94 55.02 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.747 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -103.85 90.81 3.74 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.566 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.49 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -103.52 38.3 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 58.8 m-85 -133.76 -0.16 3.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.958 -0.464 . . . . 0.0 111.038 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 59.47 136.94 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.131 0.894 . . . . 0.0 109.477 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 8.5 t80 -126.5 -48.0 1.56 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.641 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 46.59 58.31 4.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.23 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -65.45 -128.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.697 HD21 ' H ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER 164.43 -41.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.697 ' H ' HD21 ' A' ' 147' ' ' ASN . 7.9 m-20 -73.95 140.33 45.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 112.034 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -49.9 -21.35 1.14 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.428 ' N ' ' C ' ' A' ' 148' ' ' ASP . 77.9 mt-10 -91.27 29.4 1.44 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.528 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.579 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 31.6 p30 -153.11 171.68 18.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.555 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.457 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 14.6 tp -126.24 87.72 55.67 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.788 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 57.8 Cg_endo -64.17 143.19 83.21 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 CA-C-N 121.073 1.419 . . . . 0.0 113.858 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 12.6 p90 -167.76 172.4 9.21 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.657 0.741 . . . . 0.0 111.485 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -150.29 -165.0 2.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.239 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.747 ' O ' ' O ' ' A' ' 140' ' ' ALA . 17.9 ptpt 41.36 -145.81 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -109.13 49.39 0.85 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 37.4 t0 -52.86 154.04 3.02 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.4 mp -100.24 99.27 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.7 mt -102.33 90.47 3.91 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.473 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -69.04 147.1 52.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.967 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.1 mp -80.44 131.25 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.05 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.593 ' NH2' HD22 ' A' ' 172' ' ' ASN . 13.1 ttm180 -85.85 -43.09 13.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.212 0.529 . . . . 0.0 110.909 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 164' ' ' ASP . 38.2 t0 -153.58 -24.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.326 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 165' ' ' LYS . 12.7 tttm 59.48 99.25 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -85.56 -44.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.989 1.793 . . . . 0.0 111.732 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.98 174.91 6.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -88.49 -38.46 14.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.972 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.524 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 95.5 mt-30 -80.38 -15.47 56.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.566 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.427 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 64.5 m95 -131.49 154.63 48.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 12.5 m0 -143.37 133.37 24.19 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.593 HD22 ' NH2' ' A' ' 163' ' ' ARG . 47.3 t-20 -85.02 117.79 24.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.84 178.7 6.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.734 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.5 111.28 15.51 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.656 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -60.88 140.37 57.71 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.19 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.2 ttt -52.1 -0.74 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.656 ' H ' ' C ' ' A' ' 175' ' ' ASP . 86.5 m-20 -84.82 -23.02 29.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.394 0.616 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.52 41.24 2.78 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.105 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -139.85 142.23 36.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.033 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.64 130.29 49.49 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.474 0.654 . . . . 0.0 111.525 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -162.77 159.57 31.94 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.437 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 mtp -69.84 149.58 47.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.137 0.494 . . . . 0.0 111.199 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.57 141.55 39.32 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.724 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.38 119.05 5.89 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 N-CA-C 108.073 -1.549 . . . . 0.0 108.073 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.544 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 35.7 t -54.2 -50.63 83.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.8 Cg_endo -50.9 -27.84 22.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.185 1.924 . . . . 0.0 112.873 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.489 ' OH ' ' O ' ' A' ' 268' ' ' THR . 8.0 m-85 -71.32 4.91 2.53 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.38 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.7 163.02 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.699 0.285 . . . . 0.0 110.596 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.533 ' OE2' ' NE ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -76.31 -71.45 0.39 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.677 -178.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 O-C-N 123.974 0.796 . . . . 0.0 110.614 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.554 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.465 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.2 -165.04 40.8 Favored Glycine 1 CA--C 1.439 -4.675 0 CA-C-O 122.306 0.948 . . . . 0.0 113.944 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.411 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.6 Cg_endo -44.43 102.73 0.03 OUTLIER 'Cis proline' 1 N--CA 1.538 4.114 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -0.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 10.5 m-30 -115.27 -124.37 0.29 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.6 OUTLIER -143.71 130.93 20.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 119.667 1.121 . . . . 0.0 109.83 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -106.04 -168.03 1.38 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.618 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.37 93.99 1.35 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.0 123.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.347 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.96 9.08 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.041 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -168.61 128.03 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.311 0.576 . . . . 0.0 109.504 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.436 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.4 ttmt -170.51 -144.39 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.862 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.436 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 2.1 ptt85 -160.48 -136.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.507 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.408 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 3.7 t -137.01 61.95 37.18 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.667 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.613 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -102.1 70.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.806 3.004 . . . . 0.0 112.081 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.657 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.1 OUTLIER -47.78 158.53 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.54 -3.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.897 0.38 . . . . 0.0 111.767 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.73 ' O ' ' N ' ' A' ' 254' ' ' LYS . 30.1 m-85 -80.15 -59.04 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -47.14 60.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 125.653 1.846 . . . . 0.0 112.179 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 252' ' ' TYR . 34.0 mtmt 87.49 -51.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.961 1.413 . . . . 0.0 109.422 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 4.4 m 164.29 -17.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.175 0.922 . . . . 0.0 110.373 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.493 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -45.16 170.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.573 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 257' ' ' LEU . 0.4 OUTLIER -109.54 150.26 28.42 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.778 0.431 . . . . 0.0 110.563 -177.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.613 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -97.17 116.59 29.64 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 122.07 -0.394 . . . . 0.0 111.119 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.414 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 2.2 mt -137.58 -172.59 3.27 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.74 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -145.56 147.43 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.043 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 68.8 t -54.73 97.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.888 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 122.15 10.26 6.29 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 56.2 mm-40 -91.81 -130.64 0.11 Allowed 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 166.32 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 9.1 p -127.41 142.75 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.466 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 268' ' ' THR . 2.9 ttmm -99.04 84.15 3.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.56 150.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.518 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.489 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -148.25 -47.68 0.16 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.579 -178.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 5.6 tppt? -84.05 151.73 24.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.36 134.19 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.407 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.659 ' N ' HD21 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -177.31 -170.57 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.135 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.523 ' HG3' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER 60.39 -143.32 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.687 178.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.3 p -137.04 -4.35 1.94 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.734 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 177.74 13.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 118.924 -1.608 . . . . 0.0 112.517 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 1.2 mp0 -101.28 -74.76 0.61 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 271' ' ' ASN . 9.9 m95 76.63 169.01 0.25 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 75.0 mt-10 -131.95 143.06 49.84 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.543 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -136.68 145.34 17.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 121.853 0.696 . . . . 0.0 113.599 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.64 130.8 55.32 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 113.945 -1.127 . . . . 0.0 110.674 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.414 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.0 OUTLIER -110.55 -90.84 0.47 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 283' ' ' LYS . 22.8 t-20 -104.54 50.56 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 89.92 -31.04 5.49 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 281' ' ' ASN . 0.1 OUTLIER -63.91 75.68 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.284 -0.958 . . . . 0.0 111.156 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 282' ' ' GLY . 50.9 mtt180 -71.92 160.89 31.77 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.357 0.599 . . . . 0.0 110.344 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 173.54 -161.71 32.48 Favored Glycine 0 C--O 1.217 -0.928 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.506 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 41.1 p-80 -130.04 168.8 16.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.223 0.535 . . . . 0.0 110.801 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 173.47 116.13 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.239 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 290' ' ' THR . 52.7 Cg_exo -51.45 149.91 16.67 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.805 1.67 . . . . 0.0 111.915 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.5 OUTLIER -61.11 -4.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 288' ' ' PRO . 31.9 p -46.95 -9.25 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.89 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 289' ' ' PHE . 4.5 p-80 -153.96 84.6 1.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.325 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 291' ' ' HIS . 0.1 OUTLIER -172.68 152.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -106.14 -45.61 4.28 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 32.1 mt 77.39 113.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 122.069 0.938 . . . . 0.0 111.451 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.78 -174.54 4.81 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.265 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.423 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 67.1 t0 -106.64 58.79 0.64 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 53.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.564 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 98.3 m-85 . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.564 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.5 m 82.74 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 125.109 1.506 . . . . 0.0 111.156 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -135.63 144.69 46.22 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.838 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.568 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -100.32 96.57 7.53 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.599 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -96.99 37.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.914 0.388 . . . . 0.0 111.467 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.542 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 49.5 m-85 -137.35 1.98 2.46 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.684 0.278 . . . . 0.0 110.793 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.474 ' OD2' ' NZ ' ' A' ' 269' ' ' LYS . 0.5 OUTLIER 60.21 143.32 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.495 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.515 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 5.4 t80 -133.62 -34.92 1.01 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.545 0.611 . . . . 0.0 110.951 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 144' ' ' PHE . 7.6 p30 34.42 59.89 0.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.645 0.591 . . . . 0.0 110.663 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -66.73 -139.8 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.54 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 165.04 94.14 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.667 -0.766 . . . . 0.0 110.844 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 4.6 m-20 158.63 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.112 0.482 . . . . 0.0 110.2 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.17 -17.35 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.361 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -100.44 18.23 19.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.453 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.3 p30 -142.41 156.75 45.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.483 ' CD1' ' OD2' ' A' ' 175' ' ' ASP . 9.8 tp -121.63 85.83 44.27 Favored Pre-proline 0 C--O 1.212 -0.891 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.401 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 34.0 Cg_exo -58.26 137.27 79.71 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 C-N-CA 121.586 1.524 . . . . 0.0 112.87 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.568 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 7.1 p90 -154.01 170.03 22.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -135.82 -68.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -94.96 92.62 6.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.249 -176.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 17.35 55.42 0.01 OUTLIER Glycine 0 C--N 1.34 0.806 0 O-C-N 123.812 0.695 . . . . 0.0 112.041 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 156' ' ' LYS . 32.9 t0 -63.08 142.82 58.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.508 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.5 mp -87.31 101.87 11.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 31.0 mt -92.14 -127.56 0.1 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.356 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 174' ' ' GLU . 40.9 tttp 173.28 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.678 0.611 . . . . 0.0 110.399 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.3 mp -90.23 145.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.49 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -134.11 -39.8 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.38 104.97 6.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.856 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.463 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 12.9 pttm -113.22 74.94 2.07 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.79 -30.19 22.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.995 1.797 . . . . 0.0 112.227 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.16 158.92 17.82 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.612 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -87.09 -37.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.736 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.42 HE22 ' CD ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -78.94 -29.52 44.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.621 -179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.465 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.4 m95 -117.27 150.95 37.93 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 8.8 m0 -145.91 136.33 24.01 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.8 112.15 16.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.47 166.62 10.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.069 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 161' ' ' LYS . 27.4 tt0 -129.31 145.95 51.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.012 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.483 ' OD2' ' CD1' ' A' ' 152' ' ' LEU . 0.5 OUTLIER -76.58 -178.93 4.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.664 0.745 . . . . 0.0 110.73 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.4 ttt -80.11 -11.45 59.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.0 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -100.94 -25.48 14.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.1 43.67 0.51 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -117.56 126.16 52.09 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.783 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.68 42.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.456 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -150.59 148.52 19.79 Favored Glycine 0 C--N 1.312 -0.793 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.875 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 159.67 20.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.44 0.638 . . . . 0.0 110.656 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 7.8 pt -150.49 142.48 15.61 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.732 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.33 110.76 3.04 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 N-CA-C 109.852 -0.865 . . . . 0.0 109.852 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.511 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 50.3 t -44.6 -51.58 20.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.613 -0.679 . . . . 0.0 112.048 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.8 Cg_endo -47.26 -29.3 9.21 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.146 1.898 . . . . 0.0 112.841 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.545 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.2 m-85 -69.73 -6.33 31.16 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.058 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.53 167.22 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 111.007 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -150.22 61.19 0.97 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt . . . . . 0 C--N 1.315 -0.909 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.035 179.659 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 120.892 0.377 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -34.72 160.27 0.01 OUTLIER Glycine 1 CA--C 1.45 -4.021 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.951 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.482 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 3.1 Cg_exo -73.24 126.08 11.46 Favored 'Cis proline' 0 C--N 1.285 -2.799 0 O-C-N 122.3 0.632 . . . . 0.0 113.071 -5.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.49 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 40.9 m-85 -153.71 -124.62 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.518 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 2.2 m-30 -140.7 113.21 8.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 118.752 0.705 . . . . 0.0 109.71 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 264' ' ' LEU . . . -105.65 144.48 32.34 Favored 'General case' 0 C--O 1.2 -1.515 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -101.1 112.52 25.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.19 0.519 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.454 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 9.5 p -79.05 122.26 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.74 21.51 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.72 104.54 0.02 OUTLIER 'General case' 0 N--CA 1.46 0.064 0 CA-C-O 121.525 0.678 . . . . 0.0 111.154 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.409 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 0.1 OUTLIER -139.99 -140.11 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.743 178.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.409 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 2.1 ptt85 -157.2 -139.61 0.07 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.834 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 80.4 t -135.94 69.36 64.51 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.985 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 45.4 Cg_endo -96.28 -179.72 0.48 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.976 2.45 . . . . 0.0 111.208 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.711 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.8 OUTLIER -141.99 137.2 31.0 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.683 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.43 -5.51 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.303 0.377 . . . . 0.0 111.504 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.711 ' H ' ' C ' ' A' ' 250' ' ' ASN . 51.2 m-85 -93.41 -55.79 3.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.14 71.76 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.998 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.597 ' N ' ' O ' ' A' ' 252' ' ' TYR . 30.9 mtmt 74.91 -5.22 2.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 124.343 1.027 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.507 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 0.3 OUTLIER 87.24 51.88 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.398 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -104.71 113.87 27.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.594 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -49.26 155.21 0.72 Allowed 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.922 -0.486 . . . . 0.0 111.444 -179.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.453 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -106.5 114.51 28.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.633 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.56 -173.94 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.337 0.589 . . . . 0.0 111.328 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.2 tt0 -146.26 152.07 38.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.786 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.96 115.14 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.66 10.33 17.03 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 23.0 mm-40 -107.56 -152.49 0.48 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.595 ' HB2' ' O ' ' A' ' 241' ' ' ALA . 0.2 OUTLIER -171.89 152.31 2.97 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.994 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.45 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 13.3 p -135.8 156.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.459 ' HZ1' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.62 99.29 9.84 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 268' ' ' THR . 10.7 t -65.81 156.85 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.545 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -158.25 -62.42 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.152 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -80.42 141.67 35.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -177.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.437 HD11 ' H ' ' A' ' 270' ' ' ILE . 0.9 OUTLIER -140.59 147.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.288 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.532 ' C ' HD21 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -176.53 -159.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.5 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 47.7 mtm 52.1 -120.66 1.7 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.886 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.8 p -135.48 -10.65 2.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.237 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . 177.69 -46.39 0.1 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.559 -1.781 . . . . 0.0 113.126 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.433 ' N ' ' CD ' ' A' ' 275' ' ' GLN . 24.2 mp0 -65.79 64.39 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 3.1 p-90 -74.66 -171.95 1.4 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.171 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 86.0 mt-10 -108.61 166.9 10.44 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.535 1.147 . . . . 0.0 111.618 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -149.18 -170.81 17.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.896 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.405 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -157.08 127.68 6.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.304 0.574 . . . . 0.0 111.655 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.529 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -138.94 74.28 1.47 Allowed 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.302 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 7.2 m-20 85.74 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.731 0.777 . . . . 0.0 109.33 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.09 -33.73 4.37 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.78 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.03 93.64 0.59 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.405 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 83.9 mtt180 -94.75 168.46 10.81 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.438 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 255' ' ' THR . . . 162.95 137.53 2.21 Favored Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.994 177.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.601 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.7 p80 -65.06 175.31 1.62 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.142 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 0.3 OUTLIER 166.21 144.53 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.408 178.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 39.9 Cg_exo -55.28 137.99 78.43 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.436 2.091 . . . . 0.0 113.331 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 2.0 t80 -73.77 -5.8 43.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.253 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 34.8 p -67.72 2.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 8.5 p80 -136.32 47.51 2.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.417 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.3 151.37 13.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -111.01 -53.8 2.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 2.0 mt 91.27 119.73 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.324 1.059 . . . . 0.0 111.346 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 297' ' ' GLN . 8.7 mp -70.46 -170.59 0.4 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 296' ' ' ASP . 40.8 t0 -66.51 9.4 0.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 295' ' ' LEU . 40.6 tt0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.57 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 1.7 m-85 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.57 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 2.3 m 93.12 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 125.682 1.864 . . . . 0.0 111.59 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -121.35 125.67 47.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.439 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -98.9 95.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.331 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -106.1 35.05 3.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.755 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 47.6 m-85 -134.26 0.85 3.14 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.29 -0.256 . . . . 0.0 111.029 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.89 137.95 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.66 0 O-C-N 124.281 0.988 . . . . 0.0 108.786 -178.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 145' ' ' ASN . 8.6 t80 -121.54 -47.89 2.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.092 0.406 . . . . 0.0 110.399 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 144' ' ' PHE . 65.7 t30 40.97 60.9 1.87 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.213 0.53 . . . . 0.0 109.958 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.17 -155.55 1.41 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.722 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.629 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.2 OUTLIER 169.62 94.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.188 -1.006 . . . . 0.0 110.27 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -159.97 -146.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 111.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' A' ' 150' ' ' GLU . 58.7 p30 -75.86 57.51 1.05 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.581 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 151' ' ' ASP . 92.2 mt-10 98.01 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.402 1.064 . . . . 0.0 111.496 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.629 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 14.1 p-10 -28.91 161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.681 0.613 . . . . 0.0 110.705 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.8 tp -106.72 75.34 0.39 Allowed Pre-proline 0 C--O 1.215 -0.758 0 O-C-N 122.075 -0.391 . . . . 0.0 111.117 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.75 118.72 5.81 Favored 'Trans proline' 0 C--N 1.295 -2.255 0 CA-C-N 119.386 0.816 . . . . 0.0 110.968 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 15.5 p90 -134.25 163.6 29.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.416 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.425 ' CG ' ' H ' ' A' ' 156' ' ' LYS . 1.1 tpmp? -96.13 -135.35 0.23 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 158' ' ' ASP . 50.8 mtmt -96.56 174.94 6.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 159' ' ' ILE . . . 33.11 22.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.873 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.634 ' N ' ' O ' ' A' ' 156' ' ' LYS . 6.3 t0 -72.69 137.46 46.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 117.257 0.528 . . . . 0.0 109.816 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.7 mp -104.06 103.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.7 mt -108.35 107.93 18.7 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.065 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -62.89 140.12 58.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.34 130.95 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.165 0.507 . . . . 0.0 110.409 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -44.07 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -155.1 133.2 11.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.503 ' CG ' ' NE1' ' A' ' 171' ' ' TRP . 2.6 ttmm -106.42 70.55 0.24 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.698 -0.191 . . . . 0.0 110.727 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.25 -54.74 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.165 1.244 . . . . 0.0 111.495 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -100.78 -172.8 2.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.18 -32.88 7.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.57 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 94.2 mt-30 -83.29 -31.32 26.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.473 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 81.2 m95 -119.59 148.03 43.8 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.503 ' NE1' ' CG ' ' A' ' 165' ' ' LYS . 14.1 m0 -141.72 131.33 24.0 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 120.857 0.36 . . . . 0.0 110.104 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -81.12 105.73 12.56 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.25 174.91 5.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.047 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -123.24 130.53 52.87 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.99 165.55 0.94 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.197 0.522 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 49.8 ttp -74.07 -4.48 35.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.047 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.15 -27.85 14.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.25 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.89 48.37 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 108.279 -1.929 . . . . 0.0 108.279 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -128.07 129.0 45.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.929 -0.636 . . . . 0.0 109.678 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 125.79 49.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.344 0.593 . . . . 0.0 111.869 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -165.26 160.66 34.04 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.522 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.415 ' HG3' ' H ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -68.02 160.25 29.13 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.159 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.45 ' CD1' ' C ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -159.66 148.12 13.68 Favored Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.572 177.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.53 122.44 8.61 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.659 1.573 . . . . 0.0 109.253 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 42.7 t -58.68 -52.18 76.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.672 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.5 Cg_endo -50.78 -27.25 19.68 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.794 2.329 . . . . 0.0 114.498 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.482 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.2 m-85 -65.2 7.8 0.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.812 0.339 . . . . 0.0 111.483 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 186' ' ' PRO . 3.1 m -132.69 173.08 15.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 190' ' ' LYS . 1.9 pt-20 -141.64 39.87 1.7 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.973 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 189' ' ' GLU . 13.4 mptt . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 110.57 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.596 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 95.0 m-20 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.68 -163.38 39.21 Favored Glycine 1 CA--C 1.446 -4.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.091 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 3.5 Cg_exo -45.38 100.17 0.03 OUTLIER 'Cis proline' 0 N--CA 1.528 3.519 0 N-CA-C 117.152 1.943 . . . . 0.0 117.152 1.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.634 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 11.2 m-30 -116.26 -128.23 0.29 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.57 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.47 128.64 19.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 119.435 1.016 . . . . 0.0 109.805 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.503 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -106.16 -162.37 0.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.314 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -160.85 95.81 1.09 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.92 128.68 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.711 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.522 ' CD1' ' H ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -123.17 12.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.699 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -169.06 114.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -160.78 -145.66 0.12 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.732 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -155.48 -140.15 0.08 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.531 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 6.4 p -134.47 65.24 67.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 78.6 Cg_endo -91.91 176.47 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.339 2.026 . . . . 0.0 112.075 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.729 ' C ' ' H ' ' A' ' 252' ' ' TYR . 16.9 p30 -149.26 145.21 26.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.712 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.41 -3.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.729 ' H ' ' C ' ' A' ' 250' ' ' ASN . 48.0 m-85 -91.5 -54.09 4.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.481 0.658 . . . . 0.0 110.291 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -46.11 -66.52 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.652 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.557 ' C ' ' H ' ' A' ' 256' ' ' ALA . 27.7 mttt -148.26 33.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.275 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.6 m 70.9 -13.61 0.49 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.07 164.41 0.29 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.261 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 257' ' ' LEU . 0.2 OUTLIER -104.07 149.53 25.12 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 122.794 0.438 . . . . 0.0 110.533 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.508 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -86.81 114.55 23.57 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.9 -177.0 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.447 0.641 . . . . 0.0 111.007 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.3 tt0 -145.83 147.48 31.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.55 102.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.96 6.11 10.34 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 65.7 mm-40 -88.32 -125.25 0.05 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 161.23 140.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.566 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.7 p -130.89 140.66 48.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.175 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -99.3 86.01 3.31 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.992 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 41.3 t -53.4 152.58 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.669 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.482 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -154.37 -53.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.62 127.89 33.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -137.37 127.49 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.997 0.903 . . . . 0.0 111.913 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.627 ' C ' HD21 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -154.66 -167.96 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.549 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.498 ' CE ' HD22 ' A' ' 271' ' ' ASN . 44.7 mtm 65.41 -123.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.89 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.3 p -140.37 -5.76 1.22 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.028 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 276' ' ' TRP . . . -175.57 -52.13 0.06 OUTLIER Glycine 0 C--O 1.213 -1.203 0 C-N-CA 118.138 -1.982 . . . . 0.0 112.737 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.476 ' O ' ' HE1' ' A' ' 272' ' ' MET . 23.2 tp60 -61.34 63.9 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.59 ' N ' ' O ' ' A' ' 274' ' ' GLY . 6.4 m95 -67.41 177.93 1.74 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.518 -0.739 . . . . 0.0 111.097 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 59.1 mt-10 -130.26 156.39 44.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -133.36 -142.28 4.74 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.964 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.416 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.1 tt0 -169.35 134.32 1.48 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.925 -0.638 . . . . 0.0 112.559 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.3 OUTLIER -146.61 72.24 1.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.157 -178.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 18.2 t-20 83.27 31.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.361 0.6 . . . . 0.0 110.04 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.68 -33.43 5.71 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.134 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 13.2 ptpt -67.87 75.44 0.2 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.033 0.444 . . . . 0.0 110.991 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.542 ' NH1' ' CZ ' ' A' ' 142' ' ' PHE . 93.4 mtt180 -73.01 170.49 14.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.98 -155.13 26.04 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.3 p80 -136.36 176.51 8.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.129 0.572 . . . . 0.0 109.738 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.54 ' HB3' ' HE2' ' A' ' 291' ' ' HIS . 0.3 OUTLIER 171.27 125.09 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.223 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.86 147.94 2.98 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.666 1.578 . . . . 0.0 113.559 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.59 ' C ' ' H ' ' A' ' 291' ' ' HIS . 1.6 t80 -73.75 -5.13 38.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.1 p -60.05 5.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.266 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.59 ' H ' ' C ' ' A' ' 289' ' ' PHE . 7.4 p-80 -157.33 72.93 0.71 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 291' ' ' HIS . 0.5 OUTLIER -165.9 148.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -126.36 74.38 1.45 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.799 0.333 . . . . 0.0 110.746 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 41.9 mt -40.68 127.06 2.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 112.004 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 4.9 mp -77.31 -174.52 3.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.277 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -96.71 25.7 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.074 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.634 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 56.2 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.71 172.47 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -126.78 127.9 45.76 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.441 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -96.89 93.05 6.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.672 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.4 36.1 1.82 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.284 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.637 ' CZ ' ' NH2' ' A' ' 284' ' ' ARG . 52.0 m-85 -136.31 2.31 2.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 122.39 -0.194 . . . . 0.0 110.933 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.3 p30 56.87 141.63 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 O-C-N 124.471 1.107 . . . . 0.0 109.596 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 10.5 t80 -134.41 -44.22 0.76 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.243 0.474 . . . . 0.0 110.165 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 144' ' ' PHE . 5.1 p-10 33.85 62.25 0.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.846 0.716 . . . . 0.0 110.619 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.82 -135.82 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.689 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.1 OUTLIER 168.03 90.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.612 -0.294 . . . . 0.0 111.049 178.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.5 m-20 168.4 -170.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 150' ' ' GLU . 40.3 p-10 -93.53 -23.24 18.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.463 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 19.0 pt-20 -103.6 23.11 13.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.109 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.689 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 4.0 p-10 -131.58 148.37 52.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.2 tp -116.17 86.29 16.98 Favored Pre-proline 0 C--O 1.217 -0.649 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -65.12 140.04 63.49 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.317 1.345 . . . . 0.0 112.825 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.478 ' CZ ' ' CB ' ' A' ' 144' ' ' PHE . 10.6 p90 -158.0 160.21 37.23 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.63 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -63.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.553 0.692 . . . . 0.0 111.748 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 158' ' ' ASP . 2.5 ptmt -85.06 92.61 8.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.76 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 13.87 53.59 0.01 OUTLIER Glycine 0 N--CA 1.473 1.154 0 O-C-N 124.054 0.846 . . . . 0.0 112.287 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 156' ' ' LYS . 9.6 t70 -64.47 143.01 58.22 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.445 0.641 . . . . 0.0 109.583 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 mm -88.5 107.8 18.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.183 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 mt -116.02 117.55 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.643 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 88.1 tttt -75.49 147.18 40.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.101 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.5 mp -74.22 -59.01 3.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 70.57 -50.45 0.66 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.467 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -146.9 120.32 9.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.243 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.478 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 0.0 OUTLIER -120.48 85.17 37.18 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.398 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.89 -29.55 18.3 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.629 1.553 . . . . 0.0 112.281 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.417 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 94.8 mt-10 -119.98 160.67 22.31 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.002 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.65 -43.69 15.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.741 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.516 ' OE1' ' CD1' ' A' ' 239' ' ' PHE . 93.8 mt-30 -74.68 -29.88 61.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.478 ' NE1' ' CE2' ' A' ' 239' ' ' PHE . 77.2 m95 -119.33 151.24 38.8 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.478 ' CD1' ' CB ' ' A' ' 165' ' ' LYS . 12.4 m0 -143.35 131.1 21.4 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.096 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 162' ' ' ILE . 51.2 t30 -81.39 116.98 21.47 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 161' ' ' LYS . . . -127.13 176.87 7.05 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.242 0.339 . . . . 0.0 110.453 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.19 133.94 54.72 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.258 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.37 170.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.491 0.662 . . . . 0.0 110.916 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.5 ttt -78.51 0.41 26.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.666 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -104.4 -28.59 11.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.83 48.19 0.42 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -129.25 130.93 46.86 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.128 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.88 121.83 41.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.59 0.71 . . . . 0.0 111.874 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.86 154.41 25.49 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.765 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 152' ' ' LEU . 1.9 ttt -74.5 163.61 27.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.542 0.686 . . . . 0.0 111.084 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.431 ' H ' ' HG2' ' A' ' 182' ' ' MET . 0.0 OUTLIER -157.21 145.31 14.21 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.669 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.03 112.92 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.529 1.486 . . . . 0.0 109.441 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.528 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 49.7 t -47.63 -51.37 45.55 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.954 -0.466 . . . . 0.0 112.045 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.3 Cg_endo -47.42 -30.61 11.86 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.305 2.003 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.497 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.4 m-85 -68.21 -3.76 11.75 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.935 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.74 160.95 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.792 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -116.95 -64.31 1.33 Allowed 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.436 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 4.5 tptp . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.173 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.545 ' O ' ' NE2' ' A' ' 297' ' ' GLN . 8.1 m120 . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.5 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -72.38 -177.09 29.78 Favored Glycine 0 CA--C 1.45 -3.997 0 CA-C-O 122.554 1.085 . . . . 0.0 114.619 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.5 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.0 Cg_exo -53.7 127.91 1.32 Allowed 'Cis proline' 0 N--CA 1.528 3.502 0 N-CA-C 115.462 1.293 . . . . 0.0 115.462 -3.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.516 ' CD1' ' OE1' ' A' ' 169' ' ' GLN . 3.2 m-85 -153.86 -117.68 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.3 m-30 -141.74 123.23 14.98 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 119.141 0.882 . . . . 0.0 109.831 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.703 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -113.34 150.47 32.53 Favored 'General case' 0 C--O 1.198 -1.65 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -113.23 103.25 11.15 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.733 -0.604 . . . . 0.0 109.422 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 8.3 p -74.35 121.47 25.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.505 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.17 23.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.425 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 177.42 116.96 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.431 0.634 . . . . 0.0 109.844 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.622 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 1.4 ttmt -156.66 -158.8 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.935 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.77 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 28.7 ptt85 -153.94 144.88 22.69 Favored 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.76 91.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.637 0 O-C-N 124.041 0.838 . . . . 0.0 110.829 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.77 ' HD3' ' O ' ' A' ' 247' ' ' ARG . 70.0 Cg_endo -108.14 171.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 123.782 2.988 . . . . 0.0 113.827 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 253' ' ' ASP . 4.3 p-10 -93.04 -169.35 2.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.261 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.62 16.19 22.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 254' ' ' LYS . 5.7 m-85 -125.72 -21.62 4.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.227 0.537 . . . . 0.0 110.159 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.612 ' H ' ' ND2' ' A' ' 250' ' ' ASN . 31.5 t70 -71.78 45.05 0.11 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.928 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 255' ' ' THR . 38.7 mtmt 106.03 -10.78 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 124.717 1.261 . . . . 0.0 110.81 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.537 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 7.6 m 105.92 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.4 1.062 . . . . 0.0 110.651 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -40.21 153.2 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 O-C-N 123.262 0.351 . . . . 0.0 111.62 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.719 ' CD2' ' O ' ' A' ' 285' ' ' GLY . 0.6 OUTLIER -107.33 151.51 25.39 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.774 0.43 . . . . 0.0 110.619 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.402 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -94.78 114.54 26.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 2.1 mt -139.4 -170.92 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.355 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -146.14 149.18 33.51 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.501 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.62 106.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.09 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.97 8.68 10.44 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -94.54 -133.71 0.18 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 170.98 139.77 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.583 ' N ' HD11 ' A' ' 264' ' ' LEU . 14.7 p -127.21 143.73 39.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.449 ' HZ1' ' CB ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -97.43 92.24 5.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 11.8 t -61.93 152.09 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.733 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.497 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -151.8 -58.61 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.671 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 116.89 10.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.413 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.471 ' H ' ' CD1' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -126.95 162.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.099 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.701 HD21 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER 177.59 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.556 0.693 . . . . 0.0 110.638 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.701 ' N ' HD21 ' A' ' 271' ' ' ASN . 25.5 mtm -35.95 125.87 0.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.195 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -62.95 6.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.911 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -132.94 -50.48 0.09 OUTLIER Glycine 0 N--CA 1.467 0.729 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.579 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.6 mp0 -94.91 160.9 14.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.579 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 4.3 m95 -162.85 158.17 22.27 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.471 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -120.64 128.48 53.05 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 123.24 0.338 . . . . 0.0 111.454 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.66 -157.16 31.16 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.297 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.35 127.2 0.81 Allowed 'General case' 0 C--N 1.346 0.429 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -138.83 78.09 1.66 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.692 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.6 t-20 83.35 27.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.587 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.69 -26.73 21.99 Favored Glycine 0 N--CA 1.462 0.386 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.968 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.1 OUTLIER -73.13 73.33 1.22 Allowed 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.769 -178.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.637 ' NH2' ' CZ ' ' A' ' 142' ' ' PHE . 64.2 mtt85 -73.01 169.44 16.96 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.719 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 165.18 122.12 0.59 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 122.659 1.144 . . . . 0.0 113.065 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.627 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.4 p80 -59.4 177.08 0.2 Allowed 'General case' 0 C--N 1.284 -2.247 0 O-C-N 119.194 -2.357 . . . . 0.0 109.555 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 166.03 149.06 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 123.968 0.792 . . . . 0.0 111.428 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 32.4 Cg_exo -55.65 135.81 71.17 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.508 2.138 . . . . 0.0 113.945 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 66.6 t80 -75.16 -1.5 23.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.795 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 20.4 p -76.83 3.22 12.42 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 9.1 p80 -133.63 44.29 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.134 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.36 146.14 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -125.71 77.45 1.66 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.124 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 38.2 mt -39.67 127.08 1.97 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.81 0.814 . . . . 0.0 111.375 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.4 mp -67.75 -166.76 0.06 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.962 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -70.96 8.36 0.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 236' ' ' ASN . 47.7 tt0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.149 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 138' ' ' VAL . 21.0 m-85 . . . . . 0 C--O 1.213 -0.824 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER 78.59 157.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.565 1.165 . . . . 0.0 110.828 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -141.39 159.81 41.45 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.821 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 154' ' ' PHE . . . -59.74 172.72 0.67 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.342 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.0 mt -143.08 -58.21 0.42 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.524 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -113.33 9.78 18.31 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.33 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.524 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 78.27 137.45 0.06 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.454 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 3.6 t80 -111.22 -46.11 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.335 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.658 HD22 ' NZ ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER 47.56 63.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.75 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -63.69 -124.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.76 HD21 ' H ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER 166.8 -49.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.188 0.494 . . . . 0.0 111.863 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.76 ' H ' HD21 ' A' ' 147' ' ' ASN . 7.9 m-20 -72.32 162.96 28.75 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 27.8 p-10 -69.56 -22.72 63.52 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.806 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -87.83 24.32 1.79 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.613 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 32.2 p30 -141.48 165.59 27.08 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 8.8 tp -120.45 88.86 43.26 Favored Pre-proline 0 C--O 1.217 -0.646 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.685 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.407 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 65.6 Cg_endo -69.57 140.58 43.73 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.346 1.364 . . . . 0.0 113.068 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.449 ' CZ ' ' CB ' ' A' ' 144' ' ' PHE . 17.5 p90 -158.31 166.22 32.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.658 ' NZ ' HD22 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -139.1 148.12 42.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.42 -133.83 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.338 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -121.31 49.73 0.87 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.18 140.39 58.45 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.7 mp -84.86 100.58 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.933 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.6 mt -109.56 125.59 52.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.87 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -81.3 138.24 35.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.636 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.3 mp -72.1 -57.44 7.28 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.669 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 162' ' ' ILE . 60.9 ttt180 77.59 -46.26 0.46 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.33 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.495 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -110.4 -134.64 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.868 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 164' ' ' ASP . 8.2 pttp 149.21 60.19 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.431 0.693 . . . . 0.0 109.701 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.14 -59.37 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.64 2.227 . . . . 0.0 112.429 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.0 mt-10 -117.3 174.48 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 1.1 pm0 -83.93 -44.58 14.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.678 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.466 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 83.1 mt-30 -75.19 -27.84 59.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 62.9 m95 -119.3 154.13 33.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 9.8 m0 -149.81 142.88 24.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.611 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.636 ' O ' ' O ' ' A' ' 162' ' ' ILE . 2.9 t30 -90.13 121.19 31.96 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -124.13 172.77 8.76 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.67 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -121.58 132.2 54.55 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.82 171.57 1.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.473 0.654 . . . . 0.0 110.85 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 tpt -77.12 -3.02 37.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.813 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.32 -27.89 12.19 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.87 48.12 0.42 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -129.66 134.29 47.59 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.448 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.56 123.52 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.531 0.681 . . . . 0.0 111.577 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -153.61 149.55 21.05 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.934 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 mtp -66.95 155.98 37.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.374 0.607 . . . . 0.0 111.002 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 11.5 pt -147.63 142.99 17.3 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.211 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.3 111.66 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.223 1.282 . . . . 0.0 109.71 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.578 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 58.5 t -46.77 -51.69 36.61 Favored Pre-proline 0 CA--C 1.535 0.38 0 O-C-N 122.212 -0.305 . . . . 0.0 111.337 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.1 Cg_endo -47.26 -30.07 10.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.26 1.974 . . . . 0.0 113.047 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 268' ' ' THR . 15.9 m-85 -77.5 -7.86 56.9 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.5 m -132.94 160.43 42.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.554 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -136.71 156.53 48.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.042 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.577 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.434 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 84.9 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.906 0.384 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.508 ' HA2' ' N ' ' A' ' 239' ' ' PHE . . . -75.16 -176.44 38.32 Favored Glycine 0 CA--C 1.457 -3.552 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.406 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.3 Cg_endo -57.3 100.72 0.06 OUTLIER 'Cis proline' 0 N--CA 1.525 3.374 0 N-CA-C 115.366 1.256 . . . . 0.0 115.366 -0.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.539 ' CG ' ' OE1' ' A' ' 297' ' ' GLN . 2.4 m-85 -115.9 -131.43 0.32 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.474 ' H ' ' HB3' ' A' ' 239' ' ' PHE . 0.5 OUTLIER -144.95 132.13 20.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 118.873 0.76 . . . . 0.0 109.183 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.808 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -119.49 153.78 34.8 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.005 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -114.14 95.63 5.39 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.7 130.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.231 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.88 20.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.584 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 179.58 109.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.966 0.413 . . . . 0.0 110.314 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 287' ' ' PHE . 5.4 ttmt -162.01 -151.13 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.773 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.684 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -157.5 -137.23 0.05 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.522 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.58 61.94 39.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 250' ' ' ASN . 43.0 Cg_endo -92.81 51.47 0.46 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.598 2.199 . . . . 0.0 113.474 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.718 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.2 OUTLIER -25.09 146.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.052 0.845 . . . . 0.0 111.291 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.96 -7.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.191 0.52 . . . . 0.0 111.668 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 250' ' ' ASN . 37.5 m-85 -83.02 -62.63 1.54 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 252' ' ' TYR . 35.4 t0 -33.46 -51.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.972 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.684 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 5.4 pttt -171.51 44.22 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.13 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m 63.34 -14.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.299 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.684 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -62.42 127.12 29.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.962 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.685 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -52.36 159.28 1.01 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.092 0.472 . . . . 0.0 111.322 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.505 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -108.18 121.95 45.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.33 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.459 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.4 mt -142.7 -175.29 4.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.051 0.453 . . . . 0.0 111.203 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -144.02 151.26 39.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.236 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.94 112.14 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.676 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 5.38 20.07 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -93.65 -128.68 0.12 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.808 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 168.72 138.6 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.704 0.764 . . . . 0.0 109.612 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.63 ' N ' HD11 ' A' ' 264' ' ' LEU . 9.6 p -137.75 151.6 26.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.422 ' N ' HG21 ' A' ' 265' ' ' VAL . 4.7 ttmt -79.61 -161.32 0.32 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.277 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 269' ' ' LYS . 1.7 t -140.78 -53.43 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.453 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER 46.08 -71.67 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.3 OUTLIER -81.28 117.65 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.255 -177.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.583 ' H ' ' CD1' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -132.5 161.6 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.168 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.563 HD21 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -164.39 -108.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.162 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.563 ' N ' HD21 ' A' ' 271' ' ' ASN . 46.9 mtm -39.38 153.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.685 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.8 p -75.77 18.68 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.388 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -142.71 -75.71 0.03 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.491 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 1.9 mp0 -78.02 176.53 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.72 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.54 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 9.5 p-90 170.08 -169.57 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.532 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 269' ' ' LYS . 71.7 mt-10 -128.94 165.36 21.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.808 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -145.57 -152.77 5.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.094 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.07 125.64 0.55 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.906 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.459 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 -93.11 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -103.3 50.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.64 -31.19 5.96 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.415 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -64.8 83.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.398 -179.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -79.39 166.17 22.33 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.969 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.431 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.46 -157.59 29.83 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.444 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 10.3 p-80 -125.4 175.33 7.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 123.847 0.381 . . . . 0.0 110.916 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.54 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 164.84 112.49 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 290' ' ' THR . 51.8 Cg_exo -50.34 143.27 27.18 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.798 1.665 . . . . 0.0 112.496 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.584 ' O ' ' CD2' ' A' ' 289' ' ' PHE . 52.9 t80 -66.09 -0.84 2.65 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 288' ' ' PRO . 68.2 p -53.65 0.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.527 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.6 p80 -160.74 74.39 0.51 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.565 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.05 154.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.551 ' O ' ' HG ' ' A' ' 294' ' ' LEU . 58.0 mtp180 -101.44 -110.13 0.22 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 293' ' ' ARG . 9.4 mt 150.8 120.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.271 0.982 . . . . 0.0 110.751 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.02 -174.63 3.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.972 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.42 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 66.1 t0 -111.21 40.81 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.516 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.539 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 10.7 tp60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.757 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.55 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 74.2 m-85 . . . . . 0 C--O 1.212 -0.874 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.3 m 83.03 161.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 124.852 1.345 . . . . 0.0 110.841 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.677 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 2.6 ptp180 -132.48 151.88 51.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.536 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -101.99 92.99 5.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.086 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.09 22.97 8.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.598 ' O ' ' O ' ' A' ' 143' ' ' ASP . 57.9 m-85 -123.47 6.84 8.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.0 p30 51.86 137.04 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.276 0 O-C-N 124.59 1.181 . . . . 0.0 110.808 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.491 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 6.6 t80 -124.59 -43.23 2.04 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.225 0.466 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 144' ' ' PHE . 53.9 t-20 39.31 62.18 1.19 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.454 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.34 -146.11 0.21 Allowed Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.601 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.1 p30 171.22 91.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.063 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.4 m-20 171.57 -173.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.373 . . . . 0.0 110.212 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -93.63 -21.55 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.652 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.79 26.29 10.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.974 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 8.9 p-10 -134.17 152.37 51.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 9.5 tp -116.94 85.21 17.27 Favored Pre-proline 0 C--O 1.21 -1.01 0 CA-C-N 117.586 0.175 . . . . 0.0 110.564 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.402 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 27.3 Cg_exo -59.73 139.37 88.29 Favored 'Trans proline' 0 C--N 1.288 -2.627 0 C-N-CA 121.49 1.46 . . . . 0.0 112.864 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 9.1 p90 -159.02 158.29 32.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.258 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 156' ' ' LYS . 1.6 ttmp? -176.62 112.6 0.1 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 147.06 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.384 1.052 . . . . 0.0 110.565 178.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.09 44.75 0.91 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -79.71 153.59 29.17 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.398 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.457 ' O ' ' SD ' ' A' ' 176' ' ' MET . 3.7 tp -98.67 119.27 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 137' ' ' TYR . 10.6 mt -118.7 133.65 55.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.19 139.78 34.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.74 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.6 mp -64.46 -48.74 83.83 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.865 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.574 ' NE ' ' OD1' ' A' ' 164' ' ' ASP . 0.2 OUTLIER 69.96 -53.26 0.63 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.893 -0.504 . . . . 0.0 111.617 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.574 ' OD1' ' NE ' ' A' ' 163' ' ' ARG . 0.5 OUTLIER -116.9 -126.39 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 164' ' ' ASP . 1.3 pttm 141.55 60.89 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.72 1.208 . . . . 0.0 109.575 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.403 ' HD3' ' H ' ' A' ' 165' ' ' LYS . 47.3 Cg_endo -67.19 -46.61 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.924 1.749 . . . . 0.0 112.432 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -118.46 167.5 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -85.14 -35.08 21.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.529 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 1.8 mt-30 -84.16 -25.24 29.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.593 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.6 m95 -122.23 150.31 42.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.4 ' O ' HG13 ' A' ' 183' ' ' ILE . 11.4 m0 -141.57 129.92 22.4 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.934 0.873 . . . . 0.0 110.696 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.74 ' O ' ' O ' ' A' ' 162' ' ' ILE . 5.5 t30 -81.86 107.95 15.0 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.6 174.17 6.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.5 0.5 . . . . 0.0 110.627 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 33.1 tt0 -123.03 133.32 54.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.4 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.44 169.23 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.505 0.669 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 159' ' ' ILE . 97.4 mmm -76.64 0.67 19.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.81 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.559 ' CB ' ' HZ1' ' A' ' 179' ' ' LYS . 93.9 m-20 -104.95 -28.38 11.12 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.52 49.64 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.559 ' HZ1' ' CB ' ' A' ' 177' ' ' ASP . 18.6 mttp -130.19 135.72 48.47 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 114.241 -0.979 . . . . 0.0 110.757 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.77 125.15 52.4 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.523 0.678 . . . . 0.0 111.776 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.13 154.9 25.95 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.444 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 tpt -66.01 154.57 39.12 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 171' ' ' TRP . 1.3 pp -145.02 143.3 20.16 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.35 114.62 4.09 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 N-CA-C 108.694 -1.31 . . . . 0.0 108.694 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.516 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 41.6 t -49.92 -52.0 56.09 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.949 -0.47 . . . . 0.0 111.979 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.2 Cg_endo -49.8 -28.63 18.3 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.052 1.835 . . . . 0.0 113.773 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.445 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.8 m-85 -67.78 3.66 1.39 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 186' ' ' PRO . 17.0 m -128.11 167.61 22.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 123.263 0.352 . . . . 0.0 110.297 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.677 ' CD ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -68.39 -48.66 64.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.33 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 124.227 1.011 . . . . 0.0 111.513 -178.084 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.199 0.523 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -60.15 -177.63 1.59 Allowed Glycine 1 CA--C 1.433 -5.054 0 CA-C-O 122.446 1.026 . . . . 0.0 114.41 -179.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.48 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.7 Cg_endo -57.21 125.2 1.38 Allowed 'Cis proline' 0 N--CA 1.533 3.841 0 N-CA-C 115.608 1.349 . . . . 0.0 115.608 -2.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.597 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 12.7 m-85 -150.79 -121.37 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.602 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.529 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 1.0 OUTLIER -143.06 123.83 14.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.721 0.772 . . . . 0.0 110.484 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 264' ' ' LEU . . . -107.05 -159.24 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.032 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -162.41 87.41 0.62 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.0 p -57.94 123.61 10.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.006 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 15.73 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.726 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -175.94 112.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.294 0.569 . . . . 0.0 110.237 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.424 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.6 ttmt -158.72 -146.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.182 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.424 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 4.3 ptt85 -155.85 -142.53 0.11 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.829 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 82.0 t -132.69 66.95 77.7 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.521 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 84.0 Cg_endo -90.56 172.64 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.609 2.206 . . . . 0.0 111.231 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.75 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -145.86 142.61 28.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.29 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.46 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.75 ' H ' ' C ' ' A' ' 250' ' ' ASN . 60.9 m-85 -93.57 -54.51 3.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 110.791 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -44.67 -67.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.564 ' C ' ' H ' ' A' ' 256' ' ' ALA . 26.7 mttt -148.58 32.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.521 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 m 72.28 -15.21 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.608 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.34 156.43 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.68 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.508 HD22 ' H ' ' A' ' 257' ' ' LEU . 0.2 OUTLIER -97.17 148.0 23.51 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.961 0.504 . . . . 0.0 110.359 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -86.98 115.21 24.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 2.5 mt -139.77 -176.06 4.44 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.435 0.636 . . . . 0.0 111.126 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -146.28 147.87 31.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.702 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.59 106.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.289 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 118.03 3.96 14.94 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.1 mm-40 -87.19 -122.22 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.745 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 241' ' ' ALA . 0.4 OUTLIER 161.15 138.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.489 0.661 . . . . 0.0 109.477 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.543 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 13.5 p -130.84 140.8 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.968 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.464 ' CB ' ' HZ3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.78 88.31 3.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.925 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.79 151.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.265 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.445 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -158.75 -51.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.465 0.65 . . . . 0.0 110.227 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -74.85 116.53 15.68 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.27 104.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.76 HD21 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -87.52 -25.86 23.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 178.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.76 ' H ' HD21 ' A' ' 271' ' ' ASN . 5.4 mtm -145.96 176.88 9.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.434 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -91.58 16.11 11.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -134.39 -96.06 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.244 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 63.69 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.769 0.795 . . . . 0.0 110.763 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.532 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -69.59 178.71 2.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 1.3 mt-10 -109.12 -163.19 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.067 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -159.23 -160.33 10.33 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.753 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.409 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.5 tt0 -169.42 130.26 1.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.157 0.503 . . . . 0.0 111.683 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -147.55 75.42 1.36 Allowed 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.354 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 33.9 t30 83.81 31.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.249 0.547 . . . . 0.0 110.318 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 95.63 -31.41 7.21 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.336 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.57 76.54 0.42 Allowed 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.502 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 94.6 mtt180 -76.57 171.8 14.05 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.135 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.87 -156.68 27.68 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.543 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 6.3 p80 -124.32 169.81 11.42 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 122.889 0.476 . . . . 0.0 109.737 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 164.92 114.39 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.26 178.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 290' ' ' THR . 53.1 Cg_exo -53.05 140.98 58.87 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.626 1.551 . . . . 0.0 112.099 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.515 ' O ' ' CG ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -67.27 0.01 3.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.031 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 288' ' ' PRO . 46.2 p -55.15 1.75 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.044 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.508 ' H ' ' C ' ' A' ' 289' ' ' PHE . 5.8 p80 -151.7 65.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.901 -0.499 . . . . 0.0 110.789 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 12.2 m -156.42 153.37 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -101.53 -55.82 2.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.2 mt 86.76 119.14 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.075 0.941 . . . . 0.0 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.68 -178.41 2.66 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.689 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -87.41 47.86 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.536 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 51.7 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.456 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.698 ' O ' ' O ' ' A' ' 138' ' ' VAL . 57.6 m-85 . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.698 ' O ' ' O ' ' A' ' 137' ' ' TYR . 27.3 m 34.93 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.012 0.82 . . . . 0.0 111.528 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 36.4 ttt180 -144.49 128.82 17.85 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.996 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -98.83 84.9 3.18 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 123.524 0.515 . . . . 0.0 111.58 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.538 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -95.19 32.57 1.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.224 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 143' ' ' ASP . 45.9 m-85 -134.3 3.46 3.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 142' ' ' PHE . 3.9 p30 51.86 139.48 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 O-C-N 124.919 1.387 . . . . 0.0 110.431 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 t80 -129.31 -49.33 1.19 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 38.97 61.76 1.2 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.94 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.464 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -69.34 -149.9 0.36 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 164.99 103.26 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.428 -0.886 . . . . 0.0 109.873 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.594 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 20.4 m-20 173.01 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.442 1.089 . . . . 0.0 112.8 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 62.92 -45.03 0.2 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.904 0.752 . . . . 0.0 109.686 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 148' ' ' ASP . 96.4 mt-10 -85.89 29.41 0.72 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.505 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.575 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.5 p30 -143.52 163.95 31.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.653 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 11.4 tp -118.48 91.41 41.41 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.464 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 65.5 Cg_endo -71.91 124.57 10.24 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 121.489 1.46 . . . . 0.0 112.906 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.453 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 14.6 p90 -144.49 163.47 33.73 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.924 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 143' ' ' ASP . 0.7 OUTLIER -142.21 150.85 41.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.103 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.996 ' O ' ' O ' ' A' ' 140' ' ' ALA . 11.8 mtpt 73.12 -142.19 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.24 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -107.43 48.52 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 42.9 t0 -56.73 153.58 10.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.026 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.467 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.5 mp -102.02 106.08 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.5 mt -112.52 110.57 20.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.953 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -70.03 150.6 46.46 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.4 mp -94.38 133.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.099 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.561 ' NH2' ' ND2' ' A' ' 172' ' ' ASN . 7.8 tmm_? -107.53 -42.79 4.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.063 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -153.73 128.52 9.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 32.9 pttt -123.88 75.62 57.28 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.6 -40.44 73.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 111.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -106.21 -165.07 1.06 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -118.81 -19.94 8.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.924 0.393 . . . . 0.0 110.386 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -88.35 -33.36 17.99 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.7 m95 -118.64 151.28 38.24 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.484 ' CD1' ' CB ' ' A' ' 165' ' ' LYS . 14.9 m0 -141.02 129.67 22.78 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.091 0.948 . . . . 0.0 111.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.561 ' ND2' ' NH2' ' A' ' 163' ' ' ARG . 54.7 t30 -79.45 114.51 18.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.94 173.69 8.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.643 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.39 135.89 54.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 175.02 1.26 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.504 0.669 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.06 -4.18 48.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.794 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -101.34 -28.05 12.83 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.95 49.68 0.37 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -130.62 134.81 47.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.629 -0.786 . . . . 0.0 110.697 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.54 127.29 52.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.442 0.639 . . . . 0.0 111.733 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.53 155.08 26.16 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.268 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.48 157.83 33.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.814 0.34 . . . . 0.0 110.337 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.2 pp -144.14 142.6 20.26 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.92 113.56 3.82 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 13.6 t -46.93 -53.65 25.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 121.519 -0.738 . . . . 0.0 112.209 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 8.2 Cg_endo -48.64 -28.04 11.75 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 121.913 1.742 . . . . 0.0 113.234 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.46 ' OH ' ' O ' ' A' ' 268' ' ' THR . 8.1 m-85 -71.17 -0.77 10.5 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.299 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 185' ' ' VAL . 1.9 m -135.82 162.03 37.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.477 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -115.39 -60.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.566 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.493 ' CG ' ' H ' ' A' ' 237' ' ' GLY . 4.4 p30 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.031 0.443 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.53 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -48.49 -175.2 0.01 OUTLIER Glycine 1 CA--C 1.435 -4.944 0 CA-C-O 122.457 1.032 . . . . 0.0 113.266 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.53 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 1.6 Cg_endo -53.07 117.08 0.25 Allowed 'Cis proline' 0 N--CA 1.53 3.671 0 O-C-N 123.635 1.334 . . . . 0.0 115.313 0.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 13.2 m-85 -147.03 -118.37 0.07 Allowed 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.753 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.1 m-30 -143.46 122.68 12.98 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.902 0.858 . . . . 0.0 110.699 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.576 ' N ' HD12 ' A' ' 264' ' ' LEU . . . -106.18 -161.77 0.82 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.294 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -160.92 89.5 0.8 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.35 129.31 25.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.599 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.9 15.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.772 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -173.94 113.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.373 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.452 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.2 ttmt -158.92 -146.7 0.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.452 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.8 ptt85 -156.48 -143.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.821 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.5 69.99 76.65 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.521 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 58.2 Cg_endo -90.63 167.97 4.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.221 2.614 . . . . 0.0 112.971 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.496 ' OD1' ' CB ' ' A' ' 253' ' ' ASP . 46.0 p-10 -97.04 -166.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.275 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.45 11.69 28.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.243 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.552 ' C ' ' H ' ' A' ' 254' ' ' LYS . 6.4 m-85 -123.73 -21.98 5.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.496 ' CB ' ' OD1' ' A' ' 250' ' ' ASN . 35.9 t70 -68.3 43.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 252' ' ' TYR . 38.9 mtmt 96.96 0.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.776 0.831 . . . . 0.0 110.898 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 286' ' ' HIS . 0.2 OUTLIER 84.59 61.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.037 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -115.77 107.32 14.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 111.324 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.614 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.6 155.76 0.76 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.61 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -103.84 121.92 44.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.582 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.422 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.6 mt -142.95 -173.98 4.05 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.256 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -145.91 150.67 36.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.79 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.9 t -57.94 108.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.615 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.68 5.38 18.47 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.3 mm-40 -88.61 -123.77 0.05 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.77 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 241' ' ' ALA . 0.3 OUTLIER 162.31 138.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.562 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 13.1 p -131.39 143.16 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.754 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.428 ' HZ1' ' HD3' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -97.91 84.76 3.38 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.434 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 3.8 t -58.8 150.8 4.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.46 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -149.28 -53.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 144.86 55.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.494 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -151.16 159.33 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.044 0.449 . . . . 0.0 110.569 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.682 HD21 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -176.94 -107.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.387 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.682 ' N ' HD21 ' A' ' 271' ' ' ASN . 31.6 mtm -42.17 140.86 1.03 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.27 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -74.2 16.1 0.27 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.568 ' O ' ' NE2' ' A' ' 275' ' ' GLN . . . -138.58 -60.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.359 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 274' ' ' GLY . 1.4 mp0 -109.0 101.06 10.18 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.652 ' HA ' HD22 ' A' ' 271' ' ' ASN . 3.6 p-90 -111.9 -165.71 1.01 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 120.846 0.355 . . . . 0.0 110.259 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.5 mt-10 -129.3 167.58 17.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.786 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.87 -151.4 5.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.78 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.503 ' OE2' ' O ' ' A' ' 280' ' ' CYS . 2.5 tm-20 -172.3 128.45 0.56 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.503 ' O ' ' OE2' ' A' ' 279' ' ' GLU . 0.0 OUTLIER -108.79 -90.72 0.45 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -106.03 51.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.02 5.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.415 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.32 83.24 0.09 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 114.591 -0.804 . . . . 0.0 110.065 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -78.14 165.7 23.65 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.292 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 169.23 -158.27 30.66 Favored Glycine 0 C--O 1.215 -1.06 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.56 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 21.7 p80 -122.52 170.48 9.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.029 0.443 . . . . 0.0 110.556 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.592 ' HB3' ' HE2' ' A' ' 291' ' ' HIS . 0.7 OUTLIER 163.09 114.46 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.668 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.513 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 50.7 Cg_exo -50.83 141.31 36.15 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.828 1.686 . . . . 0.0 112.798 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -63.6 0.31 0.79 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.598 0.713 . . . . 0.0 110.018 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 288' ' ' PRO . 66.1 p -56.79 2.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.72 -0.612 . . . . 0.0 112.095 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.592 ' HE2' ' HB3' ' A' ' 287' ' ' PHE . 2.2 p-80 -150.15 64.55 0.96 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.463 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.3 151.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 294' ' ' LEU . 43.3 mtm180 -102.34 -54.74 2.62 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 5.0 mt 91.67 121.09 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.023 0.916 . . . . 0.0 111.322 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.15 -178.12 4.88 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.182 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -87.47 48.58 1.67 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.744 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 47.0 tt0 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.46 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' H ' HG12 ' A' ' 162' ' ' ILE . 1.6 t80 . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 m -134.33 164.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 111.177 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -123.33 125.99 46.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.441 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -105.5 109.53 21.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.982 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.569 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -118.96 28.47 8.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.851 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 60.0 m-85 -125.29 0.5 7.74 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.49 -0.131 . . . . 0.0 111.164 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.97 139.8 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.738 0 O-C-N 123.901 0.75 . . . . 0.0 110.288 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.607 ' CE2' ' O ' ' A' ' 145' ' ' ASN . 4.3 t80 -133.88 -45.6 0.79 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 30.0 m-80 74.86 -109.95 0.03 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.717 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.505 ' C ' ' CZ ' ' A' ' 144' ' ' PHE . . . -133.5 -172.71 13.02 Favored Glycine 0 C--N 1.275 -2.828 0 O-C-N 121.606 -0.684 . . . . 0.0 113.633 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.442 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 18.9 t30 174.03 -40.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.966 -1.117 . . . . 0.0 111.911 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 6.4 m-20 -93.03 -159.21 0.66 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 111.785 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.02 -45.09 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.483 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 151' ' ' ASP . 97.3 mt-10 -127.22 28.17 5.78 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.654 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.0 OUTLIER -37.69 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 123.908 0.755 . . . . 0.0 111.786 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.412 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 11.7 tp -127.09 98.88 29.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.922 -0.486 . . . . 0.0 111.888 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 145' ' ' ASN . 52.7 Cg_endo -75.16 133.14 16.0 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.635 1.557 . . . . 0.0 112.884 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 144' ' ' PHE . 21.2 p90 -155.18 173.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.509 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 176.12 132.28 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.811 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 2.7 mmpt? 95.22 79.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.081 0.863 . . . . 0.0 111.403 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 32.38 47.78 0.29 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.878 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.78 137.88 47.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.091 0.472 . . . . 0.0 109.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.3 mm -98.53 95.67 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.614 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mt -109.35 107.96 18.34 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.44 141.2 54.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.889 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.629 ' CG2' ' H ' ' A' ' 163' ' ' ARG . 11.8 mm -64.15 -146.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.847 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.629 ' H ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -176.55 -57.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.132 0.491 . . . . 0.0 110.747 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -136.48 -24.54 1.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.312 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.405 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 16.2 pttp 36.43 77.88 0.37 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.68 -39.05 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.93 1.753 . . . . 0.0 112.23 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.3 mt-10 -105.17 162.26 13.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 14.9 pt-20 -84.64 -41.71 16.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.773 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.419 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 36.6 mt-30 -76.77 -29.66 56.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.34 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 73.6 m95 -120.15 153.7 35.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 167' ' ' GLU . 12.5 m0 -148.22 140.74 24.42 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -83.88 117.78 23.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 171.04 8.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 111.601 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -125.0 133.15 53.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.959 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -61.76 177.19 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.463 0.649 . . . . 0.0 110.734 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 23.6 ttt -80.54 -4.66 54.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.463 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.531 ' CB ' ' HZ3' ' A' ' 179' ' ' LYS . 94.7 m-20 -102.43 -28.12 12.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.34 48.55 0.38 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.531 ' HZ3' ' CB ' ' A' ' 177' ' ' ASP . 9.1 mttp -128.87 130.63 47.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.057 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.45 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.397 0.618 . . . . 0.0 112.048 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.2 152.81 24.12 Favored Glycine 0 C--N 1.315 -0.607 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.076 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 78.7 mmm -66.19 159.59 26.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.528 0.68 . . . . 0.0 110.972 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.412 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 10.1 pt -152.85 145.84 17.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.954 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -71.3 113.71 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.431 1.421 . . . . 0.0 109.583 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.546 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 43.9 t -49.35 -52.7 46.83 Favored Pre-proline 0 CA--C 1.537 0.457 0 O-C-N 121.956 -0.465 . . . . 0.0 111.816 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.1 Cg_endo -49.6 -27.11 13.96 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.482 2.121 . . . . 0.0 113.992 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.503 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.1 m-85 -69.07 10.63 0.27 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.765 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 186' ' ' PRO . 3.1 m -131.96 168.49 23.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.6 39.4 1.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.152 0.501 . . . . 0.0 111.407 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.499 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 237' ' ' GLY . 33.8 p-10 . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.274 0.559 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -52.36 -176.52 0.05 OUTLIER Glycine 1 CA--C 1.447 -4.212 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.761 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.531 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.4 115.62 0.14 OUTLIER 'Cis proline' 0 N--CA 1.529 3.6 0 N-CA-C 116.333 1.628 . . . . 0.0 116.333 -1.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.687 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 8.0 m-85 -149.41 -126.69 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.822 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 5.5 m-30 -134.93 113.86 11.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 110.018 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.643 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.17 139.27 41.88 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -100.17 98.84 9.49 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.527 0.68 . . . . 0.0 111.181 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.562 HG13 ' H ' ' A' ' 264' ' ' LEU . 5.8 p -69.26 117.38 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.093 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.91 18.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -176.8 116.96 0.11 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.207 0.527 . . . . 0.0 110.837 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.437 ' HE2' ' CG ' ' A' ' 287' ' ' PHE . 1.9 ttmt -160.71 -151.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.822 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -156.28 -134.93 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.457 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.6 t -137.99 62.79 34.9 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.086 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 256' ' ' ALA . 41.8 Cg_endo -98.1 47.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.995 2.463 . . . . 0.0 113.023 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 252' ' ' TYR . 8.0 p-10 -22.62 152.67 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.533 1.146 . . . . 0.0 111.517 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.58 -9.21 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.506 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.799 ' O ' ' N ' ' A' ' 254' ' ' LYS . 38.1 m-85 -76.53 -63.21 1.39 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -47.05 62.42 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 125.384 1.677 . . . . 0.0 111.131 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 252' ' ' TYR . 4.2 mttm 84.26 -49.93 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.908 1.38 . . . . 0.0 109.717 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.88 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -44.31 110.88 0.24 Allowed 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.131 0.491 . . . . 0.0 111.722 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.658 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.9 OUTLIER -43.44 159.58 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.033 -0.417 . . . . 0.0 111.75 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.537 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -108.81 119.82 40.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.436 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.3 mt -141.15 -175.73 4.43 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -144.21 144.3 31.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.357 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 58.2 t -48.98 106.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.423 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.79 14.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -92.71 -41.61 10.06 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.331 0.586 . . . . 0.0 112.38 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 69.12 140.12 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.62 -178.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.502 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 9.2 p -131.43 156.92 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -102.71 88.24 3.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.639 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 5.0 t -67.76 121.95 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.005 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.503 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -110.28 -52.63 2.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.552 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 8.5 tppt? -82.08 125.89 31.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 112.119 -177.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.88 126.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.549 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.559 ' ND2' ' N ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -121.08 -106.42 0.37 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.603 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.559 ' N ' ' ND2' ' A' ' 271' ' ' ASN . 35.0 mtm -38.09 149.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.655 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.8 p -71.55 15.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -140.75 -69.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.474 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 98.0 mm-40 -82.79 173.03 12.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.61 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 5.9 p-90 170.89 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.068 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 6.6 mt-10 -126.93 173.26 9.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.68 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -150.3 -155.85 7.04 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.354 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.454 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -171.66 121.98 0.51 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.436 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -108.37 -98.03 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -95.6 50.46 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.41 -30.96 5.36 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.408 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -64.42 89.93 0.07 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.457 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.454 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 75.7 mtt180 -85.36 168.03 15.02 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.567 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.63 -156.26 28.01 Favored Glycine 0 C--N 1.308 -1.019 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.534 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 12.6 p80 -128.01 170.79 12.49 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.894 0.477 . . . . 0.0 111.066 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.61 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 168.87 114.47 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.248 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 290' ' ' THR . 68.4 Cg_exo -48.55 141.01 20.75 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.575 1.517 . . . . 0.0 112.518 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.6 OUTLIER -62.98 -1.0 0.78 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.478 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.9 p -55.89 0.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 289' ' ' PHE . 4.9 p-80 -153.13 66.38 0.78 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.75 146.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.13 81.97 2.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 27.4 mt -37.71 130.09 1.08 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.343 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.0 mp -71.93 -170.13 0.55 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.852 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.92 21.31 0.43 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.606 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.6 tt0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.428 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.564 ' O ' HG21 ' A' ' 138' ' ' VAL . 53.6 m-85 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 90.77 161.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 125.367 1.667 . . . . 0.0 111.66 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -140.85 157.78 44.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.152 0.977 . . . . 0.0 111.468 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.41 162.26 2.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.667 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.7 mt -136.36 -37.45 0.7 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.969 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.588 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 95.2 m-85 -124.87 6.66 8.04 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 79.41 142.1 0.08 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.407 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.0 t80 -121.63 -50.67 2.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.004 0.43 . . . . 0.0 111.577 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 13.5 m-80 42.83 62.7 1.69 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.409 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.53 -154.74 6.73 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 163.73 -6.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.1 -1.05 . . . . 0.0 112.085 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 150' ' ' GLU . 53.2 m-20 -55.16 -121.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.497 0.665 . . . . 0.0 111.417 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 151' ' ' ASP . 7.2 p-10 -66.59 47.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.692 ' O ' ' O ' ' A' ' 151' ' ' ASP . 21.5 mp0 67.78 19.75 9.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.692 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.9 OUTLIER -39.65 -169.86 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 O-C-N 123.863 0.727 . . . . 0.0 111.869 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.443 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 5.8 tp -113.53 91.2 19.7 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 121.242 -0.911 . . . . 0.0 111.6 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.92 128.26 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.785 0.99 . . . . 0.0 112.175 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 10.1 p90 -144.92 172.98 12.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.589 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -112.07 -106.7 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.933 0.396 . . . . 0.0 111.396 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.449 ' N ' ' HG3' ' A' ' 155' ' ' LYS . 25.5 ttpt -135.72 122.09 20.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.56 15.62 54.57 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.251 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.17 133.48 34.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.2 mm -101.67 116.13 44.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mt -122.54 122.33 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -75.16 128.71 36.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.384 0.611 . . . . 0.0 111.828 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.6 mm -66.62 126.49 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.487 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.558 ' HE ' ' HE ' ' A' ' 180' ' ' ARG . 72.5 ttt-85 -76.58 -51.99 10.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.627 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 164' ' ' ASP . 51.0 t0 -157.27 -10.33 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.357 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.472 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 4.6 ptmm? 35.97 79.98 0.28 Allowed Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.511 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.53 -44.59 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 49.8 mt-10 -91.93 158.29 16.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.913 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 15.6 pt-20 -82.28 -41.26 20.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.766 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 35.1 mt-30 -83.13 -24.47 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.437 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 63.1 m95 -124.23 150.42 45.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.472 ' CD1' ' CB ' ' A' ' 165' ' ' LYS . 13.3 m0 -140.5 133.05 28.65 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.678 0.751 . . . . 0.0 111.581 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -79.05 100.35 7.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.41 170.71 8.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -130.29 141.8 50.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.026 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.5 173.07 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.478 0.656 . . . . 0.0 110.218 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.9 mmm -77.14 -8.19 57.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.895 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -102.01 -26.5 13.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.21 47.1 0.39 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -122.6 131.68 53.94 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.288 -0.956 . . . . 0.0 110.609 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.558 ' HE ' ' HE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -109.28 113.92 27.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.831 0.824 . . . . 0.0 113.044 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -142.84 143.59 12.78 Favored Glycine 0 C--N 1.305 -1.187 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.691 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.1 mtp -62.42 161.53 11.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.485 0.66 . . . . 0.0 110.432 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.437 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 4.4 pt -150.6 145.86 18.95 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.874 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.3 118.7 5.63 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.41 1.407 . . . . 0.0 109.285 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.503 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 25.2 t -54.25 -51.49 77.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -49.64 -29.43 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.543 1.495 . . . . 0.0 113.154 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.58 ' OH ' ' O ' ' A' ' 268' ' ' THR . 10.8 m-85 -72.37 -10.62 60.03 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.328 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.3 m -132.89 165.13 33.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.519 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 190' ' ' LYS . 2.3 pp20? -143.64 -49.96 0.31 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.017 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 189' ' ' GLU . 3.2 tmtm? . . . . . 0 N--CA 1.42 -1.971 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 120.989 0.423 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -35.76 161.54 0.01 OUTLIER Glycine 1 CA--C 1.436 -4.882 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.898 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.88 115.45 3.55 Favored 'Cis proline' 0 N--CA 1.521 3.089 0 O-C-N 122.645 0.813 . . . . 0.0 112.015 -5.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.653 ' O ' ' HG3' ' A' ' 266' ' ' LYS . 43.0 m-85 -145.97 -125.86 0.07 Allowed 'General case' 0 C--O 1.189 -2.088 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.438 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -142.07 116.14 9.39 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 120.105 1.32 . . . . 0.0 109.801 -177.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 294' ' ' LEU . . . -88.93 -157.51 0.44 Allowed 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -157.7 90.49 1.08 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.563 0.696 . . . . 0.0 109.544 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.0 p -66.22 122.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.523 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.71 16.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.67 100.56 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.242 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.442 ' HE2' ' CD1' ' A' ' 287' ' ' PHE . 0.3 OUTLIER -134.14 -143.16 0.2 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 10.5 ptt85 -158.83 -134.89 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 81.1 t -135.79 68.17 65.04 Favored Pre-proline 0 N--CA 1.473 0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.876 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 67.7 Cg_endo -92.82 177.8 1.41 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 123.355 2.703 . . . . 0.0 111.694 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.658 ' O ' ' N ' ' A' ' 252' ' ' TYR . 24.6 p30 -147.21 145.16 29.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.862 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.81 -14.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.562 0.539 . . . . 0.0 111.313 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.658 ' N ' ' O ' ' A' ' 250' ' ' ASN . 44.1 m-85 -83.54 -55.54 4.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.285 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 33.1 t70 -52.41 67.94 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 124.736 1.273 . . . . 0.0 111.691 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' A' ' 252' ' ' TYR . 31.3 mtmt 73.52 -7.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 0.0 111.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 1.4 m 92.64 52.8 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.129 0.893 . . . . 0.0 111.903 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -109.87 112.72 24.92 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.605 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.6 OUTLIER -41.88 157.98 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.94 116.33 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.522 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.0 -175.35 4.12 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 263' ' ' GLU . 2.3 tt0 -148.02 148.67 30.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.981 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 56.3 t -45.52 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.044 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 103.63 13.09 28.84 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 260' ' ' GLU . 37.8 mm-40 -90.11 -35.1 15.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.26 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.83 139.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.958 0.885 . . . . 0.0 110.774 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.56 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 9.1 p -136.17 164.69 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.082 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -108.33 103.17 12.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 269' ' ' LYS . 1.2 t -57.1 -53.92 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.58 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 62.48 -66.01 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 124.473 1.108 . . . . 0.0 109.974 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -65.47 150.05 49.01 Favored 'General case' 0 C--O 1.181 -2.524 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.735 -177.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 269' ' ' LYS . 0.1 OUTLIER -162.86 128.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.171 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.598 ' ND2' ' HG3' ' A' ' 272' ' ' MET . 0.1 OUTLIER -155.2 -40.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 177.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.655 ' HE2' ' H ' ' A' ' 274' ' ' GLY . 0.0 OUTLIER -124.3 173.24 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.87 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 1.5 p -105.98 20.2 19.33 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.655 ' H ' ' HE2' ' A' ' 272' ' ' MET . . . -118.99 -74.25 0.44 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.84 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.668 HE22 ' C ' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -54.64 -91.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 123.422 1.582 . . . . 0.0 110.393 -178.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.87 ' HE1' ' C ' ' A' ' 273' ' ' SER . 1.2 m0 88.1 127.54 0.03 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 21.4 mt-10 -86.54 168.51 13.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.712 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 284' ' ' ARG . . . -155.19 136.33 5.08 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.902 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.434 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -122.99 125.45 45.27 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.463 0.743 . . . . 0.0 110.364 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 281' ' ' ASN . 0.1 OUTLIER -143.23 78.89 1.62 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.063 -176.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.7 m-20 84.33 41.67 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.819 0.819 . . . . 0.0 109.351 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.41 -35.96 3.4 Favored Glycine 0 CA--C 1.495 -1.162 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.112 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -61.82 104.22 0.42 Allowed 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 114.588 -0.806 . . . . 0.0 109.773 -176.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 278' ' ' GLY . 33.2 mtt85 -108.8 165.84 11.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 121.397 0.618 . . . . 0.0 109.834 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 173.17 -148.83 10.65 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.559 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 16.8 p80 -132.24 168.33 18.25 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.549 0.174 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.71 120.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.805 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.533 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 74.5 Cg_exo -46.01 134.53 14.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.864 1.71 . . . . 0.0 113.679 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.687 ' HB2' ' CE3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -66.73 -3.62 7.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.663 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.2 p -62.16 -0.49 0.54 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.6 p-80 -139.17 54.5 1.72 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.204 0.456 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.29 148.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.7 -46.92 3.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 1.3 mt 82.96 131.39 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.223 1.011 . . . . 0.0 112.01 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 297' ' ' GLN . 9.3 mp -79.4 -168.05 1.4 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.849 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -74.6 12.19 0.86 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' A' ' 295' ' ' LEU . 56.6 tt0 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.044 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.647 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 80.7 m-85 . . . . . 0 CA--C 1.486 -1.483 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.995 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.647 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.4 m 84.44 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 125.427 1.704 . . . . 0.0 111.107 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -121.34 139.7 53.08 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 120.93 0.395 . . . . 0.0 110.324 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.497 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -105.27 98.75 8.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.98 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.465 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -114.69 32.98 5.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.606 -178.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CE1' ' NH1' ' A' ' 284' ' ' ARG . 69.6 m-85 -125.22 1.74 7.84 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.53 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 269' ' ' LYS . 0.2 OUTLIER 60.96 136.83 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.029 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.453 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 4.4 t80 -134.56 -35.26 0.9 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 111.339 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 40.21 61.34 1.56 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.355 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.465 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -64.58 -119.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.534 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.9 OUTLIER 170.54 -92.37 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.902 0.382 . . . . 0.0 111.733 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.636 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 28.8 m-20 -49.95 178.2 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.206 0.527 . . . . 0.0 111.133 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.638 ' C ' ' H ' ' A' ' 151' ' ' ASP . 99.9 m-20 -68.54 -42.37 78.51 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.854 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.26 3.98 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.638 ' H ' ' C ' ' A' ' 149' ' ' ASP . 2.7 p30 -133.79 150.2 51.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.45 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 8.7 tp -119.6 89.43 41.04 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-O 120.406 0.146 . . . . 0.0 110.685 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.461 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 37.6 Cg_exo -57.48 147.29 79.23 Favored 'Trans proline' 0 C--N 1.288 -2.618 0 C-N-CA 122.236 1.957 . . . . 0.0 113.612 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.497 ' CE1' ' HB3' ' A' ' 140' ' ' ALA . 5.9 p90 -172.53 156.89 3.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.618 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 157' ' ' GLY . 3.4 ttmp? -169.69 -55.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.436 0.636 . . . . 0.0 111.697 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.7 mmmm -45.14 -16.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.999 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 155' ' ' LYS . . . 102.09 57.29 0.81 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -90.47 150.59 21.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.415 0.626 . . . . 0.0 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.6 mm -94.61 115.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 137' ' ' TYR . 8.6 mt -113.26 120.91 42.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.688 -176.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 65.9 tttm -68.87 141.66 55.01 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.642 ' O ' ' O ' ' A' ' 172' ' ' ASN . 34.7 mm -75.98 -64.17 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.866 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 162' ' ' ILE . 56.0 ttt180 79.96 -44.07 0.27 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.869 0.366 . . . . 0.0 111.31 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -146.08 122.49 10.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.454 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.526 ' CG ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 ttmt -107.67 74.67 0.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.24 -60.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.166 1.911 . . . . 0.0 111.994 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.98 161.0 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -84.79 -34.81 22.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.632 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 92.8 mt-30 -83.53 -29.08 28.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.444 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.422 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 70.9 m95 -122.99 149.85 43.76 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.526 ' NE1' ' CG ' ' A' ' 165' ' ' LYS . 17.1 m0 -138.34 129.6 27.35 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.349 0.595 . . . . 0.0 111.418 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 162' ' ' ILE . 53.1 t30 -80.81 108.04 14.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.62 171.64 7.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.569 0.543 . . . . 0.0 111.087 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -125.14 135.7 52.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.111 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.37 172.32 2.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.445 0.641 . . . . 0.0 110.578 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.0 mmm -79.89 -0.0 33.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.004 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -104.43 -27.73 11.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.55 49.82 0.34 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -131.08 134.33 46.51 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.644 -0.778 . . . . 0.0 110.81 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.14 51.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.527 0.68 . . . . 0.0 111.99 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.03 154.25 25.34 Favored Glycine 0 C--N 1.317 -0.516 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.086 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 tpt -68.35 162.78 24.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.371 0.605 . . . . 0.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.457 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 5.4 pt -154.8 143.2 14.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.432 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.19 118.05 5.46 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.346 1.364 . . . . 0.0 108.888 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.546 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 15.6 t -50.99 -53.46 47.87 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 121.755 -0.59 . . . . 0.0 111.712 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 16.5 Cg_endo -51.93 -25.29 21.37 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 122.313 2.009 . . . . 0.0 113.578 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.501 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.8 m-85 -72.2 9.7 0.93 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 186' ' ' PRO . 4.8 m -135.4 167.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.948 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -91.94 -70.56 0.68 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.452 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.8 tptp . . . . . 0 CA--C 1.51 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.516 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 141.95 -173.52 23.6 Favored Glycine 1 CA--C 1.442 -4.488 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.615 178.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.46 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 5.9 Cg_exo -46.0 105.77 0.03 OUTLIER 'Cis proline' 1 N--CA 1.536 4.024 0 O-C-N 123.755 1.397 . . . . 0.0 115.488 0.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.604 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.1 m-30 -120.57 -127.78 0.27 Allowed 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.624 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.8 OUTLIER -141.46 124.01 15.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.66 0.743 . . . . 0.0 110.198 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.589 ' N ' HD12 ' A' ' 264' ' ' LEU . . . -104.59 -163.0 0.93 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.387 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -161.47 89.87 0.77 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.214 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.466 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 5.3 p -64.7 121.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.505 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.98 12.32 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -169.01 120.39 0.74 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 110.565 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.44 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 1.9 ttmt -163.04 -145.56 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.591 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.44 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.4 ptt85 -155.75 -142.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.654 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.7 t -132.84 67.83 78.3 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 74.5 Cg_endo -91.62 172.7 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.135 2.557 . . . . 0.0 111.61 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.773 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.0 OUTLIER -143.98 140.83 29.85 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.914 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.32 -2.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.887 0.742 . . . . 0.0 112.184 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.773 ' H ' ' C ' ' A' ' 250' ' ' ASN . 2.5 m-85 -96.78 -54.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 123.591 0.756 . . . . 0.0 110.044 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -44.41 -65.84 0.47 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 256' ' ' ALA . 25.8 mttt -149.05 33.3 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.757 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.408 ' O ' ' CA ' ' A' ' 285' ' ' GLY . 1.7 m 71.19 -16.53 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.822 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -48.81 161.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 257' ' ' LEU . 0.2 OUTLIER -105.29 150.53 25.08 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -91.57 119.44 31.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 3.7 mt -140.48 -172.14 3.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -147.23 146.13 29.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.065 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 68.9 t -55.35 102.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.639 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 121.84 8.01 7.66 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 64.8 mm-40 -90.57 -124.8 0.07 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.841 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 241' ' ' ALA . 0.3 OUTLIER 161.61 136.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.554 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 10.7 p -126.29 142.78 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.287 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 239' ' ' PHE . 2.6 ttmt -100.63 83.36 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.188 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 75.2 t -51.96 151.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.391 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.501 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -151.7 -51.34 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.693 -178.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.524 ' O ' ' OE1' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -70.52 104.13 2.68 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.076 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.14 154.61 3.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -171.63 -97.83 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.153 179.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.632 ' C ' ' H ' ' A' ' 274' ' ' GLY . 19.3 mtm -59.0 134.91 57.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.831 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.9 p -66.97 25.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.632 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -152.12 -69.89 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.476 ' O ' ' CE ' ' A' ' 272' ' ' MET . 21.4 mp0 -92.19 112.52 24.49 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.148 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.565 ' HA ' HD22 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -116.18 -171.8 2.06 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.524 ' OE1' ' O ' ' A' ' 269' ' ' LYS . 54.8 mp0 -97.09 -160.49 0.8 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.492 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -173.76 117.71 0.66 Allowed Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.525 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.415 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.2 tt0 -99.49 127.82 45.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.34 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.571 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -144.39 78.97 1.59 Allowed 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 3.9 m-20 82.63 30.09 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 0.0 109.921 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 93.95 -32.64 5.72 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.405 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.571 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.4 OUTLIER -66.21 72.81 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.762 -178.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.554 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 90.5 mtt180 -72.82 168.04 19.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 123.886 0.741 . . . . 0.0 109.918 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 168.94 -158.07 30.48 Favored Glycine 0 C--O 1.206 -1.653 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.588 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 3.8 p80 -124.71 167.41 14.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.249 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 167.65 115.14 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.223 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.5 Cg_exo -51.68 145.13 31.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.963 1.775 . . . . 0.0 112.304 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.593 ' C ' ' H ' ' A' ' 291' ' ' HIS . 0.2 OUTLIER -64.25 -0.11 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 110.465 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.2 p -56.27 3.85 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 O-C-N 121.81 -0.556 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.593 ' H ' ' C ' ' A' ' 289' ' ' PHE . 3.9 p-80 -156.11 69.69 0.66 Allowed 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.86 154.33 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -129.35 76.19 1.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.24 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 63.6 mt -38.08 127.97 1.3 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.438 0.637 . . . . 0.0 111.368 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.97 -99.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.767 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -159.02 -85.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.412 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.604 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 3.9 tp-100 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.474 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.584 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 13.1 p90 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.902 -0.57 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.4 m 86.17 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 125.0 1.437 . . . . 0.0 111.646 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -128.15 138.29 52.44 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 157' ' ' GLY . . . -96.84 98.92 10.52 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.753 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.497 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -104.51 37.51 2.1 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.271 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 53.5 m-85 -135.17 0.82 2.88 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.515 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER 60.55 139.51 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.887 0.742 . . . . 0.0 109.273 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.42 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 5.0 t80 -128.48 -38.68 1.72 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.079 0.399 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t30 40.54 56.25 2.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.517 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.67 -132.3 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.563 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.8 OUTLIER 169.5 -89.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.355 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 150' ' ' GLU . 1.7 m-20 -19.58 134.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 112.225 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.2 -3.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.442 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.592 ' H ' ' C ' ' A' ' 148' ' ' ASP . 12.5 pt-20 -108.12 16.76 23.03 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 8.2 p30 -137.54 152.82 49.86 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 182' ' ' MET . 12.6 tp -107.72 90.35 6.16 Favored Pre-proline 0 C--O 1.215 -0.76 0 CA-C-N 118.181 0.446 . . . . 0.0 110.717 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.421 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 74.1 Cg_endo -66.97 146.47 77.62 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 C-N-CA 121.364 1.376 . . . . 0.0 114.082 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.434 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 11.8 p90 -169.97 162.84 9.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.82 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -152.76 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.885 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -97.93 129.44 44.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.879 0.847 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . 88.89 12.39 64.0 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -75.04 139.8 43.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.7 mp -97.56 114.76 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.413 ' CD1' ' CD2' ' A' ' 154' ' ' PHE . 10.8 mt -125.42 133.9 52.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.923 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -81.6 140.2 34.58 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.108 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.2 mp -66.37 -52.07 51.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.635 ' CZ ' HH21 ' A' ' 180' ' ' ARG . 54.1 ttt85 66.85 -48.18 0.46 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.306 0.379 . . . . 0.0 111.215 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 162' ' ' ILE . 41.0 t0 -152.93 133.5 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.432 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.44 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.9 pttp -133.94 78.67 59.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.64 -31.2 7.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.165 1.91 . . . . 0.0 112.539 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -101.81 -174.47 2.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 168' ' ' GLU . 1.5 pm0 -115.25 -13.97 11.71 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -109.47 -29.33 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.825 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 76.5 m95 -121.04 146.25 46.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.513 ' O ' HG21 ' A' ' 183' ' ' ILE . 16.4 m0 -137.38 125.61 23.14 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 162' ' ' ILE . 18.9 t-20 -76.09 101.62 5.39 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.38 173.56 6.25 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.467 0.479 . . . . 0.0 111.079 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 21.4 tt0 -121.45 123.63 42.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.067 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.75 173.35 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.234 0.54 . . . . 0.0 110.211 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 96.1 mtp -72.84 -3.05 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.851 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 179' ' ' LYS . 89.5 m-20 -98.63 -20.23 17.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.361 0.601 . . . . 0.0 110.905 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 120.68 -28.89 6.03 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 177' ' ' ASP . 16.9 mttp -52.49 146.79 9.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.19 0.519 . . . . 0.0 110.813 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.635 HH21 ' CZ ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -114.67 130.62 56.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.344 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.84 157.12 28.37 Favored Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.387 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.471 ' O ' ' N ' ' A' ' 152' ' ' LEU . 1.8 tpt -68.4 163.28 23.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.169 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.513 HG21 ' O ' ' A' ' 171' ' ' TRP . 0.0 OUTLIER -161.32 147.79 11.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.554 178.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.07 115.84 4.47 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.107 1.205 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 38.3 t -53.49 -52.05 70.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 122.041 -0.412 . . . . 0.0 111.541 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.2 Cg_endo -49.11 -27.7 12.81 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.487 2.125 . . . . 0.0 113.345 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.3 m-85 -65.28 4.95 0.43 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.055 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 186' ' ' PRO . 1.8 m -130.43 168.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 123.109 0.256 . . . . 0.0 110.764 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -100.09 -66.34 0.91 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.027 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 45.0 tptt . . . . . 0 CA--C 1.542 0.653 0 O-C-N 124.993 1.433 . . . . 0.0 109.703 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 15.4 p30 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.55 0.691 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.49 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -61.37 -175.73 1.8 Allowed Glycine 1 CA--C 1.447 -4.164 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.23 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.49 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.9 Cg_endo -53.21 122.97 0.4 Allowed 'Cis proline' 0 N--CA 1.525 3.367 0 N-CA-C 116.481 1.685 . . . . 0.0 116.481 -1.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.2 m-85 -154.67 -121.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.7 OUTLIER -145.18 135.09 23.69 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 118.976 0.807 . . . . 0.0 108.962 -179.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 294' ' ' LEU . . . -117.94 -148.51 0.42 Allowed 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.174 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 262' ' ' GLY . 21.6 tpp180 -161.93 95.15 0.96 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.627 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 263' ' ' GLU . 2.9 p -61.62 137.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.783 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.8 20.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 176.48 103.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.88 -143.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.959 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -155.51 -139.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.015 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 248' ' ' VAL . 70.8 t -133.91 68.65 75.11 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-O 121.215 0.531 . . . . 0.0 110.887 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.614 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 61.3 Cg_endo -91.63 175.63 2.17 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.816 2.344 . . . . 0.0 111.209 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.767 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.9 OUTLIER -142.89 140.0 31.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -37.1 -8.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.46 0.648 . . . . 0.0 111.983 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.767 ' N ' ' O ' ' A' ' 250' ' ' ASN . 4.8 m-85 -92.41 -48.77 6.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 250' ' ' ASN . 27.9 t0 -65.09 56.39 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.661 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.531 ' C ' ' H ' ' A' ' 256' ' ' ALA . 33.0 mtmt 85.55 20.28 0.1 Allowed 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.642 1.214 . . . . 0.0 111.47 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.519 ' O ' ' O ' ' A' ' 284' ' ' ARG . 2.4 m 75.49 -19.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.021 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -39.74 107.52 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.638 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -47.03 157.3 0.17 Allowed 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.777 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -110.17 124.43 51.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.954 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 1.3 mt -142.66 -179.08 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.069 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 6.7 tt0 -133.86 146.06 50.24 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.787 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 52.9 t -45.96 110.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.102 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.781 ' O ' ' O ' ' A' ' 263' ' ' GLU . . . 131.06 -70.56 0.52 Allowed Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.781 ' O ' ' O ' ' A' ' 262' ' ' GLY . 4.1 mm-40 -29.08 -163.4 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.444 0 O-C-N 125.764 1.508 . . . . 0.0 114.142 -172.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.418 ' CB ' ' O ' ' A' ' 241' ' ' ALA . 3.8 pp -155.57 166.04 34.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.281 1.038 . . . . 0.0 112.518 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.09 143.22 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.525 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.477 ' HZ1' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -101.39 85.32 2.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.591 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.2 155.49 2.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.939 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.48 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -156.73 -56.24 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.038 0.446 . . . . 0.0 109.807 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.406 ' N ' ' HG1' ' A' ' 268' ' ' THR . 0.1 OUTLIER -66.45 102.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.689 -178.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 5.7 mt -115.17 106.46 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.871 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.61 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -111.45 -101.53 0.4 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.623 ' O ' ' CE3' ' A' ' 276' ' ' TRP . 38.6 mtm -51.26 148.33 4.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.003 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 p -72.17 16.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -140.86 -80.9 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.227 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -86.18 116.37 24.33 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 121.002 0.429 . . . . 0.0 111.358 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -134.58 -172.92 3.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.742 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.53 -171.79 2.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.92 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -159.89 -152.78 6.64 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.056 -1.068 . . . . 0.0 112.348 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 281' ' ' ASN . 0.5 OUTLIER -168.59 139.33 2.53 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.192 0.52 . . . . 0.0 112.168 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.562 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -148.05 76.25 1.37 Allowed 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.102 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 279' ' ' GLU . 1.5 m120 84.35 36.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.81 -35.84 3.67 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.843 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -63.89 88.0 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.169 0.509 . . . . 0.0 110.257 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.519 ' O ' ' O ' ' A' ' 255' ' ' THR . 43.9 mtt85 -86.45 168.1 14.07 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.278 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.484 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.11 -154.6 24.68 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.583 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 13.1 p80 -129.37 172.14 11.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.2 114.39 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.431 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.526 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 54.5 Cg_exo -48.4 129.53 19.67 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.222 1.281 . . . . 0.0 112.255 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -62.98 -1.92 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.275 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 288' ' ' PRO . 53.0 p -58.77 2.21 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.889 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.2 p-80 -142.82 50.88 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.739 0.304 . . . . 0.0 111.633 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.89 166.3 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 294' ' ' LEU . 18.8 mtm180 -136.85 77.02 1.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.529 0.204 . . . . 0.0 110.878 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 35.1 mt -34.29 134.37 0.2 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.398 0.618 . . . . 0.0 111.274 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.4 mp -79.08 -165.39 0.75 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.365 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 42.5 p-10 -77.43 -0.42 25.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.63 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 27.5 tt0 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.09 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.671 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.671 ' O ' ' O ' ' A' ' 137' ' ' TYR . 32.6 m 36.38 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 122.08 0.943 . . . . 0.0 112.635 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 14.9 ttp180 -143.47 120.38 11.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.413 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.445 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -98.78 91.51 5.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 124.321 1.013 . . . . 0.0 111.812 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.479 ' CD1' ' CD2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.78 18.97 16.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.285 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.575 ' CE1' ' CZ ' ' A' ' 284' ' ' ARG . 46.8 m-85 -114.98 0.91 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.7 OUTLIER 58.57 138.01 0.01 OUTLIER 'General case' 0 C--O 1.209 -1.035 0 O-C-N 124.407 1.067 . . . . 0.0 110.014 -179.194 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.433 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 17.2 t80 -130.06 -46.69 1.12 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.905 0.321 . . . . 0.0 110.44 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 144' ' ' PHE . 66.3 t30 36.04 58.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.484 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -61.6 -93.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 170.31 15.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.966 0.888 . . . . 0.0 110.316 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 1.3 p-10 33.66 -159.2 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.156 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.511 ' N ' ' OD2' ' A' ' 148' ' ' ASP . 97.7 m-20 48.64 38.81 12.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 149' ' ' ASP . 3.6 mm-40 149.71 -10.2 0.0 OUTLIER 'General case' 0 C--N 1.345 0.386 0 O-C-N 124.701 1.251 . . . . 0.0 108.987 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 148' ' ' ASP . 0.2 OUTLIER -157.45 -178.02 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.793 -178.06 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.511 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 10.7 tp -118.04 87.67 29.27 Favored Pre-proline 0 C--O 1.206 -1.203 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.449 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 71.6 Cg_endo -71.38 139.74 35.4 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 CA-C-N 120.03 1.046 . . . . 0.0 112.079 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 14.1 p90 -160.9 163.76 31.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HZ1' ' HB2' ' A' ' 143' ' ' ASP . 6.9 tttp -155.88 169.08 25.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.811 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 157' ' ' GLY . 3.5 ttmt 50.43 82.67 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.334 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.1 47.41 0.01 OUTLIER Glycine 0 N--CA 1.467 0.715 0 O-C-N 123.834 0.709 . . . . 0.0 113.008 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 156' ' ' LYS . 35.3 t0 -62.71 159.69 15.74 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.547 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.5 mp -109.2 106.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.4 mt -109.47 106.84 16.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.458 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -64.73 129.12 38.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.64 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.653 ' CG2' ' H ' ' A' ' 163' ' ' ARG . 42.7 mm -66.44 -134.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.857 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.653 ' H ' ' CG2' ' A' ' 162' ' ' ILE . 77.4 ttt180 175.75 -48.78 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.518 0.675 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.63 -19.12 0.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.071 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.4 pttt 37.04 72.89 0.76 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 123.205 0.315 . . . . 0.0 111.202 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.28 -43.15 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.592 1.528 . . . . 0.0 112.059 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.59 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 76.4 mm-40 -99.29 157.06 16.65 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.909 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.06 -36.46 21.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.381 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -82.59 -26.14 32.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.831 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 85.2 m95 -127.32 150.98 49.34 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.59 ' CD1' ' O ' ' A' ' 167' ' ' GLU . 13.0 m0 -145.07 136.03 24.73 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.874 0.368 . . . . 0.0 110.234 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -86.8 110.36 19.89 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.62 -178.58 3.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.633 . . . . 0.0 111.528 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -123.68 125.35 44.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.8 172.5 0.26 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.94 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -78.61 2.67 18.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.059 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.99 -29.26 10.57 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.05 51.16 0.52 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -135.81 140.51 44.29 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.644 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.06 121.43 44.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 111.343 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.28 153.29 24.67 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.191 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.5 mtp -65.9 152.41 44.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.49 143.36 38.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.023 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.57 114.58 4.05 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.314 1.343 . . . . 0.0 108.914 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.552 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 47.4 t -52.85 -51.23 76.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.823 -0.548 . . . . 0.0 111.944 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.6 Cg_endo -48.56 -29.39 13.94 Favored 'Trans proline' 0 N--CA 1.504 2.137 0 C-N-CA 122.669 2.246 . . . . 0.0 113.014 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.8 m-85 -67.93 -0.92 4.8 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.712 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 139' ' ' ARG . 17.2 m -128.98 166.41 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.283 0.364 . . . . 0.0 110.633 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -146.72 50.58 1.12 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.43 ' C ' ' CD ' ' A' ' 190' ' ' LYS . 3.8 tmtt? . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.125 0.488 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.583 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -59.83 -178.61 1.62 Allowed Glycine 1 CA--C 1.427 -5.427 0 CA-C-O 122.631 1.128 . . . . 0.0 115.464 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.583 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 3.3 Cg_exo -52.44 127.83 1.01 Allowed 'Cis proline' 1 N--CA 1.538 4.095 0 O-C-N 124.766 1.929 . . . . 0.0 115.698 -1.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.6 m-85 -155.24 -122.87 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.72 123.85 14.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 120.389 1.45 . . . . 0.0 109.165 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.649 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -108.53 141.75 39.96 Favored 'General case' 0 C--O 1.19 -2.043 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.247 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -104.57 96.99 6.97 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 121.616 0.722 . . . . 0.0 110.664 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.9 p -69.1 112.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.616 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -105.78 17.79 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.194 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -176.79 119.84 0.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.085 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.549 ' HZ2' ' CD1' ' A' ' 259' ' ' LEU . 1.5 ttmt -161.24 -145.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.982 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 2.9 ptt85 -156.25 -141.42 0.09 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.821 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 69.3 t -134.6 69.39 72.4 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 59.7 Cg_endo -98.46 177.93 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.381 2.721 . . . . 0.0 111.915 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.725 ' C ' ' H ' ' A' ' 252' ' ' TYR . 1.5 p-10 -157.25 151.73 25.24 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.896 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -41.5 -4.85 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.725 ' H ' ' C ' ' A' ' 250' ' ' ASN . 38.2 m-85 -95.19 -53.11 3.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.294 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 17.9 t0 -45.61 -57.84 3.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.899 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.508 ' CE ' HH21 ' A' ' 247' ' ' ARG . 13.1 pttt -169.82 39.66 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.157 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 56.92 46.09 20.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -121.45 119.57 32.44 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.774 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.68 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -51.02 159.62 0.57 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 123.083 0.553 . . . . 0.0 112.329 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.506 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -106.38 114.35 28.41 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.549 ' CD1' ' HZ2' ' A' ' 246' ' ' LYS . 1.0 OUTLIER -139.59 -178.37 5.37 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.871 0.843 . . . . 0.0 111.607 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -144.67 143.96 31.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.906 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.6 t -47.7 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.637 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.24 7.39 10.13 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -86.85 -39.08 16.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.567 0.699 . . . . 0.0 112.641 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.649 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 66.49 139.45 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.18 0.99 . . . . 0.0 109.416 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.529 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.6 p -136.71 155.33 33.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.946 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -100.64 96.31 7.26 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.312 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.813 ' O ' ' N ' ' A' ' 269' ' ' LYS . 34.2 t -50.49 -37.22 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.448 ' CG2' ' H ' ' A' ' 269' ' ' LYS . 15.1 t 39.58 -64.25 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 O-C-N 124.3 1.0 . . . . 0.0 112.019 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' A' ' 267' ' ' VAL . 7.8 tppt? -76.13 114.25 14.58 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.592 ' H ' ' CD1' ' A' ' 270' ' ' ILE . 0.2 OUTLIER -119.82 107.88 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.028 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.739 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -114.83 -93.38 0.49 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.631 0.729 . . . . 0.0 110.505 179.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.739 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 26.8 mtm -55.22 134.84 49.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.143 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.417 ' HA ' ' CH2' ' A' ' 276' ' ' TRP . 5.7 p -63.16 14.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.788 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -144.37 -61.6 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.204 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.519 ' O ' ' O ' ' A' ' 287' ' ' PHE . 1.1 mp0 -60.34 -86.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.607 0.717 . . . . 0.0 110.353 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.55 ' CZ3' ' O ' ' A' ' 272' ' ' MET . 47.6 m95 95.95 144.23 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.565 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 11.6 mt-10 -99.2 107.65 20.04 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.375 0.607 . . . . 0.0 112.187 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -67.66 -178.94 13.66 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 118.734 -1.698 . . . . 0.0 113.465 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.461 ' H ' ' CG2' ' A' ' 265' ' ' VAL . 4.1 tt0 -168.35 107.53 0.5 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.649 -0.776 . . . . 0.0 110.368 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -129.58 75.75 1.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.988 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 37.0 t30 85.17 29.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.998 0.428 . . . . 0.0 110.346 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 99.17 -30.01 10.7 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.484 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -68.4 77.29 0.27 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.575 ' CZ ' ' CE1' ' A' ' 142' ' ' PHE . 87.0 mtt180 -79.18 175.84 10.22 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.428 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.05 -147.88 11.64 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 8.2 p80 -141.8 175.37 9.76 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 118.279 1.039 . . . . 0.0 109.378 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.657 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.3 m-85 161.62 152.84 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 O-C-N 123.687 0.617 . . . . 0.0 111.534 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.478 ' HD2' ' HE2' ' A' ' 291' ' ' HIS . 51.2 Cg_endo -72.75 148.52 46.73 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 123.096 2.531 . . . . 0.0 112.983 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 29.4 t80 -74.58 -2.15 24.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.158 0.504 . . . . 0.0 109.77 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 23.5 p -61.39 -8.33 3.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.049 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.517 ' CE1' ' CE ' ' A' ' 246' ' ' LYS . 7.0 p80 -136.79 53.9 1.89 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.9 150.58 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 294' ' ' LEU . 30.5 mmm-85 -131.91 77.1 1.74 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.667 0.27 . . . . 0.0 110.952 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 293' ' ' ARG . 45.1 mt -34.13 122.22 0.48 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.487 1.137 . . . . 0.0 112.187 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.1 mp -61.01 -173.56 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.082 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 296' ' ' ASP . 26.7 p-10 -74.94 18.42 0.18 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.061 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.478 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.5 tt0 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.528 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.1 m -148.33 164.93 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.739 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -128.42 132.24 48.47 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -101.57 96.87 7.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.651 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.451 ' CD1' ' CD2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.95 18.69 17.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.46 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.597 ' CE1' ' NH1' ' A' ' 284' ' ' ARG . 51.1 m-85 -115.69 5.01 14.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.5 p30 56.86 149.12 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.947 0 O-C-N 124.44 1.087 . . . . 0.0 109.903 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 10.3 t80 -140.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.167 0.439 . . . . 0.0 110.761 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 42.12 63.55 1.33 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.228 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.529 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.45 -126.12 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.542 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 165.2 -40.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.026 0.413 . . . . 0.0 112.111 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 20.0 m-20 -73.65 160.23 31.89 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.211 0.529 . . . . 0.0 111.217 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.3 -17.59 63.74 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.503 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 150' ' ' GLU . 55.2 mp0 -98.36 31.28 2.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 38.0 p30 -145.55 164.18 32.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.029 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 11.9 tp -122.01 84.5 45.09 Favored Pre-proline 0 C--O 1.213 -0.835 0 CA-C-O 120.39 0.138 . . . . 0.0 111.149 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.529 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 24.5 Cg_exo -59.98 140.15 91.35 Favored 'Trans proline' 0 C--N 1.284 -2.831 0 C-N-CA 122.442 2.094 . . . . 0.0 113.528 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.477 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 11.6 p90 -162.32 158.47 24.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.344 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -54.02 0.65 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.447 0.641 . . . . 0.0 112.059 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 158' ' ' ASP . 15.4 mmtt -88.6 90.54 8.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.614 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 14.56 53.65 0.01 OUTLIER Glycine 0 C--N 1.343 0.971 0 O-C-N 124.115 0.884 . . . . 0.0 111.844 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 156' ' ' LYS . 34.5 t0 -66.12 139.59 58.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.404 0.621 . . . . 0.0 109.82 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.4 mp -86.41 100.06 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.35 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.8 mt -106.52 106.56 17.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.749 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.61 141.4 48.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.606 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.5 mp -81.04 139.49 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -114.18 -47.62 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.532 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -140.95 113.81 8.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.151 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.442 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 29.6 pttt -112.37 75.16 1.65 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.324 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.81 -25.07 24.15 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.122 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -118.79 166.83 12.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.635 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -95.87 -28.82 14.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.767 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.414 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 78.8 mt-30 -85.16 -19.65 31.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.548 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 65.7 m95 -131.17 154.61 48.2 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 12.7 m0 -144.67 135.32 24.65 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.272 0.558 . . . . 0.0 111.231 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.72 115.23 24.03 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.62 -178.5 4.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.746 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -125.89 137.77 53.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.655 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.4 OUTLIER -85.1 135.36 34.02 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.222 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -45.74 -8.19 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.568 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.655 ' H ' ' C ' ' A' ' 175' ' ' ASP . 56.5 m-20 -78.03 -31.48 50.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 110.759 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.59 45.26 0.92 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.695 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -143.79 143.28 31.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.612 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.55 129.89 53.72 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.65 155.09 26.14 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.534 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.03 152.56 44.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.17 142.24 26.52 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.53 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -69.49 118.99 6.01 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.096 1.198 . . . . 0.0 109.048 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 24.1 t -53.96 -52.1 71.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 121.874 -0.516 . . . . 0.0 111.779 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.6 Cg_endo -53.02 -24.64 25.6 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.317 2.011 . . . . 0.0 113.618 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.654 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.5 m-85 -68.59 0.38 4.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.812 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.06 166.24 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.535 0.207 . . . . 0.0 110.476 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 190' ' ' LYS . 1.9 pt-20 -130.29 58.6 1.67 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.846 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 13.1 mptt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 70.2 m-20 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -94.04 -167.91 37.54 Favored Glycine 1 CA--C 1.445 -4.3 0 CA-C-O 121.773 0.652 . . . . 0.0 113.965 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 2.4 Cg_endo -47.55 98.32 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.752 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 0.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.609 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 4.0 m-30 -117.06 -130.7 0.31 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.414 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 2.3 m-30 -137.11 119.51 15.81 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.765 0.793 . . . . 0.0 109.169 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.728 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -111.75 142.35 44.2 Favored 'General case' 0 C--O 1.188 -2.159 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.047 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 15.6 tpp180 -103.96 110.44 22.59 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.672 ' O ' ' O ' ' A' ' 261' ' ' VAL . 7.5 p -82.58 74.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 123.702 0.626 . . . . 0.0 111.936 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.771 ' HA ' ' O ' ' A' ' 261' ' ' VAL . 1.4 pt -60.81 24.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.645 ' H ' ' C ' ' A' ' 243' ' ' VAL . 1.6 mm-40 173.46 130.88 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.492 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.519 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 0.6 OUTLIER -165.68 -144.81 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.444 176.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.519 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 4.3 ptt85 -156.91 -140.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.381 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 76.7 t -138.3 68.59 47.35 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.69 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.584 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 55.7 Cg_endo -96.07 179.65 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.422 2.748 . . . . 0.0 111.75 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.812 ' C ' ' H ' ' A' ' 252' ' ' TYR . 10.7 p-10 -148.66 145.64 27.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.362 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.88 4.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.812 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.0 m-85 -98.82 -55.4 2.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.952 0.901 . . . . 0.0 110.58 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -44.6 -67.41 0.29 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.846 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.523 ' O ' ' CE1' ' A' ' 286' ' ' HIS . 27.1 mtmt -149.11 36.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.453 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 60.45 38.63 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.475 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -109.0 170.55 7.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.475 ' H ' HD21 ' A' ' 257' ' ' LEU . 0.3 OUTLIER -112.32 152.64 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.122 0.569 . . . . 0.0 110.807 -178.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.584 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -97.89 119.35 36.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.464 0.649 . . . . 0.0 111.684 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.78 -163.03 1.61 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.52 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 261' ' ' VAL . 0.3 OUTLIER -132.58 -176.98 4.28 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.771 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 2.3 t -61.11 -34.35 59.86 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 CA-C-O 121.575 0.703 . . . . 0.0 112.379 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 260' ' ' GLU . . . -128.41 38.46 2.06 Favored Glycine 0 C--N 1.277 -2.701 0 O-C-N 120.539 -1.351 . . . . 0.0 111.581 -176.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -86.29 -35.68 19.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.279 0.561 . . . . 0.0 111.389 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.728 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.1 OUTLIER 64.27 139.1 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.061 -178.432 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.545 ' N ' HD11 ' A' ' 264' ' ' LEU . 14.4 p -128.51 150.74 34.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.375 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -100.92 86.92 3.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.989 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 40.9 t -50.97 153.09 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.482 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.654 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -153.33 -53.46 0.11 Allowed 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.125 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 1.9 tpmt? -67.6 146.16 54.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.279 0.562 . . . . 0.0 111.298 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.48 162.65 30.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.62 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.758 HD22 ' HA ' ' A' ' 276' ' ' TRP . 0.1 OUTLIER 171.74 -101.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.639 ' SD ' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER -73.66 163.04 28.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.508 ' HA ' ' HE1' ' A' ' 276' ' ' TRP . 2.1 p -98.74 29.79 3.59 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.427 ' C ' ' NE2' ' A' ' 275' ' ' GLN . . . -139.65 -39.72 0.09 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.531 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.427 ' NE2' ' C ' ' A' ' 274' ' ' GLY . 1.0 OUTLIER -96.05 -79.72 0.44 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.218 0.532 . . . . 0.0 111.182 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.758 ' HA ' HD22 ' A' ' 271' ' ' ASN . 17.0 m95 77.6 166.49 0.23 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.194 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 90.3 mt-10 -132.27 148.51 52.45 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -129.09 -141.81 5.19 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 115.094 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -173.03 129.79 0.48 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.572 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.4 OUTLIER -144.32 75.21 1.45 Allowed 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.825 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 13.8 t-20 84.69 27.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.434 0.635 . . . . 0.0 110.001 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 95.78 -32.05 6.68 Favored Glycine 0 N--CA 1.459 0.198 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.49 72.6 0.08 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.597 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 77.2 mtt180 -71.49 168.91 16.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.249 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 170.57 -159.1 31.24 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.632 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 0.0 OUTLIER -135.76 176.15 8.94 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.872 0.469 . . . . 0.0 110.069 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 2.8 m-85 170.54 154.89 0.2 Allowed Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.944 0.778 . . . . 0.0 111.158 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.83 155.59 43.74 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.022 2.481 . . . . 0.0 112.071 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 64.0 t80 -74.77 0.48 15.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.554 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 41.4 p -62.68 0.46 0.5 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.507 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 287' ' ' PHE . 0.6 OUTLIER -156.42 62.38 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.611 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -158.05 143.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -127.66 81.15 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 19.4 mt -40.68 131.24 2.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.857 0.837 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.43 -171.61 3.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.272 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -101.2 33.73 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.609 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 56.0 tt0 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.432 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.714 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.198 -1.656 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.714 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.8 m 90.36 168.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 124.241 0.963 . . . . 0.0 111.922 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -140.63 156.34 46.29 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 155' ' ' LYS . . . -56.73 168.62 0.58 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.67 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -136.02 -36.56 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.643 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.549 ' CE2' ' CZ ' ' A' ' 284' ' ' ARG . 92.5 m-85 -130.51 6.6 4.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.567 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.485 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 78.02 136.71 0.06 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.8 t80 -108.27 -49.26 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 110.879 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 4.0 m120 41.28 66.92 0.6 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.26 -122.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 146' ' ' GLY . 1.7 p30 168.21 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.576 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.594 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 9.0 m-20 -80.66 154.01 27.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.0 -16.83 64.62 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.036 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.15 24.74 4.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 7.5 p30 -144.82 162.44 36.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.038 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.4 tp -112.31 89.71 12.82 Favored Pre-proline 0 C--O 1.215 -0.737 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.491 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 59.6 Cg_endo -69.17 127.18 14.68 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 121.692 1.595 . . . . 0.0 112.859 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 144' ' ' PHE . 16.7 p90 -147.75 166.94 25.97 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.588 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.481 ' NZ ' ' OD1' ' A' ' 145' ' ' ASN . 1.4 tptp -106.65 -141.11 0.37 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 158' ' ' ASP . 24.7 pttm -91.24 174.13 7.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 36.29 20.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 156' ' ' LYS . 14.5 t0 -79.27 132.66 36.55 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.26 111.88 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.095 0.474 . . . . 0.0 110.858 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.412 ' CD1' ' CD2' ' A' ' 154' ' ' PHE . 7.9 mt -120.57 128.63 53.24 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.6 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.501 ' HZ2' ' CB ' ' A' ' 161' ' ' LYS . 7.8 ttpm? -83.27 135.17 34.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.7 mp -66.3 -51.53 57.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.485 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.601 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 54.2 ttt85 65.94 -49.44 0.41 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.713 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' ILE . 68.2 t0 -149.96 128.43 12.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.115 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.528 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 3.5 ptmm? -121.44 81.74 39.05 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.866 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 -44.01 53.74 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.61 2.207 . . . . 0.0 112.372 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -119.37 176.93 5.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -93.36 -41.82 9.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 240' ' ' TYR . 86.4 mt-30 -72.44 -32.75 66.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.366 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.4 m95 -119.92 153.75 35.43 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.528 ' CD1' ' CB ' ' A' ' 165' ' ' LYS . 14.0 m0 -143.64 135.69 26.67 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 120.992 0.425 . . . . 0.0 110.739 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.694 ' O ' ' O ' ' A' ' 162' ' ' ILE . 46.4 t30 -86.59 107.78 18.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.68 -179.09 3.55 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.546 0.529 . . . . 0.0 110.379 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -126.13 136.09 52.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.514 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 171.39 3.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.651 0.739 . . . . 0.0 110.636 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 1.28 23.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.608 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -105.46 -28.94 10.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.16 50.48 0.34 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -134.24 138.76 45.29 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.35 -0.925 . . . . 0.0 111.212 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.601 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.1 OUTLIER -108.92 122.12 46.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.569 0.7 . . . . 0.0 111.76 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.0 24.41 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.771 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.08 162.06 25.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 -179.121 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.404 ' H ' ' HG3' ' A' ' 182' ' ' MET . 0.0 OUTLIER -157.62 152.16 20.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.954 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.04 113.44 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.199 1.266 . . . . 0.0 110.554 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.57 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 42.4 t -50.48 -50.96 68.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.953 -0.467 . . . . 0.0 111.275 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.0 Cg_endo -45.87 -34.66 12.65 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.933 1.755 . . . . 0.0 112.84 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 7.2 m-85 -63.81 -8.23 10.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.975 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 185' ' ' VAL . 1.3 m -135.22 166.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.812 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 190' ' ' LYS . 0.6 OUTLIER -150.43 -51.18 0.13 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.644 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.509 ' N ' ' OE1' ' A' ' 189' ' ' GLU . 13.9 mmtp . . . . . 0 CA--C 1.516 -0.341 0 O-C-N 123.639 0.587 . . . . 0.0 111.485 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.45 ' CA ' ' C ' ' A' ' 238' ' ' PRO . . . -55.83 -168.97 0.07 OUTLIER Glycine 1 CA--C 1.439 -4.698 0 CA-C-O 122.314 0.952 . . . . 0.0 114.096 -179.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.45 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.7 Cg_exo -47.61 110.82 0.08 OUTLIER 'Cis proline' 1 N--CA 1.544 4.45 0 O-C-N 123.917 1.482 . . . . 0.0 115.253 0.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.631 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.0 m-30 -126.7 -136.45 0.25 Allowed 'General case' 0 C--O 1.212 -0.887 0 O-C-N 124.242 0.964 . . . . 0.0 109.128 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 169' ' ' GLN . 2.7 m-30 -134.86 114.58 12.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.903 0.859 . . . . 0.0 109.754 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.802 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -107.41 140.79 39.8 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.695 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -104.32 100.77 10.49 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.396 -0.815 . . . . 0.0 109.792 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.46 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 4.9 p -71.92 121.74 22.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.178 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.564 ' CD1' ' H ' ' A' ' 244' ' ' ILE . 0.2 OUTLIER -121.62 20.67 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -172.9 108.33 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.418 0.628 . . . . 0.0 109.695 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.424 ' HE2' ' CG ' ' A' ' 287' ' ' PHE . 1.9 ttmt -154.49 -140.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.53 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -158.21 -142.12 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 248' ' ' VAL . 66.0 t -134.47 70.49 72.4 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.761 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.483 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 44.8 Cg_endo -90.16 168.91 4.34 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.954 2.436 . . . . 0.0 111.475 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.773 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -131.57 130.2 41.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.831 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.33 -4.87 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.832 0.708 . . . . 0.0 111.994 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.773 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.4 m-85 -93.39 -54.67 3.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.848 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 250' ' ' ASN . 41.9 t0 -41.35 -62.57 0.83 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.553 -177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.6 mtmt -151.34 26.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.999 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.2 m 75.21 -21.48 0.3 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.628 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.566 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -42.24 107.44 0.08 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.224 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.655 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -44.92 157.77 0.07 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.363 178.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.23 121.42 44.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.752 0.658 . . . . 0.0 110.723 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.405 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.4 mt -140.42 -173.95 3.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.928 0.394 . . . . 0.0 111.243 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -144.95 152.28 39.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.955 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.85 106.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.621 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.94 8.72 8.64 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -96.8 -135.93 0.24 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.802 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.1 OUTLIER 172.1 136.8 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.515 ' N ' HD11 ' A' ' 264' ' ' LEU . 14.8 p -127.09 153.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.014 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 239' ' ' PHE . 1.8 ttmm -105.48 95.15 5.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 268' ' ' THR . 18.2 t -63.03 161.46 2.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.058 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -152.66 -62.38 0.16 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.657 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -71.69 132.14 44.15 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.425 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -148.05 145.39 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.375 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.605 HD22 ' CE ' ' A' ' 272' ' ' MET . 0.1 OUTLIER 174.49 -136.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.876 179.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.605 ' CE ' HD22 ' A' ' 271' ' ' ASN . 47.6 mtm 54.51 -122.47 1.96 Allowed 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.259 0.552 . . . . 0.0 111.163 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -143.96 -16.63 0.6 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.035 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.525 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -168.13 -15.14 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.232 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.589 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.0 mp0 -97.06 159.58 14.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.632 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.589 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -167.57 161.02 13.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.556 -178.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -93.84 -168.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.255 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.29 179.36 28.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.507 ' OE1' ' NH2' ' A' ' 284' ' ' ARG . 5.2 tt0 -168.8 113.82 0.59 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.118 0.485 . . . . 0.0 110.686 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.529 ' SG ' ' CG ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -109.45 -99.85 0.39 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -91.64 48.68 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.33 -29.62 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' SG ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.7 92.5 0.22 Allowed 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.303 -177.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.549 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 78.3 mtt180 -87.11 172.35 10.01 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.159 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.45 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 166.04 -152.44 21.63 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.564 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 11.3 p80 -126.23 166.87 16.29 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.15 0.5 . . . . 0.0 109.783 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 164.75 110.72 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.798 177.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.561 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 36.3 Cg_exo -54.91 141.37 78.08 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.978 1.786 . . . . 0.0 112.598 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.596 ' O ' ' CD1' ' A' ' 289' ' ' PHE . 0.5 OUTLIER -61.24 -1.43 0.49 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 288' ' ' PRO . 39.9 p -46.9 -7.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.092 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 289' ' ' PHE . 0.9 OUTLIER -150.27 80.2 1.35 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.016 -178.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.471 ' C ' ' HE ' ' A' ' 293' ' ' ARG . 0.0 OUTLIER -168.92 151.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.471 ' HE ' ' C ' ' A' ' 292' ' ' VAL . 0.2 OUTLIER -123.45 74.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.64 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 293' ' ' ARG . 68.2 mt -36.49 131.64 0.65 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.1 mp -78.85 -171.97 2.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -91.8 17.14 9.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.45 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.631 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 62.4 tt0 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.307 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.621 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.268 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.621 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.2 m 81.75 162.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 O-C-N 125.183 1.552 . . . . 0.0 111.928 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -132.31 142.33 49.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.598 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -99.83 102.94 14.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.626 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.522 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -101.4 20.56 15.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.717 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.522 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 51.9 m-85 -121.14 1.92 10.34 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.884 -0.144 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.504 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 60.56 139.13 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.797 0 O-C-N 123.999 0.812 . . . . 0.0 109.968 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 13.1 t80 -128.86 -50.57 1.23 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.569 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 144' ' ' PHE . 47.5 t30 37.36 58.07 1.29 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.517 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.435 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -65.77 -150.3 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.572 HD21 ' N ' ' A' ' 148' ' ' ASP . 0.1 OUTLIER 165.6 -15.05 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.855 -0.672 . . . . 0.0 111.207 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' A' ' 149' ' ' ASP . 63.2 m-20 -49.66 -166.71 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' A' ' 148' ' ' ASP . 98.9 m-20 -16.44 -68.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.311 0.382 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 151' ' ' ASP . 17.3 pt-20 -171.07 40.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.027 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 150' ' ' GLU . 1.4 m-20 -53.74 -157.56 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.491 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 13.5 tp -123.92 84.4 54.58 Favored Pre-proline 0 C--O 1.217 -0.622 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.688 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.435 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 56.1 Cg_endo -68.17 121.25 8.23 Favored 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 121.669 1.58 . . . . 0.0 112.438 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 7.7 p90 -140.2 -177.59 5.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 5.8 mttp 179.69 121.84 0.06 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.576 -0.725 . . . . 0.0 109.128 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 105.93 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.635 1.209 . . . . 0.0 110.96 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 19.86 52.48 0.01 OUTLIER Glycine 0 N--CA 1.472 1.038 0 O-C-N 123.564 0.54 . . . . 0.0 111.919 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 156' ' ' LYS . 8.1 t70 -74.46 142.26 44.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.083 0.468 . . . . 0.0 110.329 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.05 96.44 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 mt -102.34 103.67 14.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.805 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -53.21 132.91 39.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.737 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 172' ' ' ASN . 40.1 mm -71.3 -55.15 14.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.113 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.672 HH12 HH11 ' A' ' 180' ' ' ARG . 32.1 ttm180 78.56 -52.03 0.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.551 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 165' ' ' LYS . 50.0 p-10 -120.3 -120.34 0.3 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.21 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.536 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 2.7 pttp 141.87 62.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 124.438 1.086 . . . . 0.0 109.963 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.25 -65.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.567 2.178 . . . . 0.0 112.697 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.7 mt-10 -108.33 168.85 9.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.13 -37.95 25.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -79.73 -23.46 42.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -126.88 152.47 47.01 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 12.8 m0 -147.16 138.5 23.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.682 ' O ' ' O ' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -90.23 121.63 32.42 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.11 -178.14 4.42 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.66 0.6 . . . . 0.0 110.002 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.495 ' CD ' ' NH2' ' A' ' 163' ' ' ARG . 49.1 tt0 -124.62 130.02 51.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.287 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 176' ' ' MET . 9.2 t70 -56.29 177.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.397 0.618 . . . . 0.0 110.879 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.451 ' H ' ' CG ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -80.04 -4.95 54.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.383 177.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -104.91 -27.64 11.58 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.78 48.46 0.33 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -129.29 129.04 44.39 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.856 -0.672 . . . . 0.0 111.376 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.672 HH11 HH12 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -97.65 121.19 39.26 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.79 0.805 . . . . 0.0 111.467 -178.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -152.76 149.43 21.05 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.217 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.52 153.46 41.39 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.122 0.487 . . . . 0.0 110.09 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.94 143.56 28.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.472 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.58 114.57 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.437 1.424 . . . . 0.0 109.978 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 54.2 t -52.15 -48.86 87.51 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.079 -0.388 . . . . 0.0 110.941 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 12.2 Cg_endo -50.49 -27.73 19.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.912 1.742 . . . . 0.0 113.314 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.59 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.8 m-85 -72.24 -5.54 36.62 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.509 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.1 m -128.1 168.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.259 0.349 . . . . 0.0 110.759 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 190' ' ' LYS . 2.5 pt-20 -134.59 67.53 1.5 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.517 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 O-C-N 123.922 0.764 . . . . 0.0 111.327 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.601 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 83.4 m-20 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.424 ' CA ' ' C ' ' A' ' 238' ' ' PRO . . . -103.61 -169.48 25.55 Favored Glycine 1 CA--C 1.435 -4.908 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.98 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.424 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.4 Cg_exo -48.12 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.533 3.851 0 O-C-N 123.442 1.233 . . . . 0.0 114.799 0.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 236' ' ' ASN . 2.3 m-30 -120.66 -135.94 0.32 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 1.8 m-30 -138.79 118.97 13.52 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.584 0.707 . . . . 0.0 109.592 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.548 ' N ' HD11 ' A' ' 264' ' ' LEU . . . -98.4 -162.86 0.99 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -157.43 86.94 0.95 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.654 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.515 HG11 ' H ' ' A' ' 264' ' ' LEU . 8.2 p -63.21 112.57 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.5 ' CD1' HH21 ' A' ' 293' ' ' ARG . 1.1 pt -103.83 16.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -176.2 124.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.202 0.525 . . . . 0.0 111.131 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.476 ' HE2' ' CG ' ' A' ' 287' ' ' PHE . 2.5 ttmt -165.08 -157.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.217 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.43 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 1.6 ptt85 -145.82 -134.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.466 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.426 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 4.6 t -139.38 60.44 16.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.72 ' O ' ' O ' ' A' ' 250' ' ' ASN . 95.9 Cg_endo -94.68 44.04 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.812 2.341 . . . . 0.0 113.322 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.726 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.3 p-10 -21.23 153.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.014 0.821 . . . . 0.0 111.465 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.2 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.688 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 254' ' ' LYS . 31.9 m-85 -79.28 -64.52 1.17 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.2 t70 -45.98 63.42 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 125.142 1.526 . . . . 0.0 110.319 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.828 ' N ' ' O ' ' A' ' 252' ' ' TYR . 33.7 mtmt 81.34 -48.47 0.25 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.618 1.199 . . . . 0.0 110.364 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.65 -25.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.849 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.668 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -41.34 108.56 0.09 Allowed 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.951 0.405 . . . . 0.0 111.48 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -43.07 159.98 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.431 0 O-C-N 122.11 -0.369 . . . . 0.0 110.963 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.541 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -112.17 122.51 47.94 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.515 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 0.8 OUTLIER -140.68 -174.07 3.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.086 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -145.84 145.33 30.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.159 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 66.4 t -46.82 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.39 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 11.84 10.6 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 264' ' ' LEU . 56.3 mm-40 -88.3 -36.32 16.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.281 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 135.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.614 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.577 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.3 p -133.45 159.37 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.39 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 6.1 ttmt -103.33 94.9 5.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.927 ' O ' ' N ' ' A' ' 269' ' ' LYS . 2.6 t -46.03 -42.4 4.41 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.527 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.59 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 7.9 t 35.16 -60.07 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.927 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER -73.77 110.49 8.1 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.9 mt -136.6 101.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.598 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.897 HD21 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -93.05 -31.64 14.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 179.373 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.897 ' H ' HD21 ' A' ' 271' ' ' ASN . 29.1 mtm -131.28 172.49 12.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.999 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.9 p -91.22 5.62 48.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . -124.33 -90.69 0.89 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.791 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.48 69.2 10.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 0.0 110.722 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 0.4 OUTLIER -77.78 178.48 7.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.623 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 3.4 mt-10 -104.19 -167.41 1.36 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -157.76 -171.39 23.67 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.425 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.0 tt0 -170.44 109.54 0.36 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.765 0.317 . . . . 0.0 111.516 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -100.84 -101.69 0.25 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -90.6 47.64 1.45 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.14 -28.31 9.0 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.419 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.86 91.55 0.2 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.122 -178.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 84.5 mtt180 -85.54 173.31 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.099 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.502 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 161.79 -151.12 21.15 Favored Glycine 0 C--O 1.215 -1.052 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.52 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 14.3 p-80 -130.4 169.3 15.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.474 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.66 116.04 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.547 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 290' ' ' THR . 22.6 Cg_endo -62.72 162.48 24.83 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.106 1.87 . . . . 0.0 112.912 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.551 ' C ' ' H ' ' A' ' 291' ' ' HIS . 82.8 t80 -65.48 1.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.682 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.486 ' H ' ' C ' ' A' ' 288' ' ' PRO . 71.7 p -51.2 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 289' ' ' PHE . 1.7 p80 -172.29 85.98 0.07 Allowed 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.391 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.0 OUTLIER -174.27 148.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.5 HH21 ' CD1' ' A' ' 244' ' ' ILE . 24.3 mmt180 -130.15 81.96 2.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 36.9 mt -43.69 133.96 4.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.381 0.61 . . . . 0.0 111.066 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.0 mp -88.11 -169.95 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -100.55 14.97 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.582 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 239' ' ' PHE . 34.2 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.365 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 p90 . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.88 167.19 16.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -119.72 126.23 50.57 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.073 0.464 . . . . 0.0 110.038 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -92.0 89.28 6.91 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.97 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -100.38 31.47 3.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.385 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 143' ' ' ASP . 50.4 m-85 -132.56 2.98 3.84 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.392 -0.193 . . . . 0.0 110.811 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.3 p30 52.7 137.63 0.0 OUTLIER 'General case' 0 C--O 1.208 -1.109 0 O-C-N 124.924 1.39 . . . . 0.0 110.11 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 6.3 t80 -122.76 -42.77 2.29 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.735 0.302 . . . . 0.0 110.636 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.419 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 62.9 t-20 42.77 59.14 2.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.491 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -65.43 -145.36 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.3 p30 168.39 82.89 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.931 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.506 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 5.2 m-20 174.94 179.06 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 110.349 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -87.94 -21.07 25.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.203 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -103.48 26.12 8.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.4 p30 -141.18 158.75 43.48 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 tp -118.51 89.45 36.76 Favored Pre-proline 0 C--O 1.215 -0.748 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.34 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 139.93 52.2 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 CA-C-N 120.314 1.148 . . . . 0.0 112.542 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.435 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 16.0 p90 -158.79 161.72 36.98 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.576 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER 176.84 125.68 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.507 0.504 . . . . 0.0 110.101 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 11.3 ptpt 136.0 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.521 1.138 . . . . 0.0 109.796 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.76 51.17 0.38 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -83.86 158.7 21.55 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.134 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.6 mm -109.14 112.88 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.381 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -112.94 126.0 55.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.821 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -81.01 143.75 32.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 111.145 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.7 mp -94.98 156.28 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.588 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 174' ' ' GLU . 21.5 ttm105 -135.8 -33.65 0.85 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.473 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.77 128.56 11.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.1 pttm -121.67 79.26 39.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.118 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.21 -42.2 69.35 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.181 1.921 . . . . 0.0 111.989 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -117.37 178.17 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.493 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.58 -29.73 13.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.006 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.59 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 78.9 mt-30 -80.8 -27.34 36.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.864 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.453 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 71.7 m95 -123.3 151.96 41.88 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.428 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 13.5 m0 -143.22 135.65 27.3 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 120.84 0.352 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.52 108.34 12.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.8 163.09 13.22 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.81 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 16.0 tt0 -122.77 128.36 50.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.09 177.76 0.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.68 0.752 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 98.1 mmm -74.82 -2.25 25.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.609 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -99.41 -20.67 16.35 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.464 0.649 . . . . 0.0 110.843 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.82 -28.52 6.39 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -53.01 146.05 11.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.073 0.463 . . . . 0.0 110.532 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 132.54 56.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.658 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.51 151.61 23.16 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.222 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 84.1 mmm -67.34 159.25 29.72 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.318 0.58 . . . . 0.0 110.387 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 6.7 pt -151.26 142.7 15.53 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.952 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.53 115.62 4.28 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.447 1.431 . . . . 0.0 110.015 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 36.3 t -50.24 -52.94 49.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.7 Cg_endo -51.58 -25.99 21.24 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 122.383 2.055 . . . . 0.0 113.291 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.537 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.6 m-85 -69.89 0.92 5.02 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.413 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 185' ' ' VAL . 2.1 m -132.39 161.68 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -93.98 -62.42 1.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.729 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 17.3 tptm . . . . . 0 CA--C 1.539 0.533 0 O-C-N 124.81 1.319 . . . . 0.0 109.757 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.567 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 36.7 p-10 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 236' ' ' ASN . . . -89.23 -165.55 41.24 Favored Glycine 1 CA--C 1.436 -4.85 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.749 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.7 Cg_endo -45.05 100.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.536 3.994 0 N-CA-C 116.843 1.824 . . . . 0.0 116.843 1.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.567 ' CZ ' ' O ' ' A' ' 236' ' ' ASN . 8.4 m-30 -114.55 -130.66 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.29 127.6 18.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 109.227 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 294' ' ' LEU . . . -104.51 -165.09 1.11 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.222 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -156.48 94.77 1.51 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.6 p -73.71 116.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.0 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.589 ' CD1' ' H ' ' A' ' 244' ' ' ILE . 0.0 OUTLIER -110.21 18.03 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.993 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 244' ' ' ILE . 2.3 mm-40 -174.38 121.06 0.26 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -168.55 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.551 178.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.655 HH21 ' HZ1' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -154.57 -134.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.634 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.421 ' O ' ' OD2' ' A' ' 253' ' ' ASP . 3.4 t -137.84 62.89 36.39 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.607 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.71 ' O ' ' O ' ' A' ' 250' ' ' ASN . 11.6 Cg_endo -98.62 31.04 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.959 1.773 . . . . 0.0 114.417 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 249' ' ' PRO . 13.5 p30 -24.93 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.463 1.102 . . . . 0.0 112.588 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.26 -22.32 29.15 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.442 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.405 ' C ' ' OD1' ' A' ' 250' ' ' ASN . 32.9 m-85 -111.34 47.71 0.99 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 254' ' ' LYS . 1.2 m-20 -151.42 15.98 0.7 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.655 ' HZ1' HH21 ' A' ' 247' ' ' ARG . 28.1 mtmt 147.22 -65.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 41.7 m 166.77 -16.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.199 0.937 . . . . 0.0 110.428 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ASN . . . -82.02 170.24 15.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.294 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.795 ' CD2' ' O ' ' A' ' 285' ' ' GLY . 0.5 OUTLIER -87.26 151.18 23.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.68 0.392 . . . . 0.0 110.623 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -96.45 121.71 38.57 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.124 0.42 . . . . 0.0 111.118 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.408 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.5 mt -142.33 -171.78 3.47 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.646 0.736 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -144.79 148.44 34.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.272 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 81.1 t -53.11 100.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.509 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.62 9.71 9.94 Favored Glycine 0 CA--C 1.51 -0.233 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 264' ' ' LEU . 12.5 mm-40 -86.99 -36.23 18.38 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 136.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.116 0.96 . . . . 0.0 109.12 -178.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.552 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 12.5 p -131.63 150.67 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -107.33 91.94 3.86 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.67 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.34 159.63 2.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.846 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.537 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.4 OUTLIER -157.76 -44.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.63 142.84 57.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.225 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 271' ' ' ASN . 74.0 mt -132.34 156.08 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.618 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER 172.32 -91.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.801 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.676 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 3.9 mtm -69.03 135.72 51.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.137 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.3 p -74.71 20.49 0.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -148.03 -50.46 0.02 OUTLIER Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.151 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.492 ' O ' ' HE1' ' A' ' 272' ' ' MET . 1.0 OUTLIER -105.33 98.34 8.06 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 1.6 m95 -101.49 173.74 6.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -115.83 127.25 54.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.023 0.439 . . . . 0.0 110.614 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -79.58 -164.37 28.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.256 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.423 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 3.3 tt0 -172.7 112.26 0.25 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.848 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.419 ' SG ' ' HG3' ' A' ' 283' ' ' LYS . 0.1 OUTLIER -107.96 -98.08 0.37 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -93.07 40.34 1.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.17 -21.46 42.1 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.596 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -68.63 75.26 0.28 Allowed 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 114.576 -0.812 . . . . 0.0 110.369 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.423 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 89.9 mtt180 -74.54 166.12 24.06 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.256 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.795 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 157.74 129.23 1.09 Allowed Glycine 0 C--O 1.198 -2.14 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.519 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -59.02 174.99 0.32 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 117.963 -3.081 . . . . 0.0 110.329 -175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.557 ' CZ ' ' NH1' ' A' ' 247' ' ' ARG . 0.1 OUTLIER -179.66 115.95 0.22 Allowed Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.114 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.534 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 85.0 Cg_exo -44.33 130.38 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.055 1.055 . . . . 0.0 112.783 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.661 ' C ' ' H ' ' A' ' 291' ' ' HIS . 0.0 OUTLIER -62.6 -3.3 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.903 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.4 p -52.02 4.47 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.661 ' H ' ' C ' ' A' ' 289' ' ' PHE . 5.7 p80 -156.5 74.71 0.83 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 291' ' ' HIS . 1.3 m -166.58 150.96 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -108.82 -44.39 4.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.0 mt 74.31 118.41 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.503 1.144 . . . . 0.0 111.578 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 8.9 mp -88.46 -175.42 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.855 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.33 -52.35 23.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.441 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.403 ' OXT' ' OE1' ' A' ' 169' ' ' GLN . 55.5 tt0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.706 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.568 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.568 ' O ' ' O ' ' A' ' 137' ' ' TYR . 31.5 m 42.9 -179.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 124.06 0.85 . . . . 0.0 110.303 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -133.08 121.72 23.07 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.436 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -95.3 100.01 11.86 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.057 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.459 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -111.29 32.29 5.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.921 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 143' ' ' ASP . 43.7 m-85 -127.63 2.9 6.14 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.72 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.1 p30 58.88 138.03 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 124.464 1.102 . . . . 0.0 109.811 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 7.6 t80 -130.11 -49.78 1.11 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.04 0.382 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 40.13 65.78 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.77 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.43 -138.55 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.639 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.3 p30 172.86 101.08 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.323 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 9.8 m-20 151.1 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.363 1.039 . . . . 0.0 110.697 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.42 -15.81 26.71 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -105.36 24.8 11.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.855 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.639 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.9 p-10 -137.48 152.64 49.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.3 tp -116.33 87.89 21.54 Favored Pre-proline 0 C--O 1.214 -0.792 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.542 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.98 122.76 9.65 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.347 1.364 . . . . 0.0 112.201 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.436 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 14.5 p90 -139.21 169.27 18.08 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -171.04 122.01 0.56 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.553 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.1 mtpp 98.64 74.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.675 1.234 . . . . 0.0 111.589 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 30.82 55.26 0.26 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.068 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 31.2 t0 -73.58 150.52 41.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.9 0.381 . . . . 0.0 110.708 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.444 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.6 mp -102.51 108.76 24.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 mt -121.71 106.22 11.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.235 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -61.31 133.51 55.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.802 0.689 . . . . 0.0 112.785 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.4 mp -78.64 132.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.717 178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.63 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 12.8 tpt180 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.529 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -147.18 121.28 9.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.437 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 10.6 ptmt -112.7 75.2 1.8 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.817 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.84 -35.74 11.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.981 1.788 . . . . 0.0 112.122 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -103.66 168.7 8.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.149 0.5 . . . . 0.0 110.607 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.71 -38.38 11.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.37 -22.29 32.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.514 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 69.6 m95 -120.8 151.67 39.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 12.4 m0 -145.43 135.98 24.25 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.085 0.469 . . . . 0.0 110.738 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.12 107.97 13.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.34 164.95 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.978 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 14.4 tt0 -127.34 136.96 52.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.609 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.68 -175.28 1.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.492 0.663 . . . . 0.0 110.461 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 87.2 mmm -76.28 -15.45 60.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.955 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.52 -22.27 22.51 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.275 0.56 . . . . 0.0 111.011 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.67 -19.98 9.55 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -52.73 143.61 15.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.63 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -115.85 124.76 51.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.503 0.668 . . . . 0.0 111.225 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.18 145.54 14.65 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.705 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mtp -64.59 160.19 20.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.566 0.698 . . . . 0.0 110.458 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 5.1 pt -151.75 144.32 16.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.881 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.71 110.01 2.98 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.025 1.15 . . . . 0.0 110.657 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.514 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 55.6 t -44.22 -52.69 15.67 Favored Pre-proline 0 C--O 1.218 -0.604 0 O-C-N 121.882 -0.511 . . . . 0.0 111.821 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.9 Cg_endo -48.39 -24.54 6.27 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.887 1.724 . . . . 0.0 113.509 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.421 ' HH ' ' H ' ' A' ' 270' ' ' ILE . 7.5 m-85 -74.29 5.52 4.45 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.311 -0.555 . . . . 0.0 112.004 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.4 m -133.64 162.79 38.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.419 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' A' ' 190' ' ' LYS . 0.2 OUTLIER -121.74 -67.18 0.98 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.458 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 21.9 tptm . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -168.05 160.74 34.4 Favored Glycine 1 CA--C 1.448 -4.15 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.405 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.418 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 9.0 Cg_exo -72.48 131.94 24.1 Favored 'Cis proline' 0 C--N 1.285 -2.766 0 O-C-N 122.257 0.609 . . . . 0.0 110.931 -6.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 37.4 m-85 -159.74 -123.17 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -145.2 121.74 11.07 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.337 0.517 . . . . 0.0 111.103 -178.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.577 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -101.55 -158.49 0.67 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.592 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -159.47 94.95 1.2 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 9.8 p -73.61 110.66 7.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.431 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.72 22.69 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.731 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 177.81 110.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.521 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.7 ttmt -153.62 -145.94 0.18 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.404 0.621 . . . . 0.0 110.284 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.521 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.0 ptt85 -155.41 -144.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.621 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 8.7 p -131.96 66.38 77.55 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.485 0.66 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 60.1 Cg_endo -83.38 157.72 14.68 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.81 2.34 . . . . 0.0 113.574 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -90.9 -172.44 3.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.286 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -103.68 -3.63 24.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.661 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.577 ' C ' ' H ' ' A' ' 254' ' ' LYS . 25.5 m-85 -89.05 -27.67 20.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 32.9 t70 -70.03 43.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.198 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 252' ' ' TYR . 38.5 mtmt 99.04 -45.55 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.424 1.09 . . . . 0.0 108.945 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 284' ' ' ARG . 0.9 OUTLIER 149.18 5.99 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.907 0 O-C-N 125.132 1.52 . . . . 0.0 110.364 179.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 255' ' ' THR . . . -35.71 115.87 0.34 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.206 0.527 . . . . 0.0 111.774 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.542 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -68.68 117.64 10.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -71.23 125.29 26.55 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.323 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.476 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 2.6 mt -142.14 -175.67 4.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.712 0.768 . . . . 0.0 111.238 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -145.61 138.94 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.33 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 53.1 t -44.01 105.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.147 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.54 7.13 24.57 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.362 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' LEU . 43.8 mm-40 -83.7 -37.34 22.85 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 241' ' ' ALA . 0.2 OUTLIER 62.5 135.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.549 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.7 p -131.14 152.51 37.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.302 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 279' ' ' GLU . 0.9 OUTLIER -103.86 108.67 20.09 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.377 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.458 HG12 ' CD2' ' A' ' 276' ' ' TRP . 97.9 t -72.43 157.05 6.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.494 ' O ' ' OG1' ' A' ' 268' ' ' THR . 0.0 OUTLIER 177.83 43.82 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -157.51 98.74 1.7 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 120.827 -1.171 . . . . 0.0 109.15 178.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 270' ' ' ILE . 1.6 mp -113.33 133.31 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.38 0.61 . . . . 0.0 111.233 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.706 HD21 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -112.81 -29.62 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.98 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.706 ' H ' HD21 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -134.54 -164.4 1.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.536 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -109.66 19.33 19.31 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.181 -0.325 . . . . 0.0 110.705 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.502 ' N ' ' SD ' ' A' ' 272' ' ' MET . . . -130.81 -100.3 0.85 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.704 ' N ' ' SD ' ' A' ' 272' ' ' MET . 50.6 mm-40 -76.24 105.29 7.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.987 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.458 ' CD2' HG12 ' A' ' 267' ' ' VAL . 0.4 OUTLIER -98.05 178.45 5.1 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.623 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.477 ' OE2' ' OD1' ' A' ' 271' ' ' ASN . 24.8 mp0 -95.39 -152.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.751 -178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.32 -177.88 34.79 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 266' ' ' LYS . 2.4 tm-20 -169.75 117.06 0.58 Allowed 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 117.226 0.513 . . . . 0.0 110.768 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.603 ' HG ' ' CD ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -107.08 -56.56 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -136.92 38.22 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 284' ' ' ARG . . . 93.28 -21.31 41.1 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.942 ' O ' ' O ' ' A' ' 284' ' ' ARG . 0.0 OUTLIER -57.54 -6.73 0.51 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.386 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.942 ' O ' ' O ' ' A' ' 283' ' ' LYS . 13.9 mtt85 15.86 -177.21 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 O-C-N 126.023 2.077 . . . . 0.0 113.104 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 150.02 -145.38 13.42 Favored Glycine 0 C--N 1.287 -2.182 0 O-C-N 120.652 -1.28 . . . . 0.0 110.549 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.2 p80 -145.37 177.86 8.52 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 114.351 -0.924 . . . . 0.0 109.206 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.619 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.4 m-85 159.06 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 O-C-N 123.877 0.736 . . . . 0.0 109.143 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.0 Cg_exo -51.54 153.96 9.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.93 1.753 . . . . 0.0 113.214 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 46.9 t80 -65.13 2.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 288' ' ' PRO . 32.3 p -51.77 -38.31 54.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.51 72.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.58 144.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -123.55 75.5 1.34 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.065 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 8.3 mt -43.61 125.95 4.27 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.575 0.702 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.9 mp -71.15 -173.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.015 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -83.18 39.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.843 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.502 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 82.2 mt-30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.195 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.687 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 5.8 p90 . . . . . 0 C--O 1.209 -1.029 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.687 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 2.8 m 93.78 152.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 125.686 1.866 . . . . 0.0 111.984 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -120.81 133.21 55.32 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.331 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . . . -94.08 93.71 7.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.007 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.448 ' CD1' ' H ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.35 20.03 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.034 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.454 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -115.93 -9.36 11.8 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.481 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 72.3 136.32 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.048 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.1 t80 -128.83 -43.22 1.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.854 0.359 . . . . 0.0 110.125 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 146' ' ' GLY . 21.9 t-20 41.62 62.49 1.54 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 145' ' ' ASN . . . -62.57 -122.43 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.478 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 1.0 OUTLIER 169.56 -65.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.879 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 150' ' ' GLU . 18.2 m-20 -53.81 142.65 23.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.783 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 31.2 p-10 -61.47 -1.2 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 148' ' ' ASP . 47.5 mt-10 -105.68 13.76 29.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.269 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 20.5 p30 -130.78 163.26 27.71 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.448 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 3.8 tp -104.35 91.71 4.17 Favored Pre-proline 0 C--O 1.211 -0.966 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.303 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.467 ' O ' ' OD2' ' A' ' 175' ' ' ASP . 72.7 Cg_endo -70.49 139.13 37.03 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 CA-C-N 120.825 1.33 . . . . 0.0 112.804 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.499 ' CD1' ' CB ' ' A' ' 140' ' ' ALA . 12.5 p90 -167.42 157.05 10.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -174.35 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.349 179.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -61.02 -3.28 0.75 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.265 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 155' ' ' LYS . . . 92.85 56.94 1.45 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 27.0 t0 -81.74 157.85 24.39 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.502 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.6 mp -98.63 98.12 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 137' ' ' TYR . 96.3 mt -91.83 94.13 9.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.128 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 52.8 tttp -68.87 132.44 46.74 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.518 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.22 142.81 15.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.27 -48.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.64 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -153.24 64.05 0.76 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.641 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.403 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 11.8 pttp -49.54 106.48 0.63 Allowed Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 119.402 -0.332 . . . . 0.0 110.787 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.79 -48.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.443 1.428 . . . . 0.0 112.438 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.02 172.75 6.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.775 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -85.51 -34.47 21.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.4 -15.57 45.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.468 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 48.1 m95 -131.46 151.53 51.48 Favored 'General case' 0 C--O 1.228 -0.074 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.422 ' O ' ' CG1' ' A' ' 183' ' ' ILE . 12.9 m0 -139.78 134.44 31.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.907 0.86 . . . . 0.0 112.496 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -91.55 101.03 13.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.27 -179.26 3.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.51 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.88 112.72 13.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.624 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.4 OUTLIER -63.81 140.58 58.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.951 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 95.2 mtp -47.85 -8.14 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.426 0.454 . . . . 0.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.624 ' H ' ' C ' ' A' ' 175' ' ' ASP . 96.6 m-20 -72.98 -21.78 60.79 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.667 0.746 . . . . 0.0 110.048 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.49 44.06 3.54 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.631 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -142.46 143.92 32.81 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.161 -0.519 . . . . 0.0 109.76 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.05 127.95 53.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.534 0.683 . . . . 0.0 110.964 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -156.07 153.1 24.48 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.361 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.54 152.79 44.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.468 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 1.3 pt -143.4 146.58 36.53 Favored Pre-proline 0 N--CA 1.455 -0.191 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.46 140.46 63.41 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.481 -1.392 . . . . 0.0 108.481 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 38.5 t -79.93 -37.9 1.14 Allowed Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.661 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 36.4 Cg_endo -68.88 -21.0 38.43 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.271 1.981 . . . . 0.0 112.914 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.1 m-85 -77.88 4.51 11.77 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.976 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.01 161.17 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.424 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 1.1 pp20? -146.35 153.58 40.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 13.4 tptm . . . . . 0 C--N 1.316 -0.866 0 C-N-CA 124.276 1.03 . . . . 0.0 111.808 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 239' ' ' PHE . . . -165.11 134.41 3.31 Favored Glycine 1 CA--C 1.445 -4.322 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.061 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -71.56 97.49 0.15 OUTLIER 'Cis proline' 0 N--CA 1.529 3.615 0 CA-C-N 118.171 0.985 . . . . 0.0 112.134 -6.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 4.3 m-85 -117.09 -134.34 0.34 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -146.19 137.54 24.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 118.986 0.812 . . . . 0.0 109.768 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -122.93 140.26 53.18 Favored 'General case' 0 C--O 1.195 -1.768 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.147 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -104.17 111.04 23.48 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.366 0.603 . . . . 0.0 110.704 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 3.1 p -79.63 127.46 39.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.141 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.44 15.74 7.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -174.08 112.21 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.633 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.518 ' HZ3' ' CB ' ' A' ' 287' ' ' PHE . 2.5 ttmt -165.13 -156.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.266 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.92 -138.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.134 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 73.4 t -132.83 60.89 53.08 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 120.677 0.275 . . . . 0.0 111.194 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 18.0 Cg_endo -96.72 -170.82 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.479 2.119 . . . . 0.0 111.394 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.1 p-10 -157.9 153.34 26.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.142 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 256' ' ' ALA . . . -41.16 -11.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 254' ' ' LYS . 33.4 m-85 -73.83 -53.12 10.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 250' ' ' ASN . 35.9 t70 -53.58 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 125.813 1.946 . . . . 0.0 111.702 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' A' ' 252' ' ' TYR . 29.7 mtmt 82.33 -43.11 0.14 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.269 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.558 ' O ' ' ND1' ' A' ' 286' ' ' HIS . 0.1 OUTLIER 158.37 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.405 0.621 . . . . 0.0 110.029 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -109.95 165.01 12.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.864 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.452 ' N ' HD21 ' A' ' 257' ' ' LEU . 0.3 OUTLIER -114.77 151.78 33.2 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -178.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.423 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -88.64 113.66 24.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 258' ' ' ALA . 0.4 OUTLIER -143.28 174.57 10.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.798 177.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -142.95 148.84 37.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.386 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 73.3 t -52.65 99.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.957 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 127.79 -2.94 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.39 -163.25 1.03 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.072 0.463 . . . . 0.0 110.621 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER -159.11 149.37 19.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.755 0.788 . . . . 0.0 111.117 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.542 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.0 p -133.48 141.48 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -74.26 176.01 7.06 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.915 ' O ' ' N ' ' A' ' 269' ' ' LYS . 18.4 t -119.29 -36.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.144 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.415 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 20.64 -55.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.904 1.378 . . . . 0.0 114.178 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.915 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -84.7 116.11 23.05 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.388 0.613 . . . . 0.0 111.853 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 270' ' ' ILE . 0.6 OUTLIER -136.92 154.1 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.501 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.536 ' O ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -174.69 158.37 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.99 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.534 ' O ' ' O ' ' A' ' 271' ' ' ASN . 3.9 mtm 52.52 162.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.462 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 p -88.98 27.94 1.26 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -149.07 -85.5 0.06 OUTLIER Glycine 0 C--O 1.209 -1.464 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.325 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 275' ' ' GLN . 1.8 mp0 -61.99 168.78 3.0 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 178.1 -174.17 0.15 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.28 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -144.64 147.5 33.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.494 -1.685 . . . . 0.0 113.598 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -131.16 131.92 6.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.037 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 281' ' ' ASN . 6.2 tm-20 -103.45 125.14 49.86 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.541 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' CYS . . . . . 0.623 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -125.88 84.37 2.27 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.099 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE2' ' A' ' 279' ' ' GLU . 2.4 m120 76.36 21.49 1.39 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.086 -1.009 . . . . 0.0 110.654 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 104.21 -32.83 7.11 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.475 -0.329 . . . . 0.0 112.65 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.623 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.8 OUTLIER -63.06 60.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.954 0.407 . . . . 0.0 110.754 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 282' ' ' GLY . 52.8 mtt180 -60.86 162.25 7.08 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.527 0.68 . . . . 0.0 109.939 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.98 -170.68 43.46 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.634 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.7 p-80 -140.39 95.3 2.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.866 1.333 . . . . 0.0 112.654 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.518 ' CB ' ' HZ3' ' A' ' 246' ' ' LYS . 0.7 OUTLIER -101.23 129.38 27.15 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 113.714 -1.585 . . . . 0.0 109.646 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -50.55 153.91 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.367 1.378 . . . . 0.0 112.528 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.573 ' C ' ' H ' ' A' ' 291' ' ' HIS . 90.3 t80 -72.01 -3.55 23.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.431 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 67.8 p -55.63 10.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.676 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' A' ' 289' ' ' PHE . 1.2 p80 -176.19 68.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.625 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.07 153.73 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 294' ' ' LEU . 27.8 mmm-85 -130.98 66.32 1.54 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.401 0.143 . . . . 0.0 111.357 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 293' ' ' ARG . 11.3 mt -31.32 129.05 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.107 0.956 . . . . 0.0 112.499 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.17 -106.53 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.23 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 34.5 t0 -173.82 44.45 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 296' ' ' ASP . 7.6 tt0 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.136 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -83.29 -103.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.152 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -44.61 152.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.47 . . . . 0.0 110.471 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.62 166.06 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.428 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -115.49 131.54 56.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -102.23 92.68 4.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.724 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.575 ' CD1' ' H ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -103.27 22.63 13.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.942 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 143' ' ' ASP . 65.3 m-85 -119.45 2.46 11.26 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.6 p30 55.39 138.76 0.0 OUTLIER 'General case' 0 C--O 1.21 -0.992 0 O-C-N 124.365 1.041 . . . . 0.0 110.422 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 6.7 t80 -127.99 -41.54 1.62 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.844 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 144' ' ' PHE . 39.3 t-20 36.21 59.22 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.478 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.02 -141.28 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.571 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.2 OUTLIER 166.8 88.28 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.413 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 3.6 m-20 171.97 -178.42 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.211 0.529 . . . . 0.0 110.33 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 149' ' ' ASP . 60.9 t0 -91.0 -20.4 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.388 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.26 25.81 9.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.693 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.7 p-10 -141.33 156.63 45.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.4 tp -120.17 82.31 30.06 Favored Pre-proline 0 C--O 1.216 -0.695 0 CA-C-O 120.755 0.312 . . . . 0.0 110.999 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.42 136.79 74.09 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 121.456 1.437 . . . . 0.0 112.108 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.45 ' CZ ' ' CB ' ' A' ' 144' ' ' PHE . 10.6 p90 -152.09 165.14 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.524 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -175.86 102.93 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.795 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.577 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.5 tppp? 127.61 77.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.652 1.22 . . . . 0.0 110.959 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.71 49.73 0.02 OUTLIER Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 156' ' ' LYS . 28.7 t0 -72.91 144.87 47.19 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.922 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' A' ' 159' ' ' ILE . 10.7 tp -104.17 109.54 27.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.37 122.79 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.675 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -77.91 141.84 38.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.91 139.13 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.7 tpt85 -117.9 -43.36 2.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.276 0.56 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.32 129.08 11.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.684 ' NZ ' ' HE1' ' A' ' 171' ' ' TRP . 0.1 OUTLIER -119.48 77.53 19.48 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.145 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.03 -44.36 50.47 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.295 1.996 . . . . 0.0 111.732 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.49 177.02 4.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -96.57 -32.05 12.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.511 ' NE2' ' CZ ' ' A' ' 240' ' ' TYR . 85.2 mt-30 -77.17 -28.12 53.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.468 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.494 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 66.0 m95 -123.84 153.59 40.83 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.684 ' HE1' ' NZ ' ' A' ' 165' ' ' LYS . 17.4 m0 -143.65 136.7 27.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.4 108.03 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.44 168.32 9.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.957 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -126.63 138.36 53.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.894 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -68.09 174.56 3.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.302 0.572 . . . . 0.0 110.698 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ptm -79.88 -2.57 44.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.349 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -101.92 -28.25 12.51 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.6 48.69 0.45 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.57 132.56 49.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.671 -0.764 . . . . 0.0 109.568 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 125.86 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.322 0.582 . . . . 0.0 111.951 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.24 153.34 24.6 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.565 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 32.3 mtp -66.51 160.8 24.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.432 0.634 . . . . 0.0 110.817 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.3 pt -152.05 143.06 15.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.794 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -69.4 114.69 3.73 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.639 1.559 . . . . 0.0 110.013 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.551 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 27.0 t -49.98 -52.81 49.2 Favored Pre-proline 0 C--O 1.216 -0.673 0 O-C-N 121.927 -0.483 . . . . 0.0 111.69 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.6 Cg_endo -49.5 -24.71 9.48 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.147 1.898 . . . . 0.0 113.367 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.487 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.9 m-85 -74.54 3.72 7.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -134.86 162.29 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 39.3 mt-10 -81.28 -59.37 2.67 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.276 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 18.0 tptm 137.02 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 O-C-N 124.515 1.134 . . . . 0.0 109.891 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 43.3 t 59.95 70.78 0.61 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -157.46 100.18 1.89 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.229 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.29 155.0 36.94 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.024 1.816 . . . . 0.0 112.58 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 195' ' ' SER . 77.8 p -171.85 -64.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.437 ' N ' ' OG ' ' A' ' 194' ' ' SER . 24.1 p -86.65 172.51 10.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.573 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -87.45 160.78 18.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.466 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.0 m 61.64 84.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.65 -33.21 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.4 m -45.05 108.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.605 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -82.25 -18.97 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 201' ' ' LEU . 1.0 OUTLIER -172.52 -2.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 201' ' ' LEU . 7.8 m -30.59 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.371 0.419 . . . . 0.0 111.278 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.85 66.23 1.23 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.3 -121.59 4.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 205' ' ' ASN . 48.4 p30 -150.34 74.37 1.19 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.914 0.387 . . . . 0.0 110.698 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -48.37 -26.61 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.384 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 208' ' ' SER . 67.3 t0 -64.44 133.28 52.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 14.2 p -76.24 159.01 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.674 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.6 m -80.15 154.84 27.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.41 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.505 ' CD2' ' H ' ' A' ' 210' ' ' HIS . 2.5 p80 -79.15 151.69 75.87 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.72 143.18 73.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.477 2.118 . . . . 0.0 111.836 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.624 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 3.4 tt0 -91.76 -41.78 0.37 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.148 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 25.0 Cg_exo -61.36 142.4 95.66 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.499 2.133 . . . . 0.0 111.734 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.97 114.8 20.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.254 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 130.93 12.07 2.21 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 40.36 77.1 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.97 -48.92 19.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.387 2.058 . . . . 0.0 112.109 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.75 148.78 0.51 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.69 -8.29 22.85 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.551 2.167 . . . . 0.0 112.091 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.97 -166.07 13.07 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.484 ' CG ' ' OE1' ' A' ' 224' ' ' GLN . 60.5 Cg_endo -78.71 164.02 25.99 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.692 2.261 . . . . 0.0 112.225 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.516 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 68.5 t80 -58.12 173.01 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -38.76 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 222' ' ' TYR . 6.9 mt-30 -120.02 95.96 49.25 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.332 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.15 -9.35 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.287 1.991 . . . . 0.0 112.024 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 224' ' ' GLN . 4.4 p -103.96 -167.87 1.42 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.668 ' C ' ' H ' ' A' ' 229' ' ' THR . 34.1 mm -114.45 32.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.339 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.442 ' H ' ' HG ' ' A' ' 226' ' ' SER . 93.9 m-20 -63.54 29.91 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.668 ' H ' ' C ' ' A' ' 227' ' ' ILE . 0.6 OUTLIER -58.56 159.36 12.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.3 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 229' ' ' THR . 80.8 Cg_exo -35.47 -101.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 122.611 2.207 . . . . 0.0 112.124 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.08 97.8 43.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 122.081 -0.387 . . . . 0.0 110.889 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.99 -62.01 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.986 1.791 . . . . 0.0 112.457 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.635 ' C ' ' H ' ' A' ' 235' ' ' GLN . 19.4 t-20 -176.22 115.68 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.536 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 20.7 tp 63.37 -29.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.142 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.635 ' H ' ' C ' ' A' ' 233' ' ' ASN . 52.7 tt0 73.65 140.98 0.06 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -56.25 -41.21 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.035 0.445 . . . . 0.0 110.061 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -62.22 -165.29 0.44 Allowed Glycine 1 CA--C 1.447 -4.171 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.373 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.417 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.0 Cg_endo -46.78 98.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.767 0 N-CA-C 116.141 1.554 . . . . 0.0 116.141 0.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 10.3 m-30 -116.51 -132.09 0.32 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.511 ' CZ ' ' NE2' ' A' ' 169' ' ' GLN . 2.0 m-30 -136.34 115.88 12.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.67 0.748 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.681 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -106.85 140.81 39.09 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.943 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -103.91 97.71 7.66 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.74 127.21 23.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.142 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.48 22.91 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.99 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.283 0.564 . . . . 0.0 110.159 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.483 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.7 ttmt -146.76 -146.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.31 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.483 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 0.6 OUTLIER -155.97 -145.53 0.16 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.626 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 97.0 t -132.91 74.13 74.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.463 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 18.9 Cg_endo -91.65 169.93 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.036 2.491 . . . . 0.0 111.323 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.7 OUTLIER -127.12 127.34 44.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.792 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.07 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.856 0.722 . . . . 0.0 112.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.758 ' N ' ' O ' ' A' ' 250' ' ' ASN . 50.9 m-85 -91.76 -53.04 4.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 250' ' ' ASN . 42.1 t0 -41.24 -62.02 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.119 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.0 mttt -151.75 25.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.791 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.9 m 73.83 -18.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.589 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -43.95 108.69 0.12 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.633 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.67 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -47.48 159.85 0.13 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -108.21 119.01 38.25 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.091 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.433 HD13 ' HZ3' ' A' ' 246' ' ' LYS . 1.2 mt -141.67 -175.17 4.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.222 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.6 tt0 -144.94 152.08 39.64 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.37 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.0 t -59.75 115.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.84 6.67 24.49 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 8.1 mm-40 -97.53 -139.76 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.681 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 175.37 139.99 0.05 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.404 0.621 . . . . 0.0 109.366 179.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.598 ' N ' HD11 ' A' ' 264' ' ' LEU . 12.5 p -128.1 152.77 36.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -103.83 88.15 2.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.541 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.58 124.36 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.153 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.524 ' HG1' ' N ' ' A' ' 269' ' ' LYS . 0.6 OUTLIER -116.57 -53.56 2.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.232 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.524 ' N ' ' HG1' ' A' ' 268' ' ' THR . 0.1 OUTLIER -72.2 127.25 31.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.15 -178.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.411 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 0.8 OUTLIER -149.19 103.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.548 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.732 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -97.73 -88.53 0.3 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.492 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.732 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 38.1 mtm -67.07 178.73 1.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.4 p -98.95 16.63 21.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -130.54 -87.32 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.889 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -91.96 105.3 17.59 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.015 0.436 . . . . 0.0 110.935 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.543 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 4.6 p-90 -120.33 -164.95 1.13 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 269' ' ' LYS . 41.0 mt-10 -123.99 163.21 21.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.861 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.74 -158.21 7.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.909 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -170.32 131.19 0.95 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.0 OUTLIER -112.82 -92.86 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 283' ' ' LYS . 27.7 t-20 -101.4 54.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.95 3.81 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 281' ' ' ASN . 0.0 OUTLIER -61.41 90.4 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.774 -0.713 . . . . 0.0 110.144 -178.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 255' ' ' THR . 42.3 mtt85 -88.05 164.29 15.83 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 171.46 -157.46 27.95 Favored Glycine 0 C--O 1.213 -1.202 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.591 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -123.89 174.73 7.36 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.2 m-85 160.28 135.02 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.107 0 O-C-N 123.768 0.667 . . . . 0.0 111.731 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.53 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 23.7 Cg_exo -64.07 142.64 81.79 Favored 'Trans proline' 0 N--CA 1.507 2.297 0 C-N-CA 122.351 2.034 . . . . 0.0 112.25 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.23 2.63 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.277 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 66.2 p -68.68 2.78 2.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.955 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 7.6 p80 -137.31 39.84 2.47 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.61 161.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 121.992 -0.442 . . . . 0.0 109.977 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 294' ' ' LEU . 29.2 mtt180 -132.63 77.81 1.77 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.554 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 293' ' ' ARG . 84.3 mt -32.77 135.52 0.09 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.845 0.831 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.3 mp -84.34 -167.31 1.72 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.028 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -93.79 13.25 23.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.642 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 63.0 tt0 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.304 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -83.77 -85.27 0.13 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.75 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.502 ' OH ' ' SG ' ' A' ' 191' ' ' CYS . 0.0 OUTLIER 72.98 116.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.205 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.3 m -140.67 172.17 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.421 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -131.26 136.37 48.13 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.317 0.58 . . . . 0.0 111.017 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.53 172.22 0.71 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.475 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.411 ' O ' ' ND2' ' A' ' 205' ' ' ASN . 78.8 mt -140.35 -45.17 0.41 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.627 ' CE2' ' NH2' ' A' ' 284' ' ' ARG . 95.1 m-85 -113.49 9.59 18.07 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.825 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.546 ' CG ' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 67.11 136.08 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.735 0.647 . . . . 0.0 109.337 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 9.1 t80 -112.64 -54.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.372 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.3 t30 49.99 55.14 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.523 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.488 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -65.94 -124.95 0.01 OUTLIER Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.565 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 176.66 -90.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 81.0 m-20 -22.94 139.24 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -57.08 -7.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.528 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 148' ' ' ASP . 6.5 pt-20 -97.88 7.22 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.565 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 12.9 p30 -133.29 157.61 45.04 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 9.2 tp -111.16 93.64 18.78 Favored Pre-proline 0 C--O 1.214 -0.814 0 CA-C-N 118.506 0.594 . . . . 0.0 111.095 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 95.5 Cg_endo -69.53 141.43 46.13 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 CA-C-N 120.567 1.238 . . . . 0.0 114.006 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 20.3 p90 -159.13 159.72 34.78 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.67 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER -126.97 96.76 4.72 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.839 ' O ' ' N ' ' A' ' 158' ' ' ASP . 59.0 pttt 27.39 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.611 1.194 . . . . 0.0 110.739 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 30.9 13.74 0.0 OUTLIER Glycine 0 CA--C 1.541 1.69 0 N-CA-C 113.948 0.339 . . . . 0.0 113.948 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.839 ' N ' ' O ' ' A' ' 156' ' ' LYS . 17.3 t0 -85.36 155.88 21.12 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 117.08 0.44 . . . . 0.0 110.324 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.3 mm -125.58 106.2 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.689 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 23.6 mt -121.63 133.71 54.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -97.84 139.73 33.27 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.4 mp -83.48 159.26 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.03 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -142.2 -43.73 0.33 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.283 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -136.52 113.58 10.54 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.54 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 14.3 pttm -112.71 74.07 1.6 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.77 -28.74 51.29 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.621 1.548 . . . . 0.0 111.881 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.9 162.69 18.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.667 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.85 -35.0 18.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.508 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 79.0 mt-30 -80.7 -22.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -124.75 153.87 41.76 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 11.2 m0 -145.83 138.16 25.51 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -86.06 106.89 17.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.08 6.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.761 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 30.3 tt0 -126.38 138.32 53.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.969 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.87 173.41 7.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.578 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.9 tpt -77.53 -0.94 28.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.21 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 79.9 m-20 -102.66 -29.67 11.39 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.536 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.96 47.92 0.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 9.8 mttp -128.66 135.88 49.88 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 114.105 -1.048 . . . . 0.0 108.982 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.35 123.34 50.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.412 0.625 . . . . 0.0 111.519 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -151.6 149.03 20.71 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.021 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 151.27 46.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 111.174 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.05 145.77 37.42 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -74.44 112.9 3.66 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.42 1.413 . . . . 0.0 109.438 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.501 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 51.7 t -48.62 -51.56 51.73 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -45.74 -31.38 7.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.077 1.852 . . . . 0.0 113.096 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.484 ' OH ' ' O ' ' A' ' 268' ' ' THR . 9.6 m-85 -69.4 -6.66 31.51 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.089 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.2 m -129.93 163.66 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.524 ' OE1' ' NH1' ' A' ' 192' ' ' ARG . 1.1 pt-20 -117.4 -51.73 2.5 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER 142.24 -4.15 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.224 1.41 . . . . 0.0 110.003 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.502 ' SG ' ' OH ' ' A' ' 137' ' ' TYR . 12.5 t 57.54 113.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -70.3 155.91 92.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.842 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 192' ' ' ARG . 74.2 Cg_exo -43.17 176.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.218 1.945 . . . . 0.0 112.15 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 194' ' ' SER . 9.2 t -99.1 59.98 1.18 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.351 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 36.4 t -168.89 157.22 7.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 56.62 44.53 23.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.761 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 200' ' ' THR . 84.2 p -99.33 82.56 2.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.545 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.6 t -75.23 -50.35 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.788 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 200' ' ' THR . 72.2 m -61.81 -48.13 81.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 197' ' ' SER . 2.9 m 32.25 41.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.385 0.428 . . . . 0.0 111.023 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 55.1 tp -162.53 126.85 3.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.279 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 65.1 p -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.374 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.99 32.02 61.22 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 51.11 93.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 141' ' ' LEU . 90.8 m-20 -63.08 -38.62 91.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.95 0.405 . . . . 0.0 110.589 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 209' ' ' SER . 88.9 mt-30 -136.89 17.23 3.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.553 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.92 -42.74 89.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.8 m -61.47 -43.84 98.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.734 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 206' ' ' GLN . 46.1 t -156.01 176.72 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.501 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 211' ' ' PRO . 0.7 OUTLIER -170.85 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.531 ' N ' ' ND1' ' A' ' 210' ' ' HIS . 19.3 Cg_endo -54.22 -41.81 72.8 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.605 1.536 . . . . 0.0 112.097 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 38.34 72.17 0.95 Allowed Pre-proline 0 N--CA 1.462 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.93 98.57 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.524 2.15 . . . . 0.0 111.649 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 4.3 mm? -90.57 134.44 34.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -53.87 -68.25 1.74 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.21 72.42 0.03 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.85 -36.85 92.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.73 2.286 . . . . 0.0 111.736 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -129.37 80.0 73.0 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.577 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.06 -27.49 64.89 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.684 2.256 . . . . 0.0 111.88 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.49 -114.76 3.91 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.22 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.216 0 CA-C-N 119.582 1.691 . . . . 0.0 112.042 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 82.3 t80 -168.03 162.41 13.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.337 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -46.42 98.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.606 ' C ' ' H ' ' A' ' 226' ' ' SER . 87.2 mt-30 -143.09 97.44 5.73 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.592 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -54.69 11.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.205 1.937 . . . . 0.0 112.985 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.606 ' H ' ' C ' ' A' ' 224' ' ' GLN . 50.1 m -158.41 -152.98 0.36 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 227' ' ' ILE . 96.5 mt 58.81 -74.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 226' ' ' SER . 4.1 p-10 -103.34 45.43 0.96 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.314 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 230' ' ' PRO . 0.2 OUTLIER -90.78 161.49 35.86 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 229' ' ' THR . 52.7 Cg_exo -49.14 -128.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.742 2.294 . . . . 0.0 112.661 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.13 161.39 31.39 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.773 -0.579 . . . . 0.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.61 -140.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.142 1.894 . . . . 0.0 111.869 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 234' ' ' LEU . 3.6 p30 -84.51 153.86 23.04 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.575 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 235' ' ' GLN . 5.2 tp 35.07 68.89 0.18 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.693 ' NE2' ' H ' ' A' ' 235' ' ' GLN . 1.1 mm-40 -38.74 144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.428 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -43.44 110.29 0.19 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.69 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.484 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 136.72 -165.84 24.97 Favored Glycine 1 CA--C 1.448 -4.155 0 CA-C-O 121.72 0.622 . . . . 0.0 113.52 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 1.9 Cg_endo -47.41 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.535 3.918 0 N-CA-C 116.701 1.769 . . . . 0.0 116.701 1.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.568 ' CG ' ' OE1' ' A' ' 297' ' ' GLN . 11.6 m-30 -118.23 -134.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.31 129.5 19.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.248 0.931 . . . . 0.0 109.246 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -102.04 -162.34 0.92 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.464 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -157.34 92.84 1.27 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.19 129.37 27.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.741 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.5 18.31 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.214 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 178.06 101.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.374 0.607 . . . . 0.0 110.053 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -144.89 -142.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.489 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.0 ptt85 -153.77 -142.02 0.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.994 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 54.3 t -133.62 69.3 76.44 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 110.85 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.575 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 59.0 Cg_endo -91.2 177.0 2.08 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.838 2.359 . . . . 0.0 110.762 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.724 ' O ' ' N ' ' A' ' 252' ' ' TYR . 1.3 p-10 -144.26 139.01 28.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -36.51 -10.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.399 0.619 . . . . 0.0 112.305 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.724 ' N ' ' O ' ' A' ' 250' ' ' ASN . 6.6 m-85 -89.51 -50.27 6.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 250' ' ' ASN . 25.7 t0 -62.71 60.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.624 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.448 ' C ' ' HG1' ' A' ' 255' ' ' THR . 32.6 mtmt 82.53 15.78 0.4 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.167 0.917 . . . . 0.0 111.061 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.485 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.5 m 80.88 -17.93 0.53 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.675 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.02 109.15 0.11 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.624 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.16 156.06 0.6 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.521 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.04 122.14 46.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.12 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.407 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.5 mt -142.07 -178.81 5.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.886 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -143.44 149.93 38.3 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.936 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.73 114.78 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.428 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 107.29 7.82 32.0 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 57.8 mm-40 -93.53 -127.62 0.11 Allowed 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 165.97 139.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.031 0.919 . . . . 0.0 110.336 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.595 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.5 p -134.75 155.6 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.56 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.438 ' H ' HG22 ' A' ' 265' ' ' VAL . 0.2 OUTLIER -85.31 -158.5 0.38 Allowed 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.726 ' O ' ' N ' ' A' ' 269' ' ' LYS . 0.9 OUTLIER -142.65 -44.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.075 176.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.484 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER 35.14 -72.93 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -74.35 123.6 24.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.975 -177.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 162.31 36.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.827 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.661 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -156.46 -98.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.526 0.679 . . . . 0.0 110.359 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.661 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 34.8 mtm -55.16 152.89 7.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.601 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.9 p -71.58 15.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.539 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.71 -73.63 0.04 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.554 ' O ' ' ND2' ' A' ' 271' ' ' ASN . 13.4 mp0 -78.89 166.02 22.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.896 0.379 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.539 ' NE1' ' O ' ' A' ' 274' ' ' GLY . 1.5 p-90 177.81 179.49 0.3 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.617 0.723 . . . . 0.0 110.711 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 2.6 mt-10 -107.92 -178.53 3.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.607 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -157.72 -165.84 16.04 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.422 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -163.55 123.44 2.15 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.411 0.624 . . . . 0.0 112.269 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.8 OUTLIER -133.75 74.0 1.53 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.354 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER 83.99 37.08 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.644 0.735 . . . . 0.0 109.676 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 93.34 -36.07 3.87 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.032 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -64.61 86.16 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.355 0.598 . . . . 0.0 110.264 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.627 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 77.4 mtt180 -86.27 170.13 12.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.508 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 169.23 -151.12 16.81 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -130.18 176.77 7.82 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.0 OUTLIER 157.99 112.83 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 123.461 0.476 . . . . 0.0 110.026 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.4 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 39.8 Cg_exo -54.8 148.05 47.82 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.375 2.05 . . . . 0.0 112.906 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.552 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.4 OUTLIER -66.49 -2.63 4.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.804 0.335 . . . . 0.0 110.303 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.0 p -47.7 -5.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 289' ' ' PHE . 1.6 p80 -155.71 75.15 0.9 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.12 159.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -126.52 76.37 1.62 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.743 0.306 . . . . 0.0 110.318 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 48.3 mt -39.36 127.48 1.82 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.137 0.97 . . . . 0.0 112.019 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 -172.37 2.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.098 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -110.72 48.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.823 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.568 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 34.1 tp60 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.371 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 137' ' ' TYR . 5.8 tp10 45.96 -164.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.947 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 48.5 p90 -179.55 119.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.908 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.39 165.02 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.533 ' NE ' ' OE2' ' A' ' 189' ' ' GLU . 12.7 ttp180 -122.62 136.94 55.02 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.747 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -103.85 90.81 3.74 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.566 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.49 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -103.52 38.3 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 58.8 m-85 -133.76 -0.16 3.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.958 -0.464 . . . . 0.0 111.038 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 59.47 136.94 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.131 0.894 . . . . 0.0 109.477 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 8.5 t80 -126.5 -48.0 1.56 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.641 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 46.59 58.31 4.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.23 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -65.45 -128.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.697 HD21 ' H ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER 164.43 -41.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.697 ' H ' HD21 ' A' ' 147' ' ' ASN . 7.9 m-20 -73.95 140.33 45.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 112.034 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -49.9 -21.35 1.14 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.428 ' N ' ' C ' ' A' ' 148' ' ' ASP . 77.9 mt-10 -91.27 29.4 1.44 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.528 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.579 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 31.6 p30 -153.11 171.68 18.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.555 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.457 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 14.6 tp -126.24 87.72 55.67 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.788 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 57.8 Cg_endo -64.17 143.19 83.21 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 CA-C-N 121.073 1.419 . . . . 0.0 113.858 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 12.6 p90 -167.76 172.4 9.21 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.657 0.741 . . . . 0.0 111.485 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -150.29 -165.0 2.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.239 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.747 ' O ' ' O ' ' A' ' 140' ' ' ALA . 17.9 ptpt 41.36 -145.81 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -109.13 49.39 0.85 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 37.4 t0 -52.86 154.04 3.02 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.4 mp -100.24 99.27 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.7 mt -102.33 90.47 3.91 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.473 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -69.04 147.1 52.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.967 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.1 mp -80.44 131.25 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.05 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.593 ' NH2' HD22 ' A' ' 172' ' ' ASN . 13.1 ttm180 -85.85 -43.09 13.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.212 0.529 . . . . 0.0 110.909 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 164' ' ' ASP . 38.2 t0 -153.58 -24.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.326 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 165' ' ' LYS . 12.7 tttm 59.48 99.25 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -85.56 -44.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.989 1.793 . . . . 0.0 111.732 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.98 174.91 6.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -88.49 -38.46 14.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.972 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.524 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 95.5 mt-30 -80.38 -15.47 56.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.566 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.427 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 64.5 m95 -131.49 154.63 48.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 12.5 m0 -143.37 133.37 24.19 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.593 HD22 ' NH2' ' A' ' 163' ' ' ARG . 47.3 t-20 -85.02 117.79 24.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.84 178.7 6.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.734 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.5 111.28 15.51 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.656 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -60.88 140.37 57.71 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.19 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.2 ttt -52.1 -0.74 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.656 ' H ' ' C ' ' A' ' 175' ' ' ASP . 86.5 m-20 -84.82 -23.02 29.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.394 0.616 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.52 41.24 2.78 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.105 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -139.85 142.23 36.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.033 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.64 130.29 49.49 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.474 0.654 . . . . 0.0 111.525 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -162.77 159.57 31.94 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.437 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 mtp -69.84 149.58 47.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.137 0.494 . . . . 0.0 111.199 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.57 141.55 39.32 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.724 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.38 119.05 5.89 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 N-CA-C 108.073 -1.549 . . . . 0.0 108.073 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.544 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 35.7 t -54.2 -50.63 83.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.8 Cg_endo -50.9 -27.84 22.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.185 1.924 . . . . 0.0 112.873 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.489 ' OH ' ' O ' ' A' ' 268' ' ' THR . 8.0 m-85 -71.32 4.91 2.53 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.38 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 17.7 m -130.7 163.02 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.699 0.285 . . . . 0.0 110.596 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.533 ' OE2' ' NE ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -76.31 -71.45 0.39 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.677 -178.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.436 ' HZ3' ' HB3' ' A' ' 193' ' ' PRO . 0.0 OUTLIER 169.75 -161.89 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 123.974 0.796 . . . . 0.0 110.614 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 10.0 p -162.46 9.48 0.06 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.073 0.463 . . . . 0.0 110.65 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -120.27 83.65 32.98 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.637 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 194' ' ' SER . 87.6 Cg_endo -79.91 -117.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.459 2.106 . . . . 0.0 111.86 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 193' ' ' PRO . 7.3 p 56.27 145.17 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.026 0.441 . . . . 0.0 110.949 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.8 p -91.59 -11.94 35.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.746 0.308 . . . . 0.0 110.291 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 197' ' ' SER . . . -67.26 94.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 196' ' ' ALA . 47.4 m 54.32 108.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.661 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.49 134.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.227 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.1 m -59.22 -97.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 33.7 p -141.28 170.9 14.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.11 80.04 9.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 19.4 p -85.7 88.45 7.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.594 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 132.98 64.56 0.08 OUTLIER Glycine 0 N--CA 1.466 0.643 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.03 174.36 42.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -92.75 -162.42 0.93 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 55.93 107.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.589 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 208' ' ' SER . 57.8 t0 -157.76 -131.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.361 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.523 ' H ' ' CG ' ' A' ' 207' ' ' ASP . 5.9 m -68.75 133.69 48.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 69.3 m -62.67 -47.78 82.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.498 ' ND1' ' N ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -143.19 91.87 6.91 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.331 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -54.32 157.06 12.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.254 1.969 . . . . 0.0 111.949 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -114.59 87.0 13.46 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.418 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.08 -40.49 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 112.287 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 70.0 mt -114.11 73.98 0.85 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.036 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.34 92.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 140.57 88.89 0.15 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -55.52 143.01 80.07 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.25 1.967 . . . . 0.0 112.017 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 220' ' ' GLY . 13.9 pt-20 -178.12 76.07 0.22 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.375 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.45 78.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.853 2.369 . . . . 0.0 113.148 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 218' ' ' GLU . . . 129.92 -177.15 18.33 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.413 ' HG3' HD21 ' A' ' 228' ' ' ASN . 25.9 Cg_exo -62.92 149.98 89.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.593 2.195 . . . . 0.0 112.469 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.532 ' CD1' ' OE2' ' A' ' 218' ' ' GLU . 38.9 p90 -121.46 170.53 9.56 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.05 95.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.051 0.453 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' TYR . 35.4 tp60 -143.18 129.68 10.48 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.26 -27.73 13.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.69 1.593 . . . . 0.0 112.532 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 10.1 m -109.41 10.88 25.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.86 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 227' ' ' ILE . 3.7 mp 53.06 -95.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.353 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.413 HD21 ' HG3' ' A' ' 221' ' ' PRO . 13.7 m120 -58.53 115.82 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.056 0.455 . . . . 0.0 110.103 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.2 p -77.61 151.22 79.97 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.45 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.28 79.96 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.997 1.798 . . . . 0.0 111.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.627 ' C ' ' H ' ' A' ' 233' ' ' ASN . 1.8 pt? -128.77 147.17 63.35 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.99 23.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.504 2.123 0 C-N-CA 122.403 2.068 . . . . 0.0 112.615 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.627 ' H ' ' C ' ' A' ' 231' ' ' LEU . 0.7 OUTLIER 44.24 49.76 7.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.702 ' C ' ' H ' ' A' ' 236' ' ' ASN . 14.6 tp -57.69 -122.53 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.385 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 60.37 -19.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.618 0.247 . . . . 0.0 110.571 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -100.53 -40.69 7.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.465 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.2 -165.04 40.8 Favored Glycine 1 CA--C 1.439 -4.675 0 CA-C-O 122.306 0.948 . . . . 0.0 113.944 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.411 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.6 Cg_endo -44.43 102.73 0.03 OUTLIER 'Cis proline' 1 N--CA 1.538 4.114 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -0.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 10.5 m-30 -115.27 -124.37 0.29 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.6 OUTLIER -143.71 130.93 20.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 119.667 1.121 . . . . 0.0 109.83 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -106.04 -168.03 1.38 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.618 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.37 93.99 1.35 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.0 123.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.347 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.96 9.08 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.041 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -168.61 128.03 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.311 0.576 . . . . 0.0 109.504 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.436 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.4 ttmt -170.51 -144.39 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.862 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.436 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 2.1 ptt85 -160.48 -136.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.507 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.408 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 3.7 t -137.01 61.95 37.18 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.667 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.613 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -102.1 70.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.806 3.004 . . . . 0.0 112.081 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.657 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.1 OUTLIER -47.78 158.53 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.54 -3.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.897 0.38 . . . . 0.0 111.767 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.73 ' O ' ' N ' ' A' ' 254' ' ' LYS . 30.1 m-85 -80.15 -59.04 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -47.14 60.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 125.653 1.846 . . . . 0.0 112.179 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 252' ' ' TYR . 34.0 mtmt 87.49 -51.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.961 1.413 . . . . 0.0 109.422 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 4.4 m 164.29 -17.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.175 0.922 . . . . 0.0 110.373 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.493 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -45.16 170.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.573 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 257' ' ' LEU . 0.4 OUTLIER -109.54 150.26 28.42 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.778 0.431 . . . . 0.0 110.563 -177.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.613 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -97.17 116.59 29.64 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 122.07 -0.394 . . . . 0.0 111.119 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.414 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 2.2 mt -137.58 -172.59 3.27 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.74 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -145.56 147.43 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.043 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 68.8 t -54.73 97.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.888 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 122.15 10.26 6.29 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 56.2 mm-40 -91.81 -130.64 0.11 Allowed 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 166.32 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 9.1 p -127.41 142.75 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.466 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 268' ' ' THR . 2.9 ttmm -99.04 84.15 3.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.56 150.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.518 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.489 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -148.25 -47.68 0.16 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.579 -178.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 5.6 tppt? -84.05 151.73 24.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.36 134.19 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.407 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.659 ' N ' HD21 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -177.31 -170.57 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.135 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.523 ' HG3' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER 60.39 -143.32 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.687 178.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.3 p -137.04 -4.35 1.94 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.734 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 177.74 13.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 118.924 -1.608 . . . . 0.0 112.517 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 1.2 mp0 -101.28 -74.76 0.61 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 271' ' ' ASN . 9.9 m95 76.63 169.01 0.25 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 75.0 mt-10 -131.95 143.06 49.84 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.543 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -136.68 145.34 17.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 121.853 0.696 . . . . 0.0 113.599 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.64 130.8 55.32 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 113.945 -1.127 . . . . 0.0 110.674 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.414 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.0 OUTLIER -110.55 -90.84 0.47 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 283' ' ' LYS . 22.8 t-20 -104.54 50.56 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 89.92 -31.04 5.49 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 281' ' ' ASN . 0.1 OUTLIER -63.91 75.68 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.284 -0.958 . . . . 0.0 111.156 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 282' ' ' GLY . 50.9 mtt180 -71.92 160.89 31.77 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.357 0.599 . . . . 0.0 110.344 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 173.54 -161.71 32.48 Favored Glycine 0 C--O 1.217 -0.928 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.506 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 41.1 p-80 -130.04 168.8 16.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.223 0.535 . . . . 0.0 110.801 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 173.47 116.13 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.239 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 290' ' ' THR . 52.7 Cg_exo -51.45 149.91 16.67 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.805 1.67 . . . . 0.0 111.915 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.5 OUTLIER -61.11 -4.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 288' ' ' PRO . 31.9 p -46.95 -9.25 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.89 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 289' ' ' PHE . 4.5 p-80 -153.96 84.6 1.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.325 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 291' ' ' HIS . 0.1 OUTLIER -172.68 152.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -106.14 -45.61 4.28 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 32.1 mt 77.39 113.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 122.069 0.938 . . . . 0.0 111.451 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.78 -174.54 4.81 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.265 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.423 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 67.1 t0 -106.64 58.79 0.64 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 53.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -60.15 -71.52 0.13 Allowed 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.564 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 98.3 m-85 -24.66 -100.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.926 0 O-C-N 123.542 0.526 . . . . 0.0 111.777 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.564 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.5 m 82.74 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 125.109 1.506 . . . . 0.0 111.156 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.564 ' NH1' ' O ' ' A' ' 200' ' ' THR . 4.2 ptp180 -135.63 144.69 46.22 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.838 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.568 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -100.32 96.57 7.53 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.599 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -96.99 37.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.914 0.388 . . . . 0.0 111.467 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.542 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 49.5 m-85 -137.35 1.98 2.46 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.684 0.278 . . . . 0.0 110.793 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.474 ' OD2' ' NZ ' ' A' ' 269' ' ' LYS . 0.5 OUTLIER 60.21 143.32 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.495 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.515 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 5.4 t80 -133.62 -34.92 1.01 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.545 0.611 . . . . 0.0 110.951 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 144' ' ' PHE . 7.6 p30 34.42 59.89 0.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.645 0.591 . . . . 0.0 110.663 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -66.73 -139.8 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.54 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 165.04 94.14 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.667 -0.766 . . . . 0.0 110.844 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 4.6 m-20 158.63 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.112 0.482 . . . . 0.0 110.2 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.17 -17.35 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.361 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -100.44 18.23 19.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.453 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.3 p30 -142.41 156.75 45.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.483 ' CD1' ' OD2' ' A' ' 175' ' ' ASP . 9.8 tp -121.63 85.83 44.27 Favored Pre-proline 0 C--O 1.212 -0.891 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.401 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 34.0 Cg_exo -58.26 137.27 79.71 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 C-N-CA 121.586 1.524 . . . . 0.0 112.87 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.568 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 7.1 p90 -154.01 170.03 22.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -135.82 -68.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -94.96 92.62 6.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.249 -176.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 17.35 55.42 0.01 OUTLIER Glycine 0 C--N 1.34 0.806 0 O-C-N 123.812 0.695 . . . . 0.0 112.041 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 156' ' ' LYS . 32.9 t0 -63.08 142.82 58.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.508 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.5 mp -87.31 101.87 11.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 31.0 mt -92.14 -127.56 0.1 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.356 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 174' ' ' GLU . 40.9 tttp 173.28 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.678 0.611 . . . . 0.0 110.399 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.3 mp -90.23 145.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.49 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -134.11 -39.8 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.38 104.97 6.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.856 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.463 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 12.9 pttm -113.22 74.94 2.07 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.79 -30.19 22.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.995 1.797 . . . . 0.0 112.227 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.16 158.92 17.82 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.612 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -87.09 -37.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.736 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.42 HE22 ' CD ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -78.94 -29.52 44.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.621 -179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.465 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.4 m95 -117.27 150.95 37.93 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 8.8 m0 -145.91 136.33 24.01 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.8 112.15 16.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.47 166.62 10.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.069 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 161' ' ' LYS . 27.4 tt0 -129.31 145.95 51.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.012 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.483 ' OD2' ' CD1' ' A' ' 152' ' ' LEU . 0.5 OUTLIER -76.58 -178.93 4.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.664 0.745 . . . . 0.0 110.73 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.4 ttt -80.11 -11.45 59.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.0 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -100.94 -25.48 14.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.1 43.67 0.51 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -117.56 126.16 52.09 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.783 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.68 42.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.456 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -150.59 148.52 19.79 Favored Glycine 0 C--N 1.312 -0.793 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.875 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 159.67 20.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.44 0.638 . . . . 0.0 110.656 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 7.8 pt -150.49 142.48 15.61 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.732 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.33 110.76 3.04 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 N-CA-C 109.852 -0.865 . . . . 0.0 109.852 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.511 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 50.3 t -44.6 -51.58 20.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.613 -0.679 . . . . 0.0 112.048 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.8 Cg_endo -47.26 -29.3 9.21 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.146 1.898 . . . . 0.0 112.841 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.545 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.2 m-85 -69.73 -6.33 31.16 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.058 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.53 167.22 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 111.007 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -150.22 61.19 0.97 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 52.6 -174.5 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.035 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 23.9 t -143.79 -33.85 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.654 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 44.85 71.92 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.02 -21.65 59.73 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.869 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 83.2 p -66.32 -27.62 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.656 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 196' ' ' ALA . 50.9 p -66.52 -59.02 4.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.801 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 195' ' ' SER . . . 53.49 56.88 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.748 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 199' ' ' SER . 5.7 t -86.38 74.95 9.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.58 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 82.0 t 39.99 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.988 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 197' ' ' SER . 82.5 p -80.06 51.14 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.211 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.564 ' O ' ' NH1' ' A' ' 139' ' ' ARG . 8.4 m -64.87 -31.24 72.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.48 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 201' ' ' LEU . 9.4 mp -78.65 -70.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.681 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 30.7 p -84.97 99.12 10.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.665 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 171.57 89.47 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.6 129.13 1.03 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.545 ' CG ' ' H ' ' A' ' 206' ' ' GLN . 49.4 t30 40.89 -155.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 110.631 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.545 ' H ' ' CG ' ' A' ' 205' ' ' ASN . 58.0 tp60 -169.74 52.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.225 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 208' ' ' SER . 93.7 m-20 54.9 35.42 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.687 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 207' ' ' ASP . 55.2 p 55.77 160.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 89.5 p -81.41 -15.23 55.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.558 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.453 ' ND1' ' OD1' ' A' ' 271' ' ' ASN . 74.1 m-70 53.33 82.84 0.24 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.234 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.71 143.42 69.82 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.629 2.219 . . . . 0.0 111.84 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.501 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 2.3 mp0 -48.38 148.59 3.24 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.658 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.1 -36.12 11.39 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.219 1.946 . . . . 0.0 112.004 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tp 67.51 6.38 4.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.301 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 40.18 -141.17 0.83 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 175.94 172.36 40.65 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.21 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.794 2.329 . . . . 0.0 111.68 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.06 66.46 77.59 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.463 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.39 -5.45 16.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.854 2.369 . . . . 0.0 111.916 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.47 -74.65 0.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.12 -179.53 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.631 2.221 . . . . 0.0 112.006 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.537 ' O ' ' NE2' ' A' ' 224' ' ' GLN . 48.4 p90 -59.33 169.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.84 105.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 110.364 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.61 ' H ' ' NE2' ' A' ' 224' ' ' GLN . 0.0 OUTLIER -127.28 146.56 58.55 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.06 -30.8 66.03 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.271 1.981 . . . . 0.0 112.402 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 68.4 p -133.48 -96.98 0.29 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.7 tp -150.63 43.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.117 0.484 . . . . 0.0 110.077 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -176.19 172.71 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.657 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 53.9 p -72.76 127.9 89.04 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.623 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.56 -151.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.956 1.771 . . . . 0.0 112.53 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.462 ' CB ' ' HE1' ' A' ' 276' ' ' TRP . 10.6 tp -78.29 126.94 82.5 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.357 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.482 ' O ' ' ND2' ' A' ' 233' ' ' ASN . 45.5 Cg_endo -68.66 -58.33 0.12 Allowed 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.793 1.662 . . . . 0.0 113.061 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 232' ' ' PRO . 26.5 m120 -149.99 -167.94 2.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.175 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 235' ' ' GLN . 30.9 tp -39.31 -84.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.407 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 237' ' ' GLY . 6.4 mm100 55.87 154.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.186 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 44.08 -87.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.433 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 235' ' ' GLN . . . -34.72 160.27 0.01 OUTLIER Glycine 1 CA--C 1.45 -4.021 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.951 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.482 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 3.1 Cg_exo -73.24 126.08 11.46 Favored 'Cis proline' 0 C--N 1.285 -2.799 0 O-C-N 122.3 0.632 . . . . 0.0 113.071 -5.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.49 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 40.9 m-85 -153.71 -124.62 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.518 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 2.2 m-30 -140.7 113.21 8.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 118.752 0.705 . . . . 0.0 109.71 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 264' ' ' LEU . . . -105.65 144.48 32.34 Favored 'General case' 0 C--O 1.2 -1.515 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -101.1 112.52 25.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.19 0.519 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.454 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 9.5 p -79.05 122.26 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.74 21.51 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.72 104.54 0.02 OUTLIER 'General case' 0 N--CA 1.46 0.064 0 CA-C-O 121.525 0.678 . . . . 0.0 111.154 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.409 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 0.1 OUTLIER -139.99 -140.11 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.743 178.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.409 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 2.1 ptt85 -157.2 -139.61 0.07 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.834 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 80.4 t -135.94 69.36 64.51 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.985 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 45.4 Cg_endo -96.28 -179.72 0.48 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.976 2.45 . . . . 0.0 111.208 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.711 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.8 OUTLIER -141.99 137.2 31.0 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.683 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.43 -5.51 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.303 0.377 . . . . 0.0 111.504 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.711 ' H ' ' C ' ' A' ' 250' ' ' ASN . 51.2 m-85 -93.41 -55.79 3.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.14 71.76 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.998 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.597 ' N ' ' O ' ' A' ' 252' ' ' TYR . 30.9 mtmt 74.91 -5.22 2.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 124.343 1.027 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.507 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 0.3 OUTLIER 87.24 51.88 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.398 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -104.71 113.87 27.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.594 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -49.26 155.21 0.72 Allowed 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.922 -0.486 . . . . 0.0 111.444 -179.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.453 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -106.5 114.51 28.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.633 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.56 -173.94 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.337 0.589 . . . . 0.0 111.328 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.2 tt0 -146.26 152.07 38.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.786 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.96 115.14 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.66 10.33 17.03 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 23.0 mm-40 -107.56 -152.49 0.48 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.595 ' HB2' ' O ' ' A' ' 241' ' ' ALA . 0.2 OUTLIER -171.89 152.31 2.97 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.994 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.45 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 13.3 p -135.8 156.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.459 ' HZ1' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.62 99.29 9.84 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 268' ' ' THR . 10.7 t -65.81 156.85 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.545 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -158.25 -62.42 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.152 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -80.42 141.67 35.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -177.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.437 HD11 ' H ' ' A' ' 270' ' ' ILE . 0.9 OUTLIER -140.59 147.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.288 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.532 ' C ' HD21 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -176.53 -159.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.5 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 47.7 mtm 52.1 -120.66 1.7 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.886 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.8 p -135.48 -10.65 2.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.237 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . 177.69 -46.39 0.1 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.559 -1.781 . . . . 0.0 113.126 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.433 ' N ' ' CD ' ' A' ' 275' ' ' GLN . 24.2 mp0 -65.79 64.39 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 3.1 p-90 -74.66 -171.95 1.4 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.171 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 86.0 mt-10 -108.61 166.9 10.44 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.535 1.147 . . . . 0.0 111.618 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -149.18 -170.81 17.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.896 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.405 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -157.08 127.68 6.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.304 0.574 . . . . 0.0 111.655 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.529 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -138.94 74.28 1.47 Allowed 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.302 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 7.2 m-20 85.74 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.731 0.777 . . . . 0.0 109.33 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.09 -33.73 4.37 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.78 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.03 93.64 0.59 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.405 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 83.9 mtt180 -94.75 168.46 10.81 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.438 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 255' ' ' THR . . . 162.95 137.53 2.21 Favored Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.994 177.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.601 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.7 p80 -65.06 175.31 1.62 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.142 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 0.3 OUTLIER 166.21 144.53 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.408 178.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 39.9 Cg_exo -55.28 137.99 78.43 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.436 2.091 . . . . 0.0 113.331 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 2.0 t80 -73.77 -5.8 43.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.253 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 34.8 p -67.72 2.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 8.5 p80 -136.32 47.51 2.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.417 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.3 151.37 13.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -111.01 -53.8 2.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 2.0 mt 91.27 119.73 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.324 1.059 . . . . 0.0 111.346 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 297' ' ' GLN . 8.7 mp -70.46 -170.59 0.4 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 296' ' ' ASP . 40.8 t0 -66.51 9.4 0.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.549 ' H ' ' C ' ' A' ' 295' ' ' LEU . 40.6 tt0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.33 -83.27 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.39 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.57 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 1.7 m-85 -58.8 -54.84 42.58 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.57 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 2.3 m 93.12 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 125.682 1.864 . . . . 0.0 111.59 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -121.35 125.67 47.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.439 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -98.9 95.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.331 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -106.1 35.05 3.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.755 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 47.6 m-85 -134.26 0.85 3.14 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.29 -0.256 . . . . 0.0 111.029 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.89 137.95 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.66 0 O-C-N 124.281 0.988 . . . . 0.0 108.786 -178.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 145' ' ' ASN . 8.6 t80 -121.54 -47.89 2.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.092 0.406 . . . . 0.0 110.399 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 144' ' ' PHE . 65.7 t30 40.97 60.9 1.87 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.213 0.53 . . . . 0.0 109.958 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.17 -155.55 1.41 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.722 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.629 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.2 OUTLIER 169.62 94.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.188 -1.006 . . . . 0.0 110.27 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -159.97 -146.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 111.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' A' ' 150' ' ' GLU . 58.7 p30 -75.86 57.51 1.05 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.581 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 151' ' ' ASP . 92.2 mt-10 98.01 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.402 1.064 . . . . 0.0 111.496 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.629 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 14.1 p-10 -28.91 161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.681 0.613 . . . . 0.0 110.705 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.8 tp -106.72 75.34 0.39 Allowed Pre-proline 0 C--O 1.215 -0.758 0 O-C-N 122.075 -0.391 . . . . 0.0 111.117 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.75 118.72 5.81 Favored 'Trans proline' 0 C--N 1.295 -2.255 0 CA-C-N 119.386 0.816 . . . . 0.0 110.968 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.439 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 15.5 p90 -134.25 163.6 29.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.416 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.425 ' CG ' ' H ' ' A' ' 156' ' ' LYS . 1.1 tpmp? -96.13 -135.35 0.23 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 158' ' ' ASP . 50.8 mtmt -96.56 174.94 6.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 159' ' ' ILE . . . 33.11 22.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.873 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.634 ' N ' ' O ' ' A' ' 156' ' ' LYS . 6.3 t0 -72.69 137.46 46.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 117.257 0.528 . . . . 0.0 109.816 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.7 mp -104.06 103.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.7 mt -108.35 107.93 18.7 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.065 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -62.89 140.12 58.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.34 130.95 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.165 0.507 . . . . 0.0 110.409 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -44.07 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -155.1 133.2 11.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.503 ' CG ' ' NE1' ' A' ' 171' ' ' TRP . 2.6 ttmm -106.42 70.55 0.24 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.698 -0.191 . . . . 0.0 110.727 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.25 -54.74 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.165 1.244 . . . . 0.0 111.495 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -100.78 -172.8 2.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.18 -32.88 7.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.57 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 94.2 mt-30 -83.29 -31.32 26.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.473 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 81.2 m95 -119.59 148.03 43.8 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.503 ' NE1' ' CG ' ' A' ' 165' ' ' LYS . 14.1 m0 -141.72 131.33 24.0 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 120.857 0.36 . . . . 0.0 110.104 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -81.12 105.73 12.56 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.25 174.91 5.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.047 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -123.24 130.53 52.87 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.99 165.55 0.94 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.197 0.522 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 49.8 ttp -74.07 -4.48 35.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.047 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.15 -27.85 14.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.25 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.89 48.37 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 108.279 -1.929 . . . . 0.0 108.279 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -128.07 129.0 45.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.929 -0.636 . . . . 0.0 109.678 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 125.79 49.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.344 0.593 . . . . 0.0 111.869 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -165.26 160.66 34.04 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.522 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.415 ' HG3' ' H ' ' A' ' 183' ' ' ILE . 0.2 OUTLIER -68.02 160.25 29.13 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.159 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.45 ' CD1' ' C ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -159.66 148.12 13.68 Favored Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.572 177.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.53 122.44 8.61 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.659 1.573 . . . . 0.0 109.253 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 42.7 t -58.68 -52.18 76.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.672 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.5 Cg_endo -50.78 -27.25 19.68 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.794 2.329 . . . . 0.0 114.498 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.482 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.2 m-85 -65.2 7.8 0.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.812 0.339 . . . . 0.0 111.483 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 186' ' ' PRO . 3.1 m -132.69 173.08 15.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 190' ' ' LYS . 1.9 pt-20 -141.64 39.87 1.7 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.973 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 189' ' ' GLU . 13.4 mptt 52.89 118.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 110.57 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 192' ' ' ARG . 47.4 t -48.06 164.51 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.589 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.441 ' N ' ' SG ' ' A' ' 191' ' ' CYS . 51.9 ttt180 67.35 93.65 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.205 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.7 -67.97 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.977 1.785 . . . . 0.0 113.003 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 p 65.13 35.76 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 m 41.4 37.52 0.67 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 197' ' ' SER . . . -124.71 -90.65 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ALA . 40.2 t 56.2 146.24 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.019 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.8 m -67.83 -41.72 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.999 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.6 m -137.44 13.68 2.99 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.797 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.5 p 45.02 -139.27 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.404 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.26 156.55 20.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.619 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -43.94 95.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -68.03 -74.85 0.55 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 52.33 -105.67 0.28 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 206' ' ' GLN . 27.1 t-20 -62.35 -117.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.668 0.271 . . . . 0.0 110.563 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.466 ' N ' ' OD1' ' A' ' 205' ' ' ASN . 78.2 mt-30 -145.08 150.62 37.15 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -158.68 173.66 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m 62.52 123.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.818 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.7 t -142.84 135.99 28.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.42 ' CB ' ' CD ' ' A' ' 211' ' ' PRO . 2.8 m-70 -78.81 -63.12 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.326 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 210' ' ' HIS . 17.9 Cg_endo -56.14 124.55 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.858 1.705 . . . . 0.0 111.574 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.4 79.06 15.94 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.35 145.08 89.48 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.7 mp -83.68 20.94 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.167 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.02 -33.87 88.35 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.79 173.23 45.08 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.71 149.25 73.14 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.771 2.314 . . . . 0.0 111.92 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -150.3 66.18 7.65 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.045 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -79.71 -155.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.959 2.439 . . . . 0.0 111.648 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 -168.58 35.31 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 228' ' ' ASN . 42.7 Cg_endo -72.18 -61.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.131 1.887 . . . . 0.0 112.344 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 224' ' ' GLN . 89.9 m-85 -142.12 160.64 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.492 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.93 94.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.306 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.709 HE21 ' H ' ' A' ' 228' ' ' ASN . 18.2 tt0 -141.88 98.99 6.2 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.836 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 226' ' ' SER . 51.4 Cg_exo -51.28 72.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.87 1.713 . . . . 0.0 111.794 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 224' ' ' GLN . 1.7 t 164.54 -40.52 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.646 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 89.0 mt 61.77 70.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.709 ' H ' HE21 ' A' ' 224' ' ' GLN . 2.3 m120 79.18 65.31 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.639 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.433 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.1 OUTLIER -51.95 176.28 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -176.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.564 ' HB3' ' N ' ' A' ' 289' ' ' PHE . 38.3 Cg_endo -85.22 154.63 10.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.952 2.435 . . . . 0.0 110.805 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.632 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 3.5 mp -95.04 164.82 18.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.5 68.99 4.33 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.674 1.582 . . . . 0.0 110.613 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -90.13 17.32 7.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.09 0.472 . . . . 0.0 110.834 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.688 ' C ' ' H ' ' A' ' 236' ' ' ASN . 5.0 tp -72.91 -125.15 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.722 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.519 ' H ' ' CG ' ' A' ' 234' ' ' LEU . 78.4 mm-40 56.17 -5.63 0.03 OUTLIER 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 234' ' ' LEU . 95.0 m-20 -107.87 -56.88 2.17 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.603 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.68 -163.38 39.21 Favored Glycine 1 CA--C 1.446 -4.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.091 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 3.5 Cg_exo -45.38 100.17 0.03 OUTLIER 'Cis proline' 0 N--CA 1.528 3.519 0 N-CA-C 117.152 1.943 . . . . 0.0 117.152 1.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.634 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 11.2 m-30 -116.26 -128.23 0.29 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.57 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.47 128.64 19.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 119.435 1.016 . . . . 0.0 109.805 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.503 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -106.16 -162.37 0.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.314 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -160.85 95.81 1.09 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.92 128.68 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.711 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.522 ' CD1' ' H ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -123.17 12.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.699 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -169.06 114.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -160.78 -145.66 0.12 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.732 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -155.48 -140.15 0.08 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.531 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 6.4 p -134.47 65.24 67.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 78.6 Cg_endo -91.91 176.47 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.339 2.026 . . . . 0.0 112.075 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.729 ' C ' ' H ' ' A' ' 252' ' ' TYR . 16.9 p30 -149.26 145.21 26.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.712 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.41 -3.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.729 ' H ' ' C ' ' A' ' 250' ' ' ASN . 48.0 m-85 -91.5 -54.09 4.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.481 0.658 . . . . 0.0 110.291 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -46.11 -66.52 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.652 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.557 ' C ' ' H ' ' A' ' 256' ' ' ALA . 27.7 mttt -148.26 33.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.275 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.6 m 70.9 -13.61 0.49 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.07 164.41 0.29 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.261 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 257' ' ' LEU . 0.2 OUTLIER -104.07 149.53 25.12 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 122.794 0.438 . . . . 0.0 110.533 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.508 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -86.81 114.55 23.57 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.9 -177.0 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.447 0.641 . . . . 0.0 111.007 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.3 tt0 -145.83 147.48 31.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.55 102.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.96 6.11 10.34 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 65.7 mm-40 -88.32 -125.25 0.05 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 161.23 140.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.566 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.7 p -130.89 140.66 48.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.175 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -99.3 86.01 3.31 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.992 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 41.3 t -53.4 152.58 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.669 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.482 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -154.37 -53.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.62 127.89 33.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -137.37 127.49 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.997 0.903 . . . . 0.0 111.913 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.627 ' C ' HD21 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -154.66 -167.96 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.549 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.498 ' CE ' HD22 ' A' ' 271' ' ' ASN . 44.7 mtm 65.41 -123.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.89 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.3 p -140.37 -5.76 1.22 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.028 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 276' ' ' TRP . . . -175.57 -52.13 0.06 OUTLIER Glycine 0 C--O 1.213 -1.203 0 C-N-CA 118.138 -1.982 . . . . 0.0 112.737 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.476 ' O ' ' HE1' ' A' ' 272' ' ' MET . 23.2 tp60 -61.34 63.9 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.632 ' HE1' ' C ' ' A' ' 231' ' ' LEU . 6.4 m95 -67.41 177.93 1.74 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.518 -0.739 . . . . 0.0 111.097 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 59.1 mt-10 -130.26 156.39 44.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -133.36 -142.28 4.74 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.964 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.416 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.1 tt0 -169.35 134.32 1.48 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.925 -0.638 . . . . 0.0 112.559 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.3 OUTLIER -146.61 72.24 1.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.157 -178.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 18.2 t-20 83.27 31.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.361 0.6 . . . . 0.0 110.04 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.68 -33.43 5.71 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.134 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 13.2 ptpt -67.87 75.44 0.2 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.033 0.444 . . . . 0.0 110.991 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.542 ' NH1' ' CZ ' ' A' ' 142' ' ' PHE . 93.4 mtt180 -73.01 170.49 14.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.98 -155.13 26.04 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.3 p80 -136.36 176.51 8.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.129 0.572 . . . . 0.0 109.738 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.54 ' HB3' ' HE2' ' A' ' 291' ' ' HIS . 0.3 OUTLIER 171.27 125.09 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.223 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.86 147.94 2.98 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.666 1.578 . . . . 0.0 113.559 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.59 ' C ' ' H ' ' A' ' 291' ' ' HIS . 1.6 t80 -73.75 -5.13 38.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.1 p -60.05 5.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.266 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.59 ' H ' ' C ' ' A' ' 289' ' ' PHE . 7.4 p-80 -157.33 72.93 0.71 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 291' ' ' HIS . 0.5 OUTLIER -165.9 148.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -126.36 74.38 1.45 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.799 0.333 . . . . 0.0 110.746 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 41.9 mt -40.68 127.06 2.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 112.004 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 4.9 mp -77.31 -174.52 3.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.277 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -96.71 25.7 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.074 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.634 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 56.2 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' CG ' ' A' ' 137' ' ' TYR . 2.0 tp10 -164.93 171.49 14.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.346 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 191' ' ' CYS . 0.5 OUTLIER 174.27 150.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.71 172.47 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -126.78 127.9 45.76 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.441 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -96.89 93.05 6.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.672 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.4 36.1 1.82 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.284 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.637 ' CZ ' ' NH2' ' A' ' 284' ' ' ARG . 52.0 m-85 -136.31 2.31 2.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 122.39 -0.194 . . . . 0.0 110.933 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.3 p30 56.87 141.63 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 O-C-N 124.471 1.107 . . . . 0.0 109.596 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 10.5 t80 -134.41 -44.22 0.76 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.243 0.474 . . . . 0.0 110.165 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 144' ' ' PHE . 5.1 p-10 33.85 62.25 0.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.846 0.716 . . . . 0.0 110.619 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.82 -135.82 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.689 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.1 OUTLIER 168.03 90.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.612 -0.294 . . . . 0.0 111.049 178.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.5 m-20 168.4 -170.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 150' ' ' GLU . 40.3 p-10 -93.53 -23.24 18.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.463 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 19.0 pt-20 -103.6 23.11 13.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.109 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.689 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 4.0 p-10 -131.58 148.37 52.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.2 tp -116.17 86.29 16.98 Favored Pre-proline 0 C--O 1.217 -0.649 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -65.12 140.04 63.49 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.317 1.345 . . . . 0.0 112.825 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.478 ' CZ ' ' CB ' ' A' ' 144' ' ' PHE . 10.6 p90 -158.0 160.21 37.23 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.63 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -63.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.553 0.692 . . . . 0.0 111.748 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 158' ' ' ASP . 2.5 ptmt -85.06 92.61 8.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.76 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 13.87 53.59 0.01 OUTLIER Glycine 0 N--CA 1.473 1.154 0 O-C-N 124.054 0.846 . . . . 0.0 112.287 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 156' ' ' LYS . 9.6 t70 -64.47 143.01 58.22 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.445 0.641 . . . . 0.0 109.583 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 mm -88.5 107.8 18.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.183 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 mt -116.02 117.55 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.643 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 88.1 tttt -75.49 147.18 40.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.101 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.5 mp -74.22 -59.01 3.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 70.57 -50.45 0.66 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.467 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -146.9 120.32 9.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.243 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.478 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 0.0 OUTLIER -120.48 85.17 37.18 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.398 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.89 -29.55 18.3 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.629 1.553 . . . . 0.0 112.281 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.417 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 94.8 mt-10 -119.98 160.67 22.31 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.002 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.65 -43.69 15.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.741 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.516 ' OE1' ' CD1' ' A' ' 239' ' ' PHE . 93.8 mt-30 -74.68 -29.88 61.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.478 ' NE1' ' CE2' ' A' ' 239' ' ' PHE . 77.2 m95 -119.33 151.24 38.8 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.478 ' CD1' ' CB ' ' A' ' 165' ' ' LYS . 12.4 m0 -143.35 131.1 21.4 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.096 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 162' ' ' ILE . 51.2 t30 -81.39 116.98 21.47 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 161' ' ' LYS . . . -127.13 176.87 7.05 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.242 0.339 . . . . 0.0 110.453 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.19 133.94 54.72 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.258 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.37 170.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.491 0.662 . . . . 0.0 110.916 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.5 ttt -78.51 0.41 26.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.666 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -104.4 -28.59 11.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.83 48.19 0.42 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -129.25 130.93 46.86 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.128 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.88 121.83 41.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.59 0.71 . . . . 0.0 111.874 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.86 154.41 25.49 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.765 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 152' ' ' LEU . 1.9 ttt -74.5 163.61 27.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.542 0.686 . . . . 0.0 111.084 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.431 ' H ' ' HG2' ' A' ' 182' ' ' MET . 0.0 OUTLIER -157.21 145.31 14.21 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.669 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.03 112.92 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.529 1.486 . . . . 0.0 109.441 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.528 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 49.7 t -47.63 -51.37 45.55 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.954 -0.466 . . . . 0.0 112.045 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.3 Cg_endo -47.42 -30.61 11.86 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.305 2.003 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.497 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.4 m-85 -68.21 -3.76 11.75 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.935 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.74 160.95 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.792 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -116.95 -64.31 1.33 Allowed 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.436 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 4.5 tptp -177.71 -173.17 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.491 ' O ' ' CD1' ' A' ' 137' ' ' TYR . 50.9 t -173.37 64.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.986 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.53 149.71 84.03 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.572 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.47 -31.33 0.36 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.212 1.942 . . . . 0.0 112.302 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.1 m -64.71 -99.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.0 t -66.38 80.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.605 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 170.49 110.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.242 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 98.0 p -166.08 -133.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.453 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.95 159.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 47.7 t -49.06 147.81 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.029 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 201' ' ' LEU . 48.0 m -155.11 91.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.303 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 200' ' ' THR . 0.4 OUTLIER 20.79 64.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.705 0.628 . . . . 0.0 111.201 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 97.7 m -124.58 110.38 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -178.31 -104.31 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.67 70.12 1.9 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -87.81 95.74 10.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.485 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -67.92 116.1 8.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 209' ' ' SER . 34.0 t0 -95.22 111.2 23.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.296 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 m 44.88 -90.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.536 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 207' ' ' ASP . 59.7 m -130.56 152.56 49.79 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.296 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 211' ' ' PRO . 0.0 OUTLIER 165.77 -46.83 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.897 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 73.2 Cg_endo -80.42 102.2 1.4 Allowed 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.59 1.527 . . . . 0.0 112.115 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.431 HE22 ' CA ' ' A' ' 215' ' ' GLY . 0.6 OUTLIER -174.83 57.86 0.19 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.955 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.26 151.16 86.56 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 112.228 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 3.8 mm? 43.89 71.26 0.25 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.431 ' CA ' HE22 ' A' ' 212' ' ' GLN . . . -109.66 45.72 1.28 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.8 81.15 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.56 150.08 71.52 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.504 2.136 . . . . 0.0 111.889 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.427 ' CB ' ' CD ' ' A' ' 219' ' ' PRO . 4.8 mt-10 -153.22 -64.14 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.035 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 218' ' ' GLU . 25.7 Cg_endo -58.88 141.02 97.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.832 1.688 . . . . 0.0 111.902 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.28 -163.27 22.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -81.15 -80.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.569 2.18 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -172.1 145.05 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.183 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.32 100.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.058 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -138.9 162.01 55.01 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 226' ' ' SER . 53.4 Cg_exo -48.35 -23.24 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.223 1.949 . . . . 0.0 112.134 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 227' ' ' ILE . 0.9 OUTLIER 165.28 -88.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.718 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.532 ' N ' ' OG ' ' A' ' 226' ' ' SER . 95.4 mt 61.18 -58.59 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 124.508 1.13 . . . . 0.0 110.693 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.567 ' N ' HD21 ' A' ' 228' ' ' ASN . 0.0 OUTLIER -171.35 54.77 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.687 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 1.5 p -60.13 151.78 64.98 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.7 57.14 0.74 Allowed 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.747 2.298 . . . . 0.0 111.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.467 ' O ' ' CD1' ' A' ' 231' ' ' LEU . 4.3 pp -134.45 130.13 19.88 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.69 -35.09 0.33 Allowed 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.735 1.623 . . . . 0.0 110.9 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.532 ' O ' ' O ' ' A' ' 234' ' ' LEU . 0.2 OUTLIER 70.68 111.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.409 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.778 ' O ' ' N ' ' A' ' 236' ' ' ASN . 2.4 tp -43.45 -101.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 38.92 -76.06 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 124.285 0.99 . . . . 0.0 110.029 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.778 ' N ' ' O ' ' A' ' 234' ' ' LEU . 8.1 m120 -52.0 -80.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.5 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -72.38 -177.09 29.78 Favored Glycine 0 CA--C 1.45 -3.997 0 CA-C-O 122.554 1.085 . . . . 0.0 114.619 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.5 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.0 Cg_exo -53.7 127.91 1.32 Allowed 'Cis proline' 0 N--CA 1.528 3.502 0 N-CA-C 115.462 1.293 . . . . 0.0 115.462 -3.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.516 ' CD1' ' OE1' ' A' ' 169' ' ' GLN . 3.2 m-85 -153.86 -117.68 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.3 m-30 -141.74 123.23 14.98 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 119.141 0.882 . . . . 0.0 109.831 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.703 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -113.34 150.47 32.53 Favored 'General case' 0 C--O 1.198 -1.65 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -113.23 103.25 11.15 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.733 -0.604 . . . . 0.0 109.422 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 8.3 p -74.35 121.47 25.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.505 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.17 23.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.425 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 177.42 116.96 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.431 0.634 . . . . 0.0 109.844 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.622 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 1.4 ttmt -156.66 -158.8 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.935 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.77 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 28.7 ptt85 -153.94 144.88 22.69 Favored 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.76 91.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.637 0 O-C-N 124.041 0.838 . . . . 0.0 110.829 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.77 ' HD3' ' O ' ' A' ' 247' ' ' ARG . 70.0 Cg_endo -108.14 171.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 123.782 2.988 . . . . 0.0 113.827 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 253' ' ' ASP . 4.3 p-10 -93.04 -169.35 2.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.261 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.62 16.19 22.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.522 ' C ' ' H ' ' A' ' 254' ' ' LYS . 5.7 m-85 -125.72 -21.62 4.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.227 0.537 . . . . 0.0 110.159 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.612 ' H ' ' ND2' ' A' ' 250' ' ' ASN . 31.5 t70 -71.78 45.05 0.11 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.928 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 255' ' ' THR . 38.7 mtmt 106.03 -10.78 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 124.717 1.261 . . . . 0.0 110.81 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.537 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 7.6 m 105.92 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.4 1.062 . . . . 0.0 110.651 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -40.21 153.2 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 O-C-N 123.262 0.351 . . . . 0.0 111.62 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.719 ' CD2' ' O ' ' A' ' 285' ' ' GLY . 0.6 OUTLIER -107.33 151.51 25.39 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.774 0.43 . . . . 0.0 110.619 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.402 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -94.78 114.54 26.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 2.1 mt -139.4 -170.92 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.355 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -146.14 149.18 33.51 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.501 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.62 106.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.09 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.97 8.68 10.44 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -94.54 -133.71 0.18 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 170.98 139.77 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.583 ' N ' HD11 ' A' ' 264' ' ' LEU . 14.7 p -127.21 143.73 39.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.449 ' HZ1' ' CB ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -97.43 92.24 5.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 11.8 t -61.93 152.09 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.733 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.497 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -151.8 -58.61 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.671 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 116.89 10.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.413 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.471 ' H ' ' CD1' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -126.95 162.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.099 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.701 HD21 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER 177.59 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.556 0.693 . . . . 0.0 110.638 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.701 ' N ' HD21 ' A' ' 271' ' ' ASN . 25.5 mtm -35.95 125.87 0.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.195 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -62.95 6.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.911 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -132.94 -50.48 0.09 OUTLIER Glycine 0 N--CA 1.467 0.729 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.579 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.6 mp0 -94.91 160.9 14.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.579 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 4.3 m95 -162.85 158.17 22.27 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.471 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -120.64 128.48 53.05 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 123.24 0.338 . . . . 0.0 111.454 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.66 -157.16 31.16 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.297 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.35 127.2 0.81 Allowed 'General case' 0 C--N 1.346 0.429 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -138.83 78.09 1.66 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.692 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.6 t-20 83.35 27.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.587 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.69 -26.73 21.99 Favored Glycine 0 N--CA 1.462 0.386 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.968 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.1 OUTLIER -73.13 73.33 1.22 Allowed 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.769 -178.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.637 ' NH2' ' CZ ' ' A' ' 142' ' ' PHE . 64.2 mtt85 -73.01 169.44 16.96 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.719 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 165.18 122.12 0.59 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 122.659 1.144 . . . . 0.0 113.065 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.627 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.4 p80 -59.4 177.08 0.2 Allowed 'General case' 0 C--N 1.284 -2.247 0 O-C-N 119.194 -2.357 . . . . 0.0 109.555 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 166.03 149.06 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 123.968 0.792 . . . . 0.0 111.428 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 32.4 Cg_exo -55.65 135.81 71.17 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.508 2.138 . . . . 0.0 113.945 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 66.6 t80 -75.16 -1.5 23.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.795 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 20.4 p -76.83 3.22 12.42 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 9.1 p80 -133.63 44.29 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.134 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.36 146.14 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -125.71 77.45 1.66 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.124 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 38.2 mt -39.67 127.08 1.97 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.81 0.814 . . . . 0.0 111.375 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.4 mp -67.75 -166.76 0.06 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.962 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -70.96 8.36 0.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 236' ' ' ASN . 47.7 tt0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.149 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 33.9 m . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 37.8 tt0 -140.21 139.29 35.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.394 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 138' ' ' VAL . 21.0 m-85 90.41 -133.56 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 O-C-N 123.513 0.508 . . . . 0.0 110.435 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER 78.59 157.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.565 1.165 . . . . 0.0 110.828 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.625 ' NH1' ' HG ' ' A' ' 191' ' ' CYS . 26.1 ptt180 -141.39 159.81 41.45 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 154' ' ' PHE . . . -59.74 172.72 0.67 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.342 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.0 mt -143.08 -58.21 0.42 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.524 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -113.33 9.78 18.31 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.33 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.524 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 78.27 137.45 0.06 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.454 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 3.6 t80 -111.22 -46.11 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.335 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.658 HD22 ' NZ ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER 47.56 63.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.75 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -63.69 -124.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.76 HD21 ' H ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER 166.8 -49.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.188 0.494 . . . . 0.0 111.863 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.76 ' H ' HD21 ' A' ' 147' ' ' ASN . 7.9 m-20 -72.32 162.96 28.75 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 27.8 p-10 -69.56 -22.72 63.52 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.806 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -87.83 24.32 1.79 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.613 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 32.2 p30 -141.48 165.59 27.08 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 8.8 tp -120.45 88.86 43.26 Favored Pre-proline 0 C--O 1.217 -0.646 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.685 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.407 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 65.6 Cg_endo -69.57 140.58 43.73 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.346 1.364 . . . . 0.0 113.068 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.449 ' CZ ' ' CB ' ' A' ' 144' ' ' PHE . 17.5 p90 -158.31 166.22 32.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.658 ' NZ ' HD22 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -139.1 148.12 42.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.42 -133.83 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.338 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -121.31 49.73 0.87 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.18 140.39 58.45 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.7 mp -84.86 100.58 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.933 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.6 mt -109.56 125.59 52.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.87 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -81.3 138.24 35.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.636 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.3 mp -72.1 -57.44 7.28 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.669 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 162' ' ' ILE . 60.9 ttt180 77.59 -46.26 0.46 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.33 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.495 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -110.4 -134.64 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.868 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 164' ' ' ASP . 8.2 pttp 149.21 60.19 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.431 0.693 . . . . 0.0 109.701 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.14 -59.37 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.64 2.227 . . . . 0.0 112.429 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.0 mt-10 -117.3 174.48 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 1.1 pm0 -83.93 -44.58 14.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.678 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.466 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 83.1 mt-30 -75.19 -27.84 59.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 62.9 m95 -119.3 154.13 33.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 9.8 m0 -149.81 142.88 24.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.611 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.636 ' O ' ' O ' ' A' ' 162' ' ' ILE . 2.9 t30 -90.13 121.19 31.96 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -124.13 172.77 8.76 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.67 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -121.58 132.2 54.55 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -60.82 171.57 1.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.473 0.654 . . . . 0.0 110.85 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 tpt -77.12 -3.02 37.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.813 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.32 -27.89 12.19 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.87 48.12 0.42 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -129.66 134.29 47.59 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.448 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.56 123.52 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.531 0.681 . . . . 0.0 111.577 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -153.61 149.55 21.05 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.934 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 mtp -66.95 155.98 37.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.374 0.607 . . . . 0.0 111.002 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 11.5 pt -147.63 142.99 17.3 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.211 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.3 111.66 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.223 1.282 . . . . 0.0 109.71 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.578 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 58.5 t -46.77 -51.69 36.61 Favored Pre-proline 0 CA--C 1.535 0.38 0 O-C-N 122.212 -0.305 . . . . 0.0 111.337 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.1 Cg_endo -47.26 -30.07 10.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.26 1.974 . . . . 0.0 113.047 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 268' ' ' THR . 15.9 m-85 -77.5 -7.86 56.9 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.5 m -132.94 160.43 42.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.554 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.664 ' C ' ' H ' ' A' ' 191' ' ' CYS . 8.3 pt-20 -136.71 156.53 48.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.042 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -60.8 12.3 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.577 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.664 ' H ' ' C ' ' A' ' 189' ' ' GLU . 50.0 t 58.13 43.37 20.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.39 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -157.49 58.65 1.53 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.613 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' SER . 73.7 Cg_endo -77.39 -2.88 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.811 2.341 . . . . 0.0 112.15 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.2 m -42.69 85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 193' ' ' PRO . 3.7 t 66.27 6.12 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.744 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.01 146.49 54.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.71 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 78.2 p -64.2 -16.54 62.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.39 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.9 t -73.46 80.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.303 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.5 t 42.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 201' ' ' LEU . 30.6 m -68.51 123.3 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 201' ' ' LEU . 9.2 mp 30.87 -107.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.34 0.4 . . . . 0.0 110.984 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 200' ' ' THR . 71.8 p -50.81 171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.292 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 177.36 -33.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -138.61 -128.9 2.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.689 HD21 ' H ' ' A' ' 205' ' ' ASN . 0.0 OUTLIER -127.76 127.64 43.95 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.888 0.375 . . . . 0.0 110.49 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 48.71 -126.85 2.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.367 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.15 -84.29 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.239 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.7 p -86.51 140.56 29.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.439 ' C ' ' CG ' ' A' ' 210' ' ' HIS . 29.3 t -71.93 -11.24 60.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.505 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.439 ' CG ' ' C ' ' A' ' 209' ' ' SER . 5.0 m80 74.42 150.24 0.13 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.67 -47.15 11.75 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.08 1.853 . . . . 0.0 112.422 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 40.25 71.99 1.11 Allowed Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.66 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.64 143.07 99.73 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.778 2.319 . . . . 0.0 111.959 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 tp -170.06 55.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 273' ' ' SER . . . 76.24 75.85 0.85 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.78 -71.98 0.13 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.29 -21.86 71.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.7 2.267 . . . . 0.0 111.842 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 220' ' ' GLY . 13.6 mp0 -51.42 150.55 6.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.588 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -38.41 83.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.824 2.349 . . . . 0.0 112.498 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 218' ' ' GLU . . . 47.93 -172.28 0.04 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.68 148.47 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.814 2.343 . . . . 0.0 112.315 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.538 ' O ' ' NE2' ' A' ' 224' ' ' GLN . 60.4 m-85 -66.72 170.85 5.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.265 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' A' ' 224' ' ' GLN . . . -41.21 93.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 222' ' ' TYR . 1.8 mp0 -128.75 162.67 50.1 Favored Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.22 -43.17 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 228' ' ' ASN . 33.4 t -159.6 155.11 25.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 227' ' ' ILE . 14.7 mm -65.4 61.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 226' ' ' SER . 70.5 m-80 -134.66 73.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.3 p -70.69 151.14 95.4 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.703 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -39.83 -64.82 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.407 2.071 . . . . 0.0 112.123 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.6 tp -133.38 105.32 12.14 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.459 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 233' ' ' ASN . 73.7 Cg_endo -80.71 81.8 2.64 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.875 1.717 . . . . 0.0 112.468 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 271' ' ' ASN . 89.2 m-20 40.83 -164.93 0.0 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.06 109.6 4.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.463 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -152.38 11.65 0.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.08 0.467 . . . . 0.0 110.637 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.434 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 84.9 m-20 -152.94 -75.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.026 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.508 ' HA2' ' N ' ' A' ' 239' ' ' PHE . . . -75.16 -176.44 38.32 Favored Glycine 0 CA--C 1.457 -3.552 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.406 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.3 Cg_endo -57.3 100.72 0.06 OUTLIER 'Cis proline' 0 N--CA 1.525 3.374 0 N-CA-C 115.366 1.256 . . . . 0.0 115.366 -0.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.539 ' CG ' ' OE1' ' A' ' 297' ' ' GLN . 2.4 m-85 -115.9 -131.43 0.32 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.474 ' H ' ' HB3' ' A' ' 239' ' ' PHE . 0.5 OUTLIER -144.95 132.13 20.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 118.873 0.76 . . . . 0.0 109.183 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.808 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -119.49 153.78 34.8 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.005 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -114.14 95.63 5.39 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.7 130.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.231 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.88 20.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.584 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 179.58 109.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.966 0.413 . . . . 0.0 110.314 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 287' ' ' PHE . 5.4 ttmt -162.01 -151.13 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.773 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.684 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -157.5 -137.23 0.05 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.522 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.58 61.94 39.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 250' ' ' ASN . 43.0 Cg_endo -92.81 51.47 0.46 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.598 2.199 . . . . 0.0 113.474 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.718 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.2 OUTLIER -25.09 146.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.052 0.845 . . . . 0.0 111.291 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.96 -7.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.191 0.52 . . . . 0.0 111.668 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 250' ' ' ASN . 37.5 m-85 -83.02 -62.63 1.54 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 252' ' ' TYR . 35.4 t0 -33.46 -51.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.972 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.684 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 5.4 pttt -171.51 44.22 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.13 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m 63.34 -14.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.299 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.684 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -62.42 127.12 29.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.962 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.685 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -52.36 159.28 1.01 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.092 0.472 . . . . 0.0 111.322 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.505 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -108.18 121.95 45.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.33 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.459 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.4 mt -142.7 -175.29 4.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.051 0.453 . . . . 0.0 111.203 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -144.02 151.26 39.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.236 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.94 112.14 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.676 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 5.38 20.07 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -93.65 -128.68 0.12 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.808 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 168.72 138.6 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.704 0.764 . . . . 0.0 109.612 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.63 ' N ' HD11 ' A' ' 264' ' ' LEU . 9.6 p -137.75 151.6 26.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.422 ' N ' HG21 ' A' ' 265' ' ' VAL . 4.7 ttmt -79.61 -161.32 0.32 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.277 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 269' ' ' LYS . 1.7 t -140.78 -53.43 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.453 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER 46.08 -71.67 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.3 OUTLIER -81.28 117.65 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.255 -177.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.583 ' H ' ' CD1' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -132.5 161.6 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.168 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.563 HD21 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -164.39 -108.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.162 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.563 ' N ' HD21 ' A' ' 271' ' ' ASN . 46.9 mtm -39.38 153.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.685 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 215' ' ' GLY . 4.8 p -75.77 18.68 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.388 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -142.71 -75.71 0.03 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.491 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 1.9 mp0 -78.02 176.53 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.72 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.54 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 9.5 p-90 170.08 -169.57 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.532 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 269' ' ' LYS . 71.7 mt-10 -128.94 165.36 21.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.808 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -145.57 -152.77 5.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.094 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.07 125.64 0.55 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.906 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.459 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 -93.11 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -103.3 50.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.64 -31.19 5.96 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.415 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -64.8 83.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.398 -179.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -79.39 166.17 22.33 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.969 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.431 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.46 -157.59 29.83 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.444 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 10.3 p-80 -125.4 175.33 7.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 123.847 0.381 . . . . 0.0 110.916 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.54 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 164.84 112.49 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 290' ' ' THR . 51.8 Cg_exo -50.34 143.27 27.18 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.798 1.665 . . . . 0.0 112.496 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.584 ' O ' ' CD2' ' A' ' 289' ' ' PHE . 52.9 t80 -66.09 -0.84 2.65 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 288' ' ' PRO . 68.2 p -53.65 0.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.527 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.6 p80 -160.74 74.39 0.51 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.565 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -166.05 154.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.551 ' O ' ' HG ' ' A' ' 294' ' ' LEU . 58.0 mtp180 -101.44 -110.13 0.22 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 293' ' ' ARG . 9.4 mt 150.8 120.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.271 0.982 . . . . 0.0 110.751 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.02 -174.63 3.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.972 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.42 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 66.1 t0 -111.21 40.81 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.516 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.539 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 10.7 tp60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.757 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.487 ' OE2' ' O ' ' A' ' 191' ' ' CYS . 49.7 tp10 -147.94 161.38 41.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.55 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 74.2 m-85 -121.01 -93.88 0.51 Allowed 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.504 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.3 m 83.03 161.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 124.852 1.345 . . . . 0.0 110.841 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.677 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 2.6 ptp180 -132.48 151.88 51.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.536 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -101.99 92.99 5.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.086 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.09 22.97 8.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.598 ' O ' ' O ' ' A' ' 143' ' ' ASP . 57.9 m-85 -123.47 6.84 8.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.0 p30 51.86 137.04 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.276 0 O-C-N 124.59 1.181 . . . . 0.0 110.808 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.491 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 6.6 t80 -124.59 -43.23 2.04 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.225 0.466 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 144' ' ' PHE . 53.9 t-20 39.31 62.18 1.19 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.454 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.34 -146.11 0.21 Allowed Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.601 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.1 p30 171.22 91.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.063 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.4 m-20 171.57 -173.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.373 . . . . 0.0 110.212 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -93.63 -21.55 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.652 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.79 26.29 10.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.974 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 8.9 p-10 -134.17 152.37 51.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 9.5 tp -116.94 85.21 17.27 Favored Pre-proline 0 C--O 1.21 -1.01 0 CA-C-N 117.586 0.175 . . . . 0.0 110.564 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.402 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 27.3 Cg_exo -59.73 139.37 88.29 Favored 'Trans proline' 0 C--N 1.288 -2.627 0 C-N-CA 121.49 1.46 . . . . 0.0 112.864 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 9.1 p90 -159.02 158.29 32.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.258 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 156' ' ' LYS . 1.6 ttmp? -176.62 112.6 0.1 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 147.06 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.384 1.052 . . . . 0.0 110.565 178.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.09 44.75 0.91 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -79.71 153.59 29.17 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.398 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.457 ' O ' ' SD ' ' A' ' 176' ' ' MET . 3.7 tp -98.67 119.27 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 137' ' ' TYR . 10.6 mt -118.7 133.65 55.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.19 139.78 34.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.74 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.6 mp -64.46 -48.74 83.83 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.865 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.574 ' NE ' ' OD1' ' A' ' 164' ' ' ASP . 0.2 OUTLIER 69.96 -53.26 0.63 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.893 -0.504 . . . . 0.0 111.617 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.574 ' OD1' ' NE ' ' A' ' 163' ' ' ARG . 0.5 OUTLIER -116.9 -126.39 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 164' ' ' ASP . 1.3 pttm 141.55 60.89 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.72 1.208 . . . . 0.0 109.575 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.403 ' HD3' ' H ' ' A' ' 165' ' ' LYS . 47.3 Cg_endo -67.19 -46.61 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.924 1.749 . . . . 0.0 112.432 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -118.46 167.5 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -85.14 -35.08 21.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.529 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 1.8 mt-30 -84.16 -25.24 29.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.593 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.6 m95 -122.23 150.31 42.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.4 ' O ' HG13 ' A' ' 183' ' ' ILE . 11.4 m0 -141.57 129.92 22.4 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.934 0.873 . . . . 0.0 110.696 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.74 ' O ' ' O ' ' A' ' 162' ' ' ILE . 5.5 t30 -81.86 107.95 15.0 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.6 174.17 6.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.5 0.5 . . . . 0.0 110.627 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 33.1 tt0 -123.03 133.32 54.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.4 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.44 169.23 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.505 0.669 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 159' ' ' ILE . 97.4 mmm -76.64 0.67 19.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.81 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.559 ' CB ' ' HZ1' ' A' ' 179' ' ' LYS . 93.9 m-20 -104.95 -28.38 11.12 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.52 49.64 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.559 ' HZ1' ' CB ' ' A' ' 177' ' ' ASP . 18.6 mttp -130.19 135.72 48.47 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 114.241 -0.979 . . . . 0.0 110.757 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.77 125.15 52.4 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.523 0.678 . . . . 0.0 111.776 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.13 154.9 25.95 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.444 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 tpt -66.01 154.57 39.12 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 171' ' ' TRP . 1.3 pp -145.02 143.3 20.16 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.35 114.62 4.09 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 N-CA-C 108.694 -1.31 . . . . 0.0 108.694 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.516 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 41.6 t -49.92 -52.0 56.09 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.949 -0.47 . . . . 0.0 111.979 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.2 Cg_endo -49.8 -28.63 18.3 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.052 1.835 . . . . 0.0 113.773 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.445 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.8 m-85 -67.78 3.66 1.39 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 186' ' ' PRO . 17.0 m -128.11 167.61 22.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 123.263 0.352 . . . . 0.0 110.297 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.677 ' CD ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -68.39 -48.66 64.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.33 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 81.78 79.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.227 1.011 . . . . 0.0 111.513 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.487 ' O ' ' OE2' ' A' ' 136' ' ' GLU . 1.1 t -91.35 95.37 9.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.862 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 194' ' ' SER . 0.0 OUTLIER 179.01 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 192' ' ' ARG . 49.5 Cg_endo -68.46 21.14 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.942 1.761 . . . . 0.0 111.889 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 192' ' ' ARG . 26.0 p -168.33 -22.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 194' ' ' SER . 0.5 OUTLIER 76.63 -51.96 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.03 158.36 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.625 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 11.0 p -71.27 155.98 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.28 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.93 135.06 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 25.9 m 47.91 -110.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.422 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.7 m 68.41 99.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.402 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 35.9 tp 38.65 73.22 0.11 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.8 t -128.23 22.73 6.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.318 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -167.34 -161.87 17.73 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 206' ' ' GLN . . . -77.84 -5.42 86.58 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.83 9.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.574 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 204' ' ' GLY . 88.0 mt-30 -132.98 -46.52 0.85 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.528 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 209' ' ' SER . 55.0 t0 49.68 34.56 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.8 t -54.03 89.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 207' ' ' ASP . 58.4 m -131.5 42.53 3.18 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -131.29 150.97 77.97 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.5 90.87 0.34 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.597 2.198 . . . . 0.0 112.004 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 22.3 tt0 -166.2 47.73 0.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.478 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 29.9 Cg_endo -62.2 -25.86 77.25 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.744 2.296 . . . . 0.0 112.017 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.1 -75.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.645 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 176.85 163.96 29.92 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.502 ' N ' ' CD ' ' A' ' 217' ' ' PRO . . . -154.55 49.41 0.49 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 216' ' ' GLY . 29.5 Cg_endo -62.67 -61.89 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.573 2.182 . . . . 0.0 111.56 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.546 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 1.1 tt0 -106.2 -45.33 0.13 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 66.4 Cg_endo -84.49 159.09 12.64 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.325 2.016 . . . . 0.0 111.658 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -104.0 -68.88 0.77 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.67 -174.63 2.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.663 2.242 . . . . 0.0 112.067 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 224' ' ' GLN . 75.4 m-85 -67.59 160.52 27.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.19 94.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.189 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.529 ' OE1' ' ND2' ' A' ' 228' ' ' ASN . 34.1 mm-40 -96.07 147.7 33.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.526 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.26 -43.93 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.464 2.109 . . . . 0.0 112.196 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 62.1 m -104.86 20.92 17.91 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.726 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 229' ' ' THR . 5.1 mp 44.92 56.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.529 ' ND2' ' OE1' ' A' ' 224' ' ' GLN . 43.9 m-80 -59.93 75.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.922 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 227' ' ' ILE . 14.5 p -112.25 147.98 38.14 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.08 -91.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.568 2.179 . . . . 0.0 111.763 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.601 ' O ' ' O ' ' A' ' 232' ' ' PRO . 1.6 mp -118.32 139.9 27.41 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.243 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.601 ' O ' ' O ' ' A' ' 231' ' ' LEU . 71.8 Cg_exo -47.52 -131.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.522 2.148 . . . . 0.0 111.986 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 235' ' ' GLN . 51.7 p-10 -127.42 163.11 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.1 tp 64.39 -64.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 233' ' ' ASN . 29.2 mm100 55.2 -165.64 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.494 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -66.76 -50.28 63.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 0.0 110.865 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -60.15 -177.63 1.59 Allowed Glycine 1 CA--C 1.433 -5.054 0 CA-C-O 122.446 1.026 . . . . 0.0 114.41 -179.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.48 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.7 Cg_endo -57.21 125.2 1.38 Allowed 'Cis proline' 0 N--CA 1.533 3.841 0 N-CA-C 115.608 1.349 . . . . 0.0 115.608 -2.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.597 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 12.7 m-85 -150.79 -121.37 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.602 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.529 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 1.0 OUTLIER -143.06 123.83 14.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.721 0.772 . . . . 0.0 110.484 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 264' ' ' LEU . . . -107.05 -159.24 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.032 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -162.41 87.41 0.62 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.0 p -57.94 123.61 10.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.006 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 15.73 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.726 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -175.94 112.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.294 0.569 . . . . 0.0 110.237 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.424 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.6 ttmt -158.72 -146.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.182 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.424 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 4.3 ptt85 -155.85 -142.53 0.11 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.829 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 82.0 t -132.69 66.95 77.7 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.521 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 84.0 Cg_endo -90.56 172.64 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.609 2.206 . . . . 0.0 111.231 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.75 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -145.86 142.61 28.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.29 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.46 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.75 ' H ' ' C ' ' A' ' 250' ' ' ASN . 60.9 m-85 -93.57 -54.51 3.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 110.791 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -44.67 -67.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.564 ' C ' ' H ' ' A' ' 256' ' ' ALA . 26.7 mttt -148.58 32.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.521 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 m 72.28 -15.21 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.608 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.34 156.43 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.68 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.508 HD22 ' H ' ' A' ' 257' ' ' LEU . 0.2 OUTLIER -97.17 148.0 23.51 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.961 0.504 . . . . 0.0 110.359 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -86.98 115.21 24.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 2.5 mt -139.77 -176.06 4.44 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.435 0.636 . . . . 0.0 111.126 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -146.28 147.87 31.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.702 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.59 106.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.289 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 118.03 3.96 14.94 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.1 mm-40 -87.19 -122.22 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.745 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 241' ' ' ALA . 0.4 OUTLIER 161.15 138.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.489 0.661 . . . . 0.0 109.477 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.543 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 13.5 p -130.84 140.8 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.968 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.464 ' CB ' ' HZ3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.78 88.31 3.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.925 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.79 151.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.265 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.445 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -158.75 -51.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.465 0.65 . . . . 0.0 110.227 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -74.85 116.53 15.68 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.27 104.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.76 HD21 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -87.52 -25.86 23.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 178.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.76 ' H ' HD21 ' A' ' 271' ' ' ASN . 5.4 mtm -145.96 176.88 9.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.434 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -91.58 16.11 11.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -134.39 -96.06 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.244 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 63.69 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.769 0.795 . . . . 0.0 110.763 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.532 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -69.59 178.71 2.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 1.3 mt-10 -109.12 -163.19 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.067 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -159.23 -160.33 10.33 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.753 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.409 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.5 tt0 -169.42 130.26 1.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.157 0.503 . . . . 0.0 111.683 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -147.55 75.42 1.36 Allowed 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.354 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 33.9 t30 83.81 31.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.249 0.547 . . . . 0.0 110.318 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 95.63 -31.41 7.21 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.336 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.57 76.54 0.42 Allowed 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.502 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 94.6 mtt180 -76.57 171.8 14.05 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.135 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.87 -156.68 27.68 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.543 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 6.3 p80 -124.32 169.81 11.42 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 122.889 0.476 . . . . 0.0 109.737 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 164.92 114.39 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.26 178.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 290' ' ' THR . 53.1 Cg_exo -53.05 140.98 58.87 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.626 1.551 . . . . 0.0 112.099 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.515 ' O ' ' CG ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -67.27 0.01 3.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.031 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 288' ' ' PRO . 46.2 p -55.15 1.75 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.044 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.508 ' H ' ' C ' ' A' ' 289' ' ' PHE . 5.8 p80 -151.7 65.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.901 -0.499 . . . . 0.0 110.789 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 12.2 m -156.42 153.37 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -101.53 -55.82 2.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.2 mt 86.76 119.14 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.075 0.941 . . . . 0.0 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.68 -178.41 2.66 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.689 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -87.41 47.86 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.536 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 51.7 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.456 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 136' ' ' GLU . 33.7 m . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 137' ' ' TYR . 16.5 tp10 93.0 155.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 123.558 0.536 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.698 ' O ' ' O ' ' A' ' 138' ' ' VAL . 57.6 m-85 -160.98 -20.58 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.698 ' O ' ' O ' ' A' ' 137' ' ' TYR . 27.3 m 34.93 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.012 0.82 . . . . 0.0 111.528 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 36.4 ttt180 -144.49 128.82 17.85 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.996 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -98.83 84.9 3.18 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 123.524 0.515 . . . . 0.0 111.58 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.538 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -95.19 32.57 1.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.224 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 143' ' ' ASP . 45.9 m-85 -134.3 3.46 3.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 142' ' ' PHE . 3.9 p30 51.86 139.48 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 O-C-N 124.919 1.387 . . . . 0.0 110.431 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 t80 -129.31 -49.33 1.19 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 38.97 61.76 1.2 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.94 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.464 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -69.34 -149.9 0.36 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 164.99 103.26 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.428 -0.886 . . . . 0.0 109.873 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.594 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 20.4 m-20 173.01 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.442 1.089 . . . . 0.0 112.8 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 62.92 -45.03 0.2 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.904 0.752 . . . . 0.0 109.686 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 148' ' ' ASP . 96.4 mt-10 -85.89 29.41 0.72 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.505 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.575 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.5 p30 -143.52 163.95 31.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.653 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 11.4 tp -118.48 91.41 41.41 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.464 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 65.5 Cg_endo -71.91 124.57 10.24 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 121.489 1.46 . . . . 0.0 112.906 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.453 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 14.6 p90 -144.49 163.47 33.73 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.924 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 143' ' ' ASP . 0.7 OUTLIER -142.21 150.85 41.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.103 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.996 ' O ' ' O ' ' A' ' 140' ' ' ALA . 11.8 mtpt 73.12 -142.19 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.24 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -107.43 48.52 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 42.9 t0 -56.73 153.58 10.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.026 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.467 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.5 mp -102.02 106.08 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.5 mt -112.52 110.57 20.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.953 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -70.03 150.6 46.46 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.4 mp -94.38 133.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.099 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.561 ' NH2' ' ND2' ' A' ' 172' ' ' ASN . 7.8 tmm_? -107.53 -42.79 4.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.063 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -153.73 128.52 9.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 32.9 pttt -123.88 75.62 57.28 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.6 -40.44 73.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 111.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -106.21 -165.07 1.06 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -118.81 -19.94 8.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.924 0.393 . . . . 0.0 110.386 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -88.35 -33.36 17.99 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.7 m95 -118.64 151.28 38.24 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.484 ' CD1' ' CB ' ' A' ' 165' ' ' LYS . 14.9 m0 -141.02 129.67 22.78 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.091 0.948 . . . . 0.0 111.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.561 ' ND2' ' NH2' ' A' ' 163' ' ' ARG . 54.7 t30 -79.45 114.51 18.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.94 173.69 8.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.643 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.39 135.89 54.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 175.02 1.26 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.504 0.669 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.06 -4.18 48.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.794 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -101.34 -28.05 12.83 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.95 49.68 0.37 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -130.62 134.81 47.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.629 -0.786 . . . . 0.0 110.697 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.54 127.29 52.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.442 0.639 . . . . 0.0 111.733 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.53 155.08 26.16 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.268 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.48 157.83 33.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.814 0.34 . . . . 0.0 110.337 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.2 pp -144.14 142.6 20.26 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.92 113.56 3.82 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 13.6 t -46.93 -53.65 25.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 121.519 -0.738 . . . . 0.0 112.209 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 8.2 Cg_endo -48.64 -28.04 11.75 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 121.913 1.742 . . . . 0.0 113.234 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.46 ' OH ' ' O ' ' A' ' 268' ' ' THR . 8.1 m-85 -71.17 -0.77 10.5 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.299 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 185' ' ' VAL . 1.9 m -135.82 162.03 37.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.477 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -115.39 -60.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 0.4 OUTLIER 176.16 -165.4 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.566 -179.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.401 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 8.8 p -133.35 34.13 3.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.795 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.447 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 19.2 ttp-105 -166.87 53.42 0.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 56.8 Cg_endo -70.07 135.96 31.0 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.448 2.099 . . . . 0.0 111.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.5 p -113.5 46.38 1.28 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.4 p -164.68 -156.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.317 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -114.53 -75.92 0.58 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.267 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.8 p -110.87 105.91 14.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.269 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.02 -82.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 200' ' ' THR . 31.1 t -75.73 135.49 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 199' ' ' SER . 3.3 p 64.97 110.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 200' ' ' THR . 0.2 OUTLIER 79.24 86.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.362 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 94.9 m -124.19 121.95 36.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -168.01 151.07 17.81 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.07 -36.77 92.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 207' ' ' ASP . 77.7 m-20 -121.15 34.1 5.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.362 0.125 . . . . 0.0 110.82 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 70.28 -46.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.437 0.46 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 205' ' ' ASN . 97.9 m-20 54.82 37.27 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 7.3 p -67.01 155.33 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.374 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.3 t -156.68 85.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.1 m80 54.15 66.39 4.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.54 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.05 85.92 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.556 2.171 . . . . 0.0 112.13 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.59 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 0.0 OUTLIER -96.03 -43.56 0.26 Allowed Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.366 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 56.4 Cg_endo -83.95 15.46 2.14 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.1 tt -86.89 117.09 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.132 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 160.4 138.39 2.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -92.38 -58.13 1.39 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.86 97.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.448 2.098 . . . . 0.0 112.004 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.504 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 55.3 tt0 -172.82 50.03 0.1 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.483 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 46.5 Cg_endo -66.96 147.47 80.32 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.704 2.269 . . . . 0.0 111.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -80.36 -98.07 0.34 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.83 142.47 31.86 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.791 1.661 . . . . 0.0 112.068 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.575 ' CD2' ' N ' ' A' ' 223' ' ' ALA . 76.7 t80 -59.26 173.19 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.774 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.575 ' N ' ' CD2' ' A' ' 222' ' ' TYR . . . -38.63 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.404 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' TYR . 0.4 OUTLIER -110.95 97.98 36.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.807 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.96 -17.57 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.198 1.932 . . . . 0.0 111.607 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.2 m -116.07 63.6 0.7 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.82 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.553 ' H ' ' CD1' ' A' ' 227' ' ' ILE . 0.0 OUTLIER -40.88 102.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.369 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -80.7 -0.52 38.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.317 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.04 177.58 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.427 ' CG ' ' HE1' ' A' ' 276' ' ' TRP . 33.8 Cg_exo -63.25 -14.35 41.42 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.948 2.432 . . . . 0.0 111.719 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.9 mt -126.97 91.92 45.75 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.21 163.24 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.938 2.425 . . . . 0.0 112.535 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 235' ' ' GLN . 10.1 m120 59.21 75.75 0.39 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.841 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.517 ' H ' ' CD1' ' A' ' 227' ' ' ILE . 13.0 tp 25.41 43.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.623 0.725 . . . . 0.0 110.996 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.769 ' O ' ' N ' ' A' ' 237' ' ' GLY . 13.3 mt-30 37.26 34.06 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.493 ' CG ' ' H ' ' A' ' 237' ' ' GLY . 4.4 p30 46.1 -67.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.538 1.149 . . . . 0.0 109.971 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.769 ' N ' ' O ' ' A' ' 235' ' ' GLN . . . -48.49 -175.2 0.01 OUTLIER Glycine 1 CA--C 1.435 -4.944 0 CA-C-O 122.457 1.032 . . . . 0.0 113.266 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.53 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 1.6 Cg_endo -53.07 117.08 0.25 Allowed 'Cis proline' 0 N--CA 1.53 3.671 0 O-C-N 123.635 1.334 . . . . 0.0 115.313 0.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 13.2 m-85 -147.03 -118.37 0.07 Allowed 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.753 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.1 m-30 -143.46 122.68 12.98 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.902 0.858 . . . . 0.0 110.699 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.576 ' N ' HD12 ' A' ' 264' ' ' LEU . . . -106.18 -161.77 0.82 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.294 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -160.92 89.5 0.8 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.35 129.31 25.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.599 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.9 15.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.772 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -173.94 113.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.373 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.452 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.2 ttmt -158.92 -146.7 0.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.452 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.8 ptt85 -156.48 -143.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.821 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.5 69.99 76.65 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.521 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 58.2 Cg_endo -90.63 167.97 4.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.221 2.614 . . . . 0.0 112.971 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.496 ' OD1' ' CB ' ' A' ' 253' ' ' ASP . 46.0 p-10 -97.04 -166.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.275 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.45 11.69 28.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.243 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.552 ' C ' ' H ' ' A' ' 254' ' ' LYS . 6.4 m-85 -123.73 -21.98 5.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.496 ' CB ' ' OD1' ' A' ' 250' ' ' ASN . 35.9 t70 -68.3 43.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 252' ' ' TYR . 38.9 mtmt 96.96 0.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.776 0.831 . . . . 0.0 110.898 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 286' ' ' HIS . 0.2 OUTLIER 84.59 61.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.037 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -115.77 107.32 14.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 111.324 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.614 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.6 155.76 0.76 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.61 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -103.84 121.92 44.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.582 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.422 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.6 mt -142.95 -173.98 4.05 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.256 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -145.91 150.67 36.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.79 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.9 t -57.94 108.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.615 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.68 5.38 18.47 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.3 mm-40 -88.61 -123.77 0.05 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.77 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 241' ' ' ALA . 0.3 OUTLIER 162.31 138.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.562 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 13.1 p -131.39 143.16 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.754 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.428 ' HZ1' ' HD3' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -97.91 84.76 3.38 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.434 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 3.8 t -58.8 150.8 4.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.46 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER -149.28 -53.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 144.86 55.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.494 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -151.16 159.33 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.044 0.449 . . . . 0.0 110.569 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.682 HD21 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -176.94 -107.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.387 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.682 ' N ' HD21 ' A' ' 271' ' ' ASN . 31.6 mtm -42.17 140.86 1.03 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.27 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -74.2 16.1 0.27 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.568 ' O ' ' NE2' ' A' ' 275' ' ' GLN . . . -138.58 -60.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.359 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 274' ' ' GLY . 1.4 mp0 -109.0 101.06 10.18 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.652 ' HA ' HD22 ' A' ' 271' ' ' ASN . 3.6 p-90 -111.9 -165.71 1.01 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 120.846 0.355 . . . . 0.0 110.259 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.5 mt-10 -129.3 167.58 17.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.786 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.87 -151.4 5.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.78 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.503 ' OE2' ' O ' ' A' ' 280' ' ' CYS . 2.5 tm-20 -172.3 128.45 0.56 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.503 ' O ' ' OE2' ' A' ' 279' ' ' GLU . 0.0 OUTLIER -108.79 -90.72 0.45 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -106.03 51.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.02 5.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.415 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.32 83.24 0.09 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 114.591 -0.804 . . . . 0.0 110.065 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -78.14 165.7 23.65 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.292 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 169.23 -158.27 30.66 Favored Glycine 0 C--O 1.215 -1.06 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.56 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 21.7 p80 -122.52 170.48 9.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.029 0.443 . . . . 0.0 110.556 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.592 ' HB3' ' HE2' ' A' ' 291' ' ' HIS . 0.7 OUTLIER 163.09 114.46 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.668 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.513 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 50.7 Cg_exo -50.83 141.31 36.15 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.828 1.686 . . . . 0.0 112.798 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -63.6 0.31 0.79 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.598 0.713 . . . . 0.0 110.018 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 288' ' ' PRO . 66.1 p -56.79 2.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.72 -0.612 . . . . 0.0 112.095 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.592 ' HE2' ' HB3' ' A' ' 287' ' ' PHE . 2.2 p-80 -150.15 64.55 0.96 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.463 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.3 151.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 294' ' ' LEU . 43.3 mtm180 -102.34 -54.74 2.62 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 5.0 mt 91.67 121.09 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.023 0.916 . . . . 0.0 111.322 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.15 -178.12 4.88 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.182 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -87.47 48.58 1.67 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.744 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 47.0 tt0 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.46 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.55 ' N ' ' SG ' ' A' ' 191' ' ' CYS . 35.7 tt0 -143.1 140.8 31.03 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.451 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' H ' HG12 ' A' ' 162' ' ' ILE . 1.6 t80 78.65 107.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.118 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 m -134.33 164.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 111.177 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -123.33 125.99 46.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.441 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -105.5 109.53 21.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.982 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.569 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -118.96 28.47 8.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.851 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 60.0 m-85 -125.29 0.5 7.74 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.49 -0.131 . . . . 0.0 111.164 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.97 139.8 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.738 0 O-C-N 123.901 0.75 . . . . 0.0 110.288 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.607 ' CE2' ' O ' ' A' ' 145' ' ' ASN . 4.3 t80 -133.88 -45.6 0.79 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 30.0 m-80 74.86 -109.95 0.03 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.717 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.505 ' C ' ' CZ ' ' A' ' 144' ' ' PHE . . . -133.5 -172.71 13.02 Favored Glycine 0 C--N 1.275 -2.828 0 O-C-N 121.606 -0.684 . . . . 0.0 113.633 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.442 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 18.9 t30 174.03 -40.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.966 -1.117 . . . . 0.0 111.911 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 6.4 m-20 -93.03 -159.21 0.66 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 111.785 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.02 -45.09 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.483 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 151' ' ' ASP . 97.3 mt-10 -127.22 28.17 5.78 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.654 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.0 OUTLIER -37.69 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 123.908 0.755 . . . . 0.0 111.786 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.412 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 11.7 tp -127.09 98.88 29.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.922 -0.486 . . . . 0.0 111.888 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 145' ' ' ASN . 52.7 Cg_endo -75.16 133.14 16.0 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.635 1.557 . . . . 0.0 112.884 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 144' ' ' PHE . 21.2 p90 -155.18 173.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.509 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 176.12 132.28 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.811 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 2.7 mmpt? 95.22 79.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.081 0.863 . . . . 0.0 111.403 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 32.38 47.78 0.29 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.878 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.78 137.88 47.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.091 0.472 . . . . 0.0 109.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.3 mm -98.53 95.67 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.614 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mt -109.35 107.96 18.34 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 136' ' ' GLU . 65.1 tttm -69.44 141.2 54.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.889 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.629 ' CG2' ' H ' ' A' ' 163' ' ' ARG . 11.8 mm -64.15 -146.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.847 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.629 ' H ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -176.55 -57.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.132 0.491 . . . . 0.0 110.747 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -136.48 -24.54 1.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.312 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.405 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 16.2 pttp 36.43 77.88 0.37 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.68 -39.05 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.93 1.753 . . . . 0.0 112.23 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.3 mt-10 -105.17 162.26 13.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 14.9 pt-20 -84.64 -41.71 16.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.773 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.419 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 36.6 mt-30 -76.77 -29.66 56.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.34 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 73.6 m95 -120.15 153.7 35.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 167' ' ' GLU . 12.5 m0 -148.22 140.74 24.42 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -83.88 117.78 23.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 171.04 8.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 111.601 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -125.0 133.15 53.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.959 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -61.76 177.19 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.463 0.649 . . . . 0.0 110.734 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 23.6 ttt -80.54 -4.66 54.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.463 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.531 ' CB ' ' HZ3' ' A' ' 179' ' ' LYS . 94.7 m-20 -102.43 -28.12 12.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.34 48.55 0.38 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.531 ' HZ3' ' CB ' ' A' ' 177' ' ' ASP . 9.1 mttp -128.87 130.63 47.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.057 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.45 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.397 0.618 . . . . 0.0 112.048 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.2 152.81 24.12 Favored Glycine 0 C--N 1.315 -0.607 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.076 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 78.7 mmm -66.19 159.59 26.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.528 0.68 . . . . 0.0 110.972 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.412 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 10.1 pt -152.85 145.84 17.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.954 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -71.3 113.71 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.431 1.421 . . . . 0.0 109.583 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.546 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 43.9 t -49.35 -52.7 46.83 Favored Pre-proline 0 CA--C 1.537 0.457 0 O-C-N 121.956 -0.465 . . . . 0.0 111.816 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.1 Cg_endo -49.6 -27.11 13.96 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.482 2.121 . . . . 0.0 113.992 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.503 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.1 m-85 -69.07 10.63 0.27 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.765 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 186' ' ' PRO . 3.1 m -131.96 168.49 23.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.6 39.4 1.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.152 0.501 . . . . 0.0 111.407 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 191' ' ' CYS . 37.6 mmtt -139.76 152.38 46.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.499 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 136' ' ' GLU . 47.3 t 48.52 100.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.602 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.691 ' NE ' ' H ' ' A' ' 194' ' ' SER . 0.0 OUTLIER 78.58 79.39 0.12 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.21 -9.63 2.4 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.794 2.329 . . . . 0.0 112.207 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.691 ' H ' ' NE ' ' A' ' 192' ' ' ARG . 3.0 t 42.38 40.31 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.3 p -153.57 174.88 13.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -85.76 -90.01 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 94.3 p -111.61 -1.71 15.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.791 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.63 100.73 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 43.1 m -62.14 -41.69 98.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 77.5 m -147.54 -87.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.547 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 203' ' ' GLY . 55.1 tp -126.72 -35.81 2.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 201' ' ' LEU . 17.7 p 57.07 3.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.566 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 201' ' ' LEU . . . -55.62 -67.02 2.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 71.81 23.15 78.4 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.2 96.23 3.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.892 0.377 . . . . 0.0 110.698 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 53.26 73.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -92.1 1.76 57.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.553 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.4 t -70.16 148.27 48.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -60.38 -76.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.669 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 46.77 71.65 1.52 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.57 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.4 141.67 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.481 2.121 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.62 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 2.7 mt-30 -107.81 -39.34 0.15 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.219 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 23.6 Cg_exo -62.46 157.0 48.47 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 217' ' ' PRO . 10.7 mp 59.67 -68.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.599 0.562 . . . . 0.0 110.761 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 213' ' ' PRO . . . 46.3 -119.54 4.15 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.93 -72.26 0.99 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 214' ' ' LEU . 44.3 Cg_endo -66.45 148.94 84.66 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.731 2.288 . . . . 0.0 111.953 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 220' ' ' GLY . 49.0 mt-10 -142.91 73.2 18.78 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.446 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -6.94 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.875 2.384 . . . . 0.0 111.862 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 218' ' ' GLU . . . 110.29 177.63 20.86 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.61 -173.46 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.675 2.25 . . . . 0.0 112.165 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.515 ' O ' ' N ' ' A' ' 224' ' ' GLN . 61.9 t80 -58.53 171.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.946 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.482 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -40.12 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 222' ' ' TYR . 1.0 OUTLIER -137.36 106.78 8.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -47.79 -60.99 0.67 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.659 1.572 . . . . 0.0 112.161 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.9 m -85.82 -150.31 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.5 mm -101.3 47.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -84.2 109.3 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 230' ' ' PRO . 0.6 OUTLIER -100.75 159.76 28.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.454 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 229' ' ' THR . 94.4 Cg_exo -37.4 -117.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.409 2.739 . . . . 0.0 112.88 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.99 93.22 47.66 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 -32.46 71.26 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.391 2.061 . . . . 0.0 112.282 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 235' ' ' GLN . 64.2 t30 -71.06 155.6 40.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.663 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 235' ' ' GLN . 7.6 tp -67.24 9.61 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.551 ' H ' ' C ' ' A' ' 233' ' ' ASN . 50.9 tt0 60.23 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 237' ' ' GLY . 33.8 p-10 -38.79 -42.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.609 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -52.36 -176.52 0.05 OUTLIER Glycine 1 CA--C 1.447 -4.212 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.761 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.531 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.4 115.62 0.14 OUTLIER 'Cis proline' 0 N--CA 1.529 3.6 0 N-CA-C 116.333 1.628 . . . . 0.0 116.333 -1.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.687 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 8.0 m-85 -149.41 -126.69 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.822 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 5.5 m-30 -134.93 113.86 11.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 110.018 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.643 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.17 139.27 41.88 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -100.17 98.84 9.49 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.527 0.68 . . . . 0.0 111.181 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.562 HG13 ' H ' ' A' ' 264' ' ' LEU . 5.8 p -69.26 117.38 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.093 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.91 18.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -176.8 116.96 0.11 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.207 0.527 . . . . 0.0 110.837 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.437 ' HE2' ' CG ' ' A' ' 287' ' ' PHE . 1.9 ttmt -160.71 -151.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.822 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -156.28 -134.93 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.457 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.6 t -137.99 62.79 34.9 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.086 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 256' ' ' ALA . 41.8 Cg_endo -98.1 47.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.995 2.463 . . . . 0.0 113.023 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 252' ' ' TYR . 8.0 p-10 -22.62 152.67 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.533 1.146 . . . . 0.0 111.517 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.58 -9.21 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.506 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.799 ' O ' ' N ' ' A' ' 254' ' ' LYS . 38.1 m-85 -76.53 -63.21 1.39 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -47.05 62.42 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 125.384 1.677 . . . . 0.0 111.131 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 252' ' ' TYR . 4.2 mttm 84.26 -49.93 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.908 1.38 . . . . 0.0 109.717 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.88 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -44.31 110.88 0.24 Allowed 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.131 0.491 . . . . 0.0 111.722 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.658 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.9 OUTLIER -43.44 159.58 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.033 -0.417 . . . . 0.0 111.75 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.537 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -108.81 119.82 40.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.436 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.3 mt -141.15 -175.73 4.43 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -144.21 144.3 31.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.357 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 58.2 t -48.98 106.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.423 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.79 14.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -92.71 -41.61 10.06 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.331 0.586 . . . . 0.0 112.38 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 69.12 140.12 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.62 -178.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.502 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 9.2 p -131.43 156.92 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -102.71 88.24 3.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.639 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 5.0 t -67.76 121.95 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.005 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.503 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -110.28 -52.63 2.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.552 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 8.5 tppt? -82.08 125.89 31.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 112.119 -177.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.88 126.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.549 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.559 ' ND2' ' N ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -121.08 -106.42 0.37 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.603 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.559 ' N ' ' ND2' ' A' ' 271' ' ' ASN . 35.0 mtm -38.09 149.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.655 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.8 p -71.55 15.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -140.75 -69.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.474 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 98.0 mm-40 -82.79 173.03 12.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.61 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 5.9 p-90 170.89 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.068 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 6.6 mt-10 -126.93 173.26 9.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.68 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -150.3 -155.85 7.04 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.354 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.454 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -171.66 121.98 0.51 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.436 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -108.37 -98.03 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -95.6 50.46 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.41 -30.96 5.36 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.408 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -64.42 89.93 0.07 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.457 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.454 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 75.7 mtt180 -85.36 168.03 15.02 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.567 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.63 -156.26 28.01 Favored Glycine 0 C--N 1.308 -1.019 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.534 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 12.6 p80 -128.01 170.79 12.49 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.894 0.477 . . . . 0.0 111.066 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.61 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 168.87 114.47 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.248 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 290' ' ' THR . 68.4 Cg_exo -48.55 141.01 20.75 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.575 1.517 . . . . 0.0 112.518 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.6 OUTLIER -62.98 -1.0 0.78 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.478 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.9 p -55.89 0.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 289' ' ' PHE . 4.9 p-80 -153.13 66.38 0.78 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.75 146.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.13 81.97 2.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 27.4 mt -37.71 130.09 1.08 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.343 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.0 mp -71.93 -170.13 0.55 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.852 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.92 21.31 0.43 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.606 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.6 tt0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.428 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -109.56 -142.7 0.38 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.42 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.564 ' O ' HG21 ' A' ' 138' ' ' VAL . 53.6 m-85 -129.3 -90.57 0.48 Allowed 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.457 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 90.77 161.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 125.367 1.667 . . . . 0.0 111.66 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -140.85 157.78 44.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.152 0.977 . . . . 0.0 111.468 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.41 162.26 2.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.667 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.7 mt -136.36 -37.45 0.7 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.969 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.588 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 95.2 m-85 -124.87 6.66 8.04 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 79.41 142.1 0.08 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.407 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.0 t80 -121.63 -50.67 2.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.004 0.43 . . . . 0.0 111.577 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 13.5 m-80 42.83 62.7 1.69 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.409 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.53 -154.74 6.73 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 163.73 -6.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.1 -1.05 . . . . 0.0 112.085 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 150' ' ' GLU . 53.2 m-20 -55.16 -121.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.497 0.665 . . . . 0.0 111.417 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 151' ' ' ASP . 7.2 p-10 -66.59 47.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.692 ' O ' ' O ' ' A' ' 151' ' ' ASP . 21.5 mp0 67.78 19.75 9.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.692 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.9 OUTLIER -39.65 -169.86 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 O-C-N 123.863 0.727 . . . . 0.0 111.869 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.443 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 5.8 tp -113.53 91.2 19.7 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 121.242 -0.911 . . . . 0.0 111.6 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.92 128.26 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.785 0.99 . . . . 0.0 112.175 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 10.1 p90 -144.92 172.98 12.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.589 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -112.07 -106.7 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.933 0.396 . . . . 0.0 111.396 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.449 ' N ' ' HG3' ' A' ' 155' ' ' LYS . 25.5 ttpt -135.72 122.09 20.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.56 15.62 54.57 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.251 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.17 133.48 34.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.2 mm -101.67 116.13 44.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mt -122.54 122.33 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -75.16 128.71 36.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.384 0.611 . . . . 0.0 111.828 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.6 mm -66.62 126.49 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.487 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.558 ' HE ' ' HE ' ' A' ' 180' ' ' ARG . 72.5 ttt-85 -76.58 -51.99 10.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.627 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 164' ' ' ASP . 51.0 t0 -157.27 -10.33 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.357 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.472 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 4.6 ptmm? 35.97 79.98 0.28 Allowed Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.511 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.53 -44.59 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 49.8 mt-10 -91.93 158.29 16.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.913 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 15.6 pt-20 -82.28 -41.26 20.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.766 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 35.1 mt-30 -83.13 -24.47 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.437 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 63.1 m95 -124.23 150.42 45.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.472 ' CD1' ' CB ' ' A' ' 165' ' ' LYS . 13.3 m0 -140.5 133.05 28.65 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.678 0.751 . . . . 0.0 111.581 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -79.05 100.35 7.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.41 170.71 8.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -130.29 141.8 50.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.026 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.5 173.07 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.478 0.656 . . . . 0.0 110.218 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.9 mmm -77.14 -8.19 57.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.895 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -102.01 -26.5 13.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.21 47.1 0.39 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -122.6 131.68 53.94 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.288 -0.956 . . . . 0.0 110.609 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.558 ' HE ' ' HE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -109.28 113.92 27.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.831 0.824 . . . . 0.0 113.044 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -142.84 143.59 12.78 Favored Glycine 0 C--N 1.305 -1.187 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.691 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.1 mtp -62.42 161.53 11.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.485 0.66 . . . . 0.0 110.432 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.437 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 4.4 pt -150.6 145.86 18.95 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.874 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.3 118.7 5.63 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.41 1.407 . . . . 0.0 109.285 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.503 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 25.2 t -54.25 -51.49 77.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -49.64 -29.43 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.543 1.495 . . . . 0.0 113.154 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.58 ' OH ' ' O ' ' A' ' 268' ' ' THR . 10.8 m-85 -72.37 -10.62 60.03 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.328 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 1.3 m -132.89 165.13 33.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.519 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 190' ' ' LYS . 2.3 pp20? -143.64 -49.96 0.31 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.017 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.585 ' HD2' ' H ' ' A' ' 191' ' ' CYS . 3.2 tmtm? -171.95 -140.78 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.585 ' H ' ' HD2' ' A' ' 190' ' ' LYS . 6.8 t -168.27 102.63 0.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -73.73 149.87 88.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.784 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.76 -166.97 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.157 1.905 . . . . 0.0 111.81 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t 37.81 -132.79 0.12 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.1 t -134.63 -125.07 0.16 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.44 97.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.419 ' C ' ' H ' ' A' ' 199' ' ' SER . 10.4 m 51.18 -137.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.504 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.473 ' C ' ' H ' ' A' ' 200' ' ' THR . 34.7 m -80.77 33.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.423 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 200' ' ' THR . 1.3 t 72.15 -43.18 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 198' ' ' VAL . 69.0 p 50.47 -164.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.48 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.433 ' C ' ' HG1' ' A' ' 202' ' ' THR . 11.1 mp 56.28 -174.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 201' ' ' LEU . 17.2 p 47.95 -95.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.565 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 205' ' ' ASN . . . -168.64 -148.6 5.81 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.44 0.05 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 203' ' ' GLY . 11.7 t-20 58.59 89.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.684 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.54 173.88 11.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 54.59 -168.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.2 p -68.43 153.83 43.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 210' ' ' HIS . 24.3 t -79.36 96.74 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 209' ' ' SER . 58.3 m80 -157.82 75.4 3.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.42 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.16 148.55 89.19 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.879 2.386 . . . . 0.0 112.046 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 55.76 58.35 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.653 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.78 156.41 60.73 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.763 2.309 . . . . 0.0 111.932 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 64.7 mt -56.67 -62.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.1 54.54 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 218' ' ' GLU . . . 82.2 179.47 52.84 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.6 29.83 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.752 2.301 . . . . 0.0 111.974 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.605 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 2.0 tp10 -63.66 -42.53 72.82 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.546 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 31.6 Cg_exo -57.85 -145.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.545 2.163 . . . . 0.0 111.978 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -178.0 -67.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.731 2.287 . . . . 0.0 112.265 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 224' ' ' GLN . 92.7 m-85 -58.75 169.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.034 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.01 94.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.434 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 222' ' ' TYR . 8.8 tp-100 -132.92 92.82 24.93 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.278 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.34 -14.36 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.432 2.088 . . . . 0.0 112.095 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 p -92.22 -177.73 4.75 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.293 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.403 ' C ' ' CG ' ' A' ' 228' ' ' ASN . 47.2 mm -119.22 72.14 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.516 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.579 ' O ' ' NE2' ' A' ' 275' ' ' GLN . 0.0 OUTLIER 65.51 100.34 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.735 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER -79.81 -171.92 0.31 Allowed Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.371 -177.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.781 ' O ' ' N ' ' A' ' 271' ' ' ASN . 7.3 Cg_exo -70.03 -173.03 0.67 Allowed 'Trans proline' 0 N--CA 1.51 2.445 0 C-N-CA 124.061 3.174 . . . . 0.0 117.942 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 1.102 ' O ' ' HB ' ' A' ' 270' ' ' ILE . 2.6 tt -48.47 138.58 11.43 Favored Pre-proline 0 C--O 1.177 -2.734 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.834 -175.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.63 -70.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.239 0 CA-C-N 123.939 2.443 . . . . 0.0 113.314 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 235' ' ' GLN . 24.7 t-20 -45.55 103.77 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.816 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 4.7 tt -40.96 93.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.174 0.512 . . . . 0.0 110.532 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 233' ' ' ASN . 58.2 mm-40 -63.83 -50.82 67.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.98 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -56.08 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.111 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -35.76 161.54 0.01 OUTLIER Glycine 1 CA--C 1.436 -4.882 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.898 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.88 115.45 3.55 Favored 'Cis proline' 0 N--CA 1.521 3.089 0 O-C-N 122.645 0.813 . . . . 0.0 112.015 -5.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.653 ' O ' ' HG3' ' A' ' 266' ' ' LYS . 43.0 m-85 -145.97 -125.86 0.07 Allowed 'General case' 0 C--O 1.189 -2.088 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.438 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -142.07 116.14 9.39 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 120.105 1.32 . . . . 0.0 109.801 -177.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 294' ' ' LEU . . . -88.93 -157.51 0.44 Allowed 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -157.7 90.49 1.08 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.563 0.696 . . . . 0.0 109.544 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.526 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.0 p -66.22 122.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.523 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.71 16.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.67 100.56 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.242 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.442 ' HE2' ' CD1' ' A' ' 287' ' ' PHE . 0.3 OUTLIER -134.14 -143.16 0.2 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 10.5 ptt85 -158.83 -134.89 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 81.1 t -135.79 68.17 65.04 Favored Pre-proline 0 N--CA 1.473 0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.876 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.531 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 67.7 Cg_endo -92.82 177.8 1.41 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 123.355 2.703 . . . . 0.0 111.694 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.658 ' O ' ' N ' ' A' ' 252' ' ' TYR . 24.6 p30 -147.21 145.16 29.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.862 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.81 -14.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.562 0.539 . . . . 0.0 111.313 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.658 ' N ' ' O ' ' A' ' 250' ' ' ASN . 44.1 m-85 -83.54 -55.54 4.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.285 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 33.1 t70 -52.41 67.94 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 124.736 1.273 . . . . 0.0 111.691 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' A' ' 252' ' ' TYR . 31.3 mtmt 73.52 -7.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 0.0 111.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 1.4 m 92.64 52.8 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.129 0.893 . . . . 0.0 111.903 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -109.87 112.72 24.92 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.605 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.6 OUTLIER -41.88 157.98 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.94 116.33 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.522 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.0 -175.35 4.12 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 263' ' ' GLU . 2.3 tt0 -148.02 148.67 30.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.981 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 56.3 t -45.52 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.044 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 103.63 13.09 28.84 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 260' ' ' GLU . 37.8 mm-40 -90.11 -35.1 15.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.26 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.83 139.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.958 0.885 . . . . 0.0 110.774 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.56 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 9.1 p -136.17 164.69 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.082 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -108.33 103.17 12.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 269' ' ' LYS . 1.2 t -57.1 -53.92 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.58 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 62.48 -66.01 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 124.473 1.108 . . . . 0.0 109.974 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 230' ' ' PRO . 0.1 OUTLIER -65.47 150.05 49.01 Favored 'General case' 0 C--O 1.181 -2.524 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.735 -177.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 1.102 ' HB ' ' O ' ' A' ' 231' ' ' LEU . 0.1 OUTLIER -162.86 128.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.171 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.781 ' N ' ' O ' ' A' ' 230' ' ' PRO . 0.1 OUTLIER -155.2 -40.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 177.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.678 ' O ' ' HA ' ' A' ' 231' ' ' LEU . 0.0 OUTLIER -124.3 173.24 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.87 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 1.5 p -105.98 20.2 19.33 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.655 ' H ' ' HE2' ' A' ' 272' ' ' MET . . . -118.99 -74.25 0.44 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.84 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.668 HE22 ' C ' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -54.64 -91.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 123.422 1.582 . . . . 0.0 110.393 -178.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.87 ' HE1' ' C ' ' A' ' 273' ' ' SER . 1.2 m0 88.1 127.54 0.03 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.764 ' H ' ' HD3' ' A' ' 230' ' ' PRO . 21.4 mt-10 -86.54 168.51 13.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.712 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 284' ' ' ARG . . . -155.19 136.33 5.08 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.902 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.434 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -122.99 125.45 45.27 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.463 0.743 . . . . 0.0 110.364 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 281' ' ' ASN . 0.1 OUTLIER -143.23 78.89 1.62 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.063 -176.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.7 m-20 84.33 41.67 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.819 0.819 . . . . 0.0 109.351 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.41 -35.96 3.4 Favored Glycine 0 CA--C 1.495 -1.162 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.112 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -61.82 104.22 0.42 Allowed 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 114.588 -0.806 . . . . 0.0 109.773 -176.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 278' ' ' GLY . 33.2 mtt85 -108.8 165.84 11.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 121.397 0.618 . . . . 0.0 109.834 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 173.17 -148.83 10.65 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.559 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 16.8 p80 -132.24 168.33 18.25 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.549 0.174 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.71 120.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.805 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.533 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 74.5 Cg_exo -46.01 134.53 14.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.864 1.71 . . . . 0.0 113.679 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.687 ' HB2' ' CE3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -66.73 -3.62 7.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.663 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.2 p -62.16 -0.49 0.54 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.6 p-80 -139.17 54.5 1.72 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.204 0.456 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.29 148.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.7 -46.92 3.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 1.3 mt 82.96 131.39 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.223 1.011 . . . . 0.0 112.01 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 297' ' ' GLN . 9.3 mp -79.4 -168.05 1.4 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.849 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -74.6 12.19 0.86 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' A' ' 295' ' ' LEU . 56.6 tt0 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.044 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 137' ' ' TYR . 50.1 tp10 -167.21 159.54 12.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.123 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.647 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 80.7 m-85 -132.83 -78.78 0.49 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.995 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.647 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.4 m 84.44 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 125.427 1.704 . . . . 0.0 111.107 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -121.34 139.7 53.08 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 120.93 0.395 . . . . 0.0 110.324 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.497 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . . . -105.27 98.75 8.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.98 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -114.69 32.98 5.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.606 -178.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CE1' ' NH1' ' A' ' 284' ' ' ARG . 69.6 m-85 -125.22 1.74 7.84 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.53 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 269' ' ' LYS . 0.2 OUTLIER 60.96 136.83 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.029 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.453 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 4.4 t80 -134.56 -35.26 0.9 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 111.339 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 40.21 61.34 1.56 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.355 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.465 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -64.58 -119.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.534 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.9 OUTLIER 170.54 -92.37 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.902 0.382 . . . . 0.0 111.733 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.636 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 28.8 m-20 -49.95 178.2 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.206 0.527 . . . . 0.0 111.133 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.638 ' C ' ' H ' ' A' ' 151' ' ' ASP . 99.9 m-20 -68.54 -42.37 78.51 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.854 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.26 3.98 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.638 ' H ' ' C ' ' A' ' 149' ' ' ASP . 2.7 p30 -133.79 150.2 51.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.45 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 8.7 tp -119.6 89.43 41.04 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-O 120.406 0.146 . . . . 0.0 110.685 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.461 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 37.6 Cg_exo -57.48 147.29 79.23 Favored 'Trans proline' 0 C--N 1.288 -2.618 0 C-N-CA 122.236 1.957 . . . . 0.0 113.612 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.497 ' CE1' ' HB3' ' A' ' 140' ' ' ALA . 5.9 p90 -172.53 156.89 3.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.618 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 157' ' ' GLY . 3.4 ttmp? -169.69 -55.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.436 0.636 . . . . 0.0 111.697 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.7 mmmm -45.14 -16.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.999 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 155' ' ' LYS . . . 102.09 57.29 0.81 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -90.47 150.59 21.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.415 0.626 . . . . 0.0 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.6 mm -94.61 115.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 137' ' ' TYR . 8.6 mt -113.26 120.91 42.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.688 -176.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 65.9 tttm -68.87 141.66 55.01 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.642 ' O ' ' O ' ' A' ' 172' ' ' ASN . 34.7 mm -75.98 -64.17 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.866 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 162' ' ' ILE . 56.0 ttt180 79.96 -44.07 0.27 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.869 0.366 . . . . 0.0 111.31 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -146.08 122.49 10.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.454 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.526 ' CG ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 ttmt -107.67 74.67 0.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.24 -60.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.166 1.911 . . . . 0.0 111.994 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.98 161.0 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -84.79 -34.81 22.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.632 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 92.8 mt-30 -83.53 -29.08 28.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.444 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.422 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 70.9 m95 -122.99 149.85 43.76 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.526 ' NE1' ' CG ' ' A' ' 165' ' ' LYS . 17.1 m0 -138.34 129.6 27.35 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.349 0.595 . . . . 0.0 111.418 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 162' ' ' ILE . 53.1 t30 -80.81 108.04 14.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.62 171.64 7.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.569 0.543 . . . . 0.0 111.087 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -125.14 135.7 52.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.111 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.37 172.32 2.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.445 0.641 . . . . 0.0 110.578 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.0 mmm -79.89 -0.0 33.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.004 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -104.43 -27.73 11.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.55 49.82 0.34 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.7 mttt -131.08 134.33 46.51 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.644 -0.778 . . . . 0.0 110.81 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.14 51.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.527 0.68 . . . . 0.0 111.99 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.03 154.25 25.34 Favored Glycine 0 C--N 1.317 -0.516 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.086 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 tpt -68.35 162.78 24.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.371 0.605 . . . . 0.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.457 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 5.4 pt -154.8 143.2 14.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.432 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.19 118.05 5.46 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.346 1.364 . . . . 0.0 108.888 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.546 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 15.6 t -50.99 -53.46 47.87 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 121.755 -0.59 . . . . 0.0 111.712 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 16.5 Cg_endo -51.93 -25.29 21.37 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 122.313 2.009 . . . . 0.0 113.578 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.501 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.8 m-85 -72.2 9.7 0.93 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 186' ' ' PRO . 4.8 m -135.4 167.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.948 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -91.94 -70.56 0.68 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.452 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.472 ' O ' ' CB ' ' A' ' 191' ' ' CYS . 4.8 tptp -178.56 -61.3 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 190' ' ' LYS . 1.5 p 163.31 -82.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.723 0.639 . . . . 0.0 110.263 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.583 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 0.0 OUTLIER -95.57 -44.91 0.27 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.642 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 50.0 Cg_exo -52.71 -131.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.735 2.29 . . . . 0.0 112.304 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 195' ' ' SER . 71.0 p -162.14 3.02 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.284 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 194' ' ' SER . 3.8 p 70.25 -53.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 195' ' ' SER . . . -161.82 169.79 20.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 198' ' ' VAL . 43.1 t -132.64 -134.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.897 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 197' ' ' SER . 20.6 m 31.17 42.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.454 0.471 . . . . 0.0 111.272 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.4 p -146.8 133.65 20.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 34.1 p -64.16 -34.33 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.529 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.93 113.13 5.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.172 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 17.7 m -64.67 -52.58 56.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.569 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -152.72 104.6 0.26 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.89 119.08 0.59 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.606 ' ND2' ' H ' ' A' ' 206' ' ' GLN . 0.4 OUTLIER -173.32 -152.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.266 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.606 ' H ' ' ND2' ' A' ' 205' ' ' ASN . 11.7 tp-100 -142.35 119.62 11.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.402 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.94 132.58 41.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.351 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' A' ' 210' ' ' HIS . 46.4 p -158.03 165.17 35.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 210' ' ' HIS . 78.2 p -61.63 -41.91 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' SER . 24.1 m-70 56.77 153.48 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.24 76.73 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.373 2.049 . . . . 0.0 111.771 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 0.0 OUTLIER -79.31 -40.53 1.49 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 38.9 Cg_exo -59.16 142.79 99.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.38 2.053 . . . . 0.0 112.083 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 19.1 tp -168.03 -44.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.566 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 117.15 120.44 3.12 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -134.23 -172.19 12.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.92 -41.62 69.76 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.668 2.245 . . . . 0.0 111.922 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.96 149.25 36.0 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.677 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.48 -25.55 48.12 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.513 2.142 . . . . 0.0 112.051 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.36 68.09 1.46 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.97 150.16 37.88 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.616 2.211 . . . . 0.0 111.956 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -73.53 168.77 18.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.232 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.22 115.92 0.67 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.314 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 226' ' ' SER . 0.5 OUTLIER -140.2 170.73 9.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.602 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 226' ' ' SER . 29.3 Cg_exo -61.38 51.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.629 2.219 . . . . 0.0 112.732 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 224' ' ' GLN . 0.7 OUTLIER 76.56 72.46 0.07 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.546 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 26.7 mt -139.22 62.08 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.203 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 64.67 67.87 0.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.827 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.6 p -126.41 149.49 67.64 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.378 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.24 164.45 35.69 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 122.775 2.316 . . . . 0.0 111.646 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.482 ' HG ' ' NE1' ' A' ' 276' ' ' TRP . 2.5 pp -60.0 146.45 82.4 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.66 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.48 133.77 35.93 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.232 1.955 . . . . 0.0 112.382 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 1.1 m-80 -45.87 135.52 7.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' A' ' 236' ' ' ASN . 7.1 tp 29.32 -135.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.142 0.901 . . . . 0.0 110.923 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.519 ' C ' ' H ' ' A' ' 237' ' ' GLY . 74.1 mm-40 56.86 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.773 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 234' ' ' LEU . 19.2 m-80 -72.62 43.69 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.379 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 235' ' ' GLN . . . 141.95 -173.52 23.6 Favored Glycine 1 CA--C 1.442 -4.488 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.615 178.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.46 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 5.9 Cg_exo -46.0 105.77 0.03 OUTLIER 'Cis proline' 1 N--CA 1.536 4.024 0 O-C-N 123.755 1.397 . . . . 0.0 115.488 0.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.604 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.1 m-30 -120.57 -127.78 0.27 Allowed 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.624 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.8 OUTLIER -141.46 124.01 15.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.66 0.743 . . . . 0.0 110.198 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.589 ' N ' HD12 ' A' ' 264' ' ' LEU . . . -104.59 -163.0 0.93 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.387 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -161.47 89.87 0.77 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.214 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.466 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 5.3 p -64.7 121.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.505 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.98 12.32 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -169.01 120.39 0.74 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 110.565 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.44 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 1.9 ttmt -163.04 -145.56 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.591 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.44 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.4 ptt85 -155.75 -142.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.654 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.7 t -132.84 67.83 78.3 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 74.5 Cg_endo -91.62 172.7 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.135 2.557 . . . . 0.0 111.61 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.773 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.0 OUTLIER -143.98 140.83 29.85 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.914 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.32 -2.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.887 0.742 . . . . 0.0 112.184 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.773 ' H ' ' C ' ' A' ' 250' ' ' ASN . 2.5 m-85 -96.78 -54.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 123.591 0.756 . . . . 0.0 110.044 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -44.41 -65.84 0.47 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 256' ' ' ALA . 25.8 mttt -149.05 33.3 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.757 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.408 ' O ' ' CA ' ' A' ' 285' ' ' GLY . 1.7 m 71.19 -16.53 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.822 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -48.81 161.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 257' ' ' LEU . 0.2 OUTLIER -105.29 150.53 25.08 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -91.57 119.44 31.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 3.7 mt -140.48 -172.14 3.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -147.23 146.13 29.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.065 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 68.9 t -55.35 102.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.639 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 121.84 8.01 7.66 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 64.8 mm-40 -90.57 -124.8 0.07 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.841 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 241' ' ' ALA . 0.3 OUTLIER 161.61 136.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.554 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 10.7 p -126.29 142.78 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.287 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 239' ' ' PHE . 2.6 ttmt -100.63 83.36 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.188 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 75.2 t -51.96 151.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.391 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.501 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -151.7 -51.34 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.693 -178.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.524 ' O ' ' OE1' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -70.52 104.13 2.68 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.076 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.425 HG12 ' H ' ' A' ' 234' ' ' LEU . 1.7 mp -95.14 154.61 3.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.624 ' ND2' ' N ' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -171.63 -97.83 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.153 179.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.632 ' C ' ' H ' ' A' ' 274' ' ' GLY . 19.3 mtm -59.0 134.91 57.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.831 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.9 p -66.97 25.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.632 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -152.12 -69.89 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.537 ' OE1' ' NE2' ' A' ' 212' ' ' GLN . 21.4 mp0 -92.19 112.52 24.49 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.148 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.565 ' HA ' HD22 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -116.18 -171.8 2.06 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.524 ' OE1' ' O ' ' A' ' 269' ' ' LYS . 54.8 mp0 -97.09 -160.49 0.8 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.492 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -173.76 117.71 0.66 Allowed Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.525 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.415 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.2 tt0 -99.49 127.82 45.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.34 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.571 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -144.39 78.97 1.59 Allowed 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 3.9 m-20 82.63 30.09 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 0.0 109.921 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 93.95 -32.64 5.72 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.405 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.571 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.4 OUTLIER -66.21 72.81 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.762 -178.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.554 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 90.5 mtt180 -72.82 168.04 19.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 123.886 0.741 . . . . 0.0 109.918 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 168.94 -158.07 30.48 Favored Glycine 0 C--O 1.206 -1.653 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.588 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 3.8 p80 -124.71 167.41 14.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.249 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 167.65 115.14 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.223 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.5 Cg_exo -51.68 145.13 31.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.963 1.775 . . . . 0.0 112.304 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.593 ' C ' ' H ' ' A' ' 291' ' ' HIS . 0.2 OUTLIER -64.25 -0.11 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 110.465 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.2 p -56.27 3.85 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 O-C-N 121.81 -0.556 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.593 ' H ' ' C ' ' A' ' 289' ' ' PHE . 3.9 p-80 -156.11 69.69 0.66 Allowed 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.86 154.33 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -129.35 76.19 1.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.24 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 63.6 mt -38.08 127.97 1.3 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.438 0.637 . . . . 0.0 111.368 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.97 -99.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.767 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -159.02 -85.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.412 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.604 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 3.9 tp-100 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.474 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 137' ' ' TYR . 11.0 m . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 57.77 -75.18 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 123.34 0.4 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.584 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 13.1 p90 -70.74 -55.68 8.08 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.902 -0.57 . . . . 0.0 112.247 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.584 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.4 m 86.17 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 125.0 1.437 . . . . 0.0 111.646 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -128.15 138.29 52.44 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 157' ' ' GLY . . . -96.84 98.92 10.52 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.753 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.497 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -104.51 37.51 2.1 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.271 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 53.5 m-85 -135.17 0.82 2.88 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.515 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER 60.55 139.51 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.887 0.742 . . . . 0.0 109.273 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.42 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 5.0 t80 -128.48 -38.68 1.72 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.079 0.399 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t30 40.54 56.25 2.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.517 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.67 -132.3 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.563 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.8 OUTLIER 169.5 -89.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.355 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 150' ' ' GLU . 1.7 m-20 -19.58 134.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 112.225 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.2 -3.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.442 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.592 ' H ' ' C ' ' A' ' 148' ' ' ASP . 12.5 pt-20 -108.12 16.76 23.03 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.58 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 8.2 p30 -137.54 152.82 49.86 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 182' ' ' MET . 12.6 tp -107.72 90.35 6.16 Favored Pre-proline 0 C--O 1.215 -0.76 0 CA-C-N 118.181 0.446 . . . . 0.0 110.717 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.421 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 74.1 Cg_endo -66.97 146.47 77.62 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 C-N-CA 121.364 1.376 . . . . 0.0 114.082 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.434 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 11.8 p90 -169.97 162.84 9.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.82 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -152.76 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.885 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -97.93 129.44 44.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.879 0.847 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . 88.89 12.39 64.0 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -75.04 139.8 43.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.7 mp -97.56 114.76 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.413 ' CD1' ' CD2' ' A' ' 154' ' ' PHE . 10.8 mt -125.42 133.9 52.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.923 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -81.6 140.2 34.58 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.108 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.2 mp -66.37 -52.07 51.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.635 ' CZ ' HH21 ' A' ' 180' ' ' ARG . 54.1 ttt85 66.85 -48.18 0.46 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.306 0.379 . . . . 0.0 111.215 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 162' ' ' ILE . 41.0 t0 -152.93 133.5 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.432 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.44 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.9 pttp -133.94 78.67 59.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.64 -31.2 7.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.165 1.91 . . . . 0.0 112.539 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -101.81 -174.47 2.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 168' ' ' GLU . 1.5 pm0 -115.25 -13.97 11.71 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -109.47 -29.33 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.825 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 76.5 m95 -121.04 146.25 46.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.513 ' O ' HG21 ' A' ' 183' ' ' ILE . 16.4 m0 -137.38 125.61 23.14 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 162' ' ' ILE . 18.9 t-20 -76.09 101.62 5.39 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.38 173.56 6.25 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.467 0.479 . . . . 0.0 111.079 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 21.4 tt0 -121.45 123.63 42.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.067 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.75 173.35 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.234 0.54 . . . . 0.0 110.211 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 96.1 mtp -72.84 -3.05 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.851 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 179' ' ' LYS . 89.5 m-20 -98.63 -20.23 17.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.361 0.601 . . . . 0.0 110.905 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 120.68 -28.89 6.03 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 177' ' ' ASP . 16.9 mttp -52.49 146.79 9.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.19 0.519 . . . . 0.0 110.813 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.635 HH21 ' CZ ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -114.67 130.62 56.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.344 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.84 157.12 28.37 Favored Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.387 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.471 ' O ' ' N ' ' A' ' 152' ' ' LEU . 1.8 tpt -68.4 163.28 23.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.169 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.513 HG21 ' O ' ' A' ' 171' ' ' TRP . 0.0 OUTLIER -161.32 147.79 11.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.554 178.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.07 115.84 4.47 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.107 1.205 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 38.3 t -53.49 -52.05 70.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 122.041 -0.412 . . . . 0.0 111.541 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.2 Cg_endo -49.11 -27.7 12.81 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.487 2.125 . . . . 0.0 113.345 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.3 m-85 -65.28 4.95 0.43 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.055 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 186' ' ' PRO . 1.8 m -130.43 168.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 123.109 0.256 . . . . 0.0 110.764 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -100.09 -66.34 0.91 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.027 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 45.0 tptt 134.91 -4.27 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.993 1.433 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 12.9 t 56.93 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.921 -0.487 . . . . 0.0 109.912 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 194' ' ' SER . 15.1 ptt180 -163.64 78.61 1.62 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.53 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.24 39.47 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.176 2.584 . . . . 0.0 112.377 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 192' ' ' ARG . 34.6 t -80.22 -6.62 58.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.625 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.6 p -152.59 172.34 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.49 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -171.24 -169.23 0.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.5 t 76.56 137.68 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.844 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.79 -43.3 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.414 ' O ' ' OG1' ' A' ' 200' ' ' THR . 8.0 m -56.11 143.04 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.41 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 199' ' ' SER . 4.8 p 59.25 109.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.254 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.87 94.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.289 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 48.6 p -77.35 104.16 7.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.22 -29.01 13.19 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.09 -54.31 3.89 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 49.77 98.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -137.02 -174.75 3.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.489 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 55.52 35.87 26.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.6 m -91.68 115.68 28.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.3 m -152.9 148.03 26.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.372 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -40.63 111.64 0.8 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.595 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.05 162.38 37.09 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.655 1.57 . . . . 0.0 111.95 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -40.7 150.05 0.3 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -47.74 139.54 18.69 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.627 1.551 . . . . 0.0 112.353 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.14 10.79 40.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.491 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 177.82 157.19 18.12 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -65.31 -179.47 8.06 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.77 -43.16 53.19 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.323 2.015 . . . . 0.0 112.417 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 39.17 73.13 0.84 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.051 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -61.99 150.27 87.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.976 2.451 . . . . 0.0 112.053 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 156.61 -75.58 0.21 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.74 177.48 4.83 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.518 2.145 . . . . 0.0 112.227 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 224' ' ' GLN . 99.1 m-85 -58.97 163.15 3.66 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.216 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.78 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.904 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.701 ' NE2' ' H ' ' A' ' 228' ' ' ASN . 0.0 OUTLIER -143.38 146.12 34.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.784 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -48.56 -57.27 2.45 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.577 1.518 . . . . 0.0 112.912 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.628 ' C ' HE22 ' A' ' 224' ' ' GLN . 1.5 t 169.58 -12.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 110.957 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.503 ' H ' ' CD1' ' A' ' 227' ' ' ILE . 0.1 OUTLIER -77.44 13.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.6 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.701 ' H ' ' NE2' ' A' ' 224' ' ' GLN . 2.9 m120 66.83 -133.9 0.14 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.057 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 69.2 p -113.31 116.62 46.37 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.771 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.26 -157.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 121.429 1.419 . . . . 0.0 112.26 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.443 ' CG ' ' NE1' ' A' ' 276' ' ' TRP . 0.1 OUTLIER -61.37 146.57 88.98 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.445 -178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.89 143.78 33.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.126 1.884 . . . . 0.0 111.681 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 235' ' ' GLN . 11.3 m120 37.76 -155.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 111.153 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -69.69 4.22 2.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.61 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 233' ' ' ASN . 3.5 tt0 66.02 129.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -40.66 -34.04 0.34 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.55 0.691 . . . . 0.0 110.39 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.49 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -61.37 -175.73 1.8 Allowed Glycine 1 CA--C 1.447 -4.164 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.23 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.49 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.9 Cg_endo -53.21 122.97 0.4 Allowed 'Cis proline' 0 N--CA 1.525 3.367 0 N-CA-C 116.481 1.685 . . . . 0.0 116.481 -1.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.2 m-85 -154.67 -121.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.7 OUTLIER -145.18 135.09 23.69 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 118.976 0.807 . . . . 0.0 108.962 -179.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 294' ' ' LEU . . . -117.94 -148.51 0.42 Allowed 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.174 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 262' ' ' GLY . 21.6 tpp180 -161.93 95.15 0.96 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.627 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 263' ' ' GLU . 2.9 p -61.62 137.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.783 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.8 20.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 176.48 103.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.88 -143.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.959 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -155.51 -139.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.015 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 248' ' ' VAL . 70.8 t -133.91 68.65 75.11 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-O 121.215 0.531 . . . . 0.0 110.887 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.614 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 61.3 Cg_endo -91.63 175.63 2.17 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.816 2.344 . . . . 0.0 111.209 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.767 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.9 OUTLIER -142.89 140.0 31.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -37.1 -8.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.46 0.648 . . . . 0.0 111.983 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.767 ' N ' ' O ' ' A' ' 250' ' ' ASN . 4.8 m-85 -92.41 -48.77 6.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 250' ' ' ASN . 27.9 t0 -65.09 56.39 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.661 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.531 ' C ' ' H ' ' A' ' 256' ' ' ALA . 33.0 mtmt 85.55 20.28 0.1 Allowed 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.642 1.214 . . . . 0.0 111.47 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.519 ' O ' ' O ' ' A' ' 284' ' ' ARG . 2.4 m 75.49 -19.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.021 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -39.74 107.52 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.638 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -47.03 157.3 0.17 Allowed 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.777 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -110.17 124.43 51.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.954 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 1.3 mt -142.66 -179.08 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.069 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 6.7 tt0 -133.86 146.06 50.24 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.787 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 52.9 t -45.96 110.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.102 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.781 ' O ' ' O ' ' A' ' 263' ' ' GLU . . . 131.06 -70.56 0.52 Allowed Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.781 ' O ' ' O ' ' A' ' 262' ' ' GLY . 4.1 mm-40 -29.08 -163.4 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.444 0 O-C-N 125.764 1.508 . . . . 0.0 114.142 -172.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.418 ' CB ' ' O ' ' A' ' 241' ' ' ALA . 3.8 pp -155.57 166.04 34.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.281 1.038 . . . . 0.0 112.518 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.09 143.22 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.525 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.477 ' HZ1' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -101.39 85.32 2.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.591 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.41 HG23 HE22 ' A' ' 235' ' ' GLN . 3.0 t -58.2 155.49 2.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.939 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.48 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -156.73 -56.24 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.038 0.446 . . . . 0.0 109.807 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.406 ' N ' ' HG1' ' A' ' 268' ' ' THR . 0.1 OUTLIER -66.45 102.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.689 -178.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 5.7 mt -115.17 106.46 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.871 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.61 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -111.45 -101.53 0.4 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.623 ' O ' ' CE3' ' A' ' 276' ' ' TRP . 38.6 mtm -51.26 148.33 4.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.003 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 p -72.17 16.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -140.86 -80.9 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.227 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -86.18 116.37 24.33 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 121.002 0.429 . . . . 0.0 111.358 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -134.58 -172.92 3.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.742 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.53 -171.79 2.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.92 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -159.89 -152.78 6.64 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.056 -1.068 . . . . 0.0 112.348 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 281' ' ' ASN . 0.5 OUTLIER -168.59 139.33 2.53 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.192 0.52 . . . . 0.0 112.168 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.562 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -148.05 76.25 1.37 Allowed 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.102 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 279' ' ' GLU . 1.5 m120 84.35 36.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.81 -35.84 3.67 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.843 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -63.89 88.0 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.169 0.509 . . . . 0.0 110.257 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.519 ' O ' ' O ' ' A' ' 255' ' ' THR . 43.9 mtt85 -86.45 168.1 14.07 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.278 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.484 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.11 -154.6 24.68 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.583 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 13.1 p80 -129.37 172.14 11.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.2 114.39 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.431 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.526 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 54.5 Cg_exo -48.4 129.53 19.67 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.222 1.281 . . . . 0.0 112.255 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -62.98 -1.92 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.275 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 288' ' ' PRO . 53.0 p -58.77 2.21 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.889 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.2 p-80 -142.82 50.88 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.739 0.304 . . . . 0.0 111.633 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.89 166.3 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 294' ' ' LEU . 18.8 mtm180 -136.85 77.02 1.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.529 0.204 . . . . 0.0 110.878 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 35.1 mt -34.29 134.37 0.2 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.398 0.618 . . . . 0.0 111.274 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.4 mp -79.08 -165.39 0.75 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.365 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 42.5 p-10 -77.43 -0.42 25.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.63 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 27.5 tt0 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.09 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -152.8 167.57 28.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.483 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.671 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -162.02 -22.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.671 ' O ' ' O ' ' A' ' 137' ' ' TYR . 32.6 m 36.38 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 122.08 0.943 . . . . 0.0 112.635 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 14.9 ttp180 -143.47 120.38 11.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.413 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.445 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -98.78 91.51 5.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 124.321 1.013 . . . . 0.0 111.812 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.479 ' CD1' ' CD2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.78 18.97 16.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.285 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.575 ' CE1' ' CZ ' ' A' ' 284' ' ' ARG . 46.8 m-85 -114.98 0.91 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.7 OUTLIER 58.57 138.01 0.01 OUTLIER 'General case' 0 C--O 1.209 -1.035 0 O-C-N 124.407 1.067 . . . . 0.0 110.014 -179.194 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.433 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 17.2 t80 -130.06 -46.69 1.12 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.905 0.321 . . . . 0.0 110.44 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 144' ' ' PHE . 66.3 t30 36.04 58.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.484 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -61.6 -93.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 170.31 15.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.966 0.888 . . . . 0.0 110.316 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 1.3 p-10 33.66 -159.2 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.156 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.511 ' N ' ' OD2' ' A' ' 148' ' ' ASP . 97.7 m-20 48.64 38.81 12.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 149' ' ' ASP . 3.6 mm-40 149.71 -10.2 0.0 OUTLIER 'General case' 0 C--N 1.345 0.386 0 O-C-N 124.701 1.251 . . . . 0.0 108.987 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 148' ' ' ASP . 0.2 OUTLIER -157.45 -178.02 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.793 -178.06 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.511 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 10.7 tp -118.04 87.67 29.27 Favored Pre-proline 0 C--O 1.206 -1.203 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.449 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 71.6 Cg_endo -71.38 139.74 35.4 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 CA-C-N 120.03 1.046 . . . . 0.0 112.079 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 152' ' ' LEU . 14.1 p90 -160.9 163.76 31.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HZ1' ' HB2' ' A' ' 143' ' ' ASP . 6.9 tttp -155.88 169.08 25.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.811 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 157' ' ' GLY . 3.5 ttmt 50.43 82.67 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.334 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.1 47.41 0.01 OUTLIER Glycine 0 N--CA 1.467 0.715 0 O-C-N 123.834 0.709 . . . . 0.0 113.008 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 156' ' ' LYS . 35.3 t0 -62.71 159.69 15.74 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.547 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.5 mp -109.2 106.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.4 mt -109.47 106.84 16.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.458 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -64.73 129.12 38.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.64 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.653 ' CG2' ' H ' ' A' ' 163' ' ' ARG . 42.7 mm -66.44 -134.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.857 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.653 ' H ' ' CG2' ' A' ' 162' ' ' ILE . 77.4 ttt180 175.75 -48.78 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.518 0.675 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.63 -19.12 0.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.071 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.4 pttt 37.04 72.89 0.76 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 123.205 0.315 . . . . 0.0 111.202 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.28 -43.15 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.592 1.528 . . . . 0.0 112.059 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.59 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 76.4 mm-40 -99.29 157.06 16.65 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.909 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.06 -36.46 21.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.381 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -82.59 -26.14 32.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.831 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 85.2 m95 -127.32 150.98 49.34 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.59 ' CD1' ' O ' ' A' ' 167' ' ' GLU . 13.0 m0 -145.07 136.03 24.73 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.874 0.368 . . . . 0.0 110.234 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -86.8 110.36 19.89 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.62 -178.58 3.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.633 . . . . 0.0 111.528 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -123.68 125.35 44.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.8 172.5 0.26 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.94 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -78.61 2.67 18.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.059 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.99 -29.26 10.57 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.05 51.16 0.52 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -135.81 140.51 44.29 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.644 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.06 121.43 44.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 111.343 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.28 153.29 24.67 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.191 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.5 mtp -65.9 152.41 44.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.49 143.36 38.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.023 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.57 114.58 4.05 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.314 1.343 . . . . 0.0 108.914 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.552 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 47.4 t -52.85 -51.23 76.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.823 -0.548 . . . . 0.0 111.944 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.6 Cg_endo -48.56 -29.39 13.94 Favored 'Trans proline' 0 N--CA 1.504 2.137 0 C-N-CA 122.669 2.246 . . . . 0.0 113.014 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.8 m-85 -67.93 -0.92 4.8 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.712 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 139' ' ' ARG . 17.2 m -128.98 166.41 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.283 0.364 . . . . 0.0 110.633 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -146.72 50.58 1.12 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 191' ' ' CYS . 3.8 tmtt? -161.96 105.24 1.19 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.553 ' SG ' ' CH2' ' A' ' 171' ' ' TRP . 0.0 OUTLIER 160.27 -27.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.081 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 193' ' ' PRO . 14.7 mtp180 -162.11 -62.84 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.481 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 192' ' ' ARG . 17.8 Cg_endo -56.49 -36.3 97.49 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.371 2.047 . . . . 0.0 112.109 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 p -39.56 110.06 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.415 . . . . 0.0 110.756 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 97.2 p -64.9 160.61 20.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.52 79.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.654 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.3 m -157.92 173.94 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.1 t 56.35 93.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.501 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -170.75 70.44 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.5 p -103.4 135.79 44.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.306 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -40.13 79.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.939 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 31.65 74.93 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.414 0.446 . . . . 0.0 111.428 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.27 93.94 2.06 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -165.55 -149.16 5.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 55.69 65.29 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.432 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 47.91 94.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.375 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 208' ' ' SER . 91.6 m-20 -88.38 110.06 20.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.139 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 207' ' ' ASP . 82.8 p 54.1 163.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.726 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.408 ' H ' ' CD2' ' A' ' 210' ' ' HIS . 4.3 t -165.09 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 210' ' ' HIS . 0.2 OUTLIER 58.99 167.42 0.08 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.53 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.0 145.73 96.61 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.715 1.61 . . . . 0.0 111.748 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.433 ' OE1' ' OE1' ' A' ' 275' ' ' GLN . 1.0 OUTLIER -62.06 172.16 1.28 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 215' ' ' GLY . 50.5 Cg_exo -51.69 -35.93 59.55 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.287 1.992 . . . . 0.0 111.873 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 65.6 tp 49.89 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.77 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 213' ' ' PRO . . . -71.67 -30.46 66.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -44.62 153.6 0.47 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.55 -19.47 42.44 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.607 2.205 . . . . 0.0 111.929 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.11 145.81 12.1 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.025 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.65 160.58 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.716 1.61 . . . . 0.0 112.274 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.477 ' H ' ' HD3' ' A' ' 221' ' ' PRO . . . 144.34 63.65 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.436 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.477 ' HD3' ' H ' ' A' ' 220' ' ' GLY . 69.7 Cg_endo -81.36 158.7 19.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.339 2.026 . . . . 0.0 112.264 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -83.88 167.9 16.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.409 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.4 121.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.331 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -143.68 162.67 40.43 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.689 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.409 ' O ' ' OG ' ' A' ' 226' ' ' SER . 52.6 Cg_exo -50.19 -42.63 46.21 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.169 1.913 . . . . 0.0 112.863 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 225' ' ' PRO . 0.8 OUTLIER -169.94 59.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.49 73.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 50.62 84.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.155 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.425 ' H ' ' HG1' ' A' ' 229' ' ' THR . 5.3 p -107.76 125.63 31.76 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.06 -165.89 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 121.278 1.319 . . . . 0.0 111.832 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.7 tp -124.81 91.46 49.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 233' ' ' ASN . 31.6 Cg_exo -58.38 -173.63 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.222 1.948 . . . . 0.0 111.752 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 232' ' ' PRO . 4.3 t-20 79.37 162.21 0.19 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.082 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 25.4 tp -60.81 -8.71 3.25 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 73.48 154.15 0.15 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -62.0 -39.99 94.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.913 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.583 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -59.83 -178.61 1.62 Allowed Glycine 1 CA--C 1.427 -5.427 0 CA-C-O 122.631 1.128 . . . . 0.0 115.464 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.583 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 3.3 Cg_exo -52.44 127.83 1.01 Allowed 'Cis proline' 1 N--CA 1.538 4.095 0 O-C-N 124.766 1.929 . . . . 0.0 115.698 -1.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.6 m-85 -155.24 -122.87 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.72 123.85 14.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 120.389 1.45 . . . . 0.0 109.165 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.649 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -108.53 141.75 39.96 Favored 'General case' 0 C--O 1.19 -2.043 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.247 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -104.57 96.99 6.97 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 121.616 0.722 . . . . 0.0 110.664 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.9 p -69.1 112.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.616 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -105.78 17.79 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.194 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -176.79 119.84 0.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.085 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.549 ' HZ2' ' CD1' ' A' ' 259' ' ' LEU . 1.5 ttmt -161.24 -145.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.982 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 2.9 ptt85 -156.25 -141.42 0.09 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.821 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 69.3 t -134.6 69.39 72.4 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 59.7 Cg_endo -98.46 177.93 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.381 2.721 . . . . 0.0 111.915 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.725 ' C ' ' H ' ' A' ' 252' ' ' TYR . 1.5 p-10 -157.25 151.73 25.24 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.896 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -41.5 -4.85 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.725 ' H ' ' C ' ' A' ' 250' ' ' ASN . 38.2 m-85 -95.19 -53.11 3.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.294 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 17.9 t0 -45.61 -57.84 3.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.899 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.508 ' CE ' HH21 ' A' ' 247' ' ' ARG . 13.1 pttt -169.82 39.66 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.157 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 56.92 46.09 20.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -121.45 119.57 32.44 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.774 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.68 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -51.02 159.62 0.57 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 123.083 0.553 . . . . 0.0 112.329 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.506 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -106.38 114.35 28.41 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.549 ' CD1' ' HZ2' ' A' ' 246' ' ' LYS . 1.0 OUTLIER -139.59 -178.37 5.37 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.871 0.843 . . . . 0.0 111.607 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -144.67 143.96 31.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.906 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.6 t -47.7 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.637 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.24 7.39 10.13 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -86.85 -39.08 16.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.567 0.699 . . . . 0.0 112.641 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.649 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER 66.49 139.45 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.18 0.99 . . . . 0.0 109.416 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.529 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.6 p -136.71 155.33 33.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.946 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -100.64 96.31 7.26 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.312 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.813 ' O ' ' N ' ' A' ' 269' ' ' LYS . 34.2 t -50.49 -37.22 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.448 ' CG2' ' H ' ' A' ' 269' ' ' LYS . 15.1 t 39.58 -64.25 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 O-C-N 124.3 1.0 . . . . 0.0 112.019 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' A' ' 267' ' ' VAL . 7.8 tppt? -76.13 114.25 14.58 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.592 ' H ' ' CD1' ' A' ' 270' ' ' ILE . 0.2 OUTLIER -119.82 107.88 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.028 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.739 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -114.83 -93.38 0.49 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.631 0.729 . . . . 0.0 110.505 179.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.739 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 26.8 mtm -55.22 134.84 49.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.143 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.417 ' HA ' ' CH2' ' A' ' 276' ' ' TRP . 5.7 p -63.16 14.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.788 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -144.37 -61.6 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.204 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.519 ' O ' ' O ' ' A' ' 287' ' ' PHE . 1.1 mp0 -60.34 -86.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.607 0.717 . . . . 0.0 110.353 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.55 ' CZ3' ' O ' ' A' ' 272' ' ' MET . 47.6 m95 95.95 144.23 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.565 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 11.6 mt-10 -99.2 107.65 20.04 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.375 0.607 . . . . 0.0 112.187 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -67.66 -178.94 13.66 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 118.734 -1.698 . . . . 0.0 113.465 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.461 ' H ' ' CG2' ' A' ' 265' ' ' VAL . 4.1 tt0 -168.35 107.53 0.5 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.649 -0.776 . . . . 0.0 110.368 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -129.58 75.75 1.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.988 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 37.0 t30 85.17 29.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.998 0.428 . . . . 0.0 110.346 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 99.17 -30.01 10.7 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.484 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -68.4 77.29 0.27 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.575 ' CZ ' ' CE1' ' A' ' 142' ' ' PHE . 87.0 mtt180 -79.18 175.84 10.22 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.428 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.05 -147.88 11.64 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 8.2 p80 -141.8 175.37 9.76 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 118.279 1.039 . . . . 0.0 109.378 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.657 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.3 m-85 161.62 152.84 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 O-C-N 123.687 0.617 . . . . 0.0 111.534 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.478 ' HD2' ' HE2' ' A' ' 291' ' ' HIS . 51.2 Cg_endo -72.75 148.52 46.73 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 123.096 2.531 . . . . 0.0 112.983 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 29.4 t80 -74.58 -2.15 24.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.158 0.504 . . . . 0.0 109.77 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 23.5 p -61.39 -8.33 3.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.049 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.517 ' CE1' ' CE ' ' A' ' 246' ' ' LYS . 7.0 p80 -136.79 53.9 1.89 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.9 150.58 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 294' ' ' LEU . 30.5 mmm-85 -131.91 77.1 1.74 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.667 0.27 . . . . 0.0 110.952 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 293' ' ' ARG . 45.1 mt -34.13 122.22 0.48 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.487 1.137 . . . . 0.0 112.187 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.1 mp -61.01 -173.56 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.082 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 296' ' ' ASP . 26.7 p-10 -74.94 18.42 0.18 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.061 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.478 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.5 tt0 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.528 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 136' ' ' GLU . 35.3 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.64 ' O ' ' CG ' ' A' ' 137' ' ' TYR . 12.1 tp10 -160.2 166.6 29.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 136' ' ' GLU . 25.7 m-85 -173.32 135.93 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.29 0.369 . . . . 0.0 110.324 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.1 m -148.33 164.93 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.739 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -128.42 132.24 48.47 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -101.57 96.87 7.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.651 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.451 ' CD1' ' CD2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.95 18.69 17.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.46 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.597 ' CE1' ' NH1' ' A' ' 284' ' ' ARG . 51.1 m-85 -115.69 5.01 14.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.5 p30 56.86 149.12 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.947 0 O-C-N 124.44 1.087 . . . . 0.0 109.903 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.46 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 10.3 t80 -140.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.167 0.439 . . . . 0.0 110.761 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 42.12 63.55 1.33 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.228 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.529 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.45 -126.12 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.542 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 165.2 -40.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.026 0.413 . . . . 0.0 112.111 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 20.0 m-20 -73.65 160.23 31.89 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.211 0.529 . . . . 0.0 111.217 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.3 -17.59 63.74 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.503 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 150' ' ' GLU . 55.2 mp0 -98.36 31.28 2.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 38.0 p30 -145.55 164.18 32.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.029 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 11.9 tp -122.01 84.5 45.09 Favored Pre-proline 0 C--O 1.213 -0.835 0 CA-C-O 120.39 0.138 . . . . 0.0 111.149 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.529 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 24.5 Cg_exo -59.98 140.15 91.35 Favored 'Trans proline' 0 C--N 1.284 -2.831 0 C-N-CA 122.442 2.094 . . . . 0.0 113.528 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.477 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 11.6 p90 -162.32 158.47 24.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.344 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -54.02 0.65 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.447 0.641 . . . . 0.0 112.059 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 158' ' ' ASP . 15.4 mmtt -88.6 90.54 8.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.614 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 14.56 53.65 0.01 OUTLIER Glycine 0 C--N 1.343 0.971 0 O-C-N 124.115 0.884 . . . . 0.0 111.844 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 156' ' ' LYS . 34.5 t0 -66.12 139.59 58.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.404 0.621 . . . . 0.0 109.82 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.4 mp -86.41 100.06 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.35 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.8 mt -106.52 106.56 17.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.749 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.61 141.4 48.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.606 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.5 mp -81.04 139.49 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -114.18 -47.62 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.532 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -140.95 113.81 8.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.151 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.442 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 29.6 pttt -112.37 75.16 1.65 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.324 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.81 -25.07 24.15 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.122 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -118.79 166.83 12.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.635 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -95.87 -28.82 14.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.767 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.414 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 78.8 mt-30 -85.16 -19.65 31.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.548 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 65.7 m95 -131.17 154.61 48.2 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 12.7 m0 -144.67 135.32 24.65 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.272 0.558 . . . . 0.0 111.231 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.72 115.23 24.03 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.62 -178.5 4.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.746 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -125.89 137.77 53.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.655 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.4 OUTLIER -85.1 135.36 34.02 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.222 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -45.74 -8.19 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.568 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.655 ' H ' ' C ' ' A' ' 175' ' ' ASP . 56.5 m-20 -78.03 -31.48 50.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 110.759 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.59 45.26 0.92 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.695 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -143.79 143.28 31.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.612 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.55 129.89 53.72 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.65 155.09 26.14 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.534 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.03 152.56 44.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.17 142.24 26.52 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.53 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -69.49 118.99 6.01 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.096 1.198 . . . . 0.0 109.048 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 24.1 t -53.96 -52.1 71.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 121.874 -0.516 . . . . 0.0 111.779 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.6 Cg_endo -53.02 -24.64 25.6 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.317 2.011 . . . . 0.0 113.618 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.654 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.5 m-85 -68.59 0.38 4.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.812 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.06 166.24 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.535 0.207 . . . . 0.0 110.476 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 191' ' ' CYS . 1.9 pt-20 -130.29 58.6 1.67 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.846 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 13.1 mptt 37.44 25.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' GLU . 18.4 t 39.66 78.44 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -64.14 150.14 92.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.479 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.4 -32.59 60.37 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.339 2.026 . . . . 0.0 112.116 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 36.6 m -157.66 85.22 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.352 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 70.6 m -56.77 -46.21 81.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.22 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 61.73 179.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.53 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 t -121.2 35.6 4.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.52 -41.24 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.541 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.695 ' HG ' ' H ' ' A' ' 200' ' ' THR . 31.8 t -151.19 -179.89 7.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.364 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.695 ' H ' ' HG ' ' A' ' 199' ' ' SER . 41.2 p -94.32 102.4 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.298 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.4 tp -173.33 51.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.93 -38.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 205' ' ' ASN . . . 174.64 -87.43 0.08 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.48 -8.64 2.9 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 203' ' ' GLY . 34.3 m120 54.38 47.81 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -50.0 116.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.303 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 209' ' ' SER . 97.4 m-20 -76.69 -86.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.439 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.433 ' OG ' ' OG1' ' A' ' 255' ' ' THR . 32.3 t 43.38 -87.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 207' ' ' ASP . 29.7 t -126.15 121.17 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.179 0.514 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.452 ' N ' ' HD2' ' A' ' 211' ' ' PRO . 0.2 OUTLIER 164.44 -57.54 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.669 -178.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 210' ' ' HIS . 47.4 Cg_endo -65.53 -165.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.823 1.682 . . . . 0.0 112.036 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 211' ' ' PRO . 0.0 OUTLIER -46.85 177.36 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.288 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.94 143.58 99.53 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.334 2.023 . . . . 0.0 111.85 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 215' ' ' GLY . 81.1 mt -89.66 -86.85 0.18 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 214' ' ' LEU . . . -55.45 -156.8 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.553 ' N ' ' CD ' ' A' ' 217' ' ' PRO . . . -107.37 -45.98 1.11 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 216' ' ' GLY . 31.4 Cg_exo -57.93 138.96 88.64 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.542 2.161 . . . . 0.0 111.963 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -155.14 78.35 4.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.879 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.35 144.04 84.11 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.709 2.272 . . . . 0.0 112.205 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 46.98 -117.05 2.81 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.483 ' O ' ' CD1' ' A' ' 222' ' ' TYR . 59.7 Cg_endo -74.28 -61.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.466 1.633 . . . . 0.0 112.456 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.483 ' CD1' ' O ' ' A' ' 221' ' ' PRO . 68.7 m-85 -153.63 168.44 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.432 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.57 97.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.15 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 226' ' ' SER . 0.2 OUTLIER -137.02 123.93 13.88 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.557 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 226' ' ' SER . 36.5 Cg_exo -59.23 40.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.201 0 C-N-CA 122.423 2.082 . . . . 0.0 112.266 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 228' ' ' ASN . 1.8 m 160.89 130.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.488 ' O ' ' CG2' ' A' ' 227' ' ' ILE . 9.7 tp -60.87 74.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 110.175 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 226' ' ' SER . 0.2 OUTLIER -178.12 168.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.088 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 230' ' ' PRO . 2.1 p -111.54 90.8 13.0 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.437 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 229' ' ' THR . 50.5 Cg_exo -42.86 -103.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.105 1.87 . . . . 0.0 113.177 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 71.6 mt -51.62 137.13 33.23 Favored Pre-proline 0 N--CA 1.447 -0.611 0 O-C-N 122.263 -0.273 . . . . 0.0 111.152 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.48 -93.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.94 1.76 . . . . 0.0 111.94 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.48 ' CG ' ' H ' ' A' ' 234' ' ' LEU . 54.2 t30 -126.58 -169.17 1.98 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.48 ' H ' ' CG ' ' A' ' 233' ' ' ASN . 31.9 tp -40.06 100.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.31 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.602 ' C ' ' H ' ' A' ' 237' ' ' GLY . 12.8 mm100 -53.16 159.8 1.2 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.924 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 70.2 m-20 -54.36 -2.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.593 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 235' ' ' GLN . . . -94.04 -167.91 37.54 Favored Glycine 1 CA--C 1.445 -4.3 0 CA-C-O 121.773 0.652 . . . . 0.0 113.965 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 2.4 Cg_endo -47.55 98.32 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.752 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 0.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.609 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 4.0 m-30 -117.06 -130.7 0.31 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.414 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 2.3 m-30 -137.11 119.51 15.81 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.765 0.793 . . . . 0.0 109.169 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.728 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -111.75 142.35 44.2 Favored 'General case' 0 C--O 1.188 -2.159 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.047 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 15.6 tpp180 -103.96 110.44 22.59 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.672 ' O ' ' O ' ' A' ' 261' ' ' VAL . 7.5 p -82.58 74.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 123.702 0.626 . . . . 0.0 111.936 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.771 ' HA ' ' O ' ' A' ' 261' ' ' VAL . 1.4 pt -60.81 24.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.645 ' H ' ' C ' ' A' ' 243' ' ' VAL . 1.6 mm-40 173.46 130.88 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.492 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.519 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 0.6 OUTLIER -165.68 -144.81 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.444 176.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.519 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 4.3 ptt85 -156.91 -140.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.381 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 76.7 t -138.3 68.59 47.35 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.69 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.584 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 55.7 Cg_endo -96.07 179.65 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.422 2.748 . . . . 0.0 111.75 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.812 ' C ' ' H ' ' A' ' 252' ' ' TYR . 10.7 p-10 -148.66 145.64 27.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.362 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.88 4.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.812 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.0 m-85 -98.82 -55.4 2.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.952 0.901 . . . . 0.0 110.58 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -44.6 -67.41 0.29 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.846 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.523 ' O ' ' CE1' ' A' ' 286' ' ' HIS . 27.1 mtmt -149.11 36.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.453 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.433 ' OG1' ' OG ' ' A' ' 208' ' ' SER . 0.6 OUTLIER 60.45 38.63 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.005 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.475 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -109.0 170.55 7.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.475 ' H ' HD21 ' A' ' 257' ' ' LEU . 0.3 OUTLIER -112.32 152.64 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.122 0.569 . . . . 0.0 110.807 -178.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.584 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -97.89 119.35 36.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.464 0.649 . . . . 0.0 111.684 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.78 -163.03 1.61 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.52 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 261' ' ' VAL . 0.3 OUTLIER -132.58 -176.98 4.28 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.771 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 2.3 t -61.11 -34.35 59.86 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 CA-C-O 121.575 0.703 . . . . 0.0 112.379 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 260' ' ' GLU . . . -128.41 38.46 2.06 Favored Glycine 0 C--N 1.277 -2.701 0 O-C-N 120.539 -1.351 . . . . 0.0 111.581 -176.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -86.29 -35.68 19.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.279 0.561 . . . . 0.0 111.389 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.728 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.1 OUTLIER 64.27 139.1 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.061 -178.432 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.545 ' N ' HD11 ' A' ' 264' ' ' LEU . 14.4 p -128.51 150.74 34.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.375 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -100.92 86.92 3.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.989 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 40.9 t -50.97 153.09 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.482 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.654 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -153.33 -53.46 0.11 Allowed 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.125 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 1.9 tpmt? -67.6 146.16 54.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.279 0.562 . . . . 0.0 111.298 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.48 162.65 30.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.62 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.758 HD22 ' HA ' ' A' ' 276' ' ' TRP . 0.1 OUTLIER 171.74 -101.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.639 ' SD ' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER -73.66 163.04 28.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.508 ' HA ' ' HE1' ' A' ' 276' ' ' TRP . 2.1 p -98.74 29.79 3.59 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.427 ' C ' ' NE2' ' A' ' 275' ' ' GLN . . . -139.65 -39.72 0.09 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.531 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.455 ' OE1' ' OE1' ' A' ' 224' ' ' GLN . 1.0 OUTLIER -96.05 -79.72 0.44 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.218 0.532 . . . . 0.0 111.182 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.758 ' HA ' HD22 ' A' ' 271' ' ' ASN . 17.0 m95 77.6 166.49 0.23 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.194 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 90.3 mt-10 -132.27 148.51 52.45 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -129.09 -141.81 5.19 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 115.094 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -173.03 129.79 0.48 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.572 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.4 OUTLIER -144.32 75.21 1.45 Allowed 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.825 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 13.8 t-20 84.69 27.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.434 0.635 . . . . 0.0 110.001 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 95.78 -32.05 6.68 Favored Glycine 0 N--CA 1.459 0.198 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.49 72.6 0.08 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.597 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 77.2 mtt180 -71.49 168.91 16.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.249 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 170.57 -159.1 31.24 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.632 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 0.0 OUTLIER -135.76 176.15 8.94 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.872 0.469 . . . . 0.0 110.069 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 2.8 m-85 170.54 154.89 0.2 Allowed Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.944 0.778 . . . . 0.0 111.158 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.83 155.59 43.74 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.022 2.481 . . . . 0.0 112.071 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 64.0 t80 -74.77 0.48 15.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.554 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 41.4 p -62.68 0.46 0.5 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.507 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 287' ' ' PHE . 0.6 OUTLIER -156.42 62.38 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.611 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -158.05 143.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -127.66 81.15 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 19.4 mt -40.68 131.24 2.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.857 0.837 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.43 -171.61 3.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.272 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -101.2 33.73 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.609 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 56.0 tt0 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.432 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 178.04 -174.2 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 O-C-N 124.113 0.883 . . . . 0.0 110.436 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.714 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -128.6 -89.34 0.52 Allowed 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.168 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.714 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.8 m 90.36 168.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 124.241 0.963 . . . . 0.0 111.922 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -140.63 156.34 46.29 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 155' ' ' LYS . . . -56.73 168.62 0.58 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.67 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -136.02 -36.56 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.643 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.549 ' CE2' ' CZ ' ' A' ' 284' ' ' ARG . 92.5 m-85 -130.51 6.6 4.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.567 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.485 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 78.02 136.71 0.06 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.8 t80 -108.27 -49.26 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 110.879 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 4.0 m120 41.28 66.92 0.6 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.26 -122.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 146' ' ' GLY . 1.7 p30 168.21 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.576 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.594 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 9.0 m-20 -80.66 154.01 27.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.0 -16.83 64.62 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.036 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.15 24.74 4.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 7.5 p30 -144.82 162.44 36.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.038 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.4 tp -112.31 89.71 12.82 Favored Pre-proline 0 C--O 1.215 -0.737 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.491 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 59.6 Cg_endo -69.17 127.18 14.68 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 121.692 1.595 . . . . 0.0 112.859 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 144' ' ' PHE . 16.7 p90 -147.75 166.94 25.97 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.588 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.481 ' NZ ' ' OD1' ' A' ' 145' ' ' ASN . 1.4 tptp -106.65 -141.11 0.37 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 158' ' ' ASP . 24.7 pttm -91.24 174.13 7.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 36.29 20.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 156' ' ' LYS . 14.5 t0 -79.27 132.66 36.55 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.26 111.88 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.095 0.474 . . . . 0.0 110.858 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.412 ' CD1' ' CD2' ' A' ' 154' ' ' PHE . 7.9 mt -120.57 128.63 53.24 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.6 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.501 ' HZ2' ' CB ' ' A' ' 161' ' ' LYS . 7.8 ttpm? -83.27 135.17 34.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.7 mp -66.3 -51.53 57.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.485 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.601 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 54.2 ttt85 65.94 -49.44 0.41 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.713 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 162' ' ' ILE . 68.2 t0 -149.96 128.43 12.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.115 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.528 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 3.5 ptmm? -121.44 81.74 39.05 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.866 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 -44.01 53.74 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.61 2.207 . . . . 0.0 112.372 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -119.37 176.93 5.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -93.36 -41.82 9.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 240' ' ' TYR . 86.4 mt-30 -72.44 -32.75 66.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.366 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.4 m95 -119.92 153.75 35.43 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.528 ' CD1' ' CB ' ' A' ' 165' ' ' LYS . 14.0 m0 -143.64 135.69 26.67 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 120.992 0.425 . . . . 0.0 110.739 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.694 ' O ' ' O ' ' A' ' 162' ' ' ILE . 46.4 t30 -86.59 107.78 18.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.68 -179.09 3.55 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.546 0.529 . . . . 0.0 110.379 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -126.13 136.09 52.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.514 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 171.39 3.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.651 0.739 . . . . 0.0 110.636 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 1.28 23.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.608 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -105.46 -28.94 10.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.16 50.48 0.34 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -134.24 138.76 45.29 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.35 -0.925 . . . . 0.0 111.212 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.601 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.1 OUTLIER -108.92 122.12 46.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.569 0.7 . . . . 0.0 111.76 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.0 24.41 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.771 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.08 162.06 25.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 -179.121 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.404 ' H ' ' HG3' ' A' ' 182' ' ' MET . 0.0 OUTLIER -157.62 152.16 20.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.954 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.04 113.44 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.199 1.266 . . . . 0.0 110.554 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.57 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 42.4 t -50.48 -50.96 68.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.953 -0.467 . . . . 0.0 111.275 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.0 Cg_endo -45.87 -34.66 12.65 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.933 1.755 . . . . 0.0 112.84 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 7.2 m-85 -63.81 -8.23 10.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.975 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 185' ' ' VAL . 1.3 m -135.22 166.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.812 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 190' ' ' LYS . 0.6 OUTLIER -150.43 -51.18 0.13 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.644 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.509 ' N ' ' OE1' ' A' ' 189' ' ' GLU . 13.9 mmtp -26.9 136.12 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.639 0.587 . . . . 0.0 111.485 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 42.7 t 55.48 102.06 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.066 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.508 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 0.0 OUTLIER 177.38 -48.3 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.255 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 71.2 Cg_endo -84.07 67.51 6.87 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.405 2.07 . . . . 0.0 111.763 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.9 m 63.86 47.6 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.5 t 61.69 136.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -169.65 46.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 78.0 p -61.81 -35.1 77.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.515 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.01 75.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -170.64 21.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.669 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.8 t -55.62 147.7 17.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.326 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 201' ' ' LEU . 10.1 mp -65.65 -75.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 6.7 p 55.33 55.85 7.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -154.71 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -135.81 30.25 2.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -79.57 66.58 5.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.373 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -163.87 101.16 0.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.591 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -151.21 70.02 0.97 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.474 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 70.8 m -61.73 -97.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.606 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 41.1 t -157.87 151.83 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -166.27 71.77 1.18 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.41 144.73 99.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.735 2.29 . . . . 0.0 111.975 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.632 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 2.5 tt0 -81.97 -41.07 0.99 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 26.8 Cg_exo -60.4 148.56 90.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.628 2.219 . . . . 0.0 111.971 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.47 112.4 4.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.164 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.9 140.56 26.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.452 ' N ' ' CD ' ' A' ' 217' ' ' PRO . . . 156.07 -52.63 0.43 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 216' ' ' GLY . 31.5 Cg_exo -57.08 140.2 92.02 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.727 2.284 . . . . 0.0 111.85 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.01 147.7 70.47 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.339 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.71 115.3 0.33 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.275 1.983 . . . . 0.0 112.472 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -118.96 56.31 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.4 -153.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.847 2.364 . . . . 0.0 111.89 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 224' ' ' GLN . 97.6 m-85 -57.3 149.84 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.18 89.65 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 222' ' ' TYR . 53.9 mt-30 -148.39 147.8 26.74 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.371 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 226' ' ' SER . 50.5 Cg_endo -71.34 23.22 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.559 2.173 . . . . 0.0 111.435 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 224' ' ' GLN . 0.7 OUTLIER 78.93 28.45 0.4 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.28 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.9 tt -84.75 -5.57 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.542 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.522 ' ND2' ' CD ' ' A' ' 224' ' ' GLN . 0.0 OUTLIER -144.35 46.56 1.41 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.037 0.446 . . . . 0.0 110.003 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.4 p -57.45 152.17 34.95 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.446 ' HB2' ' HE1' ' A' ' 276' ' ' TRP . 65.1 Cg_exo -37.05 -82.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 122.552 2.168 . . . . 0.0 112.651 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.55 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -131.04 92.87 32.23 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 233' ' ' ASN . 51.6 Cg_exo -53.81 74.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.452 2.101 . . . . 0.0 112.265 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 231' ' ' LEU . 65.6 m-80 48.73 179.85 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.444 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 236' ' ' ASN . 31.4 tp -53.22 -106.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.211 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 61.66 -67.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 234' ' ' LEU . 97.3 m-20 -68.04 -110.81 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.696 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.45 ' CA ' ' C ' ' A' ' 238' ' ' PRO . . . -55.83 -168.97 0.07 OUTLIER Glycine 1 CA--C 1.439 -4.698 0 CA-C-O 122.314 0.952 . . . . 0.0 114.096 -179.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.45 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.7 Cg_exo -47.61 110.82 0.08 OUTLIER 'Cis proline' 1 N--CA 1.544 4.45 0 O-C-N 123.917 1.482 . . . . 0.0 115.253 0.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.631 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.0 m-30 -126.7 -136.45 0.25 Allowed 'General case' 0 C--O 1.212 -0.887 0 O-C-N 124.242 0.964 . . . . 0.0 109.128 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 169' ' ' GLN . 2.7 m-30 -134.86 114.58 12.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.903 0.859 . . . . 0.0 109.754 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.802 ' O ' HD11 ' A' ' 264' ' ' LEU . . . -107.41 140.79 39.8 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.695 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -104.32 100.77 10.49 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.396 -0.815 . . . . 0.0 109.792 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.46 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 4.9 p -71.92 121.74 22.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.178 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.564 ' CD1' ' H ' ' A' ' 244' ' ' ILE . 0.2 OUTLIER -121.62 20.67 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -172.9 108.33 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.418 0.628 . . . . 0.0 109.695 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.424 ' HE2' ' CG ' ' A' ' 287' ' ' PHE . 1.9 ttmt -154.49 -140.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.53 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -158.21 -142.12 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 248' ' ' VAL . 66.0 t -134.47 70.49 72.4 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.761 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.483 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 44.8 Cg_endo -90.16 168.91 4.34 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.954 2.436 . . . . 0.0 111.475 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.773 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -131.57 130.2 41.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.831 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.33 -4.87 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.832 0.708 . . . . 0.0 111.994 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.773 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.4 m-85 -93.39 -54.67 3.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.848 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 250' ' ' ASN . 41.9 t0 -41.35 -62.57 0.83 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.553 -177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.6 mtmt -151.34 26.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.999 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.2 m 75.21 -21.48 0.3 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.628 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.566 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -42.24 107.44 0.08 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.224 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.655 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -44.92 157.77 0.07 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.363 178.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.23 121.42 44.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.752 0.658 . . . . 0.0 110.723 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.405 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.4 mt -140.42 -173.95 3.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.928 0.394 . . . . 0.0 111.243 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -144.95 152.28 39.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.955 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.85 106.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.621 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.94 8.72 8.64 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -96.8 -135.93 0.24 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.802 HD11 ' O ' ' A' ' 241' ' ' ALA . 0.1 OUTLIER 172.1 136.8 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.515 ' N ' HD11 ' A' ' 264' ' ' LEU . 14.8 p -127.09 153.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.014 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 239' ' ' PHE . 1.8 ttmm -105.48 95.15 5.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 268' ' ' THR . 18.2 t -63.03 161.46 2.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.058 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -152.66 -62.38 0.16 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.657 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -71.69 132.14 44.15 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.425 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -148.05 145.39 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.375 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.605 HD22 ' CE ' ' A' ' 272' ' ' MET . 0.1 OUTLIER 174.49 -136.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.876 179.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.605 ' CE ' HD22 ' A' ' 271' ' ' ASN . 47.6 mtm 54.51 -122.47 1.96 Allowed 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.259 0.552 . . . . 0.0 111.163 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -143.96 -16.63 0.6 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.035 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.525 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -168.13 -15.14 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.232 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.589 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.0 mp0 -97.06 159.58 14.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.632 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.589 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -167.57 161.02 13.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.556 -178.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -93.84 -168.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.255 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.29 179.36 28.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.507 ' OE1' ' NH2' ' A' ' 284' ' ' ARG . 5.2 tt0 -168.8 113.82 0.59 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.118 0.485 . . . . 0.0 110.686 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.529 ' SG ' ' CG ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -109.45 -99.85 0.39 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -91.64 48.68 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.33 -29.62 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' SG ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.7 92.5 0.22 Allowed 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.303 -177.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.549 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 78.3 mtt180 -87.11 172.35 10.01 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.159 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.45 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 166.04 -152.44 21.63 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.564 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 11.3 p80 -126.23 166.87 16.29 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.15 0.5 . . . . 0.0 109.783 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 164.75 110.72 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.798 177.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.561 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 36.3 Cg_exo -54.91 141.37 78.08 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.978 1.786 . . . . 0.0 112.598 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.596 ' O ' ' CD1' ' A' ' 289' ' ' PHE . 0.5 OUTLIER -61.24 -1.43 0.49 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 288' ' ' PRO . 39.9 p -46.9 -7.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.092 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 289' ' ' PHE . 0.9 OUTLIER -150.27 80.2 1.35 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.016 -178.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.471 ' C ' ' HE ' ' A' ' 293' ' ' ARG . 0.0 OUTLIER -168.92 151.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.471 ' HE ' ' C ' ' A' ' 292' ' ' VAL . 0.2 OUTLIER -123.45 74.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.64 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 293' ' ' ARG . 68.2 mt -36.49 131.64 0.65 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.1 mp -78.85 -171.97 2.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -91.8 17.14 9.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.45 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.631 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 62.4 tt0 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.307 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.483 ' C ' ' CD1' ' A' ' 137' ' ' TYR . 42.4 tp10 -164.94 152.41 11.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.621 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 0.7 OUTLIER -142.47 -68.22 0.37 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.268 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.621 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 1.2 m 81.75 162.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 O-C-N 125.183 1.552 . . . . 0.0 111.928 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -132.31 142.33 49.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.598 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -99.83 102.94 14.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.626 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.522 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -101.4 20.56 15.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.717 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 51.9 m-85 -121.14 1.92 10.34 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.884 -0.144 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.504 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 60.56 139.13 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.797 0 O-C-N 123.999 0.812 . . . . 0.0 109.968 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.452 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 13.1 t80 -128.86 -50.57 1.23 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.569 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 144' ' ' PHE . 47.5 t30 37.36 58.07 1.29 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.517 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.435 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -65.77 -150.3 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.572 HD21 ' N ' ' A' ' 148' ' ' ASP . 0.1 OUTLIER 165.6 -15.05 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.855 -0.672 . . . . 0.0 111.207 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' A' ' 149' ' ' ASP . 63.2 m-20 -49.66 -166.71 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' A' ' 148' ' ' ASP . 98.9 m-20 -16.44 -68.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.311 0.382 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 151' ' ' ASP . 17.3 pt-20 -171.07 40.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.027 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 150' ' ' GLU . 1.4 m-20 -53.74 -157.56 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.491 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 13.5 tp -123.92 84.4 54.58 Favored Pre-proline 0 C--O 1.217 -0.622 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.688 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.435 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 56.1 Cg_endo -68.17 121.25 8.23 Favored 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 121.669 1.58 . . . . 0.0 112.438 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 7.7 p90 -140.2 -177.59 5.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 5.8 mttp 179.69 121.84 0.06 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.576 -0.725 . . . . 0.0 109.128 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 105.93 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.635 1.209 . . . . 0.0 110.96 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 19.86 52.48 0.01 OUTLIER Glycine 0 N--CA 1.472 1.038 0 O-C-N 123.564 0.54 . . . . 0.0 111.919 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 156' ' ' LYS . 8.1 t70 -74.46 142.26 44.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.083 0.468 . . . . 0.0 110.329 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.05 96.44 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 mt -102.34 103.67 14.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.805 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -53.21 132.91 39.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.737 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 172' ' ' ASN . 40.1 mm -71.3 -55.15 14.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.113 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.672 HH12 HH11 ' A' ' 180' ' ' ARG . 32.1 ttm180 78.56 -52.03 0.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.551 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 165' ' ' LYS . 50.0 p-10 -120.3 -120.34 0.3 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.21 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.536 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 2.7 pttp 141.87 62.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 124.438 1.086 . . . . 0.0 109.963 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.25 -65.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.567 2.178 . . . . 0.0 112.697 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.7 mt-10 -108.33 168.85 9.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.13 -37.95 25.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -79.73 -23.46 42.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -126.88 152.47 47.01 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 12.8 m0 -147.16 138.5 23.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.682 ' O ' ' O ' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -90.23 121.63 32.42 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.11 -178.14 4.42 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.66 0.6 . . . . 0.0 110.002 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.495 ' CD ' ' NH2' ' A' ' 163' ' ' ARG . 49.1 tt0 -124.62 130.02 51.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.287 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 176' ' ' MET . 9.2 t70 -56.29 177.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.397 0.618 . . . . 0.0 110.879 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.451 ' H ' ' CG ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -80.04 -4.95 54.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.383 177.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -104.91 -27.64 11.58 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.78 48.46 0.33 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -129.29 129.04 44.39 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.856 -0.672 . . . . 0.0 111.376 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.672 HH11 HH12 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -97.65 121.19 39.26 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.79 0.805 . . . . 0.0 111.467 -178.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -152.76 149.43 21.05 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.217 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.52 153.46 41.39 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.122 0.487 . . . . 0.0 110.09 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.94 143.56 28.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.472 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.58 114.57 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.437 1.424 . . . . 0.0 109.978 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.599 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 54.2 t -52.15 -48.86 87.51 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.079 -0.388 . . . . 0.0 110.941 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 12.2 Cg_endo -50.49 -27.73 19.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.912 1.742 . . . . 0.0 113.314 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.59 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.8 m-85 -72.24 -5.54 36.62 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.509 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.1 m -128.1 168.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.259 0.349 . . . . 0.0 110.759 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.497 ' O ' ' C ' ' A' ' 190' ' ' LYS . 2.5 pt-20 -134.59 67.53 1.5 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.517 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER 21.61 49.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.922 0.764 . . . . 0.0 111.327 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 189' ' ' GLU . 29.4 t 41.45 69.04 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.022 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -76.35 129.42 80.1 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.649 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -46.99 137.95 16.25 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.211 1.94 . . . . 0.0 112.394 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.492 ' HG ' ' H ' ' A' ' 195' ' ' SER . 5.3 p -159.79 -98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.404 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.492 ' H ' ' HG ' ' A' ' 194' ' ' SER . 24.3 p 56.41 52.03 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 53.56 72.63 0.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 198' ' ' VAL . 80.9 p -149.98 -99.77 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.429 ' N ' ' OG ' ' A' ' 197' ' ' SER . 7.9 p -60.96 -46.78 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.407 ' N ' ' CG1' ' A' ' 198' ' ' VAL . 5.2 p -91.38 139.38 30.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.501 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 201' ' ' LEU . 60.4 p -66.38 131.35 45.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.271 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 200' ' ' THR . 2.9 tp 55.37 164.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.409 ' H ' ' HG ' ' A' ' 201' ' ' LEU . 72.2 p -76.31 171.63 14.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.81 82.16 0.02 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -58.92 133.93 52.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -157.83 179.01 9.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.313 . . . . 0.0 110.338 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -99.45 160.37 14.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 35.7 p-10 -67.59 115.76 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.458 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 56.0 m -153.65 -124.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.2 t -133.19 -34.29 1.09 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.427 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 53.43 64.34 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.08 -179.05 4.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.708 2.272 . . . . 0.0 111.818 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -139.62 72.81 36.04 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -61.33 143.32 97.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.915 2.41 . . . . 0.0 112.011 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.5 tt -164.2 111.12 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.294 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -168.82 -63.44 0.03 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.11 73.75 0.72 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -61.57 147.35 95.61 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.954 2.436 . . . . 0.0 111.803 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.447 ' CB ' ' CD ' ' A' ' 219' ' ' PRO . 5.0 mt-10 -155.65 -64.14 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.656 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 218' ' ' GLU . 30.8 Cg_endo -61.39 143.13 97.51 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.066 1.844 . . . . 0.0 111.963 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.96 -145.79 0.45 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.97 -177.49 3.76 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.39 2.06 . . . . 0.0 111.885 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -59.76 137.61 58.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.48 94.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.318 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -144.06 155.73 58.53 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.16 -0.54 4.23 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.731 2.287 . . . . 0.0 111.8 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 228' ' ' ASN . 49.6 m -108.86 -6.51 15.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 39.0 mm 53.14 -87.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.524 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 226' ' ' SER . 87.0 m-20 -76.94 81.87 3.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.07 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.452 ' H ' ' HG1' ' A' ' 229' ' ' THR . 2.9 p -69.87 150.78 96.43 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.791 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -37.62 -80.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 122.849 2.366 . . . . 0.0 112.491 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.71 94.2 35.5 Favored Pre-proline 0 C--O 1.232 0.137 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.18 169.01 19.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.364 2.043 . . . . 0.0 111.872 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 74.92 145.7 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.427 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.552 ' C ' ' H ' ' A' ' 236' ' ' ASN . 5.2 tp -54.88 128.11 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.877 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.531 ' N ' ' OE1' ' A' ' 235' ' ' GLN . 0.9 OUTLIER -70.51 39.95 0.05 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.467 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.601 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 83.4 m-20 56.29 4.86 0.15 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.17 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 235' ' ' GLN . . . -103.61 -169.48 25.55 Favored Glycine 1 CA--C 1.435 -4.908 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.98 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.424 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.4 Cg_exo -48.12 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.533 3.851 0 O-C-N 123.442 1.233 . . . . 0.0 114.799 0.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 236' ' ' ASN . 2.3 m-30 -120.66 -135.94 0.32 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 1.8 m-30 -138.79 118.97 13.52 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.584 0.707 . . . . 0.0 109.592 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.548 ' N ' HD11 ' A' ' 264' ' ' LEU . . . -98.4 -162.86 0.99 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -157.43 86.94 0.95 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.654 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.515 HG11 ' H ' ' A' ' 264' ' ' LEU . 8.2 p -63.21 112.57 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.5 ' CD1' HH21 ' A' ' 293' ' ' ARG . 1.1 pt -103.83 16.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -176.2 124.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.202 0.525 . . . . 0.0 111.131 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.476 ' HE2' ' CG ' ' A' ' 287' ' ' PHE . 2.5 ttmt -165.08 -157.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.217 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.43 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 1.6 ptt85 -145.82 -134.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.466 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.426 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 4.6 t -139.38 60.44 16.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.72 ' O ' ' O ' ' A' ' 250' ' ' ASN . 95.9 Cg_endo -94.68 44.04 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.812 2.341 . . . . 0.0 113.322 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.726 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.3 p-10 -21.23 153.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.014 0.821 . . . . 0.0 111.465 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.2 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.688 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 254' ' ' LYS . 31.9 m-85 -79.28 -64.52 1.17 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.2 t70 -45.98 63.42 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 125.142 1.526 . . . . 0.0 110.319 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.828 ' N ' ' O ' ' A' ' 252' ' ' TYR . 33.7 mtmt 81.34 -48.47 0.25 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.618 1.199 . . . . 0.0 110.364 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.65 -25.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.849 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.668 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -41.34 108.56 0.09 Allowed 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.951 0.405 . . . . 0.0 111.48 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -43.07 159.98 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.431 0 O-C-N 122.11 -0.369 . . . . 0.0 110.963 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.541 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -112.17 122.51 47.94 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.515 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 0.8 OUTLIER -140.68 -174.07 3.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.086 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -145.84 145.33 30.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.159 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 66.4 t -46.82 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.39 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 11.84 10.6 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 264' ' ' LEU . 56.3 mm-40 -88.3 -36.32 16.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.281 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 135.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.614 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.577 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.3 p -133.45 159.37 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.39 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 6.1 ttmt -103.33 94.9 5.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.927 ' O ' ' N ' ' A' ' 269' ' ' LYS . 2.6 t -46.03 -42.4 4.41 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.527 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.59 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 7.9 t 35.16 -60.07 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.927 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER -73.77 110.49 8.1 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.9 mt -136.6 101.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.598 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.897 HD21 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -93.05 -31.64 14.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 179.373 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.897 ' H ' HD21 ' A' ' 271' ' ' ASN . 29.1 mtm -131.28 172.49 12.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.999 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.9 p -91.22 5.62 48.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . -124.33 -90.69 0.89 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.791 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.48 69.2 10.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 0.0 110.722 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 0.4 OUTLIER -77.78 178.48 7.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.623 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 3.4 mt-10 -104.19 -167.41 1.36 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -157.76 -171.39 23.67 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.425 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.0 tt0 -170.44 109.54 0.36 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.765 0.317 . . . . 0.0 111.516 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.515 ' SG ' ' CD2' ' A' ' 259' ' ' LEU . 0.1 OUTLIER -100.84 -101.69 0.25 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -90.6 47.64 1.45 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.14 -28.31 9.0 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.419 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.86 91.55 0.2 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.122 -178.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 84.5 mtt180 -85.54 173.31 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.099 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.502 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 161.79 -151.12 21.15 Favored Glycine 0 C--O 1.215 -1.052 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.52 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 14.3 p-80 -130.4 169.3 15.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.474 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.66 116.04 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.547 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 290' ' ' THR . 22.6 Cg_endo -62.72 162.48 24.83 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.106 1.87 . . . . 0.0 112.912 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.551 ' C ' ' H ' ' A' ' 291' ' ' HIS . 82.8 t80 -65.48 1.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.682 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.486 ' H ' ' C ' ' A' ' 288' ' ' PRO . 71.7 p -51.2 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 289' ' ' PHE . 1.7 p80 -172.29 85.98 0.07 Allowed 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.391 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.0 OUTLIER -174.27 148.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.5 HH21 ' CD1' ' A' ' 244' ' ' ILE . 24.3 mmt180 -130.15 81.96 2.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 36.9 mt -43.69 133.96 4.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.381 0.61 . . . . 0.0 111.066 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.0 mp -88.11 -169.95 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -100.55 14.97 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.582 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 239' ' ' PHE . 34.2 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.365 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -139.87 162.24 35.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.923 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 p90 175.03 144.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.88 167.19 16.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -119.72 126.23 50.57 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.073 0.464 . . . . 0.0 110.038 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -92.0 89.28 6.91 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.97 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -100.38 31.47 3.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.385 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 143' ' ' ASP . 50.4 m-85 -132.56 2.98 3.84 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.392 -0.193 . . . . 0.0 110.811 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.3 p30 52.7 137.63 0.0 OUTLIER 'General case' 0 C--O 1.208 -1.109 0 O-C-N 124.924 1.39 . . . . 0.0 110.11 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 6.3 t80 -122.76 -42.77 2.29 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.735 0.302 . . . . 0.0 110.636 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.419 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 62.9 t-20 42.77 59.14 2.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.491 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -65.43 -145.36 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.3 p30 168.39 82.89 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.931 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.506 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 5.2 m-20 174.94 179.06 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 110.349 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -87.94 -21.07 25.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.203 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -103.48 26.12 8.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.4 p30 -141.18 158.75 43.48 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 tp -118.51 89.45 36.76 Favored Pre-proline 0 C--O 1.215 -0.748 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.34 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 139.93 52.2 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 CA-C-N 120.314 1.148 . . . . 0.0 112.542 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.435 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 16.0 p90 -158.79 161.72 36.98 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.576 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER 176.84 125.68 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.507 0.504 . . . . 0.0 110.101 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 11.3 ptpt 136.0 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.521 1.138 . . . . 0.0 109.796 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.76 51.17 0.38 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -83.86 158.7 21.55 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.134 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.6 mm -109.14 112.88 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.381 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -112.94 126.0 55.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.821 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -81.01 143.75 32.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 111.145 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.7 mp -94.98 156.28 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.588 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 174' ' ' GLU . 21.5 ttm105 -135.8 -33.65 0.85 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.473 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.77 128.56 11.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.1 pttm -121.67 79.26 39.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.118 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.21 -42.2 69.35 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.181 1.921 . . . . 0.0 111.989 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -117.37 178.17 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.493 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.58 -29.73 13.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.006 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.59 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 78.9 mt-30 -80.8 -27.34 36.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.864 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.453 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 71.7 m95 -123.3 151.96 41.88 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.428 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 13.5 m0 -143.22 135.65 27.3 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 120.84 0.352 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.52 108.34 12.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.8 163.09 13.22 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.81 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 16.0 tt0 -122.77 128.36 50.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.09 177.76 0.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.68 0.752 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 98.1 mmm -74.82 -2.25 25.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.609 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -99.41 -20.67 16.35 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.464 0.649 . . . . 0.0 110.843 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.82 -28.52 6.39 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -53.01 146.05 11.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.073 0.463 . . . . 0.0 110.532 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 132.54 56.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.658 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.51 151.61 23.16 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.222 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 84.1 mmm -67.34 159.25 29.72 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.318 0.58 . . . . 0.0 110.387 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 6.7 pt -151.26 142.7 15.53 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.952 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.53 115.62 4.28 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.447 1.431 . . . . 0.0 110.015 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 36.3 t -50.24 -52.94 49.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.7 Cg_endo -51.58 -25.99 21.24 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 122.383 2.055 . . . . 0.0 113.291 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.537 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.6 m-85 -69.89 0.92 5.02 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.413 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 185' ' ' VAL . 2.1 m -132.39 161.68 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -93.98 -62.42 1.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.729 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 17.3 tptm 132.81 -5.22 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.81 1.319 . . . . 0.0 109.757 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 190' ' ' LYS . 36.7 t 57.71 110.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 18.1 ttm180 69.94 51.22 0.4 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.394 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 69.8 Cg_endo -71.44 49.95 1.2 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 111.927 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m 69.38 -46.92 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 193' ' ' PRO . 39.5 p -167.93 165.56 13.71 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 69.28 73.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.44 . . . . 0.0 111.256 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.4 p -161.46 7.86 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.63 -42.71 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.352 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.8 p -151.3 148.67 28.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.481 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.551 ' HG1' ' H ' ' A' ' 201' ' ' LEU . 5.6 t -162.34 170.47 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.737 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -170.27 166.13 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.6 p -142.94 155.1 44.64 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.42 88.83 0.3 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 167.8 133.75 1.6 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -97.17 176.16 6.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.339 . . . . 0.0 110.565 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.619 ' H ' ' NE2' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -77.63 -172.99 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.489 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.461 ' OD1' ' CG2' ' A' ' 270' ' ' ILE . 99.4 m-20 -60.71 92.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.362 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.5 p -165.66 -13.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.563 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.0 t -105.6 118.16 35.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -139.11 75.35 34.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.161 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 -30.21 53.13 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.921 2.414 . . . . 0.0 111.92 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 1.8 tm0? -173.15 -43.16 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.249 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 32.9 Cg_exo -60.9 145.62 98.78 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.345 2.03 . . . . 0.0 112.155 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.43 ' O ' ' OD1' ' A' ' 228' ' ' ASN . 2.0 pp -144.02 141.39 30.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -44.59 -52.33 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.6 57.91 4.78 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.3 -39.73 9.55 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.514 2.143 . . . . 0.0 112.342 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.8 OUTLIER -101.61 -45.97 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.269 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 32.3 Cg_exo -55.25 -63.06 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.281 1.987 . . . . 0.0 112.117 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.94 71.75 0.29 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.538 ' CG ' HD21 ' A' ' 228' ' ' ASN . 73.0 Cg_endo -76.32 -90.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.2 1.933 . . . . 0.0 111.984 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -144.79 151.53 38.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.32 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.62 95.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.473 ' NE2' ' CG1' ' A' ' 227' ' ' ILE . 21.2 mt-30 -122.57 138.97 30.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.464 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.93 12.5 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.041 1.828 . . . . 0.0 112.147 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 224' ' ' GLN . 1.0 OUTLIER -128.16 -73.63 0.59 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.936 0.398 . . . . 0.0 111.754 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.473 ' CG1' ' NE2' ' A' ' 224' ' ' GLN . 28.7 mm -56.19 -55.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.856 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.538 HD21 ' CG ' ' A' ' 221' ' ' PRO . 70.3 m-80 -136.89 84.2 2.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 1.9 p -67.84 151.66 97.0 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.21 135.7 48.13 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.289 1.993 . . . . 0.0 112.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.527 ' HB3' ' HE1' ' A' ' 276' ' ' TRP . 1.2 pt? -132.16 148.08 68.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.057 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 9.12 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.139 1.892 . . . . 0.0 111.712 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' LEU . 27.9 m120 51.75 56.79 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.901 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 236' ' ' ASN . 29.8 tp -58.89 -115.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.018 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.425 ' N ' ' HG ' ' A' ' 234' ' ' LEU . 67.8 mt-30 61.03 -62.69 0.08 Allowed 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 123.493 0.495 . . . . 0.0 110.783 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.568 ' N ' ' O ' ' A' ' 234' ' ' LEU . 36.7 p-10 -58.49 -40.2 82.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.331 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 236' ' ' ASN . . . -89.23 -165.55 41.24 Favored Glycine 1 CA--C 1.436 -4.85 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.749 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.7 Cg_endo -45.05 100.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.536 3.994 0 N-CA-C 116.843 1.824 . . . . 0.0 116.843 1.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.567 ' CZ ' ' O ' ' A' ' 236' ' ' ASN . 8.4 m-30 -114.55 -130.66 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.29 127.6 18.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 109.227 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 294' ' ' LEU . . . -104.51 -165.09 1.11 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.222 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -156.48 94.77 1.51 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.6 p -73.71 116.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.0 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.589 ' CD1' ' H ' ' A' ' 244' ' ' ILE . 0.0 OUTLIER -110.21 18.03 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.993 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 244' ' ' ILE . 2.3 mm-40 -174.38 121.06 0.26 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -168.55 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.551 178.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.655 HH21 ' HZ1' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -154.57 -134.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.634 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.421 ' O ' ' OD2' ' A' ' 253' ' ' ASP . 3.4 t -137.84 62.89 36.39 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.607 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.71 ' O ' ' O ' ' A' ' 250' ' ' ASN . 11.6 Cg_endo -98.62 31.04 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.959 1.773 . . . . 0.0 114.417 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 249' ' ' PRO . 13.5 p30 -24.93 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.463 1.102 . . . . 0.0 112.588 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.26 -22.32 29.15 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.442 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.405 ' C ' ' OD1' ' A' ' 250' ' ' ASN . 32.9 m-85 -111.34 47.71 0.99 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 254' ' ' LYS . 1.2 m-20 -151.42 15.98 0.7 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.655 ' HZ1' HH21 ' A' ' 247' ' ' ARG . 28.1 mtmt 147.22 -65.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 41.7 m 166.77 -16.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.199 0.937 . . . . 0.0 110.428 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ASN . . . -82.02 170.24 15.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.294 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.795 ' CD2' ' O ' ' A' ' 285' ' ' GLY . 0.5 OUTLIER -87.26 151.18 23.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.68 0.392 . . . . 0.0 110.623 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -96.45 121.71 38.57 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.124 0.42 . . . . 0.0 111.118 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.408 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 1.5 mt -142.33 -171.78 3.47 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.646 0.736 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -144.79 148.44 34.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.272 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 81.1 t -53.11 100.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.509 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.62 9.71 9.94 Favored Glycine 0 CA--C 1.51 -0.233 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 264' ' ' LEU . 12.5 mm-40 -86.99 -36.23 18.38 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 136.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.116 0.96 . . . . 0.0 109.12 -178.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.552 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 12.5 p -131.63 150.67 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -107.33 91.94 3.86 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.67 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.34 159.63 2.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.846 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.537 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.4 OUTLIER -157.76 -44.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.63 142.84 57.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.225 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.461 ' CG2' ' OD1' ' A' ' 207' ' ' ASP . 74.0 mt -132.34 156.08 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.618 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER 172.32 -91.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.801 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.676 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 3.9 mtm -69.03 135.72 51.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.137 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.3 p -74.71 20.49 0.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -148.03 -50.46 0.02 OUTLIER Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.151 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.492 ' O ' ' HE1' ' A' ' 272' ' ' MET . 1.0 OUTLIER -105.33 98.34 8.06 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 1.6 m95 -101.49 173.74 6.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -115.83 127.25 54.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.023 0.439 . . . . 0.0 110.614 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -79.58 -164.37 28.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.256 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.423 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 3.3 tt0 -172.7 112.26 0.25 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.848 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.419 ' SG ' ' HG3' ' A' ' 283' ' ' LYS . 0.1 OUTLIER -107.96 -98.08 0.37 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -93.07 40.34 1.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.17 -21.46 42.1 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.596 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -68.63 75.26 0.28 Allowed 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 114.576 -0.812 . . . . 0.0 110.369 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.423 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 89.9 mtt180 -74.54 166.12 24.06 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.256 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.795 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 157.74 129.23 1.09 Allowed Glycine 0 C--O 1.198 -2.14 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.519 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -59.02 174.99 0.32 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 117.963 -3.081 . . . . 0.0 110.329 -175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.557 ' CZ ' ' NH1' ' A' ' 247' ' ' ARG . 0.1 OUTLIER -179.66 115.95 0.22 Allowed Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.114 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.534 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 85.0 Cg_exo -44.33 130.38 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.055 1.055 . . . . 0.0 112.783 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.661 ' C ' ' H ' ' A' ' 291' ' ' HIS . 0.0 OUTLIER -62.6 -3.3 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.903 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.4 p -52.02 4.47 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.661 ' H ' ' C ' ' A' ' 289' ' ' PHE . 5.7 p80 -156.5 74.71 0.83 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 291' ' ' HIS . 1.3 m -166.58 150.96 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -108.82 -44.39 4.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.0 mt 74.31 118.41 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.503 1.144 . . . . 0.0 111.578 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 8.9 mp -88.46 -175.42 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.855 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.33 -52.35 23.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.441 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.403 ' OXT' ' OE1' ' A' ' 169' ' ' GLN . 55.5 tt0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.706 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.601 ' C ' ' H ' ' A' ' 138' ' ' VAL . 18.2 pt-20 -151.59 -31.43 0.16 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.066 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.568 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -42.66 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.601 ' H ' ' C ' ' A' ' 136' ' ' GLU . 31.5 m 42.9 -179.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 124.06 0.85 . . . . 0.0 110.303 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -133.08 121.72 23.07 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.436 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -95.3 100.01 11.86 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.057 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.459 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -111.29 32.29 5.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.921 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 143' ' ' ASP . 43.7 m-85 -127.63 2.9 6.14 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.72 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.1 p30 58.88 138.03 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 124.464 1.102 . . . . 0.0 109.811 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 7.6 t80 -130.11 -49.78 1.11 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.04 0.382 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 40.13 65.78 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.77 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.43 -138.55 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.639 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.3 p30 172.86 101.08 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.323 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 9.8 m-20 151.1 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.363 1.039 . . . . 0.0 110.697 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.42 -15.81 26.71 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -105.36 24.8 11.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.855 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.639 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.9 p-10 -137.48 152.64 49.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.3 tp -116.33 87.89 21.54 Favored Pre-proline 0 C--O 1.214 -0.792 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.542 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.98 122.76 9.65 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.347 1.364 . . . . 0.0 112.201 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.436 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 14.5 p90 -139.21 169.27 18.08 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -171.04 122.01 0.56 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.553 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.1 mtpp 98.64 74.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.675 1.234 . . . . 0.0 111.589 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 30.82 55.26 0.26 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.068 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 31.2 t0 -73.58 150.52 41.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.9 0.381 . . . . 0.0 110.708 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.444 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.6 mp -102.51 108.76 24.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 mt -121.71 106.22 11.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.235 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -61.31 133.51 55.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.802 0.689 . . . . 0.0 112.785 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.516 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.4 mp -78.64 132.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.717 178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.63 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 12.8 tpt180 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.529 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -147.18 121.28 9.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.437 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 10.6 ptmt -112.7 75.2 1.8 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.817 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.84 -35.74 11.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.981 1.788 . . . . 0.0 112.122 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -103.66 168.7 8.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.149 0.5 . . . . 0.0 110.607 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.71 -38.38 11.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.37 -22.29 32.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.514 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 69.6 m95 -120.8 151.67 39.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 170' ' ' TRP . 12.4 m0 -145.43 135.98 24.25 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.085 0.469 . . . . 0.0 110.738 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.12 107.97 13.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.34 164.95 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.978 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 14.4 tt0 -127.34 136.96 52.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.609 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.68 -175.28 1.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.492 0.663 . . . . 0.0 110.461 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 87.2 mmm -76.28 -15.45 60.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.955 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.52 -22.27 22.51 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.275 0.56 . . . . 0.0 111.011 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.67 -19.98 9.55 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -52.73 143.61 15.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.63 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -115.85 124.76 51.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.503 0.668 . . . . 0.0 111.225 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.18 145.54 14.65 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.705 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mtp -64.59 160.19 20.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.566 0.698 . . . . 0.0 110.458 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 5.1 pt -151.75 144.32 16.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.881 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.71 110.01 2.98 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.025 1.15 . . . . 0.0 110.657 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.514 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 55.6 t -44.22 -52.69 15.67 Favored Pre-proline 0 C--O 1.218 -0.604 0 O-C-N 121.882 -0.511 . . . . 0.0 111.821 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.9 Cg_endo -48.39 -24.54 6.27 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.887 1.724 . . . . 0.0 113.509 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.421 ' HH ' ' H ' ' A' ' 270' ' ' ILE . 7.5 m-85 -74.29 5.52 4.45 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.311 -0.555 . . . . 0.0 112.004 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.4 m -133.64 162.79 38.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.419 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 191' ' ' CYS . 0.2 OUTLIER -121.74 -67.18 0.98 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 191' ' ' CYS . 21.9 tptm -37.81 93.2 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 190' ' ' LYS . 0.1 OUTLIER 160.56 105.26 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 40.87 59.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' SER . 25.9 Cg_endo -60.54 -32.38 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.504 2.136 . . . . 0.0 111.968 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.0 t 56.38 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.667 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 193' ' ' PRO . 84.1 p -81.83 -136.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.32 142.79 24.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 66.4 m -123.29 113.0 18.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.419 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.421 ' CG2' ' H ' ' A' ' 199' ' ' SER . 3.0 m -139.26 -109.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.242 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.421 ' H ' ' CG2' ' A' ' 198' ' ' VAL . 1.4 m 57.85 -170.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 58.4 m -142.97 128.62 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.509 ' CD2' ' H ' ' A' ' 201' ' ' LEU . 1.4 pt? -131.44 142.57 50.03 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 54.0 m -99.21 140.77 32.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.758 0.313 . . . . 0.0 110.182 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -69.42 -124.07 0.04 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.35 129.83 1.06 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -88.79 118.15 28.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 275' ' ' GLN . 25.9 pt20 -56.62 159.6 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.519 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 208' ' ' SER . 38.8 t70 -154.08 168.69 25.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.498 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 207' ' ' ASP . 9.1 t 59.33 135.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.564 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.8 t -161.43 -6.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 210' ' ' HIS . 17.7 t-80 -147.22 52.98 1.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.521 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 40.2 Cg_endo -66.55 -44.78 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.7 2.267 . . . . 0.0 111.847 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.521 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 12.0 pt20 -175.04 49.02 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.462 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 33.0 Cg_endo -63.24 144.13 91.04 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.593 2.196 . . . . 0.0 111.865 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 214' ' ' LEU . 3.8 mm? 43.26 -166.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.91 -132.89 0.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -63.95 165.85 29.22 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.55 -21.26 30.08 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.941 2.427 . . . . 0.0 111.882 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.446 ' CB ' ' CD ' ' A' ' 219' ' ' PRO . 0.4 OUTLIER -50.85 -63.79 1.7 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.164 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 218' ' ' GLU . 33.6 Cg_endo -61.52 143.92 97.51 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.317 2.011 . . . . 0.0 112.039 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -179.75 172.39 44.08 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.68 -80.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.032 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -100.28 143.14 30.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.08 98.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -137.98 152.9 72.98 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.636 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.73 -9.73 22.09 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.519 2.146 . . . . 0.0 111.466 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.8 m -146.03 160.79 41.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 227' ' ' ILE . 1.4 mp -87.15 90.66 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 227' ' ' ILE . 12.8 m120 34.72 69.2 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.78 175.09 0.29 Allowed Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 -177.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.8 163.75 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.902 1.734 . . . . 0.0 111.51 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.622 ' HG ' ' CE2' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -71.77 158.97 86.78 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.369 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 233' ' ' ASN . 72.9 Cg_endo -85.03 85.12 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.92 1.747 . . . . 0.0 112.319 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 234' ' ' LEU . 9.0 t30 45.98 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.863 0.301 . . . . 0.0 110.68 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.686 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 15.3 tp -36.28 -98.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 110.38 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 297' ' ' GLN . 65.1 mm-40 55.46 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.791 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 234' ' ' LEU . 19.0 m120 -76.21 32.73 0.12 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.814 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 235' ' ' GLN . . . -168.05 160.74 34.4 Favored Glycine 1 CA--C 1.448 -4.15 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.405 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.418 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 9.0 Cg_exo -72.48 131.94 24.1 Favored 'Cis proline' 0 C--N 1.285 -2.766 0 O-C-N 122.257 0.609 . . . . 0.0 110.931 -6.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 37.4 m-85 -159.74 -123.17 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -145.2 121.74 11.07 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.337 0.517 . . . . 0.0 111.103 -178.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.577 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -101.55 -158.49 0.67 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.592 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -159.47 94.95 1.2 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 9.8 p -73.61 110.66 7.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.431 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.72 22.69 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.731 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 177.81 110.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.521 ' CG ' ' H ' ' A' ' 247' ' ' ARG . 2.7 ttmt -153.62 -145.94 0.18 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.404 0.621 . . . . 0.0 110.284 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.521 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.0 ptt85 -155.41 -144.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.621 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 8.7 p -131.96 66.38 77.55 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.485 0.66 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 60.1 Cg_endo -83.38 157.72 14.68 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.81 2.34 . . . . 0.0 113.574 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -90.9 -172.44 3.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.286 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -103.68 -3.63 24.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.661 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.577 ' C ' ' H ' ' A' ' 254' ' ' LYS . 25.5 m-85 -89.05 -27.67 20.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 32.9 t70 -70.03 43.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.198 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 252' ' ' TYR . 38.5 mtmt 99.04 -45.55 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.424 1.09 . . . . 0.0 108.945 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 284' ' ' ARG . 0.9 OUTLIER 149.18 5.99 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.907 0 O-C-N 125.132 1.52 . . . . 0.0 110.364 179.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 255' ' ' THR . . . -35.71 115.87 0.34 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.206 0.527 . . . . 0.0 111.774 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.542 ' H ' ' CD2' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -68.68 117.64 10.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -71.23 125.29 26.55 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.323 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.476 ' CD2' ' SG ' ' A' ' 280' ' ' CYS . 2.6 mt -142.14 -175.67 4.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.712 0.768 . . . . 0.0 111.238 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -145.61 138.94 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.33 178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 53.1 t -44.01 105.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.147 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.54 7.13 24.57 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.362 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' LEU . 43.8 mm-40 -83.7 -37.34 22.85 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 241' ' ' ALA . 0.2 OUTLIER 62.5 135.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.549 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.7 p -131.14 152.51 37.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.302 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 279' ' ' GLU . 0.9 OUTLIER -103.86 108.67 20.09 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.377 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.458 HG12 ' CD2' ' A' ' 276' ' ' TRP . 97.9 t -72.43 157.05 6.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.494 ' O ' ' OG1' ' A' ' 268' ' ' THR . 0.0 OUTLIER 177.83 43.82 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -157.51 98.74 1.7 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 120.827 -1.171 . . . . 0.0 109.15 178.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 270' ' ' ILE . 1.6 mp -113.33 133.31 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.38 0.61 . . . . 0.0 111.233 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.706 HD21 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -112.81 -29.62 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.98 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.706 ' H ' HD21 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -134.54 -164.4 1.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.536 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -109.66 19.33 19.31 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.181 -0.325 . . . . 0.0 110.705 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.502 ' N ' ' SD ' ' A' ' 272' ' ' MET . . . -130.81 -100.3 0.85 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.704 ' N ' ' SD ' ' A' ' 272' ' ' MET . 50.6 mm-40 -76.24 105.29 7.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.987 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.622 ' CE2' ' HG ' ' A' ' 231' ' ' LEU . 0.4 OUTLIER -98.05 178.45 5.1 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.623 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.477 ' OE2' ' OD1' ' A' ' 271' ' ' ASN . 24.8 mp0 -95.39 -152.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.751 -178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.32 -177.88 34.79 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 266' ' ' LYS . 2.4 tm-20 -169.75 117.06 0.58 Allowed 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 117.226 0.513 . . . . 0.0 110.768 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.603 ' HG ' ' CD ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -107.08 -56.56 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -136.92 38.22 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 284' ' ' ARG . . . 93.28 -21.31 41.1 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.942 ' O ' ' O ' ' A' ' 284' ' ' ARG . 0.0 OUTLIER -57.54 -6.73 0.51 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.386 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.942 ' O ' ' O ' ' A' ' 283' ' ' LYS . 13.9 mtt85 15.86 -177.21 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 O-C-N 126.023 2.077 . . . . 0.0 113.104 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 150.02 -145.38 13.42 Favored Glycine 0 C--N 1.287 -2.182 0 O-C-N 120.652 -1.28 . . . . 0.0 110.549 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.2 p80 -145.37 177.86 8.52 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 114.351 -0.924 . . . . 0.0 109.206 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.619 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.4 m-85 159.06 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 O-C-N 123.877 0.736 . . . . 0.0 109.143 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.0 Cg_exo -51.54 153.96 9.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.93 1.753 . . . . 0.0 113.214 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 46.9 t80 -65.13 2.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 288' ' ' PRO . 32.3 p -51.77 -38.31 54.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.51 72.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.58 144.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -123.55 75.5 1.34 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.065 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 8.3 mt -43.61 125.95 4.27 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.575 0.702 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.9 mp -71.15 -173.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.015 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -83.18 39.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.843 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.502 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 82.2 mt-30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.195 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -157.73 -173.54 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.027 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.687 ' O ' ' CG2' ' A' ' 138' ' ' VAL . 5.8 p90 -132.7 -73.09 0.51 Allowed 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.828 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.687 ' CG2' ' O ' ' A' ' 137' ' ' TYR . 2.8 m 93.78 152.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 125.686 1.866 . . . . 0.0 111.984 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -120.81 133.21 55.32 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.331 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . . . -94.08 93.71 7.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.007 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.448 ' CD1' ' H ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.35 20.03 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.034 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.454 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -115.93 -9.36 11.8 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.481 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 72.3 136.32 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.048 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.1 t80 -128.83 -43.22 1.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.854 0.359 . . . . 0.0 110.125 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 146' ' ' GLY . 21.9 t-20 41.62 62.49 1.54 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 145' ' ' ASN . . . -62.57 -122.43 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.478 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 1.0 OUTLIER 169.56 -65.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.879 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 150' ' ' GLU . 18.2 m-20 -53.81 142.65 23.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.783 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 31.2 p-10 -61.47 -1.2 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 148' ' ' ASP . 47.5 mt-10 -105.68 13.76 29.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.269 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 20.5 p30 -130.78 163.26 27.71 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.448 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 3.8 tp -104.35 91.71 4.17 Favored Pre-proline 0 C--O 1.211 -0.966 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.303 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.467 ' O ' ' OD2' ' A' ' 175' ' ' ASP . 72.7 Cg_endo -70.49 139.13 37.03 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 CA-C-N 120.825 1.33 . . . . 0.0 112.804 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.499 ' CD1' ' CB ' ' A' ' 140' ' ' ALA . 12.5 p90 -167.42 157.05 10.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -174.35 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.349 179.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -61.02 -3.28 0.75 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.265 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 155' ' ' LYS . . . 92.85 56.94 1.45 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 27.0 t0 -81.74 157.85 24.39 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.502 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' A' ' 159' ' ' ILE . 1.6 mp -98.63 98.12 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 137' ' ' TYR . 96.3 mt -91.83 94.13 9.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.128 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 52.8 tttp -68.87 132.44 46.74 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.518 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.22 142.81 15.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.27 -48.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.64 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -153.24 64.05 0.76 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.641 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.403 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 11.8 pttp -49.54 106.48 0.63 Allowed Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 119.402 -0.332 . . . . 0.0 110.787 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.79 -48.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.443 1.428 . . . . 0.0 112.438 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.02 172.75 6.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.775 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -85.51 -34.47 21.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.4 -15.57 45.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.468 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 48.1 m95 -131.46 151.53 51.48 Favored 'General case' 0 C--O 1.228 -0.074 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.422 ' O ' ' CG1' ' A' ' 183' ' ' ILE . 12.9 m0 -139.78 134.44 31.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.907 0.86 . . . . 0.0 112.496 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -91.55 101.03 13.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.27 -179.26 3.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.51 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.88 112.72 13.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.624 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.4 OUTLIER -63.81 140.58 58.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.951 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 95.2 mtp -47.85 -8.14 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.426 0.454 . . . . 0.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.624 ' H ' ' C ' ' A' ' 175' ' ' ASP . 96.6 m-20 -72.98 -21.78 60.79 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.667 0.746 . . . . 0.0 110.048 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.49 44.06 3.54 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.631 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -142.46 143.92 32.81 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.161 -0.519 . . . . 0.0 109.76 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.05 127.95 53.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.534 0.683 . . . . 0.0 110.964 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -156.07 153.1 24.48 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.361 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.54 152.79 44.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.468 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 1.3 pt -143.4 146.58 36.53 Favored Pre-proline 0 N--CA 1.455 -0.191 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.46 140.46 63.41 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.481 -1.392 . . . . 0.0 108.481 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 38.5 t -79.93 -37.9 1.14 Allowed Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.661 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 36.4 Cg_endo -68.88 -21.0 38.43 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.271 1.981 . . . . 0.0 112.914 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.1 m-85 -77.88 4.51 11.77 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.976 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.01 161.17 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.424 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 1.1 pp20? -146.35 153.58 40.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 13.4 tptm 103.76 85.52 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.276 1.03 . . . . 0.0 111.808 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.23 -11.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.31 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 4.2 mtt-85 175.56 -49.14 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 73.2 Cg_endo -81.55 -175.48 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.032 1.821 . . . . 0.0 111.576 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 77.4 p -147.07 -151.24 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.107 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 52.0 p -145.99 -55.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -39.45 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.726 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 68.0 m -64.49 148.95 49.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.274 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.82 100.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.725 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -166.55 136.05 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.462 ' CG2' ' H ' ' A' ' 201' ' ' LEU . 2.8 m 55.39 -133.0 1.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.567 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.462 ' H ' ' CG2' ' A' ' 200' ' ' THR . 63.2 mt -60.71 130.54 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.104 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 42.1 m -158.69 97.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.567 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 134.08 86.6 0.27 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.15 45.14 0.98 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -78.77 127.81 32.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 110.439 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -145.06 158.09 43.92 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.468 ' O ' ' OG ' ' A' ' 208' ' ' SER . 63.0 t0 -62.64 -55.02 30.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 207' ' ' ASP . 1.6 m -170.54 -54.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.9 t -94.27 122.48 36.85 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.574 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.6 ' N ' ' CD ' ' A' ' 211' ' ' PRO . 0.1 OUTLIER -76.36 -42.37 3.22 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.397 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 35.7 Cg_exo -60.09 144.54 99.47 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.757 2.305 . . . . 0.0 112.318 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.631 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 2.6 tp-100 -69.18 -38.91 11.65 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.499 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 37.5 Cg_exo -60.16 140.4 92.09 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.16 1.906 . . . . 0.0 111.826 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.33 -63.57 1.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -101.74 -66.36 0.78 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 174.78 60.5 0.05 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.9 -176.46 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.705 2.27 . . . . 0.0 111.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 1.2 tt0 -177.18 -43.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.151 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 28.0 Cg_exo -61.36 9.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.511 2.141 . . . . 0.0 112.344 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 218' ' ' GLU . . . 105.86 164.74 23.24 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.33 -177.74 3.49 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.601 2.201 . . . . 0.0 111.791 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 93.0 t80 -72.58 162.38 29.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.476 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -44.46 114.66 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 226' ' ' SER . 14.9 mt-30 -143.33 164.29 32.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.524 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.489 ' O ' ' OG ' ' A' ' 226' ' ' SER . 30.8 Cg_exo -61.33 57.1 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.444 2.096 . . . . 0.0 112.168 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.641 ' C ' ' H ' ' A' ' 228' ' ' ASN . 1.5 m 165.1 -4.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 227' ' ' ILE . 1.5 mp 61.34 -24.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.816 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.641 ' H ' ' C ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -172.92 174.64 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.704 ' H ' ' NE2' ' A' ' 275' ' ' GLN . 41.5 p -129.49 83.58 64.49 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -85.34 125.59 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.365 2.71 . . . . 0.0 112.924 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 231' ' ' LEU . 0.0 OUTLIER -134.63 162.77 55.71 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.719 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 233' ' ' ASN . 66.6 Cg_exo -51.77 -71.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 121.511 1.474 . . . . 0.0 113.163 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.528 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 5.3 t-20 153.38 174.52 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.736 ' O ' ' N ' ' A' ' 236' ' ' ASN . 29.2 tp -22.42 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.727 0.642 . . . . 0.0 110.006 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLN . . . . . 0.593 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 18.7 mm-40 22.3 -73.34 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 O-C-N 125.184 1.552 . . . . 0.0 111.254 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 234' ' ' LEU . 31.3 m120 -77.35 39.88 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.191 176.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 234' ' ' LEU . . . -165.11 134.41 3.31 Favored Glycine 1 CA--C 1.445 -4.322 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.061 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -71.56 97.49 0.15 OUTLIER 'Cis proline' 0 N--CA 1.529 3.615 0 CA-C-N 118.171 0.985 . . . . 0.0 112.134 -6.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 235' ' ' GLN . 4.3 m-85 -117.09 -134.34 0.34 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -146.19 137.54 24.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 118.986 0.812 . . . . 0.0 109.768 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -122.93 140.26 53.18 Favored 'General case' 0 C--O 1.195 -1.768 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.147 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -104.17 111.04 23.48 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.366 0.603 . . . . 0.0 110.704 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 3.1 p -79.63 127.46 39.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.141 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.44 15.74 7.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -174.08 112.21 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.633 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.518 ' HZ3' ' CB ' ' A' ' 287' ' ' PHE . 2.5 ttmt -165.13 -156.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.266 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.92 -138.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.134 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 248' ' ' VAL . 73.4 t -132.83 60.89 53.08 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 120.677 0.275 . . . . 0.0 111.194 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 18.0 Cg_endo -96.72 -170.82 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.479 2.119 . . . . 0.0 111.394 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.1 p-10 -157.9 153.34 26.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.142 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 256' ' ' ALA . . . -41.16 -11.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 254' ' ' LYS . 33.4 m-85 -73.83 -53.12 10.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 250' ' ' ASN . 35.9 t70 -53.58 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 125.813 1.946 . . . . 0.0 111.702 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' A' ' 252' ' ' TYR . 29.7 mtmt 82.33 -43.11 0.14 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.269 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.558 ' O ' ' ND1' ' A' ' 286' ' ' HIS . 0.1 OUTLIER 158.37 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.405 0.621 . . . . 0.0 110.029 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -109.95 165.01 12.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.864 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.452 ' N ' HD21 ' A' ' 257' ' ' LEU . 0.3 OUTLIER -114.77 151.78 33.2 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -178.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.423 ' HA ' ' HD2' ' A' ' 249' ' ' PRO . . . -88.64 113.66 24.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 258' ' ' ALA . 0.4 OUTLIER -143.28 174.57 10.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.798 177.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -142.95 148.84 37.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.386 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 73.3 t -52.65 99.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.957 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 127.79 -2.94 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.39 -163.25 1.03 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.072 0.463 . . . . 0.0 110.621 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 241' ' ' ALA . 0.0 OUTLIER -159.11 149.37 19.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.755 0.788 . . . . 0.0 111.117 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.542 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 7.0 p -133.48 141.48 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -74.26 176.01 7.06 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.915 ' O ' ' N ' ' A' ' 269' ' ' LYS . 18.4 t -119.29 -36.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.144 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.415 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 20.64 -55.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.904 1.378 . . . . 0.0 114.178 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.915 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -84.7 116.11 23.05 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.388 0.613 . . . . 0.0 111.853 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 270' ' ' ILE . 0.6 OUTLIER -136.92 154.1 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.501 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.536 ' O ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -174.69 158.37 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.99 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.534 ' O ' ' O ' ' A' ' 271' ' ' ASN . 3.9 mtm 52.52 162.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.462 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 p -88.98 27.94 1.26 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 229' ' ' THR . . . -149.07 -85.5 0.06 OUTLIER Glycine 0 C--O 1.209 -1.464 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.325 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.704 ' NE2' ' H ' ' A' ' 229' ' ' THR . 1.8 mp0 -61.99 168.78 3.0 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 178.1 -174.17 0.15 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.28 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -144.64 147.5 33.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.494 -1.685 . . . . 0.0 113.598 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -131.16 131.92 6.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.037 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 281' ' ' ASN . 6.2 tm-20 -103.45 125.14 49.86 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.541 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' CYS . . . . . 0.623 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -125.88 84.37 2.27 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.099 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE2' ' A' ' 279' ' ' GLU . 2.4 m120 76.36 21.49 1.39 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.086 -1.009 . . . . 0.0 110.654 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 104.21 -32.83 7.11 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.475 -0.329 . . . . 0.0 112.65 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.623 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.8 OUTLIER -63.06 60.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.954 0.407 . . . . 0.0 110.754 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 282' ' ' GLY . 52.8 mtt180 -60.86 162.25 7.08 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.527 0.68 . . . . 0.0 109.939 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.98 -170.68 43.46 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.634 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.7 p-80 -140.39 95.3 2.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.866 1.333 . . . . 0.0 112.654 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.518 ' CB ' ' HZ3' ' A' ' 246' ' ' LYS . 0.7 OUTLIER -101.23 129.38 27.15 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 113.714 -1.585 . . . . 0.0 109.646 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -50.55 153.91 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.367 1.378 . . . . 0.0 112.528 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.573 ' C ' ' H ' ' A' ' 291' ' ' HIS . 90.3 t80 -72.01 -3.55 23.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.431 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 67.8 p -55.63 10.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.676 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' A' ' 289' ' ' PHE . 1.2 p80 -176.19 68.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.625 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.07 153.73 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 294' ' ' LEU . 27.8 mmm-85 -130.98 66.32 1.54 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.401 0.143 . . . . 0.0 111.357 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 293' ' ' ARG . 11.3 mt -31.32 129.05 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.107 0.956 . . . . 0.0 112.499 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.17 -106.53 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.23 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 34.5 t0 -173.82 44.45 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 296' ' ' ASP . 7.6 tt0 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.136 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.3 p90 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.088 0.47 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.62 166.06 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.428 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -115.49 131.54 56.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.784 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -102.23 92.68 4.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.724 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.838 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -103.27 22.63 13.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.942 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 143' ' ' ASP . 65.3 m-85 -119.45 2.46 11.26 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.6 p30 55.39 138.76 0.0 OUTLIER 'General case' 0 C--O 1.21 -0.992 0 O-C-N 124.365 1.041 . . . . 0.0 110.422 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 6.7 t80 -127.99 -41.54 1.62 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.844 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 144' ' ' PHE . 39.3 t-20 36.21 59.22 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.478 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.02 -141.28 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.571 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 2.1 p30 166.8 88.28 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.413 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 3.6 m-20 171.97 -178.42 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.211 0.529 . . . . 0.0 110.33 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 149' ' ' ASP . 60.9 t0 -91.0 -20.4 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.388 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.26 25.81 9.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.693 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.7 p-10 -141.33 156.63 45.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.447 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 11.4 tp -120.17 82.31 30.06 Favored Pre-proline 0 C--O 1.216 -0.695 0 CA-C-O 120.755 0.312 . . . . 0.0 110.999 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.42 136.79 74.09 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 121.456 1.437 . . . . 0.0 112.108 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.784 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 10.6 p90 -152.09 165.14 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.524 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -175.86 102.93 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.795 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.577 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.5 tppp? 127.61 77.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.652 1.22 . . . . 0.0 110.959 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.71 49.73 0.02 OUTLIER Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 156' ' ' LYS . 28.7 t0 -72.91 144.87 47.19 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.922 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 159' ' ' ILE . 10.7 tp -104.17 109.54 27.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.37 122.79 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.675 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -77.91 141.84 38.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.91 139.13 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.7 tpt85 -117.9 -43.36 2.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.276 0.56 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.32 129.08 11.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.693 ' NZ ' ' HE1' ' A' ' 171' ' ' TRP . 0.1 OUTLIER -119.48 77.53 19.48 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.145 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.03 -44.36 50.47 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.295 1.996 . . . . 0.0 111.732 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.49 177.02 4.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.418 ' O ' HG21 ' A' ' 185' ' ' VAL . 25.2 mm-40 -96.57 -32.05 12.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.511 ' NE2' ' CZ ' ' A' ' 240' ' ' TYR . 85.2 mt-30 -77.17 -28.12 53.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.468 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.512 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 66.0 m95 -123.84 153.59 40.83 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.693 ' HE1' ' NZ ' ' A' ' 165' ' ' LYS . 17.4 m0 -143.65 136.7 27.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.4 108.03 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.44 168.32 9.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.957 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -126.63 138.36 53.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.894 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -68.09 174.56 3.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.302 0.572 . . . . 0.0 110.698 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ptm -79.88 -2.57 44.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.349 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -101.92 -28.25 12.51 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.6 48.69 0.45 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.57 132.56 49.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.671 -0.764 . . . . 0.0 109.568 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 125.86 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.322 0.582 . . . . 0.0 111.951 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.24 153.34 24.6 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.565 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 32.3 mtp -66.51 160.8 24.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.432 0.634 . . . . 0.0 110.817 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 8.3 pt -152.05 143.06 15.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.794 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -69.4 114.69 3.73 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.639 1.559 . . . . 0.0 110.013 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.645 HG22 ' CE3' ' A' ' 171' ' ' TRP . 27.0 t -49.98 -52.81 49.2 Favored Pre-proline 0 C--O 1.216 -0.673 0 O-C-N 121.927 -0.483 . . . . 0.0 111.69 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.6 Cg_endo -49.5 -24.71 9.48 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.147 1.898 . . . . 0.0 113.367 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.9 m-85 -74.54 3.72 7.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -134.86 162.29 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.729 ' HG3' HD11 ' A' ' 141' ' ' LEU . 39.3 mt-10 -81.28 -59.37 2.67 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.276 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 18.0 tptm . . . . . 0 C--N 1.345 0.393 0 O-C-N 124.515 1.134 . . . . 0.0 109.891 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.035 0.445 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -62.22 -165.29 0.44 Allowed Glycine 1 CA--C 1.447 -4.171 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.373 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.417 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.0 Cg_endo -46.78 98.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.767 0 N-CA-C 116.141 1.554 . . . . 0.0 116.141 0.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 10.3 m-30 -116.51 -132.09 0.32 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.511 ' CZ ' ' NE2' ' A' ' 169' ' ' GLN . 2.0 m-30 -136.34 115.88 12.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.67 0.748 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.524 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -106.85 140.81 39.09 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.943 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -103.91 97.71 7.66 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.8 p -63.74 127.21 23.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.142 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.636 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.3 pt -124.48 22.91 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.99 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.283 0.564 . . . . 0.0 110.159 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.828 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.7 ttmt -146.76 -146.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.31 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.444 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 0.6 OUTLIER -155.97 -145.53 0.16 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.626 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 248' ' ' VAL . 97.0 t -132.91 74.13 74.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.463 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.499 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 18.9 Cg_endo -91.65 169.93 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.036 2.491 . . . . 0.0 111.323 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.7 OUTLIER -127.12 127.34 44.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.792 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.07 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.856 0.722 . . . . 0.0 112.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.758 ' N ' ' O ' ' A' ' 250' ' ' ASN . 50.9 m-85 -91.76 -53.04 4.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 250' ' ' ASN . 42.1 t0 -41.24 -62.02 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.119 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.557 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.0 mttt -151.75 25.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.791 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.9 m 73.83 -18.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.589 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -43.95 108.69 0.12 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.633 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.969 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -47.48 159.85 0.13 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.826 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.21 119.01 38.25 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.091 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.828 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.2 mt -141.67 -175.17 4.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.222 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.6 tt0 -144.94 152.08 39.64 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.37 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.0 t -59.75 115.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.84 6.67 24.49 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 8.1 mm-40 -97.53 -139.76 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.032 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 175.37 139.99 0.05 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.404 0.621 . . . . 0.0 109.366 179.005 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.032 ' N ' HD12 ' A' ' 264' ' ' LEU . 12.5 p -128.1 152.77 36.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -103.83 88.15 2.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.541 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.58 124.36 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.153 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.401 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -116.57 -53.56 2.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.232 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -72.2 127.25 31.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.15 -178.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.45 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 0.8 OUTLIER -149.19 103.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.548 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -97.73 -88.53 0.3 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.492 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 38.1 mtm -67.07 178.73 1.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.062 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.4 p -98.95 16.63 21.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -130.54 -87.32 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.889 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -91.96 105.3 17.59 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.015 0.436 . . . . 0.0 110.935 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.543 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 4.6 p-90 -120.33 -164.95 1.13 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.0 mt-10 -123.99 163.21 21.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.861 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.74 -158.21 7.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.909 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -170.32 131.19 0.95 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -112.82 -92.86 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 283' ' ' LYS . 27.7 t-20 -101.4 54.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.95 3.81 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 281' ' ' ASN . 0.0 OUTLIER -61.41 90.4 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.774 -0.713 . . . . 0.0 110.144 -178.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 255' ' ' THR . 42.3 mtt85 -88.05 164.29 15.83 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 171.46 -157.46 27.95 Favored Glycine 0 C--O 1.213 -1.202 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.591 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 8.2 p80 -123.89 174.73 7.36 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.2 m-85 160.28 135.02 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.107 0 O-C-N 123.768 0.667 . . . . 0.0 111.731 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.53 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 23.7 Cg_exo -64.07 142.64 81.79 Favored 'Trans proline' 0 N--CA 1.507 2.297 0 C-N-CA 122.351 2.034 . . . . 0.0 112.25 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.819 ' CD1' HG21 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -76.23 2.63 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.277 179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 66.2 p -68.68 2.78 2.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.955 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 7.6 p80 -137.31 39.84 2.47 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.819 HG21 ' CD1' ' A' ' 289' ' ' PHE . 11.9 m -135.61 161.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 121.992 -0.442 . . . . 0.0 109.977 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.636 ' HE ' HD13 ' A' ' 244' ' ' ILE . 29.2 mtt180 -132.63 77.81 1.77 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.554 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 293' ' ' ARG . 84.3 mt -32.77 135.52 0.09 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.845 0.831 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.3 mp -84.34 -167.31 1.72 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.028 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -93.79 13.25 23.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.642 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 63.0 tt0 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.304 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.77 0.319 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 188' ' ' VAL . 6.3 m -140.67 172.17 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.421 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -131.26 136.37 48.13 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.317 0.58 . . . . 0.0 111.017 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.53 172.22 0.71 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.475 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.596 HD21 ' OE2' ' A' ' 189' ' ' GLU . 78.8 mt -140.35 -45.17 0.41 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.627 ' CE2' ' NH2' ' A' ' 284' ' ' ARG . 95.1 m-85 -113.49 9.59 18.07 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.825 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.534 ' CG ' ' HZ1' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 67.11 136.08 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.735 0.647 . . . . 0.0 109.337 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 9.1 t80 -112.64 -54.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.372 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.3 t30 49.99 55.14 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.523 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.491 ' C ' HD22 ' A' ' 147' ' ' ASN . . . -65.94 -124.95 0.01 OUTLIER Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.628 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 176.66 -90.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 81.0 m-20 -22.94 139.24 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -57.08 -7.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.528 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 148' ' ' ASP . 6.5 pt-20 -97.88 7.22 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.628 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 12.9 p30 -133.29 157.61 45.04 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 152' ' ' LEU . 9.2 tp -111.16 93.64 18.78 Favored Pre-proline 0 C--O 1.214 -0.814 0 CA-C-N 118.506 0.594 . . . . 0.0 111.095 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.404 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 95.5 Cg_endo -69.53 141.43 46.13 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 CA-C-N 120.567 1.238 . . . . 0.0 114.006 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 160' ' ' LEU . 20.3 p90 -159.13 159.72 34.78 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.67 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER -126.97 96.76 4.72 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.514 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.839 ' O ' ' N ' ' A' ' 158' ' ' ASP . 59.0 pttt 27.39 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.611 1.194 . . . . 0.0 110.739 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 30.9 13.74 0.0 OUTLIER Glycine 0 CA--C 1.541 1.69 0 N-CA-C 113.948 0.339 . . . . 0.0 113.948 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.839 ' N ' ' O ' ' A' ' 156' ' ' LYS . 17.3 t0 -85.36 155.88 21.12 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 117.08 0.44 . . . . 0.0 110.324 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.3 mm -125.58 106.2 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.689 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.435 HD11 ' CD2' ' A' ' 154' ' ' PHE . 23.6 mt -121.63 133.71 54.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -97.84 139.73 33.27 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -83.48 159.26 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.03 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -142.2 -43.73 0.33 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.283 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -136.52 113.58 10.54 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.54 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.428 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 14.3 pttm -112.71 74.07 1.6 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.77 -28.74 51.29 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.621 1.548 . . . . 0.0 111.881 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.9 162.69 18.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.667 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.85 -35.0 18.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.508 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 79.0 mt-30 -80.7 -22.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -124.75 153.87 41.76 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.54 ' CD2' HG22 ' A' ' 185' ' ' VAL . 11.2 m0 -145.83 138.16 25.51 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -86.06 106.89 17.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.08 6.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.761 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 30.3 tt0 -126.38 138.32 53.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.969 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.87 173.41 7.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.578 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.9 tpt -77.53 -0.94 28.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.21 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.456 ' HB3' ' NZ ' ' A' ' 179' ' ' LYS . 79.9 m-20 -102.66 -29.67 11.39 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.536 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.96 47.92 0.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 177' ' ' ASP . 9.8 mttp -128.66 135.88 49.88 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 114.105 -1.048 . . . . 0.0 108.982 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.35 123.34 50.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.412 0.625 . . . . 0.0 111.519 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -151.6 149.03 20.71 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.021 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 151.27 46.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 111.174 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.05 145.77 37.42 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -74.44 112.9 3.66 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.42 1.413 . . . . 0.0 109.438 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.54 HG22 ' CD2' ' A' ' 171' ' ' TRP . 51.7 t -48.62 -51.56 51.73 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -45.74 -31.38 7.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.077 1.852 . . . . 0.0 113.096 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.479 ' OH ' ' O ' ' A' ' 268' ' ' THR . 9.6 m-85 -69.4 -6.66 31.51 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.089 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 138' ' ' VAL . 1.2 m -129.93 163.66 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.596 ' OE2' HD21 ' A' ' 141' ' ' LEU . 1.1 pt-20 -117.4 -51.73 2.5 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.224 1.41 . . . . 0.0 110.003 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.37 0.129 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 136.72 -165.84 24.97 Favored Glycine 1 CA--C 1.448 -4.155 0 CA-C-O 121.72 0.622 . . . . 0.0 113.52 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 1.9 Cg_endo -47.41 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.535 3.918 0 N-CA-C 116.701 1.769 . . . . 0.0 116.701 1.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.568 ' CG ' ' OE1' ' A' ' 297' ' ' GLN . 11.6 m-30 -118.23 -134.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.31 129.5 19.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.248 0.931 . . . . 0.0 109.246 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.778 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -102.04 -162.34 0.92 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.464 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -157.34 92.84 1.27 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.19 129.37 27.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.741 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.447 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.2 pt -129.5 18.31 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.214 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 178.06 101.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.374 0.607 . . . . 0.0 110.053 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.3 ttmt -144.89 -142.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.489 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.0 ptt85 -153.77 -142.02 0.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.994 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 248' ' ' VAL . 54.3 t -133.62 69.3 76.44 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 110.85 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.607 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 59.0 Cg_endo -91.2 177.0 2.08 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.838 2.359 . . . . 0.0 110.762 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.724 ' O ' ' N ' ' A' ' 252' ' ' TYR . 1.3 p-10 -144.26 139.01 28.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -36.51 -10.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.399 0.619 . . . . 0.0 112.305 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.724 ' N ' ' O ' ' A' ' 250' ' ' ASN . 6.6 m-85 -89.51 -50.27 6.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 250' ' ' ASN . 25.7 t0 -62.71 60.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.624 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 252' ' ' TYR . 32.6 mtmt 82.53 15.78 0.4 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.167 0.917 . . . . 0.0 111.061 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.485 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.5 m 80.88 -17.93 0.53 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.675 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.02 109.15 0.11 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.958 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.16 156.06 0.6 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.521 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.867 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.04 122.14 46.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.5 mt -142.07 -178.81 5.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.886 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 6.1 tt0 -143.44 149.93 38.3 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.936 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.73 114.78 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.428 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 107.29 7.82 32.0 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 57.8 mm-40 -93.53 -127.62 0.11 Allowed 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.082 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 165.97 139.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.031 0.919 . . . . 0.0 110.336 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.082 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.5 p -134.75 155.6 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.56 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 265' ' ' VAL . 0.2 OUTLIER -85.31 -158.5 0.38 Allowed 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.726 ' O ' ' N ' ' A' ' 269' ' ' LYS . 0.9 OUTLIER -142.65 -44.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.075 176.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER 35.14 -72.93 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -74.35 123.6 24.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.975 -177.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 162.31 36.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.827 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 272' ' ' MET . 4.8 p30 -156.46 -98.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.526 0.679 . . . . 0.0 110.359 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 274' ' ' GLY . 34.8 mtm -55.16 152.89 7.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.601 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.9 p -71.58 15.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.539 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.71 -73.63 0.04 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.441 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 13.4 mp0 -78.89 166.02 22.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.896 0.379 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.539 ' NE1' ' O ' ' A' ' 274' ' ' GLY . 1.5 p-90 177.81 179.49 0.3 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.617 0.723 . . . . 0.0 110.711 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 2.6 mt-10 -107.92 -178.53 3.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.607 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -157.72 -165.84 16.04 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.462 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -163.55 123.44 2.15 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.411 0.624 . . . . 0.0 112.269 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -133.75 74.0 1.53 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.354 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 14.3 t-20 83.99 37.08 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.644 0.735 . . . . 0.0 109.676 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 93.34 -36.07 3.87 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.032 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -64.61 86.16 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.355 0.598 . . . . 0.0 110.264 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.627 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 77.4 mtt180 -86.27 170.13 12.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.508 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.505 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 169.23 -151.12 16.81 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -130.18 176.77 7.82 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.0 OUTLIER 157.99 112.83 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 123.461 0.476 . . . . 0.0 110.026 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -54.8 148.05 47.82 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.375 2.05 . . . . 0.0 112.906 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.567 ' CD2' HG23 ' A' ' 292' ' ' VAL . 0.4 OUTLIER -66.49 -2.63 4.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.804 0.335 . . . . 0.0 110.303 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.0 p -47.7 -5.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 289' ' ' PHE . 0.3 OUTLIER -155.71 75.15 0.9 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -163.12 159.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.447 ' HE ' HD13 ' A' ' 244' ' ' ILE . 37.5 mtt180 -126.52 76.37 1.62 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.743 0.306 . . . . 0.0 110.318 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 48.3 mt -39.36 127.48 1.82 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.137 0.97 . . . . 0.0 112.019 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 -172.37 2.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.098 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -110.72 48.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.823 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.568 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 34.1 tp60 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.371 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 48.5 p90 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 120.667 0.27 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 160' ' ' LEU . 30.2 m -131.39 165.02 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.533 ' NE ' ' OE2' ' A' ' 189' ' ' GLU . 12.7 ttp180 -122.62 136.94 55.02 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.747 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -103.85 90.81 3.74 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.566 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.504 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -103.52 38.3 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 58.8 m-85 -133.76 -0.16 3.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.958 -0.464 . . . . 0.0 111.038 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 59.47 136.94 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.131 0.894 . . . . 0.0 109.477 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 8.5 t80 -126.5 -48.0 1.56 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.641 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 46.59 58.31 4.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.23 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.483 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -65.45 -128.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.607 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 1.2 p30 164.43 -41.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.579 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 7.9 m-20 -73.95 140.33 45.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 112.034 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -49.9 -21.35 1.14 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.428 ' N ' ' C ' ' A' ' 148' ' ' ASP . 77.9 mt-10 -91.27 29.4 1.44 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.528 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.607 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 31.6 p30 -153.11 171.68 18.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.555 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 175' ' ' ASP . 14.6 tp -126.24 87.72 55.67 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.788 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.483 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 57.8 Cg_endo -64.17 143.19 83.21 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 CA-C-N 121.073 1.419 . . . . 0.0 113.858 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 160' ' ' LEU . 12.6 p90 -167.76 172.4 9.21 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.657 0.741 . . . . 0.0 111.485 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -150.29 -165.0 2.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.239 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.747 ' O ' ' O ' ' A' ' 140' ' ' ALA . 17.9 ptpt 41.36 -145.81 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -109.13 49.39 0.85 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 37.4 t0 -52.86 154.04 3.02 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.4 mp -100.24 99.27 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.517 ' O ' HG22 ' A' ' 138' ' ' VAL . 66.7 mt -102.33 90.47 3.91 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.473 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -69.04 147.1 52.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.967 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.1 mp -80.44 131.25 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.05 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.617 ' NH2' HD21 ' A' ' 172' ' ' ASN . 13.1 ttm180 -85.85 -43.09 13.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.212 0.529 . . . . 0.0 110.909 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 164' ' ' ASP . 38.2 t0 -153.58 -24.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.326 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.472 ' HE2' ' HE1' ' A' ' 171' ' ' TRP . 12.7 tttm 59.48 99.25 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -85.56 -44.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.989 1.793 . . . . 0.0 111.732 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.98 174.91 6.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -88.49 -38.46 14.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.972 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.524 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 95.5 mt-30 -80.38 -15.47 56.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.566 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.44 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 64.5 m95 -131.49 154.63 48.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.527 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.5 m0 -143.37 133.37 24.19 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.617 HD21 ' NH2' ' A' ' 163' ' ' ARG . 47.3 t-20 -85.02 117.79 24.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.84 178.7 6.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.734 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.5 111.28 15.51 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -60.88 140.37 57.71 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.19 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.2 ttt -52.1 -0.74 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.607 ' H ' ' C ' ' A' ' 175' ' ' ASP . 86.5 m-20 -84.82 -23.02 29.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.394 0.616 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.52 41.24 2.78 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.105 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -139.85 142.23 36.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.033 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.64 130.29 49.49 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.474 0.654 . . . . 0.0 111.525 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . 0.494 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -162.77 159.57 31.94 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.437 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 mtp -69.84 149.58 47.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.137 0.494 . . . . 0.0 111.199 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.494 HG22 ' HB3' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -134.57 141.55 39.32 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.724 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.38 119.05 5.89 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 N-CA-C 108.073 -1.549 . . . . 0.0 108.073 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.819 ' O ' HG22 ' A' ' 188' ' ' VAL . 35.7 t -54.2 -50.63 83.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.8 Cg_endo -50.9 -27.84 22.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.185 1.924 . . . . 0.0 112.873 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.0 m-85 -71.32 4.91 2.53 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.38 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.7 m -130.7 163.02 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.699 0.285 . . . . 0.0 110.596 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.533 ' OE2' ' NE ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -76.31 -71.45 0.39 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.677 -178.265 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 O-C-N 123.974 0.796 . . . . 0.0 110.614 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.554 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 5.9 p30 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.2 -165.04 40.8 Favored Glycine 1 CA--C 1.439 -4.675 0 CA-C-O 122.306 0.948 . . . . 0.0 113.944 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.411 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.6 Cg_endo -44.43 102.73 0.03 OUTLIER 'Cis proline' 1 N--CA 1.538 4.114 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -0.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 10.5 m-30 -115.27 -124.37 0.29 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.6 OUTLIER -143.71 130.93 20.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 119.667 1.121 . . . . 0.0 109.83 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.773 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.04 -168.03 1.38 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.618 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.37 93.99 1.35 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.8 p -69.0 123.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.347 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.96 9.08 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.041 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.581 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.8 mm-40 -168.61 128.03 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.311 0.576 . . . . 0.0 109.504 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.4 ttmt -170.51 -144.39 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.862 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.1 ptt85 -160.48 -136.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.507 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.428 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 3.7 t -137.01 61.95 37.18 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.667 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.679 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -102.1 70.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.806 3.004 . . . . 0.0 112.081 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.573 ' C ' ' H ' ' A' ' 252' ' ' TYR . 3.4 p30 -47.78 158.53 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.581 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.54 -3.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.897 0.38 . . . . 0.0 111.767 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.73 ' O ' ' N ' ' A' ' 254' ' ' LYS . 30.1 m-85 -80.15 -59.04 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 42.9 t0 -47.14 60.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 125.653 1.846 . . . . 0.0 112.179 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 252' ' ' TYR . 34.0 mtmt 87.49 -51.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.961 1.413 . . . . 0.0 109.422 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 4.4 m 164.29 -17.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.175 0.922 . . . . 0.0 110.373 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.537 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -45.16 170.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.573 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.781 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.4 OUTLIER -109.54 150.26 28.42 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.778 0.431 . . . . 0.0 110.563 -177.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.751 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -97.17 116.59 29.64 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 122.07 -0.394 . . . . 0.0 111.119 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.803 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.2 mt -137.58 -172.59 3.27 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.74 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 15.3 tt0 -145.56 147.43 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.043 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.581 HG22 ' HA ' ' A' ' 245' ' ' GLN . 68.8 t -54.73 97.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.888 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 122.15 10.26 6.29 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 56.2 mm-40 -91.81 -130.64 0.11 Allowed 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.063 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 166.32 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.063 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.1 p -127.41 142.75 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.466 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.519 ' O ' HG22 ' A' ' 268' ' ' THR . 2.9 ttmm -99.04 84.15 3.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.56 150.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.518 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 266' ' ' LYS . 0.2 OUTLIER -148.25 -47.68 0.16 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.579 -178.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 5.6 tppt? -84.05 151.73 24.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.36 134.19 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.407 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.531 ' O ' ' CE3' ' A' ' 276' ' ' TRP . 43.3 p-10 -177.31 -170.57 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.135 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 275' ' ' GLN . 0.0 OUTLIER 60.39 -143.32 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.687 178.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.3 p -137.04 -4.35 1.94 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.734 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 275' ' ' GLN . . . 177.74 13.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 118.924 -1.608 . . . . 0.0 112.517 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 2.8 mp0 -101.28 -74.76 0.61 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 271' ' ' ASN . 9.9 m95 76.63 169.01 0.25 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 75.0 mt-10 -131.95 143.06 49.84 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.543 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -136.68 145.34 17.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 121.853 0.696 . . . . 0.0 113.599 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.64 130.8 55.32 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 113.945 -1.127 . . . . 0.0 110.674 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.713 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -110.55 -90.84 0.47 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -104.54 50.56 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 89.92 -31.04 5.49 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.1 OUTLIER -63.91 75.68 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.284 -0.958 . . . . 0.0 111.156 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 282' ' ' GLY . 50.9 mtt180 -71.92 160.89 31.77 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.357 0.599 . . . . 0.0 110.344 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 173.54 -161.71 32.48 Favored Glycine 0 C--O 1.217 -0.928 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.537 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 41.1 p-80 -130.04 168.8 16.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.223 0.535 . . . . 0.0 110.801 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 173.47 116.13 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.239 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 290' ' ' THR . 52.7 Cg_exo -51.45 149.91 16.67 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.805 1.67 . . . . 0.0 111.915 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.5 OUTLIER -61.11 -4.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 288' ' ' PRO . 31.9 p -46.95 -9.25 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.89 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.78 ' O ' HG13 ' A' ' 292' ' ' VAL . 4.5 p-80 -153.96 84.6 1.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.325 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.1 OUTLIER -172.68 152.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -106.14 -45.61 4.28 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 32.1 mt 77.39 113.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 122.069 0.938 . . . . 0.0 111.451 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.78 -174.54 4.81 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.265 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.423 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 67.1 t0 -106.64 58.79 0.64 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 53.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.948 ' O ' HG22 ' A' ' 138' ' ' VAL . 98.3 m-85 . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.948 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 82.74 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 125.109 1.506 . . . . 0.0 111.156 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -135.63 144.69 46.22 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.838 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.708 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -100.32 96.57 7.53 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.599 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.783 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -96.99 37.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.914 0.388 . . . . 0.0 111.467 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.539 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 49.5 m-85 -137.35 1.98 2.46 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.684 0.278 . . . . 0.0 110.793 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER 60.21 143.32 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.495 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.515 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 5.4 t80 -133.62 -34.92 1.01 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.545 0.611 . . . . 0.0 110.951 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 145' ' ' ASN . 2.5 p-10 34.42 59.89 0.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.645 0.591 . . . . 0.0 110.663 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.73 -139.8 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.481 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 1.7 p30 165.04 94.14 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.667 -0.766 . . . . 0.0 110.844 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 4.6 m-20 158.63 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.112 0.482 . . . . 0.0 110.2 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.17 -17.35 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.361 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -100.44 18.23 19.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.453 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.3 p30 -142.41 156.75 45.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.733 HD11 ' OD2' ' A' ' 175' ' ' ASP . 9.8 tp -121.63 85.83 44.27 Favored Pre-proline 0 C--O 1.212 -0.891 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.26 137.27 79.71 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 C-N-CA 121.586 1.524 . . . . 0.0 112.87 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.708 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 7.1 p90 -154.01 170.03 22.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -135.82 -68.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -94.96 92.62 6.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.249 -176.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 17.35 55.42 0.01 OUTLIER Glycine 0 C--N 1.34 0.806 0 O-C-N 123.812 0.695 . . . . 0.0 112.041 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 156' ' ' LYS . 32.9 t0 -63.08 142.82 58.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.576 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.5 mp -87.31 101.87 11.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 31.0 mt -92.14 -127.56 0.1 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.356 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 174' ' ' GLU . 40.9 tttp 173.28 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.678 0.611 . . . . 0.0 110.399 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -90.23 145.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.49 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -134.11 -39.8 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.38 104.97 6.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.856 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.463 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 12.9 pttm -113.22 74.94 2.07 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.79 -30.19 22.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.995 1.797 . . . . 0.0 112.227 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.16 158.92 17.82 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.612 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -87.09 -37.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.736 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -78.94 -29.52 44.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.621 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.466 ' CZ2' ' HD2' ' A' ' 238' ' ' PRO . 77.4 m95 -117.27 150.95 37.93 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.521 ' CE3' HG22 ' A' ' 185' ' ' VAL . 8.8 m0 -145.91 136.33 24.01 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.8 112.15 16.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.47 166.62 10.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.069 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 161' ' ' LYS . 27.4 tt0 -129.31 145.95 51.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.012 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.733 ' OD2' HD11 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -76.58 -178.93 4.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.664 0.745 . . . . 0.0 110.73 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.4 ttt -80.11 -11.45 59.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.0 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -100.94 -25.48 14.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.1 43.67 0.51 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -117.56 126.16 52.09 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.783 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.68 42.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.456 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -150.59 148.52 19.79 Favored Glycine 0 C--N 1.312 -0.793 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.875 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 159.67 20.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.44 0.638 . . . . 0.0 110.656 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 7.8 pt -150.49 142.48 15.61 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.732 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.33 110.76 3.04 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 N-CA-C 109.852 -0.865 . . . . 0.0 109.852 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 188' ' ' VAL . 50.3 t -44.6 -51.58 20.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.613 -0.679 . . . . 0.0 112.048 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.8 Cg_endo -47.26 -29.3 9.21 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.146 1.898 . . . . 0.0 112.841 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.447 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.2 m-85 -69.73 -6.33 31.16 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.058 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 185' ' ' VAL . 25.0 m -129.53 167.22 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 111.007 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.783 ' CD ' HD21 ' A' ' 141' ' ' LEU . 4.4 pt-20 -150.22 61.19 0.97 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 110.938 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt . . . . . 0 C--N 1.315 -0.909 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.035 179.659 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 120.892 0.377 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -34.72 160.27 0.01 OUTLIER Glycine 1 CA--C 1.45 -4.021 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.951 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.482 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 3.1 Cg_exo -73.24 126.08 11.46 Favored 'Cis proline' 0 C--N 1.285 -2.799 0 O-C-N 122.3 0.632 . . . . 0.0 113.071 -5.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.49 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 40.9 m-85 -153.71 -124.62 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.518 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 2.2 m-30 -140.7 113.21 8.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 118.752 0.705 . . . . 0.0 109.71 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.707 ' HB2' HD23 ' A' ' 294' ' ' LEU . . . -105.65 144.48 32.34 Favored 'General case' 0 C--O 1.2 -1.515 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -101.1 112.52 25.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.19 0.519 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.5 p -79.05 122.26 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.74 21.51 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.72 104.54 0.02 OUTLIER 'General case' 0 N--CA 1.46 0.064 0 CA-C-O 121.525 0.678 . . . . 0.0 111.154 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.833 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -139.99 -140.11 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.743 178.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.1 ptt85 -157.2 -139.61 0.07 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.834 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 248' ' ' VAL . 80.4 t -135.94 69.36 64.51 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.985 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 256' ' ' ALA . 45.4 Cg_endo -96.28 -179.72 0.48 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.976 2.45 . . . . 0.0 111.208 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.709 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.8 OUTLIER -141.99 137.2 31.0 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.683 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.43 -5.51 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.303 0.377 . . . . 0.0 111.504 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.709 ' N ' ' O ' ' A' ' 250' ' ' ASN . 51.2 m-85 -93.41 -55.79 3.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.14 71.76 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.998 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 252' ' ' TYR . 30.9 mtmt 74.91 -5.22 2.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 124.343 1.027 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.53 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 0.3 OUTLIER 87.24 51.88 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.398 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 249' ' ' PRO . . . -104.71 113.87 27.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.865 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -49.26 155.21 0.72 Allowed 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.922 -0.486 . . . . 0.0 111.444 -179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.662 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -106.5 114.51 28.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.633 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.833 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.8 OUTLIER -136.56 -173.94 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.337 0.589 . . . . 0.0 111.328 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.2 tt0 -146.26 152.07 38.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.786 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.401 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 54.3 t -56.96 115.14 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.66 10.33 17.03 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 23.0 mm-40 -107.56 -152.49 0.48 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.874 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER -171.89 152.31 2.97 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.994 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.874 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.3 p -135.8 156.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.428 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.62 99.29 9.84 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 268' ' ' THR . 10.7 t -65.81 156.85 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.447 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -158.25 -62.42 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.152 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -80.42 141.67 35.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -177.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.9 OUTLIER -140.59 147.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.288 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -176.53 -159.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.5 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.407 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 47.7 mtm 52.1 -120.66 1.7 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.886 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.8 p -135.48 -10.65 2.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.237 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . 177.69 -46.39 0.1 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.559 -1.781 . . . . 0.0 113.126 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.433 ' N ' ' CD ' ' A' ' 275' ' ' GLN . 24.2 mp0 -65.79 64.39 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 3.1 p-90 -74.66 -171.95 1.4 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.171 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 86.0 mt-10 -108.61 166.9 10.44 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.535 1.147 . . . . 0.0 111.618 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -149.18 -170.81 17.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.896 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.449 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -157.08 127.68 6.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.304 0.574 . . . . 0.0 111.655 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.636 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -138.94 74.28 1.47 Allowed 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.302 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 7.2 m-20 85.74 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.731 0.777 . . . . 0.0 109.33 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.09 -33.73 4.37 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.78 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.03 93.64 0.59 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.449 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 83.9 mtt180 -94.75 168.46 10.81 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.438 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.548 ' O ' HD22 ' A' ' 257' ' ' LEU . . . 162.95 137.53 2.21 Favored Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.994 177.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 277' ' ' GLU . 2.7 p80 -65.06 175.31 1.62 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.142 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.614 ' CZ ' ' HB1' ' A' ' 256' ' ' ALA . 0.3 OUTLIER 166.21 144.53 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.408 178.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 39.9 Cg_exo -55.28 137.99 78.43 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.436 2.091 . . . . 0.0 113.331 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 2.0 t80 -73.77 -5.8 43.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.253 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 34.8 p -67.72 2.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 8.5 p80 -136.32 47.51 2.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.417 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.427 HG13 ' HD1' ' A' ' 291' ' ' HIS . 0.9 OUTLIER -149.3 151.37 13.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -111.01 -53.8 2.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.707 HD23 ' HB2' ' A' ' 241' ' ' ALA . 2.0 mt 91.27 119.73 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.324 1.059 . . . . 0.0 111.346 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 297' ' ' GLN . 8.7 mp -70.46 -170.59 0.4 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 296' ' ' ASP . 40.8 t0 -66.51 9.4 0.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 295' ' ' LEU . 40.6 tt0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.897 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.7 m-85 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 137' ' ' TYR . 2.3 m 93.12 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 125.682 1.864 . . . . 0.0 111.59 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -121.35 125.67 47.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.744 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -98.9 95.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.331 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.648 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -106.1 35.05 3.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.755 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 47.6 m-85 -134.26 0.85 3.14 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.29 -0.256 . . . . 0.0 111.029 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.89 137.95 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.66 0 O-C-N 124.281 0.988 . . . . 0.0 108.786 -178.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 8.6 t80 -121.54 -47.89 2.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.092 0.406 . . . . 0.0 110.399 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 144' ' ' PHE . 65.7 t30 40.97 60.9 1.87 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.213 0.53 . . . . 0.0 109.958 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.17 -155.55 1.41 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.722 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.629 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.9 p30 169.62 94.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.188 -1.006 . . . . 0.0 110.27 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -159.97 -146.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 111.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 58.7 p30 -75.86 57.51 1.05 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.581 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 151' ' ' ASP . 92.2 mt-10 98.01 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.402 1.064 . . . . 0.0 111.496 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.629 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 14.1 p-10 -28.91 161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.681 0.613 . . . . 0.0 110.705 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.491 HD23 HG21 ' A' ' 183' ' ' ILE . 13.8 tp -106.72 75.34 0.39 Allowed Pre-proline 0 C--O 1.215 -0.758 0 O-C-N 122.075 -0.391 . . . . 0.0 111.117 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.75 118.72 5.81 Favored 'Trans proline' 0 C--N 1.295 -2.255 0 CA-C-N 119.386 0.816 . . . . 0.0 110.968 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.744 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 15.5 p90 -134.25 163.6 29.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.416 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.411 ' CG ' ' H ' ' A' ' 156' ' ' LYS . 1.1 tpmp? -96.13 -135.35 0.23 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 158' ' ' ASP . 50.8 mtmt -96.56 174.94 6.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 159' ' ' ILE . . . 33.11 22.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.873 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.634 ' N ' ' O ' ' A' ' 156' ' ' LYS . 6.3 t0 -72.69 137.46 46.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 117.257 0.528 . . . . 0.0 109.816 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -104.06 103.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.7 mt -108.35 107.93 18.7 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.065 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -62.89 140.12 58.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.34 130.95 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.165 0.507 . . . . 0.0 110.409 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -44.07 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -155.1 133.2 11.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.535 ' HG3' ' NE1' ' A' ' 171' ' ' TRP . 2.6 ttmm -106.42 70.55 0.24 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.698 -0.191 . . . . 0.0 110.727 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.25 -54.74 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.165 1.244 . . . . 0.0 111.495 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -100.78 -172.8 2.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.18 -32.88 7.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.57 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 94.2 mt-30 -83.29 -31.32 26.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.497 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 81.2 m95 -119.59 148.03 43.8 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.567 ' CE3' HG22 ' A' ' 185' ' ' VAL . 14.1 m0 -141.72 131.33 24.0 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 120.857 0.36 . . . . 0.0 110.104 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -81.12 105.73 12.56 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.25 174.91 5.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.047 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -123.24 130.53 52.87 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.99 165.55 0.94 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.197 0.522 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 49.8 ttp -74.07 -4.48 35.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.047 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.15 -27.85 14.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.25 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.89 48.37 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 108.279 -1.929 . . . . 0.0 108.279 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -128.07 129.0 45.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.929 -0.636 . . . . 0.0 109.678 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 125.79 49.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.344 0.593 . . . . 0.0 111.869 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -165.26 160.66 34.04 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.522 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.483 ' C ' HG22 ' A' ' 183' ' ' ILE . 0.2 OUTLIER -68.02 160.25 29.13 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.159 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.868 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -159.66 148.12 13.68 Favored Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.572 177.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.53 122.44 8.61 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.659 1.573 . . . . 0.0 109.253 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.829 ' O ' HG22 ' A' ' 188' ' ' VAL . 42.7 t -58.68 -52.18 76.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.672 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.5 Cg_endo -50.78 -27.25 19.68 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.794 2.329 . . . . 0.0 114.498 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.431 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 5.2 m-85 -65.2 7.8 0.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.812 0.339 . . . . 0.0 111.483 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 185' ' ' VAL . 3.1 m -132.69 173.08 15.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.648 ' CD ' HD21 ' A' ' 141' ' ' LEU . 1.9 pt-20 -141.64 39.87 1.7 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.973 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 189' ' ' GLU . 13.4 mptt . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 110.57 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.596 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 95.0 m-20 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.68 -163.38 39.21 Favored Glycine 1 CA--C 1.446 -4.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.091 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.404 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 3.5 Cg_exo -45.38 100.17 0.03 OUTLIER 'Cis proline' 0 N--CA 1.528 3.519 0 N-CA-C 117.152 1.943 . . . . 0.0 117.152 1.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.634 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 11.2 m-30 -116.26 -128.23 0.29 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.57 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.47 128.64 19.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 119.435 1.016 . . . . 0.0 109.805 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.801 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.16 -162.37 0.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.314 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -160.85 95.81 1.09 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.92 128.68 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.711 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.978 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -123.17 12.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.699 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 261' ' ' VAL . 2.4 mm-40 -169.06 114.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.836 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.4 ttmt -160.78 -145.66 0.12 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -155.48 -140.15 0.08 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.531 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 248' ' ' VAL . 6.4 p -134.47 65.24 67.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.568 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 78.6 Cg_endo -91.91 176.47 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.339 2.026 . . . . 0.0 112.075 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.703 ' O ' ' N ' ' A' ' 252' ' ' TYR . 16.9 p30 -149.26 145.21 26.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.712 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.41 -3.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.703 ' N ' ' O ' ' A' ' 250' ' ' ASN . 48.0 m-85 -91.5 -54.09 4.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.481 0.658 . . . . 0.0 110.291 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -46.11 -66.52 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.652 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 256' ' ' ALA . 27.7 mttt -148.26 33.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.275 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.413 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 3.6 m 70.9 -13.61 0.49 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.689 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.07 164.41 0.29 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.261 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.797 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -104.07 149.53 25.12 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 122.794 0.438 . . . . 0.0 110.533 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.801 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -86.81 114.55 23.57 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.836 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.3 mt -139.9 -177.0 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.447 0.641 . . . . 0.0 111.007 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.3 tt0 -145.83 147.48 31.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 245' ' ' GLN . 71.9 t -54.55 102.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.96 6.11 10.34 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 65.7 mm-40 -88.32 -125.25 0.05 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 161.23 140.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.079 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.7 p -130.89 140.66 48.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.175 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -99.3 86.01 3.31 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.992 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.4 152.58 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.669 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.431 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -154.37 -53.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.62 127.89 33.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.787 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -137.37 127.49 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.997 0.903 . . . . 0.0 111.913 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.568 ' O ' ' CZ3' ' A' ' 276' ' ' TRP . 15.9 p30 -154.66 -167.96 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.549 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.474 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 44.7 mtm 65.41 -123.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.89 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.3 p -140.37 -5.76 1.22 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.028 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 276' ' ' TRP . . . -175.57 -52.13 0.06 OUTLIER Glycine 0 C--O 1.213 -1.203 0 C-N-CA 118.138 -1.982 . . . . 0.0 112.737 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.474 ' O ' ' HE3' ' A' ' 272' ' ' MET . 5.9 tp-100 -61.34 63.9 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.59 ' N ' ' O ' ' A' ' 274' ' ' GLY . 6.4 m95 -67.41 177.93 1.74 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.518 -0.739 . . . . 0.0 111.097 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 59.1 mt-10 -130.26 156.39 44.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -133.36 -142.28 4.74 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.964 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.479 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.1 tt0 -169.35 134.32 1.48 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.925 -0.638 . . . . 0.0 112.559 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.707 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -146.61 72.24 1.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.157 -178.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 18.2 t-20 83.27 31.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.361 0.6 . . . . 0.0 110.04 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.68 -33.43 5.71 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.134 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 13.2 ptpt -67.87 75.44 0.2 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.033 0.444 . . . . 0.0 110.991 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.542 ' NH1' ' CZ ' ' A' ' 142' ' ' PHE . 93.4 mtt180 -73.01 170.49 14.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.98 -155.13 26.04 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.3 p80 -136.36 176.51 8.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.129 0.572 . . . . 0.0 109.738 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.3 OUTLIER 171.27 125.09 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.223 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.86 147.94 2.98 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.666 1.578 . . . . 0.0 113.559 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.518 ' C ' ' H ' ' A' ' 291' ' ' HIS . 1.6 t80 -73.75 -5.13 38.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.1 p -60.05 5.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.266 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.749 ' O ' HG13 ' A' ' 292' ' ' VAL . 7.4 p-80 -157.33 72.93 0.71 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.5 OUTLIER -165.9 148.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.425 ' HG3' HD12 ' A' ' 244' ' ' ILE . 14.3 mtp180 -126.36 74.38 1.45 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.799 0.333 . . . . 0.0 110.746 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 41.9 mt -40.68 127.06 2.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 112.004 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 4.9 mp -77.31 -174.52 3.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.277 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -96.71 25.7 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.074 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.634 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 56.2 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.71 172.47 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -126.78 127.9 45.76 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.757 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -96.89 93.05 6.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.672 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.4 36.1 1.82 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.284 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.637 ' CZ ' ' NH2' ' A' ' 284' ' ' ARG . 52.0 m-85 -136.31 2.31 2.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 122.39 -0.194 . . . . 0.0 110.933 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.3 p30 56.87 141.63 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 O-C-N 124.471 1.107 . . . . 0.0 109.596 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 10.5 t80 -134.41 -44.22 0.76 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.243 0.474 . . . . 0.0 110.165 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 144' ' ' PHE . 5.1 p-10 33.85 62.25 0.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.846 0.716 . . . . 0.0 110.619 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.407 ' N ' ' HB3' ' A' ' 153' ' ' PRO . . . -64.82 -135.82 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.689 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 168.03 90.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.612 -0.294 . . . . 0.0 111.049 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.5 m-20 168.4 -170.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 150' ' ' GLU . 40.3 p-10 -93.53 -23.24 18.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.463 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 19.0 pt-20 -103.6 23.11 13.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.109 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.689 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 4.0 p-10 -131.58 148.37 52.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.2 tp -116.17 86.29 16.98 Favored Pre-proline 0 C--O 1.217 -0.649 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.407 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 53.6 Cg_endo -65.12 140.04 63.49 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.317 1.345 . . . . 0.0 112.825 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.757 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 10.6 p90 -158.0 160.21 37.23 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.63 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -63.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.553 0.692 . . . . 0.0 111.748 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 158' ' ' ASP . 2.5 ptmt -85.06 92.61 8.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.76 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 13.87 53.59 0.01 OUTLIER Glycine 0 N--CA 1.473 1.154 0 O-C-N 124.054 0.846 . . . . 0.0 112.287 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 156' ' ' LYS . 9.6 t70 -64.47 143.01 58.22 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.445 0.641 . . . . 0.0 109.583 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 mm -88.5 107.8 18.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.183 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 mt -116.02 117.55 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.643 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.562 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 88.1 tttt -75.49 147.18 40.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.101 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.5 mp -74.22 -59.01 3.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 70.57 -50.45 0.66 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.467 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -146.9 120.32 9.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.243 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.478 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 0.0 OUTLIER -120.48 85.17 37.18 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.398 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.89 -29.55 18.3 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.629 1.553 . . . . 0.0 112.281 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.417 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 94.8 mt-10 -119.98 160.67 22.31 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.002 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 168' ' ' GLU . 3.3 pt-20 -83.65 -43.69 15.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.741 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.666 ' NE2' ' CD1' ' A' ' 239' ' ' PHE . 28.0 mt-30 -74.68 -29.88 61.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.478 ' NE1' ' CE2' ' A' ' 239' ' ' PHE . 77.2 m95 -119.33 151.24 38.8 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.594 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.4 m0 -143.35 131.1 21.4 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.096 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 162' ' ' ILE . 51.2 t30 -81.39 116.98 21.47 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 161' ' ' LYS . . . -127.13 176.87 7.05 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.242 0.339 . . . . 0.0 110.453 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.19 133.94 54.72 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.258 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.434 ' HB2' HD11 ' A' ' 152' ' ' LEU . 11.0 t70 -58.37 170.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.491 0.662 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.5 ttt -78.51 0.41 26.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.666 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -104.4 -28.59 11.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.83 48.19 0.42 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -129.25 130.93 46.86 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.128 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.88 121.83 41.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.59 0.71 . . . . 0.0 111.874 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.86 154.41 25.49 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.765 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 152' ' ' LEU . 1.9 ttt -74.5 163.61 27.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.542 0.686 . . . . 0.0 111.084 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.842 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -157.21 145.31 14.21 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.669 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.03 112.92 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.529 1.486 . . . . 0.0 109.441 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.713 ' O ' HG22 ' A' ' 188' ' ' VAL . 49.7 t -47.63 -51.37 45.55 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.954 -0.466 . . . . 0.0 112.045 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.3 Cg_endo -47.42 -30.61 11.86 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.305 2.003 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.21 -3.76 11.75 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.935 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 185' ' ' VAL . 22.3 m -129.74 160.95 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.792 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.551 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -116.95 -64.31 1.33 Allowed 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.448 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 4.5 tptp . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.173 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.545 ' O ' ' NE2' ' A' ' 297' ' ' GLN . 79.4 m-20 . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.503 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -72.38 -177.09 29.78 Favored Glycine 0 CA--C 1.45 -3.997 0 CA-C-O 122.554 1.085 . . . . 0.0 114.619 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.503 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.0 Cg_exo -53.7 127.91 1.32 Allowed 'Cis proline' 0 N--CA 1.528 3.502 0 N-CA-C 115.462 1.293 . . . . 0.0 115.462 -3.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.666 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 3.2 m-85 -153.86 -117.68 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.3 m-30 -141.74 123.23 14.98 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 119.141 0.882 . . . . 0.0 109.831 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.673 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -113.34 150.47 32.53 Favored 'General case' 0 C--O 1.198 -1.65 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -113.23 103.25 11.15 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.733 -0.604 . . . . 0.0 109.422 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.3 p -74.35 121.47 25.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.505 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.17 23.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.425 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.522 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.4 mm-40 177.42 116.96 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.431 0.634 . . . . 0.0 109.844 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.869 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.4 ttmt -156.66 -158.8 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.935 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.784 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 28.7 ptt85 -153.94 144.88 22.69 Favored 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.76 91.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.637 0 O-C-N 124.041 0.838 . . . . 0.0 110.829 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.784 ' HD3' ' O ' ' A' ' 247' ' ' ARG . 70.0 Cg_endo -108.14 171.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 123.782 2.988 . . . . 0.0 113.827 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.644 ' ND2' ' H ' ' A' ' 253' ' ' ASP . 4.3 p-10 -93.04 -169.35 2.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.261 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.62 16.19 22.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 254' ' ' LYS . 5.7 m-85 -125.72 -21.62 4.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.227 0.537 . . . . 0.0 110.159 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.644 ' H ' ' ND2' ' A' ' 250' ' ' ASN . 31.5 t70 -71.78 45.05 0.11 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.928 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 255' ' ' THR . 38.7 mtmt 106.03 -10.78 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 124.717 1.261 . . . . 0.0 110.81 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.537 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 7.6 m 105.92 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.4 1.062 . . . . 0.0 110.651 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.618 ' HB1' ' CZ ' ' A' ' 287' ' ' PHE . . . -40.21 153.2 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 O-C-N 123.262 0.351 . . . . 0.0 111.62 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.86 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -107.33 151.51 25.39 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.774 0.43 . . . . 0.0 110.619 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.794 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -94.78 114.54 26.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.869 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.1 mt -139.4 -170.92 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.355 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 17.7 tt0 -146.14 149.18 33.51 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.501 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 245' ' ' GLN . 72.9 t -58.62 106.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.09 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.97 8.68 10.44 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 71.0 mm-40 -94.54 -133.71 0.18 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.973 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 170.98 139.77 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.973 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.7 p -127.21 143.73 39.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 92.24 5.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 t -61.93 152.09 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.733 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -151.8 -58.61 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.671 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 116.89 10.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.413 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.79 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -126.95 162.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.099 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 272' ' ' MET . 5.6 p30 177.59 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.556 0.693 . . . . 0.0 110.638 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.522 ' H ' ' CG ' ' A' ' 271' ' ' ASN . 25.5 mtm -35.95 125.87 0.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.195 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -62.95 6.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.911 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -132.94 -50.48 0.09 OUTLIER Glycine 0 N--CA 1.467 0.729 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.579 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.6 mp0 -94.91 160.9 14.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.579 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 4.3 m95 -162.85 158.17 22.27 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.471 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -120.64 128.48 53.05 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 123.24 0.338 . . . . 0.0 111.454 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.66 -157.16 31.16 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.297 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.35 127.2 0.81 Allowed 'General case' 0 C--N 1.346 0.429 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.677 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -138.83 78.09 1.66 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.692 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.6 t-20 83.35 27.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.587 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.69 -26.73 21.99 Favored Glycine 0 N--CA 1.462 0.386 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.968 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.1 OUTLIER -73.13 73.33 1.22 Allowed 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.769 -178.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.637 ' NH2' ' CZ ' ' A' ' 142' ' ' PHE . 64.2 mtt85 -73.01 169.44 16.96 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.719 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 165.18 122.12 0.59 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 122.659 1.144 . . . . 0.0 113.065 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.627 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.4 p80 -59.4 177.08 0.2 Allowed 'General case' 0 C--N 1.284 -2.247 0 O-C-N 119.194 -2.357 . . . . 0.0 109.555 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 166.03 149.06 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 123.968 0.792 . . . . 0.0 111.428 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 32.4 Cg_exo -55.65 135.81 71.17 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.508 2.138 . . . . 0.0 113.945 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 66.6 t80 -75.16 -1.5 23.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.795 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 20.4 p -76.83 3.22 12.42 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 9.1 p80 -133.63 44.29 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.134 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.36 146.14 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -125.71 77.45 1.66 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.124 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 294' ' ' LEU . 38.2 mt -39.67 127.08 1.97 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.81 0.814 . . . . 0.0 111.375 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.4 mp -67.75 -166.76 0.06 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.962 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -70.96 8.36 0.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 236' ' ' ASN . 47.7 tt0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.149 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.742 ' O ' HG22 ' A' ' 138' ' ' VAL . 21.0 m-85 . . . . . 0 C--O 1.213 -0.824 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER 78.59 157.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.565 1.165 . . . . 0.0 110.828 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -141.39 159.81 41.45 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.821 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . . . -59.74 172.72 0.67 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.342 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 189' ' ' GLU . 58.0 mt -143.08 -58.21 0.42 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.524 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -113.33 9.78 18.31 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.33 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.526 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 78.27 137.45 0.06 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.454 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 3.6 t80 -111.22 -46.11 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.335 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.681 HD21 ' NZ ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER 47.56 63.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.75 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -63.69 -124.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.538 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 166.8 -49.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.188 0.494 . . . . 0.0 111.863 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.613 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 7.9 m-20 -72.32 162.96 28.75 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 27.8 p-10 -69.56 -22.72 63.52 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.806 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -87.83 24.32 1.79 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.613 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 32.2 p30 -141.48 165.59 27.08 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 175' ' ' ASP . 8.8 tp -120.45 88.86 43.26 Favored Pre-proline 0 C--O 1.217 -0.646 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.685 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.405 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 65.6 Cg_endo -69.57 140.58 43.73 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.346 1.364 . . . . 0.0 113.068 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 140' ' ' ALA . 17.5 p90 -158.31 166.22 32.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.681 ' NZ ' HD21 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -139.1 148.12 42.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.42 -133.83 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.338 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -121.31 49.73 0.87 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.18 140.39 58.45 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -84.86 100.58 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.933 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.6 mt -109.56 125.59 52.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.87 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -81.3 138.24 35.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.636 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.3 mp -72.1 -57.44 7.28 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.669 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.444 ' N ' HG22 ' A' ' 162' ' ' ILE . 60.9 ttt180 77.59 -46.26 0.46 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.33 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.495 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -110.4 -134.64 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.868 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 164' ' ' ASP . 8.2 pttp 149.21 60.19 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.431 0.693 . . . . 0.0 109.701 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.4 ' CD ' ' H ' ' A' ' 165' ' ' LYS . 18.4 Cg_endo -57.14 -59.37 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.64 2.227 . . . . 0.0 112.429 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.0 mt-10 -117.3 174.48 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 1.1 pm0 -83.93 -44.58 14.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.678 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.466 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 83.1 mt-30 -75.19 -27.84 59.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 62.9 m95 -119.3 154.13 33.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.641 ' CE3' HG22 ' A' ' 185' ' ' VAL . 9.8 m0 -149.81 142.88 24.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.611 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.636 ' O ' ' O ' ' A' ' 162' ' ' ILE . 2.9 t30 -90.13 121.19 31.96 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -124.13 172.77 8.76 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.67 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -121.58 132.2 54.55 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.493 ' HB2' HD11 ' A' ' 152' ' ' LEU . 11.8 t70 -60.82 171.57 1.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.473 0.654 . . . . 0.0 110.85 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 tpt -77.12 -3.02 37.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.813 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.32 -27.89 12.19 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.87 48.12 0.42 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -129.66 134.29 47.59 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.448 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.56 123.52 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.531 0.681 . . . . 0.0 111.577 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -153.61 149.55 21.05 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.934 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 mtp -66.95 155.98 37.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.374 0.607 . . . . 0.0 111.002 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 11.5 pt -147.63 142.99 17.3 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.211 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.3 111.66 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.223 1.282 . . . . 0.0 109.71 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.641 HG22 ' CE3' ' A' ' 171' ' ' TRP . 58.5 t -46.77 -51.69 36.61 Favored Pre-proline 0 CA--C 1.535 0.38 0 O-C-N 122.212 -0.305 . . . . 0.0 111.337 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.1 Cg_endo -47.26 -30.07 10.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.26 1.974 . . . . 0.0 113.047 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 268' ' ' THR . 15.9 m-85 -77.5 -7.86 56.9 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.48 HG21 HG21 ' A' ' 138' ' ' VAL . 1.5 m -132.94 160.43 42.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.554 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.521 ' HB3' HD11 ' A' ' 141' ' ' LEU . 8.3 pt-20 -136.71 156.53 48.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.042 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.577 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.434 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 84.9 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.906 0.384 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.568 ' HA2' ' N ' ' A' ' 239' ' ' PHE . . . -75.16 -176.44 38.32 Favored Glycine 0 CA--C 1.457 -3.552 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.432 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.3 Cg_endo -57.3 100.72 0.06 OUTLIER 'Cis proline' 0 N--CA 1.525 3.374 0 N-CA-C 115.366 1.256 . . . . 0.0 115.366 -0.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.568 ' N ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 m-85 -115.9 -131.43 0.32 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.5 OUTLIER -144.95 132.13 20.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 118.873 0.76 . . . . 0.0 109.183 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.757 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -119.49 153.78 34.8 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.005 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 13.2 tpp180 -114.14 95.63 5.39 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.7 130.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.231 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.88 20.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.584 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 261' ' ' VAL . 0.9 OUTLIER 179.58 109.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.966 0.413 . . . . 0.0 110.314 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 259' ' ' LEU . 5.4 ttmt -162.01 -151.13 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.773 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.705 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -157.5 -137.23 0.05 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.522 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.58 61.94 39.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 43.0 Cg_endo -92.81 51.47 0.46 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.598 2.199 . . . . 0.0 113.474 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.718 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.2 OUTLIER -25.09 146.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.052 0.845 . . . . 0.0 111.291 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.96 -7.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.191 0.52 . . . . 0.0 111.668 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 250' ' ' ASN . 37.5 m-85 -83.02 -62.63 1.54 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 252' ' ' TYR . 35.4 t0 -33.46 -51.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.972 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.705 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 5.4 pttt -171.51 44.22 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.13 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m 63.34 -14.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.299 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -62.42 127.12 29.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.962 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.912 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -52.36 159.28 1.01 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.092 0.472 . . . . 0.0 111.322 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.909 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.18 121.95 45.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.33 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.909 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.4 mt -142.7 -175.29 4.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.051 0.453 . . . . 0.0 111.203 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.2 tt0 -144.02 151.26 39.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.236 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 245' ' ' GLN . 47.6 t -60.94 112.14 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.676 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 5.38 20.07 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 66.8 mm-40 -93.65 -128.68 0.12 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.106 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 168.72 138.6 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.704 0.764 . . . . 0.0 109.612 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.106 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.6 p -137.75 151.6 26.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 4.7 ttmt -79.61 -161.32 0.32 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.277 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 269' ' ' LYS . 1.7 t -140.78 -53.43 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.453 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER 46.08 -71.67 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.3 OUTLIER -81.28 117.65 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.255 -177.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.892 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -132.5 161.6 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.168 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -164.39 -108.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.162 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.455 ' C ' ' H ' ' A' ' 274' ' ' GLY . 46.9 mtm -39.38 153.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.685 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.8 p -75.77 18.68 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.388 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -142.71 -75.71 0.03 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.491 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 1.9 mp0 -78.02 176.53 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.72 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.54 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 9.5 p-90 170.08 -169.57 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.532 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 71.7 mt-10 -128.94 165.36 21.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.808 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -145.57 -152.77 5.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.094 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.07 125.64 0.55 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.906 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.685 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 -93.11 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -103.3 50.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.64 -31.19 5.96 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.404 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -64.8 83.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.398 -179.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -79.39 166.17 22.33 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.969 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.439 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.46 -157.59 29.83 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.45 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 16.0 p80 -125.4 175.33 7.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 123.847 0.381 . . . . 0.0 110.916 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.54 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 164.84 112.49 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.34 143.27 27.18 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.798 1.665 . . . . 0.0 112.496 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.625 ' CD1' HG23 ' A' ' 292' ' ' VAL . 52.9 t80 -66.09 -0.84 2.65 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.2 p -53.65 0.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.6 p80 -160.74 74.39 0.51 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.565 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.625 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -166.05 154.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.56 ' O ' ' HG ' ' A' ' 294' ' ' LEU . 58.0 mtp180 -101.44 -110.13 0.22 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 293' ' ' ARG . 9.4 mt 150.8 120.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.271 0.982 . . . . 0.0 110.751 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.02 -174.63 3.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.972 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.42 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 66.1 t0 -111.21 40.81 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.516 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.539 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 10.7 tp60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.757 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.906 ' O ' HG22 ' A' ' 138' ' ' VAL . 74.2 m-85 . . . . . 0 C--O 1.212 -0.874 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.906 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.3 m 83.03 161.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 124.852 1.345 . . . . 0.0 110.841 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.748 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 2.6 ptp180 -132.48 151.88 51.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -101.99 92.99 5.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.086 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -98.09 22.97 8.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.598 ' O ' ' O ' ' A' ' 143' ' ' ASP . 57.9 m-85 -123.47 6.84 8.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.0 p30 51.86 137.04 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.276 0 O-C-N 124.59 1.181 . . . . 0.0 110.808 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.491 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 6.6 t80 -124.59 -43.23 2.04 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.225 0.466 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 144' ' ' PHE . 53.9 t-20 39.31 62.18 1.19 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.454 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.34 -146.11 0.21 Allowed Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.601 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.1 p30 171.22 91.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.063 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.4 m-20 171.57 -173.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.373 . . . . 0.0 110.212 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -93.63 -21.55 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.652 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.79 26.29 10.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.974 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 8.9 p-10 -134.17 152.37 51.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 9.5 tp -116.94 85.21 17.27 Favored Pre-proline 0 C--O 1.21 -1.01 0 CA-C-N 117.586 0.175 . . . . 0.0 110.564 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -59.73 139.37 88.29 Favored 'Trans proline' 0 C--N 1.288 -2.627 0 C-N-CA 121.49 1.46 . . . . 0.0 112.864 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 9.1 p90 -159.02 158.29 32.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.258 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 156' ' ' LYS . 1.6 ttmp? -176.62 112.6 0.1 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 147.06 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.384 1.052 . . . . 0.0 110.565 178.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.09 44.75 0.91 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -79.71 153.59 29.17 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.398 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 159' ' ' ILE . 3.7 tp -98.67 119.27 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 137' ' ' TYR . 10.6 mt -118.7 133.65 55.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.19 139.78 34.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.74 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.6 mp -64.46 -48.74 83.83 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.865 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.574 ' NE ' ' OD1' ' A' ' 164' ' ' ASP . 0.2 OUTLIER 69.96 -53.26 0.63 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.893 -0.504 . . . . 0.0 111.617 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.574 ' OD1' ' NE ' ' A' ' 163' ' ' ARG . 0.5 OUTLIER -116.9 -126.39 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.498 ' H ' ' HD3' ' A' ' 166' ' ' PRO . 1.3 pttm 141.55 60.89 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.72 1.208 . . . . 0.0 109.575 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.498 ' HD3' ' H ' ' A' ' 165' ' ' LYS . 47.3 Cg_endo -67.19 -46.61 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.924 1.749 . . . . 0.0 112.432 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -118.46 167.5 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -85.14 -35.08 21.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.529 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 1.8 mt-30 -84.16 -25.24 29.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.593 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.6 m95 -122.23 150.31 42.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.462 ' CD2' HG22 ' A' ' 185' ' ' VAL . 11.4 m0 -141.57 129.92 22.4 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.934 0.873 . . . . 0.0 110.696 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.74 ' O ' ' O ' ' A' ' 162' ' ' ILE . 5.5 t30 -81.86 107.95 15.0 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.6 174.17 6.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.5 0.5 . . . . 0.0 110.627 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 33.1 tt0 -123.03 133.32 54.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.4 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.44 169.23 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.505 0.669 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 159' ' ' ILE . 97.4 mmm -76.64 0.67 19.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.81 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.459 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 93.9 m-20 -104.95 -28.38 11.12 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.52 49.64 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.459 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 18.6 mttp -130.19 135.72 48.47 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 114.241 -0.979 . . . . 0.0 110.757 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.77 125.15 52.4 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.523 0.678 . . . . 0.0 111.776 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.13 154.9 25.95 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.444 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 tpt -66.01 154.57 39.12 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 171' ' ' TRP . 1.3 pp -145.02 143.3 20.16 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.35 114.62 4.09 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 N-CA-C 108.694 -1.31 . . . . 0.0 108.694 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.884 ' O ' HG22 ' A' ' 188' ' ' VAL . 41.6 t -49.92 -52.0 56.09 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.949 -0.47 . . . . 0.0 111.979 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.2 Cg_endo -49.8 -28.63 18.3 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.052 1.835 . . . . 0.0 113.773 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.439 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 6.8 m-85 -67.78 3.66 1.39 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.0 m -128.11 167.61 22.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 123.263 0.352 . . . . 0.0 110.297 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.748 ' CD ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -68.39 -48.66 64.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.33 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.514 ' HG3' HG23 ' A' ' 188' ' ' VAL . 3.5 mppt? . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 124.227 1.011 . . . . 0.0 111.513 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.199 0.523 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -60.15 -177.63 1.59 Allowed Glycine 1 CA--C 1.433 -5.054 0 CA-C-O 122.446 1.026 . . . . 0.0 114.41 -179.004 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.475 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.7 Cg_endo -57.21 125.2 1.38 Allowed 'Cis proline' 0 N--CA 1.533 3.841 0 N-CA-C 115.608 1.349 . . . . 0.0 115.608 -2.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.597 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 12.7 m-85 -150.79 -121.37 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.602 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.529 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 1.0 OUTLIER -143.06 123.83 14.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.721 0.772 . . . . 0.0 110.484 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.883 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.05 -159.24 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.032 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -162.41 87.41 0.62 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.0 p -57.94 123.61 10.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.006 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 15.73 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.726 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.491 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -175.94 112.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.294 0.569 . . . . 0.0 110.237 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.864 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.6 ttmt -158.72 -146.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.182 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.405 HH22 ' HE3' ' A' ' 254' ' ' LYS . 4.3 ptt85 -155.85 -142.53 0.11 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.829 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.601 ' O ' HG12 ' A' ' 248' ' ' VAL . 82.0 t -132.69 66.95 77.7 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.563 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 84.0 Cg_endo -90.56 172.64 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.609 2.206 . . . . 0.0 111.231 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -145.86 142.61 28.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.29 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.46 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 250' ' ' ASN . 60.9 m-85 -93.57 -54.51 3.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 110.791 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -44.67 -67.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 256' ' ' ALA . 26.7 mttt -148.58 32.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.521 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 m 72.28 -15.21 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.608 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.34 156.43 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.68 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.8 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -97.17 148.0 23.51 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.961 0.504 . . . . 0.0 110.359 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.828 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -86.98 115.21 24.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.5 mt -139.77 -176.06 4.44 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.435 0.636 . . . . 0.0 111.126 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 11.2 tt0 -146.28 147.87 31.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.702 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 245' ' ' GLN . 93.5 t -56.59 106.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.289 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 118.03 3.96 14.94 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.1 mm-40 -87.19 -122.22 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.745 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.043 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.4 OUTLIER 161.15 138.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.489 0.661 . . . . 0.0 109.477 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.043 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.5 p -130.84 140.8 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.968 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.424 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.78 88.31 3.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.925 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.465 ' HA ' ' HA2' ' A' ' 278' ' ' GLY . 16.8 t -56.79 151.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.265 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.527 ' O ' HD12 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -158.75 -51.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.465 0.65 . . . . 0.0 110.227 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -74.85 116.53 15.68 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 268' ' ' THR . 2.4 mp -126.27 104.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.469 ' ND2' ' OE1' ' A' ' 277' ' ' GLU . 1.1 p30 -87.52 -25.86 23.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 5.4 mtm -145.96 176.88 9.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.434 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -91.58 16.11 11.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -134.39 -96.06 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.244 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.94 63.69 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.769 0.795 . . . . 0.0 110.763 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.532 ' N ' ' CD1' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -69.59 178.71 2.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.469 ' OE1' ' ND2' ' A' ' 271' ' ' ASN . 1.3 mt-10 -109.12 -163.19 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.067 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -159.23 -160.33 10.33 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.753 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.459 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.5 tt0 -169.42 130.26 1.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.157 0.503 . . . . 0.0 111.683 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.705 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -147.55 75.42 1.36 Allowed 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.354 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 33.9 t30 83.81 31.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.249 0.547 . . . . 0.0 110.318 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 95.63 -31.41 7.21 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.336 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.57 76.54 0.42 Allowed 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.502 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 94.6 mtt180 -76.57 171.8 14.05 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.135 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.87 -156.68 27.68 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.543 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 6.3 p80 -124.32 169.81 11.42 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 122.889 0.476 . . . . 0.0 109.737 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 164.92 114.39 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.26 178.276 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.05 140.98 58.87 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.626 1.551 . . . . 0.0 112.099 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.517 ' O ' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -67.27 0.01 3.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.031 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 46.2 p -55.15 1.75 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.044 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 289' ' ' PHE . 5.8 p80 -151.7 65.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.901 -0.499 . . . . 0.0 110.789 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 289' ' ' PHE . 12.2 m -156.42 153.37 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -101.53 -55.82 2.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.2 mt 86.76 119.14 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.075 0.941 . . . . 0.0 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.4 mp -72.68 -178.41 2.66 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.689 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -87.41 47.86 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.536 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 51.7 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.456 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.698 ' O ' ' O ' ' A' ' 138' ' ' VAL . 57.6 m-85 . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.698 ' O ' ' O ' ' A' ' 137' ' ' TYR . 27.3 m 34.93 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.012 0.82 . . . . 0.0 111.528 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 36.4 ttt180 -144.49 128.82 17.85 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.996 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -98.83 84.9 3.18 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 123.524 0.515 . . . . 0.0 111.58 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.553 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -95.19 32.57 1.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.224 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 143' ' ' ASP . 45.9 m-85 -134.3 3.46 3.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 142' ' ' PHE . 3.9 p30 51.86 139.48 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 O-C-N 124.919 1.387 . . . . 0.0 110.431 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 t80 -129.31 -49.33 1.19 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 t30 38.97 61.76 1.2 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.94 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -69.34 -149.9 0.36 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.594 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 1.4 p30 164.99 103.26 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.428 -0.886 . . . . 0.0 109.873 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.594 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 20.4 m-20 173.01 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.442 1.089 . . . . 0.0 112.8 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 62.92 -45.03 0.2 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.904 0.752 . . . . 0.0 109.686 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 148' ' ' ASP . 96.4 mt-10 -85.89 29.41 0.72 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.505 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.575 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.5 p30 -143.52 163.95 31.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.653 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 183' ' ' ILE . 11.4 tp -118.48 91.41 41.41 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.412 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 65.5 Cg_endo -71.91 124.57 10.24 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 121.489 1.46 . . . . 0.0 112.906 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.723 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.6 p90 -144.49 163.47 33.73 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.924 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.499 ' HZ2' ' HB2' ' A' ' 143' ' ' ASP . 0.7 OUTLIER -142.21 150.85 41.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.103 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.996 ' O ' ' O ' ' A' ' 140' ' ' ALA . 11.8 mtpt 73.12 -142.19 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.24 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -107.43 48.52 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 42.9 t0 -56.73 153.58 10.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.026 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.635 HG23 ' HB3' ' A' ' 137' ' ' TYR . 1.5 mp -102.02 106.08 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 154' ' ' PHE . 11.5 mt -112.52 110.57 20.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.953 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -70.03 150.6 46.46 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -94.38 133.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.099 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.417 ' NH2' ' OD1' ' A' ' 172' ' ' ASN . 7.8 tmm_? -107.53 -42.79 4.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.063 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -153.73 128.52 9.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 32.9 pttt -123.88 75.62 57.28 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.6 -40.44 73.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 111.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -106.21 -165.07 1.06 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -118.81 -19.94 8.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.924 0.393 . . . . 0.0 110.386 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -88.35 -33.36 17.99 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.7 m95 -118.64 151.28 38.24 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.521 ' CD2' HG22 ' A' ' 185' ' ' VAL . 14.9 m0 -141.02 129.67 22.78 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.091 0.948 . . . . 0.0 111.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.417 ' OD1' ' NH2' ' A' ' 163' ' ' ARG . 2.3 t-20 -79.45 114.51 18.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.94 173.69 8.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.643 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.39 135.89 54.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 175.02 1.26 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.504 0.669 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.06 -4.18 48.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.794 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -101.34 -28.05 12.83 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.95 49.68 0.37 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -130.62 134.81 47.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.629 -0.786 . . . . 0.0 110.697 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.54 127.29 52.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.442 0.639 . . . . 0.0 111.733 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.53 155.08 26.16 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.268 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.48 157.83 33.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.814 0.34 . . . . 0.0 110.337 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.472 HG22 ' HB3' ' A' ' 152' ' ' LEU . 1.2 pp -144.14 142.6 20.26 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.92 113.56 3.82 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.567 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 13.6 t -46.93 -53.65 25.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 121.519 -0.738 . . . . 0.0 112.209 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 8.2 Cg_endo -48.64 -28.04 11.75 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 121.913 1.742 . . . . 0.0 113.234 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -71.17 -0.77 10.5 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.299 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 185' ' ' VAL . 1.9 m -135.82 162.03 37.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.477 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.553 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.7 OUTLIER -115.39 -60.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.443 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.566 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 237' ' ' GLY . 4.4 p30 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.031 0.443 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.525 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -48.49 -175.2 0.01 OUTLIER Glycine 1 CA--C 1.435 -4.944 0 CA-C-O 122.457 1.032 . . . . 0.0 113.266 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.525 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 1.6 Cg_endo -53.07 117.08 0.25 Allowed 'Cis proline' 0 N--CA 1.53 3.671 0 O-C-N 123.635 1.334 . . . . 0.0 115.313 0.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 13.2 m-85 -147.03 -118.37 0.07 Allowed 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.753 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.1 m-30 -143.46 122.68 12.98 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.902 0.858 . . . . 0.0 110.699 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.909 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.18 -161.77 0.82 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.294 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 18.9 tpp180 -160.92 89.5 0.8 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 243' ' ' VAL . 6.0 p -62.35 129.31 25.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.599 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.9 15.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.772 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.6 mm-40 -173.94 113.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.373 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.832 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.2 ttmt -158.92 -146.7 0.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.404 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.8 ptt85 -156.48 -143.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.821 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 248' ' ' VAL . 57.5 t -133.5 69.99 76.65 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.576 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 58.2 Cg_endo -90.63 167.97 4.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.221 2.614 . . . . 0.0 112.971 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.496 ' OD1' ' CB ' ' A' ' 253' ' ' ASP . 46.0 p-10 -97.04 -166.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.275 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.45 11.69 28.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.243 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.5 ' C ' ' H ' ' A' ' 254' ' ' LYS . 6.4 m-85 -123.73 -21.98 5.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.9 t70 -68.3 43.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 253' ' ' ASP . 38.9 mtmt 96.96 0.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.776 0.831 . . . . 0.0 110.898 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 286' ' ' HIS . 0.2 OUTLIER 84.59 61.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.037 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -115.77 107.32 14.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.926 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.6 155.76 0.76 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.61 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.905 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -103.84 121.92 44.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.582 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.6 mt -142.95 -173.98 4.05 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.256 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.4 tt0 -145.91 150.67 36.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.79 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 245' ' ' GLN . 93.9 t -57.94 108.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.615 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.68 5.38 18.47 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.3 mm-40 -88.61 -123.77 0.05 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.77 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.071 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.3 OUTLIER 162.31 138.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.071 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.1 p -131.39 143.16 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.754 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.409 ' NZ ' ' HD3' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -97.91 84.76 3.38 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.434 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.8 t -58.8 150.8 4.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.28 -53.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.411 ' HE3' ' H ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -67.44 144.86 55.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.494 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.411 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -151.16 159.33 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.044 0.449 . . . . 0.0 110.569 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 272' ' ' MET . 13.6 p30 -176.94 -107.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.387 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.531 ' N ' ' OD1' ' A' ' 271' ' ' ASN . 31.6 mtm -42.17 140.86 1.03 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.27 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -74.2 16.1 0.27 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -138.58 -60.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.359 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.519 ' O ' ' HE3' ' A' ' 272' ' ' MET . 2.6 mp0 -109.0 101.06 10.18 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.512 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 3.6 p-90 -111.9 -165.71 1.01 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 120.846 0.355 . . . . 0.0 110.259 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.5 mt-10 -129.3 167.58 17.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.786 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.87 -151.4 5.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.78 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.503 ' OE2' ' O ' ' A' ' 280' ' ' CYS . 2.5 tm-20 -172.3 128.45 0.56 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.707 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -108.79 -90.72 0.45 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -106.03 51.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.02 5.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.32 83.24 0.09 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 114.591 -0.804 . . . . 0.0 110.065 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -78.14 165.7 23.65 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.292 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 169.23 -158.27 30.66 Favored Glycine 0 C--O 1.215 -1.06 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.56 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 21.7 p80 -122.52 170.48 9.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.029 0.443 . . . . 0.0 110.556 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.09 114.46 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.668 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.513 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 50.7 Cg_exo -50.83 141.31 36.15 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.828 1.686 . . . . 0.0 112.798 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -63.6 0.31 0.79 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.598 0.713 . . . . 0.0 110.018 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 288' ' ' PRO . 66.1 p -56.79 2.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.72 -0.612 . . . . 0.0 112.095 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.517 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.2 p-80 -150.15 64.55 0.96 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.463 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.534 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -160.3 151.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 294' ' ' LEU . 43.3 mtm180 -102.34 -54.74 2.62 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 5.0 mt 91.67 121.09 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.023 0.916 . . . . 0.0 111.322 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.15 -178.12 4.88 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.182 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -87.47 48.58 1.67 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.744 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 47.0 tt0 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.46 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 m -134.33 164.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 111.177 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -123.33 125.99 46.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -105.5 109.53 21.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.982 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.767 HD21 ' HG2' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -118.96 28.47 8.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.851 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 60.0 m-85 -125.29 0.5 7.74 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.49 -0.131 . . . . 0.0 111.164 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.97 139.8 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.738 0 O-C-N 123.901 0.75 . . . . 0.0 110.288 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.607 ' CE2' ' O ' ' A' ' 145' ' ' ASN . 4.3 t80 -133.88 -45.6 0.79 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 144' ' ' PHE . 30.0 m-80 74.86 -109.95 0.03 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.717 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.505 ' C ' ' CZ ' ' A' ' 144' ' ' PHE . . . -133.5 -172.71 13.02 Favored Glycine 0 C--N 1.275 -2.828 0 O-C-N 121.606 -0.684 . . . . 0.0 113.633 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 18.9 t30 174.03 -40.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.966 -1.117 . . . . 0.0 111.911 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 6.4 m-20 -93.03 -159.21 0.66 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 111.785 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.02 -45.09 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.483 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 151' ' ' ASP . 97.3 mt-10 -127.22 28.17 5.78 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.654 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.0 OUTLIER -37.69 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 123.908 0.755 . . . . 0.0 111.786 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.463 HD11 ' CG ' ' A' ' 175' ' ' ASP . 11.7 tp -127.09 98.88 29.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.922 -0.486 . . . . 0.0 111.888 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 145' ' ' ASN . 52.7 Cg_endo -75.16 133.14 16.0 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.635 1.557 . . . . 0.0 112.884 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.75 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 21.2 p90 -155.18 173.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.509 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 176.12 132.28 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.811 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 2.7 mmpt? 95.22 79.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.081 0.863 . . . . 0.0 111.403 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 32.38 47.78 0.29 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.878 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.78 137.88 47.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.091 0.472 . . . . 0.0 109.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.3 mm -98.53 95.67 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.614 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mt -109.35 107.96 18.34 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.44 141.2 54.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.889 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.913 HG22 ' H ' ' A' ' 163' ' ' ARG . 11.8 mm -64.15 -146.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.847 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.913 ' H ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -176.55 -57.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.132 0.491 . . . . 0.0 110.747 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -136.48 -24.54 1.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.312 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.405 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 16.2 pttp 36.43 77.88 0.37 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.68 -39.05 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.93 1.753 . . . . 0.0 112.23 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.3 mt-10 -105.17 162.26 13.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 14.9 pt-20 -84.64 -41.71 16.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.773 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.419 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 43.0 mt-30 -76.77 -29.66 56.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.34 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 73.6 m95 -120.15 153.7 35.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.641 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.5 m0 -148.22 140.74 24.42 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -83.88 117.78 23.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 171.04 8.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 111.601 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 68.3 tt0 -125.0 133.15 53.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.959 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.463 ' CG ' HD11 ' A' ' 152' ' ' LEU . 15.2 m-20 -61.76 177.19 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.463 0.649 . . . . 0.0 110.734 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 23.6 ttt -80.54 -4.66 54.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.463 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.419 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 94.7 m-20 -102.43 -28.12 12.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.34 48.55 0.38 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.419 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 9.1 mttp -128.87 130.63 47.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.057 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.45 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.397 0.618 . . . . 0.0 112.048 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.2 152.81 24.12 Favored Glycine 0 C--N 1.315 -0.607 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.076 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 78.7 mmm -66.19 159.59 26.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.528 0.68 . . . . 0.0 110.972 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 10.1 pt -152.85 145.84 17.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.954 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -71.3 113.71 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.431 1.421 . . . . 0.0 109.583 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.793 ' O ' HG22 ' A' ' 188' ' ' VAL . 43.9 t -49.35 -52.7 46.83 Favored Pre-proline 0 CA--C 1.537 0.457 0 O-C-N 121.956 -0.465 . . . . 0.0 111.816 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.1 Cg_endo -49.6 -27.11 13.96 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.482 2.121 . . . . 0.0 113.992 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.1 m-85 -69.07 10.63 0.27 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.765 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 185' ' ' VAL . 3.1 m -131.96 168.49 23.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.767 ' HG2' HD21 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -146.6 39.4 1.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.152 0.501 . . . . 0.0 111.407 -178.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.499 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 237' ' ' GLY . 33.8 p-10 . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.274 0.559 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.537 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -52.36 -176.52 0.05 OUTLIER Glycine 1 CA--C 1.447 -4.212 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.761 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.537 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.4 115.62 0.14 OUTLIER 'Cis proline' 0 N--CA 1.529 3.6 0 N-CA-C 116.333 1.628 . . . . 0.0 116.333 -1.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.687 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 8.0 m-85 -149.41 -126.69 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.822 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 5.5 m-30 -134.93 113.86 11.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 110.018 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 264' ' ' LEU . . . -107.17 139.27 41.88 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.424 ' HA ' ' HB2' ' A' ' 264' ' ' LEU . 17.0 tpp180 -100.17 98.84 9.49 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.527 0.68 . . . . 0.0 111.181 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.87 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.8 p -69.26 117.38 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.093 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.581 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.2 pt -110.91 18.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.444 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.8 mm-40 -176.8 116.96 0.11 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.207 0.527 . . . . 0.0 110.837 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.848 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -160.71 -151.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.822 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -156.28 -134.93 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.457 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.6 t -137.99 62.79 34.9 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.086 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 256' ' ' ALA . 41.8 Cg_endo -98.1 47.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.995 2.463 . . . . 0.0 113.023 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 252' ' ' TYR . 8.0 p-10 -22.62 152.67 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.533 1.146 . . . . 0.0 111.517 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.58 -9.21 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.506 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.799 ' O ' ' N ' ' A' ' 254' ' ' LYS . 38.1 m-85 -76.53 -63.21 1.39 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -47.05 62.42 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 125.384 1.677 . . . . 0.0 111.131 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 252' ' ' TYR . 4.2 mttm 84.26 -49.93 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.908 1.38 . . . . 0.0 109.717 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.88 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -44.31 110.88 0.24 Allowed 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.131 0.491 . . . . 0.0 111.722 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.877 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.9 OUTLIER -43.44 159.58 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.033 -0.417 . . . . 0.0 111.75 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.786 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.81 119.82 40.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.848 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.3 mt -141.15 -175.73 4.43 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.8 tt0 -144.21 144.3 31.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.357 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 244' ' ' ILE . 58.2 t -48.98 106.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.423 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.79 14.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 57.1 mm-40 -92.71 -41.61 10.06 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.331 0.586 . . . . 0.0 112.38 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.979 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 69.12 140.12 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.62 -178.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.979 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.2 p -131.43 156.92 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.485 ' N ' HG22 ' A' ' 265' ' ' VAL . 0.8 OUTLIER -102.71 88.24 3.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.639 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 5.0 t -67.76 121.95 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.005 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.61 ' O ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -110.28 -52.63 2.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 8.5 tppt? -82.08 125.89 31.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 112.119 -177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 268' ' ' THR . 4.6 mp -139.88 126.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.549 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 272' ' ' MET . 10.7 p30 -121.08 -106.42 0.37 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.603 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.509 ' H ' ' CG ' ' A' ' 271' ' ' ASN . 35.0 mtm -38.09 149.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.655 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.8 p -71.55 15.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -140.75 -69.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.474 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 29.9 mm100 -82.79 173.03 12.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.61 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 5.9 p-90 170.89 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.068 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 6.6 mt-10 -126.93 173.26 9.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.68 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -150.3 -155.85 7.04 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.354 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.495 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -171.66 121.98 0.51 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.69 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -108.37 -98.03 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -95.6 50.46 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.41 -30.96 5.36 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 89.93 0.07 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.457 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.495 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 75.7 mtt180 -85.36 168.03 15.02 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.567 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.63 -156.26 28.01 Favored Glycine 0 C--N 1.308 -1.019 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.559 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 12.6 p80 -128.01 170.79 12.49 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.894 0.477 . . . . 0.0 111.066 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.61 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 168.87 114.47 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.248 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 290' ' ' THR . 68.4 Cg_exo -48.55 141.01 20.75 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.575 1.517 . . . . 0.0 112.518 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.6 OUTLIER -62.98 -1.0 0.78 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.478 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.9 p -55.89 0.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 289' ' ' PHE . 4.9 p-80 -153.13 66.38 0.78 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.579 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -161.75 146.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.13 81.97 2.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 27.4 mt -37.71 130.09 1.08 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.343 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.0 mp -71.93 -170.13 0.55 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.852 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.92 21.31 0.43 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.606 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.6 tt0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.428 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.878 ' O ' HG22 ' A' ' 138' ' ' VAL . 53.6 m-85 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 90.77 161.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 125.367 1.667 . . . . 0.0 111.66 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -140.85 157.78 44.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.152 0.977 . . . . 0.0 111.468 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.661 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . . . -56.41 162.26 2.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.667 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.7 mt -136.36 -37.45 0.7 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.969 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.588 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 95.2 m-85 -124.87 6.66 8.04 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 79.41 142.1 0.08 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.407 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.0 t80 -121.63 -50.67 2.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.004 0.43 . . . . 0.0 111.577 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 13.5 m-80 42.83 62.7 1.69 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.409 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.416 ' N ' ' HB3' ' A' ' 153' ' ' PRO . . . -77.53 -154.74 6.73 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.6 p30 163.73 -6.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.1 -1.05 . . . . 0.0 112.085 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 147' ' ' ASN . 53.2 m-20 -55.16 -121.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.497 0.665 . . . . 0.0 111.417 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 151' ' ' ASP . 7.2 p-10 -66.59 47.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.692 ' O ' ' O ' ' A' ' 151' ' ' ASP . 21.5 mp0 67.78 19.75 9.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.692 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.9 OUTLIER -39.65 -169.86 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 O-C-N 123.863 0.727 . . . . 0.0 111.869 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.497 HD11 ' CG ' ' A' ' 175' ' ' ASP . 5.8 tp -113.53 91.2 19.7 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 121.242 -0.911 . . . . 0.0 111.6 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.416 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 67.2 Cg_endo -70.92 128.26 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.785 0.99 . . . . 0.0 112.175 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.661 ' CD1' ' HB2' ' A' ' 140' ' ' ALA . 10.1 p90 -144.92 172.98 12.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.589 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -112.07 -106.7 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.933 0.396 . . . . 0.0 111.396 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 155' ' ' LYS . 25.5 ttpt -135.72 122.09 20.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.56 15.62 54.57 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.251 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.17 133.48 34.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.2 mm -101.67 116.13 44.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mt -122.54 122.33 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -75.16 128.71 36.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.384 0.611 . . . . 0.0 111.828 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.6 mm -66.62 126.49 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.487 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.605 ' HE ' ' HE ' ' A' ' 180' ' ' ARG . 72.5 ttt-85 -76.58 -51.99 10.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.627 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 164' ' ' ASP . 51.0 t0 -157.27 -10.33 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.357 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.481 ' HB2' ' CD1' ' A' ' 171' ' ' TRP . 4.6 ptmm? 35.97 79.98 0.28 Allowed Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.511 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.53 -44.59 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 49.8 mt-10 -91.93 158.29 16.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.913 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 15.6 pt-20 -82.28 -41.26 20.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.766 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 35.1 mt-30 -83.13 -24.47 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.437 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 63.1 m95 -124.23 150.42 45.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.614 ' CD2' HG22 ' A' ' 185' ' ' VAL . 13.3 m0 -140.5 133.05 28.65 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.678 0.751 . . . . 0.0 111.581 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -79.05 100.35 7.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.41 170.71 8.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -130.29 141.8 50.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.026 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.497 ' CG ' HD11 ' A' ' 152' ' ' LEU . 31.3 m-20 -70.5 173.07 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.478 0.656 . . . . 0.0 110.218 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.9 mmm -77.14 -8.19 57.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.895 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -102.01 -26.5 13.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.21 47.1 0.39 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -122.6 131.68 53.94 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.288 -0.956 . . . . 0.0 110.609 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.605 ' HE ' ' HE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -109.28 113.92 27.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.831 0.824 . . . . 0.0 113.044 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -142.84 143.59 12.78 Favored Glycine 0 C--N 1.305 -1.187 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.691 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.1 mtp -62.42 161.53 11.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.485 0.66 . . . . 0.0 110.432 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.437 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 4.4 pt -150.6 145.86 18.95 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.874 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.3 118.7 5.63 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.41 1.407 . . . . 0.0 109.285 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.614 HG22 ' CD2' ' A' ' 171' ' ' TRP . 25.2 t -54.25 -51.49 77.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -49.64 -29.43 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.543 1.495 . . . . 0.0 113.154 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.542 ' OH ' ' O ' ' A' ' 268' ' ' THR . 10.8 m-85 -72.37 -10.62 60.03 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.328 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 138' ' ' VAL . 1.3 m -132.89 165.13 33.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.519 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 190' ' ' LYS . 2.3 pp20? -143.64 -49.96 0.31 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.017 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 189' ' ' GLU . 3.2 tmtm? . . . . . 0 N--CA 1.42 -1.971 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 120.989 0.423 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -35.76 161.54 0.01 OUTLIER Glycine 1 CA--C 1.436 -4.882 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.898 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.422 ' HD2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 Cg_exo -75.88 115.45 3.55 Favored 'Cis proline' 0 N--CA 1.521 3.089 0 O-C-N 122.645 0.813 . . . . 0.0 112.015 -5.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.718 ' O ' ' HG3' ' A' ' 266' ' ' LYS . 43.0 m-85 -145.97 -125.86 0.07 Allowed 'General case' 0 C--O 1.189 -2.088 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 0.8 OUTLIER -142.07 116.14 9.39 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 120.105 1.32 . . . . 0.0 109.801 -177.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.796 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -88.93 -157.51 0.44 Allowed 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -157.7 90.49 1.08 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.563 0.696 . . . . 0.0 109.544 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.727 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.0 p -66.22 122.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.523 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.71 16.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.67 100.56 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.242 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.838 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -134.14 -143.16 0.2 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 10.5 ptt85 -158.83 -134.89 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 248' ' ' VAL . 81.1 t -135.79 68.17 65.04 Favored Pre-proline 0 N--CA 1.473 0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.876 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.566 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 67.7 Cg_endo -92.82 177.8 1.41 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 123.355 2.703 . . . . 0.0 111.694 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.658 ' O ' ' N ' ' A' ' 252' ' ' TYR . 24.6 p30 -147.21 145.16 29.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.862 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.81 -14.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.562 0.539 . . . . 0.0 111.313 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.658 ' N ' ' O ' ' A' ' 250' ' ' ASN . 44.1 m-85 -83.54 -55.54 4.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.285 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 33.1 t70 -52.41 67.94 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 124.736 1.273 . . . . 0.0 111.691 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 252' ' ' TYR . 31.3 mtmt 73.52 -7.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 0.0 111.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 1.4 m 92.64 52.8 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.129 0.893 . . . . 0.0 111.903 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.432 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -109.87 112.72 24.92 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.924 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.6 OUTLIER -41.88 157.98 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.308 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.689 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.94 116.33 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.522 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.838 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.7 OUTLIER -139.0 -175.35 4.12 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 263' ' ' GLU . 2.3 tt0 -148.02 148.67 30.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.981 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 56.3 t -45.52 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.044 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 103.63 13.09 28.84 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 260' ' ' GLU . 37.8 mm-40 -90.11 -35.1 15.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.26 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.074 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.83 139.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.958 0.885 . . . . 0.0 110.774 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.074 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.1 p -136.17 164.69 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.082 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.718 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -108.33 103.17 12.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.585 ' C ' HG23 ' A' ' 268' ' ' THR . 1.2 t -57.1 -53.92 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER 62.48 -66.01 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 124.473 1.108 . . . . 0.0 109.974 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -65.47 150.05 49.01 Favored 'General case' 0 C--O 1.181 -2.524 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.735 -177.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.603 HD13 ' N ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -162.86 128.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.171 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.535 ' OD1' ' HG3' ' A' ' 272' ' ' MET . 13.0 p-10 -155.2 -40.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.928 ' HE3' ' H ' ' A' ' 274' ' ' GLY . 0.0 OUTLIER -124.3 173.24 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.915 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 1.5 p -105.98 20.2 19.33 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.928 ' H ' ' HE3' ' A' ' 272' ' ' MET . . . -118.99 -74.25 0.44 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.84 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.664 ' CD ' ' N ' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -54.64 -91.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 123.422 1.582 . . . . 0.0 110.393 -178.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.915 ' HE1' ' C ' ' A' ' 273' ' ' SER . 1.2 m0 88.1 127.54 0.03 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 267' ' ' VAL . 21.4 mt-10 -86.54 168.51 13.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.712 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 284' ' ' ARG . . . -155.19 136.33 5.08 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.902 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.455 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -122.99 125.45 45.27 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.463 0.743 . . . . 0.0 110.364 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.641 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -143.23 78.89 1.62 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.063 -176.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.7 m-20 84.33 41.67 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.819 0.819 . . . . 0.0 109.351 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.41 -35.96 3.4 Favored Glycine 0 CA--C 1.495 -1.162 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.112 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -61.82 104.22 0.42 Allowed 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 114.588 -0.806 . . . . 0.0 109.773 -176.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 278' ' ' GLY . 33.2 mtt85 -108.8 165.84 11.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 121.397 0.618 . . . . 0.0 109.834 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 173.17 -148.83 10.65 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.559 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 16.8 p80 -132.24 168.33 18.25 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.549 0.174 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.71 120.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.805 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 275' ' ' GLN . 74.5 Cg_exo -46.01 134.53 14.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.864 1.71 . . . . 0.0 113.679 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.726 ' HB2' ' CE3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -66.73 -3.62 7.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.663 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.2 p -62.16 -0.49 0.54 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.6 p-80 -139.17 54.5 1.72 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.204 0.456 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.29 148.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.7 -46.92 3.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 1.3 mt 82.96 131.39 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.223 1.011 . . . . 0.0 112.01 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 9.3 mp -79.4 -168.05 1.4 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.849 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -74.6 12.19 0.86 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 295' ' ' LEU . 56.6 tt0 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.044 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.005 ' O ' HG22 ' A' ' 138' ' ' VAL . 80.7 m-85 . . . . . 0 CA--C 1.486 -1.483 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.995 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 1.005 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.4 m 84.44 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 125.427 1.704 . . . . 0.0 111.107 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -121.34 139.7 53.08 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 120.93 0.395 . . . . 0.0 110.324 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.67 ' HB1' ' CD1' ' A' ' 154' ' ' PHE . . . -105.27 98.75 8.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.98 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.722 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.2 OUTLIER -114.69 32.98 5.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.606 -178.228 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.574 ' CD2' HD12 ' A' ' 141' ' ' LEU . 69.6 m-85 -125.22 1.74 7.84 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.53 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 269' ' ' LYS . 0.2 OUTLIER 60.96 136.83 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.029 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 4.4 t80 -134.56 -35.26 0.9 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 111.339 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 40.21 61.34 1.56 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.355 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.465 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -64.58 -119.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.596 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.9 OUTLIER 170.54 -92.37 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.902 0.382 . . . . 0.0 111.733 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.636 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 28.8 m-20 -49.95 178.2 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.206 0.527 . . . . 0.0 111.133 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 151' ' ' ASP . 99.9 m-20 -68.54 -42.37 78.51 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.854 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.26 3.98 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 2.7 p30 -133.79 150.2 51.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.483 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 8.7 tp -119.6 89.43 41.04 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-O 120.406 0.146 . . . . 0.0 110.685 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 37.6 Cg_exo -57.48 147.29 79.23 Favored 'Trans proline' 0 C--N 1.288 -2.618 0 C-N-CA 122.236 1.957 . . . . 0.0 113.612 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.67 ' CD1' ' HB1' ' A' ' 140' ' ' ALA . 5.9 p90 -172.53 156.89 3.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.618 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 157' ' ' GLY . 3.4 ttmp? -169.69 -55.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.436 0.636 . . . . 0.0 111.697 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 156' ' ' LYS . 8.7 mmmm -45.14 -16.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.999 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 155' ' ' LYS . . . 102.09 57.29 0.81 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -90.47 150.59 21.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.415 0.626 . . . . 0.0 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.6 mm -94.61 115.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 137' ' ' TYR . 8.6 mt -113.26 120.91 42.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.688 -176.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 65.9 tttm -68.87 141.66 55.01 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.642 ' O ' ' O ' ' A' ' 172' ' ' ASN . 34.7 mm -75.98 -64.17 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.866 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 162' ' ' ILE . 56.0 ttt180 79.96 -44.07 0.27 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.869 0.366 . . . . 0.0 111.31 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -146.08 122.49 10.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.454 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.555 ' HG3' ' NE1' ' A' ' 171' ' ' TRP . 2.4 ttmt -107.67 74.67 0.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.24 -60.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.166 1.911 . . . . 0.0 111.994 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.98 161.0 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -84.79 -34.81 22.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.632 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 92.8 mt-30 -83.53 -29.08 28.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.444 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.43 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 70.9 m95 -122.99 149.85 43.76 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.559 ' CD2' HG22 ' A' ' 185' ' ' VAL . 17.1 m0 -138.34 129.6 27.35 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.349 0.595 . . . . 0.0 111.418 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 162' ' ' ILE . 53.1 t30 -80.81 108.04 14.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.62 171.64 7.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.569 0.543 . . . . 0.0 111.087 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 72.7 tt0 -125.14 135.7 52.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.111 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.37 172.32 2.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.445 0.641 . . . . 0.0 110.578 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.0 mmm -79.89 -0.0 33.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.004 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -104.43 -27.73 11.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.55 49.82 0.34 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 174' ' ' GLU . 46.7 mttt -131.08 134.33 46.51 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.644 -0.778 . . . . 0.0 110.81 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.14 51.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.527 0.68 . . . . 0.0 111.99 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.03 154.25 25.34 Favored Glycine 0 C--N 1.317 -0.516 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.086 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 tpt -68.35 162.78 24.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.371 0.605 . . . . 0.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 5.4 pt -154.8 143.2 14.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.432 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HG2' ' CG ' ' A' ' 187' ' ' TYR . 18.4 Cg_endo -70.19 118.05 5.46 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.346 1.364 . . . . 0.0 108.888 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.896 ' O ' HG22 ' A' ' 188' ' ' VAL . 15.6 t -50.99 -53.46 47.87 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 121.755 -0.59 . . . . 0.0 111.712 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 16.5 Cg_endo -51.93 -25.29 21.37 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 122.313 2.009 . . . . 0.0 113.578 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.8 m-85 -72.2 9.7 0.93 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 185' ' ' VAL . 4.8 m -135.4 167.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.948 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.722 ' CD ' HD21 ' A' ' 141' ' ' LEU . 36.7 mt-10 -91.94 -70.56 0.68 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.452 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.619 ' O ' HG12 ' A' ' 138' ' ' VAL . 4.8 tptp . . . . . 0 CA--C 1.51 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.57 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 141.95 -173.52 23.6 Favored Glycine 1 CA--C 1.442 -4.488 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.615 178.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.483 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 5.9 Cg_exo -46.0 105.77 0.03 OUTLIER 'Cis proline' 1 N--CA 1.536 4.024 0 O-C-N 123.755 1.397 . . . . 0.0 115.488 0.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.57 ' CD1' ' HA2' ' A' ' 237' ' ' GLY . 9.1 m-30 -120.57 -127.78 0.27 Allowed 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.624 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.8 OUTLIER -141.46 124.01 15.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.66 0.743 . . . . 0.0 110.198 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.924 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -104.59 -163.0 0.93 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.387 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 19.5 tpp180 -161.47 89.87 0.77 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.214 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 243' ' ' VAL . 5.3 p -64.7 121.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.505 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.98 12.32 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.554 ' HA ' HG22 ' A' ' 261' ' ' VAL . 2.0 mm-40 -169.01 120.39 0.74 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 110.565 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.839 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -163.04 -145.56 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.591 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.4 ptt85 -155.75 -142.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.654 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 248' ' ' VAL . 78.7 t -132.84 67.83 78.3 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.608 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 74.5 Cg_endo -91.62 172.7 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.135 2.557 . . . . 0.0 111.61 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.765 ' O ' ' N ' ' A' ' 252' ' ' TYR . 1.9 p-10 -143.98 140.83 29.85 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.914 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.32 -2.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.887 0.742 . . . . 0.0 112.184 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.765 ' N ' ' O ' ' A' ' 250' ' ' ASN . 2.5 m-85 -96.78 -54.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 123.591 0.756 . . . . 0.0 110.044 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -44.41 -65.84 0.47 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.555 ' C ' ' H ' ' A' ' 256' ' ' ALA . 25.8 mttt -149.05 33.3 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.757 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.408 ' O ' ' CA ' ' A' ' 285' ' ' GLY . 1.7 m 71.19 -16.53 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.822 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -48.81 161.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.826 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -105.29 150.53 25.08 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.263 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.846 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -91.57 119.44 31.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 258' ' ' ALA . 3.7 mt -140.48 -172.14 3.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.438 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 17.8 tt0 -147.23 146.13 29.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.065 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 245' ' ' GLN . 68.9 t -55.35 102.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.639 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 121.84 8.01 7.66 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 64.8 mm-40 -90.57 -124.8 0.07 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.841 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.3 OUTLIER 161.61 136.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.053 ' N ' HD12 ' A' ' 264' ' ' LEU . 10.7 p -126.29 142.78 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.287 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 2.6 ttmt -100.63 83.36 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.188 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 75.2 t -51.96 151.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.449 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -151.7 -51.34 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.693 -178.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.524 ' O ' ' OE1' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -70.52 104.13 2.68 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.076 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 270' ' ' ILE . 1.7 mp -95.14 154.61 3.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 271' ' ' ASN . 2.2 p30 -171.63 -97.83 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.153 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.617 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 19.3 mtm -59.0 134.91 57.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.831 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.9 p -66.97 25.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -152.12 -69.89 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.617 ' O ' ' HE3' ' A' ' 272' ' ' MET . 21.4 mp0 -92.19 112.52 24.49 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.148 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.542 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -116.18 -171.8 2.06 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.524 ' OE1' ' O ' ' A' ' 269' ' ' LYS . 54.8 mp0 -97.09 -160.49 0.8 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.492 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -173.76 117.71 0.66 Allowed Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.525 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.466 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.2 tt0 -99.49 127.82 45.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.34 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.729 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -144.39 78.97 1.59 Allowed 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 3.9 m-20 82.63 30.09 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 0.0 109.921 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 93.95 -32.64 5.72 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.405 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.571 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.4 OUTLIER -66.21 72.81 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.762 -178.266 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.554 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 90.5 mtt180 -72.82 168.04 19.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 123.886 0.741 . . . . 0.0 109.918 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 168.94 -158.07 30.48 Favored Glycine 0 C--O 1.206 -1.653 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.588 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 3.8 p80 -124.71 167.41 14.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.249 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 167.65 115.14 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.223 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.5 Cg_exo -51.68 145.13 31.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.963 1.775 . . . . 0.0 112.304 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.2 OUTLIER -64.25 -0.11 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 110.465 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.2 p -56.27 3.85 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 O-C-N 121.81 -0.556 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' A' ' 289' ' ' PHE . 3.9 p-80 -156.11 69.69 0.66 Allowed 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.574 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -165.86 154.33 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -129.35 76.19 1.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.24 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.6 mt -38.08 127.97 1.3 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.438 0.637 . . . . 0.0 111.368 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.97 -99.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.767 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -159.02 -85.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.412 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.577 ' NE2' ' OE1' ' A' ' 169' ' ' GLN . 4.3 tp60 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.474 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.958 ' O ' HG22 ' A' ' 138' ' ' VAL . 13.1 p90 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.902 -0.57 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.958 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.4 m 86.17 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 125.0 1.437 . . . . 0.0 111.646 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -128.15 138.29 52.44 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -96.84 98.92 10.52 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.753 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.497 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -104.51 37.51 2.1 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.271 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 53.5 m-85 -135.17 0.82 2.88 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.515 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER 60.55 139.51 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.887 0.742 . . . . 0.0 109.273 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.0 t80 -128.48 -38.68 1.72 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.079 0.399 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t30 40.54 56.25 2.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.517 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.67 -132.3 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.631 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.8 OUTLIER 169.5 -89.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.355 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.58 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.7 m-20 -19.58 134.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 112.225 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.2 -3.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.442 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 148' ' ' ASP . 12.5 pt-20 -108.12 16.76 23.03 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.631 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 8.2 p30 -137.54 152.82 49.86 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 182' ' ' MET . 12.6 tp -107.72 90.35 6.16 Favored Pre-proline 0 C--O 1.215 -0.76 0 CA-C-N 118.181 0.446 . . . . 0.0 110.717 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 74.1 Cg_endo -66.97 146.47 77.62 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 C-N-CA 121.364 1.376 . . . . 0.0 114.082 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 11.8 p90 -169.97 162.84 9.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.82 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -152.76 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.885 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -97.93 129.44 44.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.879 0.847 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . 88.89 12.39 64.0 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.45 ' C ' HD12 ' A' ' 159' ' ' ILE . 27.0 t0 -75.04 139.8 43.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -97.56 114.76 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.459 HD11 ' CD2' ' A' ' 154' ' ' PHE . 10.8 mt -125.42 133.9 52.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.923 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -81.6 140.2 34.58 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.108 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.2 mp -66.37 -52.07 51.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.656 ' CZ ' HH21 ' A' ' 180' ' ' ARG . 54.1 ttt85 66.85 -48.18 0.46 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.306 0.379 . . . . 0.0 111.215 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 162' ' ' ILE . 41.0 t0 -152.93 133.5 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.432 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.44 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.9 pttp -133.94 78.67 59.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.64 -31.2 7.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.165 1.91 . . . . 0.0 112.539 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -101.81 -174.47 2.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 168' ' ' GLU . 1.5 pm0 -115.25 -13.97 11.71 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -109.47 -29.33 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.825 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 76.5 m95 -121.04 146.25 46.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.608 ' CD2' HG22 ' A' ' 185' ' ' VAL . 16.4 m0 -137.38 125.61 23.14 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 162' ' ' ILE . 18.9 t-20 -76.09 101.62 5.39 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.38 173.56 6.25 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.467 0.479 . . . . 0.0 111.079 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 21.4 tt0 -121.45 123.63 42.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.067 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.75 173.35 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.234 0.54 . . . . 0.0 110.211 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 96.1 mtp -72.84 -3.05 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.851 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 179' ' ' LYS . 89.5 m-20 -98.63 -20.23 17.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.361 0.601 . . . . 0.0 110.905 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 120.68 -28.89 6.03 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 177' ' ' ASP . 16.9 mttp -52.49 146.79 9.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.19 0.519 . . . . 0.0 110.813 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.656 HH21 ' CZ ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -114.67 130.62 56.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.344 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.84 157.12 28.37 Favored Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.387 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.525 ' C ' HG22 ' A' ' 183' ' ' ILE . 1.8 tpt -68.4 163.28 23.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.169 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.879 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -161.32 147.79 11.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.554 178.459 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.07 115.84 4.47 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.107 1.205 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 188' ' ' VAL . 38.3 t -53.49 -52.05 70.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 122.041 -0.412 . . . . 0.0 111.541 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.2 Cg_endo -49.11 -27.7 12.81 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.487 2.125 . . . . 0.0 113.345 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.28 4.95 0.43 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.055 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 138' ' ' VAL . 1.8 m -130.43 168.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 123.109 0.256 . . . . 0.0 110.764 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -100.09 -66.34 0.91 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.027 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 45.0 tptt . . . . . 0 CA--C 1.542 0.653 0 O-C-N 124.993 1.433 . . . . 0.0 109.703 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 15.4 p30 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.55 0.691 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.476 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -61.37 -175.73 1.8 Allowed Glycine 1 CA--C 1.447 -4.164 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.23 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.476 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.9 Cg_endo -53.21 122.97 0.4 Allowed 'Cis proline' 0 N--CA 1.525 3.367 0 N-CA-C 116.481 1.685 . . . . 0.0 116.481 -1.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.2 m-85 -154.67 -121.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.7 OUTLIER -145.18 135.09 23.69 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 118.976 0.807 . . . . 0.0 108.962 -179.063 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.541 ' O ' HD13 ' A' ' 295' ' ' LEU . . . -117.94 -148.51 0.42 Allowed 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.174 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 262' ' ' GLY . 21.6 tpp180 -161.93 95.15 0.96 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.627 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 263' ' ' GLU . 2.9 p -61.62 137.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.783 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.8 20.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 176.48 103.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -145.88 -143.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.959 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -155.51 -139.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.015 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 248' ' ' VAL . 70.8 t -133.91 68.65 75.11 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-O 121.215 0.531 . . . . 0.0 110.887 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.649 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 61.3 Cg_endo -91.63 175.63 2.17 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.816 2.344 . . . . 0.0 111.209 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.767 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.9 OUTLIER -142.89 140.0 31.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -37.1 -8.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.46 0.648 . . . . 0.0 111.983 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.767 ' N ' ' O ' ' A' ' 250' ' ' ASN . 4.8 m-85 -92.41 -48.77 6.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 250' ' ' ASN . 27.9 t0 -65.09 56.39 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.661 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 256' ' ' ALA . 33.0 mtmt 85.55 20.28 0.1 Allowed 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.642 1.214 . . . . 0.0 111.47 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.519 ' O ' ' O ' ' A' ' 284' ' ' ARG . 2.4 m 75.49 -19.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.021 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -39.74 107.52 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.949 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -47.03 157.3 0.17 Allowed 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.777 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.83 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -110.17 124.43 51.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.954 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.83 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.3 mt -142.66 -179.08 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.069 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 6.7 tt0 -133.86 146.06 50.24 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.787 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 52.9 t -45.96 110.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.102 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.781 ' O ' ' O ' ' A' ' 263' ' ' GLU . . . 131.06 -70.56 0.52 Allowed Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.781 ' O ' ' O ' ' A' ' 262' ' ' GLY . 4.1 mm-40 -29.08 -163.4 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.444 0 O-C-N 125.764 1.508 . . . . 0.0 114.142 -172.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 264' ' ' LEU . 3.8 pp -155.57 166.04 34.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.281 1.038 . . . . 0.0 112.518 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.09 143.22 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.525 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 279' ' ' GLU . 0.0 OUTLIER -101.39 85.32 2.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.591 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.2 155.49 2.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.939 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.73 -56.24 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.038 0.446 . . . . 0.0 109.807 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 102.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.689 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.61 HG23 ' CE3' ' A' ' 276' ' ' TRP . 5.7 mt -115.17 106.46 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.871 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 272' ' ' MET . 5.5 p30 -111.45 -101.53 0.4 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.623 ' O ' ' CE3' ' A' ' 276' ' ' TRP . 38.6 mtm -51.26 148.33 4.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.003 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 p -72.17 16.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.507 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.86 -80.9 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.227 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -86.18 116.37 24.33 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 121.002 0.429 . . . . 0.0 111.358 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -134.58 -172.92 3.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.742 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.53 -171.79 2.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.92 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -159.89 -152.78 6.64 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.056 -1.068 . . . . 0.0 112.348 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 281' ' ' ASN . 0.5 OUTLIER -168.59 139.33 2.53 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.192 0.52 . . . . 0.0 112.168 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.706 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -148.05 76.25 1.37 Allowed 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.102 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 279' ' ' GLU . 2.5 m-20 84.35 36.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.81 -35.84 3.67 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.843 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -63.89 88.0 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.169 0.509 . . . . 0.0 110.257 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.519 ' O ' ' O ' ' A' ' 255' ' ' THR . 43.9 mtt85 -86.45 168.1 14.07 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.278 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.11 -154.6 24.68 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.583 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 13.1 p80 -129.37 172.14 11.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.2 114.39 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.431 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.526 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 54.5 Cg_exo -48.4 129.53 19.67 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.222 1.281 . . . . 0.0 112.255 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -62.98 -1.92 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.275 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 288' ' ' PRO . 53.0 p -58.77 2.21 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.889 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.2 p-80 -142.82 50.88 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.739 0.304 . . . . 0.0 111.633 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.416 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.2 OUTLIER -145.89 166.3 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 294' ' ' LEU . 18.8 mtm180 -136.85 77.02 1.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.529 0.204 . . . . 0.0 110.878 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 35.1 mt -34.29 134.37 0.2 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.398 0.618 . . . . 0.0 111.274 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 241' ' ' ALA . 3.4 mp -79.08 -165.39 0.75 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.365 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 42.5 p-10 -77.43 -0.42 25.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.63 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 27.5 tt0 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.09 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.671 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.671 ' O ' ' O ' ' A' ' 137' ' ' TYR . 32.6 m 36.38 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 122.08 0.943 . . . . 0.0 112.635 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 14.9 ttp180 -143.47 120.38 11.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.413 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -98.78 91.51 5.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 124.321 1.013 . . . . 0.0 111.812 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.727 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -99.78 18.97 16.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.285 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.575 ' CE1' ' CZ ' ' A' ' 284' ' ' ARG . 46.8 m-85 -114.98 0.91 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.7 OUTLIER 58.57 138.01 0.01 OUTLIER 'General case' 0 C--O 1.209 -1.035 0 O-C-N 124.407 1.067 . . . . 0.0 110.014 -179.194 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.433 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 17.2 t80 -130.06 -46.69 1.12 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.905 0.321 . . . . 0.0 110.44 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 144' ' ' PHE . 66.3 t30 36.04 58.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.484 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -61.6 -93.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 170.31 15.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.966 0.888 . . . . 0.0 110.316 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 151' ' ' ASP . 1.3 p-10 33.66 -159.2 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.156 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.511 ' N ' ' OD2' ' A' ' 148' ' ' ASP . 97.7 m-20 48.64 38.81 12.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 149' ' ' ASP . 3.6 mm-40 149.71 -10.2 0.0 OUTLIER 'General case' 0 C--N 1.345 0.386 0 O-C-N 124.701 1.251 . . . . 0.0 108.987 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 0.2 OUTLIER -157.45 -178.02 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.793 -178.06 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 175' ' ' ASP . 10.7 tp -118.04 87.67 29.27 Favored Pre-proline 0 C--O 1.206 -1.203 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.508 ' HD3' ' H ' ' A' ' 148' ' ' ASP . 71.6 Cg_endo -71.38 139.74 35.4 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 CA-C-N 120.03 1.046 . . . . 0.0 112.079 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.609 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.1 p90 -160.9 163.76 31.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -155.88 169.08 25.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.811 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 157' ' ' GLY . 3.5 ttmt 50.43 82.67 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.334 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.1 47.41 0.01 OUTLIER Glycine 0 N--CA 1.467 0.715 0 O-C-N 123.834 0.709 . . . . 0.0 113.008 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.502 ' C ' HD12 ' A' ' 159' ' ' ILE . 35.3 t0 -62.71 159.69 15.74 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.547 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.565 HG23 ' CB ' ' A' ' 137' ' ' TYR . 1.5 mp -109.2 106.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 154' ' ' PHE . 6.4 mt -109.47 106.84 16.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.458 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -64.73 129.12 38.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.64 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.964 HG22 ' H ' ' A' ' 163' ' ' ARG . 42.7 mm -66.44 -134.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.857 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.964 ' H ' HG22 ' A' ' 162' ' ' ILE . 77.4 ttt180 175.75 -48.78 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.518 0.675 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.63 -19.12 0.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.071 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.4 pttt 37.04 72.89 0.76 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 123.205 0.315 . . . . 0.0 111.202 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.28 -43.15 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.592 1.528 . . . . 0.0 112.059 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.59 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 76.4 mm-40 -99.29 157.06 16.65 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.909 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.427 ' O ' HG21 ' A' ' 185' ' ' VAL . 2.7 pt-20 -85.06 -36.46 21.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.381 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -82.59 -26.14 32.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.831 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 85.2 m95 -127.32 150.98 49.34 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.666 ' CE3' HG22 ' A' ' 185' ' ' VAL . 13.0 m0 -145.07 136.03 24.73 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.874 0.368 . . . . 0.0 110.234 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -86.8 110.36 19.89 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.43 ' HB3' HG21 ' A' ' 183' ' ' ILE . . . -119.62 -178.58 3.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.633 . . . . 0.0 111.528 -178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -123.68 125.35 44.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -56.8 172.5 0.26 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.94 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -78.61 2.67 18.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.059 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.99 -29.26 10.57 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.05 51.16 0.52 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -135.81 140.51 44.29 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.644 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.06 121.43 44.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 111.343 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . 0.446 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -155.28 153.29 24.67 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.191 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.5 mtp -65.9 152.41 44.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -138.49 143.36 38.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.023 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.57 114.58 4.05 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.314 1.343 . . . . 0.0 108.914 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.801 ' O ' HG22 ' A' ' 188' ' ' VAL . 47.4 t -52.85 -51.23 76.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.823 -0.548 . . . . 0.0 111.944 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.6 Cg_endo -48.56 -29.39 13.94 Favored 'Trans proline' 0 N--CA 1.504 2.137 0 C-N-CA 122.669 2.246 . . . . 0.0 113.014 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.8 m-85 -67.93 -0.92 4.8 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.712 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.2 m -128.98 166.41 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.283 0.364 . . . . 0.0 110.633 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.727 ' CD ' HD21 ' A' ' 141' ' ' LEU . 2.5 pt-20 -146.72 50.58 1.12 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.476 ' O ' HG12 ' A' ' 138' ' ' VAL . 3.8 tmtt? . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.125 0.488 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.594 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -59.83 -178.61 1.62 Allowed Glycine 1 CA--C 1.427 -5.427 0 CA-C-O 122.631 1.128 . . . . 0.0 115.464 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.594 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 3.3 Cg_exo -52.44 127.83 1.01 Allowed 'Cis proline' 1 N--CA 1.538 4.095 0 O-C-N 124.766 1.929 . . . . 0.0 115.698 -1.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.6 m-85 -155.24 -122.87 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.72 123.85 14.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 120.389 1.45 . . . . 0.0 109.165 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.502 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -108.53 141.75 39.96 Favored 'General case' 0 C--O 1.19 -2.043 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.247 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -104.57 96.99 6.97 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 121.616 0.722 . . . . 0.0 110.664 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.824 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.9 p -69.1 112.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.616 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.589 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.2 pt -105.78 17.79 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.194 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.465 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.9 mm-40 -176.79 119.84 0.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.085 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.805 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.5 ttmt -161.24 -145.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.982 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 2.9 ptt85 -156.25 -141.42 0.09 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.821 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 248' ' ' VAL . 69.3 t -134.6 69.39 72.4 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.572 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 59.7 Cg_endo -98.46 177.93 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.381 2.721 . . . . 0.0 111.915 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.665 ' C ' ' H ' ' A' ' 252' ' ' TYR . 1.5 p-10 -157.25 151.73 25.24 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.896 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -41.5 -4.85 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.665 ' H ' ' C ' ' A' ' 250' ' ' ASN . 38.2 m-85 -95.19 -53.11 3.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.294 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 17.9 t0 -45.61 -57.84 3.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.899 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.524 ' CE ' HH21 ' A' ' 247' ' ' ARG . 13.1 pttt -169.82 39.66 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.157 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 56.92 46.09 20.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.453 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -121.45 119.57 32.44 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.774 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -51.02 159.62 0.57 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 123.083 0.553 . . . . 0.0 112.329 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.812 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -106.38 114.35 28.41 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.0 OUTLIER -139.59 -178.37 5.37 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.871 0.843 . . . . 0.0 111.607 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 8.0 tt0 -144.67 143.96 31.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.906 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 244' ' ' ILE . 84.6 t -47.7 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.637 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.24 7.39 10.13 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 12.1 mm-40 -86.85 -39.08 16.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.567 0.699 . . . . 0.0 112.641 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.008 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 66.49 139.45 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.18 0.99 . . . . 0.0 109.416 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.008 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.6 p -136.71 155.33 33.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.946 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -100.64 96.31 7.26 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.312 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.813 ' O ' ' N ' ' A' ' 269' ' ' LYS . 34.2 t -50.49 -37.22 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.519 HG23 ' N ' ' A' ' 269' ' ' LYS . 15.1 t 39.58 -64.25 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 O-C-N 124.3 1.0 . . . . 0.0 112.019 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' A' ' 267' ' ' VAL . 7.8 tppt? -76.13 114.25 14.58 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.996 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -119.82 107.88 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.028 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.546 ' ND2' ' OE2' ' A' ' 277' ' ' GLU . 2.7 p30 -114.83 -93.38 0.49 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.631 0.729 . . . . 0.0 110.505 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.55 ' O ' ' CZ3' ' A' ' 276' ' ' TRP . 26.8 mtm -55.22 134.84 49.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.143 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.459 ' HA ' ' CH2' ' A' ' 276' ' ' TRP . 5.7 p -63.16 14.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.788 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -144.37 -61.6 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.204 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 2.3 mp0 -60.34 -86.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.607 0.717 . . . . 0.0 110.353 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.573 ' CE3' HG22 ' A' ' 270' ' ' ILE . 47.6 m95 95.95 144.23 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.565 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.546 ' OE2' ' ND2' ' A' ' 271' ' ' ASN . 11.6 mt-10 -99.2 107.65 20.04 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.375 0.607 . . . . 0.0 112.187 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -67.66 -178.94 13.66 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 118.734 -1.698 . . . . 0.0 113.465 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.507 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 4.1 tt0 -168.35 107.53 0.5 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.649 -0.776 . . . . 0.0 110.368 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.698 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -129.58 75.75 1.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.988 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 37.0 t30 85.17 29.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.998 0.428 . . . . 0.0 110.346 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 99.17 -30.01 10.7 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.484 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -68.4 77.29 0.27 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.575 ' CZ ' ' CE1' ' A' ' 142' ' ' PHE . 87.0 mtt180 -79.18 175.84 10.22 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.428 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.05 -147.88 11.64 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 8.2 p80 -141.8 175.37 9.76 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 118.279 1.039 . . . . 0.0 109.378 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.657 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.3 m-85 161.62 152.84 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 O-C-N 123.687 0.617 . . . . 0.0 111.534 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.598 ' HB2' HG23 ' A' ' 290' ' ' THR . 51.2 Cg_endo -72.75 148.52 46.73 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 123.096 2.531 . . . . 0.0 112.983 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 29.4 t80 -74.58 -2.15 24.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.158 0.504 . . . . 0.0 109.77 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 288' ' ' PRO . 23.5 p -61.39 -8.33 3.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.049 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.517 ' CE1' ' CE ' ' A' ' 246' ' ' LYS . 7.0 p80 -136.79 53.9 1.89 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -152.9 150.58 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.151 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 294' ' ' LEU . 30.5 mmm-85 -131.91 77.1 1.74 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.667 0.27 . . . . 0.0 110.952 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 293' ' ' ARG . 45.1 mt -34.13 122.22 0.48 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.487 1.137 . . . . 0.0 112.187 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.1 mp -61.01 -173.56 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.082 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 296' ' ' ASP . 26.7 p-10 -74.94 18.42 0.18 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.061 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.478 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.5 tt0 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.528 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.1 m -148.33 164.93 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.739 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -128.42 132.24 48.47 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -101.57 96.87 7.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.651 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.636 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -99.95 18.69 17.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.46 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.597 ' CE1' ' NH1' ' A' ' 284' ' ' ARG . 51.1 m-85 -115.69 5.01 14.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.5 p30 56.86 149.12 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.947 0 O-C-N 124.44 1.087 . . . . 0.0 109.903 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 10.3 t80 -140.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.167 0.439 . . . . 0.0 110.761 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 42.12 63.55 1.33 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.228 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.514 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.45 -126.12 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.542 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 165.2 -40.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.026 0.413 . . . . 0.0 112.111 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 20.0 m-20 -73.65 160.23 31.89 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.211 0.529 . . . . 0.0 111.217 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.3 -17.59 63.74 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.503 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 150' ' ' GLU . 55.2 mp0 -98.36 31.28 2.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 38.0 p30 -145.55 164.18 32.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.029 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.459 ' CB ' HG22 ' A' ' 183' ' ' ILE . 11.9 tp -122.01 84.5 45.09 Favored Pre-proline 0 C--O 1.213 -0.835 0 CA-C-O 120.39 0.138 . . . . 0.0 111.149 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.514 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 24.5 Cg_exo -59.98 140.15 91.35 Favored 'Trans proline' 0 C--N 1.284 -2.831 0 C-N-CA 122.442 2.094 . . . . 0.0 113.528 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.702 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 11.6 p90 -162.32 158.47 24.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.344 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -54.02 0.65 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.447 0.641 . . . . 0.0 112.059 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 158' ' ' ASP . 15.4 mmtt -88.6 90.54 8.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.614 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 14.56 53.65 0.01 OUTLIER Glycine 0 C--N 1.343 0.971 0 O-C-N 124.115 0.884 . . . . 0.0 111.844 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 156' ' ' LYS . 34.5 t0 -66.12 139.59 58.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.404 0.621 . . . . 0.0 109.82 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.4 mp -86.41 100.06 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.35 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.404 HD11 ' CD2' ' A' ' 154' ' ' PHE . 4.8 mt -106.52 106.56 17.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.749 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.61 141.4 48.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.606 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.5 mp -81.04 139.49 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -114.18 -47.62 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.532 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -140.95 113.81 8.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.151 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.442 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 29.6 pttt -112.37 75.16 1.65 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.324 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.81 -25.07 24.15 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.122 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -118.79 166.83 12.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.635 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -95.87 -28.82 14.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.767 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -85.16 -19.65 31.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.548 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 65.7 m95 -131.17 154.61 48.2 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.552 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.7 m0 -144.67 135.32 24.65 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.272 0.558 . . . . 0.0 111.231 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.72 115.23 24.03 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.62 -178.5 4.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.746 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -125.89 137.77 53.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.4 OUTLIER -85.1 135.36 34.02 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.222 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -45.74 -8.19 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.568 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.6 ' H ' ' C ' ' A' ' 175' ' ' ASP . 56.5 m-20 -78.03 -31.48 50.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 110.759 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.59 45.26 0.92 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.695 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -143.79 143.28 31.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.612 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.55 129.89 53.72 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . 0.448 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -158.65 155.09 26.14 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.534 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.03 152.56 44.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.459 HG22 ' CB ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -141.17 142.24 26.52 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.53 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.406 ' HG2' ' CG ' ' A' ' 187' ' ' TYR . 20.5 Cg_endo -69.49 118.99 6.01 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.096 1.198 . . . . 0.0 109.048 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 24.1 t -53.96 -52.1 71.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 121.874 -0.516 . . . . 0.0 111.779 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.6 Cg_endo -53.02 -24.64 25.6 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.317 2.011 . . . . 0.0 113.618 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.529 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.5 m-85 -68.59 0.38 4.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.812 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.2 m -132.06 166.24 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.535 0.207 . . . . 0.0 110.476 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.636 ' CD ' HD21 ' A' ' 141' ' ' LEU . 1.9 pt-20 -130.29 58.6 1.67 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.846 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 13.1 mptt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 70.2 m-20 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.526 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -94.04 -167.91 37.54 Favored Glycine 1 CA--C 1.445 -4.3 0 CA-C-O 121.773 0.652 . . . . 0.0 113.965 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.55 98.32 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.752 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 0.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.526 ' CD1' ' HA2' ' A' ' 237' ' ' GLY . 4.0 m-30 -117.06 -130.7 0.31 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.412 ' H ' ' HB3' ' A' ' 239' ' ' PHE . 2.3 m-30 -137.11 119.51 15.81 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.765 0.793 . . . . 0.0 109.169 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -111.75 142.35 44.2 Favored 'General case' 0 C--O 1.188 -2.159 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.047 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 15.6 tpp180 -103.96 110.44 22.59 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.873 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.5 p -82.58 74.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 123.702 0.626 . . . . 0.0 111.936 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.825 ' HA ' ' O ' ' A' ' 261' ' ' VAL . 1.4 pt -60.81 24.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.617 ' H ' ' C ' ' A' ' 243' ' ' VAL . 1.6 mm-40 173.46 130.88 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.492 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.864 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -165.68 -144.81 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.444 176.183 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 4.3 ptt85 -156.91 -140.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.381 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 248' ' ' VAL . 76.7 t -138.3 68.59 47.35 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.69 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 55.7 Cg_endo -96.07 179.65 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.422 2.748 . . . . 0.0 111.75 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.751 ' C ' ' H ' ' A' ' 252' ' ' TYR . 10.7 p-10 -148.66 145.64 27.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.362 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.88 4.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.751 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.0 m-85 -98.82 -55.4 2.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.952 0.901 . . . . 0.0 110.58 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -44.6 -67.41 0.29 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.846 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.523 ' O ' ' CE1' ' A' ' 286' ' ' HIS . 27.1 mtmt -149.11 36.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.453 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 60.45 38.63 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' A' ' 287' ' ' PHE . . . -109.0 170.55 7.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.755 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -112.32 152.64 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.122 0.569 . . . . 0.0 110.807 -178.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.744 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -97.89 119.35 36.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.464 0.649 . . . . 0.0 111.684 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -144.78 -163.03 1.61 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.52 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.672 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -132.58 -176.98 4.28 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 2.3 t -61.11 -34.35 59.86 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 CA-C-O 121.575 0.703 . . . . 0.0 112.379 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.574 ' H ' ' HG2' ' A' ' 260' ' ' GLU . . . -128.41 38.46 2.06 Favored Glycine 0 C--N 1.277 -2.701 0 O-C-N 120.539 -1.351 . . . . 0.0 111.581 -176.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 260' ' ' GLU . 13.0 mm-40 -86.29 -35.68 19.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.279 0.561 . . . . 0.0 111.389 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.992 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.27 139.1 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.061 -178.432 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.992 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.4 p -128.51 150.74 34.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.375 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -100.92 86.92 3.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.989 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 40.9 t -50.97 153.09 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.482 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.529 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -153.33 -53.46 0.11 Allowed 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.125 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 1.9 tpmt? -67.6 146.16 54.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.279 0.562 . . . . 0.0 111.298 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.589 HG23 ' CZ3' ' A' ' 276' ' ' TRP . 3.0 mt -126.48 162.65 30.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.62 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.566 ' N ' HG22 ' A' ' 270' ' ' ILE . 0.7 OUTLIER 171.74 -101.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.583 ' CE ' ' H ' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -73.66 163.04 28.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.551 ' HA ' ' HE1' ' A' ' 276' ' ' TRP . 2.1 p -98.74 29.79 3.59 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -139.65 -39.72 0.09 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.531 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -96.05 -79.72 0.44 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.218 0.532 . . . . 0.0 111.182 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.589 ' CZ3' HG23 ' A' ' 270' ' ' ILE . 17.0 m95 77.6 166.49 0.23 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.194 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 90.3 mt-10 -132.27 148.51 52.45 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -129.09 -141.81 5.19 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 115.094 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.413 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.3 tt0 -173.03 129.79 0.48 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.522 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.71 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.4 OUTLIER -144.32 75.21 1.45 Allowed 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.825 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 13.8 t-20 84.69 27.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.434 0.635 . . . . 0.0 110.001 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 95.78 -32.05 6.68 Favored Glycine 0 N--CA 1.459 0.198 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.49 72.6 0.08 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.597 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 77.2 mtt180 -71.49 168.91 16.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.249 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 170.57 -159.1 31.24 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.632 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 0.0 OUTLIER -135.76 176.15 8.94 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.872 0.469 . . . . 0.0 110.069 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 2.8 m-85 170.54 154.89 0.2 Allowed Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.944 0.778 . . . . 0.0 111.158 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.631 ' HB2' HG23 ' A' ' 290' ' ' THR . 56.2 Cg_endo -74.83 155.59 43.74 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.022 2.481 . . . . 0.0 112.071 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 292' ' ' VAL . 64.0 t80 -74.77 0.48 15.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.554 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.631 HG23 ' HB2' ' A' ' 288' ' ' PRO . 41.4 p -62.68 0.46 0.5 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.507 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.42 62.38 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.611 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -158.05 143.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -127.66 81.15 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 19.4 mt -40.68 131.24 2.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.857 0.837 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.43 -171.61 3.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.272 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -101.2 33.73 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.459 ' OE1' ' CZ ' ' A' ' 239' ' ' PHE . 8.7 tt0 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.432 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.031 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.198 -1.656 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 1.031 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.8 m 90.36 168.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 124.241 0.963 . . . . 0.0 111.922 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -140.63 156.34 46.29 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 155' ' ' LYS . . . -56.73 168.62 0.58 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.67 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -136.02 -36.56 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.643 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.549 ' CE2' ' CZ ' ' A' ' 284' ' ' ARG . 92.5 m-85 -130.51 6.6 4.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.567 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 78.02 136.71 0.06 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.8 t80 -108.27 -49.26 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 110.879 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.461 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 4.0 m120 41.28 66.92 0.6 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.26 -122.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 146' ' ' GLY . 1.7 p30 168.21 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.576 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.594 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 9.0 m-20 -80.66 154.01 27.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.0 -16.83 64.62 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.036 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.15 24.74 4.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 7.5 p30 -144.82 162.44 36.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.038 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.4 tp -112.31 89.71 12.82 Favored Pre-proline 0 C--O 1.215 -0.737 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 59.6 Cg_endo -69.17 127.18 14.68 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 121.692 1.595 . . . . 0.0 112.859 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CG ' HD11 ' A' ' 160' ' ' LEU . 16.7 p90 -147.75 166.94 25.97 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.588 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 143' ' ' ASP . 1.4 tptp -106.65 -141.11 0.37 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 158' ' ' ASP . 24.7 pttm -91.24 174.13 7.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 36.29 20.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 156' ' ' LYS . 14.5 t0 -79.27 132.66 36.55 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.26 111.88 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.095 0.474 . . . . 0.0 110.858 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.44 HD11 ' CG ' ' A' ' 154' ' ' PHE . 7.9 mt -120.57 128.63 53.24 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.6 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 7.8 ttpm? -83.27 135.17 34.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.7 mp -66.3 -51.53 57.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.485 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.601 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 54.2 ttt85 65.94 -49.44 0.41 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.713 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 162' ' ' ILE . 68.2 t0 -149.96 128.43 12.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.115 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.528 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 3.5 ptmm? -121.44 81.74 39.05 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.866 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 -44.01 53.74 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.61 2.207 . . . . 0.0 112.372 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -119.37 176.93 5.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.438 ' O ' HG21 ' A' ' 185' ' ' VAL . 3.5 mm-40 -93.36 -41.82 9.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 240' ' ' TYR . 86.4 mt-30 -72.44 -32.75 66.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.366 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.4 m95 -119.92 153.75 35.43 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.647 ' CD2' HG22 ' A' ' 185' ' ' VAL . 14.0 m0 -143.64 135.69 26.67 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 120.992 0.425 . . . . 0.0 110.739 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.694 ' O ' ' O ' ' A' ' 162' ' ' ILE . 46.4 t30 -86.59 107.78 18.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.68 -179.09 3.55 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.546 0.529 . . . . 0.0 110.379 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 74.0 tt0 -126.13 136.09 52.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.514 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 171.39 3.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.651 0.739 . . . . 0.0 110.636 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 1.28 23.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.608 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -105.46 -28.94 10.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.16 50.48 0.34 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 174' ' ' GLU . 36.2 mttt -134.24 138.76 45.29 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.35 -0.925 . . . . 0.0 111.212 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.601 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.1 OUTLIER -108.92 122.12 46.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.569 0.7 . . . . 0.0 111.76 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.0 24.41 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.771 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.08 162.06 25.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 -179.121 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.789 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -157.62 152.16 20.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.954 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.04 113.44 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.199 1.266 . . . . 0.0 110.554 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.647 HG22 ' CD2' ' A' ' 171' ' ' TRP . 42.4 t -50.48 -50.96 68.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.953 -0.467 . . . . 0.0 111.275 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.0 Cg_endo -45.87 -34.66 12.65 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.933 1.755 . . . . 0.0 112.84 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 7.2 m-85 -63.81 -8.23 10.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.975 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.987 HG21 HG21 ' A' ' 138' ' ' VAL . 1.3 m -135.22 166.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.812 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 190' ' ' LYS . 0.6 OUTLIER -150.43 -51.18 0.13 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.644 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.746 ' O ' HG12 ' A' ' 138' ' ' VAL . 13.9 mmtp . . . . . 0 CA--C 1.516 -0.341 0 O-C-N 123.639 0.587 . . . . 0.0 111.485 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.49 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -55.83 -168.97 0.07 OUTLIER Glycine 1 CA--C 1.439 -4.698 0 CA-C-O 122.314 0.952 . . . . 0.0 114.096 -179.088 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.45 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.7 Cg_exo -47.61 110.82 0.08 OUTLIER 'Cis proline' 1 N--CA 1.544 4.45 0 O-C-N 123.917 1.482 . . . . 0.0 115.253 0.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.631 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.0 m-30 -126.7 -136.45 0.25 Allowed 'General case' 0 C--O 1.212 -0.887 0 O-C-N 124.242 0.964 . . . . 0.0 109.128 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 169' ' ' GLN . 2.7 m-30 -134.86 114.58 12.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.903 0.859 . . . . 0.0 109.754 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.41 140.79 39.8 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.695 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 10.7 tpp85 -104.32 100.77 10.49 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.396 -0.815 . . . . 0.0 109.792 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 243' ' ' VAL . 4.9 p -71.92 121.74 22.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.178 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.997 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.2 OUTLIER -121.62 20.67 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -172.9 108.33 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.418 0.628 . . . . 0.0 109.695 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -154.49 -140.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.53 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -158.21 -142.12 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 248' ' ' VAL . 66.0 t -134.47 70.49 72.4 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.761 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.513 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 44.8 Cg_endo -90.16 168.91 4.34 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.954 2.436 . . . . 0.0 111.475 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.734 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -131.57 130.2 41.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.831 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.33 -4.87 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.832 0.708 . . . . 0.0 111.994 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.734 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.4 m-85 -93.39 -54.67 3.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.848 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 250' ' ' ASN . 41.9 t0 -41.35 -62.57 0.83 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.553 -177.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.6 mtmt -151.34 26.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.999 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.2 m 75.21 -21.48 0.3 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.628 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -42.24 107.44 0.08 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.224 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.96 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -44.92 157.77 0.07 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.363 178.151 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.809 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.23 121.42 44.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.752 0.658 . . . . 0.0 110.723 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.4 mt -140.42 -173.95 3.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.928 0.394 . . . . 0.0 111.243 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.2 tt0 -144.95 152.28 39.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.955 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.85 106.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.621 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.94 8.72 8.64 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 46.7 mm-40 -96.8 -135.93 0.24 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 172.1 136.8 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.999 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.8 p -127.09 153.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.014 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 265' ' ' VAL . 1.8 ttmm -105.48 95.15 5.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 268' ' ' THR . 18.2 t -63.03 161.46 2.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.058 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -152.66 -62.38 0.16 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.657 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -71.69 132.14 44.15 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.425 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.745 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -148.05 145.39 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.375 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.4 p30 174.49 -136.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.876 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 47.6 mtm 54.51 -122.47 1.96 Allowed 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.259 0.552 . . . . 0.0 111.163 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -143.96 -16.63 0.6 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.035 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.525 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -168.13 -15.14 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.232 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.589 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.0 mp0 -97.06 159.58 14.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.632 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.589 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -167.57 161.02 13.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.556 -178.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 8.7 mt-10 -93.84 -168.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.255 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.29 179.36 28.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.507 ' OE1' ' NH2' ' A' ' 284' ' ' ARG . 5.2 tt0 -168.8 113.82 0.59 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.118 0.485 . . . . 0.0 110.686 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.628 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -109.45 -99.85 0.39 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -91.64 48.68 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.33 -29.62 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' SG ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.7 92.5 0.22 Allowed 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.303 -177.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.549 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 78.3 mtt180 -87.11 172.35 10.01 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.159 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 166.04 -152.44 21.63 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.564 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 11.3 p80 -126.23 166.87 16.29 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.15 0.5 . . . . 0.0 109.783 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 164.75 110.72 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.798 177.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 290' ' ' THR . 36.3 Cg_exo -54.91 141.37 78.08 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.978 1.786 . . . . 0.0 112.598 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.656 ' CD2' HG23 ' A' ' 292' ' ' VAL . 0.5 OUTLIER -61.24 -1.43 0.49 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 288' ' ' PRO . 39.9 p -46.9 -7.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.092 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 289' ' ' PHE . 0.1 OUTLIER -150.27 80.2 1.35 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.016 -178.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.656 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -168.92 151.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 244' ' ' ILE . 0.2 OUTLIER -123.45 74.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.64 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 293' ' ' ARG . 68.2 mt -36.49 131.64 0.65 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.1 mp -78.85 -171.97 2.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -91.8 17.14 9.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.45 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.631 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 62.4 tt0 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.307 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.973 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.268 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.2 m 81.75 162.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 O-C-N 125.183 1.552 . . . . 0.0 111.928 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -132.31 142.33 49.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.598 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -99.83 102.94 14.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.626 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.631 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -101.4 20.56 15.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.717 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.522 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 51.9 m-85 -121.14 1.92 10.34 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.884 -0.144 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.504 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 60.56 139.13 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.797 0 O-C-N 123.999 0.812 . . . . 0.0 109.968 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 13.1 t80 -128.86 -50.57 1.23 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.569 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 144' ' ' PHE . 47.5 t30 37.36 58.07 1.29 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.517 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -65.77 -150.3 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.6 p30 165.6 -15.05 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.855 -0.672 . . . . 0.0 111.207 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' A' ' 149' ' ' ASP . 63.2 m-20 -49.66 -166.71 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' A' ' 148' ' ' ASP . 98.9 m-20 -16.44 -68.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.311 0.382 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 151' ' ' ASP . 17.3 pt-20 -171.07 40.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.027 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 150' ' ' GLU . 1.4 m-20 -53.74 -157.56 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.491 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 13.5 tp -123.92 84.4 54.58 Favored Pre-proline 0 C--O 1.217 -0.622 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.688 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.401 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 56.1 Cg_endo -68.17 121.25 8.23 Favored 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 121.669 1.58 . . . . 0.0 112.438 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 7.7 p90 -140.2 -177.59 5.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 5.8 mttp 179.69 121.84 0.06 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.576 -0.725 . . . . 0.0 109.128 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 105.93 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.635 1.209 . . . . 0.0 110.96 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 19.86 52.48 0.01 OUTLIER Glycine 0 N--CA 1.472 1.038 0 O-C-N 123.564 0.54 . . . . 0.0 111.919 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 156' ' ' LYS . 8.1 t70 -74.46 142.26 44.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.083 0.468 . . . . 0.0 110.329 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.05 96.44 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 mt -102.34 103.67 14.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.805 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 88.1 tttt -53.21 132.91 39.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.737 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 172' ' ' ASN . 40.1 mm -71.3 -55.15 14.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.113 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.699 HH12 HH11 ' A' ' 180' ' ' ARG . 32.1 ttm180 78.56 -52.03 0.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.551 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 165' ' ' LYS . 50.0 p-10 -120.3 -120.34 0.3 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.21 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.503 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 2.7 pttp 141.87 62.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 124.438 1.086 . . . . 0.0 109.963 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.25 -65.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.567 2.178 . . . . 0.0 112.697 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.7 mt-10 -108.33 168.85 9.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.548 ' O ' HG21 ' A' ' 185' ' ' VAL . 2.7 pt-20 -82.13 -37.95 25.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.652 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -79.73 -23.46 42.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -126.88 152.47 47.01 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.723 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.8 m0 -147.16 138.5 23.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.682 ' O ' ' O ' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -90.23 121.63 32.42 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.11 -178.14 4.42 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.66 0.6 . . . . 0.0 110.002 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.495 ' CD ' ' NH2' ' A' ' 163' ' ' ARG . 49.1 tt0 -124.62 130.02 51.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.287 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.487 ' HB2' HD11 ' A' ' 152' ' ' LEU . 9.2 t70 -56.29 177.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.397 0.618 . . . . 0.0 110.879 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -80.04 -4.95 54.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.383 177.81 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -104.91 -27.64 11.58 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.78 48.46 0.33 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -129.29 129.04 44.39 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.856 -0.672 . . . . 0.0 111.376 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.699 HH11 HH12 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -97.65 121.19 39.26 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.79 0.805 . . . . 0.0 111.467 -178.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -152.76 149.43 21.05 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.217 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.52 153.46 41.39 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.122 0.487 . . . . 0.0 110.09 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.94 143.56 28.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.472 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.4 ' HB3' ' CG ' ' A' ' 238' ' ' PRO . 37.1 Cg_endo -74.58 114.57 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.437 1.424 . . . . 0.0 109.978 175.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.723 HG22 ' CE3' ' A' ' 171' ' ' TRP . 54.2 t -52.15 -48.86 87.51 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.079 -0.388 . . . . 0.0 110.941 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 12.2 Cg_endo -50.49 -27.73 19.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.912 1.742 . . . . 0.0 113.314 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.528 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.8 m-85 -72.24 -5.54 36.62 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.509 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 185' ' ' VAL . 21.1 m -128.1 168.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.259 0.349 . . . . 0.0 110.759 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.631 ' CD ' HD21 ' A' ' 141' ' ' LEU . 2.5 pt-20 -134.59 67.53 1.5 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.517 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 O-C-N 123.922 0.764 . . . . 0.0 111.327 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.601 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 83.4 m-20 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -103.61 -169.48 25.55 Favored Glycine 1 CA--C 1.435 -4.908 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.98 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.424 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.4 Cg_exo -48.12 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.533 3.851 0 O-C-N 123.442 1.233 . . . . 0.0 114.799 0.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 236' ' ' ASN . 2.3 m-30 -120.66 -135.94 0.32 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 1.8 m-30 -138.79 118.97 13.52 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.584 0.707 . . . . 0.0 109.592 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.874 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -98.4 -162.86 0.99 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -157.43 86.94 0.95 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.654 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 264' ' ' LEU . 8.2 p -63.21 112.57 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.575 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.1 pt -103.83 16.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.533 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.2 mm-40 -176.2 124.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.202 0.525 . . . . 0.0 111.131 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.5 ttmt -165.08 -157.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.217 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.6 ptt85 -145.82 -134.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.466 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.439 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 4.6 t -139.38 60.44 16.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.72 ' O ' ' O ' ' A' ' 250' ' ' ASN . 95.9 Cg_endo -94.68 44.04 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.812 2.341 . . . . 0.0 113.322 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.726 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.3 p-10 -21.23 153.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.014 0.821 . . . . 0.0 111.465 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.2 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.688 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 254' ' ' LYS . 31.9 m-85 -79.28 -64.52 1.17 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.2 t70 -45.98 63.42 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 125.142 1.526 . . . . 0.0 110.319 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.828 ' N ' ' O ' ' A' ' 252' ' ' TYR . 33.7 mtmt 81.34 -48.47 0.25 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.618 1.199 . . . . 0.0 110.364 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.65 -25.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.849 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.668 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -41.34 108.56 0.09 Allowed 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.951 0.405 . . . . 0.0 111.48 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -43.07 159.98 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.431 0 O-C-N 122.11 -0.369 . . . . 0.0 110.963 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.814 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -112.17 122.51 47.94 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -140.68 -174.07 3.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.086 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.1 tt0 -145.84 145.33 30.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.159 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 245' ' ' GLN . 66.4 t -46.82 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.39 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 11.84 10.6 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 56.3 mm-40 -88.3 -36.32 16.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.281 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.082 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 135.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.614 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.082 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.3 p -133.45 159.37 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.39 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.565 ' N ' HG22 ' A' ' 265' ' ' VAL . 6.1 ttmt -103.33 94.9 5.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.927 ' O ' ' N ' ' A' ' 269' ' ' LYS . 2.6 t -46.03 -42.4 4.41 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.527 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.651 HG23 ' N ' ' A' ' 269' ' ' LYS . 7.9 t 35.16 -60.07 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.927 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER -73.77 110.49 8.1 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.9 mt -136.6 101.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.598 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.436 ' ND2' ' OE2' ' A' ' 277' ' ' GLU . 2.6 p30 -93.05 -31.64 14.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 29.1 mtm -131.28 172.49 12.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.999 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.9 p -91.22 5.62 48.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . -124.33 -90.69 0.89 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.791 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.48 69.2 10.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 0.0 110.722 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 0.4 OUTLIER -77.78 178.48 7.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.623 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 3.4 mt-10 -104.19 -167.41 1.36 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -157.76 -171.39 23.67 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.0 tt0 -170.44 109.54 0.36 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.765 0.317 . . . . 0.0 111.516 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.67 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -100.84 -101.69 0.25 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -90.6 47.64 1.45 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.14 -28.31 9.0 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.41 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.86 91.55 0.2 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.122 -178.644 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.469 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 84.5 mtt180 -85.54 173.31 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.099 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 161.79 -151.12 21.15 Favored Glycine 0 C--O 1.215 -1.052 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.543 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 11.3 p80 -130.4 169.3 15.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.474 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.66 116.04 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.547 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.733 ' HB2' HG23 ' A' ' 290' ' ' THR . 22.6 Cg_endo -62.72 162.48 24.83 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.106 1.87 . . . . 0.0 112.912 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.654 ' CD1' HG23 ' A' ' 292' ' ' VAL . 82.8 t80 -65.48 1.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.682 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 288' ' ' PRO . 71.7 p -51.2 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.536 ' O ' HG13 ' A' ' 292' ' ' VAL . 1.7 p80 -172.29 85.98 0.07 Allowed 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.391 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.654 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -174.27 148.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.575 ' HE ' HD13 ' A' ' 244' ' ' ILE . 24.3 mmt180 -130.15 81.96 2.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 36.9 mt -43.69 133.96 4.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.381 0.61 . . . . 0.0 111.066 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.0 mp -88.11 -169.95 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -100.55 14.97 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.582 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 239' ' ' PHE . 34.2 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.365 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 p90 . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.88 167.19 16.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -119.72 126.23 50.57 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.073 0.464 . . . . 0.0 110.038 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.735 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -92.0 89.28 6.91 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.97 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -100.38 31.47 3.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.385 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 143' ' ' ASP . 50.4 m-85 -132.56 2.98 3.84 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.392 -0.193 . . . . 0.0 110.811 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.3 p30 52.7 137.63 0.0 OUTLIER 'General case' 0 C--O 1.208 -1.109 0 O-C-N 124.924 1.39 . . . . 0.0 110.11 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 6.3 t80 -122.76 -42.77 2.29 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.735 0.302 . . . . 0.0 110.636 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 42.77 59.14 2.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.43 -145.36 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.9 OUTLIER 168.39 82.89 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.931 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.506 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 5.2 m-20 174.94 179.06 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 110.349 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -87.94 -21.07 25.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.203 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -103.48 26.12 8.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.4 p30 -141.18 158.75 43.48 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 152' ' ' LEU . 10.5 tp -118.51 89.45 36.76 Favored Pre-proline 0 C--O 1.215 -0.748 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 139.93 52.2 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 CA-C-N 120.314 1.148 . . . . 0.0 112.542 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.735 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 16.0 p90 -158.79 161.72 36.98 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.576 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER 176.84 125.68 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.507 0.504 . . . . 0.0 110.101 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 11.3 ptpt 136.0 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.521 1.138 . . . . 0.0 109.796 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.76 51.17 0.38 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -83.86 158.7 21.55 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.134 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.6 mm -109.14 112.88 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.381 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -112.94 126.0 55.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.821 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 162' ' ' ILE . 62.4 tttm -81.01 143.75 32.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 111.145 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.7 mp -94.98 156.28 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.588 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.518 HH21 ' CD ' ' A' ' 174' ' ' GLU . 21.5 ttm105 -135.8 -33.65 0.85 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.473 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.77 128.56 11.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.1 pttm -121.67 79.26 39.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.118 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.21 -42.2 69.35 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.181 1.921 . . . . 0.0 111.989 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -117.37 178.17 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.493 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.58 -29.73 13.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.006 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.528 ' NE2' ' OXT' ' A' ' 297' ' ' GLN . 33.9 mt-30 -80.8 -27.34 36.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.864 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.466 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 71.7 m95 -123.3 151.96 41.88 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.516 ' CD2' HG22 ' A' ' 185' ' ' VAL . 13.5 m0 -143.22 135.65 27.3 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 120.84 0.352 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.52 108.34 12.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.8 163.09 13.22 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.81 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 16.0 tt0 -122.77 128.36 50.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.09 177.76 0.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.68 0.752 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 98.1 mmm -74.82 -2.25 25.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.609 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -99.41 -20.67 16.35 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.464 0.649 . . . . 0.0 110.843 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.82 -28.52 6.39 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 179' ' ' LYS . 41.3 mttt -53.01 146.05 11.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.073 0.463 . . . . 0.0 110.532 -177.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 132.54 56.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.658 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.51 151.61 23.16 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.222 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 84.1 mmm -67.34 159.25 29.72 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.318 0.58 . . . . 0.0 110.387 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 6.7 pt -151.26 142.7 15.53 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.952 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.53 115.62 4.28 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.447 1.431 . . . . 0.0 110.015 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 36.3 t -50.24 -52.94 49.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.7 Cg_endo -51.58 -25.99 21.24 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 122.383 2.055 . . . . 0.0 113.291 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.6 m-85 -69.89 0.92 5.02 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.413 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.1 m -132.39 161.68 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -93.98 -62.42 1.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.729 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 17.3 tptm . . . . . 0 CA--C 1.539 0.533 0 O-C-N 124.81 1.319 . . . . 0.0 109.757 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.567 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 36.7 p-10 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.579 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.23 -165.55 41.24 Favored Glycine 1 CA--C 1.436 -4.85 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.749 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.7 Cg_endo -45.05 100.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.536 3.994 0 N-CA-C 116.843 1.824 . . . . 0.0 116.843 1.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.579 ' CD1' ' HA2' ' A' ' 237' ' ' GLY . 8.4 m-30 -114.55 -130.66 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.437 ' CD1' ' OE1' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.29 127.6 18.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 109.227 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.788 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -104.51 -165.09 1.11 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.222 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -156.48 94.77 1.51 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.72 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.6 p -73.71 116.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.0 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.753 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.0 OUTLIER -110.21 18.03 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.993 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 244' ' ' ILE . 2.3 mm-40 -174.38 121.06 0.26 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.778 ' CD ' HD12 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -168.55 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.551 178.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.661 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -154.57 -134.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.634 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.421 ' O ' ' OD2' ' A' ' 253' ' ' ASP . 3.4 t -137.84 62.89 36.39 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.607 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.71 ' O ' ' O ' ' A' ' 250' ' ' ASN . 11.6 Cg_endo -98.62 31.04 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.959 1.773 . . . . 0.0 114.417 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 249' ' ' PRO . 13.5 p30 -24.93 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.463 1.102 . . . . 0.0 112.588 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.26 -22.32 29.15 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.442 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.405 ' C ' ' OD1' ' A' ' 250' ' ' ASN . 32.9 m-85 -111.34 47.71 0.99 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 249' ' ' PRO . 1.2 m-20 -151.42 15.98 0.7 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.661 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 28.1 mtmt 147.22 -65.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 41.7 m 166.77 -16.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.199 0.937 . . . . 0.0 110.428 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ASN . . . -82.02 170.24 15.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.294 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.005 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -87.26 151.18 23.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.68 0.392 . . . . 0.0 110.623 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.854 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -96.45 121.71 38.57 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.124 0.42 . . . . 0.0 111.118 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.854 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.5 mt -142.33 -171.78 3.47 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.646 0.736 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.453 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.1 tt0 -144.79 148.44 34.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.272 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.57 HG13 ' HA ' ' A' ' 244' ' ' ILE . 81.1 t -53.11 100.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.509 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.62 9.71 9.94 Favored Glycine 0 CA--C 1.51 -0.233 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 12.5 mm-40 -86.99 -36.23 18.38 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.066 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 136.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.116 0.96 . . . . 0.0 109.12 -178.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.066 ' N ' HD12 ' A' ' 264' ' ' LEU . 12.5 p -131.63 150.67 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -107.33 91.94 3.86 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.67 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.682 HG22 ' HA2' ' A' ' 278' ' ' GLY . 55.6 t -62.34 159.63 2.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.846 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.491 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.4 OUTLIER -157.76 -44.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.477 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.415 ' HE3' ' H ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -62.63 142.84 57.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.225 -177.151 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.415 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 74.0 mt -132.34 156.08 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.618 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 272' ' ' MET . 1.7 p30 172.32 -91.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.801 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.505 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 3.9 mtm -69.03 135.72 51.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.137 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.3 p -74.71 20.49 0.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -148.03 -50.46 0.02 OUTLIER Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.151 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.505 ' O ' ' HE3' ' A' ' 272' ' ' MET . 1.0 OUTLIER -105.33 98.34 8.06 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.556 ' N ' ' CD1' ' A' ' 276' ' ' TRP . 1.6 m95 -101.49 173.74 6.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -115.83 127.25 54.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.023 0.439 . . . . 0.0 110.614 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' A' ' 267' ' ' VAL . . . -79.58 -164.37 28.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.256 -177.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 3.3 tt0 -172.7 112.26 0.25 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.848 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.731 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -107.96 -98.08 0.37 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -93.07 40.34 1.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.17 -21.46 42.1 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.628 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -68.63 75.26 0.28 Allowed 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 114.576 -0.812 . . . . 0.0 110.369 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.469 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 89.9 mtt180 -74.54 166.12 24.06 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.256 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.795 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 157.74 129.23 1.09 Allowed Glycine 0 C--O 1.198 -2.14 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.519 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -59.02 174.99 0.32 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 117.963 -3.081 . . . . 0.0 110.329 -175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.557 ' CZ ' ' NH1' ' A' ' 247' ' ' ARG . 0.1 OUTLIER -179.66 115.95 0.22 Allowed Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.114 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.534 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 85.0 Cg_exo -44.33 130.38 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.055 1.055 . . . . 0.0 112.783 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.631 ' C ' ' H ' ' A' ' 291' ' ' HIS . 0.0 OUTLIER -62.6 -3.3 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.903 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.4 p -52.02 4.47 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.73 ' O ' HG13 ' A' ' 292' ' ' VAL . 5.7 p80 -156.5 74.71 0.83 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 291' ' ' HIS . 1.3 m -166.58 150.96 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -108.82 -44.39 4.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.0 mt 74.31 118.41 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.503 1.144 . . . . 0.0 111.578 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 8.9 mp -88.46 -175.42 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.855 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.33 -52.35 23.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.441 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.528 ' OXT' ' NE2' ' A' ' 169' ' ' GLN . 55.5 tt0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.706 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.568 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 190' ' ' LYS . 31.5 m 42.9 -179.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 124.06 0.85 . . . . 0.0 110.303 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -133.08 121.72 23.07 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.736 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -95.3 100.01 11.86 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.057 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.611 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -111.29 32.29 5.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.921 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 143' ' ' ASP . 43.7 m-85 -127.63 2.9 6.14 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.72 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.1 p30 58.88 138.03 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 124.464 1.102 . . . . 0.0 109.811 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 7.6 t80 -130.11 -49.78 1.11 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.04 0.382 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 40.13 65.78 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.77 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.43 -138.55 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.639 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 172.86 101.08 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.323 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 9.8 m-20 151.1 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.363 1.039 . . . . 0.0 110.697 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.42 -15.81 26.71 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -105.36 24.8 11.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.855 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.639 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.9 p-10 -137.48 152.64 49.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.553 HD11 ' CG ' ' A' ' 175' ' ' ASP . 11.3 tp -116.33 87.89 21.54 Favored Pre-proline 0 C--O 1.214 -0.792 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.542 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.98 122.76 9.65 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.347 1.364 . . . . 0.0 112.201 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.736 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.5 p90 -139.21 169.27 18.08 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -171.04 122.01 0.56 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.553 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.1 mtpp 98.64 74.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.675 1.234 . . . . 0.0 111.589 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 30.82 55.26 0.26 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.068 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 31.2 t0 -73.58 150.52 41.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.9 0.381 . . . . 0.0 110.708 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.444 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.6 mp -102.51 108.76 24.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 mt -121.71 106.22 11.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.235 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -61.31 133.51 55.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.802 0.689 . . . . 0.0 112.785 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -78.64 132.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.717 178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.63 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 12.8 tpt180 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.529 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -147.18 121.28 9.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.437 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 10.6 ptmt -112.7 75.2 1.8 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.817 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.84 -35.74 11.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.981 1.788 . . . . 0.0 112.122 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -103.66 168.7 8.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.149 0.5 . . . . 0.0 110.607 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.71 -38.38 11.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.37 -22.29 32.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.514 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 69.6 m95 -120.8 151.67 39.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.709 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.4 m0 -145.43 135.98 24.25 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.085 0.469 . . . . 0.0 110.738 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.12 107.97 13.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.34 164.95 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.978 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 14.4 tt0 -127.34 136.96 52.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.609 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.553 ' CG ' HD11 ' A' ' 152' ' ' LEU . 46.4 m-20 -71.68 -175.28 1.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.492 0.663 . . . . 0.0 110.461 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 87.2 mmm -76.28 -15.45 60.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.955 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.52 -22.27 22.51 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.275 0.56 . . . . 0.0 111.011 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.67 -19.98 9.55 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -52.73 143.61 15.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.63 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -115.85 124.76 51.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.503 0.668 . . . . 0.0 111.225 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.18 145.54 14.65 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.705 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mtp -64.59 160.19 20.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.566 0.698 . . . . 0.0 110.458 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 5.1 pt -151.75 144.32 16.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.881 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.71 110.01 2.98 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.025 1.15 . . . . 0.0 110.657 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.709 HG22 ' CE3' ' A' ' 171' ' ' TRP . 55.6 t -44.22 -52.69 15.67 Favored Pre-proline 0 C--O 1.218 -0.604 0 O-C-N 121.882 -0.511 . . . . 0.0 111.821 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.9 Cg_endo -48.39 -24.54 6.27 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.887 1.724 . . . . 0.0 113.509 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.29 5.52 4.45 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.311 -0.555 . . . . 0.0 112.004 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -133.64 162.79 38.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.419 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.611 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -121.74 -67.18 0.98 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.591 ' O ' HG12 ' A' ' 138' ' ' VAL . 21.9 tptm . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.405 ' CB ' HD13 ' A' ' 294' ' ' LEU . 19.0 m120 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -168.05 160.74 34.4 Favored Glycine 1 CA--C 1.448 -4.15 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.405 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.418 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 9.0 Cg_exo -72.48 131.94 24.1 Favored 'Cis proline' 0 C--N 1.285 -2.766 0 O-C-N 122.257 0.609 . . . . 0.0 110.931 -6.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 37.4 m-85 -159.74 -123.17 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -145.2 121.74 11.07 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.337 0.517 . . . . 0.0 111.103 -178.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.857 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -101.55 -158.49 0.67 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.592 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -159.47 94.95 1.2 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.74 HG12 ' H ' ' A' ' 264' ' ' LEU . 9.8 p -73.61 110.66 7.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.431 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.502 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -108.72 22.69 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.731 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 177.81 110.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.7 ttmt -153.62 -145.94 0.18 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.404 0.621 . . . . 0.0 110.284 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.474 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.0 ptt85 -155.41 -144.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.621 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 248' ' ' VAL . 8.7 p -131.96 66.38 77.55 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.485 0.66 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.527 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 60.1 Cg_endo -83.38 157.72 14.68 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.81 2.34 . . . . 0.0 113.574 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -90.9 -172.44 3.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.286 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -103.68 -3.63 24.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.661 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 254' ' ' LYS . 25.5 m-85 -89.05 -27.67 20.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 32.9 t70 -70.03 43.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.198 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 255' ' ' THR . 38.5 mtmt 99.04 -45.55 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.424 1.09 . . . . 0.0 108.945 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.9 OUTLIER 149.18 5.99 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.907 0 O-C-N 125.132 1.52 . . . . 0.0 110.364 179.219 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 249' ' ' PRO . . . -35.71 115.87 0.34 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.206 0.527 . . . . 0.0 111.774 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -68.68 117.64 10.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.858 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -71.23 125.29 26.55 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.323 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 258' ' ' ALA . 2.6 mt -142.14 -175.67 4.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.712 0.768 . . . . 0.0 111.238 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.41 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 10.2 tt0 -145.61 138.94 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.33 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.502 HG13 ' HA ' ' A' ' 244' ' ' ILE . 53.1 t -44.01 105.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.147 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.54 7.13 24.57 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.362 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' LEU . 43.8 mm-40 -83.7 -37.34 22.85 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 1.073 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.5 135.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 1.073 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.7 p -131.14 152.51 37.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.302 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 279' ' ' GLU . 0.9 OUTLIER -103.86 108.67 20.09 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.377 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' A' ' 276' ' ' TRP . 97.9 t -72.43 157.05 6.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.501 HG22 ' C ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER 177.83 43.82 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.703 ' C ' HD12 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -157.51 98.74 1.7 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 120.827 -1.171 . . . . 0.0 109.15 178.119 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.703 HD12 ' C ' ' A' ' 269' ' ' LYS . 1.6 mp -113.33 133.31 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.38 0.61 . . . . 0.0 111.233 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.627 ' ND2' ' OE2' ' A' ' 277' ' ' GLU . 0.5 OUTLIER -112.81 -29.62 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.98 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.704 ' SD ' ' N ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -134.54 -164.4 1.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.536 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -109.66 19.33 19.31 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.181 -0.325 . . . . 0.0 110.705 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.502 ' N ' ' SD ' ' A' ' 272' ' ' MET . . . -130.81 -100.3 0.85 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.704 ' N ' ' SD ' ' A' ' 272' ' ' MET . 50.6 mm-40 -76.24 105.29 7.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.987 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.802 ' CE3' HG11 ' A' ' 267' ' ' VAL . 0.4 OUTLIER -98.05 178.45 5.1 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.623 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.627 ' OE2' ' ND2' ' A' ' 271' ' ' ASN . 24.8 mp0 -95.39 -152.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.751 -178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 277' ' ' GLU . . . -161.32 -177.88 34.79 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 266' ' ' LYS . 2.4 tm-20 -169.75 117.06 0.58 Allowed 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 117.226 0.513 . . . . 0.0 110.768 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -107.08 -56.56 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -136.92 38.22 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 284' ' ' ARG . . . 93.28 -21.31 41.1 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.942 ' O ' ' O ' ' A' ' 284' ' ' ARG . 0.0 OUTLIER -57.54 -6.73 0.51 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.386 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.942 ' O ' ' O ' ' A' ' 283' ' ' LYS . 13.9 mtt85 15.86 -177.21 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 O-C-N 126.023 2.077 . . . . 0.0 113.104 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 150.02 -145.38 13.42 Favored Glycine 0 C--N 1.287 -2.182 0 O-C-N 120.652 -1.28 . . . . 0.0 110.549 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.2 p80 -145.37 177.86 8.52 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 114.351 -0.924 . . . . 0.0 109.206 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.619 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.4 m-85 159.06 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 O-C-N 123.877 0.736 . . . . 0.0 109.143 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.0 Cg_exo -51.54 153.96 9.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.93 1.753 . . . . 0.0 113.214 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 46.9 t80 -65.13 2.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 288' ' ' PRO . 32.3 p -51.77 -38.31 54.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.51 72.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -163.58 144.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.419 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -123.55 75.5 1.34 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.065 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 8.3 mt -43.61 125.95 4.27 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.575 0.702 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.9 mp -71.15 -173.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.015 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -83.18 39.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.843 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.502 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 82.2 mt-30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.195 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 1.034 ' O ' HG22 ' A' ' 138' ' ' VAL . 5.8 p90 . . . . . 0 C--O 1.209 -1.029 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 137' ' ' TYR . 2.8 m 93.78 152.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 125.686 1.866 . . . . 0.0 111.984 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.416 ' NH1' HD23 ' A' ' 141' ' ' LEU . 15.9 ttp85 -120.81 133.21 55.32 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.331 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . . . -94.08 93.71 7.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.007 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.65 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.35 20.03 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.034 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.454 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -115.93 -9.36 11.8 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.481 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 72.3 136.32 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.048 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.1 t80 -128.83 -43.22 1.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.854 0.359 . . . . 0.0 110.125 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 146' ' ' GLY . 21.9 t-20 41.62 62.49 1.54 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 145' ' ' ASN . . . -62.57 -122.43 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 1.0 OUTLIER 169.56 -65.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.879 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.525 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 18.2 m-20 -53.81 142.65 23.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.783 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 31.2 p-10 -61.47 -1.2 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 148' ' ' ASP . 47.5 mt-10 -105.68 13.76 29.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.269 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 20.5 p30 -130.78 163.26 27.71 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.645 HD13 ' N ' ' A' ' 181' ' ' GLY . 3.8 tp -104.35 91.71 4.17 Favored Pre-proline 0 C--O 1.211 -0.966 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.303 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.467 ' O ' ' OD2' ' A' ' 175' ' ' ASP . 72.7 Cg_endo -70.49 139.13 37.03 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 CA-C-N 120.825 1.33 . . . . 0.0 112.804 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 160' ' ' LEU . 12.5 p90 -167.42 157.05 10.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -174.35 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.349 179.06 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -61.02 -3.28 0.75 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.265 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 155' ' ' LYS . . . 92.85 56.94 1.45 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.471 ' C ' HD12 ' A' ' 159' ' ' ILE . 27.0 t0 -81.74 157.85 24.39 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.502 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.6 mp -98.63 98.12 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.685 HD11 ' CD2' ' A' ' 154' ' ' PHE . 96.3 mt -91.83 94.13 9.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.128 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 52.8 tttp -68.87 132.44 46.74 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.518 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.22 142.81 15.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.27 -48.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.64 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -153.24 64.05 0.76 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.641 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.403 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 11.8 pttp -49.54 106.48 0.63 Allowed Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 119.402 -0.332 . . . . 0.0 110.787 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.79 -48.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.443 1.428 . . . . 0.0 112.438 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.02 172.75 6.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.775 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 168' ' ' GLU . 5.0 pt-20 -85.51 -34.47 21.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.4 -15.57 45.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.468 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 48.1 m95 -131.46 151.53 51.48 Favored 'General case' 0 C--O 1.228 -0.074 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.589 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.9 m0 -139.78 134.44 31.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.907 0.86 . . . . 0.0 112.496 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -91.55 101.03 13.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.27 -179.26 3.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.51 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.88 112.72 13.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.642 ' H ' HD11 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -63.81 140.58 58.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.951 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 95.2 mtp -47.85 -8.14 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.426 0.454 . . . . 0.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 175' ' ' ASP . 96.6 m-20 -72.98 -21.78 60.79 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.667 0.746 . . . . 0.0 110.048 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.49 44.06 3.54 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.631 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.478 ' O ' HD11 ' A' ' 152' ' ' LEU . 11.4 ptpt -142.46 143.92 32.81 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.161 -0.519 . . . . 0.0 109.76 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.05 127.95 53.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.534 0.683 . . . . 0.0 110.964 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLY . . . . . 0.645 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -156.07 153.1 24.48 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.361 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.54 152.79 44.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.468 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 1.3 pt -143.4 146.58 36.53 Favored Pre-proline 0 N--CA 1.455 -0.191 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.46 140.46 63.41 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.481 -1.392 . . . . 0.0 108.481 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 38.5 t -79.93 -37.9 1.14 Allowed Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.661 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 36.4 Cg_endo -68.88 -21.0 38.43 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.271 1.981 . . . . 0.0 112.914 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.1 m-85 -77.88 4.51 11.77 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.976 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 185' ' ' VAL . 26.5 m -136.01 161.17 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.424 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.644 ' CG ' HD21 ' A' ' 141' ' ' LEU . 1.1 pp20? -146.35 153.58 40.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 13.4 tptm . . . . . 0 C--N 1.316 -0.866 0 C-N-CA 124.276 1.03 . . . . 0.0 111.808 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.444 ' HA2' ' N ' ' A' ' 239' ' ' PHE . . . -165.11 134.41 3.31 Favored Glycine 1 CA--C 1.445 -4.322 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.061 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.411 ' HD2' ' CZ2' ' A' ' 170' ' ' TRP . 4.0 Cg_exo -71.56 97.49 0.15 OUTLIER 'Cis proline' 0 N--CA 1.529 3.615 0 CA-C-N 118.171 0.985 . . . . 0.0 112.134 -6.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 4.3 m-85 -117.09 -134.34 0.34 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -146.19 137.54 24.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 118.986 0.812 . . . . 0.0 109.768 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.592 ' H ' HD13 ' A' ' 264' ' ' LEU . . . -122.93 140.26 53.18 Favored 'General case' 0 C--O 1.195 -1.768 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.147 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -104.17 111.04 23.48 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.366 0.603 . . . . 0.0 110.704 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.1 p -79.63 127.46 39.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.141 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.44 15.74 7.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -174.08 112.21 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.633 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.897 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.5 ttmt -165.13 -156.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.266 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.92 -138.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.134 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.697 ' O ' HG12 ' A' ' 248' ' ' VAL . 73.4 t -132.83 60.89 53.08 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 120.677 0.275 . . . . 0.0 111.194 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 258' ' ' ALA . 18.0 Cg_endo -96.72 -170.82 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.479 2.119 . . . . 0.0 111.394 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.1 p-10 -157.9 153.34 26.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.142 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 256' ' ' ALA . . . -41.16 -11.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 254' ' ' LYS . 33.4 m-85 -73.83 -53.12 10.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 250' ' ' ASN . 35.9 t70 -53.58 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 125.813 1.946 . . . . 0.0 111.702 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' A' ' 252' ' ' TYR . 29.7 mtmt 82.33 -43.11 0.14 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.269 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.558 ' O ' ' ND1' ' A' ' 286' ' ' HIS . 0.1 OUTLIER 158.37 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.405 0.621 . . . . 0.0 110.029 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -109.95 165.01 12.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.864 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.834 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -114.77 151.78 33.2 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -178.232 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.963 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -88.64 113.66 24.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 258' ' ' ALA . 0.4 OUTLIER -143.28 174.57 10.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.798 177.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -142.95 148.84 37.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.386 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 245' ' ' GLN . 73.3 t -52.65 99.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.957 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 127.79 -2.94 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.39 -163.25 1.03 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.072 0.463 . . . . 0.0 110.621 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.96 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER -159.11 149.37 19.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.755 0.788 . . . . 0.0 111.117 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.96 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.0 p -133.48 141.48 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -74.26 176.01 7.06 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.915 ' O ' ' N ' ' A' ' 269' ' ' LYS . 18.4 t -119.29 -36.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.144 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 269' ' ' LYS . 0.0 OUTLIER 20.64 -55.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.904 1.378 . . . . 0.0 114.178 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.915 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -84.7 116.11 23.05 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.388 0.613 . . . . 0.0 111.853 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.6 OUTLIER -136.92 154.1 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.501 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 272' ' ' MET . 43.9 p30 -174.69 158.37 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.99 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.534 ' O ' ' O ' ' A' ' 271' ' ' ASN . 3.9 mtm 52.52 162.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.462 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 p -88.98 27.94 1.26 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -149.07 -85.5 0.06 OUTLIER Glycine 0 C--O 1.209 -1.464 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.325 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 275' ' ' GLN . 1.8 mp0 -61.99 168.78 3.0 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 178.1 -174.17 0.15 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.28 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -144.64 147.5 33.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.494 -1.685 . . . . 0.0 113.598 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -131.16 131.92 6.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.037 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 281' ' ' ASN . 6.2 tm-20 -103.45 125.14 49.86 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.541 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' CYS . . . . . 0.623 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -125.88 84.37 2.27 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.099 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE2' ' A' ' 279' ' ' GLU . 2.4 m120 76.36 21.49 1.39 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.086 -1.009 . . . . 0.0 110.654 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 104.21 -32.83 7.11 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.475 -0.329 . . . . 0.0 112.65 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.623 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.8 OUTLIER -63.06 60.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.954 0.407 . . . . 0.0 110.754 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 282' ' ' GLY . 52.8 mtt180 -60.86 162.25 7.08 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.527 0.68 . . . . 0.0 109.939 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.98 -170.68 43.46 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.634 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.7 p-80 -140.39 95.3 2.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.866 1.333 . . . . 0.0 112.654 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.533 ' HE2' ' HB1' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -101.23 129.38 27.15 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 113.714 -1.585 . . . . 0.0 109.646 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -50.55 153.91 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.367 1.378 . . . . 0.0 112.528 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.536 ' C ' ' H ' ' A' ' 291' ' ' HIS . 90.3 t80 -72.01 -3.55 23.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.431 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 67.8 p -55.63 10.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.676 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' HIS . . . . . 0.536 ' H ' ' C ' ' A' ' 289' ' ' PHE . 1.2 p80 -176.19 68.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.625 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.534 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -155.07 153.73 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 294' ' ' LEU . 27.8 mmm-85 -130.98 66.32 1.54 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.401 0.143 . . . . 0.0 111.357 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 241' ' ' ALA . 11.3 mt -31.32 129.05 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.107 0.956 . . . . 0.0 112.499 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.17 -106.53 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.23 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 34.5 t0 -173.82 44.45 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 296' ' ' ASP . 7.6 tt0 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.136 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -83.29 -103.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.152 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -44.61 152.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.47 . . . . 0.0 110.471 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.62 166.06 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.428 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -115.49 131.54 56.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.784 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -102.23 92.68 4.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.724 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.838 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -103.27 22.63 13.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.942 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 143' ' ' ASP . 65.3 m-85 -119.45 2.46 11.26 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.6 p30 55.39 138.76 0.0 OUTLIER 'General case' 0 C--O 1.21 -0.992 0 O-C-N 124.365 1.041 . . . . 0.0 110.422 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 6.7 t80 -127.99 -41.54 1.62 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.844 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 144' ' ' PHE . 39.3 t-20 36.21 59.22 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.478 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.02 -141.28 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.571 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 2.1 p30 166.8 88.28 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.413 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 3.6 m-20 171.97 -178.42 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.211 0.529 . . . . 0.0 110.33 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 149' ' ' ASP . 60.9 t0 -91.0 -20.4 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.388 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.26 25.81 9.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.693 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.7 p-10 -141.33 156.63 45.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.447 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 11.4 tp -120.17 82.31 30.06 Favored Pre-proline 0 C--O 1.216 -0.695 0 CA-C-O 120.755 0.312 . . . . 0.0 110.999 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.42 136.79 74.09 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 121.456 1.437 . . . . 0.0 112.108 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.784 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 10.6 p90 -152.09 165.14 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.524 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -175.86 102.93 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.795 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.577 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.5 tppp? 127.61 77.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.652 1.22 . . . . 0.0 110.959 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.71 49.73 0.02 OUTLIER Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 156' ' ' LYS . 28.7 t0 -72.91 144.87 47.19 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.922 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 159' ' ' ILE . 10.7 tp -104.17 109.54 27.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.37 122.79 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.675 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -77.91 141.84 38.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.91 139.13 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.7 tpt85 -117.9 -43.36 2.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.276 0.56 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.32 129.08 11.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.693 ' NZ ' ' HE1' ' A' ' 171' ' ' TRP . 0.1 OUTLIER -119.48 77.53 19.48 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.145 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.03 -44.36 50.47 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.295 1.996 . . . . 0.0 111.732 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.49 177.02 4.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.418 ' O ' HG21 ' A' ' 185' ' ' VAL . 25.2 mm-40 -96.57 -32.05 12.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.511 ' NE2' ' CZ ' ' A' ' 240' ' ' TYR . 85.2 mt-30 -77.17 -28.12 53.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.468 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.512 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 66.0 m95 -123.84 153.59 40.83 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.693 ' HE1' ' NZ ' ' A' ' 165' ' ' LYS . 17.4 m0 -143.65 136.7 27.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.4 108.03 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.44 168.32 9.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.957 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -126.63 138.36 53.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.894 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -68.09 174.56 3.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.302 0.572 . . . . 0.0 110.698 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ptm -79.88 -2.57 44.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.349 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -101.92 -28.25 12.51 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.6 48.69 0.45 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.57 132.56 49.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.671 -0.764 . . . . 0.0 109.568 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 125.86 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.322 0.582 . . . . 0.0 111.951 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.24 153.34 24.6 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.565 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 32.3 mtp -66.51 160.8 24.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.432 0.634 . . . . 0.0 110.817 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 8.3 pt -152.05 143.06 15.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.794 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -69.4 114.69 3.73 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.639 1.559 . . . . 0.0 110.013 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.645 HG22 ' CE3' ' A' ' 171' ' ' TRP . 27.0 t -49.98 -52.81 49.2 Favored Pre-proline 0 C--O 1.216 -0.673 0 O-C-N 121.927 -0.483 . . . . 0.0 111.69 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.6 Cg_endo -49.5 -24.71 9.48 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.147 1.898 . . . . 0.0 113.367 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.9 m-85 -74.54 3.72 7.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -134.86 162.29 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.729 ' HG3' HD11 ' A' ' 141' ' ' LEU . 39.3 mt-10 -81.28 -59.37 2.67 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.276 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 18.0 tptm 137.02 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 O-C-N 124.515 1.134 . . . . 0.0 109.891 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 43.3 t 59.95 70.78 0.61 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -157.46 100.18 1.89 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.229 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.29 155.0 36.94 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.024 1.816 . . . . 0.0 112.58 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 195' ' ' SER . 77.8 p -171.85 -64.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.437 ' N ' ' OG ' ' A' ' 194' ' ' SER . 24.1 p -86.65 172.51 10.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.573 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -87.45 160.78 18.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.466 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.0 m 61.64 84.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.65 -33.21 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.4 m -45.05 108.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.605 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -82.25 -18.97 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 201' ' ' LEU . 1.0 OUTLIER -172.52 -2.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 201' ' ' LEU . 7.8 m -30.59 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.371 0.419 . . . . 0.0 111.278 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.85 66.23 1.23 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.3 -121.59 4.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 205' ' ' ASN . 48.4 p30 -150.34 74.37 1.19 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.914 0.387 . . . . 0.0 110.698 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -48.37 -26.61 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.384 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 208' ' ' SER . 67.3 t0 -64.44 133.28 52.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 14.2 p -76.24 159.01 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.674 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.6 m -80.15 154.84 27.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.41 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -79.15 151.69 75.87 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.72 143.18 73.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.477 2.118 . . . . 0.0 111.836 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.624 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 3.4 tt0 -91.76 -41.78 0.37 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.148 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 25.0 Cg_exo -61.36 142.4 95.66 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.499 2.133 . . . . 0.0 111.734 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.97 114.8 20.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.254 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 130.93 12.07 2.21 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 40.36 77.1 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.97 -48.92 19.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.387 2.058 . . . . 0.0 112.109 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.75 148.78 0.51 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.69 -8.29 22.85 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.551 2.167 . . . . 0.0 112.091 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.97 -166.07 13.07 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.484 ' CG ' ' OE1' ' A' ' 224' ' ' GLN . 60.5 Cg_endo -78.71 164.02 25.99 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.692 2.261 . . . . 0.0 112.225 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.516 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 68.5 t80 -58.12 173.01 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -38.76 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 222' ' ' TYR . 6.9 mt-30 -120.02 95.96 49.25 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.332 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.15 -9.35 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.287 1.991 . . . . 0.0 112.024 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 224' ' ' GLN . 4.4 p -103.96 -167.87 1.42 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.643 ' C ' ' H ' ' A' ' 229' ' ' THR . 34.1 mm -114.45 32.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.339 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -63.54 29.91 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.643 ' H ' ' C ' ' A' ' 227' ' ' ILE . 0.6 OUTLIER -58.56 159.36 12.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.3 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 229' ' ' THR . 80.8 Cg_exo -35.47 -101.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 122.611 2.207 . . . . 0.0 112.124 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.471 HD21 ' OE1' ' A' ' 235' ' ' GLN . 0.2 OUTLIER -113.08 97.8 43.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 122.081 -0.387 . . . . 0.0 110.889 -179.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.99 -62.01 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.986 1.791 . . . . 0.0 112.457 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 235' ' ' GLN . 19.4 t-20 -176.22 115.68 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.536 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 235' ' ' GLN . 20.7 tp 63.37 -29.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.142 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.625 ' H ' ' C ' ' A' ' 233' ' ' ASN . 52.7 tt0 73.65 140.98 0.06 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -56.25 -41.21 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.035 0.445 . . . . 0.0 110.061 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -62.22 -165.29 0.44 Allowed Glycine 1 CA--C 1.447 -4.171 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.373 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.417 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.0 Cg_endo -46.78 98.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.767 0 N-CA-C 116.141 1.554 . . . . 0.0 116.141 0.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 10.3 m-30 -116.51 -132.09 0.32 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.511 ' CZ ' ' NE2' ' A' ' 169' ' ' GLN . 2.0 m-30 -136.34 115.88 12.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.67 0.748 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.524 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -106.85 140.81 39.09 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.943 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -103.91 97.71 7.66 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.8 p -63.74 127.21 23.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.142 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.636 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.3 pt -124.48 22.91 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.99 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.283 0.564 . . . . 0.0 110.159 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.828 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.7 ttmt -146.76 -146.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.31 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.444 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 0.6 OUTLIER -155.97 -145.53 0.16 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.626 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 248' ' ' VAL . 97.0 t -132.91 74.13 74.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.463 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.499 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 18.9 Cg_endo -91.65 169.93 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.036 2.491 . . . . 0.0 111.323 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.7 OUTLIER -127.12 127.34 44.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.792 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.07 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.856 0.722 . . . . 0.0 112.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.758 ' N ' ' O ' ' A' ' 250' ' ' ASN . 50.9 m-85 -91.76 -53.04 4.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 250' ' ' ASN . 42.1 t0 -41.24 -62.02 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.119 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.557 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.0 mttt -151.75 25.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.791 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.9 m 73.83 -18.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.589 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -43.95 108.69 0.12 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.633 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.969 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -47.48 159.85 0.13 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.826 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.21 119.01 38.25 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.091 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.828 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.2 mt -141.67 -175.17 4.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.222 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.6 tt0 -144.94 152.08 39.64 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.37 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.0 t -59.75 115.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.84 6.67 24.49 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 8.1 mm-40 -97.53 -139.76 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.032 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 175.37 139.99 0.05 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.404 0.621 . . . . 0.0 109.366 179.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.032 ' N ' HD12 ' A' ' 264' ' ' LEU . 12.5 p -128.1 152.77 36.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -103.83 88.15 2.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.541 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.484 HG11 ' OE1' ' A' ' 235' ' ' GLN . 3.3 t -64.58 124.36 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.153 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.401 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -116.57 -53.56 2.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.232 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -72.2 127.25 31.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.15 -178.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.45 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 0.8 OUTLIER -149.19 103.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.548 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -97.73 -88.53 0.3 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.492 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 38.1 mtm -67.07 178.73 1.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.062 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.4 p -98.95 16.63 21.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -130.54 -87.32 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.889 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -91.96 105.3 17.59 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.015 0.436 . . . . 0.0 110.935 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.543 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 4.6 p-90 -120.33 -164.95 1.13 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.0 mt-10 -123.99 163.21 21.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.861 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.74 -158.21 7.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.909 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -170.32 131.19 0.95 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -112.82 -92.86 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 283' ' ' LYS . 27.7 t-20 -101.4 54.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.95 3.81 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 281' ' ' ASN . 0.0 OUTLIER -61.41 90.4 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.774 -0.713 . . . . 0.0 110.144 -178.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 255' ' ' THR . 42.3 mtt85 -88.05 164.29 15.83 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 171.46 -157.46 27.95 Favored Glycine 0 C--O 1.213 -1.202 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.591 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -123.89 174.73 7.36 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.2 m-85 160.28 135.02 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.107 0 O-C-N 123.768 0.667 . . . . 0.0 111.731 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.53 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 23.7 Cg_exo -64.07 142.64 81.79 Favored 'Trans proline' 0 N--CA 1.507 2.297 0 C-N-CA 122.351 2.034 . . . . 0.0 112.25 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.819 ' CD1' HG21 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -76.23 2.63 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.277 179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 66.2 p -68.68 2.78 2.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.955 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 7.6 p80 -137.31 39.84 2.47 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.819 HG21 ' CD1' ' A' ' 289' ' ' PHE . 11.9 m -135.61 161.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 121.992 -0.442 . . . . 0.0 109.977 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.636 ' HE ' HD13 ' A' ' 244' ' ' ILE . 29.2 mtt180 -132.63 77.81 1.77 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.554 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 293' ' ' ARG . 84.3 mt -32.77 135.52 0.09 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.845 0.831 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.3 mp -84.34 -167.31 1.72 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.028 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -93.79 13.25 23.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.642 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 63.0 tt0 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.304 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -83.77 -85.27 0.13 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.75 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.455 ' OH ' ' SG ' ' A' ' 191' ' ' CYS . 0.0 OUTLIER 72.98 116.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.205 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 188' ' ' VAL . 6.3 m -140.67 172.17 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.421 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -131.26 136.37 48.13 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.317 0.58 . . . . 0.0 111.017 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.53 172.22 0.71 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.475 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.596 HD21 ' OE2' ' A' ' 189' ' ' GLU . 78.8 mt -140.35 -45.17 0.41 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.627 ' CE2' ' NH2' ' A' ' 284' ' ' ARG . 95.1 m-85 -113.49 9.59 18.07 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.825 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.534 ' CG ' ' HZ1' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 67.11 136.08 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.735 0.647 . . . . 0.0 109.337 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 9.1 t80 -112.64 -54.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.372 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.3 t30 49.99 55.14 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.523 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.491 ' C ' HD22 ' A' ' 147' ' ' ASN . . . -65.94 -124.95 0.01 OUTLIER Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.628 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 176.66 -90.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 81.0 m-20 -22.94 139.24 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -57.08 -7.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.528 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 148' ' ' ASP . 6.5 pt-20 -97.88 7.22 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.628 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 12.9 p30 -133.29 157.61 45.04 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 152' ' ' LEU . 9.2 tp -111.16 93.64 18.78 Favored Pre-proline 0 C--O 1.214 -0.814 0 CA-C-N 118.506 0.594 . . . . 0.0 111.095 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.404 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 95.5 Cg_endo -69.53 141.43 46.13 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 CA-C-N 120.567 1.238 . . . . 0.0 114.006 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 160' ' ' LEU . 20.3 p90 -159.13 159.72 34.78 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.67 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER -126.97 96.76 4.72 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.839 ' O ' ' N ' ' A' ' 158' ' ' ASP . 59.0 pttt 27.39 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.611 1.194 . . . . 0.0 110.739 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 30.9 13.74 0.0 OUTLIER Glycine 0 CA--C 1.541 1.69 0 N-CA-C 113.948 0.339 . . . . 0.0 113.948 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.839 ' N ' ' O ' ' A' ' 156' ' ' LYS . 17.3 t0 -85.36 155.88 21.12 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 117.08 0.44 . . . . 0.0 110.324 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.3 mm -125.58 106.2 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.689 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.435 HD11 ' CD2' ' A' ' 154' ' ' PHE . 23.6 mt -121.63 133.71 54.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -97.84 139.73 33.27 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -83.48 159.26 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.03 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -142.2 -43.73 0.33 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.283 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -136.52 113.58 10.54 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.54 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 14.3 pttm -112.71 74.07 1.6 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.77 -28.74 51.29 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.621 1.548 . . . . 0.0 111.881 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.9 162.69 18.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.667 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.85 -35.0 18.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.508 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 79.0 mt-30 -80.7 -22.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -124.75 153.87 41.76 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.54 ' CD2' HG22 ' A' ' 185' ' ' VAL . 11.2 m0 -145.83 138.16 25.51 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -86.06 106.89 17.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.08 6.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.761 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 30.3 tt0 -126.38 138.32 53.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.969 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.87 173.41 7.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.578 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.9 tpt -77.53 -0.94 28.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.21 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.456 ' HB3' ' NZ ' ' A' ' 179' ' ' LYS . 79.9 m-20 -102.66 -29.67 11.39 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.536 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.96 47.92 0.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 177' ' ' ASP . 9.8 mttp -128.66 135.88 49.88 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 114.105 -1.048 . . . . 0.0 108.982 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.35 123.34 50.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.412 0.625 . . . . 0.0 111.519 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -151.6 149.03 20.71 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.021 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 151.27 46.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 111.174 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.05 145.77 37.42 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -74.44 112.9 3.66 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.42 1.413 . . . . 0.0 109.438 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.54 HG22 ' CD2' ' A' ' 171' ' ' TRP . 51.7 t -48.62 -51.56 51.73 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -45.74 -31.38 7.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.077 1.852 . . . . 0.0 113.096 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.479 ' OH ' ' O ' ' A' ' 268' ' ' THR . 9.6 m-85 -69.4 -6.66 31.51 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.089 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 138' ' ' VAL . 1.2 m -129.93 163.66 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.596 ' OE2' HD21 ' A' ' 141' ' ' LEU . 1.1 pt-20 -117.4 -51.73 2.5 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER 142.24 -4.15 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.224 1.41 . . . . 0.0 110.003 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.455 ' SG ' ' OH ' ' A' ' 137' ' ' TYR . 12.5 t 57.54 113.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -70.3 155.91 92.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.842 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 192' ' ' ARG . 74.2 Cg_exo -43.17 176.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.218 1.945 . . . . 0.0 112.15 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.2 t -99.1 59.98 1.18 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.351 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 36.4 t -168.89 157.22 7.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 56.62 44.53 23.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.761 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 200' ' ' THR . 84.2 p -99.33 82.56 2.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.545 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.6 t -75.23 -50.35 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.788 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 200' ' ' THR . 72.2 m -61.81 -48.13 81.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 197' ' ' SER . 2.9 m 32.25 41.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.385 0.428 . . . . 0.0 111.023 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 203' ' ' GLY . 55.1 tp -162.53 126.85 3.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.279 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 65.1 p -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.374 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' H ' ' HG ' ' A' ' 201' ' ' LEU . . . 72.99 32.02 61.22 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 51.11 93.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 141' ' ' LEU . 90.8 m-20 -63.08 -38.62 91.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.95 0.405 . . . . 0.0 110.589 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 209' ' ' SER . 88.9 mt-30 -136.89 17.23 3.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.553 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.92 -42.74 89.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.8 m -61.47 -43.84 98.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.734 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 206' ' ' GLN . 46.1 t -156.01 176.72 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.501 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 211' ' ' PRO . 0.7 OUTLIER -170.85 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.531 ' N ' ' ND1' ' A' ' 210' ' ' HIS . 19.3 Cg_endo -54.22 -41.81 72.8 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.605 1.536 . . . . 0.0 112.097 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 38.34 72.17 0.95 Allowed Pre-proline 0 N--CA 1.462 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.93 98.57 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.524 2.15 . . . . 0.0 111.649 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.448 ' N ' HD22 ' A' ' 214' ' ' LEU . 4.3 mm? -90.57 134.44 34.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -53.87 -68.25 1.74 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.21 72.42 0.03 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.85 -36.85 92.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.73 2.286 . . . . 0.0 111.736 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -129.37 80.0 73.0 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.577 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.06 -27.49 64.89 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.684 2.256 . . . . 0.0 111.88 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.49 -114.76 3.91 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.22 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.216 0 CA-C-N 119.582 1.691 . . . . 0.0 112.042 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 82.3 t80 -168.03 162.41 13.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.337 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -46.42 98.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.596 ' C ' ' H ' ' A' ' 226' ' ' SER . 28.4 mt-30 -143.09 97.44 5.73 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.592 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -54.69 11.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.205 1.937 . . . . 0.0 112.985 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.596 ' H ' ' C ' ' A' ' 224' ' ' GLN . 50.1 m -158.41 -152.98 0.36 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 96.5 mt 58.81 -74.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 226' ' ' SER . 4.1 p-10 -103.34 45.43 0.96 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.314 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 230' ' ' PRO . 0.2 OUTLIER -90.78 161.49 35.86 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 229' ' ' THR . 52.7 Cg_exo -49.14 -128.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.742 2.294 . . . . 0.0 112.661 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.13 161.39 31.39 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.773 -0.579 . . . . 0.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.61 -140.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.142 1.894 . . . . 0.0 111.869 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 234' ' ' LEU . 3.3 p-10 -84.51 153.86 23.04 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.575 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 235' ' ' GLN . 5.2 tp 35.07 68.89 0.18 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.735 ' NE2' ' H ' ' A' ' 235' ' ' GLN . 1.1 mm-40 -38.74 144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.428 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -43.44 110.29 0.19 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.69 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 136.72 -165.84 24.97 Favored Glycine 1 CA--C 1.448 -4.155 0 CA-C-O 121.72 0.622 . . . . 0.0 113.52 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 1.9 Cg_endo -47.41 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.535 3.918 0 N-CA-C 116.701 1.769 . . . . 0.0 116.701 1.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.568 ' CG ' ' OE1' ' A' ' 297' ' ' GLN . 11.6 m-30 -118.23 -134.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.31 129.5 19.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.248 0.931 . . . . 0.0 109.246 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.778 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -102.04 -162.34 0.92 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.464 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -157.34 92.84 1.27 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.19 129.37 27.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.741 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.447 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.2 pt -129.5 18.31 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.214 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 178.06 101.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.374 0.607 . . . . 0.0 110.053 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.3 ttmt -144.89 -142.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.489 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.0 ptt85 -153.77 -142.02 0.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.994 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 248' ' ' VAL . 54.3 t -133.62 69.3 76.44 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 110.85 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.607 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 59.0 Cg_endo -91.2 177.0 2.08 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.838 2.359 . . . . 0.0 110.762 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.724 ' O ' ' N ' ' A' ' 252' ' ' TYR . 1.3 p-10 -144.26 139.01 28.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -36.51 -10.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.399 0.619 . . . . 0.0 112.305 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.724 ' N ' ' O ' ' A' ' 250' ' ' ASN . 6.6 m-85 -89.51 -50.27 6.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 250' ' ' ASN . 25.7 t0 -62.71 60.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.624 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 252' ' ' TYR . 32.6 mtmt 82.53 15.78 0.4 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.167 0.917 . . . . 0.0 111.061 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.485 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.5 m 80.88 -17.93 0.53 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.675 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.02 109.15 0.11 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.958 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.16 156.06 0.6 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.521 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.867 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.04 122.14 46.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.5 mt -142.07 -178.81 5.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.886 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 6.1 tt0 -143.44 149.93 38.3 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.936 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.73 114.78 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.428 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 107.29 7.82 32.0 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 57.8 mm-40 -93.53 -127.62 0.11 Allowed 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.082 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 165.97 139.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.031 0.919 . . . . 0.0 110.336 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.082 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.5 p -134.75 155.6 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.56 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 265' ' ' VAL . 0.2 OUTLIER -85.31 -158.5 0.38 Allowed 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.726 ' O ' ' N ' ' A' ' 269' ' ' LYS . 0.9 OUTLIER -142.65 -44.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.075 176.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER 35.14 -72.93 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -74.35 123.6 24.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.975 -177.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 162.31 36.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.827 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 272' ' ' MET . 4.8 p30 -156.46 -98.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.526 0.679 . . . . 0.0 110.359 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 274' ' ' GLY . 34.8 mtm -55.16 152.89 7.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.601 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.9 p -71.58 15.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.539 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.71 -73.63 0.04 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.441 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 13.4 mp0 -78.89 166.02 22.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.896 0.379 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.539 ' NE1' ' O ' ' A' ' 274' ' ' GLY . 1.5 p-90 177.81 179.49 0.3 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.617 0.723 . . . . 0.0 110.711 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 2.6 mt-10 -107.92 -178.53 3.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.607 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -157.72 -165.84 16.04 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.462 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -163.55 123.44 2.15 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.411 0.624 . . . . 0.0 112.269 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -133.75 74.0 1.53 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.354 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 14.3 t-20 83.99 37.08 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.644 0.735 . . . . 0.0 109.676 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 93.34 -36.07 3.87 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.032 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -64.61 86.16 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.355 0.598 . . . . 0.0 110.264 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.627 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 77.4 mtt180 -86.27 170.13 12.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.508 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.505 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 169.23 -151.12 16.81 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -130.18 176.77 7.82 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.0 OUTLIER 157.99 112.83 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 123.461 0.476 . . . . 0.0 110.026 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.4 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 39.8 Cg_exo -54.8 148.05 47.82 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.375 2.05 . . . . 0.0 112.906 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.567 ' CD2' HG23 ' A' ' 292' ' ' VAL . 0.4 OUTLIER -66.49 -2.63 4.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.804 0.335 . . . . 0.0 110.303 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.0 p -47.7 -5.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 289' ' ' PHE . 1.6 p80 -155.71 75.15 0.9 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -163.12 159.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.447 ' HE ' HD13 ' A' ' 244' ' ' ILE . 37.5 mtt180 -126.52 76.37 1.62 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.743 0.306 . . . . 0.0 110.318 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 48.3 mt -39.36 127.48 1.82 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.137 0.97 . . . . 0.0 112.019 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 -172.37 2.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.098 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -110.72 48.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.823 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.568 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 34.1 tp60 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.371 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 137' ' ' TYR . 5.8 tp10 45.96 -164.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.947 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 48.5 p90 -179.55 119.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.908 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 160' ' ' LEU . 30.2 m -131.39 165.02 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.533 ' NE ' ' OE2' ' A' ' 189' ' ' GLU . 12.7 ttp180 -122.62 136.94 55.02 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.747 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -103.85 90.81 3.74 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.566 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.504 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -103.52 38.3 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 58.8 m-85 -133.76 -0.16 3.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.958 -0.464 . . . . 0.0 111.038 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 59.47 136.94 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.131 0.894 . . . . 0.0 109.477 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 8.5 t80 -126.5 -48.0 1.56 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.641 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 46.59 58.31 4.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.23 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.483 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -65.45 -128.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.607 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 1.2 p30 164.43 -41.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.579 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 7.9 m-20 -73.95 140.33 45.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 112.034 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -49.9 -21.35 1.14 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.428 ' N ' ' C ' ' A' ' 148' ' ' ASP . 77.9 mt-10 -91.27 29.4 1.44 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.528 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.607 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 31.6 p30 -153.11 171.68 18.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.555 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 175' ' ' ASP . 14.6 tp -126.24 87.72 55.67 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.788 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.483 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 57.8 Cg_endo -64.17 143.19 83.21 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 CA-C-N 121.073 1.419 . . . . 0.0 113.858 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 160' ' ' LEU . 12.6 p90 -167.76 172.4 9.21 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.657 0.741 . . . . 0.0 111.485 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -150.29 -165.0 2.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.239 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.747 ' O ' ' O ' ' A' ' 140' ' ' ALA . 17.9 ptpt 41.36 -145.81 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -109.13 49.39 0.85 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 37.4 t0 -52.86 154.04 3.02 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.4 mp -100.24 99.27 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.517 ' O ' HG22 ' A' ' 138' ' ' VAL . 66.7 mt -102.33 90.47 3.91 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.473 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -69.04 147.1 52.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.967 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.1 mp -80.44 131.25 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.05 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.617 ' NH2' HD21 ' A' ' 172' ' ' ASN . 13.1 ttm180 -85.85 -43.09 13.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.212 0.529 . . . . 0.0 110.909 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 164' ' ' ASP . 38.2 t0 -153.58 -24.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.326 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.472 ' HE2' ' HE1' ' A' ' 171' ' ' TRP . 12.7 tttm 59.48 99.25 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -85.56 -44.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.989 1.793 . . . . 0.0 111.732 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.98 174.91 6.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -88.49 -38.46 14.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.972 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.524 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 95.5 mt-30 -80.38 -15.47 56.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.566 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.44 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 64.5 m95 -131.49 154.63 48.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.527 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.5 m0 -143.37 133.37 24.19 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.617 HD21 ' NH2' ' A' ' 163' ' ' ARG . 47.3 t-20 -85.02 117.79 24.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.84 178.7 6.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.734 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.5 111.28 15.51 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -60.88 140.37 57.71 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.19 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.2 ttt -52.1 -0.74 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.607 ' H ' ' C ' ' A' ' 175' ' ' ASP . 86.5 m-20 -84.82 -23.02 29.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.394 0.616 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.52 41.24 2.78 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.105 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -139.85 142.23 36.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.033 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.64 130.29 49.49 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.474 0.654 . . . . 0.0 111.525 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.494 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -162.77 159.57 31.94 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.437 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 mtp -69.84 149.58 47.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.137 0.494 . . . . 0.0 111.199 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.494 HG22 ' HB3' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -134.57 141.55 39.32 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.724 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.38 119.05 5.89 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 N-CA-C 108.073 -1.549 . . . . 0.0 108.073 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.819 ' O ' HG22 ' A' ' 188' ' ' VAL . 35.7 t -54.2 -50.63 83.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.8 Cg_endo -50.9 -27.84 22.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.185 1.924 . . . . 0.0 112.873 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.0 m-85 -71.32 4.91 2.53 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.38 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.7 m -130.7 163.02 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.699 0.285 . . . . 0.0 110.596 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.533 ' OE2' ' NE ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -76.31 -71.45 0.39 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.677 -178.265 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.75 -161.89 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 123.974 0.796 . . . . 0.0 110.614 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 10.0 p -162.46 9.48 0.06 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.073 0.463 . . . . 0.0 110.65 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -120.27 83.65 32.98 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.637 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 194' ' ' SER . 87.6 Cg_endo -79.91 -117.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.459 2.106 . . . . 0.0 111.86 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 193' ' ' PRO . 7.3 p 56.27 145.17 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.026 0.441 . . . . 0.0 110.949 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.8 p -91.59 -11.94 35.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.746 0.308 . . . . 0.0 110.291 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 197' ' ' SER . . . -67.26 94.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 196' ' ' ALA . 47.4 m 54.32 108.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.661 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.49 134.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.227 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.1 m -59.22 -97.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 33.7 p -141.28 170.9 14.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.11 80.04 9.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 19.4 p -85.7 88.45 7.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.594 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 132.98 64.56 0.08 OUTLIER Glycine 0 N--CA 1.466 0.643 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.03 174.36 42.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -92.75 -162.42 0.93 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 55.93 107.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.589 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 208' ' ' SER . 57.8 t0 -157.76 -131.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.361 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.492 ' H ' ' CG ' ' A' ' 207' ' ' ASP . 5.9 m -68.75 133.69 48.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 69.3 m -62.67 -47.78 82.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.498 ' ND1' ' N ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -143.19 91.87 6.91 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.331 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -54.32 157.06 12.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.254 1.969 . . . . 0.0 111.949 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -114.59 87.0 13.46 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.418 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.08 -40.49 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 112.287 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 70.0 mt -114.11 73.98 0.85 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.036 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.34 92.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 140.57 88.89 0.15 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -55.52 143.01 80.07 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.25 1.967 . . . . 0.0 112.017 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 220' ' ' GLY . 13.9 pt-20 -178.12 76.07 0.22 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.375 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.45 78.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.853 2.369 . . . . 0.0 113.148 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 218' ' ' GLU . . . 129.92 -177.15 18.33 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.92 149.98 89.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.593 2.195 . . . . 0.0 112.469 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.532 ' CD1' ' OE2' ' A' ' 218' ' ' GLU . 38.9 p90 -121.46 170.53 9.56 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.05 95.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.051 0.453 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' TYR . 35.4 tp60 -143.18 129.68 10.48 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.26 -27.73 13.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.69 1.593 . . . . 0.0 112.532 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.406 ' C ' HD12 ' A' ' 227' ' ' ILE . 10.1 m -109.41 10.88 25.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.687 ' N ' HD12 ' A' ' 227' ' ' ILE . 3.7 mp 53.06 -95.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.353 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -58.53 115.82 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.056 0.455 . . . . 0.0 110.103 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.2 p -77.61 151.22 79.97 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.45 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.28 79.96 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.997 1.798 . . . . 0.0 111.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 233' ' ' ASN . 1.8 pt? -128.77 147.17 63.35 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.99 23.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.504 2.123 0 C-N-CA 122.403 2.068 . . . . 0.0 112.615 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 231' ' ' LEU . 46.7 t-20 44.24 49.76 7.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.68 ' C ' ' H ' ' A' ' 236' ' ' ASN . 14.6 tp -57.69 -122.53 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.385 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 60.37 -19.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.618 0.247 . . . . 0.0 110.571 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.68 ' H ' ' C ' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -100.53 -40.69 7.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.2 -165.04 40.8 Favored Glycine 1 CA--C 1.439 -4.675 0 CA-C-O 122.306 0.948 . . . . 0.0 113.944 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.411 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.6 Cg_endo -44.43 102.73 0.03 OUTLIER 'Cis proline' 1 N--CA 1.538 4.114 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -0.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 10.5 m-30 -115.27 -124.37 0.29 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.6 OUTLIER -143.71 130.93 20.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 119.667 1.121 . . . . 0.0 109.83 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.773 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.04 -168.03 1.38 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.618 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.37 93.99 1.35 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.8 p -69.0 123.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.347 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.96 9.08 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.041 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.581 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.8 mm-40 -168.61 128.03 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.311 0.576 . . . . 0.0 109.504 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.4 ttmt -170.51 -144.39 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.862 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.1 ptt85 -160.48 -136.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.507 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.428 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 3.7 t -137.01 61.95 37.18 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.667 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.679 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -102.1 70.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.806 3.004 . . . . 0.0 112.081 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.573 ' C ' ' H ' ' A' ' 252' ' ' TYR . 3.4 p30 -47.78 158.53 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.581 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.54 -3.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.897 0.38 . . . . 0.0 111.767 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.73 ' O ' ' N ' ' A' ' 254' ' ' LYS . 30.1 m-85 -80.15 -59.04 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 42.9 t0 -47.14 60.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 125.653 1.846 . . . . 0.0 112.179 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 252' ' ' TYR . 34.0 mtmt 87.49 -51.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.961 1.413 . . . . 0.0 109.422 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 4.4 m 164.29 -17.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.175 0.922 . . . . 0.0 110.373 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.537 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -45.16 170.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.573 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.781 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.4 OUTLIER -109.54 150.26 28.42 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.778 0.431 . . . . 0.0 110.563 -177.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.751 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -97.17 116.59 29.64 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 122.07 -0.394 . . . . 0.0 111.119 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.803 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.2 mt -137.58 -172.59 3.27 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.74 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 15.3 tt0 -145.56 147.43 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.043 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.581 HG22 ' HA ' ' A' ' 245' ' ' GLN . 68.8 t -54.73 97.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.888 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 122.15 10.26 6.29 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 56.2 mm-40 -91.81 -130.64 0.11 Allowed 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.063 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 166.32 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.063 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.1 p -127.41 142.75 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.466 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.519 ' O ' HG22 ' A' ' 268' ' ' THR . 2.9 ttmm -99.04 84.15 3.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.4 ' CG1' HD13 ' A' ' 234' ' ' LEU . 94.0 t -50.56 150.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.518 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 266' ' ' LYS . 0.2 OUTLIER -148.25 -47.68 0.16 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.579 -178.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 5.6 tppt? -84.05 151.73 24.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.36 134.19 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.407 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.531 ' O ' ' CE3' ' A' ' 276' ' ' TRP . 43.3 p-10 -177.31 -170.57 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.135 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 275' ' ' GLN . 0.0 OUTLIER 60.39 -143.32 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.687 178.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.3 p -137.04 -4.35 1.94 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.734 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 275' ' ' GLN . . . 177.74 13.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 118.924 -1.608 . . . . 0.0 112.517 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 2.8 mp0 -101.28 -74.76 0.61 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 271' ' ' ASN . 9.9 m95 76.63 169.01 0.25 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 75.0 mt-10 -131.95 143.06 49.84 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.543 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -136.68 145.34 17.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 121.853 0.696 . . . . 0.0 113.599 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.64 130.8 55.32 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 113.945 -1.127 . . . . 0.0 110.674 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.713 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -110.55 -90.84 0.47 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -104.54 50.56 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 89.92 -31.04 5.49 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.1 OUTLIER -63.91 75.68 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.284 -0.958 . . . . 0.0 111.156 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 282' ' ' GLY . 50.9 mtt180 -71.92 160.89 31.77 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.357 0.599 . . . . 0.0 110.344 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 173.54 -161.71 32.48 Favored Glycine 0 C--O 1.217 -0.928 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.537 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 41.1 p-80 -130.04 168.8 16.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.223 0.535 . . . . 0.0 110.801 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 173.47 116.13 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.239 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 290' ' ' THR . 52.7 Cg_exo -51.45 149.91 16.67 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.805 1.67 . . . . 0.0 111.915 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.5 OUTLIER -61.11 -4.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 288' ' ' PRO . 31.9 p -46.95 -9.25 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.89 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.78 ' O ' HG13 ' A' ' 292' ' ' VAL . 4.5 p-80 -153.96 84.6 1.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.325 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.1 OUTLIER -172.68 152.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -106.14 -45.61 4.28 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 32.1 mt 77.39 113.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 122.069 0.938 . . . . 0.0 111.451 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.78 -174.54 4.81 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.265 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.423 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 67.1 t0 -106.64 58.79 0.64 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 53.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 138' ' ' VAL . 0.7 OUTLIER -60.15 -71.52 0.13 Allowed 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.948 ' O ' HG22 ' A' ' 138' ' ' VAL . 98.3 m-85 -24.66 -100.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.926 0 O-C-N 123.542 0.526 . . . . 0.0 111.777 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.948 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 82.74 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 125.109 1.506 . . . . 0.0 111.156 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.564 ' NH1' ' O ' ' A' ' 200' ' ' THR . 4.2 ptp180 -135.63 144.69 46.22 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.838 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.708 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -100.32 96.57 7.53 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.599 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.783 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -96.99 37.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.914 0.388 . . . . 0.0 111.467 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.539 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 49.5 m-85 -137.35 1.98 2.46 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.684 0.278 . . . . 0.0 110.793 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER 60.21 143.32 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.495 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.515 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 5.4 t80 -133.62 -34.92 1.01 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.545 0.611 . . . . 0.0 110.951 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 145' ' ' ASN . 2.5 p-10 34.42 59.89 0.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.645 0.591 . . . . 0.0 110.663 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.73 -139.8 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.481 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 1.7 p30 165.04 94.14 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.667 -0.766 . . . . 0.0 110.844 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 4.6 m-20 158.63 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.112 0.482 . . . . 0.0 110.2 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.17 -17.35 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.361 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -100.44 18.23 19.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.453 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.3 p30 -142.41 156.75 45.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.733 HD11 ' OD2' ' A' ' 175' ' ' ASP . 9.8 tp -121.63 85.83 44.27 Favored Pre-proline 0 C--O 1.212 -0.891 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.26 137.27 79.71 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 C-N-CA 121.586 1.524 . . . . 0.0 112.87 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.708 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 7.1 p90 -154.01 170.03 22.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -135.82 -68.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -94.96 92.62 6.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.249 -176.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 17.35 55.42 0.01 OUTLIER Glycine 0 C--N 1.34 0.806 0 O-C-N 123.812 0.695 . . . . 0.0 112.041 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 156' ' ' LYS . 32.9 t0 -63.08 142.82 58.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.576 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.5 mp -87.31 101.87 11.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 31.0 mt -92.14 -127.56 0.1 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.356 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 174' ' ' GLU . 40.9 tttp 173.28 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.678 0.611 . . . . 0.0 110.399 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.588 HD13 ' O ' ' A' ' 136' ' ' GLU . 1.3 mp -90.23 145.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.49 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -134.11 -39.8 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.38 104.97 6.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.856 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.463 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 12.9 pttm -113.22 74.94 2.07 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.79 -30.19 22.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.995 1.797 . . . . 0.0 112.227 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.16 158.92 17.82 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.612 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -87.09 -37.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.736 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -78.94 -29.52 44.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.621 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.466 ' CZ2' ' HD2' ' A' ' 238' ' ' PRO . 77.4 m95 -117.27 150.95 37.93 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.521 ' CE3' HG22 ' A' ' 185' ' ' VAL . 8.8 m0 -145.91 136.33 24.01 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.8 112.15 16.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.47 166.62 10.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.069 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 161' ' ' LYS . 27.4 tt0 -129.31 145.95 51.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.012 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.733 ' OD2' HD11 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -76.58 -178.93 4.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.664 0.745 . . . . 0.0 110.73 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.4 ttt -80.11 -11.45 59.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.0 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -100.94 -25.48 14.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.1 43.67 0.51 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -117.56 126.16 52.09 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.783 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.68 42.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.456 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -150.59 148.52 19.79 Favored Glycine 0 C--N 1.312 -0.793 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.875 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 159.67 20.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.44 0.638 . . . . 0.0 110.656 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 7.8 pt -150.49 142.48 15.61 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.732 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.33 110.76 3.04 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 N-CA-C 109.852 -0.865 . . . . 0.0 109.852 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 188' ' ' VAL . 50.3 t -44.6 -51.58 20.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.613 -0.679 . . . . 0.0 112.048 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.8 Cg_endo -47.26 -29.3 9.21 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.146 1.898 . . . . 0.0 112.841 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -69.73 -6.33 31.16 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.058 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 185' ' ' VAL . 25.0 m -129.53 167.22 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 111.007 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.783 ' CD ' HD21 ' A' ' 141' ' ' LEU . 4.4 pt-20 -150.22 61.19 0.97 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 110.938 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 52.6 -174.5 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.035 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 23.9 t -143.79 -33.85 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.654 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 44.85 71.92 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.02 -21.65 59.73 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.869 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 83.2 p -66.32 -27.62 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.656 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 196' ' ' ALA . 50.9 p -66.52 -59.02 4.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.801 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 195' ' ' SER . . . 53.49 56.88 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.748 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 199' ' ' SER . 5.7 t -86.38 74.95 9.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.58 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 82.0 t 39.99 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.988 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 197' ' ' SER . 82.5 p -80.06 51.14 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.211 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.564 ' O ' ' NH1' ' A' ' 139' ' ' ARG . 8.4 m -64.87 -31.24 72.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.48 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 201' ' ' LEU . 9.4 mp -78.65 -70.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.681 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 30.7 p -84.97 99.12 10.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.665 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 171.57 89.47 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.6 129.13 1.03 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 206' ' ' GLN . 5.3 t-20 40.89 -155.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 110.631 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.509 ' H ' ' CG ' ' A' ' 205' ' ' ASN . 58.0 tp60 -169.74 52.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.225 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 208' ' ' SER . 93.7 m-20 54.9 35.42 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.687 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 207' ' ' ASP . 55.2 p 55.77 160.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 89.5 p -81.41 -15.23 55.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.558 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.425 ' ND1' ' OD1' ' A' ' 271' ' ' ASN . 74.1 m-70 53.33 82.84 0.24 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.234 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.71 143.42 69.82 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.629 2.219 . . . . 0.0 111.84 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.576 ' H ' ' CD ' ' A' ' 212' ' ' GLN . 2.3 mp0 -48.38 148.59 3.24 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.658 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.1 -36.12 11.39 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.219 1.946 . . . . 0.0 112.004 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tp 67.51 6.38 4.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.301 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 40.18 -141.17 0.83 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 175.94 172.36 40.65 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.21 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.794 2.329 . . . . 0.0 111.68 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.06 66.46 77.59 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.463 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.39 -5.45 16.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.854 2.369 . . . . 0.0 111.916 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.47 -74.65 0.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.12 -179.53 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.631 2.221 . . . . 0.0 112.006 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.537 ' O ' ' NE2' ' A' ' 224' ' ' GLN . 48.4 p90 -59.33 169.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.84 105.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 110.364 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.625 ' NE2' ' H ' ' A' ' 224' ' ' GLN . 0.0 OUTLIER -127.28 146.56 58.55 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.06 -30.8 66.03 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.271 1.981 . . . . 0.0 112.402 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 227' ' ' ILE . 68.4 p -133.48 -96.98 0.29 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 227' ' ' ILE . 10.7 tp -150.63 43.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.117 0.484 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -176.19 172.71 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.657 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 53.9 p -72.76 127.9 89.04 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.623 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.56 -151.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.956 1.771 . . . . 0.0 112.53 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.503 ' CB ' ' HE1' ' A' ' 276' ' ' TRP . 10.6 tp -78.29 126.94 82.5 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.357 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.66 -58.33 0.12 Allowed 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.793 1.662 . . . . 0.0 113.061 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -149.99 -167.94 2.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.175 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 235' ' ' GLN . 30.9 tp -39.31 -84.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.407 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 237' ' ' GLY . 6.4 mm100 55.87 154.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.186 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 44.08 -87.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.433 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 235' ' ' GLN . . . -34.72 160.27 0.01 OUTLIER Glycine 1 CA--C 1.45 -4.021 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.951 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.482 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 3.1 Cg_exo -73.24 126.08 11.46 Favored 'Cis proline' 0 C--N 1.285 -2.799 0 O-C-N 122.3 0.632 . . . . 0.0 113.071 -5.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.49 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 40.9 m-85 -153.71 -124.62 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.518 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 2.2 m-30 -140.7 113.21 8.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 118.752 0.705 . . . . 0.0 109.71 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.707 ' HB2' HD23 ' A' ' 294' ' ' LEU . . . -105.65 144.48 32.34 Favored 'General case' 0 C--O 1.2 -1.515 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -101.1 112.52 25.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.19 0.519 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.5 p -79.05 122.26 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.74 21.51 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.72 104.54 0.02 OUTLIER 'General case' 0 N--CA 1.46 0.064 0 CA-C-O 121.525 0.678 . . . . 0.0 111.154 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.833 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -139.99 -140.11 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.743 178.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.1 ptt85 -157.2 -139.61 0.07 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.834 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 248' ' ' VAL . 80.4 t -135.94 69.36 64.51 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.985 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 256' ' ' ALA . 45.4 Cg_endo -96.28 -179.72 0.48 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.976 2.45 . . . . 0.0 111.208 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.709 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.8 OUTLIER -141.99 137.2 31.0 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.683 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.43 -5.51 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.303 0.377 . . . . 0.0 111.504 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.709 ' N ' ' O ' ' A' ' 250' ' ' ASN . 51.2 m-85 -93.41 -55.79 3.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.14 71.76 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.998 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 252' ' ' TYR . 30.9 mtmt 74.91 -5.22 2.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 124.343 1.027 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.53 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 0.3 OUTLIER 87.24 51.88 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.398 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 249' ' ' PRO . . . -104.71 113.87 27.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.865 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -49.26 155.21 0.72 Allowed 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.922 -0.486 . . . . 0.0 111.444 -179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.662 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -106.5 114.51 28.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.633 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.833 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.8 OUTLIER -136.56 -173.94 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.337 0.589 . . . . 0.0 111.328 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.2 tt0 -146.26 152.07 38.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.786 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.401 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 54.3 t -56.96 115.14 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.66 10.33 17.03 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 23.0 mm-40 -107.56 -152.49 0.48 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.874 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER -171.89 152.31 2.97 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.994 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.874 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.3 p -135.8 156.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.428 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.62 99.29 9.84 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 268' ' ' THR . 10.7 t -65.81 156.85 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.408 ' N ' ' CG1' ' A' ' 267' ' ' VAL . 0.6 OUTLIER -158.25 -62.42 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.152 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -80.42 141.67 35.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -177.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.9 OUTLIER -140.59 147.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.288 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.567 ' C ' HD22 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -176.53 -159.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.5 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.49 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 47.7 mtm 52.1 -120.66 1.7 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.886 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.8 p -135.48 -10.65 2.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.237 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . 177.69 -46.39 0.1 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.559 -1.781 . . . . 0.0 113.126 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.49 ' O ' ' HE3' ' A' ' 272' ' ' MET . 24.2 mp0 -65.79 64.39 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 3.1 p-90 -74.66 -171.95 1.4 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.171 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 86.0 mt-10 -108.61 166.9 10.44 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.535 1.147 . . . . 0.0 111.618 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -149.18 -170.81 17.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.896 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.449 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -157.08 127.68 6.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.304 0.574 . . . . 0.0 111.655 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.636 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -138.94 74.28 1.47 Allowed 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.302 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 7.2 m-20 85.74 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.731 0.777 . . . . 0.0 109.33 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.09 -33.73 4.37 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.78 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.03 93.64 0.59 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.449 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 83.9 mtt180 -94.75 168.46 10.81 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.438 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.548 ' O ' HD22 ' A' ' 257' ' ' LEU . . . 162.95 137.53 2.21 Favored Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.994 177.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 277' ' ' GLU . 2.7 p80 -65.06 175.31 1.62 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.142 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.614 ' CZ ' ' HB1' ' A' ' 256' ' ' ALA . 0.3 OUTLIER 166.21 144.53 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.408 178.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 39.9 Cg_exo -55.28 137.99 78.43 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.436 2.091 . . . . 0.0 113.331 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 2.0 t80 -73.77 -5.8 43.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.253 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 34.8 p -67.72 2.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 8.5 p80 -136.32 47.51 2.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.417 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.427 HG13 ' HD1' ' A' ' 291' ' ' HIS . 0.9 OUTLIER -149.3 151.37 13.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -111.01 -53.8 2.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.707 HD23 ' HB2' ' A' ' 241' ' ' ALA . 2.0 mt 91.27 119.73 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.324 1.059 . . . . 0.0 111.346 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 297' ' ' GLN . 8.7 mp -70.46 -170.59 0.4 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 296' ' ' ASP . 40.8 t0 -66.51 9.4 0.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 295' ' ' LEU . 40.6 tt0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 162' ' ' ILE . 6.2 tp10 -54.33 -83.27 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.39 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.897 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.7 m-85 -58.8 -54.84 42.58 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 137' ' ' TYR . 2.3 m 93.12 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 125.682 1.864 . . . . 0.0 111.59 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -121.35 125.67 47.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.744 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -98.9 95.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.331 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.648 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -106.1 35.05 3.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.755 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 47.6 m-85 -134.26 0.85 3.14 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.29 -0.256 . . . . 0.0 111.029 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.89 137.95 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.66 0 O-C-N 124.281 0.988 . . . . 0.0 108.786 -178.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 8.6 t80 -121.54 -47.89 2.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.092 0.406 . . . . 0.0 110.399 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 144' ' ' PHE . 65.7 t30 40.97 60.9 1.87 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.213 0.53 . . . . 0.0 109.958 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.17 -155.55 1.41 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.722 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.629 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.9 p30 169.62 94.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.188 -1.006 . . . . 0.0 110.27 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -159.97 -146.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 111.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 58.7 p30 -75.86 57.51 1.05 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.581 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 151' ' ' ASP . 92.2 mt-10 98.01 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.402 1.064 . . . . 0.0 111.496 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.629 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 14.1 p-10 -28.91 161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.681 0.613 . . . . 0.0 110.705 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.491 HD23 HG21 ' A' ' 183' ' ' ILE . 13.8 tp -106.72 75.34 0.39 Allowed Pre-proline 0 C--O 1.215 -0.758 0 O-C-N 122.075 -0.391 . . . . 0.0 111.117 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.75 118.72 5.81 Favored 'Trans proline' 0 C--N 1.295 -2.255 0 CA-C-N 119.386 0.816 . . . . 0.0 110.968 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.744 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 15.5 p90 -134.25 163.6 29.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.416 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.411 ' CG ' ' H ' ' A' ' 156' ' ' LYS . 1.1 tpmp? -96.13 -135.35 0.23 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 158' ' ' ASP . 50.8 mtmt -96.56 174.94 6.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 159' ' ' ILE . . . 33.11 22.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.873 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.634 ' N ' ' O ' ' A' ' 156' ' ' LYS . 6.3 t0 -72.69 137.46 46.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 117.257 0.528 . . . . 0.0 109.816 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -104.06 103.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.7 mt -108.35 107.93 18.7 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.065 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -62.89 140.12 58.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 136' ' ' GLU . 48.7 mm -81.34 130.95 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.165 0.507 . . . . 0.0 110.409 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -44.07 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -155.1 133.2 11.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.535 ' HG3' ' NE1' ' A' ' 171' ' ' TRP . 2.6 ttmm -106.42 70.55 0.24 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.698 -0.191 . . . . 0.0 110.727 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.25 -54.74 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.165 1.244 . . . . 0.0 111.495 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -100.78 -172.8 2.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.18 -32.88 7.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.57 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 94.2 mt-30 -83.29 -31.32 26.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.497 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 81.2 m95 -119.59 148.03 43.8 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.567 ' CE3' HG22 ' A' ' 185' ' ' VAL . 14.1 m0 -141.72 131.33 24.0 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 120.857 0.36 . . . . 0.0 110.104 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -81.12 105.73 12.56 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.25 174.91 5.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.047 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -123.24 130.53 52.87 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.99 165.55 0.94 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.197 0.522 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 49.8 ttp -74.07 -4.48 35.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.047 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.15 -27.85 14.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.25 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.89 48.37 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 108.279 -1.929 . . . . 0.0 108.279 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -128.07 129.0 45.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.929 -0.636 . . . . 0.0 109.678 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 125.79 49.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.344 0.593 . . . . 0.0 111.869 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -165.26 160.66 34.04 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.522 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.483 ' C ' HG22 ' A' ' 183' ' ' ILE . 0.2 OUTLIER -68.02 160.25 29.13 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.159 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.868 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -159.66 148.12 13.68 Favored Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.572 177.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.53 122.44 8.61 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.659 1.573 . . . . 0.0 109.253 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.829 ' O ' HG22 ' A' ' 188' ' ' VAL . 42.7 t -58.68 -52.18 76.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.672 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.5 Cg_endo -50.78 -27.25 19.68 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.794 2.329 . . . . 0.0 114.498 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.431 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 5.2 m-85 -65.2 7.8 0.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.812 0.339 . . . . 0.0 111.483 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 185' ' ' VAL . 3.1 m -132.69 173.08 15.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.648 ' CD ' HD21 ' A' ' 141' ' ' LEU . 1.9 pt-20 -141.64 39.87 1.7 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.973 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 189' ' ' GLU . 13.4 mptt 52.89 118.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 110.57 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.502 ' H ' ' HA ' ' A' ' 138' ' ' VAL . 47.4 t -48.06 164.51 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.589 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.441 ' N ' ' SG ' ' A' ' 191' ' ' CYS . 51.9 ttt180 67.35 93.65 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.205 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.7 -67.97 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.977 1.785 . . . . 0.0 113.003 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 p 65.13 35.76 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 m 41.4 37.52 0.67 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 197' ' ' SER . . . -124.71 -90.65 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ALA . 40.2 t 56.2 146.24 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.019 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 199' ' ' SER . 25.8 m -67.83 -41.72 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.999 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.49 ' N ' HG23 ' A' ' 198' ' ' VAL . 14.6 m -137.44 13.68 2.99 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.797 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.5 p 45.02 -139.27 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.404 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.26 156.55 20.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.619 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -43.94 95.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -68.03 -74.85 0.55 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 52.33 -105.67 0.28 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 206' ' ' GLN . 27.1 t-20 -62.35 -117.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.668 0.271 . . . . 0.0 110.563 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.466 ' N ' ' OD1' ' A' ' 205' ' ' ASN . 78.2 mt-30 -145.08 150.62 37.15 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -158.68 173.66 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m 62.52 123.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.818 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.7 t -142.84 135.99 28.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.42 ' CB ' ' CD ' ' A' ' 211' ' ' PRO . 2.8 m-70 -78.81 -63.12 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.326 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 210' ' ' HIS . 17.9 Cg_endo -56.14 124.55 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.858 1.705 . . . . 0.0 111.574 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.4 79.06 15.94 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.35 145.08 89.48 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.7 mp -83.68 20.94 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.167 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.02 -33.87 88.35 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.79 173.23 45.08 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.71 149.25 73.14 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.771 2.314 . . . . 0.0 111.92 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -150.3 66.18 7.65 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.045 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -79.71 -155.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.959 2.439 . . . . 0.0 111.648 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 -168.58 35.31 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.456 ' HG3' HD21 ' A' ' 228' ' ' ASN . 42.7 Cg_endo -72.18 -61.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.131 1.887 . . . . 0.0 112.344 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 224' ' ' GLN . 89.9 m-85 -142.12 160.64 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.492 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.93 94.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.306 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 226' ' ' SER . 28.1 tt0 -141.88 98.99 6.2 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.836 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 226' ' ' SER . 51.4 Cg_exo -51.28 72.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.87 1.713 . . . . 0.0 111.794 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 224' ' ' GLN . 1.7 t 164.54 -40.52 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.646 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 227' ' ' ILE . 89.0 mt 61.77 70.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.456 HD21 ' HG3' ' A' ' 221' ' ' PRO . 2.3 m120 79.18 65.31 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.639 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.433 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.1 OUTLIER -51.95 176.28 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -176.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.586 ' HB3' ' N ' ' A' ' 289' ' ' PHE . 38.3 Cg_endo -85.22 154.63 10.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.952 2.435 . . . . 0.0 110.805 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.658 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 3.5 mp -95.04 164.82 18.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.5 68.99 4.33 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.674 1.582 . . . . 0.0 110.613 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -90.13 17.32 7.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.09 0.472 . . . . 0.0 110.834 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.665 ' C ' ' H ' ' A' ' 236' ' ' ASN . 5.0 tp -72.91 -125.15 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.722 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.482 ' H ' ' CG ' ' A' ' 234' ' ' LEU . 78.4 mm-40 56.17 -5.63 0.03 OUTLIER 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.665 ' H ' ' C ' ' A' ' 234' ' ' LEU . 95.0 m-20 -107.87 -56.88 2.17 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.603 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.68 -163.38 39.21 Favored Glycine 1 CA--C 1.446 -4.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.091 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.404 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 3.5 Cg_exo -45.38 100.17 0.03 OUTLIER 'Cis proline' 0 N--CA 1.528 3.519 0 N-CA-C 117.152 1.943 . . . . 0.0 117.152 1.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.634 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 11.2 m-30 -116.26 -128.23 0.29 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.57 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.47 128.64 19.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 119.435 1.016 . . . . 0.0 109.805 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.801 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.16 -162.37 0.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.314 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -160.85 95.81 1.09 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.92 128.68 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.711 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.978 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -123.17 12.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.699 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 261' ' ' VAL . 2.4 mm-40 -169.06 114.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.836 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.4 ttmt -160.78 -145.66 0.12 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -155.48 -140.15 0.08 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.531 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 248' ' ' VAL . 6.4 p -134.47 65.24 67.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.568 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 78.6 Cg_endo -91.91 176.47 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.339 2.026 . . . . 0.0 112.075 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.703 ' O ' ' N ' ' A' ' 252' ' ' TYR . 16.9 p30 -149.26 145.21 26.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.712 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.41 -3.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.703 ' N ' ' O ' ' A' ' 250' ' ' ASN . 48.0 m-85 -91.5 -54.09 4.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.481 0.658 . . . . 0.0 110.291 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -46.11 -66.52 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.652 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 256' ' ' ALA . 27.7 mttt -148.26 33.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.275 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.413 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 3.6 m 70.9 -13.61 0.49 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.689 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.07 164.41 0.29 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.261 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.797 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -104.07 149.53 25.12 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 122.794 0.438 . . . . 0.0 110.533 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.801 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -86.81 114.55 23.57 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.836 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.3 mt -139.9 -177.0 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.447 0.641 . . . . 0.0 111.007 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.3 tt0 -145.83 147.48 31.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 245' ' ' GLN . 71.9 t -54.55 102.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.96 6.11 10.34 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 65.7 mm-40 -88.32 -125.25 0.05 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 161.23 140.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.079 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.7 p -130.89 140.66 48.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.175 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -99.3 86.01 3.31 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.992 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.4 152.58 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.669 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.431 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -154.37 -53.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.62 127.89 33.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.787 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -137.37 127.49 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.997 0.903 . . . . 0.0 111.913 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.568 ' O ' ' CZ3' ' A' ' 276' ' ' TRP . 15.9 p30 -154.66 -167.96 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.549 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.474 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 44.7 mtm 65.41 -123.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.89 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.3 p -140.37 -5.76 1.22 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.028 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 276' ' ' TRP . . . -175.57 -52.13 0.06 OUTLIER Glycine 0 C--O 1.213 -1.203 0 C-N-CA 118.138 -1.982 . . . . 0.0 112.737 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.474 ' O ' ' HE3' ' A' ' 272' ' ' MET . 5.9 tp-100 -61.34 63.9 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.658 ' HE1' ' C ' ' A' ' 231' ' ' LEU . 6.4 m95 -67.41 177.93 1.74 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.518 -0.739 . . . . 0.0 111.097 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 59.1 mt-10 -130.26 156.39 44.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -133.36 -142.28 4.74 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.964 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.479 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.1 tt0 -169.35 134.32 1.48 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.925 -0.638 . . . . 0.0 112.559 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.707 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -146.61 72.24 1.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.157 -178.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 18.2 t-20 83.27 31.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.361 0.6 . . . . 0.0 110.04 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.68 -33.43 5.71 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.134 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 13.2 ptpt -67.87 75.44 0.2 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.033 0.444 . . . . 0.0 110.991 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.542 ' NH1' ' CZ ' ' A' ' 142' ' ' PHE . 93.4 mtt180 -73.01 170.49 14.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.98 -155.13 26.04 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.3 p80 -136.36 176.51 8.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.129 0.572 . . . . 0.0 109.738 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.3 OUTLIER 171.27 125.09 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.223 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.86 147.94 2.98 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.666 1.578 . . . . 0.0 113.559 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.586 ' N ' ' HB3' ' A' ' 230' ' ' PRO . 1.6 t80 -73.75 -5.13 38.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.1 p -60.05 5.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.266 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.749 ' O ' HG13 ' A' ' 292' ' ' VAL . 7.4 p-80 -157.33 72.93 0.71 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.5 OUTLIER -165.9 148.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.425 ' HG3' HD12 ' A' ' 244' ' ' ILE . 14.3 mtp180 -126.36 74.38 1.45 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.799 0.333 . . . . 0.0 110.746 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 41.9 mt -40.68 127.06 2.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 112.004 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 4.9 mp -77.31 -174.52 3.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.277 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -96.71 25.7 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.074 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.634 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 56.2 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' CG ' ' A' ' 137' ' ' TYR . 2.0 tp10 -164.93 171.49 14.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.346 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 191' ' ' CYS . 0.5 OUTLIER 174.27 150.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.71 172.47 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -126.78 127.9 45.76 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.757 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -96.89 93.05 6.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.672 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.4 36.1 1.82 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.284 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.637 ' CZ ' ' NH2' ' A' ' 284' ' ' ARG . 52.0 m-85 -136.31 2.31 2.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 122.39 -0.194 . . . . 0.0 110.933 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.3 p30 56.87 141.63 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 O-C-N 124.471 1.107 . . . . 0.0 109.596 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 10.5 t80 -134.41 -44.22 0.76 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.243 0.474 . . . . 0.0 110.165 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 144' ' ' PHE . 5.1 p-10 33.85 62.25 0.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.846 0.716 . . . . 0.0 110.619 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.407 ' N ' ' HB3' ' A' ' 153' ' ' PRO . . . -64.82 -135.82 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.689 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 168.03 90.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.612 -0.294 . . . . 0.0 111.049 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.5 m-20 168.4 -170.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 150' ' ' GLU . 40.3 p-10 -93.53 -23.24 18.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.463 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 19.0 pt-20 -103.6 23.11 13.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.109 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.689 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 4.0 p-10 -131.58 148.37 52.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.2 tp -116.17 86.29 16.98 Favored Pre-proline 0 C--O 1.217 -0.649 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.407 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 53.6 Cg_endo -65.12 140.04 63.49 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.317 1.345 . . . . 0.0 112.825 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.757 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 10.6 p90 -158.0 160.21 37.23 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.63 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -63.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.553 0.692 . . . . 0.0 111.748 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 158' ' ' ASP . 2.5 ptmt -85.06 92.61 8.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.76 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 13.87 53.59 0.01 OUTLIER Glycine 0 N--CA 1.473 1.154 0 O-C-N 124.054 0.846 . . . . 0.0 112.287 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 156' ' ' LYS . 9.6 t70 -64.47 143.01 58.22 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.445 0.641 . . . . 0.0 109.583 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 191' ' ' CYS . 42.8 mm -88.5 107.8 18.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.183 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 mt -116.02 117.55 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.643 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.562 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 88.1 tttt -75.49 147.18 40.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.101 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.5 mp -74.22 -59.01 3.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 70.57 -50.45 0.66 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.467 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -146.9 120.32 9.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.243 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.478 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 0.0 OUTLIER -120.48 85.17 37.18 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.398 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.89 -29.55 18.3 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.629 1.553 . . . . 0.0 112.281 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.417 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 94.8 mt-10 -119.98 160.67 22.31 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.002 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 168' ' ' GLU . 3.3 pt-20 -83.65 -43.69 15.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.741 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.666 ' NE2' ' CD1' ' A' ' 239' ' ' PHE . 28.0 mt-30 -74.68 -29.88 61.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.478 ' NE1' ' CE2' ' A' ' 239' ' ' PHE . 77.2 m95 -119.33 151.24 38.8 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.594 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.4 m0 -143.35 131.1 21.4 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.096 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 162' ' ' ILE . 51.2 t30 -81.39 116.98 21.47 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 161' ' ' LYS . . . -127.13 176.87 7.05 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.242 0.339 . . . . 0.0 110.453 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.19 133.94 54.72 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.258 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.434 ' HB2' HD11 ' A' ' 152' ' ' LEU . 11.0 t70 -58.37 170.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.491 0.662 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.5 ttt -78.51 0.41 26.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.666 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -104.4 -28.59 11.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.83 48.19 0.42 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -129.25 130.93 46.86 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.128 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.88 121.83 41.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.59 0.71 . . . . 0.0 111.874 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.86 154.41 25.49 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.765 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 152' ' ' LEU . 1.9 ttt -74.5 163.61 27.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.542 0.686 . . . . 0.0 111.084 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.842 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -157.21 145.31 14.21 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.669 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.03 112.92 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.529 1.486 . . . . 0.0 109.441 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.713 ' O ' HG22 ' A' ' 188' ' ' VAL . 49.7 t -47.63 -51.37 45.55 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.954 -0.466 . . . . 0.0 112.045 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.3 Cg_endo -47.42 -30.61 11.86 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.305 2.003 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.21 -3.76 11.75 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.935 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 185' ' ' VAL . 22.3 m -129.74 160.95 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.792 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.551 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -116.95 -64.31 1.33 Allowed 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.448 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 4.5 tptp -177.71 -173.17 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 159' ' ' ILE . 50.9 t -173.37 64.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.986 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.53 149.71 84.03 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.572 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.47 -31.33 0.36 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.212 1.942 . . . . 0.0 112.302 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.1 m -64.71 -99.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.511 ' O ' ' HB2' ' A' ' 196' ' ' ALA . 35.0 t -66.38 80.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.605 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 195' ' ' SER . . . 170.49 110.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.242 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 98.0 p -166.08 -133.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.453 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 199' ' ' SER . 7.7 p -51.95 159.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.516 ' N ' HG22 ' A' ' 198' ' ' VAL . 47.7 t -49.06 147.81 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.029 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 201' ' ' LEU . 48.0 m -155.11 91.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.303 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 200' ' ' THR . 0.4 OUTLIER 20.79 64.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.705 0.628 . . . . 0.0 111.201 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 97.7 m -124.58 110.38 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -178.31 -104.31 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.67 70.12 1.9 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -87.81 95.74 10.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.485 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -67.92 116.1 8.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 209' ' ' SER . 34.0 t0 -95.22 111.2 23.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.296 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 m 44.88 -90.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.536 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 207' ' ' ASP . 59.7 m -130.56 152.56 49.79 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.296 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 211' ' ' PRO . 0.0 OUTLIER 165.77 -46.83 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.897 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 73.2 Cg_endo -80.42 102.2 1.4 Allowed 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.59 1.527 . . . . 0.0 112.115 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.462 HE22 ' CA ' ' A' ' 215' ' ' GLY . 0.6 OUTLIER -174.83 57.86 0.19 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.955 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.26 151.16 86.56 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 112.228 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.53 HD22 ' H ' ' A' ' 214' ' ' LEU . 3.8 mm? 43.89 71.26 0.25 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.462 ' CA ' HE22 ' A' ' 212' ' ' GLN . . . -109.66 45.72 1.28 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.8 81.15 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.56 150.08 71.52 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.504 2.136 . . . . 0.0 111.889 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.451 ' H ' ' HD2' ' A' ' 219' ' ' PRO . 4.8 mt-10 -153.22 -64.14 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.035 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 218' ' ' GLU . 25.7 Cg_endo -58.88 141.02 97.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.832 1.688 . . . . 0.0 111.902 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.28 -163.27 22.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -81.15 -80.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.569 2.18 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -172.1 145.05 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.183 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.32 100.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.058 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -138.9 162.01 55.01 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 226' ' ' SER . 53.4 Cg_exo -48.35 -23.24 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.223 1.949 . . . . 0.0 112.134 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 228' ' ' ASN . 0.9 OUTLIER 165.28 -88.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.718 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.532 ' N ' ' OG ' ' A' ' 226' ' ' SER . 95.4 mt 61.18 -58.59 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 124.508 1.13 . . . . 0.0 110.693 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.568 ' N ' ' O ' ' A' ' 226' ' ' SER . 21.9 p-10 -171.35 54.77 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.687 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 1.5 p -60.13 151.78 64.98 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.7 57.14 0.74 Allowed 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.747 2.298 . . . . 0.0 111.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.815 ' O ' HD12 ' A' ' 231' ' ' LEU . 4.3 pp -134.45 130.13 19.88 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 276' ' ' TRP . 73.9 Cg_endo -82.69 -35.09 0.33 Allowed 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.735 1.623 . . . . 0.0 110.9 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.532 ' O ' ' O ' ' A' ' 234' ' ' LEU . 11.5 t-20 70.68 111.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.409 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.778 ' O ' ' N ' ' A' ' 236' ' ' ASN . 2.4 tp -43.45 -101.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 38.92 -76.06 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 124.285 0.99 . . . . 0.0 110.029 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.778 ' N ' ' O ' ' A' ' 234' ' ' LEU . 79.4 m-20 -52.0 -80.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.503 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -72.38 -177.09 29.78 Favored Glycine 0 CA--C 1.45 -3.997 0 CA-C-O 122.554 1.085 . . . . 0.0 114.619 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.503 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.0 Cg_exo -53.7 127.91 1.32 Allowed 'Cis proline' 0 N--CA 1.528 3.502 0 N-CA-C 115.462 1.293 . . . . 0.0 115.462 -3.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.666 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 3.2 m-85 -153.86 -117.68 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.3 m-30 -141.74 123.23 14.98 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 119.141 0.882 . . . . 0.0 109.831 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.673 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -113.34 150.47 32.53 Favored 'General case' 0 C--O 1.198 -1.65 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -113.23 103.25 11.15 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.733 -0.604 . . . . 0.0 109.422 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.3 p -74.35 121.47 25.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.505 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.17 23.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.425 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.522 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.4 mm-40 177.42 116.96 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.431 0.634 . . . . 0.0 109.844 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.869 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.4 ttmt -156.66 -158.8 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.935 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.784 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 28.7 ptt85 -153.94 144.88 22.69 Favored 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.76 91.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.637 0 O-C-N 124.041 0.838 . . . . 0.0 110.829 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.784 ' HD3' ' O ' ' A' ' 247' ' ' ARG . 70.0 Cg_endo -108.14 171.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 123.782 2.988 . . . . 0.0 113.827 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.644 ' ND2' ' H ' ' A' ' 253' ' ' ASP . 4.3 p-10 -93.04 -169.35 2.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.261 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.62 16.19 22.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 254' ' ' LYS . 5.7 m-85 -125.72 -21.62 4.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.227 0.537 . . . . 0.0 110.159 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.644 ' H ' ' ND2' ' A' ' 250' ' ' ASN . 31.5 t70 -71.78 45.05 0.11 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.928 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 255' ' ' THR . 38.7 mtmt 106.03 -10.78 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 124.717 1.261 . . . . 0.0 110.81 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.537 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 7.6 m 105.92 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.4 1.062 . . . . 0.0 110.651 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.618 ' HB1' ' CZ ' ' A' ' 287' ' ' PHE . . . -40.21 153.2 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 O-C-N 123.262 0.351 . . . . 0.0 111.62 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.86 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -107.33 151.51 25.39 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.774 0.43 . . . . 0.0 110.619 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.794 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -94.78 114.54 26.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.869 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.1 mt -139.4 -170.92 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.355 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 17.7 tt0 -146.14 149.18 33.51 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.501 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 245' ' ' GLN . 72.9 t -58.62 106.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.09 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.97 8.68 10.44 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 71.0 mm-40 -94.54 -133.71 0.18 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.973 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 170.98 139.77 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.973 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.7 p -127.21 143.73 39.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 92.24 5.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 t -61.93 152.09 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.733 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -151.8 -58.61 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.671 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 116.89 10.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.413 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.79 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -126.95 162.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.099 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 272' ' ' MET . 5.6 p30 177.59 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.556 0.693 . . . . 0.0 110.638 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.522 ' H ' ' CG ' ' A' ' 271' ' ' ASN . 25.5 mtm -35.95 125.87 0.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.195 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -62.95 6.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.911 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -132.94 -50.48 0.09 OUTLIER Glycine 0 N--CA 1.467 0.729 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.579 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.6 mp0 -94.91 160.9 14.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.579 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 4.3 m95 -162.85 158.17 22.27 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.471 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -120.64 128.48 53.05 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 123.24 0.338 . . . . 0.0 111.454 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.66 -157.16 31.16 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.297 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.35 127.2 0.81 Allowed 'General case' 0 C--N 1.346 0.429 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.677 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -138.83 78.09 1.66 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.692 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.6 t-20 83.35 27.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.587 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.69 -26.73 21.99 Favored Glycine 0 N--CA 1.462 0.386 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.968 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.1 OUTLIER -73.13 73.33 1.22 Allowed 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.769 -178.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.637 ' NH2' ' CZ ' ' A' ' 142' ' ' PHE . 64.2 mtt85 -73.01 169.44 16.96 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.719 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 165.18 122.12 0.59 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 122.659 1.144 . . . . 0.0 113.065 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.627 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.4 p80 -59.4 177.08 0.2 Allowed 'General case' 0 C--N 1.284 -2.247 0 O-C-N 119.194 -2.357 . . . . 0.0 109.555 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 166.03 149.06 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 123.968 0.792 . . . . 0.0 111.428 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 32.4 Cg_exo -55.65 135.81 71.17 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.508 2.138 . . . . 0.0 113.945 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 66.6 t80 -75.16 -1.5 23.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.795 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 20.4 p -76.83 3.22 12.42 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 9.1 p80 -133.63 44.29 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.134 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.36 146.14 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -125.71 77.45 1.66 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.124 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 294' ' ' LEU . 38.2 mt -39.67 127.08 1.97 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.81 0.814 . . . . 0.0 111.375 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.4 mp -67.75 -166.76 0.06 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.962 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -70.96 8.36 0.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 236' ' ' ASN . 47.7 tt0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.149 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 33.9 m . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 37.8 tt0 -140.21 139.29 35.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.394 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.742 ' O ' HG22 ' A' ' 138' ' ' VAL . 21.0 m-85 90.41 -133.56 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 O-C-N 123.513 0.508 . . . . 0.0 110.435 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER 78.59 157.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.565 1.165 . . . . 0.0 110.828 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' NH1' ' SG ' ' A' ' 191' ' ' CYS . 26.1 ptt180 -141.39 159.81 41.45 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . . . -59.74 172.72 0.67 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.342 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 189' ' ' GLU . 58.0 mt -143.08 -58.21 0.42 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.524 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -113.33 9.78 18.31 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.33 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.526 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 78.27 137.45 0.06 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.454 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 3.6 t80 -111.22 -46.11 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.335 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.681 HD21 ' NZ ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER 47.56 63.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.75 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -63.69 -124.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.538 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 166.8 -49.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.188 0.494 . . . . 0.0 111.863 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.613 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 7.9 m-20 -72.32 162.96 28.75 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 27.8 p-10 -69.56 -22.72 63.52 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.806 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -87.83 24.32 1.79 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.613 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 32.2 p30 -141.48 165.59 27.08 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 175' ' ' ASP . 8.8 tp -120.45 88.86 43.26 Favored Pre-proline 0 C--O 1.217 -0.646 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.685 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.405 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 65.6 Cg_endo -69.57 140.58 43.73 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.346 1.364 . . . . 0.0 113.068 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 140' ' ' ALA . 17.5 p90 -158.31 166.22 32.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.681 ' NZ ' HD21 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -139.1 148.12 42.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.42 -133.83 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.338 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -121.31 49.73 0.87 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.18 140.39 58.45 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -84.86 100.58 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.933 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.6 mt -109.56 125.59 52.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.87 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -81.3 138.24 35.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.636 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.3 mp -72.1 -57.44 7.28 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.669 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.444 ' N ' HG22 ' A' ' 162' ' ' ILE . 60.9 ttt180 77.59 -46.26 0.46 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.33 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.495 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -110.4 -134.64 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.868 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 164' ' ' ASP . 8.2 pttp 149.21 60.19 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.431 0.693 . . . . 0.0 109.701 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.4 ' CD ' ' H ' ' A' ' 165' ' ' LYS . 18.4 Cg_endo -57.14 -59.37 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.64 2.227 . . . . 0.0 112.429 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.0 mt-10 -117.3 174.48 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 1.1 pm0 -83.93 -44.58 14.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.678 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.466 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 83.1 mt-30 -75.19 -27.84 59.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 62.9 m95 -119.3 154.13 33.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.641 ' CE3' HG22 ' A' ' 185' ' ' VAL . 9.8 m0 -149.81 142.88 24.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.611 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.636 ' O ' ' O ' ' A' ' 162' ' ' ILE . 2.9 t30 -90.13 121.19 31.96 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -124.13 172.77 8.76 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.67 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -121.58 132.2 54.55 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.493 ' HB2' HD11 ' A' ' 152' ' ' LEU . 11.8 t70 -60.82 171.57 1.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.473 0.654 . . . . 0.0 110.85 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 tpt -77.12 -3.02 37.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.813 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.32 -27.89 12.19 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.87 48.12 0.42 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -129.66 134.29 47.59 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.448 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.56 123.52 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.531 0.681 . . . . 0.0 111.577 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -153.61 149.55 21.05 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.934 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 mtp -66.95 155.98 37.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.374 0.607 . . . . 0.0 111.002 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 11.5 pt -147.63 142.99 17.3 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.211 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.3 111.66 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.223 1.282 . . . . 0.0 109.71 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.641 HG22 ' CE3' ' A' ' 171' ' ' TRP . 58.5 t -46.77 -51.69 36.61 Favored Pre-proline 0 CA--C 1.535 0.38 0 O-C-N 122.212 -0.305 . . . . 0.0 111.337 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.1 Cg_endo -47.26 -30.07 10.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.26 1.974 . . . . 0.0 113.047 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 268' ' ' THR . 15.9 m-85 -77.5 -7.86 56.9 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.48 HG21 HG21 ' A' ' 138' ' ' VAL . 1.5 m -132.94 160.43 42.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.554 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' A' ' 191' ' ' CYS . 8.3 pt-20 -136.71 156.53 48.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.042 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -60.8 12.3 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.577 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.632 ' H ' ' C ' ' A' ' 189' ' ' GLU . 50.0 t 58.13 43.37 20.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.39 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -157.49 58.65 1.53 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.613 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' SER . 73.7 Cg_endo -77.39 -2.88 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.811 2.341 . . . . 0.0 112.15 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.2 m -42.69 85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 193' ' ' PRO . 3.7 t 66.27 6.12 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.744 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 193' ' ' PRO . . . -67.01 146.49 54.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.71 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 78.2 p -64.2 -16.54 62.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.39 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.9 t -73.46 80.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.303 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.5 t 42.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 201' ' ' LEU . 30.6 m -68.51 123.3 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 201' ' ' LEU . 9.2 mp 30.87 -107.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.34 0.4 . . . . 0.0 110.984 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 200' ' ' THR . 71.8 p -50.81 171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.292 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 177.36 -33.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -138.61 -128.9 2.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -127.76 127.64 43.95 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.888 0.375 . . . . 0.0 110.49 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 48.71 -126.85 2.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.367 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.15 -84.29 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.239 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.7 p -86.51 140.56 29.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.439 ' C ' ' CG ' ' A' ' 210' ' ' HIS . 29.3 t -71.93 -11.24 60.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.505 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.439 ' CG ' ' C ' ' A' ' 209' ' ' SER . 5.0 m80 74.42 150.24 0.13 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.67 -47.15 11.75 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.08 1.853 . . . . 0.0 112.422 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 40.25 71.99 1.11 Allowed Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.66 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.64 143.07 99.73 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.778 2.319 . . . . 0.0 111.959 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 tp -170.06 55.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 76.24 75.85 0.85 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.454 ' H ' ' HD2' ' A' ' 217' ' ' PRO . . . -129.78 -71.98 0.13 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 216' ' ' GLY . 32.2 Cg_endo -63.29 -21.86 71.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.7 2.267 . . . . 0.0 111.842 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 220' ' ' GLY . 13.6 mp0 -51.42 150.55 6.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.588 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -38.41 83.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.824 2.349 . . . . 0.0 112.498 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 218' ' ' GLU . . . 47.93 -172.28 0.04 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.68 148.47 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.814 2.343 . . . . 0.0 112.315 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 224' ' ' GLN . 60.4 m-85 -66.72 170.85 5.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.265 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.583 ' O ' ' NE2' ' A' ' 224' ' ' GLN . . . -41.21 93.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 223' ' ' ALA . 1.9 mp0 -128.75 162.67 50.1 Favored Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.22 -43.17 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 228' ' ' ASN . 33.4 t -159.6 155.11 25.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 14.7 mm -65.4 61.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 226' ' ' SER . 31.5 m120 -134.66 73.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.3 p -70.69 151.14 95.4 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.703 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -39.83 -64.82 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.407 2.071 . . . . 0.0 112.123 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.6 tp -133.38 105.32 12.14 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.459 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 233' ' ' ASN . 73.7 Cg_endo -80.71 81.8 2.64 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.875 1.717 . . . . 0.0 112.468 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 271' ' ' ASN . 89.2 m-20 40.83 -164.93 0.0 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.06 109.6 4.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.463 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -152.38 11.65 0.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.08 0.467 . . . . 0.0 110.637 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.434 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 84.9 m-20 -152.94 -75.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.026 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.568 ' HA2' ' N ' ' A' ' 239' ' ' PHE . . . -75.16 -176.44 38.32 Favored Glycine 0 CA--C 1.457 -3.552 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.432 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.3 Cg_endo -57.3 100.72 0.06 OUTLIER 'Cis proline' 0 N--CA 1.525 3.374 0 N-CA-C 115.366 1.256 . . . . 0.0 115.366 -0.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.568 ' N ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 m-85 -115.9 -131.43 0.32 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.5 OUTLIER -144.95 132.13 20.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 118.873 0.76 . . . . 0.0 109.183 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.757 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -119.49 153.78 34.8 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.005 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 13.2 tpp180 -114.14 95.63 5.39 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.7 130.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.231 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.88 20.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.584 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 261' ' ' VAL . 0.9 OUTLIER 179.58 109.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.966 0.413 . . . . 0.0 110.314 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 259' ' ' LEU . 5.4 ttmt -162.01 -151.13 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.773 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.705 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -157.5 -137.23 0.05 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.522 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.58 61.94 39.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 43.0 Cg_endo -92.81 51.47 0.46 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.598 2.199 . . . . 0.0 113.474 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.718 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.2 OUTLIER -25.09 146.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.052 0.845 . . . . 0.0 111.291 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.96 -7.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.191 0.52 . . . . 0.0 111.668 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 250' ' ' ASN . 37.5 m-85 -83.02 -62.63 1.54 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 252' ' ' TYR . 35.4 t0 -33.46 -51.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.972 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.705 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 5.4 pttt -171.51 44.22 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.13 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m 63.34 -14.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.299 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -62.42 127.12 29.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.962 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.912 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -52.36 159.28 1.01 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.092 0.472 . . . . 0.0 111.322 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.909 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.18 121.95 45.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.33 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.909 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.4 mt -142.7 -175.29 4.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.051 0.453 . . . . 0.0 111.203 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.2 tt0 -144.02 151.26 39.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.236 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 245' ' ' GLN . 47.6 t -60.94 112.14 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.676 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 5.38 20.07 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 66.8 mm-40 -93.65 -128.68 0.12 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.106 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 168.72 138.6 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.704 0.764 . . . . 0.0 109.612 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.106 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.6 p -137.75 151.6 26.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 4.7 ttmt -79.61 -161.32 0.32 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.277 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 269' ' ' LYS . 1.7 t -140.78 -53.43 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.453 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER 46.08 -71.67 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.3 OUTLIER -81.28 117.65 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.255 -177.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.892 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -132.5 161.6 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.168 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 233' ' ' ASN . 6.4 p30 -164.39 -108.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.162 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.455 ' C ' ' H ' ' A' ' 274' ' ' GLY . 46.9 mtm -39.38 153.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.685 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.8 p -75.77 18.68 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.388 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -142.71 -75.71 0.03 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.491 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 1.9 mp0 -78.02 176.53 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.72 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.54 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 9.5 p-90 170.08 -169.57 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.532 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 71.7 mt-10 -128.94 165.36 21.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.808 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -145.57 -152.77 5.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.094 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.07 125.64 0.55 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.906 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.685 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 -93.11 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -103.3 50.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.64 -31.19 5.96 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.404 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -64.8 83.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.398 -179.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -79.39 166.17 22.33 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.969 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.439 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.46 -157.59 29.83 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.45 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 16.0 p80 -125.4 175.33 7.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 123.847 0.381 . . . . 0.0 110.916 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.54 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 164.84 112.49 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.34 143.27 27.18 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.798 1.665 . . . . 0.0 112.496 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.625 ' CD1' HG23 ' A' ' 292' ' ' VAL . 52.9 t80 -66.09 -0.84 2.65 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.2 p -53.65 0.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.6 p80 -160.74 74.39 0.51 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.565 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.625 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -166.05 154.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.56 ' O ' ' HG ' ' A' ' 294' ' ' LEU . 58.0 mtp180 -101.44 -110.13 0.22 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 293' ' ' ARG . 9.4 mt 150.8 120.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.271 0.982 . . . . 0.0 110.751 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.02 -174.63 3.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.972 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.42 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 66.1 t0 -111.21 40.81 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.516 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.539 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 10.7 tp60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.757 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.487 ' OE2' ' O ' ' A' ' 191' ' ' CYS . 49.7 tp10 -147.94 161.38 41.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.906 ' O ' HG22 ' A' ' 138' ' ' VAL . 74.2 m-85 -121.01 -93.88 0.51 Allowed 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.504 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.906 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.3 m 83.03 161.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 124.852 1.345 . . . . 0.0 110.841 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.748 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 2.6 ptp180 -132.48 151.88 51.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -101.99 92.99 5.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.086 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -98.09 22.97 8.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.598 ' O ' ' O ' ' A' ' 143' ' ' ASP . 57.9 m-85 -123.47 6.84 8.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.0 p30 51.86 137.04 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.276 0 O-C-N 124.59 1.181 . . . . 0.0 110.808 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.491 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 6.6 t80 -124.59 -43.23 2.04 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.225 0.466 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 144' ' ' PHE . 53.9 t-20 39.31 62.18 1.19 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.454 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.34 -146.11 0.21 Allowed Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.601 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.1 p30 171.22 91.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.063 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.4 m-20 171.57 -173.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.373 . . . . 0.0 110.212 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -93.63 -21.55 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.652 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.79 26.29 10.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.974 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 8.9 p-10 -134.17 152.37 51.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 9.5 tp -116.94 85.21 17.27 Favored Pre-proline 0 C--O 1.21 -1.01 0 CA-C-N 117.586 0.175 . . . . 0.0 110.564 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -59.73 139.37 88.29 Favored 'Trans proline' 0 C--N 1.288 -2.627 0 C-N-CA 121.49 1.46 . . . . 0.0 112.864 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 9.1 p90 -159.02 158.29 32.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.258 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 156' ' ' LYS . 1.6 ttmp? -176.62 112.6 0.1 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 147.06 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.384 1.052 . . . . 0.0 110.565 178.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.09 44.75 0.91 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -79.71 153.59 29.17 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.398 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 159' ' ' ILE . 3.7 tp -98.67 119.27 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 137' ' ' TYR . 10.6 mt -118.7 133.65 55.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.19 139.78 34.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.74 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.6 mp -64.46 -48.74 83.83 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.865 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.574 ' NE ' ' OD1' ' A' ' 164' ' ' ASP . 0.2 OUTLIER 69.96 -53.26 0.63 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.893 -0.504 . . . . 0.0 111.617 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.574 ' OD1' ' NE ' ' A' ' 163' ' ' ARG . 0.5 OUTLIER -116.9 -126.39 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.498 ' H ' ' HD3' ' A' ' 166' ' ' PRO . 1.3 pttm 141.55 60.89 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.72 1.208 . . . . 0.0 109.575 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.498 ' HD3' ' H ' ' A' ' 165' ' ' LYS . 47.3 Cg_endo -67.19 -46.61 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.924 1.749 . . . . 0.0 112.432 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -118.46 167.5 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -85.14 -35.08 21.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.529 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 1.8 mt-30 -84.16 -25.24 29.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.593 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.6 m95 -122.23 150.31 42.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.462 ' CD2' HG22 ' A' ' 185' ' ' VAL . 11.4 m0 -141.57 129.92 22.4 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.934 0.873 . . . . 0.0 110.696 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.74 ' O ' ' O ' ' A' ' 162' ' ' ILE . 5.5 t30 -81.86 107.95 15.0 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.6 174.17 6.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.5 0.5 . . . . 0.0 110.627 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 33.1 tt0 -123.03 133.32 54.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.4 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.44 169.23 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.505 0.669 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 159' ' ' ILE . 97.4 mmm -76.64 0.67 19.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.81 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.459 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 93.9 m-20 -104.95 -28.38 11.12 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.52 49.64 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.459 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 18.6 mttp -130.19 135.72 48.47 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 114.241 -0.979 . . . . 0.0 110.757 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.77 125.15 52.4 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.523 0.678 . . . . 0.0 111.776 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.13 154.9 25.95 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.444 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 tpt -66.01 154.57 39.12 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 171' ' ' TRP . 1.3 pp -145.02 143.3 20.16 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.35 114.62 4.09 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 N-CA-C 108.694 -1.31 . . . . 0.0 108.694 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.884 ' O ' HG22 ' A' ' 188' ' ' VAL . 41.6 t -49.92 -52.0 56.09 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.949 -0.47 . . . . 0.0 111.979 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.2 Cg_endo -49.8 -28.63 18.3 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.052 1.835 . . . . 0.0 113.773 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.439 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 6.8 m-85 -67.78 3.66 1.39 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.0 m -128.11 167.61 22.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 123.263 0.352 . . . . 0.0 110.297 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.748 ' CD ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -68.39 -48.66 64.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.33 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.514 ' HG3' HG23 ' A' ' 188' ' ' VAL . 3.5 mppt? 81.78 79.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.227 1.011 . . . . 0.0 111.513 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.487 ' O ' ' OE2' ' A' ' 136' ' ' GLU . 1.1 t -91.35 95.37 9.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.862 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 194' ' ' SER . 0.0 OUTLIER 179.01 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 192' ' ' ARG . 49.5 Cg_endo -68.46 21.14 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.942 1.761 . . . . 0.0 111.889 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 192' ' ' ARG . 26.0 p -168.33 -22.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 194' ' ' SER . 0.5 OUTLIER 76.63 -51.96 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.03 158.36 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.625 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 11.0 p -71.27 155.98 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.28 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.93 135.06 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 25.9 m 47.91 -110.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.422 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.7 m 68.41 99.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.402 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 35.9 tp 38.65 73.22 0.11 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.8 t -128.23 22.73 6.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.318 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -167.34 -161.87 17.73 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 206' ' ' GLN . . . -77.84 -5.42 86.58 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.83 9.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.574 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 204' ' ' GLY . 88.0 mt-30 -132.98 -46.52 0.85 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.528 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 209' ' ' SER . 55.0 t0 49.68 34.56 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.8 t -54.03 89.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 207' ' ' ASP . 58.4 m -131.5 42.53 3.18 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -131.29 150.97 77.97 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.5 90.87 0.34 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.597 2.198 . . . . 0.0 112.004 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 22.3 tt0 -166.2 47.73 0.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.478 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 29.9 Cg_endo -62.2 -25.86 77.25 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.744 2.296 . . . . 0.0 112.017 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.1 -75.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.645 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 176.85 163.96 29.92 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.502 ' N ' ' CD ' ' A' ' 217' ' ' PRO . . . -154.55 49.41 0.49 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 216' ' ' GLY . 29.5 Cg_endo -62.67 -61.89 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.573 2.182 . . . . 0.0 111.56 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 219' ' ' PRO . 1.1 tt0 -106.2 -45.33 0.13 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.591 ' CD ' ' H ' ' A' ' 218' ' ' GLU . 66.4 Cg_endo -84.49 159.09 12.64 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.325 2.016 . . . . 0.0 111.658 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.415 ' H ' ' HD2' ' A' ' 221' ' ' PRO . . . -104.0 -68.88 0.77 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.415 ' HD2' ' H ' ' A' ' 220' ' ' GLY . 70.9 Cg_endo -76.67 -174.63 2.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.663 2.242 . . . . 0.0 112.067 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 224' ' ' GLN . 75.4 m-85 -67.59 160.52 27.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.19 94.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.189 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.529 ' OE1' ' ND2' ' A' ' 228' ' ' ASN . 34.1 mm-40 -96.07 147.7 33.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.526 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.26 -43.93 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.464 2.109 . . . . 0.0 112.196 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 62.1 m -104.86 20.92 17.91 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.726 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 227' ' ' ILE . 5.1 mp 44.92 56.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.529 ' ND2' ' OE1' ' A' ' 224' ' ' GLN . 43.9 m-80 -59.93 75.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.922 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 227' ' ' ILE . 14.5 p -112.25 147.98 38.14 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.08 -91.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.568 2.179 . . . . 0.0 111.763 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.803 HD13 ' CG ' ' A' ' 289' ' ' PHE . 1.6 mp -118.32 139.9 27.41 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.243 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.601 ' O ' ' O ' ' A' ' 231' ' ' LEU . 71.8 Cg_exo -47.52 -131.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.522 2.148 . . . . 0.0 111.986 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 235' ' ' GLN . 51.7 p-10 -127.42 163.11 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.1 tp 64.39 -64.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 233' ' ' ASN . 89.1 mm-40 55.2 -165.64 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.494 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -66.76 -50.28 63.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 0.0 110.865 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -60.15 -177.63 1.59 Allowed Glycine 1 CA--C 1.433 -5.054 0 CA-C-O 122.446 1.026 . . . . 0.0 114.41 -179.004 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.475 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.7 Cg_endo -57.21 125.2 1.38 Allowed 'Cis proline' 0 N--CA 1.533 3.841 0 N-CA-C 115.608 1.349 . . . . 0.0 115.608 -2.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.597 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 12.7 m-85 -150.79 -121.37 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.602 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.529 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 1.0 OUTLIER -143.06 123.83 14.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.721 0.772 . . . . 0.0 110.484 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.883 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.05 -159.24 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.032 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -162.41 87.41 0.62 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.0 p -57.94 123.61 10.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.006 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 15.73 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.726 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.491 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -175.94 112.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.294 0.569 . . . . 0.0 110.237 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.864 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.6 ttmt -158.72 -146.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.182 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.405 HH22 ' HE3' ' A' ' 254' ' ' LYS . 4.3 ptt85 -155.85 -142.53 0.11 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.829 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.601 ' O ' HG12 ' A' ' 248' ' ' VAL . 82.0 t -132.69 66.95 77.7 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.563 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 84.0 Cg_endo -90.56 172.64 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.609 2.206 . . . . 0.0 111.231 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -145.86 142.61 28.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.29 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.46 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 250' ' ' ASN . 60.9 m-85 -93.57 -54.51 3.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 110.791 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -44.67 -67.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 256' ' ' ALA . 26.7 mttt -148.58 32.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.521 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 m 72.28 -15.21 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.608 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.34 156.43 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.68 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.8 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -97.17 148.0 23.51 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.961 0.504 . . . . 0.0 110.359 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.828 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -86.98 115.21 24.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.5 mt -139.77 -176.06 4.44 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.435 0.636 . . . . 0.0 111.126 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 11.2 tt0 -146.28 147.87 31.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.702 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 245' ' ' GLN . 93.5 t -56.59 106.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.289 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 118.03 3.96 14.94 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.1 mm-40 -87.19 -122.22 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.745 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.043 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.4 OUTLIER 161.15 138.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.489 0.661 . . . . 0.0 109.477 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.043 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.5 p -130.84 140.8 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.968 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.424 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.78 88.31 3.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.925 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.465 ' HA ' ' HA2' ' A' ' 278' ' ' GLY . 16.8 t -56.79 151.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.265 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.527 ' O ' HD12 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -158.75 -51.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.465 0.65 . . . . 0.0 110.227 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -74.85 116.53 15.68 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 268' ' ' THR . 2.4 mp -126.27 104.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.469 ' ND2' ' OE1' ' A' ' 277' ' ' GLU . 1.1 p30 -87.52 -25.86 23.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 5.4 mtm -145.96 176.88 9.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.434 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -91.58 16.11 11.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -134.39 -96.06 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.244 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.94 63.69 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.769 0.795 . . . . 0.0 110.763 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.532 ' N ' ' CD1' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -69.59 178.71 2.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.469 ' OE1' ' ND2' ' A' ' 271' ' ' ASN . 1.3 mt-10 -109.12 -163.19 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.067 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -159.23 -160.33 10.33 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.753 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.459 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.5 tt0 -169.42 130.26 1.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.157 0.503 . . . . 0.0 111.683 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.705 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -147.55 75.42 1.36 Allowed 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.354 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 33.9 t30 83.81 31.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.249 0.547 . . . . 0.0 110.318 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 95.63 -31.41 7.21 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.336 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.57 76.54 0.42 Allowed 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.502 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 94.6 mtt180 -76.57 171.8 14.05 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.135 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.87 -156.68 27.68 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.543 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 6.3 p80 -124.32 169.81 11.42 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 122.889 0.476 . . . . 0.0 109.737 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 164.92 114.39 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.26 178.276 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.05 140.98 58.87 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.626 1.551 . . . . 0.0 112.099 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.803 ' CG ' HD13 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -67.27 0.01 3.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.031 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 46.2 p -55.15 1.75 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.044 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 289' ' ' PHE . 5.8 p80 -151.7 65.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.901 -0.499 . . . . 0.0 110.789 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 289' ' ' PHE . 12.2 m -156.42 153.37 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -101.53 -55.82 2.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.2 mt 86.76 119.14 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.075 0.941 . . . . 0.0 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.4 mp -72.68 -178.41 2.66 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.689 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -87.41 47.86 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.536 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 51.7 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.456 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 136' ' ' GLU . 33.7 m . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 137' ' ' TYR . 16.5 tp10 93.0 155.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 123.558 0.536 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.698 ' O ' ' O ' ' A' ' 138' ' ' VAL . 57.6 m-85 -160.98 -20.58 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.698 ' O ' ' O ' ' A' ' 137' ' ' TYR . 27.3 m 34.93 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.012 0.82 . . . . 0.0 111.528 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 36.4 ttt180 -144.49 128.82 17.85 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.996 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -98.83 84.9 3.18 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 123.524 0.515 . . . . 0.0 111.58 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.553 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -95.19 32.57 1.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.224 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 143' ' ' ASP . 45.9 m-85 -134.3 3.46 3.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 142' ' ' PHE . 3.9 p30 51.86 139.48 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 O-C-N 124.919 1.387 . . . . 0.0 110.431 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 t80 -129.31 -49.33 1.19 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 t30 38.97 61.76 1.2 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.94 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -69.34 -149.9 0.36 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.594 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 1.4 p30 164.99 103.26 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.428 -0.886 . . . . 0.0 109.873 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.594 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 20.4 m-20 173.01 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.442 1.089 . . . . 0.0 112.8 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 62.92 -45.03 0.2 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.904 0.752 . . . . 0.0 109.686 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 148' ' ' ASP . 96.4 mt-10 -85.89 29.41 0.72 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.505 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.575 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.5 p30 -143.52 163.95 31.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.653 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 183' ' ' ILE . 11.4 tp -118.48 91.41 41.41 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.412 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 65.5 Cg_endo -71.91 124.57 10.24 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 121.489 1.46 . . . . 0.0 112.906 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.723 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.6 p90 -144.49 163.47 33.73 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.924 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.499 ' HZ2' ' HB2' ' A' ' 143' ' ' ASP . 0.7 OUTLIER -142.21 150.85 41.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.103 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.996 ' O ' ' O ' ' A' ' 140' ' ' ALA . 11.8 mtpt 73.12 -142.19 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.24 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -107.43 48.52 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 42.9 t0 -56.73 153.58 10.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.026 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.635 HG23 ' HB3' ' A' ' 137' ' ' TYR . 1.5 mp -102.02 106.08 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 154' ' ' PHE . 11.5 mt -112.52 110.57 20.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.953 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -70.03 150.6 46.46 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -94.38 133.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.099 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.417 ' NH2' ' OD1' ' A' ' 172' ' ' ASN . 7.8 tmm_? -107.53 -42.79 4.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.063 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -153.73 128.52 9.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 32.9 pttt -123.88 75.62 57.28 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.6 -40.44 73.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 111.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -106.21 -165.07 1.06 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -118.81 -19.94 8.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.924 0.393 . . . . 0.0 110.386 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -88.35 -33.36 17.99 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.7 m95 -118.64 151.28 38.24 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.521 ' CD2' HG22 ' A' ' 185' ' ' VAL . 14.9 m0 -141.02 129.67 22.78 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.091 0.948 . . . . 0.0 111.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.417 ' OD1' ' NH2' ' A' ' 163' ' ' ARG . 2.3 t-20 -79.45 114.51 18.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.94 173.69 8.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.643 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.39 135.89 54.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 175.02 1.26 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.504 0.669 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.06 -4.18 48.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.794 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -101.34 -28.05 12.83 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.95 49.68 0.37 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -130.62 134.81 47.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.629 -0.786 . . . . 0.0 110.697 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.54 127.29 52.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.442 0.639 . . . . 0.0 111.733 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.53 155.08 26.16 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.268 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.48 157.83 33.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.814 0.34 . . . . 0.0 110.337 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.472 HG22 ' HB3' ' A' ' 152' ' ' LEU . 1.2 pp -144.14 142.6 20.26 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.92 113.56 3.82 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.567 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 13.6 t -46.93 -53.65 25.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 121.519 -0.738 . . . . 0.0 112.209 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 8.2 Cg_endo -48.64 -28.04 11.75 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 121.913 1.742 . . . . 0.0 113.234 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -71.17 -0.77 10.5 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.299 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 185' ' ' VAL . 1.9 m -135.82 162.03 37.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.477 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.553 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.7 OUTLIER -115.39 -60.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.443 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 0.4 OUTLIER 176.16 -165.4 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.566 -179.21 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.401 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 8.8 p -133.35 34.13 3.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.795 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.447 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 19.2 ttp-105 -166.87 53.42 0.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 56.8 Cg_endo -70.07 135.96 31.0 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.448 2.099 . . . . 0.0 111.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.5 p -113.5 46.38 1.28 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.4 p -164.68 -156.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.317 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -114.53 -75.92 0.58 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.267 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.8 p -110.87 105.91 14.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.269 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.02 -82.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 200' ' ' THR . 31.1 t -75.73 135.49 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 199' ' ' SER . 3.3 p 64.97 110.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 200' ' ' THR . 0.2 OUTLIER 79.24 86.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.362 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 94.9 m -124.19 121.95 36.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -168.01 151.07 17.81 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.07 -36.77 92.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -121.15 34.1 5.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.362 0.125 . . . . 0.0 110.82 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 70.28 -46.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.437 0.46 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 54.82 37.27 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 7.3 p -67.01 155.33 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.374 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.3 t -156.68 85.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.1 m80 54.15 66.39 4.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.54 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.05 85.92 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.556 2.171 . . . . 0.0 112.13 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.59 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 0.0 OUTLIER -96.03 -43.56 0.26 Allowed Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.366 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 56.4 Cg_endo -83.95 15.46 2.14 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 215' ' ' GLY . 5.1 tt -86.89 117.09 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.132 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.578 ' N ' HD23 ' A' ' 214' ' ' LEU . . . 160.4 138.39 2.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -92.38 -58.13 1.39 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.86 97.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.448 2.098 . . . . 0.0 112.004 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.504 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 55.3 tt0 -172.82 50.03 0.1 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.483 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 46.5 Cg_endo -66.96 147.47 80.32 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.704 2.269 . . . . 0.0 111.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -80.36 -98.07 0.34 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.83 142.47 31.86 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.791 1.661 . . . . 0.0 112.068 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.575 ' CD2' ' N ' ' A' ' 223' ' ' ALA . 76.7 t80 -59.26 173.19 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.774 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.575 ' N ' ' CD2' ' A' ' 222' ' ' TYR . . . -38.63 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.404 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' TYR . 0.4 OUTLIER -110.95 97.98 36.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.807 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.96 -17.57 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.198 1.932 . . . . 0.0 111.607 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.2 m -116.07 63.6 0.7 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.82 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.79 ' H ' HD13 ' A' ' 227' ' ' ILE . 0.0 OUTLIER -40.88 102.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.369 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -80.7 -0.52 38.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.317 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.44 ' H ' HG23 ' A' ' 229' ' ' THR . 0.2 OUTLIER -58.04 177.58 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.469 ' CG ' ' HE1' ' A' ' 276' ' ' TRP . 33.8 Cg_exo -63.25 -14.35 41.42 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.948 2.432 . . . . 0.0 111.719 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.9 mt -126.97 91.92 45.75 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.21 163.24 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.938 2.425 . . . . 0.0 112.535 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 235' ' ' GLN . 50.2 m-20 59.21 75.75 0.39 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.841 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.576 ' H ' ' CD1' ' A' ' 227' ' ' ILE . 13.0 tp 25.41 43.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.623 0.725 . . . . 0.0 110.996 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.781 ' O ' ' N ' ' A' ' 237' ' ' GLY . 13.3 mt-30 37.26 34.06 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 237' ' ' GLY . 4.4 p30 46.1 -67.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.538 1.149 . . . . 0.0 109.971 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.781 ' N ' ' O ' ' A' ' 235' ' ' GLN . . . -48.49 -175.2 0.01 OUTLIER Glycine 1 CA--C 1.435 -4.944 0 CA-C-O 122.457 1.032 . . . . 0.0 113.266 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.525 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 1.6 Cg_endo -53.07 117.08 0.25 Allowed 'Cis proline' 0 N--CA 1.53 3.671 0 O-C-N 123.635 1.334 . . . . 0.0 115.313 0.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 13.2 m-85 -147.03 -118.37 0.07 Allowed 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.753 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.1 m-30 -143.46 122.68 12.98 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.902 0.858 . . . . 0.0 110.699 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.909 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.18 -161.77 0.82 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.294 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 18.9 tpp180 -160.92 89.5 0.8 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 243' ' ' VAL . 6.0 p -62.35 129.31 25.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.599 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.9 15.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.772 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.6 mm-40 -173.94 113.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.373 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.832 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.2 ttmt -158.92 -146.7 0.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.404 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.8 ptt85 -156.48 -143.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.821 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 248' ' ' VAL . 57.5 t -133.5 69.99 76.65 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.576 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 58.2 Cg_endo -90.63 167.97 4.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.221 2.614 . . . . 0.0 112.971 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.496 ' OD1' ' CB ' ' A' ' 253' ' ' ASP . 46.0 p-10 -97.04 -166.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.275 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.45 11.69 28.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.243 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.5 ' C ' ' H ' ' A' ' 254' ' ' LYS . 6.4 m-85 -123.73 -21.98 5.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.9 t70 -68.3 43.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 253' ' ' ASP . 38.9 mtmt 96.96 0.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.776 0.831 . . . . 0.0 110.898 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 286' ' ' HIS . 0.2 OUTLIER 84.59 61.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.037 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -115.77 107.32 14.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.926 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.6 155.76 0.76 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.61 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.905 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -103.84 121.92 44.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.582 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.6 mt -142.95 -173.98 4.05 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.256 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.4 tt0 -145.91 150.67 36.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.79 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 245' ' ' GLN . 93.9 t -57.94 108.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.615 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.68 5.38 18.47 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.3 mm-40 -88.61 -123.77 0.05 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.77 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.071 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.3 OUTLIER 162.31 138.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.071 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.1 p -131.39 143.16 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.754 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.409 ' NZ ' ' HD3' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -97.91 84.76 3.38 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.434 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.8 t -58.8 150.8 4.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.28 -53.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.411 ' HE3' ' H ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -67.44 144.86 55.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.494 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.411 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -151.16 159.33 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.044 0.449 . . . . 0.0 110.569 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 272' ' ' MET . 13.6 p30 -176.94 -107.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.387 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.531 ' N ' ' OD1' ' A' ' 271' ' ' ASN . 31.6 mtm -42.17 140.86 1.03 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.27 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -74.2 16.1 0.27 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -138.58 -60.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.359 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.519 ' O ' ' HE3' ' A' ' 272' ' ' MET . 2.6 mp0 -109.0 101.06 10.18 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.512 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 3.6 p-90 -111.9 -165.71 1.01 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 120.846 0.355 . . . . 0.0 110.259 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.5 mt-10 -129.3 167.58 17.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.786 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.87 -151.4 5.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.78 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.503 ' OE2' ' O ' ' A' ' 280' ' ' CYS . 2.5 tm-20 -172.3 128.45 0.56 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.707 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -108.79 -90.72 0.45 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -106.03 51.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.02 5.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.32 83.24 0.09 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 114.591 -0.804 . . . . 0.0 110.065 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -78.14 165.7 23.65 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.292 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 169.23 -158.27 30.66 Favored Glycine 0 C--O 1.215 -1.06 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.56 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 21.7 p80 -122.52 170.48 9.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.029 0.443 . . . . 0.0 110.556 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.09 114.46 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.668 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.513 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 50.7 Cg_exo -50.83 141.31 36.15 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.828 1.686 . . . . 0.0 112.798 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -63.6 0.31 0.79 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.598 0.713 . . . . 0.0 110.018 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 288' ' ' PRO . 66.1 p -56.79 2.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.72 -0.612 . . . . 0.0 112.095 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.517 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.2 p-80 -150.15 64.55 0.96 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.463 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.534 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -160.3 151.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 294' ' ' LEU . 43.3 mtm180 -102.34 -54.74 2.62 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 5.0 mt 91.67 121.09 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.023 0.916 . . . . 0.0 111.322 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.15 -178.12 4.88 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.182 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -87.47 48.58 1.67 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.744 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 47.0 tt0 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.46 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.55 ' N ' ' SG ' ' A' ' 191' ' ' CYS . 35.7 tt0 -143.1 140.8 31.03 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.451 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.518 ' H ' HG12 ' A' ' 162' ' ' ILE . 1.6 t80 78.65 107.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.118 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 m -134.33 164.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 111.177 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -123.33 125.99 46.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -105.5 109.53 21.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.982 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.767 HD21 ' HG2' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -118.96 28.47 8.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.851 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 60.0 m-85 -125.29 0.5 7.74 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.49 -0.131 . . . . 0.0 111.164 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.97 139.8 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.738 0 O-C-N 123.901 0.75 . . . . 0.0 110.288 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.607 ' CE2' ' O ' ' A' ' 145' ' ' ASN . 4.3 t80 -133.88 -45.6 0.79 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 144' ' ' PHE . 30.0 m-80 74.86 -109.95 0.03 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.717 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.505 ' C ' ' CZ ' ' A' ' 144' ' ' PHE . . . -133.5 -172.71 13.02 Favored Glycine 0 C--N 1.275 -2.828 0 O-C-N 121.606 -0.684 . . . . 0.0 113.633 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 18.9 t30 174.03 -40.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.966 -1.117 . . . . 0.0 111.911 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 6.4 m-20 -93.03 -159.21 0.66 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 111.785 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.02 -45.09 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.483 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 151' ' ' ASP . 97.3 mt-10 -127.22 28.17 5.78 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.654 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.0 OUTLIER -37.69 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 123.908 0.755 . . . . 0.0 111.786 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.463 HD11 ' CG ' ' A' ' 175' ' ' ASP . 11.7 tp -127.09 98.88 29.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.922 -0.486 . . . . 0.0 111.888 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 145' ' ' ASN . 52.7 Cg_endo -75.16 133.14 16.0 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.635 1.557 . . . . 0.0 112.884 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.75 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 21.2 p90 -155.18 173.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.509 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 176.12 132.28 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.811 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 2.7 mmpt? 95.22 79.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.081 0.863 . . . . 0.0 111.403 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 32.38 47.78 0.29 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.878 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.78 137.88 47.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.091 0.472 . . . . 0.0 109.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.3 mm -98.53 95.67 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.614 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mt -109.35 107.96 18.34 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.44 141.2 54.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.889 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.913 HG22 ' H ' ' A' ' 163' ' ' ARG . 11.8 mm -64.15 -146.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.847 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.913 ' H ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -176.55 -57.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.132 0.491 . . . . 0.0 110.747 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -136.48 -24.54 1.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.312 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.405 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 16.2 pttp 36.43 77.88 0.37 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.68 -39.05 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.93 1.753 . . . . 0.0 112.23 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.3 mt-10 -105.17 162.26 13.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 14.9 pt-20 -84.64 -41.71 16.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.773 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.419 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 43.0 mt-30 -76.77 -29.66 56.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.34 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 73.6 m95 -120.15 153.7 35.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.641 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.5 m0 -148.22 140.74 24.42 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -83.88 117.78 23.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 171.04 8.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 111.601 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 68.3 tt0 -125.0 133.15 53.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.959 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.463 ' CG ' HD11 ' A' ' 152' ' ' LEU . 15.2 m-20 -61.76 177.19 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.463 0.649 . . . . 0.0 110.734 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 23.6 ttt -80.54 -4.66 54.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.463 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.419 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 94.7 m-20 -102.43 -28.12 12.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.34 48.55 0.38 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.419 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 9.1 mttp -128.87 130.63 47.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.057 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.45 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.397 0.618 . . . . 0.0 112.048 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.2 152.81 24.12 Favored Glycine 0 C--N 1.315 -0.607 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.076 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 78.7 mmm -66.19 159.59 26.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.528 0.68 . . . . 0.0 110.972 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 10.1 pt -152.85 145.84 17.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.954 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -71.3 113.71 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.431 1.421 . . . . 0.0 109.583 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.793 ' O ' HG22 ' A' ' 188' ' ' VAL . 43.9 t -49.35 -52.7 46.83 Favored Pre-proline 0 CA--C 1.537 0.457 0 O-C-N 121.956 -0.465 . . . . 0.0 111.816 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.1 Cg_endo -49.6 -27.11 13.96 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.482 2.121 . . . . 0.0 113.992 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.1 m-85 -69.07 10.63 0.27 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.765 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 185' ' ' VAL . 3.1 m -131.96 168.49 23.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.767 ' HG2' HD21 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -146.6 39.4 1.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.152 0.501 . . . . 0.0 111.407 -178.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 191' ' ' CYS . 37.6 mmtt -139.76 152.38 46.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.499 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 136' ' ' GLU . 47.3 t 48.52 100.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.602 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.752 ' NE ' ' H ' ' A' ' 194' ' ' SER . 0.0 OUTLIER 78.58 79.39 0.12 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.21 -9.63 2.4 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.794 2.329 . . . . 0.0 112.207 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.752 ' H ' ' NE ' ' A' ' 192' ' ' ARG . 3.0 t 42.38 40.31 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.3 p -153.57 174.88 13.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -85.76 -90.01 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 94.3 p -111.61 -1.71 15.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.791 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.63 100.73 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 43.1 m -62.14 -41.69 98.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 77.5 m -147.54 -87.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.547 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 203' ' ' GLY . 55.1 tp -126.72 -35.81 2.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 17.7 p 57.07 3.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.566 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 201' ' ' LEU . . . -55.62 -67.02 2.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 71.81 23.15 78.4 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.2 96.23 3.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.892 0.377 . . . . 0.0 110.698 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 53.26 73.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -92.1 1.76 57.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.553 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.4 t -70.16 148.27 48.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -60.38 -76.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.669 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 46.77 71.65 1.52 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.57 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.4 141.67 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.481 2.121 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.673 ' H ' ' CD ' ' A' ' 213' ' ' PRO . 2.7 mt-30 -107.81 -39.34 0.15 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.219 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.673 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 23.6 Cg_exo -62.46 157.0 48.47 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 214' ' ' LEU . 10.7 mp 59.67 -68.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.599 0.562 . . . . 0.0 110.761 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 213' ' ' PRO . . . 46.3 -119.54 4.15 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.93 -72.26 0.99 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 214' ' ' LEU . 44.3 Cg_endo -66.45 148.94 84.66 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.731 2.288 . . . . 0.0 111.953 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 220' ' ' GLY . 49.0 mt-10 -142.91 73.2 18.78 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.446 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -6.94 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.875 2.384 . . . . 0.0 111.862 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 218' ' ' GLU . . . 110.29 177.63 20.86 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.61 -173.46 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.675 2.25 . . . . 0.0 112.165 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.515 ' O ' ' N ' ' A' ' 224' ' ' GLN . 61.9 t80 -58.53 171.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.946 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.482 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -40.12 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 222' ' ' TYR . 30.8 mm-40 -137.36 106.78 8.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -47.79 -60.99 0.67 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.659 1.572 . . . . 0.0 112.161 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.9 m -85.82 -150.31 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.5 mm -101.3 47.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -84.2 109.3 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 230' ' ' PRO . 0.6 OUTLIER -100.75 159.76 28.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.454 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 229' ' ' THR . 94.4 Cg_exo -37.4 -117.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.409 2.739 . . . . 0.0 112.88 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.99 93.22 47.66 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 -32.46 71.26 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.391 2.061 . . . . 0.0 112.282 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 235' ' ' GLN . 64.2 t30 -71.06 155.6 40.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.663 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 235' ' ' GLN . 7.6 tp -67.24 9.61 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 233' ' ' ASN . 50.9 tt0 60.23 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 237' ' ' GLY . 33.8 p-10 -38.79 -42.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.609 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.537 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -52.36 -176.52 0.05 OUTLIER Glycine 1 CA--C 1.447 -4.212 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.761 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.537 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.4 115.62 0.14 OUTLIER 'Cis proline' 0 N--CA 1.529 3.6 0 N-CA-C 116.333 1.628 . . . . 0.0 116.333 -1.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.687 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 8.0 m-85 -149.41 -126.69 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.822 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 5.5 m-30 -134.93 113.86 11.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 110.018 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 264' ' ' LEU . . . -107.17 139.27 41.88 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.424 ' HA ' ' HB2' ' A' ' 264' ' ' LEU . 17.0 tpp180 -100.17 98.84 9.49 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.527 0.68 . . . . 0.0 111.181 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.87 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.8 p -69.26 117.38 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.093 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.581 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.2 pt -110.91 18.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.444 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.8 mm-40 -176.8 116.96 0.11 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.207 0.527 . . . . 0.0 110.837 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.848 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -160.71 -151.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.822 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -156.28 -134.93 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.457 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.6 t -137.99 62.79 34.9 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.086 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 256' ' ' ALA . 41.8 Cg_endo -98.1 47.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.995 2.463 . . . . 0.0 113.023 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 252' ' ' TYR . 8.0 p-10 -22.62 152.67 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.533 1.146 . . . . 0.0 111.517 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.58 -9.21 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.506 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.799 ' O ' ' N ' ' A' ' 254' ' ' LYS . 38.1 m-85 -76.53 -63.21 1.39 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -47.05 62.42 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 125.384 1.677 . . . . 0.0 111.131 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 252' ' ' TYR . 4.2 mttm 84.26 -49.93 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.908 1.38 . . . . 0.0 109.717 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.88 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -44.31 110.88 0.24 Allowed 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.131 0.491 . . . . 0.0 111.722 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.877 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.9 OUTLIER -43.44 159.58 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.033 -0.417 . . . . 0.0 111.75 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.786 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.81 119.82 40.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.848 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.3 mt -141.15 -175.73 4.43 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.8 tt0 -144.21 144.3 31.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.357 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 244' ' ' ILE . 58.2 t -48.98 106.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.423 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.79 14.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 57.1 mm-40 -92.71 -41.61 10.06 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.331 0.586 . . . . 0.0 112.38 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.979 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 69.12 140.12 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.62 -178.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.979 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.2 p -131.43 156.92 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.485 ' N ' HG22 ' A' ' 265' ' ' VAL . 0.8 OUTLIER -102.71 88.24 3.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.639 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.466 HG11 ' OE1' ' A' ' 235' ' ' GLN . 5.0 t -67.76 121.95 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.005 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.61 ' O ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -110.28 -52.63 2.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 8.5 tppt? -82.08 125.89 31.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 112.119 -177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 268' ' ' THR . 4.6 mp -139.88 126.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.549 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 272' ' ' MET . 10.7 p30 -121.08 -106.42 0.37 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.603 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.509 ' H ' ' CG ' ' A' ' 271' ' ' ASN . 35.0 mtm -38.09 149.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.655 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.8 p -71.55 15.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -140.75 -69.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.474 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 29.9 mm100 -82.79 173.03 12.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.61 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 5.9 p-90 170.89 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.068 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 6.6 mt-10 -126.93 173.26 9.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.68 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -150.3 -155.85 7.04 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.354 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.495 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -171.66 121.98 0.51 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.69 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -108.37 -98.03 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -95.6 50.46 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.41 -30.96 5.36 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 89.93 0.07 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.457 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.495 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 75.7 mtt180 -85.36 168.03 15.02 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.567 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.63 -156.26 28.01 Favored Glycine 0 C--N 1.308 -1.019 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.559 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 12.6 p80 -128.01 170.79 12.49 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.894 0.477 . . . . 0.0 111.066 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.61 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 168.87 114.47 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.248 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 290' ' ' THR . 68.4 Cg_exo -48.55 141.01 20.75 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.575 1.517 . . . . 0.0 112.518 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.6 OUTLIER -62.98 -1.0 0.78 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.478 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.9 p -55.89 0.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 289' ' ' PHE . 4.9 p-80 -153.13 66.38 0.78 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.579 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -161.75 146.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.13 81.97 2.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 27.4 mt -37.71 130.09 1.08 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.343 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.0 mp -71.93 -170.13 0.55 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.852 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.92 21.31 0.43 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.606 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.6 tt0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.428 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -109.56 -142.7 0.38 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.42 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.878 ' O ' HG22 ' A' ' 138' ' ' VAL . 53.6 m-85 -129.3 -90.57 0.48 Allowed 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.457 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 90.77 161.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 125.367 1.667 . . . . 0.0 111.66 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -140.85 157.78 44.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.152 0.977 . . . . 0.0 111.468 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.661 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . . . -56.41 162.26 2.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.667 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.7 mt -136.36 -37.45 0.7 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.969 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.588 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 95.2 m-85 -124.87 6.66 8.04 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 79.41 142.1 0.08 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.407 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.0 t80 -121.63 -50.67 2.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.004 0.43 . . . . 0.0 111.577 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 13.5 m-80 42.83 62.7 1.69 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.409 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.416 ' N ' ' HB3' ' A' ' 153' ' ' PRO . . . -77.53 -154.74 6.73 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.6 p30 163.73 -6.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.1 -1.05 . . . . 0.0 112.085 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 147' ' ' ASN . 53.2 m-20 -55.16 -121.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.497 0.665 . . . . 0.0 111.417 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 151' ' ' ASP . 7.2 p-10 -66.59 47.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.692 ' O ' ' O ' ' A' ' 151' ' ' ASP . 21.5 mp0 67.78 19.75 9.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.692 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.9 OUTLIER -39.65 -169.86 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 O-C-N 123.863 0.727 . . . . 0.0 111.869 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.497 HD11 ' CG ' ' A' ' 175' ' ' ASP . 5.8 tp -113.53 91.2 19.7 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 121.242 -0.911 . . . . 0.0 111.6 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.416 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 67.2 Cg_endo -70.92 128.26 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.785 0.99 . . . . 0.0 112.175 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.661 ' CD1' ' HB2' ' A' ' 140' ' ' ALA . 10.1 p90 -144.92 172.98 12.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.589 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -112.07 -106.7 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.933 0.396 . . . . 0.0 111.396 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 155' ' ' LYS . 25.5 ttpt -135.72 122.09 20.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.56 15.62 54.57 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.251 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.17 133.48 34.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 191' ' ' CYS . 6.2 mm -101.67 116.13 44.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mt -122.54 122.33 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -75.16 128.71 36.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.384 0.611 . . . . 0.0 111.828 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.6 mm -66.62 126.49 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.487 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.605 ' HE ' ' HE ' ' A' ' 180' ' ' ARG . 72.5 ttt-85 -76.58 -51.99 10.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.627 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 164' ' ' ASP . 51.0 t0 -157.27 -10.33 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.357 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.481 ' HB2' ' CD1' ' A' ' 171' ' ' TRP . 4.6 ptmm? 35.97 79.98 0.28 Allowed Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.511 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.53 -44.59 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 49.8 mt-10 -91.93 158.29 16.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.913 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 15.6 pt-20 -82.28 -41.26 20.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.766 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 35.1 mt-30 -83.13 -24.47 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.437 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 63.1 m95 -124.23 150.42 45.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.614 ' CD2' HG22 ' A' ' 185' ' ' VAL . 13.3 m0 -140.5 133.05 28.65 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.678 0.751 . . . . 0.0 111.581 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -79.05 100.35 7.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.41 170.71 8.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -130.29 141.8 50.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.026 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.497 ' CG ' HD11 ' A' ' 152' ' ' LEU . 31.3 m-20 -70.5 173.07 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.478 0.656 . . . . 0.0 110.218 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.9 mmm -77.14 -8.19 57.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.895 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -102.01 -26.5 13.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.21 47.1 0.39 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -122.6 131.68 53.94 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.288 -0.956 . . . . 0.0 110.609 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.605 ' HE ' ' HE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -109.28 113.92 27.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.831 0.824 . . . . 0.0 113.044 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -142.84 143.59 12.78 Favored Glycine 0 C--N 1.305 -1.187 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.691 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.1 mtp -62.42 161.53 11.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.485 0.66 . . . . 0.0 110.432 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.437 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 4.4 pt -150.6 145.86 18.95 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.874 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.3 118.7 5.63 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.41 1.407 . . . . 0.0 109.285 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.614 HG22 ' CD2' ' A' ' 171' ' ' TRP . 25.2 t -54.25 -51.49 77.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -49.64 -29.43 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.543 1.495 . . . . 0.0 113.154 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.542 ' OH ' ' O ' ' A' ' 268' ' ' THR . 10.8 m-85 -72.37 -10.62 60.03 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.328 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 138' ' ' VAL . 1.3 m -132.89 165.13 33.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.519 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 190' ' ' LYS . 2.3 pp20? -143.64 -49.96 0.31 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.017 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.638 ' HD2' ' H ' ' A' ' 191' ' ' CYS . 3.2 tmtm? -171.95 -140.78 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 190' ' ' LYS . 6.8 t -168.27 102.63 0.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -73.73 149.87 88.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.784 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.76 -166.97 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.157 1.905 . . . . 0.0 111.81 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t 37.81 -132.79 0.12 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.1 t -134.63 -125.07 0.16 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.44 97.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.4 m 51.18 -137.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.504 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 200' ' ' THR . 34.7 m -80.77 33.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.423 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.405 ' O ' ' OG1' ' A' ' 200' ' ' THR . 1.3 t 72.15 -43.18 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 198' ' ' VAL . 69.0 p 50.47 -164.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.48 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 201' ' ' LEU . 11.1 mp 56.28 -174.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 17.2 p 47.95 -95.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.565 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 205' ' ' ASN . . . -168.64 -148.6 5.81 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.44 0.05 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 203' ' ' GLY . 11.7 t-20 58.59 89.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.684 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.54 173.88 11.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 54.59 -168.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.2 p -68.43 153.83 43.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 210' ' ' HIS . 24.3 t -79.36 96.74 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 209' ' ' SER . 58.3 m80 -157.82 75.4 3.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.42 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.16 148.55 89.19 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.879 2.386 . . . . 0.0 112.046 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 55.76 58.35 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.653 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.78 156.41 60.73 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.763 2.309 . . . . 0.0 111.932 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 64.7 mt -56.67 -62.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.1 54.54 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 218' ' ' GLU . . . 82.2 179.47 52.84 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.6 29.83 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.752 2.301 . . . . 0.0 111.974 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.605 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 2.0 tp10 -63.66 -42.53 72.82 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.546 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 31.6 Cg_exo -57.85 -145.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.545 2.163 . . . . 0.0 111.978 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -178.0 -67.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.731 2.287 . . . . 0.0 112.265 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 224' ' ' GLN . 92.7 m-85 -58.75 169.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.034 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.01 94.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.434 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 222' ' ' TYR . 56.2 tp60 -132.92 92.82 24.93 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.278 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.34 -14.36 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.432 2.088 . . . . 0.0 112.095 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 p -92.22 -177.73 4.75 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.293 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.403 ' C ' ' CG ' ' A' ' 228' ' ' ASN . 47.2 mm -119.22 72.14 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.516 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.579 ' O ' ' NE2' ' A' ' 275' ' ' GLN . 0.0 OUTLIER 65.51 100.34 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.594 ' C ' ' OD1' ' A' ' 271' ' ' ASN . 0.0 OUTLIER -79.81 -171.92 0.31 Allowed Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.371 -177.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.781 ' O ' ' N ' ' A' ' 271' ' ' ASN . 7.3 Cg_exo -70.03 -173.03 0.67 Allowed 'Trans proline' 0 N--CA 1.51 2.445 0 C-N-CA 124.061 3.174 . . . . 0.0 117.942 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 1.172 ' O ' ' HB ' ' A' ' 270' ' ' ILE . 2.6 tt -48.47 138.58 11.43 Favored Pre-proline 0 C--O 1.177 -2.734 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.834 -175.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.63 -70.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.239 0 CA-C-N 123.939 2.443 . . . . 0.0 113.314 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 235' ' ' GLN . 24.7 t-20 -45.55 103.77 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.816 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 4.7 tt -40.96 93.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.174 0.512 . . . . 0.0 110.532 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 233' ' ' ASN . 58.2 mm-40 -63.83 -50.82 67.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.98 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -56.08 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.111 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -35.76 161.54 0.01 OUTLIER Glycine 1 CA--C 1.436 -4.882 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.898 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.422 ' HD2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 Cg_exo -75.88 115.45 3.55 Favored 'Cis proline' 0 N--CA 1.521 3.089 0 O-C-N 122.645 0.813 . . . . 0.0 112.015 -5.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.718 ' O ' ' HG3' ' A' ' 266' ' ' LYS . 43.0 m-85 -145.97 -125.86 0.07 Allowed 'General case' 0 C--O 1.189 -2.088 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 0.8 OUTLIER -142.07 116.14 9.39 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 120.105 1.32 . . . . 0.0 109.801 -177.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.796 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -88.93 -157.51 0.44 Allowed 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -157.7 90.49 1.08 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.563 0.696 . . . . 0.0 109.544 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.727 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.0 p -66.22 122.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.523 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.71 16.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.67 100.56 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.242 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.838 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -134.14 -143.16 0.2 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 10.5 ptt85 -158.83 -134.89 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 248' ' ' VAL . 81.1 t -135.79 68.17 65.04 Favored Pre-proline 0 N--CA 1.473 0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.876 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.566 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 67.7 Cg_endo -92.82 177.8 1.41 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 123.355 2.703 . . . . 0.0 111.694 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.658 ' O ' ' N ' ' A' ' 252' ' ' TYR . 24.6 p30 -147.21 145.16 29.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.862 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.81 -14.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.562 0.539 . . . . 0.0 111.313 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.658 ' N ' ' O ' ' A' ' 250' ' ' ASN . 44.1 m-85 -83.54 -55.54 4.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.285 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 33.1 t70 -52.41 67.94 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 124.736 1.273 . . . . 0.0 111.691 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 252' ' ' TYR . 31.3 mtmt 73.52 -7.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 0.0 111.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 1.4 m 92.64 52.8 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.129 0.893 . . . . 0.0 111.903 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.432 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -109.87 112.72 24.92 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.924 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.6 OUTLIER -41.88 157.98 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.308 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.689 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.94 116.33 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.522 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.838 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.7 OUTLIER -139.0 -175.35 4.12 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 263' ' ' GLU . 2.3 tt0 -148.02 148.67 30.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.981 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 56.3 t -45.52 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.044 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 103.63 13.09 28.84 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 260' ' ' GLU . 37.8 mm-40 -90.11 -35.1 15.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.26 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.074 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.83 139.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.958 0.885 . . . . 0.0 110.774 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.074 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.1 p -136.17 164.69 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.082 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.718 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -108.33 103.17 12.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.677 HG13 ' HG2' ' A' ' 230' ' ' PRO . 1.2 t -57.1 -53.92 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER 62.48 -66.01 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 124.473 1.108 . . . . 0.0 109.974 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.775 ' O ' ' HG2' ' A' ' 230' ' ' PRO . 0.1 OUTLIER -65.47 150.05 49.01 Favored 'General case' 0 C--O 1.181 -2.524 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.735 -177.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 1.172 ' HB ' ' O ' ' A' ' 231' ' ' LEU . 0.1 OUTLIER -162.86 128.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.171 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.781 ' N ' ' O ' ' A' ' 230' ' ' PRO . 13.0 p-10 -155.2 -40.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.849 ' HE3' ' H ' ' A' ' 274' ' ' GLY . 0.0 OUTLIER -124.3 173.24 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.915 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 1.5 p -105.98 20.2 19.33 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.849 ' H ' ' HE3' ' A' ' 272' ' ' MET . . . -118.99 -74.25 0.44 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.84 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.664 ' CD ' ' N ' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -54.64 -91.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 123.422 1.582 . . . . 0.0 110.393 -178.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.915 ' HE1' ' C ' ' A' ' 273' ' ' SER . 1.2 m0 88.1 127.54 0.03 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.759 ' H ' ' HD3' ' A' ' 230' ' ' PRO . 21.4 mt-10 -86.54 168.51 13.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.712 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 284' ' ' ARG . . . -155.19 136.33 5.08 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.902 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.455 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -122.99 125.45 45.27 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.463 0.743 . . . . 0.0 110.364 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.641 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -143.23 78.89 1.62 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.063 -176.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.7 m-20 84.33 41.67 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.819 0.819 . . . . 0.0 109.351 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.41 -35.96 3.4 Favored Glycine 0 CA--C 1.495 -1.162 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.112 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -61.82 104.22 0.42 Allowed 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 114.588 -0.806 . . . . 0.0 109.773 -176.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 278' ' ' GLY . 33.2 mtt85 -108.8 165.84 11.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 121.397 0.618 . . . . 0.0 109.834 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 173.17 -148.83 10.65 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.559 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 16.8 p80 -132.24 168.33 18.25 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.549 0.174 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.71 120.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.805 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 275' ' ' GLN . 74.5 Cg_exo -46.01 134.53 14.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.864 1.71 . . . . 0.0 113.679 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.726 ' HB2' ' CE3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -66.73 -3.62 7.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.663 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.2 p -62.16 -0.49 0.54 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.6 p-80 -139.17 54.5 1.72 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.204 0.456 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.29 148.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.7 -46.92 3.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 1.3 mt 82.96 131.39 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.223 1.011 . . . . 0.0 112.01 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 9.3 mp -79.4 -168.05 1.4 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.849 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -74.6 12.19 0.86 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 295' ' ' LEU . 56.6 tt0 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.044 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 137' ' ' TYR . 50.1 tp10 -167.21 159.54 12.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.123 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.005 ' O ' HG22 ' A' ' 138' ' ' VAL . 80.7 m-85 -132.83 -78.78 0.49 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.995 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 1.005 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.4 m 84.44 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 125.427 1.704 . . . . 0.0 111.107 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -121.34 139.7 53.08 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 120.93 0.395 . . . . 0.0 110.324 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.67 ' HB1' ' CD1' ' A' ' 154' ' ' PHE . . . -105.27 98.75 8.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.98 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.722 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.2 OUTLIER -114.69 32.98 5.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.606 -178.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.574 ' CD2' HD12 ' A' ' 141' ' ' LEU . 69.6 m-85 -125.22 1.74 7.84 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.53 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 269' ' ' LYS . 0.2 OUTLIER 60.96 136.83 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.029 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 4.4 t80 -134.56 -35.26 0.9 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 111.339 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 40.21 61.34 1.56 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.355 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.465 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -64.58 -119.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.596 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.9 OUTLIER 170.54 -92.37 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.902 0.382 . . . . 0.0 111.733 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.636 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 28.8 m-20 -49.95 178.2 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.206 0.527 . . . . 0.0 111.133 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 151' ' ' ASP . 99.9 m-20 -68.54 -42.37 78.51 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.854 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.26 3.98 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 2.7 p30 -133.79 150.2 51.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.483 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 8.7 tp -119.6 89.43 41.04 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-O 120.406 0.146 . . . . 0.0 110.685 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 37.6 Cg_exo -57.48 147.29 79.23 Favored 'Trans proline' 0 C--N 1.288 -2.618 0 C-N-CA 122.236 1.957 . . . . 0.0 113.612 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.67 ' CD1' ' HB1' ' A' ' 140' ' ' ALA . 5.9 p90 -172.53 156.89 3.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.618 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 157' ' ' GLY . 3.4 ttmp? -169.69 -55.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.436 0.636 . . . . 0.0 111.697 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 156' ' ' LYS . 8.7 mmmm -45.14 -16.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.999 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 155' ' ' LYS . . . 102.09 57.29 0.81 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -90.47 150.59 21.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.415 0.626 . . . . 0.0 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.6 mm -94.61 115.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 137' ' ' TYR . 8.6 mt -113.26 120.91 42.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.688 -176.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 65.9 tttm -68.87 141.66 55.01 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.642 ' O ' ' O ' ' A' ' 172' ' ' ASN . 34.7 mm -75.98 -64.17 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.866 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 162' ' ' ILE . 56.0 ttt180 79.96 -44.07 0.27 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.869 0.366 . . . . 0.0 111.31 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -146.08 122.49 10.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.454 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.555 ' HG3' ' NE1' ' A' ' 171' ' ' TRP . 2.4 ttmt -107.67 74.67 0.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.24 -60.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.166 1.911 . . . . 0.0 111.994 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.98 161.0 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -84.79 -34.81 22.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.632 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 92.8 mt-30 -83.53 -29.08 28.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.444 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.43 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 70.9 m95 -122.99 149.85 43.76 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.559 ' CD2' HG22 ' A' ' 185' ' ' VAL . 17.1 m0 -138.34 129.6 27.35 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.349 0.595 . . . . 0.0 111.418 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 162' ' ' ILE . 53.1 t30 -80.81 108.04 14.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.62 171.64 7.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.569 0.543 . . . . 0.0 111.087 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 72.7 tt0 -125.14 135.7 52.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.111 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.37 172.32 2.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.445 0.641 . . . . 0.0 110.578 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.0 mmm -79.89 -0.0 33.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.004 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -104.43 -27.73 11.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.55 49.82 0.34 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 174' ' ' GLU . 46.7 mttt -131.08 134.33 46.51 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.644 -0.778 . . . . 0.0 110.81 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.14 51.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.527 0.68 . . . . 0.0 111.99 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.03 154.25 25.34 Favored Glycine 0 C--N 1.317 -0.516 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.086 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 tpt -68.35 162.78 24.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.371 0.605 . . . . 0.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 5.4 pt -154.8 143.2 14.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.432 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HG2' ' CG ' ' A' ' 187' ' ' TYR . 18.4 Cg_endo -70.19 118.05 5.46 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.346 1.364 . . . . 0.0 108.888 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.896 ' O ' HG22 ' A' ' 188' ' ' VAL . 15.6 t -50.99 -53.46 47.87 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 121.755 -0.59 . . . . 0.0 111.712 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 16.5 Cg_endo -51.93 -25.29 21.37 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 122.313 2.009 . . . . 0.0 113.578 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.8 m-85 -72.2 9.7 0.93 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 185' ' ' VAL . 4.8 m -135.4 167.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.948 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.722 ' CD ' HD21 ' A' ' 141' ' ' LEU . 36.7 mt-10 -91.94 -70.56 0.68 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.452 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.619 ' O ' HG12 ' A' ' 138' ' ' VAL . 4.8 tptp -178.56 -61.3 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 190' ' ' LYS . 1.5 p 163.31 -82.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.723 0.639 . . . . 0.0 110.263 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.583 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 0.0 OUTLIER -95.57 -44.91 0.27 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.642 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 50.0 Cg_exo -52.71 -131.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.735 2.29 . . . . 0.0 112.304 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 71.0 p -162.14 3.02 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.284 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 196' ' ' ALA . 3.8 p 70.25 -53.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 195' ' ' SER . . . -161.82 169.79 20.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 198' ' ' VAL . 43.1 t -132.64 -134.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.897 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 197' ' ' SER . 20.6 m 31.17 42.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.454 0.471 . . . . 0.0 111.272 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.4 p -146.8 133.65 20.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.507 ' OG1' HD23 ' A' ' 201' ' ' LEU . 34.1 p -64.16 -34.33 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.529 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.507 HD23 ' OG1' ' A' ' 200' ' ' THR . 0.2 OUTLIER -148.93 113.13 5.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.172 179.52 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 17.7 m -64.67 -52.58 56.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.569 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -152.72 104.6 0.26 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.89 119.08 0.59 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 206' ' ' GLN . 28.9 t-20 -173.32 -152.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.266 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.508 ' H ' ' CG ' ' A' ' 205' ' ' ASN . 11.7 tp-100 -142.35 119.62 11.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.402 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.94 132.58 41.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.351 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.4 p -158.03 165.17 35.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 210' ' ' HIS . 78.2 p -61.63 -41.91 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' SER . 7.9 m80 56.77 153.48 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.24 76.73 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.373 2.049 . . . . 0.0 111.771 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 0.1 OUTLIER -79.31 -40.53 1.49 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 38.9 Cg_exo -59.16 142.79 99.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.38 2.053 . . . . 0.0 112.083 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 19.1 tp -168.03 -44.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.566 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 117.15 120.44 3.12 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -134.23 -172.19 12.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.92 -41.62 69.76 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.668 2.245 . . . . 0.0 111.922 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.96 149.25 36.0 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.677 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.48 -25.55 48.12 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.513 2.142 . . . . 0.0 112.051 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.36 68.09 1.46 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.97 150.16 37.88 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.616 2.211 . . . . 0.0 111.956 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -73.53 168.77 18.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.232 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.22 115.92 0.67 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.314 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 226' ' ' SER . 4.9 mt-30 -140.2 170.73 9.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.602 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 226' ' ' SER . 29.3 Cg_exo -61.38 51.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.629 2.219 . . . . 0.0 112.732 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 224' ' ' GLN . 0.7 OUTLIER 76.56 72.46 0.07 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.546 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 26.7 mt -139.22 62.08 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.203 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.1 m120 64.67 67.87 0.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.827 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.6 p -126.41 149.49 67.64 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.378 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.24 164.45 35.69 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 122.775 2.316 . . . . 0.0 111.646 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.709 HD21 ' CD1' ' A' ' 276' ' ' TRP . 2.5 pp -60.0 146.45 82.4 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.66 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.48 133.77 35.93 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.232 1.955 . . . . 0.0 112.382 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 234' ' ' LEU . 3.8 m120 -45.87 135.52 7.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' A' ' 236' ' ' ASN . 7.1 tp 29.32 -135.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.142 0.901 . . . . 0.0 110.923 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 237' ' ' GLY . 74.1 mm-40 56.86 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.773 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 234' ' ' LEU . 11.8 m120 -72.62 43.69 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.379 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.57 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 141.95 -173.52 23.6 Favored Glycine 1 CA--C 1.442 -4.488 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.615 178.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.483 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 5.9 Cg_exo -46.0 105.77 0.03 OUTLIER 'Cis proline' 1 N--CA 1.536 4.024 0 O-C-N 123.755 1.397 . . . . 0.0 115.488 0.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.57 ' CD1' ' HA2' ' A' ' 237' ' ' GLY . 9.1 m-30 -120.57 -127.78 0.27 Allowed 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.624 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.8 OUTLIER -141.46 124.01 15.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.66 0.743 . . . . 0.0 110.198 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.924 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -104.59 -163.0 0.93 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.387 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 19.5 tpp180 -161.47 89.87 0.77 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.214 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 243' ' ' VAL . 5.3 p -64.7 121.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.505 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.98 12.32 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.554 ' HA ' HG22 ' A' ' 261' ' ' VAL . 2.0 mm-40 -169.01 120.39 0.74 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 110.565 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.839 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -163.04 -145.56 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.591 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.4 ptt85 -155.75 -142.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.654 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 248' ' ' VAL . 78.7 t -132.84 67.83 78.3 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.608 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 74.5 Cg_endo -91.62 172.7 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.135 2.557 . . . . 0.0 111.61 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.765 ' O ' ' N ' ' A' ' 252' ' ' TYR . 1.9 p-10 -143.98 140.83 29.85 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.914 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.32 -2.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.887 0.742 . . . . 0.0 112.184 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.765 ' N ' ' O ' ' A' ' 250' ' ' ASN . 2.5 m-85 -96.78 -54.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 123.591 0.756 . . . . 0.0 110.044 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -44.41 -65.84 0.47 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.555 ' C ' ' H ' ' A' ' 256' ' ' ALA . 25.8 mttt -149.05 33.3 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.757 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.408 ' O ' ' CA ' ' A' ' 285' ' ' GLY . 1.7 m 71.19 -16.53 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.822 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -48.81 161.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.826 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -105.29 150.53 25.08 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.263 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.846 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -91.57 119.44 31.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 258' ' ' ALA . 3.7 mt -140.48 -172.14 3.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.438 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 17.8 tt0 -147.23 146.13 29.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.065 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 245' ' ' GLN . 68.9 t -55.35 102.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.639 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 121.84 8.01 7.66 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 64.8 mm-40 -90.57 -124.8 0.07 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.841 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.3 OUTLIER 161.61 136.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.053 ' N ' HD12 ' A' ' 264' ' ' LEU . 10.7 p -126.29 142.78 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.287 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 2.6 ttmt -100.63 83.36 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.188 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 75.2 t -51.96 151.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.449 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -151.7 -51.34 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.693 -178.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.524 ' O ' ' OE1' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -70.52 104.13 2.68 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.076 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.542 HG12 ' H ' ' A' ' 234' ' ' LEU . 1.7 mp -95.14 154.61 3.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 271' ' ' ASN . 2.2 p30 -171.63 -97.83 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.153 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.617 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 19.3 mtm -59.0 134.91 57.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.831 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.9 p -66.97 25.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -152.12 -69.89 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.617 ' O ' ' HE3' ' A' ' 272' ' ' MET . 21.4 mp0 -92.19 112.52 24.49 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.148 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.709 ' CD1' HD21 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -116.18 -171.8 2.06 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.524 ' OE1' ' O ' ' A' ' 269' ' ' LYS . 54.8 mp0 -97.09 -160.49 0.8 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.492 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -173.76 117.71 0.66 Allowed Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.525 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.466 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.2 tt0 -99.49 127.82 45.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.34 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.729 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -144.39 78.97 1.59 Allowed 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 3.9 m-20 82.63 30.09 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 0.0 109.921 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 93.95 -32.64 5.72 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.405 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.571 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.4 OUTLIER -66.21 72.81 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.762 -178.266 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.554 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 90.5 mtt180 -72.82 168.04 19.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 123.886 0.741 . . . . 0.0 109.918 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 168.94 -158.07 30.48 Favored Glycine 0 C--O 1.206 -1.653 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.588 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 3.8 p80 -124.71 167.41 14.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.249 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 167.65 115.14 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.223 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.5 Cg_exo -51.68 145.13 31.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.963 1.775 . . . . 0.0 112.304 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.2 OUTLIER -64.25 -0.11 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 110.465 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.2 p -56.27 3.85 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 O-C-N 121.81 -0.556 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' A' ' 289' ' ' PHE . 3.9 p-80 -156.11 69.69 0.66 Allowed 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.574 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -165.86 154.33 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -129.35 76.19 1.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.24 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.6 mt -38.08 127.97 1.3 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.438 0.637 . . . . 0.0 111.368 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.97 -99.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.767 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -159.02 -85.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.412 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.577 ' NE2' ' OE1' ' A' ' 169' ' ' GLN . 4.3 tp60 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.474 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 137' ' ' TYR . 11.0 m . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 57.77 -75.18 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 123.34 0.4 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.958 ' O ' HG22 ' A' ' 138' ' ' VAL . 13.1 p90 -70.74 -55.68 8.08 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.902 -0.57 . . . . 0.0 112.247 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.958 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.4 m 86.17 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 125.0 1.437 . . . . 0.0 111.646 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -128.15 138.29 52.44 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -96.84 98.92 10.52 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.753 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.497 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -104.51 37.51 2.1 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.271 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 53.5 m-85 -135.17 0.82 2.88 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.515 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER 60.55 139.51 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.887 0.742 . . . . 0.0 109.273 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.0 t80 -128.48 -38.68 1.72 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.079 0.399 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t30 40.54 56.25 2.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.517 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.67 -132.3 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.631 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.8 OUTLIER 169.5 -89.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.355 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.58 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.7 m-20 -19.58 134.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 112.225 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.2 -3.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.442 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 148' ' ' ASP . 12.5 pt-20 -108.12 16.76 23.03 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.631 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 8.2 p30 -137.54 152.82 49.86 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 182' ' ' MET . 12.6 tp -107.72 90.35 6.16 Favored Pre-proline 0 C--O 1.215 -0.76 0 CA-C-N 118.181 0.446 . . . . 0.0 110.717 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 74.1 Cg_endo -66.97 146.47 77.62 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 C-N-CA 121.364 1.376 . . . . 0.0 114.082 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 11.8 p90 -169.97 162.84 9.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.82 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -152.76 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.885 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -97.93 129.44 44.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.879 0.847 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . 88.89 12.39 64.0 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.45 ' C ' HD12 ' A' ' 159' ' ' ILE . 27.0 t0 -75.04 139.8 43.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -97.56 114.76 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.459 HD11 ' CD2' ' A' ' 154' ' ' PHE . 10.8 mt -125.42 133.9 52.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.923 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -81.6 140.2 34.58 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.108 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.2 mp -66.37 -52.07 51.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.656 ' CZ ' HH21 ' A' ' 180' ' ' ARG . 54.1 ttt85 66.85 -48.18 0.46 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.306 0.379 . . . . 0.0 111.215 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 162' ' ' ILE . 41.0 t0 -152.93 133.5 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.432 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.44 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.9 pttp -133.94 78.67 59.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.64 -31.2 7.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.165 1.91 . . . . 0.0 112.539 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -101.81 -174.47 2.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 168' ' ' GLU . 1.5 pm0 -115.25 -13.97 11.71 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -109.47 -29.33 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.825 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 76.5 m95 -121.04 146.25 46.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.608 ' CD2' HG22 ' A' ' 185' ' ' VAL . 16.4 m0 -137.38 125.61 23.14 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 162' ' ' ILE . 18.9 t-20 -76.09 101.62 5.39 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.38 173.56 6.25 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.467 0.479 . . . . 0.0 111.079 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 21.4 tt0 -121.45 123.63 42.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.067 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.75 173.35 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.234 0.54 . . . . 0.0 110.211 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 96.1 mtp -72.84 -3.05 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.851 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 179' ' ' LYS . 89.5 m-20 -98.63 -20.23 17.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.361 0.601 . . . . 0.0 110.905 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 120.68 -28.89 6.03 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 177' ' ' ASP . 16.9 mttp -52.49 146.79 9.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.19 0.519 . . . . 0.0 110.813 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.656 HH21 ' CZ ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -114.67 130.62 56.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.344 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.84 157.12 28.37 Favored Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.387 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.525 ' C ' HG22 ' A' ' 183' ' ' ILE . 1.8 tpt -68.4 163.28 23.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.169 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.879 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -161.32 147.79 11.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.554 178.459 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.07 115.84 4.47 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.107 1.205 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 188' ' ' VAL . 38.3 t -53.49 -52.05 70.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 122.041 -0.412 . . . . 0.0 111.541 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.2 Cg_endo -49.11 -27.7 12.81 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.487 2.125 . . . . 0.0 113.345 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.28 4.95 0.43 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.055 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 138' ' ' VAL . 1.8 m -130.43 168.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 123.109 0.256 . . . . 0.0 110.764 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -100.09 -66.34 0.91 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.027 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 45.0 tptt 134.91 -4.27 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.993 1.433 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 12.9 t 56.93 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.921 -0.487 . . . . 0.0 109.912 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 194' ' ' SER . 15.1 ptt180 -163.64 78.61 1.62 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.53 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.24 39.47 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.176 2.584 . . . . 0.0 112.377 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 192' ' ' ARG . 34.6 t -80.22 -6.62 58.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.625 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.6 p -152.59 172.34 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.49 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -171.24 -169.23 0.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.5 t 76.56 137.68 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.844 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.79 -43.3 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.0 m -56.11 143.04 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.41 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 4.8 p 59.25 109.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.254 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.501 HD21 ' HA3' ' A' ' 282' ' ' GLY . 0.2 OUTLIER 54.87 94.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.289 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 48.6 p -77.35 104.16 7.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.22 -29.01 13.19 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.09 -54.31 3.89 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 49.77 98.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -137.02 -174.75 3.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.489 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 55.52 35.87 26.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.6 m -91.68 115.68 28.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.3 m -152.9 148.03 26.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.372 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -40.63 111.64 0.8 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.595 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.05 162.38 37.09 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.655 1.57 . . . . 0.0 111.95 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -40.7 150.05 0.3 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -47.74 139.54 18.69 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.627 1.551 . . . . 0.0 112.353 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.14 10.79 40.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.491 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 177.82 157.19 18.12 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -65.31 -179.47 8.06 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.77 -43.16 53.19 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.323 2.015 . . . . 0.0 112.417 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 39.17 73.13 0.84 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.051 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -61.99 150.27 87.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.976 2.451 . . . . 0.0 112.053 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 156.61 -75.58 0.21 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.74 177.48 4.83 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.518 2.145 . . . . 0.0 112.227 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 224' ' ' GLN . 99.1 m-85 -58.97 163.15 3.66 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.216 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.78 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.904 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.814 HE22 ' HA ' ' A' ' 226' ' ' SER . 4.9 pp0? -143.38 146.12 34.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.784 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -48.56 -57.27 2.45 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.577 1.518 . . . . 0.0 112.912 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.814 ' HA ' HE22 ' A' ' 224' ' ' GLN . 1.5 t 169.58 -12.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 110.957 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.575 ' H ' ' CD1' ' A' ' 227' ' ' ILE . 0.1 OUTLIER -77.44 13.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.6 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.9 m120 66.83 -133.9 0.14 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.057 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 69.2 p -113.31 116.62 46.37 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.771 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.26 -157.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 121.429 1.419 . . . . 0.0 112.26 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.707 HD21 ' CD1' ' A' ' 276' ' ' TRP . 0.1 OUTLIER -61.37 146.57 88.98 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.445 -178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.89 143.78 33.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.126 1.884 . . . . 0.0 111.681 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 235' ' ' GLN . 11.3 m120 37.76 -155.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 111.153 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 234' ' ' LEU . 1.1 pt? -69.69 4.22 2.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.61 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.469 ' HG2' ' H ' ' A' ' 237' ' ' GLY . 18.3 tt0 66.02 129.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -40.66 -34.04 0.34 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.55 0.691 . . . . 0.0 110.39 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.476 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -61.37 -175.73 1.8 Allowed Glycine 1 CA--C 1.447 -4.164 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.23 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.476 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.9 Cg_endo -53.21 122.97 0.4 Allowed 'Cis proline' 0 N--CA 1.525 3.367 0 N-CA-C 116.481 1.685 . . . . 0.0 116.481 -1.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.2 m-85 -154.67 -121.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.7 OUTLIER -145.18 135.09 23.69 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 118.976 0.807 . . . . 0.0 108.962 -179.063 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.541 ' O ' HD13 ' A' ' 295' ' ' LEU . . . -117.94 -148.51 0.42 Allowed 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.174 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 262' ' ' GLY . 21.6 tpp180 -161.93 95.15 0.96 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.627 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 263' ' ' GLU . 2.9 p -61.62 137.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.783 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.8 20.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 176.48 103.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -145.88 -143.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.959 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -155.51 -139.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.015 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 248' ' ' VAL . 70.8 t -133.91 68.65 75.11 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-O 121.215 0.531 . . . . 0.0 110.887 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.649 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 61.3 Cg_endo -91.63 175.63 2.17 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.816 2.344 . . . . 0.0 111.209 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.767 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.9 OUTLIER -142.89 140.0 31.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -37.1 -8.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.46 0.648 . . . . 0.0 111.983 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.767 ' N ' ' O ' ' A' ' 250' ' ' ASN . 4.8 m-85 -92.41 -48.77 6.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 250' ' ' ASN . 27.9 t0 -65.09 56.39 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.661 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 256' ' ' ALA . 33.0 mtmt 85.55 20.28 0.1 Allowed 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.642 1.214 . . . . 0.0 111.47 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.519 ' O ' ' O ' ' A' ' 284' ' ' ARG . 2.4 m 75.49 -19.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.021 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -39.74 107.52 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.949 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -47.03 157.3 0.17 Allowed 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.777 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.83 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -110.17 124.43 51.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.954 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.83 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.3 mt -142.66 -179.08 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.069 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 6.7 tt0 -133.86 146.06 50.24 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.787 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 52.9 t -45.96 110.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.102 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.781 ' O ' ' O ' ' A' ' 263' ' ' GLU . . . 131.06 -70.56 0.52 Allowed Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.781 ' O ' ' O ' ' A' ' 262' ' ' GLY . 4.1 mm-40 -29.08 -163.4 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.444 0 O-C-N 125.764 1.508 . . . . 0.0 114.142 -172.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 264' ' ' LEU . 3.8 pp -155.57 166.04 34.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.281 1.038 . . . . 0.0 112.518 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.09 143.22 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.525 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 279' ' ' GLU . 0.0 OUTLIER -101.39 85.32 2.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.591 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.2 155.49 2.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.939 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.73 -56.24 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.038 0.446 . . . . 0.0 109.807 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 102.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.689 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.61 HG23 ' CE3' ' A' ' 276' ' ' TRP . 5.7 mt -115.17 106.46 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.871 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 272' ' ' MET . 5.5 p30 -111.45 -101.53 0.4 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.623 ' O ' ' CE3' ' A' ' 276' ' ' TRP . 38.6 mtm -51.26 148.33 4.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.003 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 p -72.17 16.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.507 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.86 -80.9 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.227 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -86.18 116.37 24.33 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 121.002 0.429 . . . . 0.0 111.358 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.707 ' CD1' HD21 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -134.58 -172.92 3.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.742 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.53 -171.79 2.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.92 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -159.89 -152.78 6.64 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.056 -1.068 . . . . 0.0 112.348 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 281' ' ' ASN . 0.5 OUTLIER -168.59 139.33 2.53 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.192 0.52 . . . . 0.0 112.168 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.706 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -148.05 76.25 1.37 Allowed 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.102 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 279' ' ' GLU . 2.5 m-20 84.35 36.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.501 ' HA3' HD21 ' A' ' 201' ' ' LEU . . . 89.81 -35.84 3.67 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.843 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -63.89 88.0 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.169 0.509 . . . . 0.0 110.257 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.519 ' O ' ' O ' ' A' ' 255' ' ' THR . 43.9 mtt85 -86.45 168.1 14.07 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.278 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.11 -154.6 24.68 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.583 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 13.1 p80 -129.37 172.14 11.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.2 114.39 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.431 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.526 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 54.5 Cg_exo -48.4 129.53 19.67 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.222 1.281 . . . . 0.0 112.255 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -62.98 -1.92 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.275 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 288' ' ' PRO . 53.0 p -58.77 2.21 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.889 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.2 p-80 -142.82 50.88 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.739 0.304 . . . . 0.0 111.633 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.416 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.2 OUTLIER -145.89 166.3 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 294' ' ' LEU . 18.8 mtm180 -136.85 77.02 1.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.529 0.204 . . . . 0.0 110.878 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 35.1 mt -34.29 134.37 0.2 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.398 0.618 . . . . 0.0 111.274 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 241' ' ' ALA . 3.4 mp -79.08 -165.39 0.75 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.365 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 42.5 p-10 -77.43 -0.42 25.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.63 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 27.5 tt0 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.09 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -152.8 167.57 28.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.483 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.671 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -162.02 -22.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.671 ' O ' ' O ' ' A' ' 137' ' ' TYR . 32.6 m 36.38 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 122.08 0.943 . . . . 0.0 112.635 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 14.9 ttp180 -143.47 120.38 11.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.413 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -98.78 91.51 5.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 124.321 1.013 . . . . 0.0 111.812 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.727 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -99.78 18.97 16.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.285 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.575 ' CE1' ' CZ ' ' A' ' 284' ' ' ARG . 46.8 m-85 -114.98 0.91 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.7 OUTLIER 58.57 138.01 0.01 OUTLIER 'General case' 0 C--O 1.209 -1.035 0 O-C-N 124.407 1.067 . . . . 0.0 110.014 -179.194 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.433 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 17.2 t80 -130.06 -46.69 1.12 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.905 0.321 . . . . 0.0 110.44 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 144' ' ' PHE . 66.3 t30 36.04 58.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.484 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -61.6 -93.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 170.31 15.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.966 0.888 . . . . 0.0 110.316 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 151' ' ' ASP . 1.3 p-10 33.66 -159.2 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.156 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.511 ' N ' ' OD2' ' A' ' 148' ' ' ASP . 97.7 m-20 48.64 38.81 12.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 149' ' ' ASP . 3.6 mm-40 149.71 -10.2 0.0 OUTLIER 'General case' 0 C--N 1.345 0.386 0 O-C-N 124.701 1.251 . . . . 0.0 108.987 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 0.2 OUTLIER -157.45 -178.02 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.793 -178.06 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 175' ' ' ASP . 10.7 tp -118.04 87.67 29.27 Favored Pre-proline 0 C--O 1.206 -1.203 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.508 ' HD3' ' H ' ' A' ' 148' ' ' ASP . 71.6 Cg_endo -71.38 139.74 35.4 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 CA-C-N 120.03 1.046 . . . . 0.0 112.079 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.609 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.1 p90 -160.9 163.76 31.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -155.88 169.08 25.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.811 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 157' ' ' GLY . 3.5 ttmt 50.43 82.67 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.334 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.1 47.41 0.01 OUTLIER Glycine 0 N--CA 1.467 0.715 0 O-C-N 123.834 0.709 . . . . 0.0 113.008 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.502 ' C ' HD12 ' A' ' 159' ' ' ILE . 35.3 t0 -62.71 159.69 15.74 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.547 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.565 HG23 ' CB ' ' A' ' 137' ' ' TYR . 1.5 mp -109.2 106.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 154' ' ' PHE . 6.4 mt -109.47 106.84 16.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.458 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -64.73 129.12 38.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.64 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.964 HG22 ' H ' ' A' ' 163' ' ' ARG . 42.7 mm -66.44 -134.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.857 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.964 ' H ' HG22 ' A' ' 162' ' ' ILE . 77.4 ttt180 175.75 -48.78 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.518 0.675 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.63 -19.12 0.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.071 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.4 pttt 37.04 72.89 0.76 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 123.205 0.315 . . . . 0.0 111.202 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.28 -43.15 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.592 1.528 . . . . 0.0 112.059 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.59 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 76.4 mm-40 -99.29 157.06 16.65 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.909 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.427 ' O ' HG21 ' A' ' 185' ' ' VAL . 2.7 pt-20 -85.06 -36.46 21.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.381 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -82.59 -26.14 32.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.831 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 85.2 m95 -127.32 150.98 49.34 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.666 ' CE3' HG22 ' A' ' 185' ' ' VAL . 13.0 m0 -145.07 136.03 24.73 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.874 0.368 . . . . 0.0 110.234 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -86.8 110.36 19.89 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.43 ' HB3' HG21 ' A' ' 183' ' ' ILE . . . -119.62 -178.58 3.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.633 . . . . 0.0 111.528 -178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -123.68 125.35 44.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -56.8 172.5 0.26 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.94 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -78.61 2.67 18.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.059 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.99 -29.26 10.57 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.05 51.16 0.52 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -135.81 140.51 44.29 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.644 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.06 121.43 44.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 111.343 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.446 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -155.28 153.29 24.67 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.191 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.5 mtp -65.9 152.41 44.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -138.49 143.36 38.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.023 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.57 114.58 4.05 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.314 1.343 . . . . 0.0 108.914 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.801 ' O ' HG22 ' A' ' 188' ' ' VAL . 47.4 t -52.85 -51.23 76.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.823 -0.548 . . . . 0.0 111.944 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.6 Cg_endo -48.56 -29.39 13.94 Favored 'Trans proline' 0 N--CA 1.504 2.137 0 C-N-CA 122.669 2.246 . . . . 0.0 113.014 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.8 m-85 -67.93 -0.92 4.8 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.712 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.2 m -128.98 166.41 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.283 0.364 . . . . 0.0 110.633 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.727 ' CD ' HD21 ' A' ' 141' ' ' LEU . 2.5 pt-20 -146.72 50.58 1.12 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 191' ' ' CYS . 3.8 tmtt? -161.96 105.24 1.19 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.524 ' SG ' ' CH2' ' A' ' 171' ' ' TRP . 0.0 OUTLIER 160.27 -27.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.081 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 193' ' ' PRO . 14.7 mtp180 -162.11 -62.84 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.481 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 192' ' ' ARG . 17.8 Cg_endo -56.49 -36.3 97.49 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.371 2.047 . . . . 0.0 112.109 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 p -39.56 110.06 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.415 . . . . 0.0 110.756 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 97.2 p -64.9 160.61 20.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.52 79.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.654 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.3 m -157.92 173.94 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.1 t 56.35 93.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.501 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -170.75 70.44 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.5 p -103.4 135.79 44.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.306 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -40.13 79.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.939 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 31.65 74.93 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.414 0.446 . . . . 0.0 111.428 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.27 93.94 2.06 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -165.55 -149.16 5.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 55.69 65.29 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.432 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 47.91 94.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.375 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 208' ' ' SER . 91.6 m-20 -88.38 110.06 20.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.139 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 207' ' ' ASP . 82.8 p 54.1 163.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.726 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.418 ' H ' ' CE1' ' A' ' 210' ' ' HIS . 4.3 t -165.09 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.418 ' CE1' ' H ' ' A' ' 209' ' ' SER . 0.4 OUTLIER 58.99 167.42 0.08 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.53 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.0 145.73 96.61 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.715 1.61 . . . . 0.0 111.748 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.583 ' OE1' ' NE2' ' A' ' 275' ' ' GLN . 1.0 OUTLIER -62.06 172.16 1.28 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 215' ' ' GLY . 50.5 Cg_exo -51.69 -35.93 59.55 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.287 1.992 . . . . 0.0 111.873 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 65.6 tp 49.89 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.77 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 213' ' ' PRO . . . -71.67 -30.46 66.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -44.62 153.6 0.47 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.55 -19.47 42.44 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.607 2.205 . . . . 0.0 111.929 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.11 145.81 12.1 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.025 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.65 160.58 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.716 1.61 . . . . 0.0 112.274 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.558 ' H ' ' HD3' ' A' ' 221' ' ' PRO . . . 144.34 63.65 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.436 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.558 ' HD3' ' H ' ' A' ' 220' ' ' GLY . 69.7 Cg_endo -81.36 158.7 19.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.339 2.026 . . . . 0.0 112.264 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -83.88 167.9 16.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.409 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.4 121.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.331 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -143.68 162.67 40.43 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.689 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 226' ' ' SER . 52.6 Cg_exo -50.19 -42.63 46.21 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.169 1.913 . . . . 0.0 112.863 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 225' ' ' PRO . 0.8 OUTLIER -169.94 59.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 227' ' ' ILE . 3.5 mp -130.49 73.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 50.62 84.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.155 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.3 p -107.76 125.63 31.76 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.06 -165.89 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 121.278 1.319 . . . . 0.0 111.832 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.7 tp -124.81 91.46 49.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 233' ' ' ASN . 31.6 Cg_exo -58.38 -173.63 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.222 1.948 . . . . 0.0 111.752 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 232' ' ' PRO . 4.3 t-20 79.37 162.21 0.19 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.082 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.544 HD11 HD13 ' A' ' 270' ' ' ILE . 25.4 tp -60.81 -8.71 3.25 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 234' ' ' LEU . 40.7 tt0 73.48 154.15 0.15 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -62.0 -39.99 94.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.913 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.594 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -59.83 -178.61 1.62 Allowed Glycine 1 CA--C 1.427 -5.427 0 CA-C-O 122.631 1.128 . . . . 0.0 115.464 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.594 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 3.3 Cg_exo -52.44 127.83 1.01 Allowed 'Cis proline' 1 N--CA 1.538 4.095 0 O-C-N 124.766 1.929 . . . . 0.0 115.698 -1.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.6 m-85 -155.24 -122.87 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.72 123.85 14.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 120.389 1.45 . . . . 0.0 109.165 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.502 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -108.53 141.75 39.96 Favored 'General case' 0 C--O 1.19 -2.043 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.247 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -104.57 96.99 6.97 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 121.616 0.722 . . . . 0.0 110.664 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.824 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.9 p -69.1 112.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.616 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.589 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.2 pt -105.78 17.79 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.194 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.465 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.9 mm-40 -176.79 119.84 0.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.085 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.805 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.5 ttmt -161.24 -145.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.982 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 2.9 ptt85 -156.25 -141.42 0.09 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.821 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 248' ' ' VAL . 69.3 t -134.6 69.39 72.4 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.572 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 59.7 Cg_endo -98.46 177.93 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.381 2.721 . . . . 0.0 111.915 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.665 ' C ' ' H ' ' A' ' 252' ' ' TYR . 1.5 p-10 -157.25 151.73 25.24 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.896 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -41.5 -4.85 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.665 ' H ' ' C ' ' A' ' 250' ' ' ASN . 38.2 m-85 -95.19 -53.11 3.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.294 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 17.9 t0 -45.61 -57.84 3.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.899 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.524 ' CE ' HH21 ' A' ' 247' ' ' ARG . 13.1 pttt -169.82 39.66 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.157 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 56.92 46.09 20.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.453 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -121.45 119.57 32.44 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.774 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -51.02 159.62 0.57 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 123.083 0.553 . . . . 0.0 112.329 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.812 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -106.38 114.35 28.41 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.0 OUTLIER -139.59 -178.37 5.37 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.871 0.843 . . . . 0.0 111.607 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 8.0 tt0 -144.67 143.96 31.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.906 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 244' ' ' ILE . 84.6 t -47.7 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.637 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.24 7.39 10.13 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 12.1 mm-40 -86.85 -39.08 16.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.567 0.699 . . . . 0.0 112.641 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.008 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 66.49 139.45 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.18 0.99 . . . . 0.0 109.416 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.008 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.6 p -136.71 155.33 33.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.946 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -100.64 96.31 7.26 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.312 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.813 ' O ' ' N ' ' A' ' 269' ' ' LYS . 34.2 t -50.49 -37.22 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.519 HG23 ' N ' ' A' ' 269' ' ' LYS . 15.1 t 39.58 -64.25 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 O-C-N 124.3 1.0 . . . . 0.0 112.019 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' A' ' 267' ' ' VAL . 7.8 tppt? -76.13 114.25 14.58 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.996 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -119.82 107.88 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.028 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.546 ' ND2' ' OE2' ' A' ' 277' ' ' GLU . 2.7 p30 -114.83 -93.38 0.49 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.631 0.729 . . . . 0.0 110.505 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.55 ' O ' ' CZ3' ' A' ' 276' ' ' TRP . 26.8 mtm -55.22 134.84 49.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.143 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.459 ' HA ' ' CH2' ' A' ' 276' ' ' TRP . 5.7 p -63.16 14.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.788 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -144.37 -61.6 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.204 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.583 ' NE2' ' OE1' ' A' ' 212' ' ' GLN . 2.3 mp0 -60.34 -86.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.607 0.717 . . . . 0.0 110.353 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.573 ' CE3' HG22 ' A' ' 270' ' ' ILE . 47.6 m95 95.95 144.23 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.565 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.546 ' OE2' ' ND2' ' A' ' 271' ' ' ASN . 11.6 mt-10 -99.2 107.65 20.04 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.375 0.607 . . . . 0.0 112.187 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -67.66 -178.94 13.66 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 118.734 -1.698 . . . . 0.0 113.465 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.507 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 4.1 tt0 -168.35 107.53 0.5 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.649 -0.776 . . . . 0.0 110.368 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.698 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -129.58 75.75 1.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.988 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 37.0 t30 85.17 29.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.998 0.428 . . . . 0.0 110.346 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 99.17 -30.01 10.7 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.484 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -68.4 77.29 0.27 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.575 ' CZ ' ' CE1' ' A' ' 142' ' ' PHE . 87.0 mtt180 -79.18 175.84 10.22 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.428 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.05 -147.88 11.64 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 8.2 p80 -141.8 175.37 9.76 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 118.279 1.039 . . . . 0.0 109.378 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.657 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.3 m-85 161.62 152.84 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 O-C-N 123.687 0.617 . . . . 0.0 111.534 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.598 ' HB2' HG23 ' A' ' 290' ' ' THR . 51.2 Cg_endo -72.75 148.52 46.73 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 123.096 2.531 . . . . 0.0 112.983 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 29.4 t80 -74.58 -2.15 24.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.158 0.504 . . . . 0.0 109.77 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 288' ' ' PRO . 23.5 p -61.39 -8.33 3.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.049 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.517 ' CE1' ' CE ' ' A' ' 246' ' ' LYS . 7.0 p80 -136.79 53.9 1.89 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -152.9 150.58 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.151 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 294' ' ' LEU . 30.5 mmm-85 -131.91 77.1 1.74 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.667 0.27 . . . . 0.0 110.952 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 293' ' ' ARG . 45.1 mt -34.13 122.22 0.48 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.487 1.137 . . . . 0.0 112.187 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.1 mp -61.01 -173.56 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.082 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 296' ' ' ASP . 26.7 p-10 -74.94 18.42 0.18 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.061 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.478 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.5 tt0 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.528 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 136' ' ' GLU . 35.3 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.64 ' O ' ' CG ' ' A' ' 137' ' ' TYR . 12.1 tp10 -160.2 166.6 29.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 136' ' ' GLU . 25.7 m-85 -173.32 135.93 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.29 0.369 . . . . 0.0 110.324 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.1 m -148.33 164.93 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.739 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -128.42 132.24 48.47 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -101.57 96.87 7.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.651 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.636 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -99.95 18.69 17.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.46 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.597 ' CE1' ' NH1' ' A' ' 284' ' ' ARG . 51.1 m-85 -115.69 5.01 14.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.5 p30 56.86 149.12 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.947 0 O-C-N 124.44 1.087 . . . . 0.0 109.903 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 10.3 t80 -140.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.167 0.439 . . . . 0.0 110.761 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 42.12 63.55 1.33 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.228 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.514 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.45 -126.12 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.542 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 165.2 -40.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.026 0.413 . . . . 0.0 112.111 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 20.0 m-20 -73.65 160.23 31.89 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.211 0.529 . . . . 0.0 111.217 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.3 -17.59 63.74 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.503 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 150' ' ' GLU . 55.2 mp0 -98.36 31.28 2.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 38.0 p30 -145.55 164.18 32.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.029 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.459 ' CB ' HG22 ' A' ' 183' ' ' ILE . 11.9 tp -122.01 84.5 45.09 Favored Pre-proline 0 C--O 1.213 -0.835 0 CA-C-O 120.39 0.138 . . . . 0.0 111.149 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.514 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 24.5 Cg_exo -59.98 140.15 91.35 Favored 'Trans proline' 0 C--N 1.284 -2.831 0 C-N-CA 122.442 2.094 . . . . 0.0 113.528 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.702 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 11.6 p90 -162.32 158.47 24.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.344 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -54.02 0.65 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.447 0.641 . . . . 0.0 112.059 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 158' ' ' ASP . 15.4 mmtt -88.6 90.54 8.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.614 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 14.56 53.65 0.01 OUTLIER Glycine 0 C--N 1.343 0.971 0 O-C-N 124.115 0.884 . . . . 0.0 111.844 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 156' ' ' LYS . 34.5 t0 -66.12 139.59 58.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.404 0.621 . . . . 0.0 109.82 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.4 mp -86.41 100.06 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.35 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.404 HD11 ' CD2' ' A' ' 154' ' ' PHE . 4.8 mt -106.52 106.56 17.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.749 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.61 141.4 48.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.606 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.5 mp -81.04 139.49 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -114.18 -47.62 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.532 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -140.95 113.81 8.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.151 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.442 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 29.6 pttt -112.37 75.16 1.65 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.324 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.81 -25.07 24.15 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.122 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -118.79 166.83 12.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.635 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -95.87 -28.82 14.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.767 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -85.16 -19.65 31.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.548 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 65.7 m95 -131.17 154.61 48.2 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.552 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.7 m0 -144.67 135.32 24.65 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.272 0.558 . . . . 0.0 111.231 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.72 115.23 24.03 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.62 -178.5 4.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.746 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -125.89 137.77 53.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.4 OUTLIER -85.1 135.36 34.02 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.222 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -45.74 -8.19 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.568 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.6 ' H ' ' C ' ' A' ' 175' ' ' ASP . 56.5 m-20 -78.03 -31.48 50.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 110.759 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.59 45.26 0.92 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.695 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -143.79 143.28 31.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.612 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.55 129.89 53.72 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.448 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -158.65 155.09 26.14 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.534 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.03 152.56 44.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.459 HG22 ' CB ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -141.17 142.24 26.52 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.53 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.406 ' HG2' ' CG ' ' A' ' 187' ' ' TYR . 20.5 Cg_endo -69.49 118.99 6.01 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.096 1.198 . . . . 0.0 109.048 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 24.1 t -53.96 -52.1 71.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 121.874 -0.516 . . . . 0.0 111.779 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.6 Cg_endo -53.02 -24.64 25.6 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.317 2.011 . . . . 0.0 113.618 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.529 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.5 m-85 -68.59 0.38 4.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.812 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.2 m -132.06 166.24 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.535 0.207 . . . . 0.0 110.476 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.636 ' CD ' HD21 ' A' ' 141' ' ' LEU . 1.9 pt-20 -130.29 58.6 1.67 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.846 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 13.1 mptt 37.44 25.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' GLU . 18.4 t 39.66 78.44 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -64.14 150.14 92.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.479 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.4 -32.59 60.37 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.339 2.026 . . . . 0.0 112.116 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 36.6 m -157.66 85.22 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.352 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 70.6 m -56.77 -46.21 81.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.22 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 61.73 179.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.53 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 t -121.2 35.6 4.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 199' ' ' SER . 33.3 m -64.52 -41.24 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.541 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 198' ' ' VAL . 31.8 t -151.19 -179.89 7.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.364 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 41.2 p -94.32 102.4 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.298 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.4 tp -173.33 51.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.93 -38.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 205' ' ' ASN . . . 174.64 -87.43 0.08 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.48 -8.64 2.9 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 203' ' ' GLY . 34.3 m120 54.38 47.81 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -50.0 116.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.303 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 209' ' ' SER . 97.4 m-20 -76.69 -86.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.439 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.3 t 43.38 -87.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 207' ' ' ASP . 29.7 t -126.15 121.17 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.179 0.514 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.476 ' N ' ' HD2' ' A' ' 211' ' ' PRO . 0.2 OUTLIER 164.44 -57.54 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.669 -178.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 210' ' ' HIS . 47.4 Cg_endo -65.53 -165.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.823 1.682 . . . . 0.0 112.036 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 211' ' ' PRO . 0.0 OUTLIER -46.85 177.36 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.288 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.94 143.58 99.53 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.334 2.023 . . . . 0.0 111.85 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 215' ' ' GLY . 81.1 mt -89.66 -86.85 0.18 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 214' ' ' LEU . . . -55.45 -156.8 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.601 ' H ' ' CD ' ' A' ' 217' ' ' PRO . . . -107.37 -45.98 1.11 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.601 ' CD ' ' H ' ' A' ' 216' ' ' GLY . 31.4 Cg_exo -57.93 138.96 88.64 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.542 2.161 . . . . 0.0 111.963 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -155.14 78.35 4.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.879 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.35 144.04 84.11 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.709 2.272 . . . . 0.0 112.205 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 46.98 -117.05 2.81 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.483 ' O ' ' CD1' ' A' ' 222' ' ' TYR . 59.7 Cg_endo -74.28 -61.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.466 1.633 . . . . 0.0 112.456 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.483 ' CD1' ' O ' ' A' ' 221' ' ' PRO . 68.7 m-85 -153.63 168.44 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.432 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.57 97.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.15 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.595 ' OE1' ' NE2' ' A' ' 275' ' ' GLN . 0.2 OUTLIER -137.02 123.93 13.88 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.557 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 226' ' ' SER . 36.5 Cg_exo -59.23 40.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.201 0 C-N-CA 122.423 2.082 . . . . 0.0 112.266 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 228' ' ' ASN . 1.8 m 160.89 130.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 227' ' ' ILE . 9.7 tp -60.87 74.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 110.175 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 226' ' ' SER . 16.5 p30 -178.12 168.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.088 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 230' ' ' PRO . 2.1 p -111.54 90.8 13.0 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.437 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 231' ' ' LEU . 50.5 Cg_exo -42.86 -103.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.105 1.87 . . . . 0.0 113.177 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.613 HD12 ' CD1' ' A' ' 276' ' ' TRP . 71.6 mt -51.62 137.13 33.23 Favored Pre-proline 0 N--CA 1.447 -0.611 0 O-C-N 122.263 -0.273 . . . . 0.0 111.152 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.48 -93.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.94 1.76 . . . . 0.0 111.94 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.45 ' CG ' ' H ' ' A' ' 234' ' ' LEU . 54.2 t30 -126.58 -169.17 1.98 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.45 ' H ' ' CG ' ' A' ' 233' ' ' ASN . 31.9 tp -40.06 100.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.31 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.582 ' C ' ' H ' ' A' ' 237' ' ' GLY . 12.8 mm100 -53.16 159.8 1.2 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.924 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 70.2 m-20 -54.36 -2.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.593 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 235' ' ' GLN . . . -94.04 -167.91 37.54 Favored Glycine 1 CA--C 1.445 -4.3 0 CA-C-O 121.773 0.652 . . . . 0.0 113.965 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.55 98.32 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.752 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 0.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.526 ' CD1' ' HA2' ' A' ' 237' ' ' GLY . 4.0 m-30 -117.06 -130.7 0.31 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.412 ' H ' ' HB3' ' A' ' 239' ' ' PHE . 2.3 m-30 -137.11 119.51 15.81 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.765 0.793 . . . . 0.0 109.169 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -111.75 142.35 44.2 Favored 'General case' 0 C--O 1.188 -2.159 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.047 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 15.6 tpp180 -103.96 110.44 22.59 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.873 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.5 p -82.58 74.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 123.702 0.626 . . . . 0.0 111.936 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.825 ' HA ' ' O ' ' A' ' 261' ' ' VAL . 1.4 pt -60.81 24.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.617 ' H ' ' C ' ' A' ' 243' ' ' VAL . 1.6 mm-40 173.46 130.88 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.492 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.864 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -165.68 -144.81 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.444 176.183 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 4.3 ptt85 -156.91 -140.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.381 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 248' ' ' VAL . 76.7 t -138.3 68.59 47.35 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.69 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 55.7 Cg_endo -96.07 179.65 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.422 2.748 . . . . 0.0 111.75 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.751 ' C ' ' H ' ' A' ' 252' ' ' TYR . 10.7 p-10 -148.66 145.64 27.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.362 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.88 4.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.751 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.0 m-85 -98.82 -55.4 2.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.952 0.901 . . . . 0.0 110.58 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -44.6 -67.41 0.29 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.846 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.523 ' O ' ' CE1' ' A' ' 286' ' ' HIS . 27.1 mtmt -149.11 36.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.453 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 60.45 38.63 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' A' ' 287' ' ' PHE . . . -109.0 170.55 7.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.755 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -112.32 152.64 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.122 0.569 . . . . 0.0 110.807 -178.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.744 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -97.89 119.35 36.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.464 0.649 . . . . 0.0 111.684 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -144.78 -163.03 1.61 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.52 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.672 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -132.58 -176.98 4.28 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 2.3 t -61.11 -34.35 59.86 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 CA-C-O 121.575 0.703 . . . . 0.0 112.379 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.574 ' H ' ' HG2' ' A' ' 260' ' ' GLU . . . -128.41 38.46 2.06 Favored Glycine 0 C--N 1.277 -2.701 0 O-C-N 120.539 -1.351 . . . . 0.0 111.581 -176.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 260' ' ' GLU . 13.0 mm-40 -86.29 -35.68 19.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.279 0.561 . . . . 0.0 111.389 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.992 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.27 139.1 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.061 -178.432 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.992 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.4 p -128.51 150.74 34.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.375 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -100.92 86.92 3.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.989 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 40.9 t -50.97 153.09 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.482 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.529 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -153.33 -53.46 0.11 Allowed 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.125 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 1.9 tpmt? -67.6 146.16 54.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.279 0.562 . . . . 0.0 111.298 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.589 HG23 ' CZ3' ' A' ' 276' ' ' TRP . 3.0 mt -126.48 162.65 30.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.62 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.566 ' N ' HG22 ' A' ' 270' ' ' ILE . 0.7 OUTLIER 171.74 -101.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.583 ' CE ' ' H ' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -73.66 163.04 28.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.551 ' HA ' ' HE1' ' A' ' 276' ' ' TRP . 2.1 p -98.74 29.79 3.59 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -139.65 -39.72 0.09 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.531 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.595 ' NE2' ' OE1' ' A' ' 224' ' ' GLN . 2.5 mp0 -96.05 -79.72 0.44 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.218 0.532 . . . . 0.0 111.182 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.613 ' CD1' HD12 ' A' ' 231' ' ' LEU . 17.0 m95 77.6 166.49 0.23 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.194 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 90.3 mt-10 -132.27 148.51 52.45 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -129.09 -141.81 5.19 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 115.094 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.413 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.3 tt0 -173.03 129.79 0.48 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.522 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.71 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.4 OUTLIER -144.32 75.21 1.45 Allowed 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.825 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 13.8 t-20 84.69 27.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.434 0.635 . . . . 0.0 110.001 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 95.78 -32.05 6.68 Favored Glycine 0 N--CA 1.459 0.198 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.49 72.6 0.08 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.597 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 77.2 mtt180 -71.49 168.91 16.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.249 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 170.57 -159.1 31.24 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.632 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 0.0 OUTLIER -135.76 176.15 8.94 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.872 0.469 . . . . 0.0 110.069 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 2.8 m-85 170.54 154.89 0.2 Allowed Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.944 0.778 . . . . 0.0 111.158 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.631 ' HB2' HG23 ' A' ' 290' ' ' THR . 56.2 Cg_endo -74.83 155.59 43.74 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.022 2.481 . . . . 0.0 112.071 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 292' ' ' VAL . 64.0 t80 -74.77 0.48 15.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.554 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.631 HG23 ' HB2' ' A' ' 288' ' ' PRO . 41.4 p -62.68 0.46 0.5 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.507 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.42 62.38 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.611 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -158.05 143.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -127.66 81.15 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 19.4 mt -40.68 131.24 2.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.857 0.837 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.43 -171.61 3.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.272 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -101.2 33.73 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.459 ' OE1' ' CZ ' ' A' ' 239' ' ' PHE . 8.7 tt0 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.432 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 178.04 -174.2 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 O-C-N 124.113 0.883 . . . . 0.0 110.436 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.031 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -128.6 -89.34 0.52 Allowed 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.168 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 1.031 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.8 m 90.36 168.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 124.241 0.963 . . . . 0.0 111.922 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -140.63 156.34 46.29 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 155' ' ' LYS . . . -56.73 168.62 0.58 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.67 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -136.02 -36.56 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.643 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.549 ' CE2' ' CZ ' ' A' ' 284' ' ' ARG . 92.5 m-85 -130.51 6.6 4.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.567 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 78.02 136.71 0.06 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.8 t80 -108.27 -49.26 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 110.879 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.461 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 4.0 m120 41.28 66.92 0.6 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.26 -122.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 146' ' ' GLY . 1.7 p30 168.21 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.576 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.594 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 9.0 m-20 -80.66 154.01 27.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.0 -16.83 64.62 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.036 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.15 24.74 4.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 7.5 p30 -144.82 162.44 36.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.038 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.4 tp -112.31 89.71 12.82 Favored Pre-proline 0 C--O 1.215 -0.737 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 59.6 Cg_endo -69.17 127.18 14.68 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 121.692 1.595 . . . . 0.0 112.859 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CG ' HD11 ' A' ' 160' ' ' LEU . 16.7 p90 -147.75 166.94 25.97 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.588 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 143' ' ' ASP . 1.4 tptp -106.65 -141.11 0.37 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 158' ' ' ASP . 24.7 pttm -91.24 174.13 7.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 36.29 20.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 156' ' ' LYS . 14.5 t0 -79.27 132.66 36.55 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.26 111.88 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.095 0.474 . . . . 0.0 110.858 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.44 HD11 ' CG ' ' A' ' 154' ' ' PHE . 7.9 mt -120.57 128.63 53.24 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.6 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 7.8 ttpm? -83.27 135.17 34.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.7 mp -66.3 -51.53 57.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.485 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.601 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 54.2 ttt85 65.94 -49.44 0.41 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.713 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 162' ' ' ILE . 68.2 t0 -149.96 128.43 12.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.115 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.528 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 3.5 ptmm? -121.44 81.74 39.05 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.866 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 -44.01 53.74 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.61 2.207 . . . . 0.0 112.372 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -119.37 176.93 5.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.438 ' O ' HG21 ' A' ' 185' ' ' VAL . 3.5 mm-40 -93.36 -41.82 9.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 240' ' ' TYR . 86.4 mt-30 -72.44 -32.75 66.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.366 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.4 m95 -119.92 153.75 35.43 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.647 ' CD2' HG22 ' A' ' 185' ' ' VAL . 14.0 m0 -143.64 135.69 26.67 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 120.992 0.425 . . . . 0.0 110.739 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.694 ' O ' ' O ' ' A' ' 162' ' ' ILE . 46.4 t30 -86.59 107.78 18.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.68 -179.09 3.55 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.546 0.529 . . . . 0.0 110.379 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 74.0 tt0 -126.13 136.09 52.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.514 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 171.39 3.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.651 0.739 . . . . 0.0 110.636 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 1.28 23.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.608 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -105.46 -28.94 10.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.16 50.48 0.34 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 174' ' ' GLU . 36.2 mttt -134.24 138.76 45.29 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.35 -0.925 . . . . 0.0 111.212 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.601 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.1 OUTLIER -108.92 122.12 46.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.569 0.7 . . . . 0.0 111.76 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.0 24.41 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.771 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.08 162.06 25.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 -179.121 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.789 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -157.62 152.16 20.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.954 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.04 113.44 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.199 1.266 . . . . 0.0 110.554 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.647 HG22 ' CD2' ' A' ' 171' ' ' TRP . 42.4 t -50.48 -50.96 68.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.953 -0.467 . . . . 0.0 111.275 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.0 Cg_endo -45.87 -34.66 12.65 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.933 1.755 . . . . 0.0 112.84 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 7.2 m-85 -63.81 -8.23 10.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.975 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.987 HG21 HG21 ' A' ' 138' ' ' VAL . 1.3 m -135.22 166.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.812 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 190' ' ' LYS . 0.6 OUTLIER -150.43 -51.18 0.13 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.644 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.746 ' O ' HG12 ' A' ' 138' ' ' VAL . 13.9 mmtp -26.9 136.12 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.639 0.587 . . . . 0.0 111.485 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.458 ' O ' HG12 ' A' ' 138' ' ' VAL . 42.7 t 55.48 102.06 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.066 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.508 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 0.0 OUTLIER 177.38 -48.3 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.255 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 71.2 Cg_endo -84.07 67.51 6.87 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.405 2.07 . . . . 0.0 111.763 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.9 m 63.86 47.6 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.5 t 61.69 136.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -169.65 46.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 78.0 p -61.81 -35.1 77.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.515 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 198' ' ' VAL . 4.3 m -98.01 75.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -170.64 21.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.669 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.8 t -55.62 147.7 17.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.326 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 201' ' ' LEU . 10.1 mp -65.65 -75.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 6.7 p 55.33 55.85 7.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -154.71 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -135.81 30.25 2.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -79.57 66.58 5.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.373 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -163.87 101.16 0.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.591 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -151.21 70.02 0.97 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.474 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 70.8 m -61.73 -97.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.606 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 41.1 t -157.87 151.83 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -166.27 71.77 1.18 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.41 144.73 99.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.735 2.29 . . . . 0.0 111.975 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.632 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 2.5 tt0 -81.97 -41.07 0.99 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 26.8 Cg_exo -60.4 148.56 90.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.628 2.219 . . . . 0.0 111.971 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.47 112.4 4.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.164 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.9 140.56 26.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.452 ' N ' ' CD ' ' A' ' 217' ' ' PRO . . . 156.07 -52.63 0.43 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 216' ' ' GLY . 31.5 Cg_exo -57.08 140.2 92.02 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.727 2.284 . . . . 0.0 111.85 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.01 147.7 70.47 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.339 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.71 115.3 0.33 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.275 1.983 . . . . 0.0 112.472 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -118.96 56.31 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.4 -153.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.847 2.364 . . . . 0.0 111.89 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 224' ' ' GLN . 97.6 m-85 -57.3 149.84 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.18 89.65 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.62 HE21 ' CG2' ' A' ' 227' ' ' ILE . 34.5 mt-30 -148.39 147.8 26.74 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.371 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 226' ' ' SER . 50.5 Cg_endo -71.34 23.22 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.559 2.173 . . . . 0.0 111.435 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 224' ' ' GLN . 0.7 OUTLIER 78.93 28.45 0.4 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.28 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.62 ' CG2' HE21 ' A' ' 224' ' ' GLN . 20.9 tt -84.75 -5.57 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.542 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -144.35 46.56 1.41 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.037 0.446 . . . . 0.0 110.003 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.4 p -57.45 152.17 34.95 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.498 ' HB2' ' HE1' ' A' ' 276' ' ' TRP . 65.1 Cg_exo -37.05 -82.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 122.552 2.168 . . . . 0.0 112.651 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.55 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -131.04 92.87 32.23 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 233' ' ' ASN . 51.6 Cg_exo -53.81 74.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.452 2.101 . . . . 0.0 112.265 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 231' ' ' LEU . 65.6 m-80 48.73 179.85 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.444 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 236' ' ' ASN . 31.4 tp -53.22 -106.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.211 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 61.66 -67.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 234' ' ' LEU . 97.3 m-20 -68.04 -110.81 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.696 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.49 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -55.83 -168.97 0.07 OUTLIER Glycine 1 CA--C 1.439 -4.698 0 CA-C-O 122.314 0.952 . . . . 0.0 114.096 -179.088 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.45 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.7 Cg_exo -47.61 110.82 0.08 OUTLIER 'Cis proline' 1 N--CA 1.544 4.45 0 O-C-N 123.917 1.482 . . . . 0.0 115.253 0.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.631 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.0 m-30 -126.7 -136.45 0.25 Allowed 'General case' 0 C--O 1.212 -0.887 0 O-C-N 124.242 0.964 . . . . 0.0 109.128 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 169' ' ' GLN . 2.7 m-30 -134.86 114.58 12.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.903 0.859 . . . . 0.0 109.754 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.41 140.79 39.8 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.695 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 10.7 tpp85 -104.32 100.77 10.49 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.396 -0.815 . . . . 0.0 109.792 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 243' ' ' VAL . 4.9 p -71.92 121.74 22.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.178 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.997 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.2 OUTLIER -121.62 20.67 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -172.9 108.33 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.418 0.628 . . . . 0.0 109.695 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -154.49 -140.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.53 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -158.21 -142.12 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 248' ' ' VAL . 66.0 t -134.47 70.49 72.4 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.761 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.513 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 44.8 Cg_endo -90.16 168.91 4.34 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.954 2.436 . . . . 0.0 111.475 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.734 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -131.57 130.2 41.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.831 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.33 -4.87 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.832 0.708 . . . . 0.0 111.994 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.734 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.4 m-85 -93.39 -54.67 3.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.848 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 250' ' ' ASN . 41.9 t0 -41.35 -62.57 0.83 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.553 -177.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.6 mtmt -151.34 26.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.999 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.2 m 75.21 -21.48 0.3 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.628 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -42.24 107.44 0.08 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.224 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.96 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -44.92 157.77 0.07 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.363 178.151 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.809 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.23 121.42 44.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.752 0.658 . . . . 0.0 110.723 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.4 mt -140.42 -173.95 3.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.928 0.394 . . . . 0.0 111.243 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.2 tt0 -144.95 152.28 39.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.955 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.85 106.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.621 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.94 8.72 8.64 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 46.7 mm-40 -96.8 -135.93 0.24 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 172.1 136.8 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.999 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.8 p -127.09 153.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.014 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 265' ' ' VAL . 1.8 ttmm -105.48 95.15 5.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 268' ' ' THR . 18.2 t -63.03 161.46 2.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.058 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -152.66 -62.38 0.16 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.657 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -71.69 132.14 44.15 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.425 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.745 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -148.05 145.39 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.375 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 32.4 p30 174.49 -136.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.876 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 47.6 mtm 54.51 -122.47 1.96 Allowed 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.259 0.552 . . . . 0.0 111.163 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -143.96 -16.63 0.6 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.035 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.525 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -168.13 -15.14 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.232 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.589 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.0 mp0 -97.06 159.58 14.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.632 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.589 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -167.57 161.02 13.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.556 -178.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 8.7 mt-10 -93.84 -168.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.255 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.29 179.36 28.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.507 ' OE1' ' NH2' ' A' ' 284' ' ' ARG . 5.2 tt0 -168.8 113.82 0.59 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.118 0.485 . . . . 0.0 110.686 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.628 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -109.45 -99.85 0.39 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -91.64 48.68 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.33 -29.62 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' SG ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.7 92.5 0.22 Allowed 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.303 -177.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.549 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 78.3 mtt180 -87.11 172.35 10.01 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.159 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 166.04 -152.44 21.63 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.564 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 11.3 p80 -126.23 166.87 16.29 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.15 0.5 . . . . 0.0 109.783 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 164.75 110.72 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.798 177.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 290' ' ' THR . 36.3 Cg_exo -54.91 141.37 78.08 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.978 1.786 . . . . 0.0 112.598 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.656 ' CD2' HG23 ' A' ' 292' ' ' VAL . 0.5 OUTLIER -61.24 -1.43 0.49 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 288' ' ' PRO . 39.9 p -46.9 -7.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.092 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 289' ' ' PHE . 0.1 OUTLIER -150.27 80.2 1.35 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.016 -178.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.656 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -168.92 151.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 244' ' ' ILE . 0.2 OUTLIER -123.45 74.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.64 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 293' ' ' ARG . 68.2 mt -36.49 131.64 0.65 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.1 mp -78.85 -171.97 2.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -91.8 17.14 9.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.45 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.631 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 62.4 tt0 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.307 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.483 ' C ' ' CD1' ' A' ' 137' ' ' TYR . 42.4 tp10 -164.94 152.41 11.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.973 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.7 OUTLIER -142.47 -68.22 0.37 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.268 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.2 m 81.75 162.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 O-C-N 125.183 1.552 . . . . 0.0 111.928 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.447 ' HE ' ' HA ' ' A' ' 191' ' ' CYS . 9.8 ptp180 -132.31 142.33 49.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.598 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -99.83 102.94 14.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.626 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.631 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -101.4 20.56 15.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.717 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 51.9 m-85 -121.14 1.92 10.34 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.884 -0.144 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.504 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 60.56 139.13 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.797 0 O-C-N 123.999 0.812 . . . . 0.0 109.968 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 13.1 t80 -128.86 -50.57 1.23 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.569 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 144' ' ' PHE . 47.5 t30 37.36 58.07 1.29 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.517 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -65.77 -150.3 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.6 p30 165.6 -15.05 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.855 -0.672 . . . . 0.0 111.207 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' A' ' 149' ' ' ASP . 63.2 m-20 -49.66 -166.71 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' A' ' 148' ' ' ASP . 98.9 m-20 -16.44 -68.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.311 0.382 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 151' ' ' ASP . 17.3 pt-20 -171.07 40.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.027 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 150' ' ' GLU . 1.4 m-20 -53.74 -157.56 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.491 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 13.5 tp -123.92 84.4 54.58 Favored Pre-proline 0 C--O 1.217 -0.622 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.688 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.401 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 56.1 Cg_endo -68.17 121.25 8.23 Favored 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 121.669 1.58 . . . . 0.0 112.438 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 7.7 p90 -140.2 -177.59 5.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 5.8 mttp 179.69 121.84 0.06 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.576 -0.725 . . . . 0.0 109.128 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 105.93 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.635 1.209 . . . . 0.0 110.96 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 19.86 52.48 0.01 OUTLIER Glycine 0 N--CA 1.472 1.038 0 O-C-N 123.564 0.54 . . . . 0.0 111.919 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 156' ' ' LYS . 8.1 t70 -74.46 142.26 44.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.083 0.468 . . . . 0.0 110.329 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.05 96.44 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 mt -102.34 103.67 14.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.805 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 88.1 tttt -53.21 132.91 39.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.737 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 172' ' ' ASN . 40.1 mm -71.3 -55.15 14.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.113 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.699 HH12 HH11 ' A' ' 180' ' ' ARG . 32.1 ttm180 78.56 -52.03 0.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.551 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 165' ' ' LYS . 50.0 p-10 -120.3 -120.34 0.3 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.21 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.503 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 2.7 pttp 141.87 62.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 124.438 1.086 . . . . 0.0 109.963 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.25 -65.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.567 2.178 . . . . 0.0 112.697 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.7 mt-10 -108.33 168.85 9.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.548 ' O ' HG21 ' A' ' 185' ' ' VAL . 2.7 pt-20 -82.13 -37.95 25.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.652 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -79.73 -23.46 42.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -126.88 152.47 47.01 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.723 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.8 m0 -147.16 138.5 23.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.682 ' O ' ' O ' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -90.23 121.63 32.42 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.11 -178.14 4.42 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.66 0.6 . . . . 0.0 110.002 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.495 ' CD ' ' NH2' ' A' ' 163' ' ' ARG . 49.1 tt0 -124.62 130.02 51.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.287 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.487 ' HB2' HD11 ' A' ' 152' ' ' LEU . 9.2 t70 -56.29 177.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.397 0.618 . . . . 0.0 110.879 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -80.04 -4.95 54.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.383 177.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -104.91 -27.64 11.58 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.78 48.46 0.33 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -129.29 129.04 44.39 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.856 -0.672 . . . . 0.0 111.376 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.699 HH11 HH12 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -97.65 121.19 39.26 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.79 0.805 . . . . 0.0 111.467 -178.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -152.76 149.43 21.05 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.217 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.52 153.46 41.39 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.122 0.487 . . . . 0.0 110.09 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.94 143.56 28.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.472 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.4 ' HB3' ' CG ' ' A' ' 238' ' ' PRO . 37.1 Cg_endo -74.58 114.57 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.437 1.424 . . . . 0.0 109.978 175.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.723 HG22 ' CE3' ' A' ' 171' ' ' TRP . 54.2 t -52.15 -48.86 87.51 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.079 -0.388 . . . . 0.0 110.941 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 12.2 Cg_endo -50.49 -27.73 19.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.912 1.742 . . . . 0.0 113.314 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.528 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.8 m-85 -72.24 -5.54 36.62 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.509 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 185' ' ' VAL . 21.1 m -128.1 168.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.259 0.349 . . . . 0.0 110.759 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.631 ' CD ' HD21 ' A' ' 141' ' ' LEU . 2.5 pt-20 -134.59 67.53 1.5 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.517 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER 21.61 49.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.922 0.764 . . . . 0.0 111.327 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 189' ' ' GLU . 29.4 t 41.45 69.04 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.022 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -76.35 129.42 80.1 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.649 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -46.99 137.95 16.25 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.211 1.94 . . . . 0.0 112.394 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.3 p -159.79 -98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.404 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.3 p 56.41 52.03 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 53.56 72.63 0.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 198' ' ' VAL . 80.9 p -149.98 -99.77 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.566 HG13 ' N ' ' A' ' 199' ' ' SER . 7.9 p -60.96 -46.78 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.566 ' N ' HG13 ' A' ' 198' ' ' VAL . 5.2 p -91.38 139.38 30.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.501 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 201' ' ' LEU . 60.4 p -66.38 131.35 45.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.271 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 200' ' ' THR . 2.9 tp 55.37 164.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.402 ' H ' ' HG ' ' A' ' 201' ' ' LEU . 72.2 p -76.31 171.63 14.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.81 82.16 0.02 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -58.92 133.93 52.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -157.83 179.01 9.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.313 . . . . 0.0 110.338 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -99.45 160.37 14.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 207' ' ' ASP . 35.7 p-10 -67.59 115.76 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.458 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 56.0 m -153.65 -124.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.2 t -133.19 -34.29 1.09 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.427 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 53.43 64.34 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.08 -179.05 4.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.708 2.272 . . . . 0.0 111.818 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -139.62 72.81 36.04 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -61.33 143.32 97.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.915 2.41 . . . . 0.0 112.011 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 215' ' ' GLY . 2.5 tt -164.2 111.12 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.294 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.523 ' N ' HD23 ' A' ' 214' ' ' LEU . . . -168.82 -63.44 0.03 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.458 ' H ' ' HD3' ' A' ' 217' ' ' PRO . . . 111.11 73.75 0.72 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.458 ' HD3' ' H ' ' A' ' 216' ' ' GLY . 24.9 Cg_exo -61.57 147.35 95.61 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.954 2.436 . . . . 0.0 111.803 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.462 ' H ' ' HD2' ' A' ' 219' ' ' PRO . 5.0 mt-10 -155.65 -64.14 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.656 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.462 ' HD2' ' H ' ' A' ' 218' ' ' GLU . 30.8 Cg_endo -61.39 143.13 97.51 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.066 1.844 . . . . 0.0 111.963 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.96 -145.79 0.45 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.97 -177.49 3.76 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.39 2.06 . . . . 0.0 111.885 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -59.76 137.61 58.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.48 94.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.318 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.432 ' NE2' HG21 ' A' ' 229' ' ' THR . 12.1 mt-30 -144.06 155.73 58.53 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.16 -0.54 4.23 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.731 2.287 . . . . 0.0 111.8 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 228' ' ' ASN . 49.6 m -108.86 -6.51 15.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 39.0 mm 53.14 -87.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.524 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 226' ' ' SER . 87.0 m-20 -76.94 81.87 3.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.07 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.432 HG21 ' NE2' ' A' ' 224' ' ' GLN . 2.9 p -69.87 150.78 96.43 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.791 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -37.62 -80.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 122.849 2.366 . . . . 0.0 112.491 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.71 94.2 35.5 Favored Pre-proline 0 C--O 1.232 0.137 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.18 169.01 19.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.364 2.043 . . . . 0.0 111.872 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 74.92 145.7 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.427 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.548 HD21 ' O ' ' A' ' 237' ' ' GLY . 5.2 tp -54.88 128.11 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.877 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.531 ' N ' ' OE1' ' A' ' 235' ' ' GLN . 0.9 OUTLIER -70.51 39.95 0.05 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.467 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.601 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 83.4 m-20 56.29 4.86 0.15 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.17 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.548 ' O ' HD21 ' A' ' 234' ' ' LEU . . . -103.61 -169.48 25.55 Favored Glycine 1 CA--C 1.435 -4.908 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.98 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.424 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.4 Cg_exo -48.12 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.533 3.851 0 O-C-N 123.442 1.233 . . . . 0.0 114.799 0.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 236' ' ' ASN . 2.3 m-30 -120.66 -135.94 0.32 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 1.8 m-30 -138.79 118.97 13.52 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.584 0.707 . . . . 0.0 109.592 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.874 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -98.4 -162.86 0.99 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -157.43 86.94 0.95 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.654 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 264' ' ' LEU . 8.2 p -63.21 112.57 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.575 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.1 pt -103.83 16.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.533 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.2 mm-40 -176.2 124.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.202 0.525 . . . . 0.0 111.131 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.5 ttmt -165.08 -157.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.217 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.6 ptt85 -145.82 -134.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.466 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.439 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 4.6 t -139.38 60.44 16.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.72 ' O ' ' O ' ' A' ' 250' ' ' ASN . 95.9 Cg_endo -94.68 44.04 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.812 2.341 . . . . 0.0 113.322 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.726 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.3 p-10 -21.23 153.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.014 0.821 . . . . 0.0 111.465 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.2 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.688 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 254' ' ' LYS . 31.9 m-85 -79.28 -64.52 1.17 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.2 t70 -45.98 63.42 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 125.142 1.526 . . . . 0.0 110.319 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.828 ' N ' ' O ' ' A' ' 252' ' ' TYR . 33.7 mtmt 81.34 -48.47 0.25 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.618 1.199 . . . . 0.0 110.364 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.65 -25.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.849 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.668 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -41.34 108.56 0.09 Allowed 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.951 0.405 . . . . 0.0 111.48 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -43.07 159.98 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.431 0 O-C-N 122.11 -0.369 . . . . 0.0 110.963 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.814 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -112.17 122.51 47.94 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -140.68 -174.07 3.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.086 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.1 tt0 -145.84 145.33 30.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.159 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 245' ' ' GLN . 66.4 t -46.82 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.39 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 11.84 10.6 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 56.3 mm-40 -88.3 -36.32 16.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.281 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.082 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 135.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.614 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.082 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.3 p -133.45 159.37 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.39 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.565 ' N ' HG22 ' A' ' 265' ' ' VAL . 6.1 ttmt -103.33 94.9 5.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.927 ' O ' ' N ' ' A' ' 269' ' ' LYS . 2.6 t -46.03 -42.4 4.41 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.527 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.651 HG23 ' N ' ' A' ' 269' ' ' LYS . 7.9 t 35.16 -60.07 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.927 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER -73.77 110.49 8.1 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.9 mt -136.6 101.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.598 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.436 ' ND2' ' OE2' ' A' ' 277' ' ' GLU . 2.6 p30 -93.05 -31.64 14.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' MET . . . . . . . . . . . . . 29.1 mtm -131.28 172.49 12.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.999 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.9 p -91.22 5.62 48.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . -124.33 -90.69 0.89 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.791 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.48 69.2 10.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 0.0 110.722 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 0.4 OUTLIER -77.78 178.48 7.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.623 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 3.4 mt-10 -104.19 -167.41 1.36 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -157.76 -171.39 23.67 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.0 tt0 -170.44 109.54 0.36 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.765 0.317 . . . . 0.0 111.516 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.67 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -100.84 -101.69 0.25 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -90.6 47.64 1.45 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.14 -28.31 9.0 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.41 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.86 91.55 0.2 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.122 -178.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.469 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 84.5 mtt180 -85.54 173.31 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.099 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 161.79 -151.12 21.15 Favored Glycine 0 C--O 1.215 -1.052 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.543 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 11.3 p80 -130.4 169.3 15.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.474 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.66 116.04 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.547 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.733 ' HB2' HG23 ' A' ' 290' ' ' THR . 22.6 Cg_endo -62.72 162.48 24.83 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.106 1.87 . . . . 0.0 112.912 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.654 ' CD1' HG23 ' A' ' 292' ' ' VAL . 82.8 t80 -65.48 1.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.682 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 288' ' ' PRO . 71.7 p -51.2 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.536 ' O ' HG13 ' A' ' 292' ' ' VAL . 1.7 p80 -172.29 85.98 0.07 Allowed 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.391 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.654 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -174.27 148.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.575 ' HE ' HD13 ' A' ' 244' ' ' ILE . 24.3 mmt180 -130.15 81.96 2.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 36.9 mt -43.69 133.96 4.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.381 0.61 . . . . 0.0 111.066 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.0 mp -88.11 -169.95 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -100.55 14.97 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.582 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 239' ' ' PHE . 34.2 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.365 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -139.87 162.24 35.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.923 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 p90 175.03 144.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.88 167.19 16.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -119.72 126.23 50.57 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.073 0.464 . . . . 0.0 110.038 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.735 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -92.0 89.28 6.91 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.97 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -100.38 31.47 3.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.385 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 143' ' ' ASP . 50.4 m-85 -132.56 2.98 3.84 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.392 -0.193 . . . . 0.0 110.811 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.3 p30 52.7 137.63 0.0 OUTLIER 'General case' 0 C--O 1.208 -1.109 0 O-C-N 124.924 1.39 . . . . 0.0 110.11 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 6.3 t80 -122.76 -42.77 2.29 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.735 0.302 . . . . 0.0 110.636 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 42.77 59.14 2.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.43 -145.36 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.9 OUTLIER 168.39 82.89 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.931 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.506 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 5.2 m-20 174.94 179.06 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 110.349 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -87.94 -21.07 25.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.203 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -103.48 26.12 8.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.4 p30 -141.18 158.75 43.48 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 152' ' ' LEU . 10.5 tp -118.51 89.45 36.76 Favored Pre-proline 0 C--O 1.215 -0.748 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 139.93 52.2 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 CA-C-N 120.314 1.148 . . . . 0.0 112.542 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.735 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 16.0 p90 -158.79 161.72 36.98 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.576 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.519 ' HZ2' ' HB3' ' A' ' 155' ' ' LYS . 0.4 OUTLIER 176.84 125.68 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.507 0.504 . . . . 0.0 110.101 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 11.3 ptpt 136.0 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.521 1.138 . . . . 0.0 109.796 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.76 51.17 0.38 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -83.86 158.7 21.55 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.134 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.6 mm -109.14 112.88 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.381 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -112.94 126.0 55.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.821 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 162' ' ' ILE . 62.4 tttm -81.01 143.75 32.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 111.145 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.7 mp -94.98 156.28 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.588 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.518 HH21 ' CD ' ' A' ' 174' ' ' GLU . 21.5 ttm105 -135.8 -33.65 0.85 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.473 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.77 128.56 11.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.1 pttm -121.67 79.26 39.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.118 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.21 -42.2 69.35 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.181 1.921 . . . . 0.0 111.989 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -117.37 178.17 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.493 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.58 -29.73 13.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.006 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.528 ' NE2' ' OXT' ' A' ' 297' ' ' GLN . 33.9 mt-30 -80.8 -27.34 36.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.864 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.466 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 71.7 m95 -123.3 151.96 41.88 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.516 ' CD2' HG22 ' A' ' 185' ' ' VAL . 13.5 m0 -143.22 135.65 27.3 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 120.84 0.352 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.52 108.34 12.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.8 163.09 13.22 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.81 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 16.0 tt0 -122.77 128.36 50.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.09 177.76 0.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.68 0.752 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 98.1 mmm -74.82 -2.25 25.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.609 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -99.41 -20.67 16.35 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.464 0.649 . . . . 0.0 110.843 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.82 -28.52 6.39 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 179' ' ' LYS . 41.3 mttt -53.01 146.05 11.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.073 0.463 . . . . 0.0 110.532 -177.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 132.54 56.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.658 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.51 151.61 23.16 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.222 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 84.1 mmm -67.34 159.25 29.72 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.318 0.58 . . . . 0.0 110.387 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 6.7 pt -151.26 142.7 15.53 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.952 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.53 115.62 4.28 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.447 1.431 . . . . 0.0 110.015 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 36.3 t -50.24 -52.94 49.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.7 Cg_endo -51.58 -25.99 21.24 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 122.383 2.055 . . . . 0.0 113.291 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.6 m-85 -69.89 0.92 5.02 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.413 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.1 m -132.39 161.68 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -93.98 -62.42 1.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.729 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 17.3 tptm 132.81 -5.22 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.81 1.319 . . . . 0.0 109.757 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 190' ' ' LYS . 36.7 t 57.71 110.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 18.1 ttm180 69.94 51.22 0.4 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.394 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 69.8 Cg_endo -71.44 49.95 1.2 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 111.927 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m 69.38 -46.92 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 39.5 p -167.93 165.56 13.71 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 195' ' ' SER . . . 69.28 73.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.44 . . . . 0.0 111.256 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.4 p -161.46 7.86 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 199' ' ' SER . 14.5 p -62.63 -42.71 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.352 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.519 ' N ' HG13 ' A' ' 198' ' ' VAL . 26.8 p -151.3 148.67 28.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.481 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.6 t -162.34 170.47 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.737 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.733 ' C ' HD22 ' A' ' 201' ' ' LEU . 0.0 OUTLIER -170.27 166.13 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.6 p -142.94 155.1 44.64 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.42 88.83 0.3 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 167.8 133.75 1.6 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -97.17 176.16 6.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.339 . . . . 0.0 110.565 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.649 ' NE2' ' H ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -77.63 -172.99 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.489 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.461 ' OD1' ' CG2' ' A' ' 270' ' ' ILE . 99.4 m-20 -60.71 92.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.362 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.5 p -165.66 -13.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.563 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.0 t -105.6 118.16 35.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -139.11 75.35 34.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.161 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 -30.21 53.13 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.921 2.414 . . . . 0.0 111.92 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.608 ' H ' ' CD ' ' A' ' 213' ' ' PRO . 1.8 tm0? -173.15 -43.16 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.249 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.608 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 32.9 Cg_exo -60.9 145.62 98.78 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.345 2.03 . . . . 0.0 112.155 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.579 ' O ' ' ND2' ' A' ' 228' ' ' ASN . 2.0 pp -144.02 141.39 30.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -44.59 -52.33 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.6 57.91 4.78 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.3 -39.73 9.55 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.514 2.143 . . . . 0.0 112.342 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.8 OUTLIER -101.61 -45.97 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.269 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 32.3 Cg_exo -55.25 -63.06 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.281 1.987 . . . . 0.0 112.117 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.94 71.75 0.29 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.32 -90.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.2 1.933 . . . . 0.0 111.984 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -144.79 151.53 38.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.32 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.62 95.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -122.57 138.97 30.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.464 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.446 ' C ' HG22 ' A' ' 229' ' ' THR . 61.3 Cg_endo -71.93 12.5 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.041 1.828 . . . . 0.0 112.147 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.16 -73.63 0.59 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.936 0.398 . . . . 0.0 111.754 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 28.7 mm -56.19 -55.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.856 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 214' ' ' LEU . 31.4 m120 -136.89 84.2 2.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.446 HG22 ' C ' ' A' ' 225' ' ' PRO . 1.9 p -67.84 151.66 97.0 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.21 135.7 48.13 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.289 1.993 . . . . 0.0 112.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 231' ' ' LEU . 1.2 pt? -132.16 148.08 68.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.057 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 9.12 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.139 1.892 . . . . 0.0 111.712 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' LEU . 27.9 m120 51.75 56.79 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.901 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 236' ' ' ASN . 29.8 tp -58.89 -115.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.018 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.437 ' N ' ' HG ' ' A' ' 234' ' ' LEU . 67.8 mt-30 61.03 -62.69 0.08 Allowed 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 123.493 0.495 . . . . 0.0 110.783 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.568 ' N ' ' O ' ' A' ' 234' ' ' LEU . 36.7 p-10 -58.49 -40.2 82.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.331 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.579 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.23 -165.55 41.24 Favored Glycine 1 CA--C 1.436 -4.85 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.749 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.7 Cg_endo -45.05 100.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.536 3.994 0 N-CA-C 116.843 1.824 . . . . 0.0 116.843 1.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.579 ' CD1' ' HA2' ' A' ' 237' ' ' GLY . 8.4 m-30 -114.55 -130.66 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.437 ' CD1' ' OE1' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.29 127.6 18.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 109.227 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.788 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -104.51 -165.09 1.11 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.222 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -156.48 94.77 1.51 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.72 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.6 p -73.71 116.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.0 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.753 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.0 OUTLIER -110.21 18.03 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.993 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 244' ' ' ILE . 2.3 mm-40 -174.38 121.06 0.26 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.778 ' CD ' HD12 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -168.55 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.551 178.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.661 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -154.57 -134.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.634 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.421 ' O ' ' OD2' ' A' ' 253' ' ' ASP . 3.4 t -137.84 62.89 36.39 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.607 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.71 ' O ' ' O ' ' A' ' 250' ' ' ASN . 11.6 Cg_endo -98.62 31.04 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.959 1.773 . . . . 0.0 114.417 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 249' ' ' PRO . 13.5 p30 -24.93 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.463 1.102 . . . . 0.0 112.588 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.26 -22.32 29.15 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.442 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.405 ' C ' ' OD1' ' A' ' 250' ' ' ASN . 32.9 m-85 -111.34 47.71 0.99 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 249' ' ' PRO . 1.2 m-20 -151.42 15.98 0.7 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.661 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 28.1 mtmt 147.22 -65.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 41.7 m 166.77 -16.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.199 0.937 . . . . 0.0 110.428 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ASN . . . -82.02 170.24 15.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.294 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.005 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -87.26 151.18 23.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.68 0.392 . . . . 0.0 110.623 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.854 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -96.45 121.71 38.57 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.124 0.42 . . . . 0.0 111.118 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.854 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.5 mt -142.33 -171.78 3.47 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.646 0.736 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.453 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.1 tt0 -144.79 148.44 34.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.272 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.57 HG13 ' HA ' ' A' ' 244' ' ' ILE . 81.1 t -53.11 100.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.509 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.62 9.71 9.94 Favored Glycine 0 CA--C 1.51 -0.233 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 12.5 mm-40 -86.99 -36.23 18.38 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.066 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 136.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.116 0.96 . . . . 0.0 109.12 -178.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.066 ' N ' HD12 ' A' ' 264' ' ' LEU . 12.5 p -131.63 150.67 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -107.33 91.94 3.86 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.67 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.682 HG22 ' HA2' ' A' ' 278' ' ' GLY . 55.6 t -62.34 159.63 2.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.846 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.491 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.4 OUTLIER -157.76 -44.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.477 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.415 ' HE3' ' H ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -62.63 142.84 57.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.225 -177.151 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.461 ' CG2' ' OD1' ' A' ' 207' ' ' ASP . 74.0 mt -132.34 156.08 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.618 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 272' ' ' MET . 1.7 p30 172.32 -91.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.801 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.505 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 3.9 mtm -69.03 135.72 51.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.137 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.3 p -74.71 20.49 0.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -148.03 -50.46 0.02 OUTLIER Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.151 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.505 ' O ' ' HE3' ' A' ' 272' ' ' MET . 1.0 OUTLIER -105.33 98.34 8.06 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.572 ' HE1' ' HB3' ' A' ' 231' ' ' LEU . 1.6 m95 -101.49 173.74 6.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -115.83 127.25 54.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.023 0.439 . . . . 0.0 110.614 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' A' ' 267' ' ' VAL . . . -79.58 -164.37 28.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.256 -177.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 3.3 tt0 -172.7 112.26 0.25 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.848 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.731 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -107.96 -98.08 0.37 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -93.07 40.34 1.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.17 -21.46 42.1 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.628 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -68.63 75.26 0.28 Allowed 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 114.576 -0.812 . . . . 0.0 110.369 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.469 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 89.9 mtt180 -74.54 166.12 24.06 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.256 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.795 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 157.74 129.23 1.09 Allowed Glycine 0 C--O 1.198 -2.14 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.519 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -59.02 174.99 0.32 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 117.963 -3.081 . . . . 0.0 110.329 -175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.557 ' CZ ' ' NH1' ' A' ' 247' ' ' ARG . 0.1 OUTLIER -179.66 115.95 0.22 Allowed Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.114 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.534 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 85.0 Cg_exo -44.33 130.38 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.055 1.055 . . . . 0.0 112.783 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.631 ' C ' ' H ' ' A' ' 291' ' ' HIS . 0.0 OUTLIER -62.6 -3.3 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.903 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.4 p -52.02 4.47 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.73 ' O ' HG13 ' A' ' 292' ' ' VAL . 5.7 p80 -156.5 74.71 0.83 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 291' ' ' HIS . 1.3 m -166.58 150.96 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -108.82 -44.39 4.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.0 mt 74.31 118.41 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.503 1.144 . . . . 0.0 111.578 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 8.9 mp -88.46 -175.42 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.855 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.33 -52.35 23.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.441 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.528 ' OXT' ' NE2' ' A' ' 169' ' ' GLN . 55.5 tt0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.706 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.569 ' N ' ' HH ' ' A' ' 137' ' ' TYR . 15.8 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.947 ' O ' HG13 ' A' ' 138' ' ' VAL . 18.2 pt-20 -151.59 -31.43 0.16 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.066 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.569 ' HH ' ' N ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -42.66 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.593 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.947 HG13 ' O ' ' A' ' 136' ' ' GLU . 31.5 m 42.9 -179.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 124.06 0.85 . . . . 0.0 110.303 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -133.08 121.72 23.07 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.736 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -95.3 100.01 11.86 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.057 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.611 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -111.29 32.29 5.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.921 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 143' ' ' ASP . 43.7 m-85 -127.63 2.9 6.14 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.72 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.1 p30 58.88 138.03 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 124.464 1.102 . . . . 0.0 109.811 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 7.6 t80 -130.11 -49.78 1.11 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.04 0.382 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 40.13 65.78 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.77 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.43 -138.55 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.639 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 172.86 101.08 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.323 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 9.8 m-20 151.1 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.363 1.039 . . . . 0.0 110.697 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.42 -15.81 26.71 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -105.36 24.8 11.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.855 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.639 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.9 p-10 -137.48 152.64 49.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.553 HD11 ' CG ' ' A' ' 175' ' ' ASP . 11.3 tp -116.33 87.89 21.54 Favored Pre-proline 0 C--O 1.214 -0.792 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.542 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.98 122.76 9.65 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.347 1.364 . . . . 0.0 112.201 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.736 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.5 p90 -139.21 169.27 18.08 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -171.04 122.01 0.56 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.553 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.1 mtpp 98.64 74.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.675 1.234 . . . . 0.0 111.589 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 30.82 55.26 0.26 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.068 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 31.2 t0 -73.58 150.52 41.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.9 0.381 . . . . 0.0 110.708 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.444 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.6 mp -102.51 108.76 24.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 mt -121.71 106.22 11.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.235 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -61.31 133.51 55.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.802 0.689 . . . . 0.0 112.785 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -78.64 132.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.717 178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.63 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 12.8 tpt180 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.529 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -147.18 121.28 9.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.437 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 10.6 ptmt -112.7 75.2 1.8 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.817 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.84 -35.74 11.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.981 1.788 . . . . 0.0 112.122 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -103.66 168.7 8.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.149 0.5 . . . . 0.0 110.607 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.71 -38.38 11.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.37 -22.29 32.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.514 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 69.6 m95 -120.8 151.67 39.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.709 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.4 m0 -145.43 135.98 24.25 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.085 0.469 . . . . 0.0 110.738 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.12 107.97 13.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.34 164.95 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.978 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 14.4 tt0 -127.34 136.96 52.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.609 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.553 ' CG ' HD11 ' A' ' 152' ' ' LEU . 46.4 m-20 -71.68 -175.28 1.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.492 0.663 . . . . 0.0 110.461 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 87.2 mmm -76.28 -15.45 60.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.955 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.52 -22.27 22.51 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.275 0.56 . . . . 0.0 111.011 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.67 -19.98 9.55 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -52.73 143.61 15.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.63 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -115.85 124.76 51.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.503 0.668 . . . . 0.0 111.225 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.18 145.54 14.65 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.705 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mtp -64.59 160.19 20.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.566 0.698 . . . . 0.0 110.458 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 5.1 pt -151.75 144.32 16.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.881 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.71 110.01 2.98 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.025 1.15 . . . . 0.0 110.657 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.709 HG22 ' CE3' ' A' ' 171' ' ' TRP . 55.6 t -44.22 -52.69 15.67 Favored Pre-proline 0 C--O 1.218 -0.604 0 O-C-N 121.882 -0.511 . . . . 0.0 111.821 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.9 Cg_endo -48.39 -24.54 6.27 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.887 1.724 . . . . 0.0 113.509 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.29 5.52 4.45 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.311 -0.555 . . . . 0.0 112.004 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -133.64 162.79 38.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.419 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.611 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -121.74 -67.18 0.98 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.591 ' O ' HG12 ' A' ' 138' ' ' VAL . 21.9 tptm -37.81 93.2 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.507 ' HB2' HG12 ' A' ' 138' ' ' VAL . 0.1 OUTLIER 160.56 105.26 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 40.87 59.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' SER . 25.9 Cg_endo -60.54 -32.38 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.504 2.136 . . . . 0.0 111.968 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.0 t 56.38 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.667 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 193' ' ' PRO . 84.1 p -81.83 -136.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.32 142.79 24.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 66.4 m -123.29 113.0 18.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.419 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 199' ' ' SER . 3.0 m -139.26 -109.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.242 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.458 ' H ' HG23 ' A' ' 198' ' ' VAL . 1.4 m 57.85 -170.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 58.4 m -142.97 128.62 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.919 ' H ' HD23 ' A' ' 201' ' ' LEU . 1.4 pt? -131.44 142.57 50.03 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 54.0 m -99.21 140.77 32.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.758 0.313 . . . . 0.0 110.182 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -69.42 -124.07 0.04 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.35 129.83 1.06 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -88.79 118.15 28.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 275' ' ' GLN . 25.9 pt20 -56.62 159.6 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.519 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 208' ' ' SER . 38.8 t70 -154.08 168.69 25.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.498 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 207' ' ' ASP . 9.1 t 59.33 135.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.564 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.8 t -161.43 -6.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.535 ' O ' ' ND1' ' A' ' 210' ' ' HIS . 17.7 t-80 -147.22 52.98 1.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.521 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 40.2 Cg_endo -66.55 -44.78 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.7 2.267 . . . . 0.0 111.847 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.521 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 12.0 pt20 -175.04 49.02 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.462 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 33.0 Cg_endo -63.24 144.13 91.04 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.593 2.196 . . . . 0.0 111.865 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 214' ' ' LEU . 3.8 mm? 43.26 -166.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.91 -132.89 0.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -63.95 165.85 29.22 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.55 -21.26 30.08 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.941 2.427 . . . . 0.0 111.882 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.446 ' CB ' ' CD ' ' A' ' 219' ' ' PRO . 0.4 OUTLIER -50.85 -63.79 1.7 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.164 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 218' ' ' GLU . 33.6 Cg_endo -61.52 143.92 97.51 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.317 2.011 . . . . 0.0 112.039 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -179.75 172.39 44.08 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.68 -80.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.032 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -100.28 143.14 30.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.08 98.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -137.98 152.9 72.98 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.636 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.73 -9.73 22.09 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.519 2.146 . . . . 0.0 111.466 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.8 m -146.03 160.79 41.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 227' ' ' ILE . 1.4 mp -87.15 90.66 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 227' ' ' ILE . 12.8 m120 34.72 69.2 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.44 ' H ' HG23 ' A' ' 229' ' ' THR . 0.2 OUTLIER -57.78 175.09 0.29 Allowed Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 -177.474 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.8 163.75 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.902 1.734 . . . . 0.0 111.51 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.761 ' C ' HD22 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -71.77 158.97 86.78 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.369 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 233' ' ' ASN . 72.9 Cg_endo -85.03 85.12 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.92 1.747 . . . . 0.0 112.319 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 234' ' ' LEU . 9.0 t30 45.98 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.863 0.301 . . . . 0.0 110.68 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.702 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 15.3 tp -36.28 -98.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 110.38 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 297' ' ' GLN . 65.1 mm-40 55.46 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.791 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 234' ' ' LEU . 19.0 m120 -76.21 32.73 0.12 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.814 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 235' ' ' GLN . . . -168.05 160.74 34.4 Favored Glycine 1 CA--C 1.448 -4.15 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.405 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.418 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 9.0 Cg_exo -72.48 131.94 24.1 Favored 'Cis proline' 0 C--N 1.285 -2.766 0 O-C-N 122.257 0.609 . . . . 0.0 110.931 -6.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 37.4 m-85 -159.74 -123.17 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -145.2 121.74 11.07 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.337 0.517 . . . . 0.0 111.103 -178.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.857 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -101.55 -158.49 0.67 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.592 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -159.47 94.95 1.2 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.74 HG12 ' H ' ' A' ' 264' ' ' LEU . 9.8 p -73.61 110.66 7.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.431 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.502 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -108.72 22.69 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.731 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 177.81 110.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.7 ttmt -153.62 -145.94 0.18 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.404 0.621 . . . . 0.0 110.284 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.474 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.0 ptt85 -155.41 -144.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.621 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 248' ' ' VAL . 8.7 p -131.96 66.38 77.55 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.485 0.66 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.527 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 60.1 Cg_endo -83.38 157.72 14.68 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.81 2.34 . . . . 0.0 113.574 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -90.9 -172.44 3.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.286 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -103.68 -3.63 24.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.661 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 254' ' ' LYS . 25.5 m-85 -89.05 -27.67 20.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 32.9 t70 -70.03 43.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.198 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 255' ' ' THR . 38.5 mtmt 99.04 -45.55 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.424 1.09 . . . . 0.0 108.945 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.9 OUTLIER 149.18 5.99 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.907 0 O-C-N 125.132 1.52 . . . . 0.0 110.364 179.219 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 249' ' ' PRO . . . -35.71 115.87 0.34 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.206 0.527 . . . . 0.0 111.774 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -68.68 117.64 10.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.858 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -71.23 125.29 26.55 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.323 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 258' ' ' ALA . 2.6 mt -142.14 -175.67 4.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.712 0.768 . . . . 0.0 111.238 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.41 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 10.2 tt0 -145.61 138.94 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.33 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.502 HG13 ' HA ' ' A' ' 244' ' ' ILE . 53.1 t -44.01 105.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.147 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.54 7.13 24.57 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.362 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' LEU . 43.8 mm-40 -83.7 -37.34 22.85 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 1.073 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.5 135.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 1.073 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.7 p -131.14 152.51 37.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.302 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 279' ' ' GLU . 0.9 OUTLIER -103.86 108.67 20.09 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.377 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' A' ' 276' ' ' TRP . 97.9 t -72.43 157.05 6.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.501 HG22 ' C ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER 177.83 43.82 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.703 ' C ' HD12 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -157.51 98.74 1.7 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 120.827 -1.171 . . . . 0.0 109.15 178.119 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.703 HD12 ' C ' ' A' ' 269' ' ' LYS . 1.6 mp -113.33 133.31 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.38 0.61 . . . . 0.0 111.233 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.627 ' ND2' ' OE2' ' A' ' 277' ' ' GLU . 0.5 OUTLIER -112.81 -29.62 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.98 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.704 ' SD ' ' N ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -134.54 -164.4 1.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.536 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -109.66 19.33 19.31 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.181 -0.325 . . . . 0.0 110.705 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.502 ' N ' ' SD ' ' A' ' 272' ' ' MET . . . -130.81 -100.3 0.85 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.704 ' N ' ' SD ' ' A' ' 272' ' ' MET . 50.6 mm-40 -76.24 105.29 7.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.987 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.802 ' CE3' HG11 ' A' ' 267' ' ' VAL . 0.4 OUTLIER -98.05 178.45 5.1 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.623 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.627 ' OE2' ' ND2' ' A' ' 271' ' ' ASN . 24.8 mp0 -95.39 -152.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.751 -178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 277' ' ' GLU . . . -161.32 -177.88 34.79 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 266' ' ' LYS . 2.4 tm-20 -169.75 117.06 0.58 Allowed 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 117.226 0.513 . . . . 0.0 110.768 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -107.08 -56.56 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -136.92 38.22 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 284' ' ' ARG . . . 93.28 -21.31 41.1 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.942 ' O ' ' O ' ' A' ' 284' ' ' ARG . 0.0 OUTLIER -57.54 -6.73 0.51 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.386 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.942 ' O ' ' O ' ' A' ' 283' ' ' LYS . 13.9 mtt85 15.86 -177.21 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 O-C-N 126.023 2.077 . . . . 0.0 113.104 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 150.02 -145.38 13.42 Favored Glycine 0 C--N 1.287 -2.182 0 O-C-N 120.652 -1.28 . . . . 0.0 110.549 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.2 p80 -145.37 177.86 8.52 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 114.351 -0.924 . . . . 0.0 109.206 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.619 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.4 m-85 159.06 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 O-C-N 123.877 0.736 . . . . 0.0 109.143 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.0 Cg_exo -51.54 153.96 9.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.93 1.753 . . . . 0.0 113.214 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 46.9 t80 -65.13 2.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 288' ' ' PRO . 32.3 p -51.77 -38.31 54.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.51 72.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -163.58 144.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.419 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -123.55 75.5 1.34 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.065 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 8.3 mt -43.61 125.95 4.27 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.575 0.702 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.9 mp -71.15 -173.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.015 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -83.18 39.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.843 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.502 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 82.2 mt-30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.195 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -157.73 -173.54 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.027 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 1.034 ' O ' HG22 ' A' ' 138' ' ' VAL . 5.8 p90 -132.7 -73.09 0.51 Allowed 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.828 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 137' ' ' TYR . 2.8 m 93.78 152.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 125.686 1.866 . . . . 0.0 111.984 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.416 ' NH1' HD23 ' A' ' 141' ' ' LEU . 15.9 ttp85 -120.81 133.21 55.32 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.331 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . . . -94.08 93.71 7.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.007 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.65 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.35 20.03 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.034 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.454 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -115.93 -9.36 11.8 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.481 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 72.3 136.32 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.048 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.1 t80 -128.83 -43.22 1.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.854 0.359 . . . . 0.0 110.125 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 146' ' ' GLY . 21.9 t-20 41.62 62.49 1.54 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 145' ' ' ASN . . . -62.57 -122.43 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 1.0 OUTLIER 169.56 -65.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.879 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.525 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 18.2 m-20 -53.81 142.65 23.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.783 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 31.2 p-10 -61.47 -1.2 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 148' ' ' ASP . 47.5 mt-10 -105.68 13.76 29.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.269 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 20.5 p30 -130.78 163.26 27.71 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.645 HD13 ' N ' ' A' ' 181' ' ' GLY . 3.8 tp -104.35 91.71 4.17 Favored Pre-proline 0 C--O 1.211 -0.966 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.303 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.467 ' O ' ' OD2' ' A' ' 175' ' ' ASP . 72.7 Cg_endo -70.49 139.13 37.03 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 CA-C-N 120.825 1.33 . . . . 0.0 112.804 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 160' ' ' LEU . 12.5 p90 -167.42 157.05 10.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -174.35 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.349 179.06 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -61.02 -3.28 0.75 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.265 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 155' ' ' LYS . . . 92.85 56.94 1.45 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.471 ' C ' HD12 ' A' ' 159' ' ' ILE . 27.0 t0 -81.74 157.85 24.39 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.502 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.6 mp -98.63 98.12 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.685 HD11 ' CD2' ' A' ' 154' ' ' PHE . 96.3 mt -91.83 94.13 9.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.128 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 52.8 tttp -68.87 132.44 46.74 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.518 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.22 142.81 15.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.27 -48.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.64 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -153.24 64.05 0.76 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.641 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.403 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 11.8 pttp -49.54 106.48 0.63 Allowed Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 119.402 -0.332 . . . . 0.0 110.787 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.79 -48.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.443 1.428 . . . . 0.0 112.438 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.02 172.75 6.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.775 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 168' ' ' GLU . 5.0 pt-20 -85.51 -34.47 21.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.4 -15.57 45.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.468 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 48.1 m95 -131.46 151.53 51.48 Favored 'General case' 0 C--O 1.228 -0.074 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.589 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.9 m0 -139.78 134.44 31.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.907 0.86 . . . . 0.0 112.496 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -91.55 101.03 13.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.27 -179.26 3.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.51 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.88 112.72 13.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.642 ' H ' HD11 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -63.81 140.58 58.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.951 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 95.2 mtp -47.85 -8.14 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.426 0.454 . . . . 0.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 175' ' ' ASP . 96.6 m-20 -72.98 -21.78 60.79 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.667 0.746 . . . . 0.0 110.048 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.49 44.06 3.54 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.631 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.478 ' O ' HD11 ' A' ' 152' ' ' LEU . 11.4 ptpt -142.46 143.92 32.81 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.161 -0.519 . . . . 0.0 109.76 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.05 127.95 53.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.534 0.683 . . . . 0.0 110.964 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.645 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -156.07 153.1 24.48 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.361 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.54 152.79 44.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.468 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 1.3 pt -143.4 146.58 36.53 Favored Pre-proline 0 N--CA 1.455 -0.191 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.46 140.46 63.41 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.481 -1.392 . . . . 0.0 108.481 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 38.5 t -79.93 -37.9 1.14 Allowed Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.661 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 36.4 Cg_endo -68.88 -21.0 38.43 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.271 1.981 . . . . 0.0 112.914 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.1 m-85 -77.88 4.51 11.77 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.976 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 185' ' ' VAL . 26.5 m -136.01 161.17 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.424 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.644 ' CG ' HD21 ' A' ' 141' ' ' LEU . 1.1 pp20? -146.35 153.58 40.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 13.4 tptm 103.76 85.52 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.276 1.03 . . . . 0.0 111.808 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.664 ' HB3' HG12 ' A' ' 138' ' ' VAL . 0.8 OUTLIER -171.23 -11.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.31 -179.395 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 4.2 mtt-85 175.56 -49.14 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 73.2 Cg_endo -81.55 -175.48 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.032 1.821 . . . . 0.0 111.576 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 77.4 p -147.07 -151.24 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.107 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 52.0 p -145.99 -55.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -39.45 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.726 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 68.0 m -64.49 148.95 49.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.274 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 198' ' ' VAL . 7.5 p -59.82 100.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.725 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -166.55 136.05 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 201' ' ' LEU . 2.8 m 55.39 -133.0 1.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.567 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 200' ' ' THR . 63.2 mt -60.71 130.54 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.104 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 42.1 m -158.69 97.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.567 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 134.08 86.6 0.27 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.15 45.14 0.98 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -78.77 127.81 32.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 110.439 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -145.06 158.09 43.92 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.449 ' O ' ' OG ' ' A' ' 208' ' ' SER . 63.0 t0 -62.64 -55.02 30.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 207' ' ' ASP . 1.6 m -170.54 -54.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.9 t -94.27 122.48 36.85 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.574 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.6 ' N ' ' CD ' ' A' ' 211' ' ' PRO . 0.1 OUTLIER -76.36 -42.37 3.22 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.397 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 35.7 Cg_exo -60.09 144.54 99.47 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.757 2.305 . . . . 0.0 112.318 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.631 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 2.6 tp-100 -69.18 -38.91 11.65 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.499 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 37.5 Cg_exo -60.16 140.4 92.09 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.16 1.906 . . . . 0.0 111.826 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.33 -63.57 1.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -101.74 -66.36 0.78 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 174.78 60.5 0.05 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.9 -176.46 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.705 2.27 . . . . 0.0 111.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 1.2 tt0 -177.18 -43.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.151 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 28.0 Cg_exo -61.36 9.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.511 2.141 . . . . 0.0 112.344 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 218' ' ' GLU . . . 105.86 164.74 23.24 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.33 -177.74 3.49 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.601 2.201 . . . . 0.0 111.791 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 93.0 t80 -72.58 162.38 29.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.476 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -44.46 114.66 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 226' ' ' SER . 14.9 mt-30 -143.33 164.29 32.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.524 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.489 ' O ' ' OG ' ' A' ' 226' ' ' SER . 30.8 Cg_exo -61.33 57.1 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.444 2.096 . . . . 0.0 112.168 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 228' ' ' ASN . 1.5 m 165.1 -4.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 227' ' ' ILE . 1.5 mp 61.34 -24.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.816 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.621 ' H ' ' C ' ' A' ' 226' ' ' SER . 26.7 p30 -172.92 174.64 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 274' ' ' GLY . 41.5 p -129.49 83.58 64.49 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -85.34 125.59 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.365 2.71 . . . . 0.0 112.924 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.76 ' H ' HD13 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -134.63 162.77 55.71 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.719 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 233' ' ' ASN . 66.6 Cg_exo -51.77 -71.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 121.511 1.474 . . . . 0.0 113.163 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.528 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 5.3 t-20 153.38 174.52 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.736 ' O ' ' N ' ' A' ' 236' ' ' ASN . 29.2 tp -22.42 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.727 0.642 . . . . 0.0 110.006 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLN . . . . . 0.593 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 18.7 mm-40 22.3 -73.34 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 O-C-N 125.184 1.552 . . . . 0.0 111.254 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 234' ' ' LEU . 31.3 m120 -77.35 39.88 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.191 176.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 234' ' ' LEU . . . -165.11 134.41 3.31 Favored Glycine 1 CA--C 1.445 -4.322 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.061 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.411 ' HD2' ' CZ2' ' A' ' 170' ' ' TRP . 4.0 Cg_exo -71.56 97.49 0.15 OUTLIER 'Cis proline' 0 N--CA 1.529 3.615 0 CA-C-N 118.171 0.985 . . . . 0.0 112.134 -6.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 235' ' ' GLN . 4.3 m-85 -117.09 -134.34 0.34 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -146.19 137.54 24.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 118.986 0.812 . . . . 0.0 109.768 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.592 ' H ' HD13 ' A' ' 264' ' ' LEU . . . -122.93 140.26 53.18 Favored 'General case' 0 C--O 1.195 -1.768 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.147 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -104.17 111.04 23.48 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.366 0.603 . . . . 0.0 110.704 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.1 p -79.63 127.46 39.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.141 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.44 15.74 7.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -174.08 112.21 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.633 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.897 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.5 ttmt -165.13 -156.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.266 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.92 -138.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.134 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.697 ' O ' HG12 ' A' ' 248' ' ' VAL . 73.4 t -132.83 60.89 53.08 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 120.677 0.275 . . . . 0.0 111.194 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 258' ' ' ALA . 18.0 Cg_endo -96.72 -170.82 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.479 2.119 . . . . 0.0 111.394 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.1 p-10 -157.9 153.34 26.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.142 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 256' ' ' ALA . . . -41.16 -11.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 254' ' ' LYS . 33.4 m-85 -73.83 -53.12 10.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 250' ' ' ASN . 35.9 t70 -53.58 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 125.813 1.946 . . . . 0.0 111.702 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' A' ' 252' ' ' TYR . 29.7 mtmt 82.33 -43.11 0.14 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.269 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.558 ' O ' ' ND1' ' A' ' 286' ' ' HIS . 0.1 OUTLIER 158.37 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.405 0.621 . . . . 0.0 110.029 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -109.95 165.01 12.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.864 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.834 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -114.77 151.78 33.2 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -178.232 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.963 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -88.64 113.66 24.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 258' ' ' ALA . 0.4 OUTLIER -143.28 174.57 10.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.798 177.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -142.95 148.84 37.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.386 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 245' ' ' GLN . 73.3 t -52.65 99.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.957 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 127.79 -2.94 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.39 -163.25 1.03 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.072 0.463 . . . . 0.0 110.621 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.96 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER -159.11 149.37 19.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.755 0.788 . . . . 0.0 111.117 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.96 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.0 p -133.48 141.48 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -74.26 176.01 7.06 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.915 ' O ' ' N ' ' A' ' 269' ' ' LYS . 18.4 t -119.29 -36.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.144 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 269' ' ' LYS . 0.0 OUTLIER 20.64 -55.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.904 1.378 . . . . 0.0 114.178 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.915 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -84.7 116.11 23.05 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.388 0.613 . . . . 0.0 111.853 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.6 OUTLIER -136.92 154.1 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.501 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 272' ' ' MET . 43.9 p30 -174.69 158.37 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.99 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.534 ' O ' ' O ' ' A' ' 271' ' ' ASN . 3.9 mtm 52.52 162.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.462 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 p -88.98 27.94 1.26 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 229' ' ' THR . . . -149.07 -85.5 0.06 OUTLIER Glycine 0 C--O 1.209 -1.464 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.325 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.484 ' HA ' ' OG1' ' A' ' 229' ' ' THR . 2.9 mp0 -61.99 168.78 3.0 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.58 ' CD1' HD12 ' A' ' 231' ' ' LEU . 16.2 p-90 178.1 -174.17 0.15 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.28 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -144.64 147.5 33.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.494 -1.685 . . . . 0.0 113.598 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -131.16 131.92 6.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.037 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 281' ' ' ASN . 6.2 tm-20 -103.45 125.14 49.86 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.541 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' CYS . . . . . 0.623 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -125.88 84.37 2.27 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.099 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE2' ' A' ' 279' ' ' GLU . 2.4 m120 76.36 21.49 1.39 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.086 -1.009 . . . . 0.0 110.654 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 104.21 -32.83 7.11 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.475 -0.329 . . . . 0.0 112.65 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.623 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.8 OUTLIER -63.06 60.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.954 0.407 . . . . 0.0 110.754 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 282' ' ' GLY . 52.8 mtt180 -60.86 162.25 7.08 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.527 0.68 . . . . 0.0 109.939 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.98 -170.68 43.46 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.634 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.7 p-80 -140.39 95.3 2.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.866 1.333 . . . . 0.0 112.654 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.533 ' HE2' ' HB1' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -101.23 129.38 27.15 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 113.714 -1.585 . . . . 0.0 109.646 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.48 ' CA ' HG22 ' A' ' 229' ' ' THR . 22.5 Cg_exo -50.55 153.91 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.367 1.378 . . . . 0.0 112.528 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.536 ' C ' ' H ' ' A' ' 291' ' ' HIS . 90.3 t80 -72.01 -3.55 23.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.431 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 67.8 p -55.63 10.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.676 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.536 ' H ' ' C ' ' A' ' 289' ' ' PHE . 1.2 p80 -176.19 68.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.625 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.534 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -155.07 153.73 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 294' ' ' LEU . 27.8 mmm-85 -130.98 66.32 1.54 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.401 0.143 . . . . 0.0 111.357 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 241' ' ' ALA . 11.3 mt -31.32 129.05 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.107 0.956 . . . . 0.0 112.499 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.17 -106.53 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.23 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 34.5 t0 -173.82 44.45 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 296' ' ' ASP . 7.6 tt0 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.136 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.3 p90 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.088 0.47 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.62 166.06 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.428 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -115.49 131.54 56.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.784 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -102.23 92.68 4.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.724 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.838 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -103.27 22.63 13.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.942 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 143' ' ' ASP . 65.3 m-85 -119.45 2.46 11.26 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.6 p30 55.39 138.76 0.0 OUTLIER 'General case' 0 C--O 1.21 -0.992 0 O-C-N 124.365 1.041 . . . . 0.0 110.422 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 6.7 t80 -127.99 -41.54 1.62 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.844 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 144' ' ' PHE . 39.3 t-20 36.21 59.22 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.478 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.02 -141.28 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.571 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.2 OUTLIER 166.8 88.28 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.413 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 3.6 m-20 171.97 -178.42 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.211 0.529 . . . . 0.0 110.33 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 149' ' ' ASP . 60.9 t0 -91.0 -20.4 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.388 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.26 25.81 9.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.693 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.7 p-10 -141.33 156.63 45.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.447 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 11.4 tp -120.17 82.31 30.06 Favored Pre-proline 0 C--O 1.216 -0.695 0 CA-C-O 120.755 0.312 . . . . 0.0 110.999 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.42 136.79 74.09 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 121.456 1.437 . . . . 0.0 112.108 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.784 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 10.6 p90 -152.09 165.14 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.524 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -175.86 102.93 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.795 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.577 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.5 tppp? 127.61 77.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.652 1.22 . . . . 0.0 110.959 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.71 49.73 0.02 OUTLIER Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 156' ' ' LYS . 28.7 t0 -72.91 144.87 47.19 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.922 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 159' ' ' ILE . 10.7 tp -104.17 109.54 27.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.37 122.79 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.675 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -77.91 141.84 38.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.91 139.13 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.7 tpt85 -117.9 -43.36 2.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.276 0.56 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.32 129.08 11.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.693 ' NZ ' ' HE1' ' A' ' 171' ' ' TRP . 0.1 OUTLIER -119.48 77.53 19.48 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.145 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.03 -44.36 50.47 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.295 1.996 . . . . 0.0 111.732 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.49 177.02 4.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.418 ' O ' HG21 ' A' ' 185' ' ' VAL . 25.2 mm-40 -96.57 -32.05 12.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.511 ' NE2' ' CZ ' ' A' ' 240' ' ' TYR . 85.2 mt-30 -77.17 -28.12 53.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.468 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.512 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 66.0 m95 -123.84 153.59 40.83 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.693 ' HE1' ' NZ ' ' A' ' 165' ' ' LYS . 17.4 m0 -143.65 136.7 27.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.4 108.03 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.44 168.32 9.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.957 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -126.63 138.36 53.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.894 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -68.09 174.56 3.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.302 0.572 . . . . 0.0 110.698 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ptm -79.88 -2.57 44.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.349 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -101.92 -28.25 12.51 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.6 48.69 0.45 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.57 132.56 49.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.671 -0.764 . . . . 0.0 109.568 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 125.86 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.322 0.582 . . . . 0.0 111.951 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.24 153.34 24.6 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.565 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 32.3 mtp -66.51 160.8 24.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.432 0.634 . . . . 0.0 110.817 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 8.3 pt -152.05 143.06 15.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.794 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -69.4 114.69 3.73 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.639 1.559 . . . . 0.0 110.013 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.645 HG22 ' CE3' ' A' ' 171' ' ' TRP . 27.0 t -49.98 -52.81 49.2 Favored Pre-proline 0 C--O 1.216 -0.673 0 O-C-N 121.927 -0.483 . . . . 0.0 111.69 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.6 Cg_endo -49.5 -24.71 9.48 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.147 1.898 . . . . 0.0 113.367 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.9 m-85 -74.54 3.72 7.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -134.86 162.29 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.729 ' HG3' HD11 ' A' ' 141' ' ' LEU . 39.3 mt-10 -81.28 -59.37 2.67 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.276 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 18.0 tptm . . . . . 0 C--N 1.345 0.393 0 O-C-N 124.515 1.134 . . . . 0.0 109.891 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.035 0.445 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -62.22 -165.29 0.44 Allowed Glycine 1 CA--C 1.447 -4.171 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.373 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.417 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.0 Cg_endo -46.78 98.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.767 0 N-CA-C 116.141 1.554 . . . . 0.0 116.141 0.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 10.3 m-30 -116.51 -132.09 0.32 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.511 ' CZ ' ' NE2' ' A' ' 169' ' ' GLN . 2.0 m-30 -136.34 115.88 12.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.67 0.748 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.524 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -106.85 140.81 39.09 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.943 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -103.91 97.71 7.66 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.8 p -63.74 127.21 23.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.142 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.636 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.3 pt -124.48 22.91 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.99 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.283 0.564 . . . . 0.0 110.159 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.828 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.7 ttmt -146.76 -146.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.31 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.444 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 0.6 OUTLIER -155.97 -145.53 0.16 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.626 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 248' ' ' VAL . 97.0 t -132.91 74.13 74.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.463 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.499 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 18.9 Cg_endo -91.65 169.93 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.036 2.491 . . . . 0.0 111.323 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.7 OUTLIER -127.12 127.34 44.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.792 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.07 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.856 0.722 . . . . 0.0 112.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.758 ' N ' ' O ' ' A' ' 250' ' ' ASN . 50.9 m-85 -91.76 -53.04 4.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 250' ' ' ASN . 42.1 t0 -41.24 -62.02 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.119 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.557 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.0 mttt -151.75 25.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.791 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.9 m 73.83 -18.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.589 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -43.95 108.69 0.12 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.633 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.969 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -47.48 159.85 0.13 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.826 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.21 119.01 38.25 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.091 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.828 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.2 mt -141.67 -175.17 4.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.222 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.6 tt0 -144.94 152.08 39.64 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.37 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.0 t -59.75 115.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.84 6.67 24.49 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 8.1 mm-40 -97.53 -139.76 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.032 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 175.37 139.99 0.05 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.404 0.621 . . . . 0.0 109.366 179.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.032 ' N ' HD12 ' A' ' 264' ' ' LEU . 12.5 p -128.1 152.77 36.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -103.83 88.15 2.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.541 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.58 124.36 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.153 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.401 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -116.57 -53.56 2.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.232 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -72.2 127.25 31.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.15 -178.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.45 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 0.8 OUTLIER -149.19 103.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.548 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.721 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -97.73 -88.53 0.3 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.492 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.721 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 38.1 mtm -67.07 178.73 1.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.4 p -98.95 16.63 21.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -130.54 -87.32 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.889 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -91.96 105.3 17.59 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.015 0.436 . . . . 0.0 110.935 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.543 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 4.6 p-90 -120.33 -164.95 1.13 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.0 mt-10 -123.99 163.21 21.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.861 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.74 -158.21 7.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.909 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -170.32 131.19 0.95 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -112.82 -92.86 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 283' ' ' LYS . 27.7 t-20 -101.4 54.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.95 3.81 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 281' ' ' ASN . 0.0 OUTLIER -61.41 90.4 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.774 -0.713 . . . . 0.0 110.144 -178.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 255' ' ' THR . 42.3 mtt85 -88.05 164.29 15.83 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 171.46 -157.46 27.95 Favored Glycine 0 C--O 1.213 -1.202 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.591 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -123.89 174.73 7.36 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.2 m-85 160.28 135.02 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.107 0 O-C-N 123.768 0.667 . . . . 0.0 111.731 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.53 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 23.7 Cg_exo -64.07 142.64 81.79 Favored 'Trans proline' 0 N--CA 1.507 2.297 0 C-N-CA 122.351 2.034 . . . . 0.0 112.25 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.819 ' CD1' HG21 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -76.23 2.63 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.277 179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 66.2 p -68.68 2.78 2.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.955 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 7.6 p80 -137.31 39.84 2.47 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.819 HG21 ' CD1' ' A' ' 289' ' ' PHE . 11.9 m -135.61 161.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 121.992 -0.442 . . . . 0.0 109.977 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.636 ' HE ' HD13 ' A' ' 244' ' ' ILE . 29.2 mtt180 -132.63 77.81 1.77 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.554 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 293' ' ' ARG . 84.3 mt -32.77 135.52 0.09 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.845 0.831 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.3 mp -84.34 -167.31 1.72 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.028 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -93.79 13.25 23.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.642 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 63.0 tt0 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.304 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.77 0.319 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 188' ' ' VAL . 6.3 m -140.67 172.17 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.421 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -131.26 136.37 48.13 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.317 0.58 . . . . 0.0 111.017 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.53 172.22 0.71 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.475 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.596 HD21 ' OE2' ' A' ' 189' ' ' GLU . 78.8 mt -140.35 -45.17 0.41 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.627 ' CE2' ' NH2' ' A' ' 284' ' ' ARG . 95.1 m-85 -113.49 9.59 18.07 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.825 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.534 ' CG ' ' HZ1' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 67.11 136.08 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.735 0.647 . . . . 0.0 109.337 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 9.1 t80 -112.64 -54.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.372 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.3 t30 49.99 55.14 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.523 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.491 ' C ' HD22 ' A' ' 147' ' ' ASN . . . -65.94 -124.95 0.01 OUTLIER Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.628 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 176.66 -90.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 81.0 m-20 -22.94 139.24 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -57.08 -7.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.528 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 148' ' ' ASP . 6.5 pt-20 -97.88 7.22 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.628 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 12.9 p30 -133.29 157.61 45.04 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 152' ' ' LEU . 9.2 tp -111.16 93.64 18.78 Favored Pre-proline 0 C--O 1.214 -0.814 0 CA-C-N 118.506 0.594 . . . . 0.0 111.095 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.404 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 95.5 Cg_endo -69.53 141.43 46.13 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 CA-C-N 120.567 1.238 . . . . 0.0 114.006 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 160' ' ' LEU . 20.3 p90 -159.13 159.72 34.78 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.67 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER -126.97 96.76 4.72 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.839 ' O ' ' N ' ' A' ' 158' ' ' ASP . 59.0 pttt 27.39 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.611 1.194 . . . . 0.0 110.739 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 30.9 13.74 0.0 OUTLIER Glycine 0 CA--C 1.541 1.69 0 N-CA-C 113.948 0.339 . . . . 0.0 113.948 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.839 ' N ' ' O ' ' A' ' 156' ' ' LYS . 17.3 t0 -85.36 155.88 21.12 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 117.08 0.44 . . . . 0.0 110.324 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.3 mm -125.58 106.2 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.689 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.435 HD11 ' CD2' ' A' ' 154' ' ' PHE . 23.6 mt -121.63 133.71 54.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -97.84 139.73 33.27 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -83.48 159.26 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.03 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -142.2 -43.73 0.33 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.283 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -136.52 113.58 10.54 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.54 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.428 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 14.3 pttm -112.71 74.07 1.6 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.77 -28.74 51.29 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.621 1.548 . . . . 0.0 111.881 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.9 162.69 18.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.667 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.85 -35.0 18.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.508 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 79.0 mt-30 -80.7 -22.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -124.75 153.87 41.76 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.54 ' CD2' HG22 ' A' ' 185' ' ' VAL . 11.2 m0 -145.83 138.16 25.51 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -86.06 106.89 17.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.08 6.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.761 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 30.3 tt0 -126.38 138.32 53.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.969 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.87 173.41 7.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.578 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.9 tpt -77.53 -0.94 28.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.21 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.456 ' HB3' ' NZ ' ' A' ' 179' ' ' LYS . 79.9 m-20 -102.66 -29.67 11.39 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.536 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.96 47.92 0.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 177' ' ' ASP . 9.8 mttp -128.66 135.88 49.88 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 114.105 -1.048 . . . . 0.0 108.982 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.35 123.34 50.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.412 0.625 . . . . 0.0 111.519 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -151.6 149.03 20.71 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.021 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 151.27 46.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 111.174 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.05 145.77 37.42 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -74.44 112.9 3.66 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.42 1.413 . . . . 0.0 109.438 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.54 HG22 ' CD2' ' A' ' 171' ' ' TRP . 51.7 t -48.62 -51.56 51.73 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -45.74 -31.38 7.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.077 1.852 . . . . 0.0 113.096 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.479 ' OH ' ' O ' ' A' ' 268' ' ' THR . 9.6 m-85 -69.4 -6.66 31.51 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.089 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 138' ' ' VAL . 1.2 m -129.93 163.66 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.596 ' OE2' HD21 ' A' ' 141' ' ' LEU . 1.1 pt-20 -117.4 -51.73 2.5 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 C-N-CA 125.224 1.41 . . . . 0.0 110.003 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.37 0.129 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 136.72 -165.84 24.97 Favored Glycine 1 CA--C 1.448 -4.155 0 CA-C-O 121.72 0.622 . . . . 0.0 113.52 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 1.9 Cg_endo -47.41 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.535 3.918 0 N-CA-C 116.701 1.769 . . . . 0.0 116.701 1.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.568 ' CG ' ' OE1' ' A' ' 297' ' ' GLN . 11.6 m-30 -118.23 -134.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.31 129.5 19.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.248 0.931 . . . . 0.0 109.246 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.778 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -102.04 -162.34 0.92 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.464 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -157.34 92.84 1.27 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.19 129.37 27.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.741 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.447 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.2 pt -129.5 18.31 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.214 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 178.06 101.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.374 0.607 . . . . 0.0 110.053 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.3 ttmt -144.89 -142.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.489 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.0 ptt85 -153.77 -142.02 0.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.994 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 248' ' ' VAL . 54.3 t -133.62 69.3 76.44 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 110.85 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.607 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 59.0 Cg_endo -91.2 177.0 2.08 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.838 2.359 . . . . 0.0 110.762 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.724 ' O ' ' N ' ' A' ' 252' ' ' TYR . 1.3 p-10 -144.26 139.01 28.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -36.51 -10.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.399 0.619 . . . . 0.0 112.305 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.724 ' N ' ' O ' ' A' ' 250' ' ' ASN . 6.6 m-85 -89.51 -50.27 6.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 250' ' ' ASN . 25.7 t0 -62.71 60.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.624 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 252' ' ' TYR . 32.6 mtmt 82.53 15.78 0.4 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.167 0.917 . . . . 0.0 111.061 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.485 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.5 m 80.88 -17.93 0.53 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.675 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.02 109.15 0.11 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.958 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.16 156.06 0.6 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.521 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.867 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.04 122.14 46.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.5 mt -142.07 -178.81 5.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.886 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 6.1 tt0 -143.44 149.93 38.3 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.936 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.73 114.78 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.428 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 107.29 7.82 32.0 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 57.8 mm-40 -93.53 -127.62 0.11 Allowed 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.082 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 165.97 139.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.031 0.919 . . . . 0.0 110.336 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.082 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.5 p -134.75 155.6 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.56 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 265' ' ' VAL . 0.2 OUTLIER -85.31 -158.5 0.38 Allowed 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.726 ' O ' ' N ' ' A' ' 269' ' ' LYS . 0.9 OUTLIER -142.65 -44.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.075 176.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER 35.14 -72.93 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -74.35 123.6 24.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.975 -177.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 162.31 36.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.827 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.67 HD22 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -156.46 -98.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.526 0.679 . . . . 0.0 110.359 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.67 ' N ' HD22 ' A' ' 271' ' ' ASN . 34.8 mtm -55.16 152.89 7.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.601 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.9 p -71.58 15.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.539 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.71 -73.63 0.04 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.554 ' O ' ' ND2' ' A' ' 271' ' ' ASN . 13.4 mp0 -78.89 166.02 22.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.896 0.379 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.539 ' NE1' ' O ' ' A' ' 274' ' ' GLY . 1.5 p-90 177.81 179.49 0.3 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.617 0.723 . . . . 0.0 110.711 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 2.6 mt-10 -107.92 -178.53 3.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.607 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -157.72 -165.84 16.04 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.462 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -163.55 123.44 2.15 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.411 0.624 . . . . 0.0 112.269 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -133.75 74.0 1.53 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.354 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER 83.99 37.08 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.644 0.735 . . . . 0.0 109.676 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 93.34 -36.07 3.87 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.032 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -64.61 86.16 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.355 0.598 . . . . 0.0 110.264 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.627 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 77.4 mtt180 -86.27 170.13 12.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.508 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.505 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 169.23 -151.12 16.81 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -130.18 176.77 7.82 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.0 OUTLIER 157.99 112.83 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 123.461 0.476 . . . . 0.0 110.026 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.4 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 39.8 Cg_exo -54.8 148.05 47.82 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.375 2.05 . . . . 0.0 112.906 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.567 ' CD2' HG23 ' A' ' 292' ' ' VAL . 0.4 OUTLIER -66.49 -2.63 4.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.804 0.335 . . . . 0.0 110.303 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.0 p -47.7 -5.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 289' ' ' PHE . 1.6 p80 -155.71 75.15 0.9 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -163.12 159.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.447 ' HE ' HD13 ' A' ' 244' ' ' ILE . 37.5 mtt180 -126.52 76.37 1.62 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.743 0.306 . . . . 0.0 110.318 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 48.3 mt -39.36 127.48 1.82 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.137 0.97 . . . . 0.0 112.019 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 -172.37 2.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.098 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -110.72 48.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.823 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.568 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 34.1 tp60 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.371 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 48.5 p90 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 120.667 0.27 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 160' ' ' LEU . 30.2 m -131.39 165.02 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.533 ' NE ' ' OE2' ' A' ' 189' ' ' GLU . 12.7 ttp180 -122.62 136.94 55.02 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.747 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -103.85 90.81 3.74 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.566 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.504 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -103.52 38.3 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 58.8 m-85 -133.76 -0.16 3.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.958 -0.464 . . . . 0.0 111.038 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 59.47 136.94 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.131 0.894 . . . . 0.0 109.477 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 8.5 t80 -126.5 -48.0 1.56 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.641 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 46.59 58.31 4.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.23 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.483 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -65.45 -128.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.705 ' N ' HD22 ' A' ' 147' ' ' ASN . 0.0 OUTLIER 164.43 -41.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.689 ' H ' HD22 ' A' ' 147' ' ' ASN . 7.9 m-20 -73.95 140.33 45.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 112.034 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -49.9 -21.35 1.14 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.428 ' N ' ' C ' ' A' ' 148' ' ' ASP . 77.9 mt-10 -91.27 29.4 1.44 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.528 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.607 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 31.6 p30 -153.11 171.68 18.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.555 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 175' ' ' ASP . 14.6 tp -126.24 87.72 55.67 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.788 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.483 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 57.8 Cg_endo -64.17 143.19 83.21 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 CA-C-N 121.073 1.419 . . . . 0.0 113.858 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 160' ' ' LEU . 12.6 p90 -167.76 172.4 9.21 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.657 0.741 . . . . 0.0 111.485 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -150.29 -165.0 2.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.239 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.747 ' O ' ' O ' ' A' ' 140' ' ' ALA . 17.9 ptpt 41.36 -145.81 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -109.13 49.39 0.85 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 37.4 t0 -52.86 154.04 3.02 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.4 mp -100.24 99.27 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.517 ' O ' HG22 ' A' ' 138' ' ' VAL . 66.7 mt -102.33 90.47 3.91 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.473 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -69.04 147.1 52.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.967 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.1 mp -80.44 131.25 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.05 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.617 ' NH2' HD21 ' A' ' 172' ' ' ASN . 13.1 ttm180 -85.85 -43.09 13.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.212 0.529 . . . . 0.0 110.909 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 164' ' ' ASP . 38.2 t0 -153.58 -24.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.326 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.472 ' HE2' ' HE1' ' A' ' 171' ' ' TRP . 12.7 tttm 59.48 99.25 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -85.56 -44.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.989 1.793 . . . . 0.0 111.732 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.98 174.91 6.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -88.49 -38.46 14.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.972 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.524 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 95.5 mt-30 -80.38 -15.47 56.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.566 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.44 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 64.5 m95 -131.49 154.63 48.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.527 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.5 m0 -143.37 133.37 24.19 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.617 HD21 ' NH2' ' A' ' 163' ' ' ARG . 47.3 t-20 -85.02 117.79 24.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.84 178.7 6.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.734 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.5 111.28 15.51 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -60.88 140.37 57.71 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.19 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.2 ttt -52.1 -0.74 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.607 ' H ' ' C ' ' A' ' 175' ' ' ASP . 86.5 m-20 -84.82 -23.02 29.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.394 0.616 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.52 41.24 2.78 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.105 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -139.85 142.23 36.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.033 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.64 130.29 49.49 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.474 0.654 . . . . 0.0 111.525 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . 0.494 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -162.77 159.57 31.94 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.437 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 mtp -69.84 149.58 47.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.137 0.494 . . . . 0.0 111.199 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.494 HG22 ' HB3' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -134.57 141.55 39.32 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.724 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.38 119.05 5.89 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 N-CA-C 108.073 -1.549 . . . . 0.0 108.073 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.819 ' O ' HG22 ' A' ' 188' ' ' VAL . 35.7 t -54.2 -50.63 83.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.8 Cg_endo -50.9 -27.84 22.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.185 1.924 . . . . 0.0 112.873 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.0 m-85 -71.32 4.91 2.53 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.38 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.7 m -130.7 163.02 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.699 0.285 . . . . 0.0 110.596 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.533 ' OE2' ' NE ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -76.31 -71.45 0.39 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.677 -178.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.224 0 O-C-N 123.974 0.796 . . . . 0.0 110.614 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.554 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.2 -165.04 40.8 Favored Glycine 1 CA--C 1.439 -4.675 0 CA-C-O 122.306 0.948 . . . . 0.0 113.944 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.411 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.6 Cg_endo -44.43 102.73 0.03 OUTLIER 'Cis proline' 1 N--CA 1.538 4.114 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -0.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 10.5 m-30 -115.27 -124.37 0.29 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.6 OUTLIER -143.71 130.93 20.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 119.667 1.121 . . . . 0.0 109.83 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.773 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.04 -168.03 1.38 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.618 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.37 93.99 1.35 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.8 p -69.0 123.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.347 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.96 9.08 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.041 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.581 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.8 mm-40 -168.61 128.03 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.311 0.576 . . . . 0.0 109.504 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.4 ttmt -170.51 -144.39 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.862 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.1 ptt85 -160.48 -136.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.507 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.428 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 3.7 t -137.01 61.95 37.18 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.667 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.679 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -102.1 70.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.806 3.004 . . . . 0.0 112.081 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.615 ' ND2' ' N ' ' A' ' 250' ' ' ASN . 0.1 OUTLIER -47.78 158.53 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.54 -3.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.897 0.38 . . . . 0.0 111.767 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.73 ' O ' ' N ' ' A' ' 254' ' ' LYS . 30.1 m-85 -80.15 -59.04 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 42.9 t0 -47.14 60.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 125.653 1.846 . . . . 0.0 112.179 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 252' ' ' TYR . 34.0 mtmt 87.49 -51.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.961 1.413 . . . . 0.0 109.422 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 4.4 m 164.29 -17.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.175 0.922 . . . . 0.0 110.373 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.537 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -45.16 170.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.573 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.781 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.4 OUTLIER -109.54 150.26 28.42 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.778 0.431 . . . . 0.0 110.563 -177.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.751 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -97.17 116.59 29.64 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 122.07 -0.394 . . . . 0.0 111.119 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.803 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.2 mt -137.58 -172.59 3.27 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.74 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 15.3 tt0 -145.56 147.43 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.043 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.581 HG22 ' HA ' ' A' ' 245' ' ' GLN . 68.8 t -54.73 97.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.888 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 122.15 10.26 6.29 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 56.2 mm-40 -91.81 -130.64 0.11 Allowed 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.063 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 166.32 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.063 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.1 p -127.41 142.75 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.466 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.519 ' O ' HG22 ' A' ' 268' ' ' THR . 2.9 ttmm -99.04 84.15 3.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 94.0 t -50.56 150.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.518 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 266' ' ' LYS . 0.2 OUTLIER -148.25 -47.68 0.16 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.579 -178.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 5.6 tppt? -84.05 151.73 24.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.36 134.19 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.407 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.653 ' N ' HD22 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -177.31 -170.57 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.135 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.564 ' HG3' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER 60.39 -143.32 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.687 178.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.3 p -137.04 -4.35 1.94 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.734 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 275' ' ' GLN . . . 177.74 13.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 118.924 -1.608 . . . . 0.0 112.517 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 1.2 mp0 -101.28 -74.76 0.61 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 271' ' ' ASN . 9.9 m95 76.63 169.01 0.25 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 75.0 mt-10 -131.95 143.06 49.84 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.543 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -136.68 145.34 17.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 121.853 0.696 . . . . 0.0 113.599 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.64 130.8 55.32 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 113.945 -1.127 . . . . 0.0 110.674 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.713 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -110.55 -90.84 0.47 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -104.54 50.56 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 89.92 -31.04 5.49 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.1 OUTLIER -63.91 75.68 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.284 -0.958 . . . . 0.0 111.156 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 282' ' ' GLY . 50.9 mtt180 -71.92 160.89 31.77 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.357 0.599 . . . . 0.0 110.344 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 173.54 -161.71 32.48 Favored Glycine 0 C--O 1.217 -0.928 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.537 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 41.1 p-80 -130.04 168.8 16.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.223 0.535 . . . . 0.0 110.801 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 173.47 116.13 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.239 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.42 ' HG3' HE21 ' A' ' 275' ' ' GLN . 52.7 Cg_exo -51.45 149.91 16.67 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.805 1.67 . . . . 0.0 111.915 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.5 OUTLIER -61.11 -4.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 288' ' ' PRO . 31.9 p -46.95 -9.25 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.89 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.78 ' O ' HG13 ' A' ' 292' ' ' VAL . 4.5 p-80 -153.96 84.6 1.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.325 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.1 OUTLIER -172.68 152.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -106.14 -45.61 4.28 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 32.1 mt 77.39 113.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 122.069 0.938 . . . . 0.0 111.451 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.78 -174.54 4.81 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.265 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.423 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 67.1 t0 -106.64 58.79 0.64 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 53.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.948 ' O ' HG22 ' A' ' 138' ' ' VAL . 98.3 m-85 . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.948 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 82.74 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 125.109 1.506 . . . . 0.0 111.156 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -135.63 144.69 46.22 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.838 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.708 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -100.32 96.57 7.53 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.599 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.783 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -96.99 37.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.914 0.388 . . . . 0.0 111.467 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.539 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 49.5 m-85 -137.35 1.98 2.46 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.684 0.278 . . . . 0.0 110.793 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER 60.21 143.32 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.495 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.515 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 5.4 t80 -133.62 -34.92 1.01 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.545 0.611 . . . . 0.0 110.951 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 144' ' ' PHE . 7.6 p30 34.42 59.89 0.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.645 0.591 . . . . 0.0 110.663 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.73 -139.8 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.54 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 165.04 94.14 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.667 -0.766 . . . . 0.0 110.844 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 4.6 m-20 158.63 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.112 0.482 . . . . 0.0 110.2 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.17 -17.35 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.361 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -100.44 18.23 19.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.453 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.3 p30 -142.41 156.75 45.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.733 HD11 ' OD2' ' A' ' 175' ' ' ASP . 9.8 tp -121.63 85.83 44.27 Favored Pre-proline 0 C--O 1.212 -0.891 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.26 137.27 79.71 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 C-N-CA 121.586 1.524 . . . . 0.0 112.87 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.708 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 7.1 p90 -154.01 170.03 22.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -135.82 -68.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -94.96 92.62 6.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.249 -176.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 17.35 55.42 0.01 OUTLIER Glycine 0 C--N 1.34 0.806 0 O-C-N 123.812 0.695 . . . . 0.0 112.041 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 156' ' ' LYS . 32.9 t0 -63.08 142.82 58.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.576 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.5 mp -87.31 101.87 11.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 31.0 mt -92.14 -127.56 0.1 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.356 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 174' ' ' GLU . 40.9 tttp 173.28 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.678 0.611 . . . . 0.0 110.399 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -90.23 145.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.49 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -134.11 -39.8 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.38 104.97 6.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.856 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.463 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 12.9 pttm -113.22 74.94 2.07 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.79 -30.19 22.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.995 1.797 . . . . 0.0 112.227 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.16 158.92 17.82 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.612 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -87.09 -37.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.736 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.45 HE22 ' CD ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -78.94 -29.52 44.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.621 -179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.466 ' CZ2' ' HD2' ' A' ' 238' ' ' PRO . 77.4 m95 -117.27 150.95 37.93 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.521 ' CE3' HG22 ' A' ' 185' ' ' VAL . 8.8 m0 -145.91 136.33 24.01 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.8 112.15 16.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.47 166.62 10.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.069 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 161' ' ' LYS . 27.4 tt0 -129.31 145.95 51.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.012 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.733 ' OD2' HD11 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -76.58 -178.93 4.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.664 0.745 . . . . 0.0 110.73 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.4 ttt -80.11 -11.45 59.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.0 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -100.94 -25.48 14.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.1 43.67 0.51 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -117.56 126.16 52.09 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.783 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.68 42.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.456 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -150.59 148.52 19.79 Favored Glycine 0 C--N 1.312 -0.793 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.875 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 159.67 20.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.44 0.638 . . . . 0.0 110.656 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 7.8 pt -150.49 142.48 15.61 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.732 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.33 110.76 3.04 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 N-CA-C 109.852 -0.865 . . . . 0.0 109.852 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 188' ' ' VAL . 50.3 t -44.6 -51.58 20.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.613 -0.679 . . . . 0.0 112.048 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.8 Cg_endo -47.26 -29.3 9.21 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.146 1.898 . . . . 0.0 112.841 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.447 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.2 m-85 -69.73 -6.33 31.16 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.058 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 185' ' ' VAL . 25.0 m -129.53 167.22 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 111.007 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.783 ' CD ' HD21 ' A' ' 141' ' ' LEU . 4.4 pt-20 -150.22 61.19 0.97 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 110.938 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt . . . . . 0 C--N 1.315 -0.909 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.035 179.659 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 120.892 0.377 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -34.72 160.27 0.01 OUTLIER Glycine 1 CA--C 1.45 -4.021 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.951 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.482 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 3.1 Cg_exo -73.24 126.08 11.46 Favored 'Cis proline' 0 C--N 1.285 -2.799 0 O-C-N 122.3 0.632 . . . . 0.0 113.071 -5.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.49 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 40.9 m-85 -153.71 -124.62 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.518 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 2.2 m-30 -140.7 113.21 8.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 118.752 0.705 . . . . 0.0 109.71 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.707 ' HB2' HD23 ' A' ' 294' ' ' LEU . . . -105.65 144.48 32.34 Favored 'General case' 0 C--O 1.2 -1.515 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -101.1 112.52 25.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.19 0.519 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.5 p -79.05 122.26 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.74 21.51 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.72 104.54 0.02 OUTLIER 'General case' 0 N--CA 1.46 0.064 0 CA-C-O 121.525 0.678 . . . . 0.0 111.154 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.833 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -139.99 -140.11 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.743 178.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.1 ptt85 -157.2 -139.61 0.07 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.834 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 248' ' ' VAL . 80.4 t -135.94 69.36 64.51 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.985 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 256' ' ' ALA . 45.4 Cg_endo -96.28 -179.72 0.48 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.976 2.45 . . . . 0.0 111.208 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.709 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.8 OUTLIER -141.99 137.2 31.0 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.683 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.43 -5.51 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.303 0.377 . . . . 0.0 111.504 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.709 ' N ' ' O ' ' A' ' 250' ' ' ASN . 51.2 m-85 -93.41 -55.79 3.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.14 71.76 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.998 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 252' ' ' TYR . 30.9 mtmt 74.91 -5.22 2.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 124.343 1.027 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.53 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 0.3 OUTLIER 87.24 51.88 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.398 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 249' ' ' PRO . . . -104.71 113.87 27.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.865 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -49.26 155.21 0.72 Allowed 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.922 -0.486 . . . . 0.0 111.444 -179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.662 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -106.5 114.51 28.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.633 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.833 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.8 OUTLIER -136.56 -173.94 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.337 0.589 . . . . 0.0 111.328 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.2 tt0 -146.26 152.07 38.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.786 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.401 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 54.3 t -56.96 115.14 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.66 10.33 17.03 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 23.0 mm-40 -107.56 -152.49 0.48 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.874 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER -171.89 152.31 2.97 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.994 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.874 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.3 p -135.8 156.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.45 ' CD ' HE22 ' A' ' 169' ' ' GLN . 0.0 OUTLIER -100.62 99.29 9.84 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 268' ' ' THR . 10.7 t -65.81 156.85 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.447 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -158.25 -62.42 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.152 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -80.42 141.67 35.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -177.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.9 OUTLIER -140.59 147.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.288 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.567 ' C ' HD22 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -176.53 -159.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.5 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.49 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 47.7 mtm 52.1 -120.66 1.7 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.886 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.8 p -135.48 -10.65 2.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.237 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . 177.69 -46.39 0.1 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.559 -1.781 . . . . 0.0 113.126 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.49 ' O ' ' HE3' ' A' ' 272' ' ' MET . 24.2 mp0 -65.79 64.39 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 3.1 p-90 -74.66 -171.95 1.4 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.171 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 86.0 mt-10 -108.61 166.9 10.44 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.535 1.147 . . . . 0.0 111.618 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -149.18 -170.81 17.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.896 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.449 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -157.08 127.68 6.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.304 0.574 . . . . 0.0 111.655 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.636 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -138.94 74.28 1.47 Allowed 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.302 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 7.2 m-20 85.74 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.731 0.777 . . . . 0.0 109.33 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.09 -33.73 4.37 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.78 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.03 93.64 0.59 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.449 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 83.9 mtt180 -94.75 168.46 10.81 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.438 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.548 ' O ' HD22 ' A' ' 257' ' ' LEU . . . 162.95 137.53 2.21 Favored Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.994 177.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 277' ' ' GLU . 2.7 p80 -65.06 175.31 1.62 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.142 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.614 ' CZ ' ' HB1' ' A' ' 256' ' ' ALA . 0.3 OUTLIER 166.21 144.53 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.408 178.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 39.9 Cg_exo -55.28 137.99 78.43 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.436 2.091 . . . . 0.0 113.331 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 2.0 t80 -73.77 -5.8 43.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.253 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 34.8 p -67.72 2.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 8.5 p80 -136.32 47.51 2.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.417 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.427 HG13 ' HD1' ' A' ' 291' ' ' HIS . 0.9 OUTLIER -149.3 151.37 13.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -111.01 -53.8 2.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.707 HD23 ' HB2' ' A' ' 241' ' ' ALA . 2.0 mt 91.27 119.73 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.324 1.059 . . . . 0.0 111.346 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 297' ' ' GLN . 8.7 mp -70.46 -170.59 0.4 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 296' ' ' ASP . 40.8 t0 -66.51 9.4 0.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 295' ' ' LEU . 40.6 tt0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.897 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.7 m-85 . . . . . 0 C--O 1.217 -0.618 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 137' ' ' TYR . 2.3 m 93.12 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 125.682 1.864 . . . . 0.0 111.59 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -121.35 125.67 47.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.744 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -98.9 95.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.331 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.648 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -106.1 35.05 3.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.755 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 47.6 m-85 -134.26 0.85 3.14 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.29 -0.256 . . . . 0.0 111.029 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.89 137.95 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.66 0 O-C-N 124.281 0.988 . . . . 0.0 108.786 -178.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 8.6 t80 -121.54 -47.89 2.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.092 0.406 . . . . 0.0 110.399 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 144' ' ' PHE . 65.7 t30 40.97 60.9 1.87 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.213 0.53 . . . . 0.0 109.958 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.17 -155.55 1.41 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.722 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.629 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.2 OUTLIER 169.62 94.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.188 -1.006 . . . . 0.0 110.27 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -159.97 -146.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 111.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 58.7 p30 -75.86 57.51 1.05 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.581 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 151' ' ' ASP . 92.2 mt-10 98.01 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.402 1.064 . . . . 0.0 111.496 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.629 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 14.1 p-10 -28.91 161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.681 0.613 . . . . 0.0 110.705 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.491 HD23 HG21 ' A' ' 183' ' ' ILE . 13.8 tp -106.72 75.34 0.39 Allowed Pre-proline 0 C--O 1.215 -0.758 0 O-C-N 122.075 -0.391 . . . . 0.0 111.117 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.75 118.72 5.81 Favored 'Trans proline' 0 C--N 1.295 -2.255 0 CA-C-N 119.386 0.816 . . . . 0.0 110.968 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.744 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 15.5 p90 -134.25 163.6 29.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.416 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.411 ' CG ' ' H ' ' A' ' 156' ' ' LYS . 1.1 tpmp? -96.13 -135.35 0.23 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 158' ' ' ASP . 50.8 mtmt -96.56 174.94 6.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 159' ' ' ILE . . . 33.11 22.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.873 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.634 ' N ' ' O ' ' A' ' 156' ' ' LYS . 6.3 t0 -72.69 137.46 46.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 117.257 0.528 . . . . 0.0 109.816 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -104.06 103.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.7 mt -108.35 107.93 18.7 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.065 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -62.89 140.12 58.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 48.7 mm -81.34 130.95 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.165 0.507 . . . . 0.0 110.409 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -44.07 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -155.1 133.2 11.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.535 ' HG3' ' NE1' ' A' ' 171' ' ' TRP . 2.6 ttmm -106.42 70.55 0.24 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.698 -0.191 . . . . 0.0 110.727 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.25 -54.74 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.165 1.244 . . . . 0.0 111.495 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -100.78 -172.8 2.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.18 -32.88 7.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.57 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 94.2 mt-30 -83.29 -31.32 26.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.497 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 81.2 m95 -119.59 148.03 43.8 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.567 ' CE3' HG22 ' A' ' 185' ' ' VAL . 14.1 m0 -141.72 131.33 24.0 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 120.857 0.36 . . . . 0.0 110.104 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -81.12 105.73 12.56 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.25 174.91 5.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.047 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -123.24 130.53 52.87 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.99 165.55 0.94 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.197 0.522 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 49.8 ttp -74.07 -4.48 35.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.047 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.15 -27.85 14.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.25 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.89 48.37 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 108.279 -1.929 . . . . 0.0 108.279 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -128.07 129.0 45.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.929 -0.636 . . . . 0.0 109.678 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 125.79 49.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.344 0.593 . . . . 0.0 111.869 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -165.26 160.66 34.04 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.522 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.483 ' C ' HG22 ' A' ' 183' ' ' ILE . 0.2 OUTLIER -68.02 160.25 29.13 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.159 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.868 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -159.66 148.12 13.68 Favored Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.572 177.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.53 122.44 8.61 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.659 1.573 . . . . 0.0 109.253 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.829 ' O ' HG22 ' A' ' 188' ' ' VAL . 42.7 t -58.68 -52.18 76.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.672 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.5 Cg_endo -50.78 -27.25 19.68 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.794 2.329 . . . . 0.0 114.498 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.431 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 5.2 m-85 -65.2 7.8 0.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.812 0.339 . . . . 0.0 111.483 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 185' ' ' VAL . 3.1 m -132.69 173.08 15.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.648 ' CD ' HD21 ' A' ' 141' ' ' LEU . 1.9 pt-20 -141.64 39.87 1.7 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.973 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 189' ' ' GLU . 13.4 mptt . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 110.57 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.596 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 95.0 m-20 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.68 -163.38 39.21 Favored Glycine 1 CA--C 1.446 -4.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.091 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.404 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 3.5 Cg_exo -45.38 100.17 0.03 OUTLIER 'Cis proline' 0 N--CA 1.528 3.519 0 N-CA-C 117.152 1.943 . . . . 0.0 117.152 1.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.634 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 11.2 m-30 -116.26 -128.23 0.29 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.57 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.47 128.64 19.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 119.435 1.016 . . . . 0.0 109.805 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.801 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.16 -162.37 0.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.314 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -160.85 95.81 1.09 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.92 128.68 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.711 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.978 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -123.17 12.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.699 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 261' ' ' VAL . 2.4 mm-40 -169.06 114.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.836 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.4 ttmt -160.78 -145.66 0.12 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -155.48 -140.15 0.08 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.531 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 248' ' ' VAL . 6.4 p -134.47 65.24 67.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.568 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 78.6 Cg_endo -91.91 176.47 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.339 2.026 . . . . 0.0 112.075 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.703 ' O ' ' N ' ' A' ' 252' ' ' TYR . 16.9 p30 -149.26 145.21 26.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.712 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.41 -3.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.703 ' N ' ' O ' ' A' ' 250' ' ' ASN . 48.0 m-85 -91.5 -54.09 4.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.481 0.658 . . . . 0.0 110.291 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -46.11 -66.52 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.652 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 256' ' ' ALA . 27.7 mttt -148.26 33.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.275 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.413 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 3.6 m 70.9 -13.61 0.49 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.689 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.07 164.41 0.29 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.261 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.797 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -104.07 149.53 25.12 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 122.794 0.438 . . . . 0.0 110.533 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.801 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -86.81 114.55 23.57 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.836 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.3 mt -139.9 -177.0 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.447 0.641 . . . . 0.0 111.007 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.3 tt0 -145.83 147.48 31.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 245' ' ' GLN . 71.9 t -54.55 102.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.96 6.11 10.34 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 65.7 mm-40 -88.32 -125.25 0.05 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 161.23 140.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.079 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.7 p -130.89 140.66 48.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.175 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -99.3 86.01 3.31 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.992 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.4 152.58 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.669 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.431 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -154.37 -53.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.62 127.89 33.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.787 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -137.37 127.49 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.997 0.903 . . . . 0.0 111.913 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.647 ' C ' HD22 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -154.66 -167.96 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.549 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.509 ' CE ' HD21 ' A' ' 271' ' ' ASN . 44.7 mtm 65.41 -123.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.89 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.3 p -140.37 -5.76 1.22 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.028 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 276' ' ' TRP . . . -175.57 -52.13 0.06 OUTLIER Glycine 0 C--O 1.213 -1.203 0 C-N-CA 118.138 -1.982 . . . . 0.0 112.737 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.506 ' O ' ' HE3' ' A' ' 272' ' ' MET . 23.2 tp60 -61.34 63.9 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.59 ' N ' ' O ' ' A' ' 274' ' ' GLY . 6.4 m95 -67.41 177.93 1.74 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.518 -0.739 . . . . 0.0 111.097 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 59.1 mt-10 -130.26 156.39 44.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -133.36 -142.28 4.74 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.964 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.479 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.1 tt0 -169.35 134.32 1.48 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.925 -0.638 . . . . 0.0 112.559 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.707 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -146.61 72.24 1.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.157 -178.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 18.2 t-20 83.27 31.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.361 0.6 . . . . 0.0 110.04 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.68 -33.43 5.71 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.134 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 13.2 ptpt -67.87 75.44 0.2 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.033 0.444 . . . . 0.0 110.991 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.542 ' NH1' ' CZ ' ' A' ' 142' ' ' PHE . 93.4 mtt180 -73.01 170.49 14.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.98 -155.13 26.04 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.3 p80 -136.36 176.51 8.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.129 0.572 . . . . 0.0 109.738 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.3 OUTLIER 171.27 125.09 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.223 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.86 147.94 2.98 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.666 1.578 . . . . 0.0 113.559 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.518 ' C ' ' H ' ' A' ' 291' ' ' HIS . 1.6 t80 -73.75 -5.13 38.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.1 p -60.05 5.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.266 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.749 ' O ' HG13 ' A' ' 292' ' ' VAL . 7.4 p-80 -157.33 72.93 0.71 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.5 OUTLIER -165.9 148.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.425 ' HG3' HD12 ' A' ' 244' ' ' ILE . 14.3 mtp180 -126.36 74.38 1.45 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.799 0.333 . . . . 0.0 110.746 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 41.9 mt -40.68 127.06 2.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 112.004 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 4.9 mp -77.31 -174.52 3.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.277 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -96.71 25.7 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.074 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.634 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 56.2 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.71 172.47 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -126.78 127.9 45.76 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.757 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -96.89 93.05 6.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.672 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.4 36.1 1.82 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.284 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.637 ' CZ ' ' NH2' ' A' ' 284' ' ' ARG . 52.0 m-85 -136.31 2.31 2.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 122.39 -0.194 . . . . 0.0 110.933 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.3 p30 56.87 141.63 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 O-C-N 124.471 1.107 . . . . 0.0 109.596 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 10.5 t80 -134.41 -44.22 0.76 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.243 0.474 . . . . 0.0 110.165 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 144' ' ' PHE . 5.1 p-10 33.85 62.25 0.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.846 0.716 . . . . 0.0 110.619 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.407 ' N ' ' HB3' ' A' ' 153' ' ' PRO . . . -64.82 -135.82 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.689 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.1 OUTLIER 168.03 90.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.612 -0.294 . . . . 0.0 111.049 178.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.5 m-20 168.4 -170.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 150' ' ' GLU . 40.3 p-10 -93.53 -23.24 18.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.463 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 19.0 pt-20 -103.6 23.11 13.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.109 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.689 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 4.0 p-10 -131.58 148.37 52.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.2 tp -116.17 86.29 16.98 Favored Pre-proline 0 C--O 1.217 -0.649 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.407 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 53.6 Cg_endo -65.12 140.04 63.49 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.317 1.345 . . . . 0.0 112.825 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.757 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 10.6 p90 -158.0 160.21 37.23 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.63 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -63.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.553 0.692 . . . . 0.0 111.748 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 158' ' ' ASP . 2.5 ptmt -85.06 92.61 8.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.76 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 13.87 53.59 0.01 OUTLIER Glycine 0 N--CA 1.473 1.154 0 O-C-N 124.054 0.846 . . . . 0.0 112.287 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 156' ' ' LYS . 9.6 t70 -64.47 143.01 58.22 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.445 0.641 . . . . 0.0 109.583 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.8 mm -88.5 107.8 18.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.183 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 mt -116.02 117.55 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.643 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.562 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 88.1 tttt -75.49 147.18 40.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.101 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.5 mp -74.22 -59.01 3.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 70.57 -50.45 0.66 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.467 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -146.9 120.32 9.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.243 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.478 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 0.0 OUTLIER -120.48 85.17 37.18 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.398 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.89 -29.55 18.3 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.629 1.553 . . . . 0.0 112.281 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.417 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 94.8 mt-10 -119.98 160.67 22.31 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.002 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 168' ' ' GLU . 3.3 pt-20 -83.65 -43.69 15.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.741 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.516 ' OE1' ' CD1' ' A' ' 239' ' ' PHE . 93.8 mt-30 -74.68 -29.88 61.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.478 ' NE1' ' CE2' ' A' ' 239' ' ' PHE . 77.2 m95 -119.33 151.24 38.8 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.594 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.4 m0 -143.35 131.1 21.4 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.096 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 162' ' ' ILE . 51.2 t30 -81.39 116.98 21.47 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 161' ' ' LYS . . . -127.13 176.87 7.05 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.242 0.339 . . . . 0.0 110.453 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.19 133.94 54.72 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.258 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.434 ' HB2' HD11 ' A' ' 152' ' ' LEU . 11.0 t70 -58.37 170.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.491 0.662 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.5 ttt -78.51 0.41 26.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.666 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -104.4 -28.59 11.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.83 48.19 0.42 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -129.25 130.93 46.86 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.128 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.88 121.83 41.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.59 0.71 . . . . 0.0 111.874 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.86 154.41 25.49 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.765 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 152' ' ' LEU . 1.9 ttt -74.5 163.61 27.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.542 0.686 . . . . 0.0 111.084 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.842 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -157.21 145.31 14.21 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.669 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.03 112.92 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.529 1.486 . . . . 0.0 109.441 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.713 ' O ' HG22 ' A' ' 188' ' ' VAL . 49.7 t -47.63 -51.37 45.55 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.954 -0.466 . . . . 0.0 112.045 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.3 Cg_endo -47.42 -30.61 11.86 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.305 2.003 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.21 -3.76 11.75 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.935 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 185' ' ' VAL . 22.3 m -129.74 160.95 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.792 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.551 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -116.95 -64.31 1.33 Allowed 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.448 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 4.5 tptp . . . . . 0 N--CA 1.45 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.173 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.545 ' O ' ' NE2' ' A' ' 297' ' ' GLN . 8.1 m120 . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.503 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -72.38 -177.09 29.78 Favored Glycine 0 CA--C 1.45 -3.997 0 CA-C-O 122.554 1.085 . . . . 0.0 114.619 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.503 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.0 Cg_exo -53.7 127.91 1.32 Allowed 'Cis proline' 0 N--CA 1.528 3.502 0 N-CA-C 115.462 1.293 . . . . 0.0 115.462 -3.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.516 ' CD1' ' OE1' ' A' ' 169' ' ' GLN . 3.2 m-85 -153.86 -117.68 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.3 m-30 -141.74 123.23 14.98 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 119.141 0.882 . . . . 0.0 109.831 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.673 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -113.34 150.47 32.53 Favored 'General case' 0 C--O 1.198 -1.65 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -113.23 103.25 11.15 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.733 -0.604 . . . . 0.0 109.422 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.3 p -74.35 121.47 25.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.505 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.17 23.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.425 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.522 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.4 mm-40 177.42 116.96 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.431 0.634 . . . . 0.0 109.844 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.869 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.4 ttmt -156.66 -158.8 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.935 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.784 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 28.7 ptt85 -153.94 144.88 22.69 Favored 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.76 91.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.637 0 O-C-N 124.041 0.838 . . . . 0.0 110.829 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.784 ' HD3' ' O ' ' A' ' 247' ' ' ARG . 70.0 Cg_endo -108.14 171.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 123.782 2.988 . . . . 0.0 113.827 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.644 ' ND2' ' H ' ' A' ' 253' ' ' ASP . 4.3 p-10 -93.04 -169.35 2.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.261 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.62 16.19 22.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 254' ' ' LYS . 5.7 m-85 -125.72 -21.62 4.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.227 0.537 . . . . 0.0 110.159 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.644 ' H ' ' ND2' ' A' ' 250' ' ' ASN . 31.5 t70 -71.78 45.05 0.11 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.928 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 255' ' ' THR . 38.7 mtmt 106.03 -10.78 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 124.717 1.261 . . . . 0.0 110.81 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.537 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 7.6 m 105.92 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.4 1.062 . . . . 0.0 110.651 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.618 ' HB1' ' CZ ' ' A' ' 287' ' ' PHE . . . -40.21 153.2 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 O-C-N 123.262 0.351 . . . . 0.0 111.62 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.86 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -107.33 151.51 25.39 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.774 0.43 . . . . 0.0 110.619 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.794 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -94.78 114.54 26.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.869 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.1 mt -139.4 -170.92 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.355 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 17.7 tt0 -146.14 149.18 33.51 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.501 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 245' ' ' GLN . 72.9 t -58.62 106.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.09 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.97 8.68 10.44 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 71.0 mm-40 -94.54 -133.71 0.18 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.973 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 170.98 139.77 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.973 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.7 p -127.21 143.73 39.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 92.24 5.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 t -61.93 152.09 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.733 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -151.8 -58.61 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.671 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 116.89 10.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.413 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.79 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -126.95 162.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.099 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER 177.59 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.556 0.693 . . . . 0.0 110.638 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.72 ' N ' HD22 ' A' ' 271' ' ' ASN . 25.5 mtm -35.95 125.87 0.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.195 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -62.95 6.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.911 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -132.94 -50.48 0.09 OUTLIER Glycine 0 N--CA 1.467 0.729 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.579 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.6 mp0 -94.91 160.9 14.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.579 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 4.3 m95 -162.85 158.17 22.27 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.471 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -120.64 128.48 53.05 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 123.24 0.338 . . . . 0.0 111.454 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.66 -157.16 31.16 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.297 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.35 127.2 0.81 Allowed 'General case' 0 C--N 1.346 0.429 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.677 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -138.83 78.09 1.66 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.692 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.6 t-20 83.35 27.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.587 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.69 -26.73 21.99 Favored Glycine 0 N--CA 1.462 0.386 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.968 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.1 OUTLIER -73.13 73.33 1.22 Allowed 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.769 -178.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.637 ' NH2' ' CZ ' ' A' ' 142' ' ' PHE . 64.2 mtt85 -73.01 169.44 16.96 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.719 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 165.18 122.12 0.59 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 122.659 1.144 . . . . 0.0 113.065 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.627 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.4 p80 -59.4 177.08 0.2 Allowed 'General case' 0 C--N 1.284 -2.247 0 O-C-N 119.194 -2.357 . . . . 0.0 109.555 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 166.03 149.06 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 123.968 0.792 . . . . 0.0 111.428 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 32.4 Cg_exo -55.65 135.81 71.17 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.508 2.138 . . . . 0.0 113.945 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 66.6 t80 -75.16 -1.5 23.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.795 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 20.4 p -76.83 3.22 12.42 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 9.1 p80 -133.63 44.29 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.134 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.36 146.14 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -125.71 77.45 1.66 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.124 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 294' ' ' LEU . 38.2 mt -39.67 127.08 1.97 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.81 0.814 . . . . 0.0 111.375 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.4 mp -67.75 -166.76 0.06 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.962 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -70.96 8.36 0.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 236' ' ' ASN . 47.7 tt0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.149 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.742 ' O ' HG22 ' A' ' 138' ' ' VAL . 21.0 m-85 . . . . . 0 C--O 1.213 -0.824 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER 78.59 157.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.565 1.165 . . . . 0.0 110.828 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -141.39 159.81 41.45 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.821 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . . . -59.74 172.72 0.67 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.342 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 189' ' ' GLU . 58.0 mt -143.08 -58.21 0.42 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.524 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -113.33 9.78 18.31 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.33 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.526 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 78.27 137.45 0.06 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.454 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 3.6 t80 -111.22 -46.11 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.335 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.681 HD21 ' NZ ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER 47.56 63.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.75 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -63.69 -124.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.746 HD22 ' H ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER 166.8 -49.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.188 0.494 . . . . 0.0 111.863 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.746 ' H ' HD22 ' A' ' 147' ' ' ASN . 7.9 m-20 -72.32 162.96 28.75 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 27.8 p-10 -69.56 -22.72 63.52 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.806 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -87.83 24.32 1.79 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.613 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 32.2 p30 -141.48 165.59 27.08 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 175' ' ' ASP . 8.8 tp -120.45 88.86 43.26 Favored Pre-proline 0 C--O 1.217 -0.646 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.685 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.405 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 65.6 Cg_endo -69.57 140.58 43.73 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.346 1.364 . . . . 0.0 113.068 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 140' ' ' ALA . 17.5 p90 -158.31 166.22 32.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.681 ' NZ ' HD21 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -139.1 148.12 42.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.42 -133.83 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.338 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -121.31 49.73 0.87 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.18 140.39 58.45 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -84.86 100.58 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.933 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.6 mt -109.56 125.59 52.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.87 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -81.3 138.24 35.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.636 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.3 mp -72.1 -57.44 7.28 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.669 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.444 ' N ' HG22 ' A' ' 162' ' ' ILE . 60.9 ttt180 77.59 -46.26 0.46 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.33 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.495 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -110.4 -134.64 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.868 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 164' ' ' ASP . 8.2 pttp 149.21 60.19 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.431 0.693 . . . . 0.0 109.701 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.4 ' CD ' ' H ' ' A' ' 165' ' ' LYS . 18.4 Cg_endo -57.14 -59.37 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.64 2.227 . . . . 0.0 112.429 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.0 mt-10 -117.3 174.48 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 1.1 pm0 -83.93 -44.58 14.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.678 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.466 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 83.1 mt-30 -75.19 -27.84 59.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 62.9 m95 -119.3 154.13 33.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.641 ' CE3' HG22 ' A' ' 185' ' ' VAL . 9.8 m0 -149.81 142.88 24.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.611 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.636 ' O ' ' O ' ' A' ' 162' ' ' ILE . 2.9 t30 -90.13 121.19 31.96 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -124.13 172.77 8.76 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.67 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -121.58 132.2 54.55 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.493 ' HB2' HD11 ' A' ' 152' ' ' LEU . 11.8 t70 -60.82 171.57 1.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.473 0.654 . . . . 0.0 110.85 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 tpt -77.12 -3.02 37.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.813 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.32 -27.89 12.19 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.87 48.12 0.42 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -129.66 134.29 47.59 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.448 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.56 123.52 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.531 0.681 . . . . 0.0 111.577 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -153.61 149.55 21.05 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.934 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 mtp -66.95 155.98 37.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.374 0.607 . . . . 0.0 111.002 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 11.5 pt -147.63 142.99 17.3 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.211 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.3 111.66 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.223 1.282 . . . . 0.0 109.71 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.641 HG22 ' CE3' ' A' ' 171' ' ' TRP . 58.5 t -46.77 -51.69 36.61 Favored Pre-proline 0 CA--C 1.535 0.38 0 O-C-N 122.212 -0.305 . . . . 0.0 111.337 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.1 Cg_endo -47.26 -30.07 10.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.26 1.974 . . . . 0.0 113.047 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 268' ' ' THR . 15.9 m-85 -77.5 -7.86 56.9 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.48 HG21 HG21 ' A' ' 138' ' ' VAL . 1.5 m -132.94 160.43 42.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.554 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.521 ' HB3' HD11 ' A' ' 141' ' ' LEU . 8.3 pt-20 -136.71 156.53 48.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.042 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.577 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.434 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 84.9 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.906 0.384 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.568 ' HA2' ' N ' ' A' ' 239' ' ' PHE . . . -75.16 -176.44 38.32 Favored Glycine 0 CA--C 1.457 -3.552 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.432 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.3 Cg_endo -57.3 100.72 0.06 OUTLIER 'Cis proline' 0 N--CA 1.525 3.374 0 N-CA-C 115.366 1.256 . . . . 0.0 115.366 -0.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.568 ' N ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 m-85 -115.9 -131.43 0.32 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.5 OUTLIER -144.95 132.13 20.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 118.873 0.76 . . . . 0.0 109.183 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.757 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -119.49 153.78 34.8 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.005 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 13.2 tpp180 -114.14 95.63 5.39 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.7 130.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.231 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.88 20.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.584 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 261' ' ' VAL . 0.9 OUTLIER 179.58 109.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.966 0.413 . . . . 0.0 110.314 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 259' ' ' LEU . 5.4 ttmt -162.01 -151.13 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.773 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.705 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -157.5 -137.23 0.05 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.522 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.58 61.94 39.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 43.0 Cg_endo -92.81 51.47 0.46 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.598 2.199 . . . . 0.0 113.474 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.718 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.2 OUTLIER -25.09 146.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.052 0.845 . . . . 0.0 111.291 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.96 -7.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.191 0.52 . . . . 0.0 111.668 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 250' ' ' ASN . 37.5 m-85 -83.02 -62.63 1.54 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 252' ' ' TYR . 35.4 t0 -33.46 -51.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.972 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.705 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 5.4 pttt -171.51 44.22 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.13 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m 63.34 -14.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.299 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -62.42 127.12 29.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.962 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.912 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -52.36 159.28 1.01 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.092 0.472 . . . . 0.0 111.322 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.909 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.18 121.95 45.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.33 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.909 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.4 mt -142.7 -175.29 4.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.051 0.453 . . . . 0.0 111.203 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.2 tt0 -144.02 151.26 39.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.236 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 245' ' ' GLN . 47.6 t -60.94 112.14 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.676 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 5.38 20.07 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 66.8 mm-40 -93.65 -128.68 0.12 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.106 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 168.72 138.6 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.704 0.764 . . . . 0.0 109.612 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.106 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.6 p -137.75 151.6 26.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 4.7 ttmt -79.61 -161.32 0.32 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.277 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 269' ' ' LYS . 1.7 t -140.78 -53.43 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.453 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER 46.08 -71.67 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.3 OUTLIER -81.28 117.65 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.255 -177.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.892 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -132.5 161.6 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.168 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -164.39 -108.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.162 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.582 ' N ' HD22 ' A' ' 271' ' ' ASN . 46.9 mtm -39.38 153.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.685 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.8 p -75.77 18.68 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.388 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -142.71 -75.71 0.03 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.491 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 1.9 mp0 -78.02 176.53 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.72 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.54 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 9.5 p-90 170.08 -169.57 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.532 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 71.7 mt-10 -128.94 165.36 21.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.808 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -145.57 -152.77 5.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.094 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.07 125.64 0.55 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.906 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.685 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 -93.11 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -103.3 50.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.64 -31.19 5.96 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.404 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -64.8 83.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.398 -179.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -79.39 166.17 22.33 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.969 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.439 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.46 -157.59 29.83 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.45 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 10.3 p-80 -125.4 175.33 7.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 123.847 0.381 . . . . 0.0 110.916 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.54 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 164.84 112.49 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.34 143.27 27.18 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.798 1.665 . . . . 0.0 112.496 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.625 ' CD1' HG23 ' A' ' 292' ' ' VAL . 52.9 t80 -66.09 -0.84 2.65 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.2 p -53.65 0.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.6 p80 -160.74 74.39 0.51 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.565 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.625 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -166.05 154.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.56 ' O ' ' HG ' ' A' ' 294' ' ' LEU . 58.0 mtp180 -101.44 -110.13 0.22 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 293' ' ' ARG . 9.4 mt 150.8 120.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.271 0.982 . . . . 0.0 110.751 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.02 -174.63 3.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.972 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.42 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 66.1 t0 -111.21 40.81 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.516 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.539 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 10.7 tp60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.757 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.906 ' O ' HG22 ' A' ' 138' ' ' VAL . 74.2 m-85 . . . . . 0 C--O 1.212 -0.874 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.906 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.3 m 83.03 161.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 124.852 1.345 . . . . 0.0 110.841 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.748 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 2.6 ptp180 -132.48 151.88 51.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -101.99 92.99 5.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.086 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -98.09 22.97 8.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.598 ' O ' ' O ' ' A' ' 143' ' ' ASP . 57.9 m-85 -123.47 6.84 8.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.0 p30 51.86 137.04 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.276 0 O-C-N 124.59 1.181 . . . . 0.0 110.808 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.491 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 6.6 t80 -124.59 -43.23 2.04 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.225 0.466 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 144' ' ' PHE . 53.9 t-20 39.31 62.18 1.19 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.454 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.34 -146.11 0.21 Allowed Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.601 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.1 p30 171.22 91.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.063 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.4 m-20 171.57 -173.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.373 . . . . 0.0 110.212 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -93.63 -21.55 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.652 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.79 26.29 10.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.974 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 8.9 p-10 -134.17 152.37 51.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 9.5 tp -116.94 85.21 17.27 Favored Pre-proline 0 C--O 1.21 -1.01 0 CA-C-N 117.586 0.175 . . . . 0.0 110.564 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -59.73 139.37 88.29 Favored 'Trans proline' 0 C--N 1.288 -2.627 0 C-N-CA 121.49 1.46 . . . . 0.0 112.864 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 9.1 p90 -159.02 158.29 32.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.258 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 156' ' ' LYS . 1.6 ttmp? -176.62 112.6 0.1 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 147.06 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.384 1.052 . . . . 0.0 110.565 178.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.09 44.75 0.91 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -79.71 153.59 29.17 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.398 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 159' ' ' ILE . 3.7 tp -98.67 119.27 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 137' ' ' TYR . 10.6 mt -118.7 133.65 55.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.19 139.78 34.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.74 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.6 mp -64.46 -48.74 83.83 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.865 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.574 ' NE ' ' OD1' ' A' ' 164' ' ' ASP . 0.2 OUTLIER 69.96 -53.26 0.63 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.893 -0.504 . . . . 0.0 111.617 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.574 ' OD1' ' NE ' ' A' ' 163' ' ' ARG . 0.5 OUTLIER -116.9 -126.39 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.498 ' H ' ' HD3' ' A' ' 166' ' ' PRO . 1.3 pttm 141.55 60.89 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.72 1.208 . . . . 0.0 109.575 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.498 ' HD3' ' H ' ' A' ' 165' ' ' LYS . 47.3 Cg_endo -67.19 -46.61 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.924 1.749 . . . . 0.0 112.432 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -118.46 167.5 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -85.14 -35.08 21.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.529 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 1.8 mt-30 -84.16 -25.24 29.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.593 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.6 m95 -122.23 150.31 42.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.462 ' CD2' HG22 ' A' ' 185' ' ' VAL . 11.4 m0 -141.57 129.92 22.4 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.934 0.873 . . . . 0.0 110.696 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.74 ' O ' ' O ' ' A' ' 162' ' ' ILE . 5.5 t30 -81.86 107.95 15.0 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.6 174.17 6.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.5 0.5 . . . . 0.0 110.627 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 33.1 tt0 -123.03 133.32 54.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.4 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.44 169.23 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.505 0.669 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 159' ' ' ILE . 97.4 mmm -76.64 0.67 19.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.81 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.459 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 93.9 m-20 -104.95 -28.38 11.12 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.52 49.64 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.459 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 18.6 mttp -130.19 135.72 48.47 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 114.241 -0.979 . . . . 0.0 110.757 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.77 125.15 52.4 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.523 0.678 . . . . 0.0 111.776 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.13 154.9 25.95 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.444 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 tpt -66.01 154.57 39.12 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 171' ' ' TRP . 1.3 pp -145.02 143.3 20.16 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.35 114.62 4.09 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 N-CA-C 108.694 -1.31 . . . . 0.0 108.694 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.884 ' O ' HG22 ' A' ' 188' ' ' VAL . 41.6 t -49.92 -52.0 56.09 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.949 -0.47 . . . . 0.0 111.979 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.2 Cg_endo -49.8 -28.63 18.3 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.052 1.835 . . . . 0.0 113.773 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.439 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 6.8 m-85 -67.78 3.66 1.39 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.0 m -128.11 167.61 22.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 123.263 0.352 . . . . 0.0 110.297 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.748 ' CD ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -68.39 -48.66 64.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.33 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.514 ' HG3' HG23 ' A' ' 188' ' ' VAL . 3.5 mppt? . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 124.227 1.011 . . . . 0.0 111.513 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.199 0.523 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -60.15 -177.63 1.59 Allowed Glycine 1 CA--C 1.433 -5.054 0 CA-C-O 122.446 1.026 . . . . 0.0 114.41 -179.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.475 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.7 Cg_endo -57.21 125.2 1.38 Allowed 'Cis proline' 0 N--CA 1.533 3.841 0 N-CA-C 115.608 1.349 . . . . 0.0 115.608 -2.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.597 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 12.7 m-85 -150.79 -121.37 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.602 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.529 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 1.0 OUTLIER -143.06 123.83 14.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.721 0.772 . . . . 0.0 110.484 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.883 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.05 -159.24 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.032 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -162.41 87.41 0.62 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.0 p -57.94 123.61 10.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.006 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 15.73 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.726 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.491 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -175.94 112.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.294 0.569 . . . . 0.0 110.237 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.864 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.6 ttmt -158.72 -146.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.182 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.405 HH22 ' HE3' ' A' ' 254' ' ' LYS . 4.3 ptt85 -155.85 -142.53 0.11 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.829 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.601 ' O ' HG12 ' A' ' 248' ' ' VAL . 82.0 t -132.69 66.95 77.7 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.563 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 84.0 Cg_endo -90.56 172.64 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.609 2.206 . . . . 0.0 111.231 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -145.86 142.61 28.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.29 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.46 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 250' ' ' ASN . 60.9 m-85 -93.57 -54.51 3.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 110.791 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -44.67 -67.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 256' ' ' ALA . 26.7 mttt -148.58 32.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.521 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 m 72.28 -15.21 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.608 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.34 156.43 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.68 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.8 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -97.17 148.0 23.51 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.961 0.504 . . . . 0.0 110.359 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.828 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -86.98 115.21 24.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.5 mt -139.77 -176.06 4.44 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.435 0.636 . . . . 0.0 111.126 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 11.2 tt0 -146.28 147.87 31.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.702 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 245' ' ' GLN . 93.5 t -56.59 106.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.289 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 118.03 3.96 14.94 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.1 mm-40 -87.19 -122.22 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.745 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.043 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.4 OUTLIER 161.15 138.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.489 0.661 . . . . 0.0 109.477 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.043 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.5 p -130.84 140.8 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.968 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.424 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.78 88.31 3.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.925 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.465 ' HA ' ' HA2' ' A' ' 278' ' ' GLY . 16.8 t -56.79 151.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.265 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.527 ' O ' HD12 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -158.75 -51.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.465 0.65 . . . . 0.0 110.227 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -74.85 116.53 15.68 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 268' ' ' THR . 2.4 mp -126.27 104.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.756 HD22 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -87.52 -25.86 23.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 178.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.756 ' H ' HD22 ' A' ' 271' ' ' ASN . 5.4 mtm -145.96 176.88 9.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.434 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -91.58 16.11 11.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -134.39 -96.06 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.244 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 63.69 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.769 0.795 . . . . 0.0 110.763 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.532 ' N ' ' CD1' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -69.59 178.71 2.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 1.3 mt-10 -109.12 -163.19 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.067 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -159.23 -160.33 10.33 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.753 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.459 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.5 tt0 -169.42 130.26 1.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.157 0.503 . . . . 0.0 111.683 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.705 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -147.55 75.42 1.36 Allowed 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.354 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 33.9 t30 83.81 31.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.249 0.547 . . . . 0.0 110.318 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 95.63 -31.41 7.21 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.336 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.57 76.54 0.42 Allowed 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.502 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 94.6 mtt180 -76.57 171.8 14.05 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.135 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.87 -156.68 27.68 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.543 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 6.3 p80 -124.32 169.81 11.42 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 122.889 0.476 . . . . 0.0 109.737 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 164.92 114.39 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.26 178.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.05 140.98 58.87 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.626 1.551 . . . . 0.0 112.099 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.517 ' O ' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -67.27 0.01 3.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.031 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 46.2 p -55.15 1.75 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.044 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 289' ' ' PHE . 5.8 p80 -151.7 65.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.901 -0.499 . . . . 0.0 110.789 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 289' ' ' PHE . 12.2 m -156.42 153.37 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -101.53 -55.82 2.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.2 mt 86.76 119.14 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.075 0.941 . . . . 0.0 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.4 mp -72.68 -178.41 2.66 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.689 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -87.41 47.86 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.536 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 51.7 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.456 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.698 ' O ' ' O ' ' A' ' 138' ' ' VAL . 57.6 m-85 . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.698 ' O ' ' O ' ' A' ' 137' ' ' TYR . 27.3 m 34.93 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.012 0.82 . . . . 0.0 111.528 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 36.4 ttt180 -144.49 128.82 17.85 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.996 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -98.83 84.9 3.18 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 123.524 0.515 . . . . 0.0 111.58 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.553 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -95.19 32.57 1.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.224 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 143' ' ' ASP . 45.9 m-85 -134.3 3.46 3.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 142' ' ' PHE . 3.9 p30 51.86 139.48 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 O-C-N 124.919 1.387 . . . . 0.0 110.431 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 t80 -129.31 -49.33 1.19 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 38.97 61.76 1.2 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.94 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -69.34 -149.9 0.36 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 164.99 103.26 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.428 -0.886 . . . . 0.0 109.873 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.594 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 20.4 m-20 173.01 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.442 1.089 . . . . 0.0 112.8 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 62.92 -45.03 0.2 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.904 0.752 . . . . 0.0 109.686 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 148' ' ' ASP . 96.4 mt-10 -85.89 29.41 0.72 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.505 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.575 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.5 p30 -143.52 163.95 31.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.653 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 183' ' ' ILE . 11.4 tp -118.48 91.41 41.41 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.412 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 65.5 Cg_endo -71.91 124.57 10.24 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 121.489 1.46 . . . . 0.0 112.906 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.723 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.6 p90 -144.49 163.47 33.73 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.924 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.499 ' HZ2' ' HB2' ' A' ' 143' ' ' ASP . 0.7 OUTLIER -142.21 150.85 41.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.103 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.996 ' O ' ' O ' ' A' ' 140' ' ' ALA . 11.8 mtpt 73.12 -142.19 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.24 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -107.43 48.52 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 42.9 t0 -56.73 153.58 10.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.026 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.635 HG23 ' HB3' ' A' ' 137' ' ' TYR . 1.5 mp -102.02 106.08 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 154' ' ' PHE . 11.5 mt -112.52 110.57 20.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.953 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -70.03 150.6 46.46 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -94.38 133.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.099 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.561 ' NH2' ' ND2' ' A' ' 172' ' ' ASN . 7.8 tmm_? -107.53 -42.79 4.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.063 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -153.73 128.52 9.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 32.9 pttt -123.88 75.62 57.28 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.6 -40.44 73.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 111.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -106.21 -165.07 1.06 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -118.81 -19.94 8.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.924 0.393 . . . . 0.0 110.386 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -88.35 -33.36 17.99 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.7 m95 -118.64 151.28 38.24 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.521 ' CD2' HG22 ' A' ' 185' ' ' VAL . 14.9 m0 -141.02 129.67 22.78 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.091 0.948 . . . . 0.0 111.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.561 ' ND2' ' NH2' ' A' ' 163' ' ' ARG . 54.7 t30 -79.45 114.51 18.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.94 173.69 8.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.643 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.39 135.89 54.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 175.02 1.26 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.504 0.669 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.06 -4.18 48.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.794 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -101.34 -28.05 12.83 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.95 49.68 0.37 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -130.62 134.81 47.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.629 -0.786 . . . . 0.0 110.697 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.54 127.29 52.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.442 0.639 . . . . 0.0 111.733 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.53 155.08 26.16 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.268 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.48 157.83 33.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.814 0.34 . . . . 0.0 110.337 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.472 HG22 ' HB3' ' A' ' 152' ' ' LEU . 1.2 pp -144.14 142.6 20.26 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.92 113.56 3.82 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.567 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 13.6 t -46.93 -53.65 25.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 121.519 -0.738 . . . . 0.0 112.209 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 8.2 Cg_endo -48.64 -28.04 11.75 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 121.913 1.742 . . . . 0.0 113.234 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -71.17 -0.77 10.5 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.299 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 185' ' ' VAL . 1.9 m -135.82 162.03 37.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.477 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.553 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.7 OUTLIER -115.39 -60.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.443 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.566 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 237' ' ' GLY . 4.4 p30 . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 121.031 0.443 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.525 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -48.49 -175.2 0.01 OUTLIER Glycine 1 CA--C 1.435 -4.944 0 CA-C-O 122.457 1.032 . . . . 0.0 113.266 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.525 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 1.6 Cg_endo -53.07 117.08 0.25 Allowed 'Cis proline' 0 N--CA 1.53 3.671 0 O-C-N 123.635 1.334 . . . . 0.0 115.313 0.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 13.2 m-85 -147.03 -118.37 0.07 Allowed 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.753 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.1 m-30 -143.46 122.68 12.98 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.902 0.858 . . . . 0.0 110.699 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.909 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.18 -161.77 0.82 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.294 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 18.9 tpp180 -160.92 89.5 0.8 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 243' ' ' VAL . 6.0 p -62.35 129.31 25.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.599 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.9 15.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.772 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.6 mm-40 -173.94 113.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.373 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.832 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.2 ttmt -158.92 -146.7 0.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.404 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.8 ptt85 -156.48 -143.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.821 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 248' ' ' VAL . 57.5 t -133.5 69.99 76.65 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.576 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 58.2 Cg_endo -90.63 167.97 4.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.221 2.614 . . . . 0.0 112.971 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.496 ' OD1' ' CB ' ' A' ' 253' ' ' ASP . 46.0 p-10 -97.04 -166.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.275 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.45 11.69 28.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.243 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.5 ' C ' ' H ' ' A' ' 254' ' ' LYS . 6.4 m-85 -123.73 -21.98 5.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.9 t70 -68.3 43.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 253' ' ' ASP . 38.9 mtmt 96.96 0.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.776 0.831 . . . . 0.0 110.898 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 286' ' ' HIS . 0.2 OUTLIER 84.59 61.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.037 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -115.77 107.32 14.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.926 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.6 155.76 0.76 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.61 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.905 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -103.84 121.92 44.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.582 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.6 mt -142.95 -173.98 4.05 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.256 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.4 tt0 -145.91 150.67 36.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.79 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 245' ' ' GLN . 93.9 t -57.94 108.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.615 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.68 5.38 18.47 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.3 mm-40 -88.61 -123.77 0.05 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.77 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.071 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.3 OUTLIER 162.31 138.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.071 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.1 p -131.39 143.16 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.754 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.409 ' NZ ' ' HD3' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -97.91 84.76 3.38 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.434 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.8 t -58.8 150.8 4.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.28 -53.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.411 ' HE3' ' H ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -67.44 144.86 55.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.494 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.411 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -151.16 159.33 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.044 0.449 . . . . 0.0 110.569 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.778 HD21 ' HA ' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -176.94 -107.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.387 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.726 ' N ' HD22 ' A' ' 271' ' ' ASN . 31.6 mtm -42.17 140.86 1.03 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.27 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -74.2 16.1 0.27 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.568 ' O ' ' NE2' ' A' ' 275' ' ' GLN . . . -138.58 -60.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.359 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 274' ' ' GLY . 1.4 mp0 -109.0 101.06 10.18 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.778 ' HA ' HD21 ' A' ' 271' ' ' ASN . 3.6 p-90 -111.9 -165.71 1.01 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 120.846 0.355 . . . . 0.0 110.259 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.5 mt-10 -129.3 167.58 17.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.786 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.87 -151.4 5.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.78 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.503 ' OE2' ' O ' ' A' ' 280' ' ' CYS . 2.5 tm-20 -172.3 128.45 0.56 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.707 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -108.79 -90.72 0.45 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -106.03 51.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.02 5.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.32 83.24 0.09 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 114.591 -0.804 . . . . 0.0 110.065 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -78.14 165.7 23.65 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.292 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 169.23 -158.27 30.66 Favored Glycine 0 C--O 1.215 -1.06 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.56 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 21.7 p80 -122.52 170.48 9.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.029 0.443 . . . . 0.0 110.556 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.09 114.46 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.668 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.513 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 50.7 Cg_exo -50.83 141.31 36.15 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.828 1.686 . . . . 0.0 112.798 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -63.6 0.31 0.79 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.598 0.713 . . . . 0.0 110.018 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 288' ' ' PRO . 66.1 p -56.79 2.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.72 -0.612 . . . . 0.0 112.095 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.517 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.2 p-80 -150.15 64.55 0.96 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.463 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.534 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -160.3 151.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 294' ' ' LEU . 43.3 mtm180 -102.34 -54.74 2.62 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 5.0 mt 91.67 121.09 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.023 0.916 . . . . 0.0 111.322 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.15 -178.12 4.88 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.182 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -87.47 48.58 1.67 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.744 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 47.0 tt0 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.46 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 m -134.33 164.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 111.177 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -123.33 125.99 46.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -105.5 109.53 21.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.982 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.767 HD21 ' HG2' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -118.96 28.47 8.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.851 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 60.0 m-85 -125.29 0.5 7.74 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.49 -0.131 . . . . 0.0 111.164 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.97 139.8 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.738 0 O-C-N 123.901 0.75 . . . . 0.0 110.288 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.607 ' CE2' ' O ' ' A' ' 145' ' ' ASN . 4.3 t80 -133.88 -45.6 0.79 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 144' ' ' PHE . 30.0 m-80 74.86 -109.95 0.03 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.717 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.505 ' C ' ' CZ ' ' A' ' 144' ' ' PHE . . . -133.5 -172.71 13.02 Favored Glycine 0 C--N 1.275 -2.828 0 O-C-N 121.606 -0.684 . . . . 0.0 113.633 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 18.9 t30 174.03 -40.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.966 -1.117 . . . . 0.0 111.911 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 6.4 m-20 -93.03 -159.21 0.66 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 111.785 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.02 -45.09 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.483 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 151' ' ' ASP . 97.3 mt-10 -127.22 28.17 5.78 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.654 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.0 OUTLIER -37.69 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 123.908 0.755 . . . . 0.0 111.786 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.463 HD11 ' CG ' ' A' ' 175' ' ' ASP . 11.7 tp -127.09 98.88 29.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.922 -0.486 . . . . 0.0 111.888 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 145' ' ' ASN . 52.7 Cg_endo -75.16 133.14 16.0 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.635 1.557 . . . . 0.0 112.884 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.75 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 21.2 p90 -155.18 173.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.509 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 176.12 132.28 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.811 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 2.7 mmpt? 95.22 79.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.081 0.863 . . . . 0.0 111.403 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 32.38 47.78 0.29 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.878 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.78 137.88 47.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.091 0.472 . . . . 0.0 109.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.3 mm -98.53 95.67 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.614 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mt -109.35 107.96 18.34 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.44 141.2 54.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.889 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.913 HG22 ' H ' ' A' ' 163' ' ' ARG . 11.8 mm -64.15 -146.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.847 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.913 ' H ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -176.55 -57.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.132 0.491 . . . . 0.0 110.747 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -136.48 -24.54 1.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.312 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.405 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 16.2 pttp 36.43 77.88 0.37 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.68 -39.05 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.93 1.753 . . . . 0.0 112.23 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.3 mt-10 -105.17 162.26 13.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 14.9 pt-20 -84.64 -41.71 16.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.773 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.419 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 36.6 mt-30 -76.77 -29.66 56.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.34 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 73.6 m95 -120.15 153.7 35.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.641 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.5 m0 -148.22 140.74 24.42 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -83.88 117.78 23.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 171.04 8.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 111.601 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 68.3 tt0 -125.0 133.15 53.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.959 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.463 ' CG ' HD11 ' A' ' 152' ' ' LEU . 15.2 m-20 -61.76 177.19 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.463 0.649 . . . . 0.0 110.734 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 23.6 ttt -80.54 -4.66 54.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.463 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.419 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 94.7 m-20 -102.43 -28.12 12.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.34 48.55 0.38 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.419 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 9.1 mttp -128.87 130.63 47.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.057 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.45 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.397 0.618 . . . . 0.0 112.048 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.2 152.81 24.12 Favored Glycine 0 C--N 1.315 -0.607 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.076 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 78.7 mmm -66.19 159.59 26.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.528 0.68 . . . . 0.0 110.972 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 10.1 pt -152.85 145.84 17.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.954 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -71.3 113.71 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.431 1.421 . . . . 0.0 109.583 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.793 ' O ' HG22 ' A' ' 188' ' ' VAL . 43.9 t -49.35 -52.7 46.83 Favored Pre-proline 0 CA--C 1.537 0.457 0 O-C-N 121.956 -0.465 . . . . 0.0 111.816 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.1 Cg_endo -49.6 -27.11 13.96 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.482 2.121 . . . . 0.0 113.992 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.1 m-85 -69.07 10.63 0.27 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.765 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 185' ' ' VAL . 3.1 m -131.96 168.49 23.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.767 ' HG2' HD21 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -146.6 39.4 1.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.152 0.501 . . . . 0.0 111.407 -178.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.499 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 237' ' ' GLY . 33.8 p-10 . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 121.274 0.559 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.537 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -52.36 -176.52 0.05 OUTLIER Glycine 1 CA--C 1.447 -4.212 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.761 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.537 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.4 115.62 0.14 OUTLIER 'Cis proline' 0 N--CA 1.529 3.6 0 N-CA-C 116.333 1.628 . . . . 0.0 116.333 -1.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.687 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 8.0 m-85 -149.41 -126.69 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.822 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 5.5 m-30 -134.93 113.86 11.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 110.018 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 264' ' ' LEU . . . -107.17 139.27 41.88 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.424 ' HA ' ' HB2' ' A' ' 264' ' ' LEU . 17.0 tpp180 -100.17 98.84 9.49 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.527 0.68 . . . . 0.0 111.181 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.87 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.8 p -69.26 117.38 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.093 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.581 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.2 pt -110.91 18.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.444 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.8 mm-40 -176.8 116.96 0.11 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.207 0.527 . . . . 0.0 110.837 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.848 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -160.71 -151.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.822 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -156.28 -134.93 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.457 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.6 t -137.99 62.79 34.9 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.086 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 256' ' ' ALA . 41.8 Cg_endo -98.1 47.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.995 2.463 . . . . 0.0 113.023 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 252' ' ' TYR . 8.0 p-10 -22.62 152.67 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.533 1.146 . . . . 0.0 111.517 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.58 -9.21 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.506 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.799 ' O ' ' N ' ' A' ' 254' ' ' LYS . 38.1 m-85 -76.53 -63.21 1.39 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -47.05 62.42 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 125.384 1.677 . . . . 0.0 111.131 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 252' ' ' TYR . 4.2 mttm 84.26 -49.93 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.908 1.38 . . . . 0.0 109.717 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.88 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -44.31 110.88 0.24 Allowed 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.131 0.491 . . . . 0.0 111.722 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.877 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.9 OUTLIER -43.44 159.58 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.033 -0.417 . . . . 0.0 111.75 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.786 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.81 119.82 40.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.848 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.3 mt -141.15 -175.73 4.43 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.8 tt0 -144.21 144.3 31.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.357 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 244' ' ' ILE . 58.2 t -48.98 106.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.423 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.79 14.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 57.1 mm-40 -92.71 -41.61 10.06 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.331 0.586 . . . . 0.0 112.38 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.979 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 69.12 140.12 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.62 -178.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.979 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.2 p -131.43 156.92 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.485 ' N ' HG22 ' A' ' 265' ' ' VAL . 0.8 OUTLIER -102.71 88.24 3.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.639 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 238' ' ' PRO . 5.0 t -67.76 121.95 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.005 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.61 ' O ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -110.28 -52.63 2.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 8.5 tppt? -82.08 125.89 31.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 112.119 -177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 268' ' ' THR . 4.6 mp -139.88 126.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.549 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -121.08 -106.42 0.37 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.603 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.559 ' N ' ' ND2' ' A' ' 271' ' ' ASN . 35.0 mtm -38.09 149.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.655 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.8 p -71.55 15.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -140.75 -69.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.474 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 98.0 mm-40 -82.79 173.03 12.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.61 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 5.9 p-90 170.89 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.068 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 6.6 mt-10 -126.93 173.26 9.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.68 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -150.3 -155.85 7.04 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.354 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.495 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -171.66 121.98 0.51 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.69 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -108.37 -98.03 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -95.6 50.46 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.41 -30.96 5.36 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 89.93 0.07 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.457 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.495 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 75.7 mtt180 -85.36 168.03 15.02 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.567 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.63 -156.26 28.01 Favored Glycine 0 C--N 1.308 -1.019 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.559 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 12.6 p80 -128.01 170.79 12.49 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.894 0.477 . . . . 0.0 111.066 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.61 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 168.87 114.47 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.248 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 290' ' ' THR . 68.4 Cg_exo -48.55 141.01 20.75 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.575 1.517 . . . . 0.0 112.518 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.6 OUTLIER -62.98 -1.0 0.78 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.478 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.9 p -55.89 0.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 289' ' ' PHE . 4.9 p-80 -153.13 66.38 0.78 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.579 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -161.75 146.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.13 81.97 2.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 27.4 mt -37.71 130.09 1.08 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.343 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.0 mp -71.93 -170.13 0.55 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.852 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.92 21.31 0.43 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.606 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.6 tt0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.428 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.878 ' O ' HG22 ' A' ' 138' ' ' VAL . 53.6 m-85 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 90.77 161.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 125.367 1.667 . . . . 0.0 111.66 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -140.85 157.78 44.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.152 0.977 . . . . 0.0 111.468 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.661 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . . . -56.41 162.26 2.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.667 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.7 mt -136.36 -37.45 0.7 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.969 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.588 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 95.2 m-85 -124.87 6.66 8.04 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 79.41 142.1 0.08 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.407 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.0 t80 -121.63 -50.67 2.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.004 0.43 . . . . 0.0 111.577 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 13.5 m-80 42.83 62.7 1.69 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.409 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.416 ' N ' ' HB3' ' A' ' 153' ' ' PRO . . . -77.53 -154.74 6.73 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 163.73 -6.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.1 -1.05 . . . . 0.0 112.085 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.483 ' N ' HD22 ' A' ' 147' ' ' ASN . 53.2 m-20 -55.16 -121.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.497 0.665 . . . . 0.0 111.417 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 151' ' ' ASP . 7.2 p-10 -66.59 47.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.692 ' O ' ' O ' ' A' ' 151' ' ' ASP . 21.5 mp0 67.78 19.75 9.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.692 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.9 OUTLIER -39.65 -169.86 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 O-C-N 123.863 0.727 . . . . 0.0 111.869 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.497 HD11 ' CG ' ' A' ' 175' ' ' ASP . 5.8 tp -113.53 91.2 19.7 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 121.242 -0.911 . . . . 0.0 111.6 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.416 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 67.2 Cg_endo -70.92 128.26 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.785 0.99 . . . . 0.0 112.175 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.661 ' CD1' ' HB2' ' A' ' 140' ' ' ALA . 10.1 p90 -144.92 172.98 12.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.589 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -112.07 -106.7 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.933 0.396 . . . . 0.0 111.396 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 155' ' ' LYS . 25.5 ttpt -135.72 122.09 20.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.56 15.62 54.57 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.251 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.17 133.48 34.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.2 mm -101.67 116.13 44.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mt -122.54 122.33 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -75.16 128.71 36.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.384 0.611 . . . . 0.0 111.828 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.6 mm -66.62 126.49 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.487 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.605 ' HE ' ' HE ' ' A' ' 180' ' ' ARG . 72.5 ttt-85 -76.58 -51.99 10.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.627 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 164' ' ' ASP . 51.0 t0 -157.27 -10.33 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.357 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.481 ' HB2' ' CD1' ' A' ' 171' ' ' TRP . 4.6 ptmm? 35.97 79.98 0.28 Allowed Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.511 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.53 -44.59 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 49.8 mt-10 -91.93 158.29 16.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.913 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 15.6 pt-20 -82.28 -41.26 20.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.766 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 35.1 mt-30 -83.13 -24.47 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.437 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 63.1 m95 -124.23 150.42 45.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.614 ' CD2' HG22 ' A' ' 185' ' ' VAL . 13.3 m0 -140.5 133.05 28.65 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.678 0.751 . . . . 0.0 111.581 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -79.05 100.35 7.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.41 170.71 8.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -130.29 141.8 50.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.026 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.497 ' CG ' HD11 ' A' ' 152' ' ' LEU . 31.3 m-20 -70.5 173.07 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.478 0.656 . . . . 0.0 110.218 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.9 mmm -77.14 -8.19 57.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.895 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -102.01 -26.5 13.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.21 47.1 0.39 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -122.6 131.68 53.94 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.288 -0.956 . . . . 0.0 110.609 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.605 ' HE ' ' HE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -109.28 113.92 27.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.831 0.824 . . . . 0.0 113.044 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -142.84 143.59 12.78 Favored Glycine 0 C--N 1.305 -1.187 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.691 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.1 mtp -62.42 161.53 11.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.485 0.66 . . . . 0.0 110.432 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.437 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 4.4 pt -150.6 145.86 18.95 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.874 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.3 118.7 5.63 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.41 1.407 . . . . 0.0 109.285 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.614 HG22 ' CD2' ' A' ' 171' ' ' TRP . 25.2 t -54.25 -51.49 77.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -49.64 -29.43 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.543 1.495 . . . . 0.0 113.154 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.542 ' OH ' ' O ' ' A' ' 268' ' ' THR . 10.8 m-85 -72.37 -10.62 60.03 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.328 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 138' ' ' VAL . 1.3 m -132.89 165.13 33.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.519 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 190' ' ' LYS . 2.3 pp20? -143.64 -49.96 0.31 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.017 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' A' ' 189' ' ' GLU . 3.2 tmtm? . . . . . 0 N--CA 1.42 -1.971 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 120.989 0.423 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -35.76 161.54 0.01 OUTLIER Glycine 1 CA--C 1.436 -4.882 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.898 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.422 ' HD2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 Cg_exo -75.88 115.45 3.55 Favored 'Cis proline' 0 N--CA 1.521 3.089 0 O-C-N 122.645 0.813 . . . . 0.0 112.015 -5.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.718 ' O ' ' HG3' ' A' ' 266' ' ' LYS . 43.0 m-85 -145.97 -125.86 0.07 Allowed 'General case' 0 C--O 1.189 -2.088 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 0.8 OUTLIER -142.07 116.14 9.39 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 120.105 1.32 . . . . 0.0 109.801 -177.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.796 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -88.93 -157.51 0.44 Allowed 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -157.7 90.49 1.08 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.563 0.696 . . . . 0.0 109.544 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.727 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.0 p -66.22 122.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.523 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.71 16.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.67 100.56 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.242 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.838 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -134.14 -143.16 0.2 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 10.5 ptt85 -158.83 -134.89 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 248' ' ' VAL . 81.1 t -135.79 68.17 65.04 Favored Pre-proline 0 N--CA 1.473 0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.876 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.566 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 67.7 Cg_endo -92.82 177.8 1.41 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 123.355 2.703 . . . . 0.0 111.694 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.658 ' O ' ' N ' ' A' ' 252' ' ' TYR . 24.6 p30 -147.21 145.16 29.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.862 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.81 -14.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.562 0.539 . . . . 0.0 111.313 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.658 ' N ' ' O ' ' A' ' 250' ' ' ASN . 44.1 m-85 -83.54 -55.54 4.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.285 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 33.1 t70 -52.41 67.94 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 124.736 1.273 . . . . 0.0 111.691 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 252' ' ' TYR . 31.3 mtmt 73.52 -7.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 0.0 111.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 1.4 m 92.64 52.8 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.129 0.893 . . . . 0.0 111.903 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.432 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -109.87 112.72 24.92 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.924 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.6 OUTLIER -41.88 157.98 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.689 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.94 116.33 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.522 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.838 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.7 OUTLIER -139.0 -175.35 4.12 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 263' ' ' GLU . 2.3 tt0 -148.02 148.67 30.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.981 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 56.3 t -45.52 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.044 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 103.63 13.09 28.84 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 260' ' ' GLU . 37.8 mm-40 -90.11 -35.1 15.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.26 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.074 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.83 139.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.958 0.885 . . . . 0.0 110.774 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.074 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.1 p -136.17 164.69 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.082 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.718 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -108.33 103.17 12.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.585 ' C ' HG23 ' A' ' 268' ' ' THR . 1.2 t -57.1 -53.92 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER 62.48 -66.01 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 124.473 1.108 . . . . 0.0 109.974 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -65.47 150.05 49.01 Favored 'General case' 0 C--O 1.181 -2.524 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.735 -177.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.603 HD13 ' N ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -162.86 128.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.171 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.673 ' ND2' ' HG3' ' A' ' 272' ' ' MET . 0.1 OUTLIER -155.2 -40.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 177.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.928 ' HE3' ' H ' ' A' ' 274' ' ' GLY . 0.0 OUTLIER -124.3 173.24 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.915 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 1.5 p -105.98 20.2 19.33 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.928 ' H ' ' HE3' ' A' ' 272' ' ' MET . . . -118.99 -74.25 0.44 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.84 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.664 ' CD ' ' N ' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -54.64 -91.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 123.422 1.582 . . . . 0.0 110.393 -178.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.915 ' HE1' ' C ' ' A' ' 273' ' ' SER . 1.2 m0 88.1 127.54 0.03 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 267' ' ' VAL . 21.4 mt-10 -86.54 168.51 13.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.712 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 284' ' ' ARG . . . -155.19 136.33 5.08 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.902 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.455 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -122.99 125.45 45.27 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.463 0.743 . . . . 0.0 110.364 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.641 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -143.23 78.89 1.62 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.063 -176.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.7 m-20 84.33 41.67 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.819 0.819 . . . . 0.0 109.351 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.41 -35.96 3.4 Favored Glycine 0 CA--C 1.495 -1.162 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.112 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -61.82 104.22 0.42 Allowed 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 114.588 -0.806 . . . . 0.0 109.773 -176.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 278' ' ' GLY . 33.2 mtt85 -108.8 165.84 11.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 121.397 0.618 . . . . 0.0 109.834 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 173.17 -148.83 10.65 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.559 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 16.8 p80 -132.24 168.33 18.25 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.549 0.174 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.71 120.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.805 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 275' ' ' GLN . 74.5 Cg_exo -46.01 134.53 14.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.864 1.71 . . . . 0.0 113.679 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.726 ' HB2' ' CE3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -66.73 -3.62 7.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.663 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.2 p -62.16 -0.49 0.54 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.6 p-80 -139.17 54.5 1.72 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.204 0.456 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.29 148.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.7 -46.92 3.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 1.3 mt 82.96 131.39 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.223 1.011 . . . . 0.0 112.01 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 9.3 mp -79.4 -168.05 1.4 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.849 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -74.6 12.19 0.86 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 295' ' ' LEU . 56.6 tt0 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.044 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.005 ' O ' HG22 ' A' ' 138' ' ' VAL . 80.7 m-85 . . . . . 0 CA--C 1.486 -1.483 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.995 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 1.005 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.4 m 84.44 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 125.427 1.704 . . . . 0.0 111.107 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -121.34 139.7 53.08 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 120.93 0.395 . . . . 0.0 110.324 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.67 ' HB1' ' CD1' ' A' ' 154' ' ' PHE . . . -105.27 98.75 8.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.98 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.722 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.2 OUTLIER -114.69 32.98 5.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.606 -178.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.574 ' CD2' HD12 ' A' ' 141' ' ' LEU . 69.6 m-85 -125.22 1.74 7.84 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.53 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 269' ' ' LYS . 0.2 OUTLIER 60.96 136.83 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.029 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 4.4 t80 -134.56 -35.26 0.9 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 111.339 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 40.21 61.34 1.56 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.355 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.465 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -64.58 -119.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.596 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.9 OUTLIER 170.54 -92.37 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.902 0.382 . . . . 0.0 111.733 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.636 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 28.8 m-20 -49.95 178.2 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.206 0.527 . . . . 0.0 111.133 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 151' ' ' ASP . 99.9 m-20 -68.54 -42.37 78.51 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.854 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.26 3.98 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 2.7 p30 -133.79 150.2 51.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.483 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 8.7 tp -119.6 89.43 41.04 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-O 120.406 0.146 . . . . 0.0 110.685 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 37.6 Cg_exo -57.48 147.29 79.23 Favored 'Trans proline' 0 C--N 1.288 -2.618 0 C-N-CA 122.236 1.957 . . . . 0.0 113.612 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.67 ' CD1' ' HB1' ' A' ' 140' ' ' ALA . 5.9 p90 -172.53 156.89 3.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.618 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 157' ' ' GLY . 3.4 ttmp? -169.69 -55.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.436 0.636 . . . . 0.0 111.697 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 156' ' ' LYS . 8.7 mmmm -45.14 -16.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.999 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 155' ' ' LYS . . . 102.09 57.29 0.81 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -90.47 150.59 21.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.415 0.626 . . . . 0.0 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.6 mm -94.61 115.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 137' ' ' TYR . 8.6 mt -113.26 120.91 42.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.688 -176.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 65.9 tttm -68.87 141.66 55.01 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.642 ' O ' ' O ' ' A' ' 172' ' ' ASN . 34.7 mm -75.98 -64.17 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.866 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 162' ' ' ILE . 56.0 ttt180 79.96 -44.07 0.27 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.869 0.366 . . . . 0.0 111.31 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -146.08 122.49 10.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.454 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.555 ' HG3' ' NE1' ' A' ' 171' ' ' TRP . 2.4 ttmt -107.67 74.67 0.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.24 -60.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.166 1.911 . . . . 0.0 111.994 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.98 161.0 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -84.79 -34.81 22.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.632 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 92.8 mt-30 -83.53 -29.08 28.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.444 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.43 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 70.9 m95 -122.99 149.85 43.76 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.559 ' CD2' HG22 ' A' ' 185' ' ' VAL . 17.1 m0 -138.34 129.6 27.35 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.349 0.595 . . . . 0.0 111.418 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 162' ' ' ILE . 53.1 t30 -80.81 108.04 14.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.62 171.64 7.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.569 0.543 . . . . 0.0 111.087 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 72.7 tt0 -125.14 135.7 52.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.111 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.37 172.32 2.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.445 0.641 . . . . 0.0 110.578 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.0 mmm -79.89 -0.0 33.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.004 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -104.43 -27.73 11.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.55 49.82 0.34 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 174' ' ' GLU . 46.7 mttt -131.08 134.33 46.51 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.644 -0.778 . . . . 0.0 110.81 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.14 51.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.527 0.68 . . . . 0.0 111.99 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.03 154.25 25.34 Favored Glycine 0 C--N 1.317 -0.516 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.086 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 tpt -68.35 162.78 24.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.371 0.605 . . . . 0.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 5.4 pt -154.8 143.2 14.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.432 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HG2' ' CG ' ' A' ' 187' ' ' TYR . 18.4 Cg_endo -70.19 118.05 5.46 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.346 1.364 . . . . 0.0 108.888 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.896 ' O ' HG22 ' A' ' 188' ' ' VAL . 15.6 t -50.99 -53.46 47.87 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 121.755 -0.59 . . . . 0.0 111.712 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 16.5 Cg_endo -51.93 -25.29 21.37 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 122.313 2.009 . . . . 0.0 113.578 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.8 m-85 -72.2 9.7 0.93 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 185' ' ' VAL . 4.8 m -135.4 167.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.948 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.722 ' CD ' HD21 ' A' ' 141' ' ' LEU . 36.7 mt-10 -91.94 -70.56 0.68 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.452 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.619 ' O ' HG12 ' A' ' 138' ' ' VAL . 4.8 tptp . . . . . 0 CA--C 1.51 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.57 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 141.95 -173.52 23.6 Favored Glycine 1 CA--C 1.442 -4.488 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.615 178.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.483 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 5.9 Cg_exo -46.0 105.77 0.03 OUTLIER 'Cis proline' 1 N--CA 1.536 4.024 0 O-C-N 123.755 1.397 . . . . 0.0 115.488 0.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.604 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.1 m-30 -120.57 -127.78 0.27 Allowed 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.624 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.8 OUTLIER -141.46 124.01 15.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.66 0.743 . . . . 0.0 110.198 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.924 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -104.59 -163.0 0.93 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.387 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 19.5 tpp180 -161.47 89.87 0.77 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.214 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 243' ' ' VAL . 5.3 p -64.7 121.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.505 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.98 12.32 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.554 ' HA ' HG22 ' A' ' 261' ' ' VAL . 2.0 mm-40 -169.01 120.39 0.74 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 110.565 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.839 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -163.04 -145.56 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.591 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.4 ptt85 -155.75 -142.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.654 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 248' ' ' VAL . 78.7 t -132.84 67.83 78.3 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.608 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 74.5 Cg_endo -91.62 172.7 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.135 2.557 . . . . 0.0 111.61 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.765 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.0 OUTLIER -143.98 140.83 29.85 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.914 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.32 -2.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.887 0.742 . . . . 0.0 112.184 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.765 ' N ' ' O ' ' A' ' 250' ' ' ASN . 2.5 m-85 -96.78 -54.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 123.591 0.756 . . . . 0.0 110.044 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -44.41 -65.84 0.47 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.555 ' C ' ' H ' ' A' ' 256' ' ' ALA . 25.8 mttt -149.05 33.3 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.757 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.408 ' O ' ' CA ' ' A' ' 285' ' ' GLY . 1.7 m 71.19 -16.53 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.822 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -48.81 161.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.826 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -105.29 150.53 25.08 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.846 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -91.57 119.44 31.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 258' ' ' ALA . 3.7 mt -140.48 -172.14 3.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.438 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 17.8 tt0 -147.23 146.13 29.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.065 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 245' ' ' GLN . 68.9 t -55.35 102.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.639 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 121.84 8.01 7.66 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 64.8 mm-40 -90.57 -124.8 0.07 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.841 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.3 OUTLIER 161.61 136.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.053 ' N ' HD12 ' A' ' 264' ' ' LEU . 10.7 p -126.29 142.78 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.287 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 2.6 ttmt -100.63 83.36 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.188 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 75.2 t -51.96 151.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.449 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -151.7 -51.34 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.693 -178.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.524 ' O ' ' OE1' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -70.52 104.13 2.68 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.076 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 270' ' ' ILE . 1.7 mp -95.14 154.61 3.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.625 HD21 ' HA ' ' A' ' 276' ' ' TRP . 0.1 OUTLIER -171.63 -97.83 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.153 179.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.648 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 19.3 mtm -59.0 134.91 57.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.831 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.9 p -66.97 25.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -152.12 -69.89 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.648 ' O ' ' HE3' ' A' ' 272' ' ' MET . 21.4 mp0 -92.19 112.52 24.49 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.148 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.625 ' HA ' HD21 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -116.18 -171.8 2.06 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.524 ' OE1' ' O ' ' A' ' 269' ' ' LYS . 54.8 mp0 -97.09 -160.49 0.8 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.492 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -173.76 117.71 0.66 Allowed Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.525 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.466 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.2 tt0 -99.49 127.82 45.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.34 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.729 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -144.39 78.97 1.59 Allowed 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 3.9 m-20 82.63 30.09 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 0.0 109.921 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 93.95 -32.64 5.72 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.405 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.571 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.4 OUTLIER -66.21 72.81 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.762 -178.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.554 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 90.5 mtt180 -72.82 168.04 19.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 123.886 0.741 . . . . 0.0 109.918 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 168.94 -158.07 30.48 Favored Glycine 0 C--O 1.206 -1.653 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.588 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 3.8 p80 -124.71 167.41 14.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.249 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 167.65 115.14 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.223 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.5 Cg_exo -51.68 145.13 31.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.963 1.775 . . . . 0.0 112.304 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.2 OUTLIER -64.25 -0.11 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 110.465 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.2 p -56.27 3.85 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 O-C-N 121.81 -0.556 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' A' ' 289' ' ' PHE . 3.9 p-80 -156.11 69.69 0.66 Allowed 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.574 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -165.86 154.33 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -129.35 76.19 1.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.24 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.6 mt -38.08 127.97 1.3 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.438 0.637 . . . . 0.0 111.368 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.97 -99.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.767 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -159.02 -85.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.412 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.604 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 3.9 tp-100 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.474 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.958 ' O ' HG22 ' A' ' 138' ' ' VAL . 13.1 p90 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.902 -0.57 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.958 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.4 m 86.17 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 125.0 1.437 . . . . 0.0 111.646 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -128.15 138.29 52.44 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -96.84 98.92 10.52 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.753 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.497 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -104.51 37.51 2.1 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.271 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 53.5 m-85 -135.17 0.82 2.88 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.515 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER 60.55 139.51 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.887 0.742 . . . . 0.0 109.273 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.0 t80 -128.48 -38.68 1.72 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.079 0.399 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t30 40.54 56.25 2.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.517 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.67 -132.3 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.631 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.8 OUTLIER 169.5 -89.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.355 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.58 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.7 m-20 -19.58 134.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 112.225 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.2 -3.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.442 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 148' ' ' ASP . 12.5 pt-20 -108.12 16.76 23.03 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.631 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 8.2 p30 -137.54 152.82 49.86 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 182' ' ' MET . 12.6 tp -107.72 90.35 6.16 Favored Pre-proline 0 C--O 1.215 -0.76 0 CA-C-N 118.181 0.446 . . . . 0.0 110.717 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 74.1 Cg_endo -66.97 146.47 77.62 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 C-N-CA 121.364 1.376 . . . . 0.0 114.082 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 11.8 p90 -169.97 162.84 9.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.82 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -152.76 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.885 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -97.93 129.44 44.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.879 0.847 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . 88.89 12.39 64.0 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.45 ' C ' HD12 ' A' ' 159' ' ' ILE . 27.0 t0 -75.04 139.8 43.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -97.56 114.76 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.459 HD11 ' CD2' ' A' ' 154' ' ' PHE . 10.8 mt -125.42 133.9 52.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.923 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -81.6 140.2 34.58 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.108 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.2 mp -66.37 -52.07 51.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.656 ' CZ ' HH21 ' A' ' 180' ' ' ARG . 54.1 ttt85 66.85 -48.18 0.46 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.306 0.379 . . . . 0.0 111.215 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 162' ' ' ILE . 41.0 t0 -152.93 133.5 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.432 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.44 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.9 pttp -133.94 78.67 59.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.64 -31.2 7.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.165 1.91 . . . . 0.0 112.539 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -101.81 -174.47 2.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 168' ' ' GLU . 1.5 pm0 -115.25 -13.97 11.71 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -109.47 -29.33 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.825 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 76.5 m95 -121.04 146.25 46.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.608 ' CD2' HG22 ' A' ' 185' ' ' VAL . 16.4 m0 -137.38 125.61 23.14 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 162' ' ' ILE . 18.9 t-20 -76.09 101.62 5.39 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.38 173.56 6.25 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.467 0.479 . . . . 0.0 111.079 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 21.4 tt0 -121.45 123.63 42.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.067 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.75 173.35 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.234 0.54 . . . . 0.0 110.211 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 96.1 mtp -72.84 -3.05 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.851 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 179' ' ' LYS . 89.5 m-20 -98.63 -20.23 17.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.361 0.601 . . . . 0.0 110.905 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 120.68 -28.89 6.03 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 177' ' ' ASP . 16.9 mttp -52.49 146.79 9.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.19 0.519 . . . . 0.0 110.813 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.656 HH21 ' CZ ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -114.67 130.62 56.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.344 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.84 157.12 28.37 Favored Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.387 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.525 ' C ' HG22 ' A' ' 183' ' ' ILE . 1.8 tpt -68.4 163.28 23.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.169 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.879 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -161.32 147.79 11.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.554 178.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.07 115.84 4.47 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.107 1.205 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 188' ' ' VAL . 38.3 t -53.49 -52.05 70.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 122.041 -0.412 . . . . 0.0 111.541 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.2 Cg_endo -49.11 -27.7 12.81 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.487 2.125 . . . . 0.0 113.345 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.28 4.95 0.43 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.055 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 138' ' ' VAL . 1.8 m -130.43 168.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 123.109 0.256 . . . . 0.0 110.764 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -100.09 -66.34 0.91 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.027 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 45.0 tptt . . . . . 0 CA--C 1.542 0.653 0 O-C-N 124.993 1.433 . . . . 0.0 109.703 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 15.4 p30 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.55 0.691 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.476 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -61.37 -175.73 1.8 Allowed Glycine 1 CA--C 1.447 -4.164 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.23 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.476 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.9 Cg_endo -53.21 122.97 0.4 Allowed 'Cis proline' 0 N--CA 1.525 3.367 0 N-CA-C 116.481 1.685 . . . . 0.0 116.481 -1.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.2 m-85 -154.67 -121.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.7 OUTLIER -145.18 135.09 23.69 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 118.976 0.807 . . . . 0.0 108.962 -179.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.541 ' O ' HD13 ' A' ' 295' ' ' LEU . . . -117.94 -148.51 0.42 Allowed 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.174 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 262' ' ' GLY . 21.6 tpp180 -161.93 95.15 0.96 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.627 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 263' ' ' GLU . 2.9 p -61.62 137.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.783 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.8 20.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 176.48 103.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -145.88 -143.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.959 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -155.51 -139.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.015 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 248' ' ' VAL . 70.8 t -133.91 68.65 75.11 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-O 121.215 0.531 . . . . 0.0 110.887 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.649 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 61.3 Cg_endo -91.63 175.63 2.17 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.816 2.344 . . . . 0.0 111.209 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.767 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.9 OUTLIER -142.89 140.0 31.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -37.1 -8.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.46 0.648 . . . . 0.0 111.983 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.767 ' N ' ' O ' ' A' ' 250' ' ' ASN . 4.8 m-85 -92.41 -48.77 6.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 250' ' ' ASN . 27.9 t0 -65.09 56.39 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.661 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 256' ' ' ALA . 33.0 mtmt 85.55 20.28 0.1 Allowed 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.642 1.214 . . . . 0.0 111.47 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.519 ' O ' ' O ' ' A' ' 284' ' ' ARG . 2.4 m 75.49 -19.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.021 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -39.74 107.52 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.949 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -47.03 157.3 0.17 Allowed 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.777 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.83 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -110.17 124.43 51.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.954 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.83 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.3 mt -142.66 -179.08 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.069 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 6.7 tt0 -133.86 146.06 50.24 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.787 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 52.9 t -45.96 110.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.102 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.781 ' O ' ' O ' ' A' ' 263' ' ' GLU . . . 131.06 -70.56 0.52 Allowed Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.781 ' O ' ' O ' ' A' ' 262' ' ' GLY . 4.1 mm-40 -29.08 -163.4 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.444 0 O-C-N 125.764 1.508 . . . . 0.0 114.142 -172.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 264' ' ' LEU . 3.8 pp -155.57 166.04 34.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.281 1.038 . . . . 0.0 112.518 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.09 143.22 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.525 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 279' ' ' GLU . 0.0 OUTLIER -101.39 85.32 2.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.591 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.2 155.49 2.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.939 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.73 -56.24 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.038 0.446 . . . . 0.0 109.807 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 102.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.689 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.61 HG23 ' CE3' ' A' ' 276' ' ' TRP . 5.7 mt -115.17 106.46 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.871 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.702 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -111.45 -101.53 0.4 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.623 ' O ' ' CE3' ' A' ' 276' ' ' TRP . 38.6 mtm -51.26 148.33 4.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.003 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 p -72.17 16.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.507 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.86 -80.9 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.227 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -86.18 116.37 24.33 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 121.002 0.429 . . . . 0.0 111.358 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -134.58 -172.92 3.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.742 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.53 -171.79 2.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.92 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -159.89 -152.78 6.64 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.056 -1.068 . . . . 0.0 112.348 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 281' ' ' ASN . 0.5 OUTLIER -168.59 139.33 2.53 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.192 0.52 . . . . 0.0 112.168 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.706 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -148.05 76.25 1.37 Allowed 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.102 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 279' ' ' GLU . 1.5 m120 84.35 36.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.81 -35.84 3.67 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.843 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -63.89 88.0 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.169 0.509 . . . . 0.0 110.257 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.519 ' O ' ' O ' ' A' ' 255' ' ' THR . 43.9 mtt85 -86.45 168.1 14.07 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.278 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.11 -154.6 24.68 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.583 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 13.1 p80 -129.37 172.14 11.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.2 114.39 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.431 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.526 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 54.5 Cg_exo -48.4 129.53 19.67 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.222 1.281 . . . . 0.0 112.255 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -62.98 -1.92 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.275 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 288' ' ' PRO . 53.0 p -58.77 2.21 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.889 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.2 p-80 -142.82 50.88 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.739 0.304 . . . . 0.0 111.633 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.416 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.2 OUTLIER -145.89 166.3 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 294' ' ' LEU . 18.8 mtm180 -136.85 77.02 1.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.529 0.204 . . . . 0.0 110.878 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 35.1 mt -34.29 134.37 0.2 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.398 0.618 . . . . 0.0 111.274 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 241' ' ' ALA . 3.4 mp -79.08 -165.39 0.75 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.365 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 42.5 p-10 -77.43 -0.42 25.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.63 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 27.5 tt0 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.09 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.671 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.671 ' O ' ' O ' ' A' ' 137' ' ' TYR . 32.6 m 36.38 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 122.08 0.943 . . . . 0.0 112.635 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 14.9 ttp180 -143.47 120.38 11.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.413 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -98.78 91.51 5.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 124.321 1.013 . . . . 0.0 111.812 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.727 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -99.78 18.97 16.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.285 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.575 ' CE1' ' CZ ' ' A' ' 284' ' ' ARG . 46.8 m-85 -114.98 0.91 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.7 OUTLIER 58.57 138.01 0.01 OUTLIER 'General case' 0 C--O 1.209 -1.035 0 O-C-N 124.407 1.067 . . . . 0.0 110.014 -179.194 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.433 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 17.2 t80 -130.06 -46.69 1.12 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.905 0.321 . . . . 0.0 110.44 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 144' ' ' PHE . 66.3 t30 36.04 58.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.484 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -61.6 -93.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 170.31 15.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.966 0.888 . . . . 0.0 110.316 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 151' ' ' ASP . 1.3 p-10 33.66 -159.2 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.156 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.511 ' N ' ' OD2' ' A' ' 148' ' ' ASP . 97.7 m-20 48.64 38.81 12.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 149' ' ' ASP . 3.6 mm-40 149.71 -10.2 0.0 OUTLIER 'General case' 0 C--N 1.345 0.386 0 O-C-N 124.701 1.251 . . . . 0.0 108.987 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 0.2 OUTLIER -157.45 -178.02 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.793 -178.06 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 175' ' ' ASP . 10.7 tp -118.04 87.67 29.27 Favored Pre-proline 0 C--O 1.206 -1.203 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.508 ' HD3' ' H ' ' A' ' 148' ' ' ASP . 71.6 Cg_endo -71.38 139.74 35.4 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 CA-C-N 120.03 1.046 . . . . 0.0 112.079 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.609 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.1 p90 -160.9 163.76 31.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -155.88 169.08 25.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.811 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 157' ' ' GLY . 3.5 ttmt 50.43 82.67 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.334 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.1 47.41 0.01 OUTLIER Glycine 0 N--CA 1.467 0.715 0 O-C-N 123.834 0.709 . . . . 0.0 113.008 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.502 ' C ' HD12 ' A' ' 159' ' ' ILE . 35.3 t0 -62.71 159.69 15.74 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.547 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.565 HG23 ' CB ' ' A' ' 137' ' ' TYR . 1.5 mp -109.2 106.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 154' ' ' PHE . 6.4 mt -109.47 106.84 16.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.458 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -64.73 129.12 38.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.64 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.964 HG22 ' H ' ' A' ' 163' ' ' ARG . 42.7 mm -66.44 -134.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.857 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.964 ' H ' HG22 ' A' ' 162' ' ' ILE . 77.4 ttt180 175.75 -48.78 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.518 0.675 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.63 -19.12 0.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.071 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.4 pttt 37.04 72.89 0.76 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 123.205 0.315 . . . . 0.0 111.202 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.28 -43.15 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.592 1.528 . . . . 0.0 112.059 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.59 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 76.4 mm-40 -99.29 157.06 16.65 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.909 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.427 ' O ' HG21 ' A' ' 185' ' ' VAL . 2.7 pt-20 -85.06 -36.46 21.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.381 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -82.59 -26.14 32.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.831 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 85.2 m95 -127.32 150.98 49.34 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.666 ' CE3' HG22 ' A' ' 185' ' ' VAL . 13.0 m0 -145.07 136.03 24.73 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.874 0.368 . . . . 0.0 110.234 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -86.8 110.36 19.89 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.43 ' HB3' HG21 ' A' ' 183' ' ' ILE . . . -119.62 -178.58 3.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.633 . . . . 0.0 111.528 -178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -123.68 125.35 44.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -56.8 172.5 0.26 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.94 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -78.61 2.67 18.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.059 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.99 -29.26 10.57 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.05 51.16 0.52 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -135.81 140.51 44.29 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.644 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.06 121.43 44.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 111.343 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . 0.446 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -155.28 153.29 24.67 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.191 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.5 mtp -65.9 152.41 44.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -138.49 143.36 38.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.023 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.57 114.58 4.05 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.314 1.343 . . . . 0.0 108.914 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.801 ' O ' HG22 ' A' ' 188' ' ' VAL . 47.4 t -52.85 -51.23 76.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.823 -0.548 . . . . 0.0 111.944 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.6 Cg_endo -48.56 -29.39 13.94 Favored 'Trans proline' 0 N--CA 1.504 2.137 0 C-N-CA 122.669 2.246 . . . . 0.0 113.014 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.8 m-85 -67.93 -0.92 4.8 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.712 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.2 m -128.98 166.41 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.283 0.364 . . . . 0.0 110.633 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.727 ' CD ' HD21 ' A' ' 141' ' ' LEU . 2.5 pt-20 -146.72 50.58 1.12 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.476 ' O ' HG12 ' A' ' 138' ' ' VAL . 3.8 tmtt? . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.125 0.488 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.594 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -59.83 -178.61 1.62 Allowed Glycine 1 CA--C 1.427 -5.427 0 CA-C-O 122.631 1.128 . . . . 0.0 115.464 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.594 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 3.3 Cg_exo -52.44 127.83 1.01 Allowed 'Cis proline' 1 N--CA 1.538 4.095 0 O-C-N 124.766 1.929 . . . . 0.0 115.698 -1.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.6 m-85 -155.24 -122.87 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.72 123.85 14.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 120.389 1.45 . . . . 0.0 109.165 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.502 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -108.53 141.75 39.96 Favored 'General case' 0 C--O 1.19 -2.043 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.247 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -104.57 96.99 6.97 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 121.616 0.722 . . . . 0.0 110.664 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.824 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.9 p -69.1 112.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.616 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.589 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.2 pt -105.78 17.79 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.194 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.465 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.9 mm-40 -176.79 119.84 0.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.085 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.805 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.5 ttmt -161.24 -145.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.982 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 2.9 ptt85 -156.25 -141.42 0.09 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.821 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 248' ' ' VAL . 69.3 t -134.6 69.39 72.4 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.572 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 59.7 Cg_endo -98.46 177.93 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.381 2.721 . . . . 0.0 111.915 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.665 ' C ' ' H ' ' A' ' 252' ' ' TYR . 1.5 p-10 -157.25 151.73 25.24 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.896 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -41.5 -4.85 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.665 ' H ' ' C ' ' A' ' 250' ' ' ASN . 38.2 m-85 -95.19 -53.11 3.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.294 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 17.9 t0 -45.61 -57.84 3.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.899 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.524 ' CE ' HH21 ' A' ' 247' ' ' ARG . 13.1 pttt -169.82 39.66 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.157 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 56.92 46.09 20.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.453 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -121.45 119.57 32.44 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.774 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -51.02 159.62 0.57 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 123.083 0.553 . . . . 0.0 112.329 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.812 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -106.38 114.35 28.41 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.0 OUTLIER -139.59 -178.37 5.37 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.871 0.843 . . . . 0.0 111.607 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 8.0 tt0 -144.67 143.96 31.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.906 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 244' ' ' ILE . 84.6 t -47.7 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.637 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.24 7.39 10.13 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 12.1 mm-40 -86.85 -39.08 16.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.567 0.699 . . . . 0.0 112.641 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.008 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 66.49 139.45 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.18 0.99 . . . . 0.0 109.416 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.008 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.6 p -136.71 155.33 33.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.946 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -100.64 96.31 7.26 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.312 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.813 ' O ' ' N ' ' A' ' 269' ' ' LYS . 34.2 t -50.49 -37.22 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.519 HG23 ' N ' ' A' ' 269' ' ' LYS . 15.1 t 39.58 -64.25 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 O-C-N 124.3 1.0 . . . . 0.0 112.019 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' A' ' 267' ' ' VAL . 7.8 tppt? -76.13 114.25 14.58 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.996 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -119.82 107.88 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.028 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.739 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -114.83 -93.38 0.49 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.631 0.729 . . . . 0.0 110.505 179.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.739 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 26.8 mtm -55.22 134.84 49.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.143 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.459 ' HA ' ' CH2' ' A' ' 276' ' ' TRP . 5.7 p -63.16 14.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.788 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -144.37 -61.6 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.204 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 1.1 mp0 -60.34 -86.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.607 0.717 . . . . 0.0 110.353 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.596 ' HA ' HD21 ' A' ' 271' ' ' ASN . 47.6 m95 95.95 144.23 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.565 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 11.6 mt-10 -99.2 107.65 20.04 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.375 0.607 . . . . 0.0 112.187 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -67.66 -178.94 13.66 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 118.734 -1.698 . . . . 0.0 113.465 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.507 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 4.1 tt0 -168.35 107.53 0.5 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.649 -0.776 . . . . 0.0 110.368 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.698 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -129.58 75.75 1.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.988 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 37.0 t30 85.17 29.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.998 0.428 . . . . 0.0 110.346 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 99.17 -30.01 10.7 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.484 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -68.4 77.29 0.27 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.575 ' CZ ' ' CE1' ' A' ' 142' ' ' PHE . 87.0 mtt180 -79.18 175.84 10.22 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.428 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.05 -147.88 11.64 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 8.2 p80 -141.8 175.37 9.76 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 118.279 1.039 . . . . 0.0 109.378 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.657 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.3 m-85 161.62 152.84 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 O-C-N 123.687 0.617 . . . . 0.0 111.534 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.598 ' HB2' HG23 ' A' ' 290' ' ' THR . 51.2 Cg_endo -72.75 148.52 46.73 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 123.096 2.531 . . . . 0.0 112.983 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 29.4 t80 -74.58 -2.15 24.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.158 0.504 . . . . 0.0 109.77 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 288' ' ' PRO . 23.5 p -61.39 -8.33 3.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.049 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.517 ' CE1' ' CE ' ' A' ' 246' ' ' LYS . 7.0 p80 -136.79 53.9 1.89 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -152.9 150.58 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 294' ' ' LEU . 30.5 mmm-85 -131.91 77.1 1.74 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.667 0.27 . . . . 0.0 110.952 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 293' ' ' ARG . 45.1 mt -34.13 122.22 0.48 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.487 1.137 . . . . 0.0 112.187 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.1 mp -61.01 -173.56 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.082 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 296' ' ' ASP . 26.7 p-10 -74.94 18.42 0.18 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.061 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.478 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.5 tt0 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.528 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.1 m -148.33 164.93 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.739 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -128.42 132.24 48.47 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -101.57 96.87 7.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.651 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.636 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -99.95 18.69 17.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.46 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.597 ' CE1' ' NH1' ' A' ' 284' ' ' ARG . 51.1 m-85 -115.69 5.01 14.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.5 p30 56.86 149.12 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.947 0 O-C-N 124.44 1.087 . . . . 0.0 109.903 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 10.3 t80 -140.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.167 0.439 . . . . 0.0 110.761 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 42.12 63.55 1.33 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.228 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.514 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.45 -126.12 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.542 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 165.2 -40.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.026 0.413 . . . . 0.0 112.111 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 20.0 m-20 -73.65 160.23 31.89 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.211 0.529 . . . . 0.0 111.217 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.3 -17.59 63.74 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.503 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 150' ' ' GLU . 55.2 mp0 -98.36 31.28 2.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 38.0 p30 -145.55 164.18 32.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.029 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.459 ' CB ' HG22 ' A' ' 183' ' ' ILE . 11.9 tp -122.01 84.5 45.09 Favored Pre-proline 0 C--O 1.213 -0.835 0 CA-C-O 120.39 0.138 . . . . 0.0 111.149 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.514 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 24.5 Cg_exo -59.98 140.15 91.35 Favored 'Trans proline' 0 C--N 1.284 -2.831 0 C-N-CA 122.442 2.094 . . . . 0.0 113.528 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.702 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 11.6 p90 -162.32 158.47 24.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.344 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -54.02 0.65 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.447 0.641 . . . . 0.0 112.059 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 158' ' ' ASP . 15.4 mmtt -88.6 90.54 8.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.614 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 14.56 53.65 0.01 OUTLIER Glycine 0 C--N 1.343 0.971 0 O-C-N 124.115 0.884 . . . . 0.0 111.844 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 156' ' ' LYS . 34.5 t0 -66.12 139.59 58.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.404 0.621 . . . . 0.0 109.82 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.4 mp -86.41 100.06 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.35 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.404 HD11 ' CD2' ' A' ' 154' ' ' PHE . 4.8 mt -106.52 106.56 17.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.749 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.61 141.4 48.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.606 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.5 mp -81.04 139.49 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -114.18 -47.62 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.532 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -140.95 113.81 8.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.151 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.442 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 29.6 pttt -112.37 75.16 1.65 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.324 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.81 -25.07 24.15 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.122 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -118.79 166.83 12.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.635 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -95.87 -28.82 14.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.767 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.414 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 78.8 mt-30 -85.16 -19.65 31.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.548 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 65.7 m95 -131.17 154.61 48.2 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.552 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.7 m0 -144.67 135.32 24.65 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.272 0.558 . . . . 0.0 111.231 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.72 115.23 24.03 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.62 -178.5 4.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.746 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -125.89 137.77 53.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.4 OUTLIER -85.1 135.36 34.02 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.222 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -45.74 -8.19 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.568 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.6 ' H ' ' C ' ' A' ' 175' ' ' ASP . 56.5 m-20 -78.03 -31.48 50.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 110.759 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.59 45.26 0.92 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.695 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -143.79 143.28 31.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.612 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.55 129.89 53.72 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . 0.448 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -158.65 155.09 26.14 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.534 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.03 152.56 44.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.459 HG22 ' CB ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -141.17 142.24 26.52 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.53 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.406 ' HG2' ' CG ' ' A' ' 187' ' ' TYR . 20.5 Cg_endo -69.49 118.99 6.01 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.096 1.198 . . . . 0.0 109.048 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 24.1 t -53.96 -52.1 71.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 121.874 -0.516 . . . . 0.0 111.779 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.6 Cg_endo -53.02 -24.64 25.6 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.317 2.011 . . . . 0.0 113.618 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.529 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.5 m-85 -68.59 0.38 4.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.812 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.2 m -132.06 166.24 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.535 0.207 . . . . 0.0 110.476 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.636 ' CD ' HD21 ' A' ' 141' ' ' LEU . 1.9 pt-20 -130.29 58.6 1.67 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.846 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 13.1 mptt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 70.2 m-20 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.817 0.342 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.526 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -94.04 -167.91 37.54 Favored Glycine 1 CA--C 1.445 -4.3 0 CA-C-O 121.773 0.652 . . . . 0.0 113.965 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.55 98.32 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.752 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 0.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.609 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 4.0 m-30 -117.06 -130.7 0.31 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.414 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 2.3 m-30 -137.11 119.51 15.81 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.765 0.793 . . . . 0.0 109.169 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -111.75 142.35 44.2 Favored 'General case' 0 C--O 1.188 -2.159 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.047 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 15.6 tpp180 -103.96 110.44 22.59 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.873 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.5 p -82.58 74.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 123.702 0.626 . . . . 0.0 111.936 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.825 ' HA ' ' O ' ' A' ' 261' ' ' VAL . 1.4 pt -60.81 24.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.617 ' H ' ' C ' ' A' ' 243' ' ' VAL . 1.6 mm-40 173.46 130.88 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.492 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.864 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -165.68 -144.81 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.444 176.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 4.3 ptt85 -156.91 -140.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.381 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 248' ' ' VAL . 76.7 t -138.3 68.59 47.35 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.69 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 55.7 Cg_endo -96.07 179.65 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.422 2.748 . . . . 0.0 111.75 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.751 ' C ' ' H ' ' A' ' 252' ' ' TYR . 10.7 p-10 -148.66 145.64 27.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.362 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.88 4.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.751 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.0 m-85 -98.82 -55.4 2.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.952 0.901 . . . . 0.0 110.58 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -44.6 -67.41 0.29 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.846 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.523 ' O ' ' CE1' ' A' ' 286' ' ' HIS . 27.1 mtmt -149.11 36.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.453 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 60.45 38.63 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' A' ' 287' ' ' PHE . . . -109.0 170.55 7.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.755 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -112.32 152.64 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.122 0.569 . . . . 0.0 110.807 -178.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.744 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -97.89 119.35 36.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.464 0.649 . . . . 0.0 111.684 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -144.78 -163.03 1.61 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.52 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.672 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -132.58 -176.98 4.28 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 2.3 t -61.11 -34.35 59.86 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 CA-C-O 121.575 0.703 . . . . 0.0 112.379 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.574 ' H ' ' HG2' ' A' ' 260' ' ' GLU . . . -128.41 38.46 2.06 Favored Glycine 0 C--N 1.277 -2.701 0 O-C-N 120.539 -1.351 . . . . 0.0 111.581 -176.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 260' ' ' GLU . 13.0 mm-40 -86.29 -35.68 19.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.279 0.561 . . . . 0.0 111.389 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.992 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.27 139.1 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.061 -178.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.992 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.4 p -128.51 150.74 34.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.375 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -100.92 86.92 3.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.989 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 40.9 t -50.97 153.09 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.482 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.529 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -153.33 -53.46 0.11 Allowed 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.125 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 1.9 tpmt? -67.6 146.16 54.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.279 0.562 . . . . 0.0 111.298 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.589 HG23 ' CZ3' ' A' ' 276' ' ' TRP . 3.0 mt -126.48 162.65 30.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.62 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.843 HD21 ' HA ' ' A' ' 276' ' ' TRP . 0.1 OUTLIER 171.74 -101.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.639 ' SD ' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER -73.66 163.04 28.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.551 ' HA ' ' HE1' ' A' ' 276' ' ' TRP . 2.1 p -98.74 29.79 3.59 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.427 ' C ' ' NE2' ' A' ' 275' ' ' GLN . . . -139.65 -39.72 0.09 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.531 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.427 ' NE2' ' C ' ' A' ' 274' ' ' GLY . 1.0 OUTLIER -96.05 -79.72 0.44 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.218 0.532 . . . . 0.0 111.182 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.843 ' HA ' HD21 ' A' ' 271' ' ' ASN . 17.0 m95 77.6 166.49 0.23 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.194 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 90.3 mt-10 -132.27 148.51 52.45 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -129.09 -141.81 5.19 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 115.094 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.413 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.3 tt0 -173.03 129.79 0.48 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.522 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.71 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.4 OUTLIER -144.32 75.21 1.45 Allowed 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.825 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 13.8 t-20 84.69 27.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.434 0.635 . . . . 0.0 110.001 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 95.78 -32.05 6.68 Favored Glycine 0 N--CA 1.459 0.198 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.49 72.6 0.08 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.597 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 77.2 mtt180 -71.49 168.91 16.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.249 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 170.57 -159.1 31.24 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.632 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 0.0 OUTLIER -135.76 176.15 8.94 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.872 0.469 . . . . 0.0 110.069 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 2.8 m-85 170.54 154.89 0.2 Allowed Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.944 0.778 . . . . 0.0 111.158 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.631 ' HB2' HG23 ' A' ' 290' ' ' THR . 56.2 Cg_endo -74.83 155.59 43.74 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.022 2.481 . . . . 0.0 112.071 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 292' ' ' VAL . 64.0 t80 -74.77 0.48 15.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.554 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.631 HG23 ' HB2' ' A' ' 288' ' ' PRO . 41.4 p -62.68 0.46 0.5 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.507 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.42 62.38 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.611 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -158.05 143.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -127.66 81.15 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 19.4 mt -40.68 131.24 2.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.857 0.837 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.43 -171.61 3.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.272 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -101.2 33.73 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.609 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 56.0 tt0 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.432 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.031 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.198 -1.656 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 1.031 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.8 m 90.36 168.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 124.241 0.963 . . . . 0.0 111.922 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -140.63 156.34 46.29 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 155' ' ' LYS . . . -56.73 168.62 0.58 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.67 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -136.02 -36.56 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.643 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.549 ' CE2' ' CZ ' ' A' ' 284' ' ' ARG . 92.5 m-85 -130.51 6.6 4.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.567 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 78.02 136.71 0.06 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.8 t80 -108.27 -49.26 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 110.879 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.461 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 4.0 m120 41.28 66.92 0.6 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.26 -122.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 146' ' ' GLY . 1.7 p30 168.21 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.576 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.594 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 9.0 m-20 -80.66 154.01 27.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.0 -16.83 64.62 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.036 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.15 24.74 4.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 7.5 p30 -144.82 162.44 36.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.038 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.4 tp -112.31 89.71 12.82 Favored Pre-proline 0 C--O 1.215 -0.737 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 59.6 Cg_endo -69.17 127.18 14.68 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 121.692 1.595 . . . . 0.0 112.859 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CG ' HD11 ' A' ' 160' ' ' LEU . 16.7 p90 -147.75 166.94 25.97 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.588 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 143' ' ' ASP . 1.4 tptp -106.65 -141.11 0.37 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 158' ' ' ASP . 24.7 pttm -91.24 174.13 7.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 36.29 20.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 156' ' ' LYS . 14.5 t0 -79.27 132.66 36.55 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.26 111.88 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.095 0.474 . . . . 0.0 110.858 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.44 HD11 ' CG ' ' A' ' 154' ' ' PHE . 7.9 mt -120.57 128.63 53.24 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.6 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 7.8 ttpm? -83.27 135.17 34.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.7 mp -66.3 -51.53 57.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.485 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.601 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 54.2 ttt85 65.94 -49.44 0.41 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.713 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 162' ' ' ILE . 68.2 t0 -149.96 128.43 12.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.115 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.528 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 3.5 ptmm? -121.44 81.74 39.05 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.866 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 -44.01 53.74 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.61 2.207 . . . . 0.0 112.372 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -119.37 176.93 5.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.438 ' O ' HG21 ' A' ' 185' ' ' VAL . 3.5 mm-40 -93.36 -41.82 9.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 240' ' ' TYR . 86.4 mt-30 -72.44 -32.75 66.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.366 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.4 m95 -119.92 153.75 35.43 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.647 ' CD2' HG22 ' A' ' 185' ' ' VAL . 14.0 m0 -143.64 135.69 26.67 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 120.992 0.425 . . . . 0.0 110.739 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.694 ' O ' ' O ' ' A' ' 162' ' ' ILE . 46.4 t30 -86.59 107.78 18.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.68 -179.09 3.55 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.546 0.529 . . . . 0.0 110.379 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 74.0 tt0 -126.13 136.09 52.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.514 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 171.39 3.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.651 0.739 . . . . 0.0 110.636 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 1.28 23.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.608 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -105.46 -28.94 10.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.16 50.48 0.34 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 174' ' ' GLU . 36.2 mttt -134.24 138.76 45.29 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.35 -0.925 . . . . 0.0 111.212 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.601 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.1 OUTLIER -108.92 122.12 46.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.569 0.7 . . . . 0.0 111.76 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.0 24.41 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.771 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.08 162.06 25.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 -179.121 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.789 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -157.62 152.16 20.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.954 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.04 113.44 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.199 1.266 . . . . 0.0 110.554 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.647 HG22 ' CD2' ' A' ' 171' ' ' TRP . 42.4 t -50.48 -50.96 68.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.953 -0.467 . . . . 0.0 111.275 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.0 Cg_endo -45.87 -34.66 12.65 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.933 1.755 . . . . 0.0 112.84 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 7.2 m-85 -63.81 -8.23 10.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.975 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.987 HG21 HG21 ' A' ' 138' ' ' VAL . 1.3 m -135.22 166.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.812 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 190' ' ' LYS . 0.6 OUTLIER -150.43 -51.18 0.13 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.644 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.746 ' O ' HG12 ' A' ' 138' ' ' VAL . 13.9 mmtp . . . . . 0 CA--C 1.516 -0.341 0 O-C-N 123.639 0.587 . . . . 0.0 111.485 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.49 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -55.83 -168.97 0.07 OUTLIER Glycine 1 CA--C 1.439 -4.698 0 CA-C-O 122.314 0.952 . . . . 0.0 114.096 -179.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.45 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.7 Cg_exo -47.61 110.82 0.08 OUTLIER 'Cis proline' 1 N--CA 1.544 4.45 0 O-C-N 123.917 1.482 . . . . 0.0 115.253 0.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.631 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.0 m-30 -126.7 -136.45 0.25 Allowed 'General case' 0 C--O 1.212 -0.887 0 O-C-N 124.242 0.964 . . . . 0.0 109.128 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 169' ' ' GLN . 2.7 m-30 -134.86 114.58 12.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.903 0.859 . . . . 0.0 109.754 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.41 140.79 39.8 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.695 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 10.7 tpp85 -104.32 100.77 10.49 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.396 -0.815 . . . . 0.0 109.792 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 243' ' ' VAL . 4.9 p -71.92 121.74 22.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.178 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.997 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.2 OUTLIER -121.62 20.67 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -172.9 108.33 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.418 0.628 . . . . 0.0 109.695 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -154.49 -140.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.53 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -158.21 -142.12 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 248' ' ' VAL . 66.0 t -134.47 70.49 72.4 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.761 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.513 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 44.8 Cg_endo -90.16 168.91 4.34 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.954 2.436 . . . . 0.0 111.475 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.734 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -131.57 130.2 41.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.831 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.33 -4.87 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.832 0.708 . . . . 0.0 111.994 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.734 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.4 m-85 -93.39 -54.67 3.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.848 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 250' ' ' ASN . 41.9 t0 -41.35 -62.57 0.83 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.553 -177.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.6 mtmt -151.34 26.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.999 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.2 m 75.21 -21.48 0.3 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.628 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -42.24 107.44 0.08 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.224 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.96 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -44.92 157.77 0.07 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.363 178.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.809 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.23 121.42 44.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.752 0.658 . . . . 0.0 110.723 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.4 mt -140.42 -173.95 3.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.928 0.394 . . . . 0.0 111.243 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.2 tt0 -144.95 152.28 39.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.955 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.85 106.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.621 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.94 8.72 8.64 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 46.7 mm-40 -96.8 -135.93 0.24 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 172.1 136.8 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.999 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.8 p -127.09 153.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.014 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 265' ' ' VAL . 1.8 ttmm -105.48 95.15 5.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 268' ' ' THR . 18.2 t -63.03 161.46 2.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.058 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -152.66 -62.38 0.16 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.657 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -71.69 132.14 44.15 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.425 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.745 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -148.05 145.39 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.375 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.655 ' C ' HD22 ' A' ' 271' ' ' ASN . 0.1 OUTLIER 174.49 -136.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.876 179.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.597 ' CE ' HD21 ' A' ' 271' ' ' ASN . 47.6 mtm 54.51 -122.47 1.96 Allowed 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.259 0.552 . . . . 0.0 111.163 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -143.96 -16.63 0.6 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.035 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.525 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -168.13 -15.14 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.232 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.589 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.0 mp0 -97.06 159.58 14.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.632 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.589 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -167.57 161.02 13.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.556 -178.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 8.7 mt-10 -93.84 -168.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.255 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.29 179.36 28.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.507 ' OE1' ' NH2' ' A' ' 284' ' ' ARG . 5.2 tt0 -168.8 113.82 0.59 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.118 0.485 . . . . 0.0 110.686 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.628 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -109.45 -99.85 0.39 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -91.64 48.68 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.33 -29.62 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' SG ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.7 92.5 0.22 Allowed 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.303 -177.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.549 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 78.3 mtt180 -87.11 172.35 10.01 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.159 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 166.04 -152.44 21.63 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.564 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 11.3 p80 -126.23 166.87 16.29 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.15 0.5 . . . . 0.0 109.783 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 164.75 110.72 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.798 177.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.561 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 36.3 Cg_exo -54.91 141.37 78.08 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.978 1.786 . . . . 0.0 112.598 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.656 ' CD2' HG23 ' A' ' 292' ' ' VAL . 0.5 OUTLIER -61.24 -1.43 0.49 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 288' ' ' PRO . 39.9 p -46.9 -7.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.092 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 289' ' ' PHE . 0.9 OUTLIER -150.27 80.2 1.35 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.016 -178.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.656 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -168.92 151.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 244' ' ' ILE . 0.2 OUTLIER -123.45 74.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.64 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 293' ' ' ARG . 68.2 mt -36.49 131.64 0.65 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.1 mp -78.85 -171.97 2.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -91.8 17.14 9.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.45 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.631 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 62.4 tt0 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.307 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.973 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.268 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.2 m 81.75 162.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 O-C-N 125.183 1.552 . . . . 0.0 111.928 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -132.31 142.33 49.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.598 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -99.83 102.94 14.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.626 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.631 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -101.4 20.56 15.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.717 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.522 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 51.9 m-85 -121.14 1.92 10.34 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.884 -0.144 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.504 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 60.56 139.13 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.797 0 O-C-N 123.999 0.812 . . . . 0.0 109.968 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 13.1 t80 -128.86 -50.57 1.23 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.569 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 144' ' ' PHE . 47.5 t30 37.36 58.07 1.29 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.517 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -65.77 -150.3 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.609 HD22 ' N ' ' A' ' 148' ' ' ASP . 0.1 OUTLIER 165.6 -15.05 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.855 -0.672 . . . . 0.0 111.207 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.609 ' N ' HD22 ' A' ' 147' ' ' ASN . 63.2 m-20 -49.66 -166.71 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' A' ' 148' ' ' ASP . 98.9 m-20 -16.44 -68.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.311 0.382 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 151' ' ' ASP . 17.3 pt-20 -171.07 40.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.027 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 150' ' ' GLU . 1.4 m-20 -53.74 -157.56 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.491 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 13.5 tp -123.92 84.4 54.58 Favored Pre-proline 0 C--O 1.217 -0.622 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.688 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.401 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 56.1 Cg_endo -68.17 121.25 8.23 Favored 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 121.669 1.58 . . . . 0.0 112.438 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 7.7 p90 -140.2 -177.59 5.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 5.8 mttp 179.69 121.84 0.06 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.576 -0.725 . . . . 0.0 109.128 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 105.93 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.635 1.209 . . . . 0.0 110.96 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 19.86 52.48 0.01 OUTLIER Glycine 0 N--CA 1.472 1.038 0 O-C-N 123.564 0.54 . . . . 0.0 111.919 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 156' ' ' LYS . 8.1 t70 -74.46 142.26 44.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.083 0.468 . . . . 0.0 110.329 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.05 96.44 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 mt -102.34 103.67 14.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.805 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 88.1 tttt -53.21 132.91 39.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.737 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 172' ' ' ASN . 40.1 mm -71.3 -55.15 14.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.113 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.699 HH12 HH11 ' A' ' 180' ' ' ARG . 32.1 ttm180 78.56 -52.03 0.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.551 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 165' ' ' LYS . 50.0 p-10 -120.3 -120.34 0.3 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.21 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.503 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 2.7 pttp 141.87 62.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 124.438 1.086 . . . . 0.0 109.963 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.25 -65.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.567 2.178 . . . . 0.0 112.697 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.7 mt-10 -108.33 168.85 9.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.548 ' O ' HG21 ' A' ' 185' ' ' VAL . 2.7 pt-20 -82.13 -37.95 25.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.652 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -79.73 -23.46 42.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -126.88 152.47 47.01 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.723 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.8 m0 -147.16 138.5 23.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.682 ' O ' ' O ' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -90.23 121.63 32.42 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.11 -178.14 4.42 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.66 0.6 . . . . 0.0 110.002 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.495 ' CD ' ' NH2' ' A' ' 163' ' ' ARG . 49.1 tt0 -124.62 130.02 51.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.287 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.487 ' HB2' HD11 ' A' ' 152' ' ' LEU . 9.2 t70 -56.29 177.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.397 0.618 . . . . 0.0 110.879 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -80.04 -4.95 54.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.383 177.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -104.91 -27.64 11.58 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.78 48.46 0.33 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -129.29 129.04 44.39 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.856 -0.672 . . . . 0.0 111.376 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.699 HH11 HH12 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -97.65 121.19 39.26 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.79 0.805 . . . . 0.0 111.467 -178.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -152.76 149.43 21.05 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.217 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.52 153.46 41.39 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.122 0.487 . . . . 0.0 110.09 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.94 143.56 28.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.472 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.4 ' HB3' ' CG ' ' A' ' 238' ' ' PRO . 37.1 Cg_endo -74.58 114.57 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.437 1.424 . . . . 0.0 109.978 175.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.723 HG22 ' CE3' ' A' ' 171' ' ' TRP . 54.2 t -52.15 -48.86 87.51 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.079 -0.388 . . . . 0.0 110.941 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 12.2 Cg_endo -50.49 -27.73 19.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.912 1.742 . . . . 0.0 113.314 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.528 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.8 m-85 -72.24 -5.54 36.62 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.509 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 185' ' ' VAL . 21.1 m -128.1 168.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.259 0.349 . . . . 0.0 110.759 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.631 ' CD ' HD21 ' A' ' 141' ' ' LEU . 2.5 pt-20 -134.59 67.53 1.5 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.517 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 O-C-N 123.922 0.764 . . . . 0.0 111.327 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.601 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 83.4 m-20 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -103.61 -169.48 25.55 Favored Glycine 1 CA--C 1.435 -4.908 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.98 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.424 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.4 Cg_exo -48.12 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.533 3.851 0 O-C-N 123.442 1.233 . . . . 0.0 114.799 0.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 236' ' ' ASN . 2.3 m-30 -120.66 -135.94 0.32 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 1.8 m-30 -138.79 118.97 13.52 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.584 0.707 . . . . 0.0 109.592 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.874 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -98.4 -162.86 0.99 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -157.43 86.94 0.95 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.654 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 264' ' ' LEU . 8.2 p -63.21 112.57 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.575 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.1 pt -103.83 16.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.533 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.2 mm-40 -176.2 124.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.202 0.525 . . . . 0.0 111.131 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.5 ttmt -165.08 -157.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.217 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.6 ptt85 -145.82 -134.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.466 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.439 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 4.6 t -139.38 60.44 16.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.72 ' O ' ' O ' ' A' ' 250' ' ' ASN . 95.9 Cg_endo -94.68 44.04 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.812 2.341 . . . . 0.0 113.322 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.726 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.3 p-10 -21.23 153.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.014 0.821 . . . . 0.0 111.465 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.2 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.688 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 254' ' ' LYS . 31.9 m-85 -79.28 -64.52 1.17 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.2 t70 -45.98 63.42 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 125.142 1.526 . . . . 0.0 110.319 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.828 ' N ' ' O ' ' A' ' 252' ' ' TYR . 33.7 mtmt 81.34 -48.47 0.25 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.618 1.199 . . . . 0.0 110.364 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.65 -25.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.849 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.668 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -41.34 108.56 0.09 Allowed 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.951 0.405 . . . . 0.0 111.48 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -43.07 159.98 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.431 0 O-C-N 122.11 -0.369 . . . . 0.0 110.963 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.814 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -112.17 122.51 47.94 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -140.68 -174.07 3.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.086 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.1 tt0 -145.84 145.33 30.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.159 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 245' ' ' GLN . 66.4 t -46.82 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.39 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 11.84 10.6 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 56.3 mm-40 -88.3 -36.32 16.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.281 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.082 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 135.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.614 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.082 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.3 p -133.45 159.37 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.39 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.565 ' N ' HG22 ' A' ' 265' ' ' VAL . 6.1 ttmt -103.33 94.9 5.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.927 ' O ' ' N ' ' A' ' 269' ' ' LYS . 2.6 t -46.03 -42.4 4.41 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.527 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.651 HG23 ' N ' ' A' ' 269' ' ' LYS . 7.9 t 35.16 -60.07 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.927 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER -73.77 110.49 8.1 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.9 mt -136.6 101.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.598 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.935 HD22 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -93.05 -31.64 14.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 179.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.935 ' H ' HD22 ' A' ' 271' ' ' ASN . 29.1 mtm -131.28 172.49 12.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.999 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.9 p -91.22 5.62 48.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . -124.33 -90.69 0.89 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.791 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.48 69.2 10.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 0.0 110.722 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.547 ' HA ' HD21 ' A' ' 271' ' ' ASN . 0.4 OUTLIER -77.78 178.48 7.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.623 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 3.4 mt-10 -104.19 -167.41 1.36 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -157.76 -171.39 23.67 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.0 tt0 -170.44 109.54 0.36 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.765 0.317 . . . . 0.0 111.516 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.67 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -100.84 -101.69 0.25 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -90.6 47.64 1.45 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.14 -28.31 9.0 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.41 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.86 91.55 0.2 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.122 -178.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.469 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 84.5 mtt180 -85.54 173.31 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.099 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 161.79 -151.12 21.15 Favored Glycine 0 C--O 1.215 -1.052 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.543 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 14.3 p-80 -130.4 169.3 15.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.474 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.66 116.04 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.547 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.733 ' HB2' HG23 ' A' ' 290' ' ' THR . 22.6 Cg_endo -62.72 162.48 24.83 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.106 1.87 . . . . 0.0 112.912 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.654 ' CD1' HG23 ' A' ' 292' ' ' VAL . 82.8 t80 -65.48 1.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.682 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 288' ' ' PRO . 71.7 p -51.2 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.536 ' O ' HG13 ' A' ' 292' ' ' VAL . 1.7 p80 -172.29 85.98 0.07 Allowed 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.391 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.654 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -174.27 148.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.575 ' HE ' HD13 ' A' ' 244' ' ' ILE . 24.3 mmt180 -130.15 81.96 2.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 36.9 mt -43.69 133.96 4.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.381 0.61 . . . . 0.0 111.066 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.0 mp -88.11 -169.95 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -100.55 14.97 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.582 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 239' ' ' PHE . 34.2 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.365 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 p90 . . . . . 0 N--CA 1.462 0.158 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.88 167.19 16.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -119.72 126.23 50.57 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.073 0.464 . . . . 0.0 110.038 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.735 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -92.0 89.28 6.91 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.97 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -100.38 31.47 3.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.385 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 143' ' ' ASP . 50.4 m-85 -132.56 2.98 3.84 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.392 -0.193 . . . . 0.0 110.811 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.3 p30 52.7 137.63 0.0 OUTLIER 'General case' 0 C--O 1.208 -1.109 0 O-C-N 124.924 1.39 . . . . 0.0 110.11 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 6.3 t80 -122.76 -42.77 2.29 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.735 0.302 . . . . 0.0 110.636 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 42.77 59.14 2.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.491 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -65.43 -145.36 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.3 p30 168.39 82.89 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.931 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.506 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 5.2 m-20 174.94 179.06 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 110.349 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -87.94 -21.07 25.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.203 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -103.48 26.12 8.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.4 p30 -141.18 158.75 43.48 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 152' ' ' LEU . 10.5 tp -118.51 89.45 36.76 Favored Pre-proline 0 C--O 1.215 -0.748 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 139.93 52.2 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 CA-C-N 120.314 1.148 . . . . 0.0 112.542 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.735 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 16.0 p90 -158.79 161.72 36.98 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.576 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER 176.84 125.68 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.507 0.504 . . . . 0.0 110.101 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 11.3 ptpt 136.0 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.521 1.138 . . . . 0.0 109.796 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.76 51.17 0.38 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -83.86 158.7 21.55 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.134 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.6 mm -109.14 112.88 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.381 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -112.94 126.0 55.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.821 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 162' ' ' ILE . 62.4 tttm -81.01 143.75 32.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 111.145 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.7 mp -94.98 156.28 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.588 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.518 HH21 ' CD ' ' A' ' 174' ' ' GLU . 21.5 ttm105 -135.8 -33.65 0.85 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.473 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.77 128.56 11.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.1 pttm -121.67 79.26 39.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.118 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.21 -42.2 69.35 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.181 1.921 . . . . 0.0 111.989 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -117.37 178.17 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.493 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.58 -29.73 13.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.006 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.59 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 78.9 mt-30 -80.8 -27.34 36.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.864 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.466 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 71.7 m95 -123.3 151.96 41.88 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.516 ' CD2' HG22 ' A' ' 185' ' ' VAL . 13.5 m0 -143.22 135.65 27.3 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 120.84 0.352 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.52 108.34 12.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.8 163.09 13.22 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.81 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 16.0 tt0 -122.77 128.36 50.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.09 177.76 0.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.68 0.752 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 98.1 mmm -74.82 -2.25 25.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.609 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -99.41 -20.67 16.35 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.464 0.649 . . . . 0.0 110.843 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.82 -28.52 6.39 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 179' ' ' LYS . 41.3 mttt -53.01 146.05 11.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.073 0.463 . . . . 0.0 110.532 -177.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 132.54 56.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.658 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.51 151.61 23.16 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.222 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 84.1 mmm -67.34 159.25 29.72 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.318 0.58 . . . . 0.0 110.387 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 6.7 pt -151.26 142.7 15.53 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.952 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.53 115.62 4.28 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.447 1.431 . . . . 0.0 110.015 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 36.3 t -50.24 -52.94 49.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.7 Cg_endo -51.58 -25.99 21.24 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 122.383 2.055 . . . . 0.0 113.291 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.6 m-85 -69.89 0.92 5.02 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.413 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.1 m -132.39 161.68 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -93.98 -62.42 1.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.729 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 17.3 tptm . . . . . 0 CA--C 1.539 0.533 0 O-C-N 124.81 1.319 . . . . 0.0 109.757 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.567 ' O ' ' CZ ' ' A' ' 239' ' ' PHE . 36.7 p-10 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.888 0.375 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.579 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.23 -165.55 41.24 Favored Glycine 1 CA--C 1.436 -4.85 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.749 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.7 Cg_endo -45.05 100.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.536 3.994 0 N-CA-C 116.843 1.824 . . . . 0.0 116.843 1.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.579 ' CD1' ' HA2' ' A' ' 237' ' ' GLY . 8.4 m-30 -114.55 -130.66 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.29 127.6 18.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 109.227 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.788 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -104.51 -165.09 1.11 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.222 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -156.48 94.77 1.51 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.72 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.6 p -73.71 116.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.0 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.753 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.0 OUTLIER -110.21 18.03 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.993 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 244' ' ' ILE . 2.3 mm-40 -174.38 121.06 0.26 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.778 ' CD ' HD12 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -168.55 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.551 178.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.661 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -154.57 -134.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.634 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.421 ' O ' ' OD2' ' A' ' 253' ' ' ASP . 3.4 t -137.84 62.89 36.39 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.607 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.71 ' O ' ' O ' ' A' ' 250' ' ' ASN . 11.6 Cg_endo -98.62 31.04 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.959 1.773 . . . . 0.0 114.417 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 249' ' ' PRO . 13.5 p30 -24.93 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.463 1.102 . . . . 0.0 112.588 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.26 -22.32 29.15 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.442 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.405 ' C ' ' OD1' ' A' ' 250' ' ' ASN . 32.9 m-85 -111.34 47.71 0.99 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 249' ' ' PRO . 1.2 m-20 -151.42 15.98 0.7 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.661 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 28.1 mtmt 147.22 -65.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 41.7 m 166.77 -16.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.199 0.937 . . . . 0.0 110.428 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ASN . . . -82.02 170.24 15.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.294 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.005 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -87.26 151.18 23.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.68 0.392 . . . . 0.0 110.623 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.854 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -96.45 121.71 38.57 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.124 0.42 . . . . 0.0 111.118 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.854 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.5 mt -142.33 -171.78 3.47 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.646 0.736 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.453 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.1 tt0 -144.79 148.44 34.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.272 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.57 HG13 ' HA ' ' A' ' 244' ' ' ILE . 81.1 t -53.11 100.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.509 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.62 9.71 9.94 Favored Glycine 0 CA--C 1.51 -0.233 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 12.5 mm-40 -86.99 -36.23 18.38 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.066 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 136.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.116 0.96 . . . . 0.0 109.12 -178.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.066 ' N ' HD12 ' A' ' 264' ' ' LEU . 12.5 p -131.63 150.67 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -107.33 91.94 3.86 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.67 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.682 HG22 ' HA2' ' A' ' 278' ' ' GLY . 55.6 t -62.34 159.63 2.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.846 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.491 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.4 OUTLIER -157.76 -44.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.415 ' HE3' ' H ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -62.63 142.84 57.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.225 -177.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.415 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 74.0 mt -132.34 156.08 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.618 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.66 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER 172.32 -91.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.801 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.66 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 3.9 mtm -69.03 135.72 51.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.137 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.3 p -74.71 20.49 0.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -148.03 -50.46 0.02 OUTLIER Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.151 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.56 ' O ' ' HE3' ' A' ' 272' ' ' MET . 1.0 OUTLIER -105.33 98.34 8.06 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.556 ' N ' ' CD1' ' A' ' 276' ' ' TRP . 1.6 m95 -101.49 173.74 6.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -115.83 127.25 54.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.023 0.439 . . . . 0.0 110.614 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' A' ' 267' ' ' VAL . . . -79.58 -164.37 28.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.256 -177.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 3.3 tt0 -172.7 112.26 0.25 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.848 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.731 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -107.96 -98.08 0.37 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -93.07 40.34 1.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.17 -21.46 42.1 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.628 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -68.63 75.26 0.28 Allowed 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 114.576 -0.812 . . . . 0.0 110.369 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.469 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 89.9 mtt180 -74.54 166.12 24.06 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.256 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.795 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 157.74 129.23 1.09 Allowed Glycine 0 C--O 1.198 -2.14 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.519 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -59.02 174.99 0.32 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 117.963 -3.081 . . . . 0.0 110.329 -175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.557 ' CZ ' ' NH1' ' A' ' 247' ' ' ARG . 0.1 OUTLIER -179.66 115.95 0.22 Allowed Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.114 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.534 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 85.0 Cg_exo -44.33 130.38 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.055 1.055 . . . . 0.0 112.783 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.631 ' C ' ' H ' ' A' ' 291' ' ' HIS . 0.0 OUTLIER -62.6 -3.3 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.903 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.4 p -52.02 4.47 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.73 ' O ' HG13 ' A' ' 292' ' ' VAL . 5.7 p80 -156.5 74.71 0.83 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 291' ' ' HIS . 1.3 m -166.58 150.96 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -108.82 -44.39 4.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.0 mt 74.31 118.41 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.503 1.144 . . . . 0.0 111.578 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 8.9 mp -88.46 -175.42 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.855 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.33 -52.35 23.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.441 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.403 ' OXT' ' OE1' ' A' ' 169' ' ' GLN . 55.5 tt0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.706 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.568 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.499 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 190' ' ' LYS . 31.5 m 42.9 -179.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 124.06 0.85 . . . . 0.0 110.303 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -133.08 121.72 23.07 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.736 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -95.3 100.01 11.86 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.057 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.611 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -111.29 32.29 5.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.921 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 143' ' ' ASP . 43.7 m-85 -127.63 2.9 6.14 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.72 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.1 p30 58.88 138.03 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 124.464 1.102 . . . . 0.0 109.811 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 7.6 t80 -130.11 -49.78 1.11 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.04 0.382 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 40.13 65.78 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.77 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.43 -138.55 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.639 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.3 p30 172.86 101.08 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.323 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 9.8 m-20 151.1 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.363 1.039 . . . . 0.0 110.697 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.42 -15.81 26.71 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -105.36 24.8 11.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.855 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.639 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.9 p-10 -137.48 152.64 49.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.553 HD11 ' CG ' ' A' ' 175' ' ' ASP . 11.3 tp -116.33 87.89 21.54 Favored Pre-proline 0 C--O 1.214 -0.792 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.542 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.98 122.76 9.65 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.347 1.364 . . . . 0.0 112.201 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.736 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.5 p90 -139.21 169.27 18.08 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -171.04 122.01 0.56 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.553 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.1 mtpp 98.64 74.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.675 1.234 . . . . 0.0 111.589 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 30.82 55.26 0.26 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.068 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 31.2 t0 -73.58 150.52 41.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.9 0.381 . . . . 0.0 110.708 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.444 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.6 mp -102.51 108.76 24.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 mt -121.71 106.22 11.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.235 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -61.31 133.51 55.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.802 0.689 . . . . 0.0 112.785 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -78.64 132.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.717 178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.63 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 12.8 tpt180 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.529 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -147.18 121.28 9.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.437 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 10.6 ptmt -112.7 75.2 1.8 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.817 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.84 -35.74 11.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.981 1.788 . . . . 0.0 112.122 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -103.66 168.7 8.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.149 0.5 . . . . 0.0 110.607 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.71 -38.38 11.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.37 -22.29 32.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.514 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 69.6 m95 -120.8 151.67 39.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.709 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.4 m0 -145.43 135.98 24.25 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.085 0.469 . . . . 0.0 110.738 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.12 107.97 13.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.34 164.95 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.978 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 14.4 tt0 -127.34 136.96 52.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.609 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.553 ' CG ' HD11 ' A' ' 152' ' ' LEU . 46.4 m-20 -71.68 -175.28 1.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.492 0.663 . . . . 0.0 110.461 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 87.2 mmm -76.28 -15.45 60.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.955 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.52 -22.27 22.51 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.275 0.56 . . . . 0.0 111.011 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.67 -19.98 9.55 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -52.73 143.61 15.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.63 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -115.85 124.76 51.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.503 0.668 . . . . 0.0 111.225 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.18 145.54 14.65 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.705 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mtp -64.59 160.19 20.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.566 0.698 . . . . 0.0 110.458 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 5.1 pt -151.75 144.32 16.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.881 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.71 110.01 2.98 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.025 1.15 . . . . 0.0 110.657 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.709 HG22 ' CE3' ' A' ' 171' ' ' TRP . 55.6 t -44.22 -52.69 15.67 Favored Pre-proline 0 C--O 1.218 -0.604 0 O-C-N 121.882 -0.511 . . . . 0.0 111.821 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.9 Cg_endo -48.39 -24.54 6.27 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.887 1.724 . . . . 0.0 113.509 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.29 5.52 4.45 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.311 -0.555 . . . . 0.0 112.004 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -133.64 162.79 38.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.419 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.611 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -121.74 -67.18 0.98 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.591 ' O ' HG12 ' A' ' 138' ' ' VAL . 21.9 tptm . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.405 ' CB ' HD13 ' A' ' 294' ' ' LEU . 19.0 m120 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -168.05 160.74 34.4 Favored Glycine 1 CA--C 1.448 -4.15 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.405 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.418 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 9.0 Cg_exo -72.48 131.94 24.1 Favored 'Cis proline' 0 C--N 1.285 -2.766 0 O-C-N 122.257 0.609 . . . . 0.0 110.931 -6.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 37.4 m-85 -159.74 -123.17 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -145.2 121.74 11.07 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.337 0.517 . . . . 0.0 111.103 -178.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.857 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -101.55 -158.49 0.67 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.592 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -159.47 94.95 1.2 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.74 HG12 ' H ' ' A' ' 264' ' ' LEU . 9.8 p -73.61 110.66 7.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.431 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.502 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -108.72 22.69 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.731 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 177.81 110.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.7 ttmt -153.62 -145.94 0.18 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.404 0.621 . . . . 0.0 110.284 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.474 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.0 ptt85 -155.41 -144.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.621 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 248' ' ' VAL . 8.7 p -131.96 66.38 77.55 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.485 0.66 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.527 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 60.1 Cg_endo -83.38 157.72 14.68 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.81 2.34 . . . . 0.0 113.574 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -90.9 -172.44 3.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.286 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -103.68 -3.63 24.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.661 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 254' ' ' LYS . 25.5 m-85 -89.05 -27.67 20.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 32.9 t70 -70.03 43.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.198 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 255' ' ' THR . 38.5 mtmt 99.04 -45.55 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.424 1.09 . . . . 0.0 108.945 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.9 OUTLIER 149.18 5.99 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.907 0 O-C-N 125.132 1.52 . . . . 0.0 110.364 179.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 249' ' ' PRO . . . -35.71 115.87 0.34 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.206 0.527 . . . . 0.0 111.774 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -68.68 117.64 10.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.858 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -71.23 125.29 26.55 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.323 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 258' ' ' ALA . 2.6 mt -142.14 -175.67 4.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.712 0.768 . . . . 0.0 111.238 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.41 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 10.2 tt0 -145.61 138.94 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.33 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.502 HG13 ' HA ' ' A' ' 244' ' ' ILE . 53.1 t -44.01 105.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.147 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.54 7.13 24.57 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.362 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' LEU . 43.8 mm-40 -83.7 -37.34 22.85 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 1.073 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.5 135.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 1.073 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.7 p -131.14 152.51 37.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.302 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 279' ' ' GLU . 0.9 OUTLIER -103.86 108.67 20.09 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.377 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' A' ' 276' ' ' TRP . 97.9 t -72.43 157.05 6.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.501 HG22 ' C ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER 177.83 43.82 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.703 ' C ' HD12 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -157.51 98.74 1.7 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 120.827 -1.171 . . . . 0.0 109.15 178.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.703 HD12 ' C ' ' A' ' 269' ' ' LYS . 1.6 mp -113.33 133.31 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.38 0.61 . . . . 0.0 111.233 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.78 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -112.81 -29.62 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.98 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.706 ' H ' HD22 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -134.54 -164.4 1.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.536 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -109.66 19.33 19.31 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.181 -0.325 . . . . 0.0 110.705 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.502 ' N ' ' SD ' ' A' ' 272' ' ' MET . . . -130.81 -100.3 0.85 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.704 ' N ' ' SD ' ' A' ' 272' ' ' MET . 50.6 mm-40 -76.24 105.29 7.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.987 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.802 ' CE3' HG11 ' A' ' 267' ' ' VAL . 0.4 OUTLIER -98.05 178.45 5.1 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.623 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.477 ' OE2' ' OD1' ' A' ' 271' ' ' ASN . 24.8 mp0 -95.39 -152.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.751 -178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 277' ' ' GLU . . . -161.32 -177.88 34.79 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 266' ' ' LYS . 2.4 tm-20 -169.75 117.06 0.58 Allowed 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 117.226 0.513 . . . . 0.0 110.768 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -107.08 -56.56 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -136.92 38.22 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 284' ' ' ARG . . . 93.28 -21.31 41.1 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.942 ' O ' ' O ' ' A' ' 284' ' ' ARG . 0.0 OUTLIER -57.54 -6.73 0.51 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.386 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.942 ' O ' ' O ' ' A' ' 283' ' ' LYS . 13.9 mtt85 15.86 -177.21 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 O-C-N 126.023 2.077 . . . . 0.0 113.104 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 150.02 -145.38 13.42 Favored Glycine 0 C--N 1.287 -2.182 0 O-C-N 120.652 -1.28 . . . . 0.0 110.549 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.2 p80 -145.37 177.86 8.52 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 114.351 -0.924 . . . . 0.0 109.206 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.619 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.4 m-85 159.06 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 O-C-N 123.877 0.736 . . . . 0.0 109.143 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.0 Cg_exo -51.54 153.96 9.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.93 1.753 . . . . 0.0 113.214 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 46.9 t80 -65.13 2.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 288' ' ' PRO . 32.3 p -51.77 -38.31 54.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.51 72.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -163.58 144.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -123.55 75.5 1.34 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.065 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 8.3 mt -43.61 125.95 4.27 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.575 0.702 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.9 mp -71.15 -173.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.015 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -83.18 39.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.843 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.502 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 82.2 mt-30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.195 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 1.034 ' O ' HG22 ' A' ' 138' ' ' VAL . 5.8 p90 . . . . . 0 C--O 1.209 -1.029 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 137' ' ' TYR . 2.8 m 93.78 152.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 125.686 1.866 . . . . 0.0 111.984 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.416 ' NH1' HD23 ' A' ' 141' ' ' LEU . 15.9 ttp85 -120.81 133.21 55.32 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.331 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . . . -94.08 93.71 7.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.007 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.65 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.35 20.03 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.034 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.454 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -115.93 -9.36 11.8 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.481 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 72.3 136.32 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.048 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.1 t80 -128.83 -43.22 1.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.854 0.359 . . . . 0.0 110.125 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 146' ' ' GLY . 21.9 t-20 41.62 62.49 1.54 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 145' ' ' ASN . . . -62.57 -122.43 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 1.0 OUTLIER 169.56 -65.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.879 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.525 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 18.2 m-20 -53.81 142.65 23.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.783 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 31.2 p-10 -61.47 -1.2 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 148' ' ' ASP . 47.5 mt-10 -105.68 13.76 29.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.269 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 20.5 p30 -130.78 163.26 27.71 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.645 HD13 ' N ' ' A' ' 181' ' ' GLY . 3.8 tp -104.35 91.71 4.17 Favored Pre-proline 0 C--O 1.211 -0.966 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.303 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.467 ' O ' ' OD2' ' A' ' 175' ' ' ASP . 72.7 Cg_endo -70.49 139.13 37.03 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 CA-C-N 120.825 1.33 . . . . 0.0 112.804 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 160' ' ' LEU . 12.5 p90 -167.42 157.05 10.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -174.35 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.349 179.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -61.02 -3.28 0.75 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.265 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 155' ' ' LYS . . . 92.85 56.94 1.45 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.471 ' C ' HD12 ' A' ' 159' ' ' ILE . 27.0 t0 -81.74 157.85 24.39 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.502 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.6 mp -98.63 98.12 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.685 HD11 ' CD2' ' A' ' 154' ' ' PHE . 96.3 mt -91.83 94.13 9.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.128 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 52.8 tttp -68.87 132.44 46.74 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.518 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.22 142.81 15.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.27 -48.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.64 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -153.24 64.05 0.76 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.641 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.403 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 11.8 pttp -49.54 106.48 0.63 Allowed Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 119.402 -0.332 . . . . 0.0 110.787 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.79 -48.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.443 1.428 . . . . 0.0 112.438 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.02 172.75 6.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.775 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 168' ' ' GLU . 5.0 pt-20 -85.51 -34.47 21.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.4 -15.57 45.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.468 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 48.1 m95 -131.46 151.53 51.48 Favored 'General case' 0 C--O 1.228 -0.074 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.589 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.9 m0 -139.78 134.44 31.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.907 0.86 . . . . 0.0 112.496 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -91.55 101.03 13.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.27 -179.26 3.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.51 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.88 112.72 13.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.642 ' H ' HD11 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -63.81 140.58 58.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.951 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 95.2 mtp -47.85 -8.14 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.426 0.454 . . . . 0.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 175' ' ' ASP . 96.6 m-20 -72.98 -21.78 60.79 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.667 0.746 . . . . 0.0 110.048 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.49 44.06 3.54 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.631 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.478 ' O ' HD11 ' A' ' 152' ' ' LEU . 11.4 ptpt -142.46 143.92 32.81 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.161 -0.519 . . . . 0.0 109.76 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.05 127.95 53.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.534 0.683 . . . . 0.0 110.964 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . 0.645 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -156.07 153.1 24.48 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.361 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.54 152.79 44.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.468 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 1.3 pt -143.4 146.58 36.53 Favored Pre-proline 0 N--CA 1.455 -0.191 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.46 140.46 63.41 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.481 -1.392 . . . . 0.0 108.481 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 38.5 t -79.93 -37.9 1.14 Allowed Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.661 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 36.4 Cg_endo -68.88 -21.0 38.43 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.271 1.981 . . . . 0.0 112.914 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.1 m-85 -77.88 4.51 11.77 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.976 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 185' ' ' VAL . 26.5 m -136.01 161.17 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.424 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.644 ' CG ' HD21 ' A' ' 141' ' ' LEU . 1.1 pp20? -146.35 153.58 40.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 13.4 tptm . . . . . 0 C--N 1.316 -0.866 0 C-N-CA 124.276 1.03 . . . . 0.0 111.808 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 31.3 m120 . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.444 ' HA2' ' N ' ' A' ' 239' ' ' PHE . . . -165.11 134.41 3.31 Favored Glycine 1 CA--C 1.445 -4.322 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.061 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.411 ' HD2' ' CZ2' ' A' ' 170' ' ' TRP . 4.0 Cg_exo -71.56 97.49 0.15 OUTLIER 'Cis proline' 0 N--CA 1.529 3.615 0 CA-C-N 118.171 0.985 . . . . 0.0 112.134 -6.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 4.3 m-85 -117.09 -134.34 0.34 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -146.19 137.54 24.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 118.986 0.812 . . . . 0.0 109.768 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.592 ' H ' HD13 ' A' ' 264' ' ' LEU . . . -122.93 140.26 53.18 Favored 'General case' 0 C--O 1.195 -1.768 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.147 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -104.17 111.04 23.48 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.366 0.603 . . . . 0.0 110.704 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.1 p -79.63 127.46 39.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.141 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.44 15.74 7.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -174.08 112.21 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.633 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.897 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.5 ttmt -165.13 -156.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.266 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.92 -138.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.134 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.697 ' O ' HG12 ' A' ' 248' ' ' VAL . 73.4 t -132.83 60.89 53.08 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 120.677 0.275 . . . . 0.0 111.194 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 258' ' ' ALA . 18.0 Cg_endo -96.72 -170.82 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.479 2.119 . . . . 0.0 111.394 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.1 p-10 -157.9 153.34 26.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.142 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 256' ' ' ALA . . . -41.16 -11.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 254' ' ' LYS . 33.4 m-85 -73.83 -53.12 10.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 250' ' ' ASN . 35.9 t70 -53.58 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 125.813 1.946 . . . . 0.0 111.702 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' A' ' 252' ' ' TYR . 29.7 mtmt 82.33 -43.11 0.14 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.269 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.558 ' O ' ' ND1' ' A' ' 286' ' ' HIS . 0.1 OUTLIER 158.37 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.405 0.621 . . . . 0.0 110.029 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -109.95 165.01 12.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.864 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.834 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -114.77 151.78 33.2 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -178.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.963 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -88.64 113.66 24.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 258' ' ' ALA . 0.4 OUTLIER -143.28 174.57 10.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.798 177.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -142.95 148.84 37.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.386 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 245' ' ' GLN . 73.3 t -52.65 99.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.957 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 127.79 -2.94 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.39 -163.25 1.03 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.072 0.463 . . . . 0.0 110.621 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.96 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER -159.11 149.37 19.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.755 0.788 . . . . 0.0 111.117 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.96 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.0 p -133.48 141.48 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -74.26 176.01 7.06 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.915 ' O ' ' N ' ' A' ' 269' ' ' LYS . 18.4 t -119.29 -36.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.144 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 269' ' ' LYS . 0.0 OUTLIER 20.64 -55.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.904 1.378 . . . . 0.0 114.178 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.915 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -84.7 116.11 23.05 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.388 0.613 . . . . 0.0 111.853 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.6 OUTLIER -136.92 154.1 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.501 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -174.69 158.37 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.99 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.534 ' O ' ' O ' ' A' ' 271' ' ' ASN . 3.9 mtm 52.52 162.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.462 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 p -88.98 27.94 1.26 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -149.07 -85.5 0.06 OUTLIER Glycine 0 C--O 1.209 -1.464 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.325 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 275' ' ' GLN . 1.8 mp0 -61.99 168.78 3.0 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.494 ' HA ' HD21 ' A' ' 271' ' ' ASN . 16.2 p-90 178.1 -174.17 0.15 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.28 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -144.64 147.5 33.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.494 -1.685 . . . . 0.0 113.598 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -131.16 131.92 6.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.037 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 281' ' ' ASN . 6.2 tm-20 -103.45 125.14 49.86 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.541 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' CYS . . . . . 0.623 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -125.88 84.37 2.27 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.099 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE2' ' A' ' 279' ' ' GLU . 2.4 m120 76.36 21.49 1.39 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.086 -1.009 . . . . 0.0 110.654 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 104.21 -32.83 7.11 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.475 -0.329 . . . . 0.0 112.65 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.623 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.8 OUTLIER -63.06 60.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.954 0.407 . . . . 0.0 110.754 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 282' ' ' GLY . 52.8 mtt180 -60.86 162.25 7.08 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.527 0.68 . . . . 0.0 109.939 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.98 -170.68 43.46 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.634 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.7 p-80 -140.39 95.3 2.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.866 1.333 . . . . 0.0 112.654 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.533 ' HE2' ' HB1' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -101.23 129.38 27.15 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 113.714 -1.585 . . . . 0.0 109.646 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -50.55 153.91 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.367 1.378 . . . . 0.0 112.528 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.536 ' C ' ' H ' ' A' ' 291' ' ' HIS . 90.3 t80 -72.01 -3.55 23.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.431 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 67.8 p -55.63 10.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.676 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' HIS . . . . . 0.536 ' H ' ' C ' ' A' ' 289' ' ' PHE . 1.2 p80 -176.19 68.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.625 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.534 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -155.07 153.73 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 294' ' ' LEU . 27.8 mmm-85 -130.98 66.32 1.54 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.401 0.143 . . . . 0.0 111.357 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 241' ' ' ALA . 11.3 mt -31.32 129.05 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.107 0.956 . . . . 0.0 112.499 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.17 -106.53 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.23 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 34.5 t0 -173.82 44.45 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 296' ' ' ASP . 7.6 tt0 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.136 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -83.29 -103.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.152 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -44.61 152.13 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.088 0.47 . . . . 0.0 110.471 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.62 166.06 27.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.428 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -115.49 131.54 56.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.784 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -102.23 92.68 4.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.724 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.838 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -103.27 22.63 13.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.942 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 143' ' ' ASP . 65.3 m-85 -119.45 2.46 11.26 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.793 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.529 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.6 p30 55.39 138.76 0.0 OUTLIER 'General case' 0 C--O 1.21 -0.992 0 O-C-N 124.365 1.041 . . . . 0.0 110.422 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 6.7 t80 -127.99 -41.54 1.62 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.844 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 144' ' ' PHE . 39.3 t-20 36.21 59.22 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.478 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.02 -141.28 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.571 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.2 OUTLIER 166.8 88.28 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.197 -0.501 . . . . 0.0 111.413 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 3.6 m-20 171.97 -178.42 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.211 0.529 . . . . 0.0 110.33 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 149' ' ' ASP . 60.9 t0 -91.0 -20.4 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.388 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.26 25.81 9.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.693 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.571 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.7 p-10 -141.33 156.63 45.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.447 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 11.4 tp -120.17 82.31 30.06 Favored Pre-proline 0 C--O 1.216 -0.695 0 CA-C-O 120.755 0.312 . . . . 0.0 110.999 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.42 136.79 74.09 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 121.456 1.437 . . . . 0.0 112.108 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.784 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 10.6 p90 -152.09 165.14 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.524 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -175.86 102.93 0.07 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 108.795 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.577 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.5 tppp? 127.61 77.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.652 1.22 . . . . 0.0 110.959 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.71 49.73 0.02 OUTLIER Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 156' ' ' LYS . 28.7 t0 -72.91 144.87 47.19 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.922 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 159' ' ' ILE . 10.7 tp -104.17 109.54 27.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.3 mt -115.37 122.79 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.675 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -77.91 141.84 38.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.91 139.13 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.131 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.7 tpt85 -117.9 -43.36 2.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.276 0.56 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.32 129.08 11.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.693 ' NZ ' ' HE1' ' A' ' 171' ' ' TRP . 0.1 OUTLIER -119.48 77.53 19.48 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.145 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.03 -44.36 50.47 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.295 1.996 . . . . 0.0 111.732 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.49 177.02 4.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.418 ' O ' HG21 ' A' ' 185' ' ' VAL . 25.2 mm-40 -96.57 -32.05 12.45 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.511 ' NE2' ' CZ ' ' A' ' 240' ' ' TYR . 85.2 mt-30 -77.17 -28.12 53.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.468 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.512 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 66.0 m95 -123.84 153.59 40.83 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.693 ' HE1' ' NZ ' ' A' ' 165' ' ' LYS . 17.4 m0 -143.65 136.7 27.66 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-O 120.997 0.427 . . . . 0.0 111.23 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.4 108.03 15.52 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.44 168.32 9.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.957 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -126.63 138.36 53.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.894 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -68.09 174.56 3.75 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.302 0.572 . . . . 0.0 110.698 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ptm -79.88 -2.57 44.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.349 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -101.92 -28.25 12.51 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.6 48.69 0.45 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.57 132.56 49.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.671 -0.764 . . . . 0.0 109.568 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 125.86 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.322 0.582 . . . . 0.0 111.951 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.24 153.34 24.6 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.565 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 32.3 mtp -66.51 160.8 24.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.432 0.634 . . . . 0.0 110.817 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 8.3 pt -152.05 143.06 15.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.794 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -69.4 114.69 3.73 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.639 1.559 . . . . 0.0 110.013 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.645 HG22 ' CE3' ' A' ' 171' ' ' TRP . 27.0 t -49.98 -52.81 49.2 Favored Pre-proline 0 C--O 1.216 -0.673 0 O-C-N 121.927 -0.483 . . . . 0.0 111.69 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.6 Cg_endo -49.5 -24.71 9.48 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.147 1.898 . . . . 0.0 113.367 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.9 m-85 -74.54 3.72 7.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -134.86 162.29 38.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.729 ' HG3' HD11 ' A' ' 141' ' ' LEU . 39.3 mt-10 -81.28 -59.37 2.67 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.276 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 18.0 tptm 137.02 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 O-C-N 124.515 1.134 . . . . 0.0 109.891 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 43.3 t 59.95 70.78 0.61 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -157.46 100.18 1.89 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.229 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.29 155.0 36.94 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.024 1.816 . . . . 0.0 112.58 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 195' ' ' SER . 77.8 p -171.85 -64.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.437 ' N ' ' OG ' ' A' ' 194' ' ' SER . 24.1 p -86.65 172.51 10.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.573 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -87.45 160.78 18.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.466 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.0 m 61.64 84.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.65 -33.21 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.677 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.4 m -45.05 108.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.605 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.1 p -82.25 -18.97 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.564 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 201' ' ' LEU . 1.0 OUTLIER -172.52 -2.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 201' ' ' LEU . 7.8 m -30.59 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.371 0.419 . . . . 0.0 111.278 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.85 66.23 1.23 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.3 -121.59 4.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 205' ' ' ASN . 48.4 p30 -150.34 74.37 1.19 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.914 0.387 . . . . 0.0 110.698 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -48.37 -26.61 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.384 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 208' ' ' SER . 67.3 t0 -64.44 133.28 52.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.479 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 14.2 p -76.24 159.01 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.674 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 6.6 m -80.15 154.84 27.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.41 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.584 ' H ' ' CD2' ' A' ' 210' ' ' HIS . 2.5 p80 -79.15 151.69 75.87 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.72 143.18 73.31 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.477 2.118 . . . . 0.0 111.836 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.624 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 3.4 tt0 -91.76 -41.78 0.37 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.148 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 25.0 Cg_exo -61.36 142.4 95.66 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.499 2.133 . . . . 0.0 111.734 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.97 114.8 20.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.254 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 130.93 12.07 2.21 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 40.36 77.1 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.97 -48.92 19.19 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.387 2.058 . . . . 0.0 112.109 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -179.75 148.78 0.51 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.69 -8.29 22.85 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.551 2.167 . . . . 0.0 112.091 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -149.97 -166.07 13.07 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.484 ' CG ' ' OE1' ' A' ' 224' ' ' GLN . 60.5 Cg_endo -78.71 164.02 25.99 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.692 2.261 . . . . 0.0 112.225 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.516 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 68.5 t80 -58.12 173.01 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -38.76 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 222' ' ' TYR . 6.9 mt-30 -120.02 95.96 49.25 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.332 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.15 -9.35 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.287 1.991 . . . . 0.0 112.024 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 224' ' ' GLN . 4.4 p -103.96 -167.87 1.42 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.643 ' C ' ' H ' ' A' ' 229' ' ' THR . 34.1 mm -114.45 32.26 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.339 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -63.54 29.91 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.643 ' H ' ' C ' ' A' ' 227' ' ' ILE . 0.6 OUTLIER -58.56 159.36 12.54 Favored Pre-proline 0 N--CA 1.452 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.3 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 229' ' ' THR . 80.8 Cg_exo -35.47 -101.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 122.611 2.207 . . . . 0.0 112.124 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.471 HD21 ' OE1' ' A' ' 235' ' ' GLN . 0.2 OUTLIER -113.08 97.8 43.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 122.081 -0.387 . . . . 0.0 110.889 -179.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.99 -62.01 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.986 1.791 . . . . 0.0 112.457 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 235' ' ' GLN . 19.4 t-20 -176.22 115.68 0.12 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.536 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 235' ' ' GLN . 20.7 tp 63.37 -29.99 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.142 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.625 ' H ' ' C ' ' A' ' 233' ' ' ASN . 52.7 tt0 73.65 140.98 0.06 Allowed 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -56.25 -41.21 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.035 0.445 . . . . 0.0 110.061 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -62.22 -165.29 0.44 Allowed Glycine 1 CA--C 1.447 -4.171 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.373 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.417 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.0 Cg_endo -46.78 98.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.767 0 N-CA-C 116.141 1.554 . . . . 0.0 116.141 0.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.642 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 10.3 m-30 -116.51 -132.09 0.32 Allowed 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.511 ' CZ ' ' NE2' ' A' ' 169' ' ' GLN . 2.0 m-30 -136.34 115.88 12.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.67 0.748 . . . . 0.0 109.254 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.524 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -106.85 140.81 39.09 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.943 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -103.91 97.71 7.66 Favored 'General case' 0 C--N 1.311 -1.066 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.8 p -63.74 127.21 23.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.142 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.636 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.3 pt -124.48 22.91 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.537 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.99 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.283 0.564 . . . . 0.0 110.159 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.828 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.7 ttmt -146.76 -146.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.31 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.444 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 0.6 OUTLIER -155.97 -145.53 0.16 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.626 179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 248' ' ' VAL . 97.0 t -132.91 74.13 74.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.463 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.499 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 18.9 Cg_endo -91.65 169.93 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 123.036 2.491 . . . . 0.0 111.323 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.7 OUTLIER -127.12 127.34 44.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.792 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.07 -8.5 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.856 0.722 . . . . 0.0 112.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.758 ' N ' ' O ' ' A' ' 250' ' ' ASN . 50.9 m-85 -91.76 -53.04 4.46 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.907 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 250' ' ' ASN . 42.1 t0 -41.24 -62.02 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.119 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.557 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.0 mttt -151.75 25.39 0.66 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.791 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.9 m 73.83 -18.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.589 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -43.95 108.69 0.12 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.633 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.969 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -47.48 159.85 0.13 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.826 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.21 119.01 38.25 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.091 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.828 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.2 mt -141.67 -175.17 4.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.222 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.6 tt0 -144.94 152.08 39.64 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.37 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.0 t -59.75 115.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.84 6.67 24.49 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 8.1 mm-40 -97.53 -139.76 0.29 Allowed 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.032 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 175.37 139.99 0.05 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.404 0.621 . . . . 0.0 109.366 179.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.032 ' N ' HD12 ' A' ' 264' ' ' LEU . 12.5 p -128.1 152.77 36.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -103.83 88.15 2.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.541 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.484 HG11 ' OE1' ' A' ' 235' ' ' GLN . 3.3 t -64.58 124.36 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.153 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.401 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -116.57 -53.56 2.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.232 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -72.2 127.25 31.98 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.15 -178.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.45 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 0.8 OUTLIER -149.19 103.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.548 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.721 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -97.73 -88.53 0.3 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.492 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.721 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 38.1 mtm -67.07 178.73 1.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.062 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.4 p -98.95 16.63 21.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.366 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -130.54 -87.32 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.889 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -91.96 105.3 17.59 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.015 0.436 . . . . 0.0 110.935 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.543 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 4.6 p-90 -120.33 -164.95 1.13 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.656 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.0 mt-10 -123.99 163.21 21.84 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.861 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.74 -158.21 7.48 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.909 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -170.32 131.19 0.95 Allowed 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -112.82 -92.86 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 283' ' ' LYS . 27.7 t-20 -101.4 54.61 0.83 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.65 -33.95 3.81 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 281' ' ' ASN . 0.0 OUTLIER -61.41 90.4 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.774 -0.713 . . . . 0.0 110.144 -178.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 255' ' ' THR . 42.3 mtt85 -88.05 164.29 15.83 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 171.46 -157.46 27.95 Favored Glycine 0 C--O 1.213 -1.202 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.591 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -123.89 174.73 7.36 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.2 m-85 160.28 135.02 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.107 0 O-C-N 123.768 0.667 . . . . 0.0 111.731 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.53 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 23.7 Cg_exo -64.07 142.64 81.79 Favored 'Trans proline' 0 N--CA 1.507 2.297 0 C-N-CA 122.351 2.034 . . . . 0.0 112.25 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.819 ' CD1' HG21 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -76.23 2.63 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.277 179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 66.2 p -68.68 2.78 2.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.955 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 7.6 p80 -137.31 39.84 2.47 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.059 -0.401 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.819 HG21 ' CD1' ' A' ' 289' ' ' PHE . 11.9 m -135.61 161.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 121.992 -0.442 . . . . 0.0 109.977 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.636 ' HE ' HD13 ' A' ' 244' ' ' ILE . 29.2 mtt180 -132.63 77.81 1.77 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.554 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 293' ' ' ARG . 84.3 mt -32.77 135.52 0.09 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.845 0.831 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.3 mp -84.34 -167.31 1.72 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.028 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -93.79 13.25 23.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.642 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 63.0 tt0 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.304 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -83.77 -85.27 0.13 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.75 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.455 ' OH ' ' SG ' ' A' ' 191' ' ' CYS . 0.0 OUTLIER 72.98 116.45 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.205 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 188' ' ' VAL . 6.3 m -140.67 172.17 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.421 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -131.26 136.37 48.13 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.317 0.58 . . . . 0.0 111.017 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.53 172.22 0.71 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.134 -1.394 . . . . 0.0 109.475 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.596 HD21 ' OE2' ' A' ' 189' ' ' GLU . 78.8 mt -140.35 -45.17 0.41 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.627 ' CE2' ' NH2' ' A' ' 284' ' ' ARG . 95.1 m-85 -113.49 9.59 18.07 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.825 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.534 ' CG ' ' HZ1' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 67.11 136.08 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 O-C-N 123.735 0.647 . . . . 0.0 109.337 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 9.1 t80 -112.64 -54.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.089 0.471 . . . . 0.0 110.372 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.3 t30 49.99 55.14 9.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.523 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.491 ' C ' HD22 ' A' ' 147' ' ' ASN . . . -65.94 -124.95 0.01 OUTLIER Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.628 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 176.66 -90.31 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.456 -0.202 . . . . 0.0 110.456 179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.504 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 81.0 m-20 -22.94 139.24 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -57.08 -7.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.528 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 148' ' ' ASP . 6.5 pt-20 -97.88 7.22 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.628 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 12.9 p30 -133.29 157.61 45.04 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 152' ' ' LEU . 9.2 tp -111.16 93.64 18.78 Favored Pre-proline 0 C--O 1.214 -0.814 0 CA-C-N 118.506 0.594 . . . . 0.0 111.095 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.404 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 95.5 Cg_endo -69.53 141.43 46.13 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 CA-C-N 120.567 1.238 . . . . 0.0 114.006 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 160' ' ' LEU . 20.3 p90 -159.13 159.72 34.78 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.67 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.727 ' O ' ' O ' ' A' ' 156' ' ' LYS . 0.4 OUTLIER -126.97 96.76 4.72 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -177.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.839 ' O ' ' N ' ' A' ' 158' ' ' ASP . 59.0 pttt 27.39 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.611 1.194 . . . . 0.0 110.739 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 30.9 13.74 0.0 OUTLIER Glycine 0 CA--C 1.541 1.69 0 N-CA-C 113.948 0.339 . . . . 0.0 113.948 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.839 ' N ' ' O ' ' A' ' 156' ' ' LYS . 17.3 t0 -85.36 155.88 21.12 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 117.08 0.44 . . . . 0.0 110.324 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 45.3 mm -125.58 106.2 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.689 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.435 HD11 ' CD2' ' A' ' 154' ' ' PHE . 23.6 mt -121.63 133.71 54.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -97.84 139.73 33.27 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -83.48 159.26 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.03 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -142.2 -43.73 0.33 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.283 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -136.52 113.58 10.54 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.54 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 14.3 pttm -112.71 74.07 1.6 Allowed Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.818 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.77 -28.74 51.29 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.621 1.548 . . . . 0.0 111.881 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.9 162.69 18.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.667 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.85 -35.0 18.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.91 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.508 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 79.0 mt-30 -80.7 -22.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.879 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -124.75 153.87 41.76 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.54 ' CD2' HG22 ' A' ' 185' ' ' VAL . 11.2 m0 -145.83 138.16 25.51 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.376 0.608 . . . . 0.0 110.373 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -86.06 106.89 17.53 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.08 6.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.761 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 30.3 tt0 -126.38 138.32 53.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.969 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.87 173.41 7.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.578 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.9 tpt -77.53 -0.94 28.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.21 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.456 ' HB3' ' NZ ' ' A' ' 179' ' ' LYS . 79.9 m-20 -102.66 -29.67 11.39 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.536 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 114.96 47.92 0.55 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 177' ' ' ASP . 9.8 mttp -128.66 135.88 49.88 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-N 114.105 -1.048 . . . . 0.0 108.982 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.35 123.34 50.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.412 0.625 . . . . 0.0 111.519 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -151.6 149.03 20.71 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.021 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttt -65.19 151.27 46.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 111.174 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.05 145.77 37.42 Favored Pre-proline 0 N--CA 1.467 0.376 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -74.44 112.9 3.66 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.42 1.413 . . . . 0.0 109.438 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.54 HG22 ' CD2' ' A' ' 171' ' ' TRP . 51.7 t -48.62 -51.56 51.73 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -45.74 -31.38 7.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.077 1.852 . . . . 0.0 113.096 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.479 ' OH ' ' O ' ' A' ' 268' ' ' THR . 9.6 m-85 -69.4 -6.66 31.51 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.089 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.47 HG21 HG21 ' A' ' 138' ' ' VAL . 1.2 m -129.93 163.66 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.596 ' OE2' HD21 ' A' ' 141' ' ' LEU . 1.1 pt-20 -117.4 -51.73 2.5 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER 142.24 -4.15 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.224 1.41 . . . . 0.0 110.003 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.455 ' SG ' ' OH ' ' A' ' 137' ' ' TYR . 12.5 t 57.54 113.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -70.3 155.91 92.69 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.842 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 192' ' ' ARG . 74.2 Cg_exo -43.17 176.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.218 1.945 . . . . 0.0 112.15 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.2 t -99.1 59.98 1.18 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.351 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 36.4 t -168.89 157.22 7.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 56.62 44.53 23.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.761 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 200' ' ' THR . 84.2 p -99.33 82.56 2.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.545 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.6 t -75.23 -50.35 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.788 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 200' ' ' THR . 72.2 m -61.81 -48.13 81.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 197' ' ' SER . 2.9 m 32.25 41.36 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.385 0.428 . . . . 0.0 111.023 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 203' ' ' GLY . 55.1 tp -162.53 126.85 3.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.279 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 65.1 p -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.374 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' H ' ' HG ' ' A' ' 201' ' ' LEU . . . 72.99 32.02 61.22 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 51.11 93.48 0.01 OUTLIER Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 141' ' ' LEU . 90.8 m-20 -63.08 -38.62 91.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.95 0.405 . . . . 0.0 110.589 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 209' ' ' SER . 88.9 mt-30 -136.89 17.23 3.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.553 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.92 -42.74 89.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.8 m -61.47 -43.84 98.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.734 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 206' ' ' GLN . 46.1 t -156.01 176.72 12.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.501 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 211' ' ' PRO . 0.7 OUTLIER -170.85 -58.5 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.531 ' N ' ' ND1' ' A' ' 210' ' ' HIS . 19.3 Cg_endo -54.22 -41.81 72.8 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.605 1.536 . . . . 0.0 112.097 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 38.34 72.17 0.95 Allowed Pre-proline 0 N--CA 1.462 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.93 98.57 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.524 2.15 . . . . 0.0 111.649 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.448 ' N ' HD22 ' A' ' 214' ' ' LEU . 4.3 mm? -90.57 134.44 34.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.853 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -53.87 -68.25 1.74 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 167.21 72.42 0.03 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.85 -36.85 92.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.73 2.286 . . . . 0.0 111.736 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -129.37 80.0 73.0 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.577 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.06 -27.49 64.89 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.684 2.256 . . . . 0.0 111.88 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.49 -114.76 3.91 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.22 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.216 0 CA-C-N 119.582 1.691 . . . . 0.0 112.042 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.445 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 82.3 t80 -168.03 162.41 13.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.337 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.445 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -46.42 98.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.596 ' C ' ' H ' ' A' ' 226' ' ' SER . 87.2 mt-30 -143.09 97.44 5.73 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.592 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -54.69 11.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.205 1.937 . . . . 0.0 112.985 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.596 ' H ' ' C ' ' A' ' 224' ' ' GLN . 50.1 m -158.41 -152.98 0.36 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 96.5 mt 58.81 -74.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 226' ' ' SER . 4.1 p-10 -103.34 45.43 0.96 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.314 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 230' ' ' PRO . 0.2 OUTLIER -90.78 161.49 35.86 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 229' ' ' THR . 52.7 Cg_exo -49.14 -128.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 122.742 2.294 . . . . 0.0 112.661 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.13 161.39 31.39 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.773 -0.579 . . . . 0.0 110.198 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.61 -140.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.142 1.894 . . . . 0.0 111.869 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.457 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 3.6 p30 -84.51 153.86 23.04 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.575 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 235' ' ' GLN . 5.2 tp 35.07 68.89 0.18 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.397 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.735 ' NE2' ' H ' ' A' ' 235' ' ' GLN . 1.1 mm-40 -38.74 144.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.428 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -43.44 110.29 0.19 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.69 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 136.72 -165.84 24.97 Favored Glycine 1 CA--C 1.448 -4.155 0 CA-C-O 121.72 0.622 . . . . 0.0 113.52 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 1.9 Cg_endo -47.41 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.535 3.918 0 N-CA-C 116.701 1.769 . . . . 0.0 116.701 1.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.568 ' CG ' ' OE1' ' A' ' 297' ' ' GLN . 11.6 m-30 -118.23 -134.37 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.31 129.5 19.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.248 0.931 . . . . 0.0 109.246 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.778 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -102.04 -162.34 0.92 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.464 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -157.34 92.84 1.27 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.19 129.37 27.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.741 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.447 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.2 pt -129.5 18.31 2.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.214 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 178.06 101.54 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.374 0.607 . . . . 0.0 110.053 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.3 ttmt -144.89 -142.79 0.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.489 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.0 ptt85 -153.77 -142.02 0.11 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.994 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 248' ' ' VAL . 54.3 t -133.62 69.3 76.44 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 110.85 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.607 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 59.0 Cg_endo -91.2 177.0 2.08 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.838 2.359 . . . . 0.0 110.762 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.724 ' O ' ' N ' ' A' ' 252' ' ' TYR . 1.3 p-10 -144.26 139.01 28.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -36.51 -10.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.399 0.619 . . . . 0.0 112.305 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.724 ' N ' ' O ' ' A' ' 250' ' ' ASN . 6.6 m-85 -89.51 -50.27 6.19 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 250' ' ' ASN . 25.7 t0 -62.71 60.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.624 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 252' ' ' TYR . 32.6 mtmt 82.53 15.78 0.4 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.167 0.917 . . . . 0.0 111.061 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.485 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.5 m 80.88 -17.93 0.53 Allowed 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.675 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.02 109.15 0.11 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.958 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.16 156.06 0.6 Allowed 'General case' 0 CA--C 1.494 -1.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.521 179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.867 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.04 122.14 46.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.12 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.5 mt -142.07 -178.81 5.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.886 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 6.1 tt0 -143.44 149.93 38.3 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.936 178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.5 t -56.73 114.78 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.428 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 107.29 7.82 32.0 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 57.8 mm-40 -93.53 -127.62 0.11 Allowed 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.082 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 165.97 139.42 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.031 0.919 . . . . 0.0 110.336 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.082 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.5 p -134.75 155.6 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.56 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 265' ' ' VAL . 0.2 OUTLIER -85.31 -158.5 0.38 Allowed 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.726 ' O ' ' N ' ' A' ' 269' ' ' LYS . 0.9 OUTLIER -142.65 -44.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.075 176.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.479 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.1 OUTLIER 35.14 -72.93 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -74.35 123.6 24.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.975 -177.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.22 162.31 36.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.827 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.67 HD22 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -156.46 -98.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.526 0.679 . . . . 0.0 110.359 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.67 ' N ' HD22 ' A' ' 271' ' ' ASN . 34.8 mtm -55.16 152.89 7.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.601 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.9 p -71.58 15.61 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.355 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.539 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.71 -73.63 0.04 OUTLIER Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.554 ' O ' ' ND2' ' A' ' 271' ' ' ASN . 13.4 mp0 -78.89 166.02 22.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.896 0.379 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.539 ' NE1' ' O ' ' A' ' 274' ' ' GLY . 1.5 p-90 177.81 179.49 0.3 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.617 0.723 . . . . 0.0 110.711 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 2.6 mt-10 -107.92 -178.53 3.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.607 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -157.72 -165.84 16.04 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.462 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -163.55 123.44 2.15 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.411 0.624 . . . . 0.0 112.269 -179.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -133.75 74.0 1.53 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.354 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER 83.99 37.08 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.644 0.735 . . . . 0.0 109.676 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 93.34 -36.07 3.87 Favored Glycine 0 C--N 1.334 0.438 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.032 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -64.61 86.16 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.355 0.598 . . . . 0.0 110.264 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.627 ' NH2' ' CE2' ' A' ' 142' ' ' PHE . 77.4 mtt180 -86.27 170.13 12.36 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.508 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.505 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 169.23 -151.12 16.81 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 18.6 p-80 -130.18 176.77 7.82 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.0 OUTLIER 157.99 112.83 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.206 0 O-C-N 123.461 0.476 . . . . 0.0 110.026 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.4 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 39.8 Cg_exo -54.8 148.05 47.82 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 122.375 2.05 . . . . 0.0 112.906 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.567 ' CD2' HG23 ' A' ' 292' ' ' VAL . 0.4 OUTLIER -66.49 -2.63 4.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.804 0.335 . . . . 0.0 110.303 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.0 p -47.7 -5.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.532 ' N ' ' O ' ' A' ' 289' ' ' PHE . 1.6 p80 -155.71 75.15 0.9 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -163.12 159.67 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.447 ' HE ' HD13 ' A' ' 244' ' ' ILE . 37.5 mtt180 -126.52 76.37 1.62 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.743 0.306 . . . . 0.0 110.318 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 48.3 mt -39.36 127.48 1.82 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.137 0.97 . . . . 0.0 112.019 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 -172.37 2.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.098 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -110.72 48.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.823 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.568 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 34.1 tp60 . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.371 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 137' ' ' TYR . 5.8 tp10 45.96 -164.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.947 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.545 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 48.5 p90 -179.55 119.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.908 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 160' ' ' LEU . 30.2 m -131.39 165.02 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.533 ' NE ' ' OE2' ' A' ' 189' ' ' GLU . 12.7 ttp180 -122.62 136.94 55.02 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.747 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -103.85 90.81 3.74 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.566 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.504 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -103.52 38.3 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.49 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 58.8 m-85 -133.76 -0.16 3.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.958 -0.464 . . . . 0.0 111.038 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 59.47 136.94 0.01 OUTLIER 'General case' 0 C--O 1.21 -1.023 0 O-C-N 124.131 0.894 . . . . 0.0 109.477 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.408 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 8.5 t80 -126.5 -48.0 1.56 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.035 0.445 . . . . 0.0 110.641 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 46.59 58.31 4.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.23 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.483 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -65.45 -128.74 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.705 ' N ' HD22 ' A' ' 147' ' ' ASN . 0.0 OUTLIER 164.43 -41.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.689 ' H ' HD22 ' A' ' 147' ' ' ASN . 7.9 m-20 -73.95 140.33 45.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 112.034 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -49.9 -21.35 1.14 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.428 ' N ' ' C ' ' A' ' 148' ' ' ASP . 77.9 mt-10 -91.27 29.4 1.44 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.528 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.607 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 31.6 p30 -153.11 171.68 18.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.555 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 175' ' ' ASP . 14.6 tp -126.24 87.72 55.67 Favored Pre-proline 0 C--O 1.212 -0.901 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.788 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.483 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 57.8 Cg_endo -64.17 143.19 83.21 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 CA-C-N 121.073 1.419 . . . . 0.0 113.858 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 160' ' ' LEU . 12.6 p90 -167.76 172.4 9.21 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.657 0.741 . . . . 0.0 111.485 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -150.29 -165.0 2.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.239 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.747 ' O ' ' O ' ' A' ' 140' ' ' ALA . 17.9 ptpt 41.36 -145.81 0.04 OUTLIER 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -109.13 49.39 0.85 Allowed Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 37.4 t0 -52.86 154.04 3.02 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.4 mp -100.24 99.27 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.517 ' O ' HG22 ' A' ' 138' ' ' VAL . 66.7 mt -102.33 90.47 3.91 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.473 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -69.04 147.1 52.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.967 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.1 mp -80.44 131.25 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.05 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.617 ' NH2' HD21 ' A' ' 172' ' ' ASN . 13.1 ttm180 -85.85 -43.09 13.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.212 0.529 . . . . 0.0 110.909 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 164' ' ' ASP . 38.2 t0 -153.58 -24.75 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.326 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.472 ' HE2' ' HE1' ' A' ' 171' ' ' TRP . 12.7 tttm 59.48 99.25 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -85.56 -44.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.989 1.793 . . . . 0.0 111.732 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -119.98 174.91 6.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.861 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 0.8 OUTLIER -88.49 -38.46 14.96 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.972 -179.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.524 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 95.5 mt-30 -80.38 -15.47 56.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.566 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.44 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 64.5 m95 -131.49 154.63 48.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.527 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.5 m0 -143.37 133.37 24.19 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.617 HD21 ' NH2' ' A' ' 163' ' ' ARG . 47.3 t-20 -85.02 117.79 24.2 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.84 178.7 6.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.008 0.433 . . . . 0.0 110.734 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.5 111.28 15.51 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.3 OUTLIER -60.88 140.37 57.71 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.19 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.2 ttt -52.1 -0.74 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.607 ' H ' ' C ' ' A' ' 175' ' ' ASP . 86.5 m-20 -84.82 -23.02 29.26 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.394 0.616 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.52 41.24 2.78 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.105 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -139.85 142.23 36.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.033 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.64 130.29 49.49 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.474 0.654 . . . . 0.0 111.525 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.494 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -162.77 159.57 31.94 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.437 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.6 mtp -69.84 149.58 47.74 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.137 0.494 . . . . 0.0 111.199 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.494 HG22 ' HB3' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -134.57 141.55 39.32 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.724 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.38 119.05 5.89 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 N-CA-C 108.073 -1.549 . . . . 0.0 108.073 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.819 ' O ' HG22 ' A' ' 188' ' ' VAL . 35.7 t -54.2 -50.63 83.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.8 Cg_endo -50.9 -27.84 22.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.185 1.924 . . . . 0.0 112.873 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.0 m-85 -71.32 4.91 2.53 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.38 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.7 m -130.7 163.02 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.699 0.285 . . . . 0.0 110.596 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.533 ' OE2' ' NE ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -76.31 -71.45 0.39 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.677 -178.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.75 -161.89 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 123.974 0.796 . . . . 0.0 110.614 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 10.0 p -162.46 9.48 0.06 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.073 0.463 . . . . 0.0 110.65 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -120.27 83.65 32.98 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.637 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 194' ' ' SER . 87.6 Cg_endo -79.91 -117.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.459 2.106 . . . . 0.0 111.86 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 193' ' ' PRO . 7.3 p 56.27 145.17 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.026 0.441 . . . . 0.0 110.949 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.8 p -91.59 -11.94 35.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.746 0.308 . . . . 0.0 110.291 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 197' ' ' SER . . . -67.26 94.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.794 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 196' ' ' ALA . 47.4 m 54.32 108.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.661 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.49 134.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.227 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 70.1 m -59.22 -97.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.651 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 33.7 p -141.28 170.9 14.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.411 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.11 80.04 9.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.225 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 19.4 p -85.7 88.45 7.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.594 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 132.98 64.56 0.08 OUTLIER Glycine 0 N--CA 1.466 0.643 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.03 174.36 42.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -92.75 -162.42 0.93 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 55.93 107.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.589 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 208' ' ' SER . 57.8 t0 -157.76 -131.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.361 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.492 ' H ' ' CG ' ' A' ' 207' ' ' ASP . 5.9 m -68.75 133.69 48.72 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 69.3 m -62.67 -47.78 82.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.498 ' ND1' ' N ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -143.19 91.87 6.91 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.331 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -54.32 157.06 12.21 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.254 1.969 . . . . 0.0 111.949 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -114.59 87.0 13.46 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.418 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.08 -40.49 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 112.287 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 70.0 mt -114.11 73.98 0.85 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.036 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.13 -39.34 92.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 140.57 88.89 0.15 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -55.52 143.01 80.07 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.25 1.967 . . . . 0.0 112.017 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 220' ' ' GLY . 13.9 pt-20 -178.12 76.07 0.22 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.375 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.45 78.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.853 2.369 . . . . 0.0 113.148 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 218' ' ' GLU . . . 129.92 -177.15 18.33 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.478 ' HG3' HD22 ' A' ' 228' ' ' ASN . 25.9 Cg_exo -62.92 149.98 89.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.593 2.195 . . . . 0.0 112.469 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.532 ' CD1' ' OE2' ' A' ' 218' ' ' GLU . 38.9 p90 -121.46 170.53 9.56 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.05 95.18 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.051 0.453 . . . . 0.0 110.589 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' TYR . 35.4 tp60 -143.18 129.68 10.48 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.406 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.26 -27.73 13.63 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.69 1.593 . . . . 0.0 112.532 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.406 ' C ' HD12 ' A' ' 227' ' ' ILE . 10.1 m -109.41 10.88 25.31 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.687 ' N ' HD12 ' A' ' 227' ' ' ILE . 3.7 mp 53.06 -95.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.353 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.478 HD22 ' HG3' ' A' ' 221' ' ' PRO . 13.7 m120 -58.53 115.82 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.056 0.455 . . . . 0.0 110.103 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 22.2 p -77.61 151.22 79.97 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.45 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.28 79.96 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.997 1.798 . . . . 0.0 111.865 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 233' ' ' ASN . 1.8 pt? -128.77 147.17 63.35 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.99 23.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.504 2.123 0 C-N-CA 122.403 2.068 . . . . 0.0 112.615 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 231' ' ' LEU . 0.7 OUTLIER 44.24 49.76 7.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.68 ' C ' ' H ' ' A' ' 236' ' ' ASN . 14.6 tp -57.69 -122.53 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.385 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 60.37 -19.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.618 0.247 . . . . 0.0 110.571 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.68 ' H ' ' C ' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -100.53 -40.69 7.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.2 -165.04 40.8 Favored Glycine 1 CA--C 1.439 -4.675 0 CA-C-O 122.306 0.948 . . . . 0.0 113.944 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.411 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.6 Cg_endo -44.43 102.73 0.03 OUTLIER 'Cis proline' 1 N--CA 1.538 4.114 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -0.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 10.5 m-30 -115.27 -124.37 0.29 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.6 OUTLIER -143.71 130.93 20.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 119.667 1.121 . . . . 0.0 109.83 -179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.773 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.04 -168.03 1.38 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.618 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.37 93.99 1.35 Allowed 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.8 p -69.0 123.04 21.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.347 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.96 9.08 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.041 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.581 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.8 mm-40 -168.61 128.03 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.311 0.576 . . . . 0.0 109.504 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.4 ttmt -170.51 -144.39 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.862 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.1 ptt85 -160.48 -136.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.507 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.428 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 3.7 t -137.01 61.95 37.18 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.667 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.679 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -102.1 70.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.806 3.004 . . . . 0.0 112.081 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.615 ' ND2' ' N ' ' A' ' 250' ' ' ASN . 0.1 OUTLIER -47.78 158.53 0.2 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.54 -3.84 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.897 0.38 . . . . 0.0 111.767 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.73 ' O ' ' N ' ' A' ' 254' ' ' LYS . 30.1 m-85 -80.15 -59.04 2.86 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 42.9 t0 -47.14 60.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 O-C-N 125.653 1.846 . . . . 0.0 112.179 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 252' ' ' TYR . 34.0 mtmt 87.49 -51.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 O-C-N 124.961 1.413 . . . . 0.0 109.422 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 4.4 m 164.29 -17.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.175 0.922 . . . . 0.0 110.373 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.537 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -45.16 170.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.573 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.781 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.4 OUTLIER -109.54 150.26 28.42 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 122.778 0.431 . . . . 0.0 110.563 -177.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.751 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -97.17 116.59 29.64 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 122.07 -0.394 . . . . 0.0 111.119 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.803 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.2 mt -137.58 -172.59 3.27 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.74 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.445 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 15.3 tt0 -145.56 147.43 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.043 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.581 HG22 ' HA ' ' A' ' 245' ' ' GLN . 68.8 t -54.73 97.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.888 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 122.15 10.26 6.29 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 56.2 mm-40 -91.81 -130.64 0.11 Allowed 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.063 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 166.32 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.063 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.1 p -127.41 142.75 42.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.466 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.519 ' O ' HG22 ' A' ' 268' ' ' THR . 2.9 ttmm -99.04 84.15 3.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.868 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.4 ' CG1' HD13 ' A' ' 234' ' ' LEU . 94.0 t -50.56 150.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.518 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 266' ' ' LYS . 0.2 OUTLIER -148.25 -47.68 0.16 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.579 -178.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 5.6 tppt? -84.05 151.73 24.8 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.36 134.19 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.407 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.653 ' N ' HD22 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -177.31 -170.57 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.135 -179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.564 ' HG3' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER 60.39 -143.32 0.52 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.687 178.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.3 p -137.04 -4.35 1.94 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.734 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 275' ' ' GLN . . . 177.74 13.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 118.924 -1.608 . . . . 0.0 112.517 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 1.2 mp0 -101.28 -74.76 0.61 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.531 ' CE3' ' O ' ' A' ' 271' ' ' ASN . 9.9 m95 76.63 169.01 0.25 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.046 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 75.0 mt-10 -131.95 143.06 49.84 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.543 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -136.68 145.34 17.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 121.853 0.696 . . . . 0.0 113.599 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -108.64 130.8 55.32 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 113.945 -1.127 . . . . 0.0 110.674 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.713 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -110.55 -90.84 0.47 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -104.54 50.56 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 89.92 -31.04 5.49 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.1 OUTLIER -63.91 75.68 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.284 -0.958 . . . . 0.0 111.156 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 282' ' ' GLY . 50.9 mtt180 -71.92 160.89 31.77 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.357 0.599 . . . . 0.0 110.344 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 173.54 -161.71 32.48 Favored Glycine 0 C--O 1.217 -0.928 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.537 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 41.1 p-80 -130.04 168.8 16.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.223 0.535 . . . . 0.0 110.801 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 173.47 116.13 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.239 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.42 ' HG3' HE21 ' A' ' 275' ' ' GLN . 52.7 Cg_exo -51.45 149.91 16.67 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.805 1.67 . . . . 0.0 111.915 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.5 OUTLIER -61.11 -4.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 288' ' ' PRO . 31.9 p -46.95 -9.25 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.89 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.78 ' O ' HG13 ' A' ' 292' ' ' VAL . 4.5 p-80 -153.96 84.6 1.15 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.325 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.1 OUTLIER -172.68 152.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -106.14 -45.61 4.28 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 32.1 mt 77.39 113.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 122.069 0.938 . . . . 0.0 111.451 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.5 mp -80.78 -174.54 4.81 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.265 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.423 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 67.1 t0 -106.64 58.79 0.64 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 53.2 tt0 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.856 ' O ' HG13 ' A' ' 138' ' ' VAL . 0.7 OUTLIER -60.15 -71.52 0.13 Allowed 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.948 ' O ' HG22 ' A' ' 138' ' ' VAL . 98.3 m-85 -24.66 -100.23 0.0 OUTLIER 'General case' 0 C--O 1.211 -0.926 0 O-C-N 123.542 0.526 . . . . 0.0 111.777 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.948 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 82.74 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 125.109 1.506 . . . . 0.0 111.156 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.564 ' NH1' ' O ' ' A' ' 200' ' ' THR . 4.2 ptp180 -135.63 144.69 46.22 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.838 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.708 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -100.32 96.57 7.53 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.599 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.783 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -96.99 37.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.914 0.388 . . . . 0.0 111.467 -178.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.539 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 49.5 m-85 -137.35 1.98 2.46 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.684 0.278 . . . . 0.0 110.793 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.5 OUTLIER 60.21 143.32 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.495 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.515 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 5.4 t80 -133.62 -34.92 1.01 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.545 0.611 . . . . 0.0 110.951 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 144' ' ' PHE . 7.6 p30 34.42 59.89 0.61 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.645 0.591 . . . . 0.0 110.663 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.73 -139.8 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.54 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 165.04 94.14 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.667 -0.766 . . . . 0.0 110.844 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.481 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 4.6 m-20 158.63 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.112 0.482 . . . . 0.0 110.2 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.17 -17.35 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.361 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -100.44 18.23 19.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.453 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.3 p30 -142.41 156.75 45.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.733 HD11 ' OD2' ' A' ' 175' ' ' ASP . 9.8 tp -121.63 85.83 44.27 Favored Pre-proline 0 C--O 1.212 -0.891 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.26 137.27 79.71 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 C-N-CA 121.586 1.524 . . . . 0.0 112.87 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.708 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 7.1 p90 -154.01 170.03 22.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.998 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -135.82 -68.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -94.96 92.62 6.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.249 -176.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 17.35 55.42 0.01 OUTLIER Glycine 0 C--N 1.34 0.806 0 O-C-N 123.812 0.695 . . . . 0.0 112.041 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 156' ' ' LYS . 32.9 t0 -63.08 142.82 58.24 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.576 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.5 mp -87.31 101.87 11.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 31.0 mt -92.14 -127.56 0.1 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.356 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 174' ' ' GLU . 40.9 tttp 173.28 124.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.678 0.611 . . . . 0.0 110.399 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.588 HD13 ' O ' ' A' ' 136' ' ' GLU . 1.3 mp -90.23 145.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.49 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -134.11 -39.8 0.84 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -135.38 104.97 6.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.856 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.463 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 12.9 pttm -113.22 74.94 2.07 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.79 -30.19 22.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.995 1.797 . . . . 0.0 112.227 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.16 158.92 17.82 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.612 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -87.09 -37.18 17.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.736 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.45 HE22 ' CD ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -78.94 -29.52 44.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.621 -179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.466 ' CZ2' ' HD2' ' A' ' 238' ' ' PRO . 77.4 m95 -117.27 150.95 37.93 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.521 ' CE3' HG22 ' A' ' 185' ' ' VAL . 8.8 m0 -145.91 136.33 24.01 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.8 112.15 16.8 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.47 166.62 10.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.069 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 161' ' ' LYS . 27.4 tt0 -129.31 145.95 51.28 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.012 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.733 ' OD2' HD11 ' A' ' 152' ' ' LEU . 0.5 OUTLIER -76.58 -178.93 4.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.664 0.745 . . . . 0.0 110.73 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.4 ttt -80.11 -11.45 59.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.0 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -100.94 -25.48 14.07 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.1 43.67 0.51 Allowed Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -117.56 126.16 52.09 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.783 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.68 42.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.456 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -150.59 148.52 19.79 Favored Glycine 0 C--N 1.312 -0.793 0 CA-C-N 114.504 -1.225 . . . . 0.0 111.875 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 159.67 20.59 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.44 0.638 . . . . 0.0 110.656 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.403 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 7.8 pt -150.49 142.48 15.61 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.732 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -72.33 110.76 3.04 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 N-CA-C 109.852 -0.865 . . . . 0.0 109.852 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 188' ' ' VAL . 50.3 t -44.6 -51.58 20.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 121.613 -0.679 . . . . 0.0 112.048 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.8 Cg_endo -47.26 -29.3 9.21 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.146 1.898 . . . . 0.0 112.841 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -69.73 -6.33 31.16 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.058 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 185' ' ' VAL . 25.0 m -129.53 167.22 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.701 0.286 . . . . 0.0 111.007 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.783 ' CD ' HD21 ' A' ' 141' ' ' LEU . 4.4 pt-20 -150.22 61.19 0.97 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 110.938 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 52.6 -174.5 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.035 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 23.9 t -143.79 -33.85 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.654 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 44.85 71.92 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.02 -21.65 59.73 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.869 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 83.2 p -66.32 -27.62 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.656 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 196' ' ' ALA . 50.9 p -66.52 -59.02 4.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.801 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 195' ' ' SER . . . 53.49 56.88 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.748 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 199' ' ' SER . 5.7 t -86.38 74.95 9.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.58 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 82.0 t 39.99 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.988 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 197' ' ' SER . 82.5 p -80.06 51.14 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.211 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.564 ' O ' ' NH1' ' A' ' 139' ' ' ARG . 8.4 m -64.87 -31.24 72.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.48 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 201' ' ' LEU . 9.4 mp -78.65 -70.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.681 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 30.7 p -84.97 99.12 10.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.665 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 171.57 89.47 0.07 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 166.6 129.13 1.03 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 206' ' ' GLN . 49.4 t30 40.89 -155.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.714 0.292 . . . . 0.0 110.631 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.509 ' H ' ' CG ' ' A' ' 205' ' ' ASN . 58.0 tp60 -169.74 52.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.225 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 208' ' ' SER . 93.7 m-20 54.9 35.42 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.687 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 207' ' ' ASP . 55.2 p 55.77 160.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 89.5 p -81.41 -15.23 55.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.558 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.425 ' ND1' ' OD1' ' A' ' 271' ' ' ASN . 74.1 m-70 53.33 82.84 0.24 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.234 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.71 143.42 69.82 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.629 2.219 . . . . 0.0 111.84 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.576 ' H ' ' CD ' ' A' ' 212' ' ' GLN . 2.3 mp0 -48.38 148.59 3.24 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.658 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.1 -36.12 11.39 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.219 1.946 . . . . 0.0 112.004 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tp 67.51 6.38 4.92 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.301 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 40.18 -141.17 0.83 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 175.94 172.36 40.65 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.21 -174.35 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.794 2.329 . . . . 0.0 111.68 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.06 66.46 77.59 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.463 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.39 -5.45 16.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.854 2.369 . . . . 0.0 111.916 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.47 -74.65 0.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.12 -179.53 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.631 2.221 . . . . 0.0 112.006 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.537 ' O ' ' NE2' ' A' ' 224' ' ' GLN . 48.4 p90 -59.33 169.34 1.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.84 105.59 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 110.364 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.625 ' NE2' ' H ' ' A' ' 224' ' ' GLN . 0.0 OUTLIER -127.28 146.56 58.55 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.06 -30.8 66.03 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.271 1.981 . . . . 0.0 112.402 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 227' ' ' ILE . 68.4 p -133.48 -96.98 0.29 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 227' ' ' ILE . 10.7 tp -150.63 43.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.117 0.484 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -176.19 172.71 2.29 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.657 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 53.9 p -72.76 127.9 89.04 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.623 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.56 -151.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.956 1.771 . . . . 0.0 112.53 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.503 ' CB ' ' HE1' ' A' ' 276' ' ' TRP . 10.6 tp -78.29 126.94 82.5 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.357 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.482 ' O ' ' ND2' ' A' ' 233' ' ' ASN . 45.5 Cg_endo -68.66 -58.33 0.12 Allowed 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.793 1.662 . . . . 0.0 113.061 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 232' ' ' PRO . 26.5 m120 -149.99 -167.94 2.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.175 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 235' ' ' GLN . 30.9 tp -39.31 -84.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.407 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.606 ' O ' ' N ' ' A' ' 237' ' ' GLY . 6.4 mm100 55.87 154.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.186 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 44.08 -87.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.433 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 235' ' ' GLN . . . -34.72 160.27 0.01 OUTLIER Glycine 1 CA--C 1.45 -4.021 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.951 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.482 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 3.1 Cg_exo -73.24 126.08 11.46 Favored 'Cis proline' 0 C--N 1.285 -2.799 0 O-C-N 122.3 0.632 . . . . 0.0 113.071 -5.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.49 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 40.9 m-85 -153.71 -124.62 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.518 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 2.2 m-30 -140.7 113.21 8.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 118.752 0.705 . . . . 0.0 109.71 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.707 ' HB2' HD23 ' A' ' 294' ' ' LEU . . . -105.65 144.48 32.34 Favored 'General case' 0 C--O 1.2 -1.515 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -101.1 112.52 25.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.19 0.519 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.5 p -79.05 122.26 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.74 21.51 6.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 178.72 104.54 0.02 OUTLIER 'General case' 0 N--CA 1.46 0.064 0 CA-C-O 121.525 0.678 . . . . 0.0 111.154 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.833 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -139.99 -140.11 0.13 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.743 178.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.1 ptt85 -157.2 -139.61 0.07 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.834 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 248' ' ' VAL . 80.4 t -135.94 69.36 64.51 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.985 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 256' ' ' ALA . 45.4 Cg_endo -96.28 -179.72 0.48 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.976 2.45 . . . . 0.0 111.208 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.709 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.8 OUTLIER -141.99 137.2 31.0 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.683 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.43 -5.51 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.303 0.377 . . . . 0.0 111.504 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.709 ' N ' ' O ' ' A' ' 250' ' ' ASN . 51.2 m-85 -93.41 -55.79 3.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.14 71.76 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.998 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 252' ' ' TYR . 30.9 mtmt 74.91 -5.22 2.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 124.343 1.027 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.53 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 0.3 OUTLIER 87.24 51.88 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.398 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 249' ' ' PRO . . . -104.71 113.87 27.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.865 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -49.26 155.21 0.72 Allowed 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 121.922 -0.486 . . . . 0.0 111.444 -179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.662 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -106.5 114.51 28.66 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.633 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.833 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.8 OUTLIER -136.56 -173.94 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.337 0.589 . . . . 0.0 111.328 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.2 tt0 -146.26 152.07 38.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.786 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.401 ' N ' ' HG3' ' A' ' 260' ' ' GLU . 54.3 t -56.96 115.14 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.66 10.33 17.03 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 23.0 mm-40 -107.56 -152.49 0.48 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.874 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER -171.89 152.31 2.97 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.994 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.874 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.3 p -135.8 156.78 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.151 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.45 ' CD ' HE22 ' A' ' 169' ' ' GLN . 0.0 OUTLIER -100.62 99.29 9.84 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 268' ' ' THR . 10.7 t -65.81 156.85 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.428 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.408 ' N ' ' CG1' ' A' ' 267' ' ' VAL . 0.6 OUTLIER -158.25 -62.42 0.08 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.152 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -80.42 141.67 35.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -177.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.9 OUTLIER -140.59 147.68 22.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.288 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.567 ' C ' HD22 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -176.53 -159.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.5 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.49 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 47.7 mtm 52.1 -120.66 1.7 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.886 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.8 p -135.48 -10.65 2.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.237 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . 177.69 -46.39 0.1 OUTLIER Glycine 0 C--N 1.338 0.642 0 C-N-CA 118.559 -1.781 . . . . 0.0 113.126 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.49 ' O ' ' HE3' ' A' ' 272' ' ' MET . 24.2 mp0 -65.79 64.39 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 274' ' ' GLY . 3.1 p-90 -74.66 -171.95 1.4 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.171 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.645 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 86.0 mt-10 -108.61 166.9 10.44 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.535 1.147 . . . . 0.0 111.618 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -149.18 -170.81 17.2 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.896 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.449 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -157.08 127.68 6.57 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.304 0.574 . . . . 0.0 111.655 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.636 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -138.94 74.28 1.47 Allowed 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.302 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 7.2 m-20 85.74 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.731 0.777 . . . . 0.0 109.33 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.09 -33.73 4.37 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.78 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.03 93.64 0.59 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.449 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 83.9 mtt180 -94.75 168.46 10.81 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.438 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.548 ' O ' HD22 ' A' ' 257' ' ' LEU . . . 162.95 137.53 2.21 Favored Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.862 -1.161 . . . . 0.0 111.994 177.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 277' ' ' GLU . 2.7 p80 -65.06 175.31 1.62 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.142 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.614 ' CZ ' ' HB1' ' A' ' 256' ' ' ALA . 0.3 OUTLIER 166.21 144.53 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.408 178.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 39.9 Cg_exo -55.28 137.99 78.43 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.436 2.091 . . . . 0.0 113.331 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 2.0 t80 -73.77 -5.8 43.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.253 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 34.8 p -67.72 2.45 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 8.5 p80 -136.32 47.51 2.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.417 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.427 HG13 ' HD1' ' A' ' 291' ' ' HIS . 0.9 OUTLIER -149.3 151.37 13.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -111.01 -53.8 2.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.707 HD23 ' HB2' ' A' ' 241' ' ' ALA . 2.0 mt 91.27 119.73 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.324 1.059 . . . . 0.0 111.346 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 297' ' ' GLN . 8.7 mp -70.46 -170.59 0.4 Allowed 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 296' ' ' ASP . 40.8 t0 -66.51 9.4 0.17 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.915 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 295' ' ' LEU . 40.6 tt0 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.42 ' O ' HG12 ' A' ' 162' ' ' ILE . 6.2 tp10 -54.33 -83.27 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.39 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.897 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.7 m-85 -58.8 -54.84 42.58 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 137' ' ' TYR . 2.3 m 93.12 155.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 O-C-N 125.682 1.864 . . . . 0.0 111.59 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -121.35 125.67 47.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.744 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -98.9 95.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.331 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.648 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -106.1 35.05 3.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.755 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.566 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 47.6 m-85 -134.26 0.85 3.14 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 122.29 -0.256 . . . . 0.0 111.029 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.89 137.95 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.66 0 O-C-N 124.281 0.988 . . . . 0.0 108.786 -178.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 8.6 t80 -121.54 -47.89 2.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.092 0.406 . . . . 0.0 110.399 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 144' ' ' PHE . 65.7 t30 40.97 60.9 1.87 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.213 0.53 . . . . 0.0 109.958 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.17 -155.55 1.41 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.722 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.629 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.2 OUTLIER 169.62 94.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.188 -1.006 . . . . 0.0 110.27 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -159.97 -146.04 0.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.396 0.617 . . . . 0.0 111.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 58.7 p30 -75.86 57.51 1.05 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.581 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 151' ' ' ASP . 92.2 mt-10 98.01 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.402 1.064 . . . . 0.0 111.496 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.629 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 14.1 p-10 -28.91 161.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.681 0.613 . . . . 0.0 110.705 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.491 HD23 HG21 ' A' ' 183' ' ' ILE . 13.8 tp -106.72 75.34 0.39 Allowed Pre-proline 0 C--O 1.215 -0.758 0 O-C-N 122.075 -0.391 . . . . 0.0 111.117 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.75 118.72 5.81 Favored 'Trans proline' 0 C--N 1.295 -2.255 0 CA-C-N 119.386 0.816 . . . . 0.0 110.968 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.744 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 15.5 p90 -134.25 163.6 29.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.416 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.411 ' CG ' ' H ' ' A' ' 156' ' ' LYS . 1.1 tpmp? -96.13 -135.35 0.23 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 158' ' ' ASP . 50.8 mtmt -96.56 174.94 6.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 159' ' ' ILE . . . 33.11 22.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.873 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.634 ' N ' ' O ' ' A' ' 156' ' ' LYS . 6.3 t0 -72.69 137.46 46.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 117.257 0.528 . . . . 0.0 109.816 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -104.06 103.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.7 mt -108.35 107.93 18.7 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.065 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -62.89 140.12 58.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 136' ' ' GLU . 48.7 mm -81.34 130.95 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.165 0.507 . . . . 0.0 110.409 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.98 -44.07 5.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -155.1 133.2 11.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.641 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.535 ' HG3' ' NE1' ' A' ' 171' ' ' TRP . 2.6 ttmm -106.42 70.55 0.24 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 119.698 -0.191 . . . . 0.0 110.727 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.25 -54.74 0.45 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.165 1.244 . . . . 0.0 111.495 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -100.78 -172.8 2.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.18 -32.88 7.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.707 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.57 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 94.2 mt-30 -83.29 -31.32 26.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.497 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 81.2 m95 -119.59 148.03 43.8 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.567 ' CE3' HG22 ' A' ' 185' ' ' VAL . 14.1 m0 -141.72 131.33 24.0 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 120.857 0.36 . . . . 0.0 110.104 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -81.12 105.73 12.56 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.25 174.91 5.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.047 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -123.24 130.53 52.87 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.877 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.99 165.55 0.94 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.197 0.522 . . . . 0.0 110.461 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 49.8 ttp -74.07 -4.48 35.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.047 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -97.15 -27.85 14.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.25 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.89 48.37 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 108.279 -1.929 . . . . 0.0 108.279 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -128.07 129.0 45.95 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.929 -0.636 . . . . 0.0 109.678 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.55 125.79 49.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.344 0.593 . . . . 0.0 111.869 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -165.26 160.66 34.04 Favored Glycine 0 CA--C 1.531 1.031 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.522 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.483 ' C ' HG22 ' A' ' 183' ' ' ILE . 0.2 OUTLIER -68.02 160.25 29.13 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.159 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.868 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -159.66 148.12 13.68 Favored Pre-proline 0 N--CA 1.469 0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.572 177.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.53 122.44 8.61 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.659 1.573 . . . . 0.0 109.253 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.829 ' O ' HG22 ' A' ' 188' ' ' VAL . 42.7 t -58.68 -52.18 76.56 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.672 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.5 Cg_endo -50.78 -27.25 19.68 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.794 2.329 . . . . 0.0 114.498 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.431 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 5.2 m-85 -65.2 7.8 0.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.812 0.339 . . . . 0.0 111.483 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 185' ' ' VAL . 3.1 m -132.69 173.08 15.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.648 ' CD ' HD21 ' A' ' 141' ' ' LEU . 1.9 pt-20 -141.64 39.87 1.7 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.973 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.522 ' O ' ' O ' ' A' ' 189' ' ' GLU . 13.4 mptt 52.89 118.13 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 110.57 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.502 ' H ' ' HA ' ' A' ' 138' ' ' VAL . 47.4 t -48.06 164.51 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.589 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.441 ' N ' ' SG ' ' A' ' 191' ' ' CYS . 51.9 ttt180 67.35 93.65 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.205 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -47.7 -67.97 0.1 Allowed 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.977 1.785 . . . . 0.0 113.003 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 p 65.13 35.76 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.899 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.3 m 41.4 37.52 0.67 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 197' ' ' SER . . . -124.71 -90.65 0.56 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ALA . 40.2 t 56.2 146.24 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.019 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 199' ' ' SER . 25.8 m -67.83 -41.72 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.999 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.49 ' N ' HG23 ' A' ' 198' ' ' VAL . 14.6 m -137.44 13.68 2.99 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.797 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.5 p 45.02 -139.27 0.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.404 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.26 156.55 20.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.619 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -43.94 95.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -68.03 -74.85 0.55 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 52.33 -105.67 0.28 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 206' ' ' GLN . 27.1 t-20 -62.35 -117.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.668 0.271 . . . . 0.0 110.563 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.466 ' N ' ' OD1' ' A' ' 205' ' ' ASN . 78.2 mt-30 -145.08 150.62 37.15 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.352 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -158.68 173.66 16.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m 62.52 123.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.818 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.7 t -142.84 135.99 28.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.42 ' CB ' ' CD ' ' A' ' 211' ' ' PRO . 2.8 m-70 -78.81 -63.12 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.326 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 210' ' ' HIS . 17.9 Cg_endo -56.14 124.55 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 121.858 1.705 . . . . 0.0 111.574 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.4 79.06 15.94 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.94 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.35 145.08 89.48 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.7 mp -83.68 20.94 1.32 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.167 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.02 -33.87 88.35 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.79 173.23 45.08 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.71 149.25 73.14 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.771 2.314 . . . . 0.0 111.92 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -150.3 66.18 7.65 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.045 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -79.71 -155.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.959 2.439 . . . . 0.0 111.648 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 -168.58 35.31 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.456 ' HG3' HD21 ' A' ' 228' ' ' ASN . 42.7 Cg_endo -72.18 -61.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.131 1.887 . . . . 0.0 112.344 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 224' ' ' GLN . 89.9 m-85 -142.12 160.64 39.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.492 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.93 94.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.306 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.808 HE21 ' H ' ' A' ' 228' ' ' ASN . 18.2 tt0 -141.88 98.99 6.2 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.836 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 226' ' ' SER . 51.4 Cg_exo -51.28 72.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.87 1.713 . . . . 0.0 111.794 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 224' ' ' GLN . 1.7 t 164.54 -40.52 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.646 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 227' ' ' ILE . 89.0 mt 61.77 70.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 -178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.808 ' H ' HE21 ' A' ' 224' ' ' GLN . 2.3 m120 79.18 65.31 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.639 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.433 ' CB ' ' CD ' ' A' ' 230' ' ' PRO . 0.1 OUTLIER -51.95 176.28 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -176.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.586 ' HB3' ' N ' ' A' ' 289' ' ' PHE . 38.3 Cg_endo -85.22 154.63 10.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.952 2.435 . . . . 0.0 110.805 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.658 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 3.5 mp -95.04 164.82 18.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.5 68.99 4.33 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.674 1.582 . . . . 0.0 110.613 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -90.13 17.32 7.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.09 0.472 . . . . 0.0 110.834 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.665 ' C ' ' H ' ' A' ' 236' ' ' ASN . 5.0 tp -72.91 -125.15 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.722 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.482 ' H ' ' CG ' ' A' ' 234' ' ' LEU . 78.4 mm-40 56.17 -5.63 0.03 OUTLIER 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.665 ' H ' ' C ' ' A' ' 234' ' ' LEU . 95.0 m-20 -107.87 -56.88 2.17 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.603 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.68 -163.38 39.21 Favored Glycine 1 CA--C 1.446 -4.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.091 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.404 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 3.5 Cg_exo -45.38 100.17 0.03 OUTLIER 'Cis proline' 0 N--CA 1.528 3.519 0 N-CA-C 117.152 1.943 . . . . 0.0 117.152 1.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.634 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 11.2 m-30 -116.26 -128.23 0.29 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.57 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.47 128.64 19.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 119.435 1.016 . . . . 0.0 109.805 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.801 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.16 -162.37 0.86 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.314 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -160.85 95.81 1.09 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.5 p -69.92 128.68 33.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.343 -0.943 . . . . 0.0 109.711 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.978 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -123.17 12.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.699 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 261' ' ' VAL . 2.4 mm-40 -169.06 114.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.836 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.4 ttmt -160.78 -145.66 0.12 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -155.48 -140.15 0.08 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.531 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 248' ' ' VAL . 6.4 p -134.47 65.24 67.14 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.568 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 78.6 Cg_endo -91.91 176.47 1.92 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.339 2.026 . . . . 0.0 112.075 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.703 ' O ' ' N ' ' A' ' 252' ' ' TYR . 16.9 p30 -149.26 145.21 26.97 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.712 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.41 -3.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.703 ' N ' ' O ' ' A' ' 250' ' ' ASN . 48.0 m-85 -91.5 -54.09 4.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.481 0.658 . . . . 0.0 110.291 178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -46.11 -66.52 0.39 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.652 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 256' ' ' ALA . 27.7 mttt -148.26 33.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.275 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.413 ' O ' ' HA2' ' A' ' 285' ' ' GLY . 3.6 m 70.9 -13.61 0.49 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.689 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.07 164.41 0.29 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.261 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.797 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -104.07 149.53 25.12 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 122.794 0.438 . . . . 0.0 110.533 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.801 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -86.81 114.55 23.57 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.836 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.3 mt -139.9 -177.0 4.78 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.447 0.641 . . . . 0.0 111.007 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.3 tt0 -145.83 147.48 31.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 245' ' ' GLN . 71.9 t -54.55 102.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.96 6.11 10.34 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 65.7 mm-40 -88.32 -125.25 0.05 Allowed 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.079 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 161.23 140.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.079 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.7 p -130.89 140.66 48.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.175 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -99.3 86.01 3.31 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.992 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.4 152.58 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.669 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.431 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -154.37 -53.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.62 127.89 33.8 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.787 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -137.37 127.49 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.997 0.903 . . . . 0.0 111.913 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.647 ' C ' HD22 ' A' ' 271' ' ' ASN . 0.1 OUTLIER -154.66 -167.96 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.549 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.509 ' CE ' HD21 ' A' ' 271' ' ' ASN . 44.7 mtm 65.41 -123.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.89 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.3 p -140.37 -5.76 1.22 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.028 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.59 ' O ' ' N ' ' A' ' 276' ' ' TRP . . . -175.57 -52.13 0.06 OUTLIER Glycine 0 C--O 1.213 -1.203 0 C-N-CA 118.138 -1.982 . . . . 0.0 112.737 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.506 ' O ' ' HE3' ' A' ' 272' ' ' MET . 23.2 tp60 -61.34 63.9 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.658 ' HE1' ' C ' ' A' ' 231' ' ' LEU . 6.4 m95 -67.41 177.93 1.74 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.518 -0.739 . . . . 0.0 111.097 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 59.1 mt-10 -130.26 156.39 44.72 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.554 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -133.36 -142.28 4.74 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.964 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.479 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.1 tt0 -169.35 134.32 1.48 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 114.925 -0.638 . . . . 0.0 112.559 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.707 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -146.61 72.24 1.27 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.157 -178.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 18.2 t-20 83.27 31.34 0.07 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.361 0.6 . . . . 0.0 110.04 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.68 -33.43 5.71 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.134 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 13.2 ptpt -67.87 75.44 0.2 Allowed 'General case' 0 CA--C 1.494 -1.198 0 CA-C-O 121.033 0.444 . . . . 0.0 110.991 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.542 ' NH1' ' CZ ' ' A' ' 142' ' ' PHE . 93.4 mtt180 -73.01 170.49 14.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.98 -155.13 26.04 Favored Glycine 0 C--N 1.303 -1.256 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.3 p80 -136.36 176.51 8.63 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.129 0.572 . . . . 0.0 109.738 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.3 OUTLIER 171.27 125.09 0.06 OUTLIER Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.223 178.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.86 147.94 2.98 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.666 1.578 . . . . 0.0 113.559 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.586 ' N ' ' HB3' ' A' ' 230' ' ' PRO . 1.6 t80 -73.75 -5.13 38.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.1 p -60.05 5.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.266 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.749 ' O ' HG13 ' A' ' 292' ' ' VAL . 7.4 p-80 -157.33 72.93 0.71 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 291' ' ' HIS . 0.5 OUTLIER -165.9 148.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.425 ' HG3' HD12 ' A' ' 244' ' ' ILE . 14.3 mtp180 -126.36 74.38 1.45 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.799 0.333 . . . . 0.0 110.746 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 41.9 mt -40.68 127.06 2.48 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 112.004 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 4.9 mp -77.31 -174.52 3.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.277 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -96.71 25.7 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.074 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.634 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 56.2 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' CG ' ' A' ' 137' ' ' TYR . 2.0 tp10 -164.93 171.49 14.0 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.346 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 191' ' ' CYS . 0.5 OUTLIER 174.27 150.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.71 172.47 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -126.78 127.9 45.76 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.146 0.498 . . . . 0.0 110.506 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.757 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -96.89 93.05 6.42 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.672 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.566 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -99.4 36.1 1.82 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.284 -179.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.637 ' CZ ' ' NH2' ' A' ' 284' ' ' ARG . 52.0 m-85 -136.31 2.31 2.74 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 122.39 -0.194 . . . . 0.0 110.933 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 142' ' ' PHE . 1.3 p30 56.87 141.63 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 O-C-N 124.471 1.107 . . . . 0.0 109.596 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.478 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 10.5 t80 -134.41 -44.22 0.76 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.243 0.474 . . . . 0.0 110.165 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 144' ' ' PHE . 5.1 p-10 33.85 62.25 0.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.846 0.716 . . . . 0.0 110.619 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.407 ' N ' ' HB3' ' A' ' 153' ' ' PRO . . . -64.82 -135.82 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.689 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 0.1 OUTLIER 168.03 90.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.612 -0.294 . . . . 0.0 111.049 178.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.5 m-20 168.4 -170.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 150' ' ' GLU . 40.3 p-10 -93.53 -23.24 18.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.463 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 19.0 pt-20 -103.6 23.11 13.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.109 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.689 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 4.0 p-10 -131.58 148.37 52.61 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.2 tp -116.17 86.29 16.98 Favored Pre-proline 0 C--O 1.217 -0.649 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.407 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 53.6 Cg_endo -65.12 140.04 63.49 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.317 1.345 . . . . 0.0 112.825 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.757 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 10.6 p90 -158.0 160.21 37.23 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.63 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -63.58 0.72 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.553 0.692 . . . . 0.0 111.748 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 158' ' ' ASP . 2.5 ptmt -85.06 92.61 8.4 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.76 -177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 13.87 53.59 0.01 OUTLIER Glycine 0 N--CA 1.473 1.154 0 O-C-N 124.054 0.846 . . . . 0.0 112.287 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 156' ' ' LYS . 9.6 t70 -64.47 143.01 58.22 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.445 0.641 . . . . 0.0 109.583 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 191' ' ' CYS . 42.8 mm -88.5 107.8 18.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.183 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.8 mt -116.02 117.55 30.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.643 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.562 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 88.1 tttt -75.49 147.18 40.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.101 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.5 mp -74.22 -59.01 3.73 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.099 0.476 . . . . 0.0 111.073 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 70.57 -50.45 0.66 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.467 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -146.9 120.32 9.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.243 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.478 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 0.0 OUTLIER -120.48 85.17 37.18 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.398 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.89 -29.55 18.3 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.629 1.553 . . . . 0.0 112.281 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.417 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 94.8 mt-10 -119.98 160.67 22.31 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.002 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 168' ' ' GLU . 3.3 pt-20 -83.65 -43.69 15.33 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.741 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.516 ' OE1' ' CD1' ' A' ' 239' ' ' PHE . 93.8 mt-30 -74.68 -29.88 61.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.478 ' NE1' ' CE2' ' A' ' 239' ' ' PHE . 77.2 m95 -119.33 151.24 38.8 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.594 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.4 m0 -143.35 131.1 21.4 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.096 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 162' ' ' ILE . 51.2 t30 -81.39 116.98 21.47 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 161' ' ' LYS . . . -127.13 176.87 7.05 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.242 0.339 . . . . 0.0 110.453 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -122.19 133.94 54.72 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.258 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.434 ' HB2' HD11 ' A' ' 152' ' ' LEU . 11.0 t70 -58.37 170.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.491 0.662 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 22.5 ttt -78.51 0.41 26.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.666 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -104.4 -28.59 11.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.83 48.19 0.42 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -129.25 130.93 46.86 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.128 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.88 121.83 41.34 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.59 0.71 . . . . 0.0 111.874 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.86 154.41 25.49 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.765 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 152' ' ' LEU . 1.9 ttt -74.5 163.61 27.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.542 0.686 . . . . 0.0 111.084 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.842 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -157.21 145.31 14.21 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.669 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.03 112.92 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.529 1.486 . . . . 0.0 109.441 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.713 ' O ' HG22 ' A' ' 188' ' ' VAL . 49.7 t -47.63 -51.37 45.55 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.954 -0.466 . . . . 0.0 112.045 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.3 Cg_endo -47.42 -30.61 11.86 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.305 2.003 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.21 -3.76 11.75 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.935 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 185' ' ' VAL . 22.3 m -129.74 160.95 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.792 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.551 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -116.95 -64.31 1.33 Allowed 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.448 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 4.5 tptp -177.71 -173.17 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 159' ' ' ILE . 50.9 t -173.37 64.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.986 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.53 149.71 84.03 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.572 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.47 -31.33 0.36 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.212 1.942 . . . . 0.0 112.302 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 74.1 m -64.71 -99.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.511 ' O ' ' HB2' ' A' ' 196' ' ' ALA . 35.0 t -66.38 80.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.605 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 195' ' ' SER . . . 170.49 110.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.242 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 98.0 p -166.08 -133.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.453 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 199' ' ' SER . 7.7 p -51.95 159.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.516 ' N ' HG22 ' A' ' 198' ' ' VAL . 47.7 t -49.06 147.81 2.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.029 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 201' ' ' LEU . 48.0 m -155.11 91.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.303 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 200' ' ' THR . 0.4 OUTLIER 20.79 64.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.705 0.628 . . . . 0.0 111.201 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 97.7 m -124.58 110.38 14.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -178.31 -104.31 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.67 70.12 1.9 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -87.81 95.74 10.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.818 0.342 . . . . 0.0 110.485 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -67.92 116.1 8.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.38 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 209' ' ' SER . 34.0 t0 -95.22 111.2 23.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.296 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 m 44.88 -90.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.536 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 207' ' ' ASP . 59.7 m -130.56 152.56 49.79 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.296 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.489 ' N ' ' CD ' ' A' ' 211' ' ' PRO . 0.0 OUTLIER 165.77 -46.83 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.897 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 73.2 Cg_endo -80.42 102.2 1.4 Allowed 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.59 1.527 . . . . 0.0 112.115 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.462 HE22 ' CA ' ' A' ' 215' ' ' GLY . 0.6 OUTLIER -174.83 57.86 0.19 Allowed Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.955 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.26 151.16 86.56 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 112.228 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.53 HD22 ' H ' ' A' ' 214' ' ' LEU . 3.8 mm? 43.89 71.26 0.25 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.462 ' CA ' HE22 ' A' ' 212' ' ' GLN . . . -109.66 45.72 1.28 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.8 81.15 0.54 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.56 150.08 71.52 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.504 2.136 . . . . 0.0 111.889 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.451 ' H ' ' HD2' ' A' ' 219' ' ' PRO . 4.8 mt-10 -153.22 -64.14 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.035 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 218' ' ' GLU . 25.7 Cg_endo -58.88 141.02 97.68 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.832 1.688 . . . . 0.0 111.902 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 129.28 -163.27 22.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -81.15 -80.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.569 2.18 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -172.1 145.05 1.73 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.183 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.32 100.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.058 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -138.9 162.01 55.01 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 226' ' ' SER . 53.4 Cg_exo -48.35 -23.24 4.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.223 1.949 . . . . 0.0 112.134 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 228' ' ' ASN . 0.9 OUTLIER 165.28 -88.34 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.718 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.532 ' N ' ' OG ' ' A' ' 226' ' ' SER . 95.4 mt 61.18 -58.59 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 124.508 1.13 . . . . 0.0 110.693 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.59 ' N ' HD22 ' A' ' 228' ' ' ASN . 0.0 OUTLIER -171.35 54.77 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.687 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 1.5 p -60.13 151.78 64.98 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.7 57.14 0.74 Allowed 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.747 2.298 . . . . 0.0 111.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.815 ' O ' HD12 ' A' ' 231' ' ' LEU . 4.3 pp -134.45 130.13 19.88 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 276' ' ' TRP . 73.9 Cg_endo -82.69 -35.09 0.33 Allowed 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 121.735 1.623 . . . . 0.0 110.9 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.532 ' O ' ' O ' ' A' ' 234' ' ' LEU . 0.2 OUTLIER 70.68 111.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.409 -178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.778 ' O ' ' N ' ' A' ' 236' ' ' ASN . 2.4 tp -43.45 -101.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 38.92 -76.06 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 124.285 0.99 . . . . 0.0 110.029 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.778 ' N ' ' O ' ' A' ' 234' ' ' LEU . 8.1 m120 -52.0 -80.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.503 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -72.38 -177.09 29.78 Favored Glycine 0 CA--C 1.45 -3.997 0 CA-C-O 122.554 1.085 . . . . 0.0 114.619 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.503 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.0 Cg_exo -53.7 127.91 1.32 Allowed 'Cis proline' 0 N--CA 1.528 3.502 0 N-CA-C 115.462 1.293 . . . . 0.0 115.462 -3.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.516 ' CD1' ' OE1' ' A' ' 169' ' ' GLN . 3.2 m-85 -153.86 -117.68 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.3 m-30 -141.74 123.23 14.98 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 119.141 0.882 . . . . 0.0 109.831 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.673 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -113.34 150.47 32.53 Favored 'General case' 0 C--O 1.198 -1.65 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -113.23 103.25 11.15 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.733 -0.604 . . . . 0.0 109.422 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.3 p -74.35 121.47 25.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.505 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.17 23.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.425 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.522 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.4 mm-40 177.42 116.96 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.431 0.634 . . . . 0.0 109.844 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.869 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.4 ttmt -156.66 -158.8 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.935 178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.784 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 28.7 ptt85 -153.94 144.88 22.69 Favored 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.76 91.63 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.637 0 O-C-N 124.041 0.838 . . . . 0.0 110.829 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.784 ' HD3' ' O ' ' A' ' 247' ' ' ARG . 70.0 Cg_endo -108.14 171.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.325 -0.686 0 C-N-CA 123.782 2.988 . . . . 0.0 113.827 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.644 ' ND2' ' H ' ' A' ' 253' ' ' ASP . 4.3 p-10 -93.04 -169.35 2.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.261 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.62 16.19 22.34 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 110.087 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 254' ' ' LYS . 5.7 m-85 -125.72 -21.62 4.39 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.227 0.537 . . . . 0.0 110.159 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.644 ' H ' ' ND2' ' A' ' 250' ' ' ASN . 31.5 t70 -71.78 45.05 0.11 Allowed 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.928 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 255' ' ' THR . 38.7 mtmt 106.03 -10.78 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 124.717 1.261 . . . . 0.0 110.81 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.537 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 7.6 m 105.92 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.4 1.062 . . . . 0.0 110.651 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.618 ' HB1' ' CZ ' ' A' ' 287' ' ' PHE . . . -40.21 153.2 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 O-C-N 123.262 0.351 . . . . 0.0 111.62 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.86 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -107.33 151.51 25.39 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.774 0.43 . . . . 0.0 110.619 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.794 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -94.78 114.54 26.44 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.869 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.1 mt -139.4 -170.92 3.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.355 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 17.7 tt0 -146.14 149.18 33.51 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.501 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 245' ' ' GLN . 72.9 t -58.62 106.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.09 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.97 8.68 10.44 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 71.0 mm-40 -94.54 -133.71 0.18 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.973 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 170.98 139.77 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.973 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.7 p -127.21 143.73 39.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.513 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 92.24 5.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 t -61.93 152.09 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.733 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -151.8 -58.61 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.671 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.53 116.89 10.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.413 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.79 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -126.95 162.02 32.59 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.099 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER 177.59 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.556 0.693 . . . . 0.0 110.638 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.72 ' N ' HD22 ' A' ' 271' ' ' ASN . 25.5 mtm -35.95 125.87 0.73 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.195 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -62.95 6.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.911 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -132.94 -50.48 0.09 OUTLIER Glycine 0 N--CA 1.467 0.729 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.579 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.6 mp0 -94.91 160.9 14.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.579 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 4.3 m95 -162.85 158.17 22.27 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.471 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -120.64 128.48 53.05 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 123.24 0.338 . . . . 0.0 111.454 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.66 -157.16 31.16 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 120.44 -0.886 . . . . 0.0 113.297 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.35 127.2 0.81 Allowed 'General case' 0 C--N 1.346 0.429 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.677 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -138.83 78.09 1.66 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.9 -1.046 . . . . 0.0 108.692 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.6 t-20 83.35 27.02 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.587 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.69 -26.73 21.99 Favored Glycine 0 N--CA 1.462 0.386 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.968 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.1 OUTLIER -73.13 73.33 1.22 Allowed 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.769 -178.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.637 ' NH2' ' CZ ' ' A' ' 142' ' ' PHE . 64.2 mtt85 -73.01 169.44 16.96 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.719 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 165.18 122.12 0.59 Allowed Glycine 0 N--CA 1.439 -1.131 0 CA-C-O 122.659 1.144 . . . . 0.0 113.065 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.627 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.4 p80 -59.4 177.08 0.2 Allowed 'General case' 0 C--N 1.284 -2.247 0 O-C-N 119.194 -2.357 . . . . 0.0 109.555 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.627 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 166.03 149.06 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 O-C-N 123.968 0.792 . . . . 0.0 111.428 178.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 291' ' ' HIS . 32.4 Cg_exo -55.65 135.81 71.17 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.508 2.138 . . . . 0.0 113.945 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 66.6 t80 -75.16 -1.5 23.47 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.795 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 20.4 p -76.83 3.22 12.42 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 288' ' ' PRO . 9.1 p80 -133.63 44.29 2.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.134 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.36 146.14 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -125.71 77.45 1.66 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.124 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 294' ' ' LEU . 38.2 mt -39.67 127.08 1.97 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.81 0.814 . . . . 0.0 111.375 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.4 mp -67.75 -166.76 0.06 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.962 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -70.96 8.36 0.94 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 236' ' ' ASN . 47.7 tt0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.149 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 33.9 m . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 37.8 tt0 -140.21 139.29 35.62 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.394 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.742 ' O ' HG22 ' A' ' 138' ' ' VAL . 21.0 m-85 90.41 -133.56 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.824 0 O-C-N 123.513 0.508 . . . . 0.0 110.435 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER 78.59 157.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.565 1.165 . . . . 0.0 110.828 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' NH1' ' SG ' ' A' ' 191' ' ' CYS . 26.1 ptt180 -141.39 159.81 41.45 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . . . -59.74 172.72 0.67 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.342 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 189' ' ' GLU . 58.0 mt -143.08 -58.21 0.42 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.524 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -113.33 9.78 18.31 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.33 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.526 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 78.27 137.45 0.06 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.454 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 3.6 t80 -111.22 -46.11 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 0.0 110.335 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.681 HD21 ' NZ ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER 47.56 63.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.75 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -63.69 -124.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.746 HD22 ' H ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER 166.8 -49.36 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.188 0.494 . . . . 0.0 111.863 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.746 ' H ' HD22 ' A' ' 147' ' ' ASN . 7.9 m-20 -72.32 162.96 28.75 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 27.8 p-10 -69.56 -22.72 63.52 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.806 178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -87.83 24.32 1.79 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.613 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 32.2 p30 -141.48 165.59 27.08 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 175' ' ' ASP . 8.8 tp -120.45 88.86 43.26 Favored Pre-proline 0 C--O 1.217 -0.646 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.685 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.405 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 65.6 Cg_endo -69.57 140.58 43.73 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 121.346 1.364 . . . . 0.0 113.068 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 140' ' ' ALA . 17.5 p90 -158.31 166.22 32.84 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.106 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.681 ' NZ ' HD21 ' A' ' 145' ' ' ASN . 0.2 OUTLIER -139.1 148.12 42.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.414 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 76.42 -133.83 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.338 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -121.31 49.73 0.87 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.18 140.39 58.45 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -84.86 100.58 8.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.933 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 137' ' ' TYR . 11.6 mt -109.56 125.59 52.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.87 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -81.3 138.24 35.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.636 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.3 mp -72.1 -57.44 7.28 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.669 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.444 ' N ' HG22 ' A' ' 162' ' ' ILE . 60.9 ttt180 77.59 -46.26 0.46 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.33 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.495 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -110.4 -134.64 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.868 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 164' ' ' ASP . 8.2 pttp 149.21 60.19 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.431 0.693 . . . . 0.0 109.701 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.4 ' CD ' ' H ' ' A' ' 165' ' ' LYS . 18.4 Cg_endo -57.14 -59.37 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.64 2.227 . . . . 0.0 112.429 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.458 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.0 mt-10 -117.3 174.48 6.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.6 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 1.1 pm0 -83.93 -44.58 14.08 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.678 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.466 ' OE1' ' NE2' ' A' ' 297' ' ' GLN . 83.1 mt-30 -75.19 -27.84 59.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.532 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 62.9 m95 -119.3 154.13 33.99 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.641 ' CE3' HG22 ' A' ' 185' ' ' VAL . 9.8 m0 -149.81 142.88 24.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.611 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.636 ' O ' ' O ' ' A' ' 162' ' ' ILE . 2.9 t30 -90.13 121.19 31.96 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -124.13 172.77 8.76 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.67 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -121.58 132.2 54.55 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.493 ' HB2' HD11 ' A' ' 152' ' ' LEU . 11.8 t70 -60.82 171.57 1.16 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.473 0.654 . . . . 0.0 110.85 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 tpt -77.12 -3.02 37.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.813 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -103.32 -27.89 12.19 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.87 48.12 0.42 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -129.66 134.29 47.59 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.448 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.56 123.52 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.531 0.681 . . . . 0.0 111.577 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -153.61 149.55 21.05 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.934 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 mtp -66.95 155.98 37.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.374 0.607 . . . . 0.0 111.002 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 11.5 pt -147.63 142.99 17.3 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.211 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -72.3 111.66 3.25 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.223 1.282 . . . . 0.0 109.71 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.641 HG22 ' CE3' ' A' ' 171' ' ' TRP . 58.5 t -46.77 -51.69 36.61 Favored Pre-proline 0 CA--C 1.535 0.38 0 O-C-N 122.212 -0.305 . . . . 0.0 111.337 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.1 Cg_endo -47.26 -30.07 10.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.26 1.974 . . . . 0.0 113.047 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' A' ' 268' ' ' THR . 15.9 m-85 -77.5 -7.86 56.9 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.613 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.48 HG21 HG21 ' A' ' 138' ' ' VAL . 1.5 m -132.94 160.43 42.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.554 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' A' ' 191' ' ' CYS . 8.3 pt-20 -136.71 156.53 48.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.042 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.433 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -60.8 12.3 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.577 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.632 ' H ' ' C ' ' A' ' 189' ' ' GLU . 50.0 t 58.13 43.37 20.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.39 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -157.49 58.65 1.53 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.613 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' SER . 73.7 Cg_endo -77.39 -2.88 13.08 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.811 2.341 . . . . 0.0 112.15 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.2 m -42.69 85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.276 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 193' ' ' PRO . 3.7 t 66.27 6.12 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.744 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 193' ' ' PRO . . . -67.01 146.49 54.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.71 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 78.2 p -64.2 -16.54 62.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.39 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.9 t -73.46 80.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.303 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.5 t 42.1 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 201' ' ' LEU . 30.6 m -68.51 123.3 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 201' ' ' LEU . 9.2 mp 30.87 -107.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.34 0.4 . . . . 0.0 110.984 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 200' ' ' THR . 71.8 p -50.81 171.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.809 0.338 . . . . 0.0 110.292 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 177.36 -33.48 0.08 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -138.61 -128.9 2.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.805 ' H ' HD22 ' A' ' 205' ' ' ASN . 0.0 OUTLIER -127.76 127.64 43.95 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.888 0.375 . . . . 0.0 110.49 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 48.71 -126.85 2.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.367 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -132.15 -84.29 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.239 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.7 p -86.51 140.56 29.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.439 ' C ' ' CG ' ' A' ' 210' ' ' HIS . 29.3 t -71.93 -11.24 60.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.505 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.439 ' CG ' ' C ' ' A' ' 209' ' ' SER . 5.0 m80 74.42 150.24 0.13 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.67 -47.15 11.75 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.08 1.853 . . . . 0.0 112.422 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 40.25 71.99 1.11 Allowed Pre-proline 0 N--CA 1.463 0.204 0 CA-C-O 120.861 0.362 . . . . 0.0 110.66 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.64 143.07 99.73 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.778 2.319 . . . . 0.0 111.959 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.2 tp -170.06 55.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.364 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 76.24 75.85 0.85 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.454 ' H ' ' HD2' ' A' ' 217' ' ' PRO . . . -129.78 -71.98 0.13 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 216' ' ' GLY . 32.2 Cg_endo -63.29 -21.86 71.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.7 2.267 . . . . 0.0 111.842 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 220' ' ' GLY . 13.6 mp0 -51.42 150.55 6.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.588 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -38.41 83.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.824 2.349 . . . . 0.0 112.498 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 218' ' ' GLU . . . 47.93 -172.28 0.04 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.68 148.47 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.814 2.343 . . . . 0.0 112.315 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.538 ' O ' ' NE2' ' A' ' 224' ' ' GLN . 60.4 m-85 -66.72 170.85 5.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.265 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' A' ' 224' ' ' GLN . . . -41.21 93.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.248 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 222' ' ' TYR . 1.8 mp0 -128.75 162.67 50.1 Favored Pre-proline 0 N--CA 1.466 0.36 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.22 -43.17 44.4 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.202 1.935 . . . . 0.0 112.238 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 228' ' ' ASN . 33.4 t -159.6 155.11 25.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.88 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 14.7 mm -65.4 61.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.563 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 226' ' ' SER . 70.5 m-80 -134.66 73.45 1.49 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 3.3 p -70.69 151.14 95.4 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.703 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -39.83 -64.82 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.407 2.071 . . . . 0.0 112.123 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.6 tp -133.38 105.32 12.14 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.459 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 233' ' ' ASN . 73.7 Cg_endo -80.71 81.8 2.64 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.875 1.717 . . . . 0.0 112.468 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 271' ' ' ASN . 89.2 m-20 40.83 -164.93 0.0 OUTLIER 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.2 tt -70.06 109.6 4.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.463 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -152.38 11.65 0.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.08 0.467 . . . . 0.0 110.637 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.434 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 84.9 m-20 -152.94 -75.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.026 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.568 ' HA2' ' N ' ' A' ' 239' ' ' PHE . . . -75.16 -176.44 38.32 Favored Glycine 0 CA--C 1.457 -3.552 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.432 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.3 Cg_endo -57.3 100.72 0.06 OUTLIER 'Cis proline' 0 N--CA 1.525 3.374 0 N-CA-C 115.366 1.256 . . . . 0.0 115.366 -0.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.568 ' N ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 m-85 -115.9 -131.43 0.32 Allowed 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.5 OUTLIER -144.95 132.13 20.5 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 118.873 0.76 . . . . 0.0 109.183 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.757 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -119.49 153.78 34.8 Favored 'General case' 0 C--O 1.195 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.005 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 13.2 tpp180 -114.14 95.63 5.39 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.7 130.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.231 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.88 20.78 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.584 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 261' ' ' VAL . 0.9 OUTLIER 179.58 109.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.966 0.413 . . . . 0.0 110.314 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.803 ' HD2' HD12 ' A' ' 259' ' ' LEU . 5.4 ttmt -162.01 -151.13 0.2 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.773 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.705 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -157.5 -137.23 0.05 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.522 -179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.58 61.94 39.79 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 43.0 Cg_endo -92.81 51.47 0.46 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.598 2.199 . . . . 0.0 113.474 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.718 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.2 OUTLIER -25.09 146.95 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.052 0.845 . . . . 0.0 111.291 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.96 -7.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.191 0.52 . . . . 0.0 111.668 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.718 ' N ' ' O ' ' A' ' 250' ' ' ASN . 37.5 m-85 -83.02 -62.63 1.54 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 252' ' ' TYR . 35.4 t0 -33.46 -51.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.972 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.705 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 5.4 pttt -171.51 44.22 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.13 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m 63.34 -14.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.299 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -62.42 127.12 29.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.962 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.912 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -52.36 159.28 1.01 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.092 0.472 . . . . 0.0 111.322 178.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.909 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.18 121.95 45.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.33 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.909 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.4 mt -142.7 -175.29 4.42 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.051 0.453 . . . . 0.0 111.203 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.2 tt0 -144.02 151.26 39.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.236 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 245' ' ' GLN . 47.6 t -60.94 112.14 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.676 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 5.38 20.07 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 66.8 mm-40 -93.65 -128.68 0.12 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.106 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 168.72 138.6 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.704 0.764 . . . . 0.0 109.612 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.106 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.6 p -137.75 151.6 26.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.089 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 4.7 ttmt -79.61 -161.32 0.32 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.277 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 269' ' ' LYS . 1.7 t -140.78 -53.43 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.453 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER 46.08 -71.67 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.3 OUTLIER -81.28 117.65 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.294 0.569 . . . . 0.0 112.255 -177.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.892 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -132.5 161.6 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.168 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -164.39 -108.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.162 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.582 ' N ' HD22 ' A' ' 271' ' ' ASN . 46.9 mtm -39.38 153.23 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.685 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.8 p -75.77 18.68 0.24 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.388 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -142.71 -75.71 0.03 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.491 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 1.9 mp0 -78.02 176.53 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.913 0.387 . . . . 0.0 110.72 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.54 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 9.5 p-90 170.08 -169.57 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.532 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 71.7 mt-10 -128.94 165.36 21.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.808 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -145.57 -152.77 5.7 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.094 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.07 125.64 0.55 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.906 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.685 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -105.18 -93.11 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -103.3 50.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.64 -31.19 5.96 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.404 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -64.8 83.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.897 -0.651 . . . . 0.0 110.398 -179.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -79.39 166.17 22.33 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.969 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.439 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.46 -157.59 29.83 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.45 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 10.3 p-80 -125.4 175.33 7.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 123.847 0.381 . . . . 0.0 110.916 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.54 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 164.84 112.49 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.714 178.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.34 143.27 27.18 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.798 1.665 . . . . 0.0 112.496 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.625 ' CD1' HG23 ' A' ' 292' ' ' VAL . 52.9 t80 -66.09 -0.84 2.65 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.2 p -53.65 0.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.6 p80 -160.74 74.39 0.51 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.565 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.625 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -166.05 154.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.56 ' O ' ' HG ' ' A' ' 294' ' ' LEU . 58.0 mtp180 -101.44 -110.13 0.22 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 293' ' ' ARG . 9.4 mt 150.8 120.85 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.271 0.982 . . . . 0.0 110.751 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.4 mp -77.02 -174.63 3.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.972 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.42 ' O ' ' OXT' ' A' ' 297' ' ' GLN . 66.1 t0 -111.21 40.81 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.516 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.539 ' OE1' ' CG ' ' A' ' 239' ' ' PHE . 10.7 tp60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.757 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.487 ' OE2' ' O ' ' A' ' 191' ' ' CYS . 49.7 tp10 -147.94 161.38 41.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.906 ' O ' HG22 ' A' ' 138' ' ' VAL . 74.2 m-85 -121.01 -93.88 0.51 Allowed 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.504 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.906 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.3 m 83.03 161.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 124.852 1.345 . . . . 0.0 110.841 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.748 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 2.6 ptp180 -132.48 151.88 51.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.541 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.669 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -101.99 92.99 5.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.086 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -98.09 22.97 8.72 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.48 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.598 ' O ' ' O ' ' A' ' 143' ' ' ASP . 57.9 m-85 -123.47 6.84 8.95 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.005 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.0 p30 51.86 137.04 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.276 0 O-C-N 124.59 1.181 . . . . 0.0 110.808 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.491 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 6.6 t80 -124.59 -43.23 2.04 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.225 0.466 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 144' ' ' PHE . 53.9 t-20 39.31 62.18 1.19 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.454 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.482 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.34 -146.11 0.21 Allowed Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.601 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.1 p30 171.22 91.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.157 -0.521 . . . . 0.0 111.063 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 2.4 m-20 171.57 -173.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.373 . . . . 0.0 110.212 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -93.63 -21.55 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.652 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -107.79 26.29 10.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.974 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 8.9 p-10 -134.17 152.37 51.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 9.5 tp -116.94 85.21 17.27 Favored Pre-proline 0 C--O 1.21 -1.01 0 CA-C-N 117.586 0.175 . . . . 0.0 110.564 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -59.73 139.37 88.29 Favored 'Trans proline' 0 C--N 1.288 -2.627 0 C-N-CA 121.49 1.46 . . . . 0.0 112.864 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.669 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 9.1 p90 -159.02 158.29 32.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.258 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 156' ' ' LYS . 1.6 ttmp? -176.62 112.6 0.1 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.867 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 147.06 -25.16 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.384 1.052 . . . . 0.0 110.565 178.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.09 44.75 0.91 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -79.71 153.59 29.17 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.398 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 159' ' ' ILE . 3.7 tp -98.67 119.27 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 137' ' ' TYR . 10.6 mt -118.7 133.65 55.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.784 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -82.19 139.78 34.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.74 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.6 mp -64.46 -48.74 83.83 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.262 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.865 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.574 ' NE ' ' OD1' ' A' ' 164' ' ' ASP . 0.2 OUTLIER 69.96 -53.26 0.63 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.893 -0.504 . . . . 0.0 111.617 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.574 ' OD1' ' NE ' ' A' ' 163' ' ' ARG . 0.5 OUTLIER -116.9 -126.39 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.498 ' H ' ' HD3' ' A' ' 166' ' ' PRO . 1.3 pttm 141.55 60.89 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.652 0 C-N-CA 124.72 1.208 . . . . 0.0 109.575 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.498 ' HD3' ' H ' ' A' ' 165' ' ' LYS . 47.3 Cg_endo -67.19 -46.61 2.87 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.924 1.749 . . . . 0.0 112.432 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -118.46 167.5 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.359 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -85.14 -35.08 21.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.529 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 1.8 mt-30 -84.16 -25.24 29.75 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.593 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.6 m95 -122.23 150.31 42.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.462 ' CD2' HG22 ' A' ' 185' ' ' VAL . 11.4 m0 -141.57 129.92 22.4 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.934 0.873 . . . . 0.0 110.696 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.74 ' O ' ' O ' ' A' ' 162' ' ' ILE . 5.5 t30 -81.86 107.95 15.0 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.6 174.17 6.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.5 0.5 . . . . 0.0 110.627 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 33.1 tt0 -123.03 133.32 54.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.4 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.44 169.23 3.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.505 0.669 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 159' ' ' ILE . 97.4 mmm -76.64 0.67 19.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.81 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.459 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 93.9 m-20 -104.95 -28.38 11.12 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.52 49.64 0.39 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.459 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 18.6 mttp -130.19 135.72 48.47 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 114.241 -0.979 . . . . 0.0 110.757 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.77 125.15 52.4 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.523 0.678 . . . . 0.0 111.776 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -158.13 154.9 25.95 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.444 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 tpt -66.01 154.57 39.12 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.894 0.378 . . . . 0.0 110.693 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 171' ' ' TRP . 1.3 pp -145.02 143.3 20.16 Favored Pre-proline 0 N--CA 1.464 0.249 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.35 114.62 4.09 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 N-CA-C 108.694 -1.31 . . . . 0.0 108.694 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.884 ' O ' HG22 ' A' ' 188' ' ' VAL . 41.6 t -49.92 -52.0 56.09 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.949 -0.47 . . . . 0.0 111.979 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 14.2 Cg_endo -49.8 -28.63 18.3 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.052 1.835 . . . . 0.0 113.773 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.439 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 6.8 m-85 -67.78 3.66 1.39 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.624 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.0 m -128.11 167.61 22.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 123.263 0.352 . . . . 0.0 110.297 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.748 ' CD ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -68.39 -48.66 64.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.33 -177.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.514 ' HG3' HG23 ' A' ' 188' ' ' VAL . 3.5 mppt? 81.78 79.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.227 1.011 . . . . 0.0 111.513 -178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.487 ' O ' ' OE2' ' A' ' 136' ' ' GLU . 1.1 t -91.35 95.37 9.97 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.862 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 194' ' ' SER . 0.0 OUTLIER 179.01 -56.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 192' ' ' ARG . 49.5 Cg_endo -68.46 21.14 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.942 1.761 . . . . 0.0 111.889 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 192' ' ' ARG . 26.0 p -168.33 -22.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 194' ' ' SER . 0.5 OUTLIER 76.63 -51.96 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.03 158.36 31.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.625 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 11.0 p -71.27 155.98 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.28 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.93 135.06 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 25.9 m 47.91 -110.36 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.422 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.7 m 68.41 99.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.402 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 35.9 tp 38.65 73.22 0.11 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.557 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.8 t -128.23 22.73 6.07 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.318 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -167.34 -161.87 17.73 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 206' ' ' GLN . . . -77.84 -5.42 86.58 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.83 9.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.574 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 204' ' ' GLY . 88.0 mt-30 -132.98 -46.52 0.85 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.528 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 209' ' ' SER . 55.0 t0 49.68 34.56 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 46.8 t -54.03 89.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 207' ' ' ASP . 58.4 m -131.5 42.53 3.18 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.52 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -131.29 150.97 77.97 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.5 90.87 0.34 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.597 2.198 . . . . 0.0 112.004 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 22.3 tt0 -166.2 47.73 0.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.478 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 29.9 Cg_endo -62.2 -25.86 77.25 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.744 2.296 . . . . 0.0 112.017 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.1 -75.19 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.645 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 176.85 163.96 29.92 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.502 ' N ' ' CD ' ' A' ' 217' ' ' PRO . . . -154.55 49.41 0.49 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.779 -0.929 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 216' ' ' GLY . 29.5 Cg_endo -62.67 -61.89 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.573 2.182 . . . . 0.0 111.56 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 219' ' ' PRO . 1.1 tt0 -106.2 -45.33 0.13 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.591 ' CD ' ' H ' ' A' ' 218' ' ' GLU . 66.4 Cg_endo -84.49 159.09 12.64 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.325 2.016 . . . . 0.0 111.658 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.415 ' H ' ' HD2' ' A' ' 221' ' ' PRO . . . -104.0 -68.88 0.77 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.415 ' HD2' ' H ' ' A' ' 220' ' ' GLY . 70.9 Cg_endo -76.67 -174.63 2.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.663 2.242 . . . . 0.0 112.067 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 224' ' ' GLN . 75.4 m-85 -67.59 160.52 27.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.19 94.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.189 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.529 ' OE1' ' ND2' ' A' ' 228' ' ' ASN . 34.1 mm-40 -96.07 147.7 33.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.526 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.26 -43.93 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.464 2.109 . . . . 0.0 112.196 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 62.1 m -104.86 20.92 17.91 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.726 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 227' ' ' ILE . 5.1 mp 44.92 56.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.529 ' ND2' ' OE1' ' A' ' 224' ' ' GLN . 43.9 m-80 -59.93 75.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.922 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 227' ' ' ILE . 14.5 p -112.25 147.98 38.14 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.08 -91.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.568 2.179 . . . . 0.0 111.763 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.803 HD13 ' CG ' ' A' ' 289' ' ' PHE . 1.6 mp -118.32 139.9 27.41 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.243 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.601 ' O ' ' O ' ' A' ' 231' ' ' LEU . 71.8 Cg_exo -47.52 -131.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.522 2.148 . . . . 0.0 111.986 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 235' ' ' GLN . 51.7 p-10 -127.42 163.11 24.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.1 tp 64.39 -64.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 233' ' ' ASN . 29.2 mm100 55.2 -165.64 0.11 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.494 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -66.76 -50.28 63.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 0.0 110.865 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -60.15 -177.63 1.59 Allowed Glycine 1 CA--C 1.433 -5.054 0 CA-C-O 122.446 1.026 . . . . 0.0 114.41 -179.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.475 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.7 Cg_endo -57.21 125.2 1.38 Allowed 'Cis proline' 0 N--CA 1.533 3.841 0 N-CA-C 115.608 1.349 . . . . 0.0 115.608 -2.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.597 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 12.7 m-85 -150.79 -121.37 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.602 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.529 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 1.0 OUTLIER -143.06 123.83 14.19 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.721 0.772 . . . . 0.0 110.484 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.883 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.05 -159.24 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.032 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -162.41 87.41 0.62 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.0 p -57.94 123.61 10.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.006 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 15.73 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.726 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.491 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -175.94 112.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.294 0.569 . . . . 0.0 110.237 -178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.864 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.6 ttmt -158.72 -146.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.182 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.405 HH22 ' HE3' ' A' ' 254' ' ' LYS . 4.3 ptt85 -155.85 -142.53 0.11 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.829 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.601 ' O ' HG12 ' A' ' 248' ' ' VAL . 82.0 t -132.69 66.95 77.7 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.605 178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.563 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 84.0 Cg_endo -90.56 172.64 3.3 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.609 2.206 . . . . 0.0 111.231 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.705 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -145.86 142.61 28.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.29 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.46 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 250' ' ' ASN . 60.9 m-85 -93.57 -54.51 3.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 110.791 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -44.67 -67.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.019 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 256' ' ' ALA . 26.7 mttt -148.58 32.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.521 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 m 72.28 -15.21 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.608 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -52.34 156.43 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.68 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.8 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -97.17 148.0 23.51 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.961 0.504 . . . . 0.0 110.359 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.828 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -86.98 115.21 24.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 246' ' ' LYS . 2.5 mt -139.77 -176.06 4.44 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.435 0.636 . . . . 0.0 111.126 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 11.2 tt0 -146.28 147.87 31.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.702 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 245' ' ' GLN . 93.5 t -56.59 106.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.289 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 118.03 3.96 14.94 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.1 mm-40 -87.19 -122.22 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.745 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.043 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.4 OUTLIER 161.15 138.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.489 0.661 . . . . 0.0 109.477 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.043 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.5 p -130.84 140.8 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.968 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.424 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -100.78 88.31 3.55 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.925 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.465 ' HA ' ' HA2' ' A' ' 278' ' ' GLY . 16.8 t -56.79 151.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.275 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.265 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.527 ' O ' HD12 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -158.75 -51.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.465 0.65 . . . . 0.0 110.227 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -74.85 116.53 15.68 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 268' ' ' THR . 2.4 mp -126.27 104.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.756 HD22 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -87.52 -25.86 23.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 178.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.756 ' H ' HD22 ' A' ' 271' ' ' ASN . 5.4 mtm -145.96 176.88 9.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.434 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -91.58 16.11 11.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -134.39 -96.06 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.244 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 63.69 0.48 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.769 0.795 . . . . 0.0 110.763 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.532 ' N ' ' CD1' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -69.59 178.71 2.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.739 177.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 1.3 mt-10 -109.12 -163.19 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.067 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -159.23 -160.33 10.33 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.753 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.459 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.5 tt0 -169.42 130.26 1.09 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.157 0.503 . . . . 0.0 111.683 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.705 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -147.55 75.42 1.36 Allowed 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.354 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 33.9 t30 83.81 31.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.249 0.547 . . . . 0.0 110.318 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 95.63 -31.41 7.21 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.336 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.3 OUTLIER -69.57 76.54 0.42 Allowed 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -178.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.502 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 94.6 mtt180 -76.57 171.8 14.05 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.135 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.87 -156.68 27.68 Favored Glycine 0 C--N 1.308 -0.985 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.543 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 6.3 p80 -124.32 169.81 11.42 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 122.889 0.476 . . . . 0.0 109.737 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 164.92 114.39 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.26 178.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.05 140.98 58.87 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.626 1.551 . . . . 0.0 112.099 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.803 ' CG ' HD13 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -67.27 0.01 3.15 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.031 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 46.2 p -55.15 1.75 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.044 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 289' ' ' PHE . 5.8 p80 -151.7 65.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.901 -0.499 . . . . 0.0 110.789 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 289' ' ' PHE . 12.2 m -156.42 153.37 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -101.53 -55.82 2.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.2 mt 86.76 119.14 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.075 0.941 . . . . 0.0 111.444 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.4 mp -72.68 -178.41 2.66 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.689 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -87.41 47.86 1.56 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.618 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.536 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 51.7 tt0 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.456 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 136' ' ' GLU . 33.7 m . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.544 ' O ' ' CG ' ' A' ' 137' ' ' TYR . 16.5 tp10 93.0 155.0 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 123.558 0.536 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.698 ' O ' ' O ' ' A' ' 138' ' ' VAL . 57.6 m-85 -160.98 -20.58 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.698 ' O ' ' O ' ' A' ' 137' ' ' TYR . 27.3 m 34.93 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.012 0.82 . . . . 0.0 111.528 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 36.4 ttt180 -144.49 128.82 17.85 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.996 ' O ' ' O ' ' A' ' 156' ' ' LYS . . . -98.83 84.9 3.18 Favored 'General case' 0 C--O 1.2 -1.526 0 O-C-N 123.524 0.515 . . . . 0.0 111.58 -177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.553 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -95.19 32.57 1.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.499 -0.481 . . . . 0.0 111.224 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 143' ' ' ASP . 45.9 m-85 -134.3 3.46 3.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 142' ' ' PHE . 3.9 p30 51.86 139.48 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 O-C-N 124.919 1.387 . . . . 0.0 110.431 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 14.8 t80 -129.31 -49.33 1.19 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.406 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 38.97 61.76 1.2 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.94 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -69.34 -149.9 0.36 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 164.99 103.26 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.428 -0.886 . . . . 0.0 109.873 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.594 ' CG ' ' O ' ' A' ' 147' ' ' ASN . 20.4 m-20 173.01 19.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.442 1.089 . . . . 0.0 112.8 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 62.92 -45.03 0.2 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 123.904 0.752 . . . . 0.0 109.686 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 148' ' ' ASP . 96.4 mt-10 -85.89 29.41 0.72 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.505 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.575 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.5 p30 -143.52 163.95 31.7 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.653 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 183' ' ' ILE . 11.4 tp -118.48 91.41 41.41 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.412 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 65.5 Cg_endo -71.91 124.57 10.24 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 121.489 1.46 . . . . 0.0 112.906 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.723 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.6 p90 -144.49 163.47 33.73 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.924 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.499 ' HZ2' ' HB2' ' A' ' 143' ' ' ASP . 0.7 OUTLIER -142.21 150.85 41.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.103 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.996 ' O ' ' O ' ' A' ' 140' ' ' ALA . 11.8 mtpt 73.12 -142.19 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.556 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.24 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -107.43 48.52 0.94 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 42.9 t0 -56.73 153.58 10.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.026 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.635 HG23 ' HB3' ' A' ' 137' ' ' TYR . 1.5 mp -102.02 106.08 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 154' ' ' PHE . 11.5 mt -112.52 110.57 20.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.953 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -70.03 150.6 46.46 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -94.38 133.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.099 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.561 ' NH2' ' ND2' ' A' ' 172' ' ' ASN . 7.8 tmm_? -107.53 -42.79 4.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.063 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -153.73 128.52 9.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 32.9 pttt -123.88 75.62 57.28 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.23 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.6 -40.44 73.68 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 111.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -106.21 -165.07 1.06 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -118.81 -19.94 8.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.924 0.393 . . . . 0.0 110.386 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -88.35 -33.36 17.99 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 81.7 m95 -118.64 151.28 38.24 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.521 ' CD2' HG22 ' A' ' 185' ' ' VAL . 14.9 m0 -141.02 129.67 22.78 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 122.091 0.948 . . . . 0.0 111.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.561 ' ND2' ' NH2' ' A' ' 163' ' ' ARG . 54.7 t30 -79.45 114.51 18.43 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -125.94 173.69 8.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.643 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.39 135.89 54.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.87 175.02 1.26 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.504 0.669 . . . . 0.0 110.459 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.06 -4.18 48.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.794 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -101.34 -28.05 12.83 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.95 49.68 0.37 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -130.62 134.81 47.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.629 -0.786 . . . . 0.0 110.697 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.54 127.29 52.23 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.442 0.639 . . . . 0.0 111.733 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.53 155.08 26.16 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.268 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.48 157.83 33.31 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.814 0.34 . . . . 0.0 110.337 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.472 HG22 ' HB3' ' A' ' 152' ' ' LEU . 1.2 pp -144.14 142.6 20.26 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.92 113.56 3.82 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.567 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 13.6 t -46.93 -53.65 25.29 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 121.519 -0.738 . . . . 0.0 112.209 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 8.2 Cg_endo -48.64 -28.04 11.75 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 121.913 1.742 . . . . 0.0 113.234 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -71.17 -0.77 10.5 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.299 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 185' ' ' VAL . 1.9 m -135.82 162.03 37.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.477 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.553 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.7 OUTLIER -115.39 -60.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.443 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 0.4 OUTLIER 176.16 -165.4 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.566 -179.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.401 ' O ' ' SG ' ' A' ' 191' ' ' CYS . 8.8 p -133.35 34.13 3.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.795 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.447 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 19.2 ttp-105 -166.87 53.42 0.27 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.383 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 56.8 Cg_endo -70.07 135.96 31.0 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.448 2.099 . . . . 0.0 111.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.5 p -113.5 46.38 1.28 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.4 p -164.68 -156.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.317 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -114.53 -75.92 0.58 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.267 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.8 p -110.87 105.91 14.88 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.269 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.02 -82.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 200' ' ' THR . 31.1 t -75.73 135.49 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 199' ' ' SER . 3.3 p 64.97 110.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 200' ' ' THR . 0.2 OUTLIER 79.24 86.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.362 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 94.9 m -124.19 121.95 36.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -168.01 151.07 17.81 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -66.07 -36.77 92.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -121.15 34.1 5.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.362 0.125 . . . . 0.0 110.82 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 70.28 -46.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.437 0.46 . . . . 0.0 110.401 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 54.82 37.27 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.36 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 7.3 p -67.01 155.33 38.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.374 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.3 t -156.68 85.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 13.1 m80 54.15 66.39 4.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.54 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -76.05 85.92 1.59 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.556 2.171 . . . . 0.0 112.13 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.59 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 0.0 OUTLIER -96.03 -43.56 0.26 Allowed Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.366 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 56.4 Cg_endo -83.95 15.46 2.14 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.514 2.143 . . . . 0.0 111.815 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 215' ' ' GLY . 5.1 tt -86.89 117.09 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.132 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.578 ' N ' HD23 ' A' ' 214' ' ' LEU . . . 160.4 138.39 2.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -92.38 -58.13 1.39 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.86 97.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.448 2.098 . . . . 0.0 112.004 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.504 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 55.3 tt0 -172.82 50.03 0.1 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.483 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 46.5 Cg_endo -66.96 147.47 80.32 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.704 2.269 . . . . 0.0 111.661 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -80.36 -98.07 0.34 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.83 142.47 31.86 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.791 1.661 . . . . 0.0 112.068 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.575 ' CD2' ' N ' ' A' ' 223' ' ' ALA . 76.7 t80 -59.26 173.19 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.774 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.575 ' N ' ' CD2' ' A' ' 222' ' ' TYR . . . -38.63 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.404 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' TYR . 0.4 OUTLIER -110.95 97.98 36.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.807 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.96 -17.57 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.198 1.932 . . . . 0.0 111.607 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 72.2 m -116.07 63.6 0.7 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.82 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.79 ' H ' HD13 ' A' ' 227' ' ' ILE . 0.0 OUTLIER -40.88 102.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.369 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -80.7 -0.52 38.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.317 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.44 ' H ' HG23 ' A' ' 229' ' ' THR . 0.2 OUTLIER -58.04 177.58 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.469 ' CG ' ' HE1' ' A' ' 276' ' ' TRP . 33.8 Cg_exo -63.25 -14.35 41.42 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.948 2.432 . . . . 0.0 111.719 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 7.9 mt -126.97 91.92 45.75 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.21 163.24 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.938 2.425 . . . . 0.0 112.535 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 235' ' ' GLN . 10.1 m120 59.21 75.75 0.39 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.841 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.576 ' H ' ' CD1' ' A' ' 227' ' ' ILE . 13.0 tp 25.41 43.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.623 0.725 . . . . 0.0 110.996 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.781 ' O ' ' N ' ' A' ' 237' ' ' GLY . 13.3 mt-30 37.26 34.06 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.061 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.463 ' CG ' ' H ' ' A' ' 237' ' ' GLY . 4.4 p30 46.1 -67.69 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.538 1.149 . . . . 0.0 109.971 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.781 ' N ' ' O ' ' A' ' 235' ' ' GLN . . . -48.49 -175.2 0.01 OUTLIER Glycine 1 CA--C 1.435 -4.944 0 CA-C-O 122.457 1.032 . . . . 0.0 113.266 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.525 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 1.6 Cg_endo -53.07 117.08 0.25 Allowed 'Cis proline' 0 N--CA 1.53 3.671 0 O-C-N 123.635 1.334 . . . . 0.0 115.313 0.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 13.2 m-85 -147.03 -118.37 0.07 Allowed 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.753 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 1.1 m-30 -143.46 122.68 12.98 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.902 0.858 . . . . 0.0 110.699 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.909 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -106.18 -161.77 0.82 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.294 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 18.9 tpp180 -160.92 89.5 0.8 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 243' ' ' VAL . 6.0 p -62.35 129.31 25.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.599 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.9 15.43 6.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.772 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.6 mm-40 -173.94 113.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.373 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.832 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.2 ttmt -158.92 -146.7 0.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.321 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.404 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.8 ptt85 -156.48 -143.74 0.12 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.821 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 248' ' ' VAL . 57.5 t -133.5 69.99 76.65 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.576 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 58.2 Cg_endo -90.63 167.97 4.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.221 2.614 . . . . 0.0 112.971 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.496 ' OD1' ' CB ' ' A' ' 253' ' ' ASP . 46.0 p-10 -97.04 -166.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.275 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.45 11.69 28.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.243 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.5 ' C ' ' H ' ' A' ' 254' ' ' LYS . 6.4 m-85 -123.73 -21.98 5.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.904 0.383 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.9 t70 -68.3 43.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.27 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 253' ' ' ASP . 38.9 mtmt 96.96 0.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.776 0.831 . . . . 0.0 110.898 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 286' ' ' HIS . 0.2 OUTLIER 84.59 61.18 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.037 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -115.77 107.32 14.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.926 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -49.6 155.76 0.76 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.61 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.905 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -103.84 121.92 44.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.582 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.6 mt -142.95 -173.98 4.05 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.256 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.4 tt0 -145.91 150.67 36.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.79 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 245' ' ' GLN . 93.9 t -57.94 108.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.615 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.68 5.38 18.47 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 70.3 mm-40 -88.61 -123.77 0.05 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.77 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.071 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.3 OUTLIER 162.31 138.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.071 ' N ' HD12 ' A' ' 264' ' ' LEU . 13.1 p -131.39 143.16 41.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.754 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.409 ' NZ ' ' HD3' ' A' ' 186' ' ' PRO . 0.5 OUTLIER -97.91 84.76 3.38 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.434 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.8 t -58.8 150.8 4.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.28 -53.76 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.411 ' HE3' ' H ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -67.44 144.86 55.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.494 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.411 ' H ' ' HE3' ' A' ' 269' ' ' LYS . 1.0 OUTLIER -151.16 159.33 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.044 0.449 . . . . 0.0 110.569 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.778 HD21 ' HA ' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -176.94 -107.33 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.387 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.726 ' N ' HD22 ' A' ' 271' ' ' ASN . 31.6 mtm -42.17 140.86 1.03 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.27 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.0 p -74.2 16.1 0.27 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.568 ' O ' ' NE2' ' A' ' 275' ' ' GLN . . . -138.58 -60.95 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.359 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 274' ' ' GLY . 1.4 mp0 -109.0 101.06 10.18 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.778 ' HA ' HD21 ' A' ' 271' ' ' ASN . 3.6 p-90 -111.9 -165.71 1.01 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 120.846 0.355 . . . . 0.0 110.259 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 41.5 mt-10 -129.3 167.58 17.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.786 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.87 -151.4 5.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.78 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.503 ' OE2' ' O ' ' A' ' 280' ' ' CYS . 2.5 tm-20 -172.3 128.45 0.56 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.707 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -108.79 -90.72 0.45 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -106.03 51.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.28 -31.02 5.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.416 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.32 83.24 0.09 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 114.591 -0.804 . . . . 0.0 110.065 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -78.14 165.7 23.65 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.292 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 169.23 -158.27 30.66 Favored Glycine 0 C--O 1.215 -1.06 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.56 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 21.7 p80 -122.52 170.48 9.95 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.029 0.443 . . . . 0.0 110.556 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.09 114.46 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.668 177.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.513 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 50.7 Cg_exo -50.83 141.31 36.15 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.828 1.686 . . . . 0.0 112.798 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -63.6 0.31 0.79 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.598 0.713 . . . . 0.0 110.018 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 288' ' ' PRO . 66.1 p -56.79 2.43 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.72 -0.612 . . . . 0.0 112.095 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.517 ' H ' ' C ' ' A' ' 289' ' ' PHE . 2.2 p-80 -150.15 64.55 0.96 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.463 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.534 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -160.3 151.41 5.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 294' ' ' LEU . 43.3 mtm180 -102.34 -54.74 2.62 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 5.0 mt 91.67 121.09 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.023 0.916 . . . . 0.0 111.322 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.15 -178.12 4.88 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.182 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -87.47 48.58 1.67 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.744 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 47.0 tt0 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.46 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.55 ' N ' ' SG ' ' A' ' 191' ' ' CYS . 35.7 tt0 -143.1 140.8 31.03 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.451 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.518 ' H ' HG12 ' A' ' 162' ' ' ILE . 1.6 t80 78.65 107.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.118 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 m -134.33 164.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 111.177 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -123.33 125.99 46.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -105.5 109.53 21.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.982 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.767 HD21 ' HG2' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -118.96 28.47 8.26 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.851 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 60.0 m-85 -125.29 0.5 7.74 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.49 -0.131 . . . . 0.0 111.164 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 58.97 139.8 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.738 0 O-C-N 123.901 0.75 . . . . 0.0 110.288 -179.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.607 ' CE2' ' O ' ' A' ' 145' ' ' ASN . 4.3 t80 -133.88 -45.6 0.79 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 144' ' ' PHE . 30.0 m-80 74.86 -109.95 0.03 OUTLIER 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 113.5 -1.682 . . . . 0.0 108.717 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.505 ' C ' ' CZ ' ' A' ' 144' ' ' PHE . . . -133.5 -172.71 13.02 Favored Glycine 0 C--N 1.275 -2.828 0 O-C-N 121.606 -0.684 . . . . 0.0 113.633 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 18.9 t30 174.03 -40.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.966 -1.117 . . . . 0.0 111.911 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 6.4 m-20 -93.03 -159.21 0.66 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.321 0.582 . . . . 0.0 111.785 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -76.02 -45.09 36.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.483 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 151' ' ' ASP . 97.3 mt-10 -127.22 28.17 5.78 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.676 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.654 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.0 OUTLIER -37.69 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 123.908 0.755 . . . . 0.0 111.786 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.463 HD11 ' CG ' ' A' ' 175' ' ' ASP . 11.7 tp -127.09 98.88 29.36 Favored Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 121.922 -0.486 . . . . 0.0 111.888 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 145' ' ' ASN . 52.7 Cg_endo -75.16 133.14 16.0 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 121.635 1.557 . . . . 0.0 112.884 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.75 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 21.2 p90 -155.18 173.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.509 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER 176.12 132.28 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.811 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 2.7 mmpt? 95.22 79.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.081 0.863 . . . . 0.0 111.403 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 32.38 47.78 0.29 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.878 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -71.78 137.88 47.97 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.091 0.472 . . . . 0.0 109.939 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 38.3 mm -98.53 95.67 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.614 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.6 mt -109.35 107.96 18.34 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.44 141.2 54.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.889 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.913 HG22 ' H ' ' A' ' 163' ' ' ARG . 11.8 mm -64.15 -146.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.847 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.913 ' H ' HG22 ' A' ' 162' ' ' ILE . 0.0 OUTLIER -176.55 -57.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.132 0.491 . . . . 0.0 110.747 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -136.48 -24.54 1.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.312 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.405 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 16.2 pttp 36.43 77.88 0.37 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.68 -39.05 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.93 1.753 . . . . 0.0 112.23 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.3 mt-10 -105.17 162.26 13.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 14.9 pt-20 -84.64 -41.71 16.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.773 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.419 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 36.6 mt-30 -76.77 -29.66 56.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.34 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.687 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 73.6 m95 -120.15 153.7 35.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.641 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.5 m0 -148.22 140.74 24.42 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -83.88 117.78 23.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 171.04 8.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.025 0.441 . . . . 0.0 111.601 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 68.3 tt0 -125.0 133.15 53.11 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.959 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.463 ' CG ' HD11 ' A' ' 152' ' ' LEU . 15.2 m-20 -61.76 177.19 0.44 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.463 0.649 . . . . 0.0 110.734 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 23.6 ttt -80.54 -4.66 54.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.463 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.419 ' CB ' ' NZ ' ' A' ' 179' ' ' LYS . 94.7 m-20 -102.43 -28.12 12.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.34 48.55 0.38 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.419 ' NZ ' ' CB ' ' A' ' 177' ' ' ASP . 9.1 mttp -128.87 130.63 47.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.057 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 125.45 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.397 0.618 . . . . 0.0 112.048 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.2 152.81 24.12 Favored Glycine 0 C--N 1.315 -0.607 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.076 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 78.7 mmm -66.19 159.59 26.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.528 0.68 . . . . 0.0 110.972 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 10.1 pt -152.85 145.84 17.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.954 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -71.3 113.71 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.431 1.421 . . . . 0.0 109.583 175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.793 ' O ' HG22 ' A' ' 188' ' ' VAL . 43.9 t -49.35 -52.7 46.83 Favored Pre-proline 0 CA--C 1.537 0.457 0 O-C-N 121.956 -0.465 . . . . 0.0 111.816 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.1 Cg_endo -49.6 -27.11 13.96 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.482 2.121 . . . . 0.0 113.992 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.1 m-85 -69.07 10.63 0.27 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.765 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 185' ' ' VAL . 3.1 m -131.96 168.49 23.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.679 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.767 ' HG2' HD21 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -146.6 39.4 1.06 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.152 0.501 . . . . 0.0 111.407 -178.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 191' ' ' CYS . 37.6 mmtt -139.76 152.38 46.55 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.499 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 136' ' ' GLU . 47.3 t 48.52 100.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.602 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.752 ' NE ' ' H ' ' A' ' 194' ' ' SER . 0.0 OUTLIER 78.58 79.39 0.12 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.21 -9.63 2.4 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.794 2.329 . . . . 0.0 112.207 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.752 ' H ' ' NE ' ' A' ' 192' ' ' ARG . 3.0 t 42.38 40.31 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.651 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.3 p -153.57 174.88 13.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.418 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -85.76 -90.01 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 94.3 p -111.61 -1.71 15.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.791 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.63 100.73 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 43.1 m -62.14 -41.69 98.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 77.5 m -147.54 -87.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.547 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 203' ' ' GLY . 55.1 tp -126.72 -35.81 2.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 17.7 p 57.07 3.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.566 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 201' ' ' LEU . . . -55.62 -67.02 2.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 71.81 23.15 78.4 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.2 96.23 3.01 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.892 0.377 . . . . 0.0 110.698 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 53.26 73.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.408 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -92.1 1.76 57.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.553 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.4 t -70.16 148.27 48.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -60.38 -76.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.669 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 46.77 71.65 1.52 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.57 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.4 141.67 96.18 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.481 2.121 . . . . 0.0 112.106 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.673 ' H ' ' CD ' ' A' ' 213' ' ' PRO . 2.7 mt-30 -107.81 -39.34 0.15 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.219 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.673 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 23.6 Cg_exo -62.46 157.0 48.47 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 214' ' ' LEU . 10.7 mp 59.67 -68.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.599 0.562 . . . . 0.0 110.761 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 213' ' ' PRO . . . 46.3 -119.54 4.15 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.93 -72.26 0.99 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 214' ' ' LEU . 44.3 Cg_endo -66.45 148.94 84.66 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.731 2.288 . . . . 0.0 111.953 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 220' ' ' GLY . 49.0 mt-10 -142.91 73.2 18.78 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.446 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -6.94 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.875 2.384 . . . . 0.0 111.862 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 218' ' ' GLU . . . 110.29 177.63 20.86 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.61 -173.46 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.675 2.25 . . . . 0.0 112.165 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.515 ' O ' ' N ' ' A' ' 224' ' ' GLN . 61.9 t80 -58.53 171.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.946 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.482 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -40.12 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 222' ' ' TYR . 1.0 OUTLIER -137.36 106.78 8.56 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -47.79 -60.99 0.67 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.659 1.572 . . . . 0.0 112.161 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.9 m -85.82 -150.31 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 16.5 mm -101.3 47.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.1 0.476 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.411 ' HB2' ' NE2' ' A' ' 224' ' ' GLN . 68.8 m-80 -84.2 109.3 17.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 230' ' ' PRO . 0.6 OUTLIER -100.75 159.76 28.69 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.454 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 229' ' ' THR . 94.4 Cg_exo -37.4 -117.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.409 2.739 . . . . 0.0 112.88 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.2 tp -119.99 93.22 47.66 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.25 -32.46 71.26 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.391 2.061 . . . . 0.0 112.282 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 235' ' ' GLN . 64.2 t30 -71.06 155.6 40.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.663 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 235' ' ' GLN . 7.6 tp -67.24 9.61 0.21 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 233' ' ' ASN . 50.9 tt0 60.23 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 237' ' ' GLY . 33.8 p-10 -38.79 -42.4 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.609 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.537 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -52.36 -176.52 0.05 OUTLIER Glycine 1 CA--C 1.447 -4.212 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.761 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.537 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.4 115.62 0.14 OUTLIER 'Cis proline' 0 N--CA 1.529 3.6 0 N-CA-C 116.333 1.628 . . . . 0.0 116.333 -1.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.687 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 8.0 m-85 -149.41 -126.69 0.05 OUTLIER 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.822 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 5.5 m-30 -134.93 113.86 11.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 110.018 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 264' ' ' LEU . . . -107.17 139.27 41.88 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.424 ' HA ' ' HB2' ' A' ' 264' ' ' LEU . 17.0 tpp180 -100.17 98.84 9.49 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.527 0.68 . . . . 0.0 111.181 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.87 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.8 p -69.26 117.38 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.093 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.581 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.2 pt -110.91 18.86 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.673 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.444 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.8 mm-40 -176.8 116.96 0.11 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.207 0.527 . . . . 0.0 110.837 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.848 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -160.71 -151.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.822 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -156.28 -134.93 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.457 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.6 t -137.99 62.79 34.9 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.086 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.657 ' O ' ' O ' ' A' ' 256' ' ' ALA . 41.8 Cg_endo -98.1 47.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.995 2.463 . . . . 0.0 113.023 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 252' ' ' TYR . 8.0 p-10 -22.62 152.67 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 124.533 1.146 . . . . 0.0 111.517 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.58 -9.21 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.506 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.799 ' O ' ' N ' ' A' ' 254' ' ' LYS . 38.1 m-85 -76.53 -63.21 1.39 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -47.05 62.42 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 125.384 1.677 . . . . 0.0 111.131 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.799 ' N ' ' O ' ' A' ' 252' ' ' TYR . 4.2 mttm 84.26 -49.93 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.908 1.38 . . . . 0.0 109.717 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.88 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.724 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -44.31 110.88 0.24 Allowed 'General case' 0 C--O 1.214 -0.769 0 CA-C-O 121.131 0.491 . . . . 0.0 111.722 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.877 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.9 OUTLIER -43.44 159.58 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.033 -0.417 . . . . 0.0 111.75 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.786 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.81 119.82 40.67 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.848 HD12 ' HD2' ' A' ' 246' ' ' LYS . 1.3 mt -141.15 -175.73 4.43 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.457 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.8 tt0 -144.21 144.3 31.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.357 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 244' ' ' ILE . 58.2 t -48.98 106.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.423 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.79 14.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 57.1 mm-40 -92.71 -41.61 10.06 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.331 0.586 . . . . 0.0 112.38 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.979 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 69.12 140.12 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.62 -178.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.979 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.2 p -131.43 156.92 43.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.485 ' N ' HG22 ' A' ' 265' ' ' VAL . 0.8 OUTLIER -102.71 88.24 3.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.639 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.466 HG11 ' OE1' ' A' ' 235' ' ' GLN . 5.0 t -67.76 121.95 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.005 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.61 ' O ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -110.28 -52.63 2.76 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 8.5 tppt? -82.08 125.89 31.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 112.119 -177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 268' ' ' THR . 4.6 mp -139.88 126.19 22.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.549 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -121.08 -106.42 0.37 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.603 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.559 ' N ' ' ND2' ' A' ' 271' ' ' ASN . 35.0 mtm -38.09 149.64 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.655 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.8 p -71.55 15.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.715 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -140.75 -69.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.474 ' C ' ' CD1' ' A' ' 276' ' ' TRP . 98.0 mm-40 -82.79 173.03 12.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.593 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.61 ' CH2' ' O ' ' A' ' 287' ' ' PHE . 5.9 p-90 170.89 -169.47 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.068 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 6.6 mt-10 -126.93 173.26 9.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.68 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -150.3 -155.85 7.04 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.354 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.495 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -171.66 121.98 0.51 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.69 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -108.37 -98.03 0.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -95.6 50.46 1.23 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.41 -30.96 5.36 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 89.93 0.07 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.457 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.495 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 75.7 mtt180 -85.36 168.03 15.02 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.567 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 166.63 -156.26 28.01 Favored Glycine 0 C--N 1.308 -1.019 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.559 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 12.6 p80 -128.01 170.79 12.49 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.894 0.477 . . . . 0.0 111.066 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.61 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.3 OUTLIER 168.87 114.47 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.248 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 290' ' ' THR . 68.4 Cg_exo -48.55 141.01 20.75 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.575 1.517 . . . . 0.0 112.518 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.6 OUTLIER -62.98 -1.0 0.78 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.478 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.9 p -55.89 0.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 289' ' ' PHE . 4.9 p-80 -153.13 66.38 0.78 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.579 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -161.75 146.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.13 81.97 2.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.338 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 27.4 mt -37.71 130.09 1.08 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.343 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.0 mp -71.93 -170.13 0.55 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.852 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.92 21.31 0.43 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.606 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.6 tt0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.428 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -109.56 -142.7 0.38 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.42 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.878 ' O ' HG22 ' A' ' 138' ' ' VAL . 53.6 m-85 -129.3 -90.57 0.48 Allowed 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.457 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.5 m 90.77 161.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 125.367 1.667 . . . . 0.0 111.66 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -140.85 157.78 44.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.152 0.977 . . . . 0.0 111.468 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.661 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . . . -56.41 162.26 2.22 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.93 -1.486 . . . . 0.0 110.667 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.7 mt -136.36 -37.45 0.7 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.969 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.588 ' O ' ' NZ ' ' A' ' 269' ' ' LYS . 95.2 m-85 -124.87 6.66 8.04 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.475 ' OD2' ' O ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER 79.41 142.1 0.08 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.407 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.0 t80 -121.63 -50.67 2.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.004 0.43 . . . . 0.0 111.577 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 13.5 m-80 42.83 62.7 1.69 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.409 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.416 ' N ' ' HB3' ' A' ' 153' ' ' PRO . . . -77.53 -154.74 6.73 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.56 ' N ' ' ND2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 163.73 -6.94 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.1 -1.05 . . . . 0.0 112.085 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.483 ' N ' HD22 ' A' ' 147' ' ' ASN . 53.2 m-20 -55.16 -121.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.497 0.665 . . . . 0.0 111.417 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 151' ' ' ASP . 7.2 p-10 -66.59 47.48 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.041 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.692 ' O ' ' O ' ' A' ' 151' ' ' ASP . 21.5 mp0 67.78 19.75 9.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.185 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.692 ' O ' ' O ' ' A' ' 150' ' ' GLU . 0.9 OUTLIER -39.65 -169.86 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 O-C-N 123.863 0.727 . . . . 0.0 111.869 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.497 HD11 ' CG ' ' A' ' 175' ' ' ASP . 5.8 tp -113.53 91.2 19.7 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 121.242 -0.911 . . . . 0.0 111.6 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.416 ' HB3' ' N ' ' A' ' 146' ' ' GLY . 67.2 Cg_endo -70.92 128.26 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 120.785 0.99 . . . . 0.0 112.175 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.661 ' CD1' ' HB2' ' A' ' 140' ' ' ALA . 10.1 p90 -144.92 172.98 12.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.589 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.535 ' NZ ' ' OD1' ' A' ' 145' ' ' ASN . 0.8 OUTLIER -112.07 -106.7 0.37 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.933 0.396 . . . . 0.0 111.396 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 155' ' ' LYS . 25.5 ttpt -135.72 122.09 20.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.56 15.62 54.57 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.251 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.17 133.48 34.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 191' ' ' CYS . 6.2 mm -101.67 116.13 44.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mt -122.54 122.33 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.05 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -75.16 128.71 36.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.384 0.611 . . . . 0.0 111.828 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.6 mm -66.62 126.49 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.487 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.605 ' HE ' ' HE ' ' A' ' 180' ' ' ARG . 72.5 ttt-85 -76.58 -51.99 10.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.627 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 164' ' ' ASP . 51.0 t0 -157.27 -10.33 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.357 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.481 ' HB2' ' CD1' ' A' ' 171' ' ' TRP . 4.6 ptmm? 35.97 79.98 0.28 Allowed Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.511 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.53 -44.59 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 49.8 mt-10 -91.93 158.29 16.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.913 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 169' ' ' GLN . 15.6 pt-20 -82.28 -41.26 20.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.766 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.408 ' N ' ' CG ' ' A' ' 168' ' ' GLU . 35.1 mt-30 -83.13 -24.47 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.437 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 63.1 m95 -124.23 150.42 45.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.614 ' CD2' HG22 ' A' ' 185' ' ' VAL . 13.3 m0 -140.5 133.05 28.65 Favored 'General case' 0 C--O 1.207 -1.139 0 CA-C-O 121.678 0.751 . . . . 0.0 111.581 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -79.05 100.35 7.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.41 170.71 8.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -130.29 141.8 50.58 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.026 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.497 ' CG ' HD11 ' A' ' 152' ' ' LEU . 31.3 m-20 -70.5 173.07 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.478 0.656 . . . . 0.0 110.218 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.9 mmm -77.14 -8.19 57.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.895 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -102.01 -26.5 13.37 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.21 47.1 0.39 Allowed Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -122.6 131.68 53.94 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.288 -0.956 . . . . 0.0 110.609 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.605 ' HE ' ' HE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -109.28 113.92 27.16 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.831 0.824 . . . . 0.0 113.044 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -142.84 143.59 12.78 Favored Glycine 0 C--N 1.305 -1.187 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.691 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 25.1 mtp -62.42 161.53 11.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.485 0.66 . . . . 0.0 110.432 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.437 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 4.4 pt -150.6 145.86 18.95 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.874 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.3 118.7 5.63 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.41 1.407 . . . . 0.0 109.285 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.614 HG22 ' CD2' ' A' ' 171' ' ' TRP . 25.2 t -54.25 -51.49 77.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 7.8 Cg_endo -49.64 -29.43 19.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.543 1.495 . . . . 0.0 113.154 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.542 ' OH ' ' O ' ' A' ' 268' ' ' THR . 10.8 m-85 -72.37 -10.62 60.03 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.328 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 138' ' ' VAL . 1.3 m -132.89 165.13 33.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.519 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 190' ' ' LYS . 2.3 pp20? -143.64 -49.96 0.31 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.017 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.638 ' HD2' ' H ' ' A' ' 191' ' ' CYS . 3.2 tmtm? -171.95 -140.78 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.638 ' H ' ' HD2' ' A' ' 190' ' ' LYS . 6.8 t -168.27 102.63 0.44 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -73.73 149.87 88.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.784 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.76 -166.97 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.157 1.905 . . . . 0.0 111.81 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t 37.81 -132.79 0.12 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.1 t -134.63 -125.07 0.16 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.44 97.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.4 m 51.18 -137.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.504 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 200' ' ' THR . 34.7 m -80.77 33.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.423 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.405 ' O ' ' OG1' ' A' ' 200' ' ' THR . 1.3 t 72.15 -43.18 0.56 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.645 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 198' ' ' VAL . 69.0 p 50.47 -164.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.48 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 201' ' ' LEU . 11.1 mp 56.28 -174.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 17.2 p 47.95 -95.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.565 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 205' ' ' ASN . . . -168.64 -148.6 5.81 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -44.7 -15.44 0.05 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 203' ' ' GLY . 11.7 t-20 58.59 89.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.684 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.54 173.88 11.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 54.59 -168.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.2 p -68.43 153.83 43.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 210' ' ' HIS . 24.3 t -79.36 96.74 6.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 209' ' ' SER . 58.3 m80 -157.82 75.4 3.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.42 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.16 148.55 89.19 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.879 2.386 . . . . 0.0 112.046 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 55.76 58.35 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.653 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.78 156.41 60.73 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.763 2.309 . . . . 0.0 111.932 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 64.7 mt -56.67 -62.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 80.78 26.1 54.54 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 218' ' ' GLU . . . 82.2 179.47 52.84 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.6 29.83 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.752 2.301 . . . . 0.0 111.974 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.605 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 2.0 tp10 -63.66 -42.53 72.82 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.546 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 31.6 Cg_exo -57.85 -145.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.545 2.163 . . . . 0.0 111.978 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -178.0 -67.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -164.84 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.731 2.287 . . . . 0.0 112.265 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 224' ' ' GLN . 92.7 m-85 -58.75 169.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.034 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.01 94.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.872 0.368 . . . . 0.0 110.434 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 222' ' ' TYR . 8.8 tp-100 -132.92 92.82 24.93 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.278 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.34 -14.36 1.01 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.432 2.088 . . . . 0.0 112.095 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 p -92.22 -177.73 4.75 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.293 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.403 ' C ' ' CG ' ' A' ' 228' ' ' ASN . 47.2 mm -119.22 72.14 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.516 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.579 ' O ' ' NE2' ' A' ' 275' ' ' GLN . 0.0 OUTLIER 65.51 100.34 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.735 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER -79.81 -171.92 0.31 Allowed Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.371 -177.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.781 ' O ' ' N ' ' A' ' 271' ' ' ASN . 7.3 Cg_exo -70.03 -173.03 0.67 Allowed 'Trans proline' 0 N--CA 1.51 2.445 0 C-N-CA 124.061 3.174 . . . . 0.0 117.942 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 1.172 ' O ' ' HB ' ' A' ' 270' ' ' ILE . 2.6 tt -48.47 138.58 11.43 Favored Pre-proline 0 C--O 1.177 -2.734 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.834 -175.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.63 -70.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.239 0 CA-C-N 123.939 2.443 . . . . 0.0 113.314 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 235' ' ' GLN . 24.7 t-20 -45.55 103.77 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.816 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 4.7 tt -40.96 93.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.174 0.512 . . . . 0.0 110.532 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 233' ' ' ASN . 58.2 mm-40 -63.83 -50.82 67.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.98 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.84 -56.08 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.111 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -35.76 161.54 0.01 OUTLIER Glycine 1 CA--C 1.436 -4.882 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.898 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.422 ' HD2' ' CZ2' ' A' ' 170' ' ' TRP . 6.3 Cg_exo -75.88 115.45 3.55 Favored 'Cis proline' 0 N--CA 1.521 3.089 0 O-C-N 122.645 0.813 . . . . 0.0 112.015 -5.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.718 ' O ' ' HG3' ' A' ' 266' ' ' LYS . 43.0 m-85 -145.97 -125.86 0.07 Allowed 'General case' 0 C--O 1.189 -2.088 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 0.8 OUTLIER -142.07 116.14 9.39 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 120.105 1.32 . . . . 0.0 109.801 -177.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.796 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -88.93 -157.51 0.44 Allowed 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.321 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -157.7 90.49 1.08 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.563 0.696 . . . . 0.0 109.544 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.727 HG12 ' H ' ' A' ' 264' ' ' LEU . 5.0 p -66.22 122.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.523 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.71 16.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.94 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.67 100.56 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.242 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.838 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -134.14 -143.16 0.2 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 10.5 ptt85 -158.83 -134.89 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 248' ' ' VAL . 81.1 t -135.79 68.17 65.04 Favored Pre-proline 0 N--CA 1.473 0.711 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.876 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.566 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 67.7 Cg_endo -92.82 177.8 1.41 Allowed 'Trans proline' 0 C--N 1.297 -2.132 0 C-N-CA 123.355 2.703 . . . . 0.0 111.694 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.658 ' O ' ' N ' ' A' ' 252' ' ' TYR . 24.6 p30 -147.21 145.16 29.38 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.862 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -37.81 -14.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 O-C-N 123.562 0.539 . . . . 0.0 111.313 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.658 ' N ' ' O ' ' A' ' 250' ' ' ASN . 44.1 m-85 -83.54 -55.54 4.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.285 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 33.1 t70 -52.41 67.94 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 124.736 1.273 . . . . 0.0 111.691 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 252' ' ' TYR . 31.3 mtmt 73.52 -7.96 1.45 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.536 1.147 . . . . 0.0 111.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 254' ' ' LYS . 1.4 m 92.64 52.8 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 O-C-N 124.129 0.893 . . . . 0.0 111.903 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.432 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -109.87 112.72 24.92 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.924 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.6 OUTLIER -41.88 157.98 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.689 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.94 116.33 31.78 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.824 -0.75 . . . . 0.0 112.522 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.838 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.7 OUTLIER -139.0 -175.35 4.12 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.638 0.733 . . . . 0.0 111.552 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 263' ' ' GLU . 2.3 tt0 -148.02 148.67 30.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.981 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 56.3 t -45.52 108.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.044 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 103.63 13.09 28.84 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 260' ' ' GLU . 37.8 mm-40 -90.11 -35.1 15.62 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.26 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.074 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.83 139.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.958 0.885 . . . . 0.0 110.774 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.074 ' N ' HD12 ' A' ' 264' ' ' LEU . 9.1 p -136.17 164.69 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.082 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.718 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -108.33 103.17 12.27 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.677 HG13 ' HG2' ' A' ' 230' ' ' PRO . 1.2 t -57.1 -53.92 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER 62.48 -66.01 0.09 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 124.473 1.108 . . . . 0.0 109.974 -178.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.775 ' O ' ' HG2' ' A' ' 230' ' ' PRO . 0.1 OUTLIER -65.47 150.05 49.01 Favored 'General case' 0 C--O 1.181 -2.524 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.735 -177.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 1.172 ' HB ' ' O ' ' A' ' 231' ' ' LEU . 0.1 OUTLIER -162.86 128.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.171 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.781 ' N ' ' O ' ' A' ' 230' ' ' PRO . 0.1 OUTLIER -155.2 -40.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 177.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.849 ' HE3' ' H ' ' A' ' 274' ' ' GLY . 0.0 OUTLIER -124.3 173.24 8.5 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.915 ' C ' ' HE1' ' A' ' 276' ' ' TRP . 1.5 p -105.98 20.2 19.33 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.849 ' H ' ' HE3' ' A' ' 272' ' ' MET . . . -118.99 -74.25 0.44 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.84 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.664 ' CD ' ' N ' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -54.64 -91.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 123.422 1.582 . . . . 0.0 110.393 -178.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.915 ' HE1' ' C ' ' A' ' 273' ' ' SER . 1.2 m0 88.1 127.54 0.03 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.759 ' H ' ' HD3' ' A' ' 230' ' ' PRO . 21.4 mt-10 -86.54 168.51 13.63 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.712 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 284' ' ' ARG . . . -155.19 136.33 5.08 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.902 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.455 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -122.99 125.45 45.27 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.463 0.743 . . . . 0.0 110.364 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.641 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -143.23 78.89 1.62 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.063 -176.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 6.7 m-20 84.33 41.67 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.819 0.819 . . . . 0.0 109.351 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.41 -35.96 3.4 Favored Glycine 0 CA--C 1.495 -1.162 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.112 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -61.82 104.22 0.42 Allowed 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 114.588 -0.806 . . . . 0.0 109.773 -176.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 278' ' ' GLY . 33.2 mtt85 -108.8 165.84 11.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 121.397 0.618 . . . . 0.0 109.834 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 173.17 -148.83 10.65 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.559 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 16.8 p80 -132.24 168.33 18.25 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.549 0.174 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.71 120.78 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.805 179.125 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 275' ' ' GLN . 74.5 Cg_exo -46.01 134.53 14.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.864 1.71 . . . . 0.0 113.679 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.726 ' HB2' ' CE3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -66.73 -3.62 7.1 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.663 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 75.2 p -62.16 -0.49 0.54 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.6 p-80 -139.17 54.5 1.72 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.204 0.456 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.29 148.67 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.7 -46.92 3.43 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 1.3 mt 82.96 131.39 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.223 1.011 . . . . 0.0 112.01 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 9.3 mp -79.4 -168.05 1.4 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.849 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -74.6 12.19 0.86 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.738 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.404 ' H ' ' C ' ' A' ' 295' ' ' LEU . 56.6 tt0 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.044 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 137' ' ' TYR . 50.1 tp10 -167.21 159.54 12.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.123 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.005 ' O ' HG22 ' A' ' 138' ' ' VAL . 80.7 m-85 -132.83 -78.78 0.49 Allowed 'General case' 0 CA--C 1.486 -1.483 0 CA-C-O 118.599 -0.715 . . . . 0.0 111.995 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 1.005 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.4 m 84.44 160.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 125.427 1.704 . . . . 0.0 111.107 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -121.34 139.7 53.08 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 120.93 0.395 . . . . 0.0 110.324 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.67 ' HB1' ' CD1' ' A' ' 154' ' ' PHE . . . -105.27 98.75 8.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.98 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.722 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.2 OUTLIER -114.69 32.98 5.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.606 -178.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.574 ' CD2' HD12 ' A' ' 141' ' ' LEU . 69.6 m-85 -125.22 1.74 7.84 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.53 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 269' ' ' LYS . 0.2 OUTLIER 60.96 136.83 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.029 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 4.4 t80 -134.56 -35.26 0.9 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.834 0.349 . . . . 0.0 111.339 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 40.21 61.34 1.56 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.355 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.465 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -64.58 -119.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.596 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.9 OUTLIER 170.54 -92.37 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.902 0.382 . . . . 0.0 111.733 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.636 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 28.8 m-20 -49.95 178.2 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.206 0.527 . . . . 0.0 111.133 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 151' ' ' ASP . 99.9 m-20 -68.54 -42.37 78.51 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.854 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.26 3.98 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.596 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 2.7 p30 -133.79 150.2 51.44 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.483 ' HB3' ' CG2' ' A' ' 183' ' ' ILE . 8.7 tp -119.6 89.43 41.04 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-O 120.406 0.146 . . . . 0.0 110.685 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 37.6 Cg_exo -57.48 147.29 79.23 Favored 'Trans proline' 0 C--N 1.288 -2.618 0 C-N-CA 122.236 1.957 . . . . 0.0 113.612 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.67 ' CD1' ' HB1' ' A' ' 140' ' ' ALA . 5.9 p90 -172.53 156.89 3.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.618 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 157' ' ' GLY . 3.4 ttmp? -169.69 -55.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.436 0.636 . . . . 0.0 111.697 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 156' ' ' LYS . 8.7 mmmm -45.14 -16.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.999 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 155' ' ' LYS . . . 102.09 57.29 0.81 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -90.47 150.59 21.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.415 0.626 . . . . 0.0 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 44.6 mm -94.61 115.65 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 137' ' ' TYR . 8.6 mt -113.26 120.91 42.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.688 -176.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 65.9 tttm -68.87 141.66 55.01 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.642 ' O ' ' O ' ' A' ' 172' ' ' ASN . 34.7 mm -75.98 -64.17 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.866 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 162' ' ' ILE . 56.0 ttt180 79.96 -44.07 0.27 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 120.869 0.366 . . . . 0.0 111.31 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -146.08 122.49 10.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.454 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.555 ' HG3' ' NE1' ' A' ' 171' ' ' TRP . 2.4 ttmt -107.67 74.67 0.46 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.24 -60.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.166 1.911 . . . . 0.0 111.994 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -99.98 161.0 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.71 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -84.79 -34.81 22.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.632 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 92.8 mt-30 -83.53 -29.08 28.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.444 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.43 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 70.9 m95 -122.99 149.85 43.76 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.559 ' CD2' HG22 ' A' ' 185' ' ' VAL . 17.1 m0 -138.34 129.6 27.35 Favored 'General case' 0 C--O 1.211 -0.956 0 CA-C-O 121.349 0.595 . . . . 0.0 111.418 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 162' ' ' ILE . 53.1 t30 -80.81 108.04 14.14 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -113.62 171.64 7.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 123.569 0.543 . . . . 0.0 111.087 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 72.7 tt0 -125.14 135.7 52.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.111 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -63.37 172.32 2.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.445 0.641 . . . . 0.0 110.578 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 97.0 mmm -79.89 -0.0 33.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.004 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -104.43 -27.73 11.75 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.55 49.82 0.34 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 174' ' ' GLU . 46.7 mttt -131.08 134.33 46.51 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.644 -0.778 . . . . 0.0 110.81 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.14 51.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.527 0.68 . . . . 0.0 111.99 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.03 154.25 25.34 Favored Glycine 0 C--N 1.317 -0.516 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.086 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 tpt -68.35 162.78 24.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.371 0.605 . . . . 0.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.483 ' CG2' ' HB3' ' A' ' 152' ' ' LEU . 5.4 pt -154.8 143.2 14.52 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.432 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HG2' ' CG ' ' A' ' 187' ' ' TYR . 18.4 Cg_endo -70.19 118.05 5.46 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.346 1.364 . . . . 0.0 108.888 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.896 ' O ' HG22 ' A' ' 188' ' ' VAL . 15.6 t -50.99 -53.46 47.87 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 121.755 -0.59 . . . . 0.0 111.712 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 16.5 Cg_endo -51.93 -25.29 21.37 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 122.313 2.009 . . . . 0.0 113.578 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.8 m-85 -72.2 9.7 0.93 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 185' ' ' VAL . 4.8 m -135.4 167.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.948 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.722 ' CD ' HD21 ' A' ' 141' ' ' LEU . 36.7 mt-10 -91.94 -70.56 0.68 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.452 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.619 ' O ' HG12 ' A' ' 138' ' ' VAL . 4.8 tptp -178.56 -61.3 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.805 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 190' ' ' LYS . 1.5 p 163.31 -82.29 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.723 0.639 . . . . 0.0 110.263 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.583 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 0.0 OUTLIER -95.57 -44.91 0.27 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.642 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 50.0 Cg_exo -52.71 -131.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.735 2.29 . . . . 0.0 112.304 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 71.0 p -162.14 3.02 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.284 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 196' ' ' ALA . 3.8 p 70.25 -53.49 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.43 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 195' ' ' SER . . . -161.82 169.79 20.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.199 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 198' ' ' VAL . 43.1 t -132.64 -134.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.897 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 197' ' ' SER . 20.6 m 31.17 42.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.454 0.471 . . . . 0.0 111.272 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 12.4 p -146.8 133.65 20.13 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.507 ' OG1' HD23 ' A' ' 201' ' ' LEU . 34.1 p -64.16 -34.33 77.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.529 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.507 HD23 ' OG1' ' A' ' 200' ' ' THR . 0.2 OUTLIER -148.93 113.13 5.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.172 179.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 17.7 m -64.67 -52.58 56.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.569 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -152.72 104.6 0.26 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.89 119.08 0.59 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.586 ' ND2' ' H ' ' A' ' 206' ' ' GLN . 0.4 OUTLIER -173.32 -152.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.266 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.586 ' H ' ' ND2' ' A' ' 205' ' ' ASN . 11.7 tp-100 -142.35 119.62 11.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.402 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.94 132.58 41.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.351 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' A' ' 210' ' ' HIS . 46.4 p -158.03 165.17 35.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.503 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 210' ' ' HIS . 78.2 p -61.63 -41.91 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.817 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 209' ' ' SER . 24.1 m-70 56.77 153.48 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.646 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.24 76.73 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.373 2.049 . . . . 0.0 111.771 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 0.0 OUTLIER -79.31 -40.53 1.49 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 38.9 Cg_exo -59.16 142.79 99.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.38 2.053 . . . . 0.0 112.083 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 19.1 tp -168.03 -44.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.566 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 117.15 120.44 3.12 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -134.23 -172.19 12.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.92 -41.62 69.76 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.668 2.245 . . . . 0.0 111.922 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -94.96 149.25 36.0 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.677 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.48 -25.55 48.12 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.513 2.142 . . . . 0.0 112.051 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.36 68.09 1.46 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.97 150.16 37.88 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.616 2.211 . . . . 0.0 111.956 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -73.53 168.77 18.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.232 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.22 115.92 0.67 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.314 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 226' ' ' SER . 0.5 OUTLIER -140.2 170.73 9.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.602 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 226' ' ' SER . 29.3 Cg_exo -61.38 51.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.629 2.219 . . . . 0.0 112.732 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 224' ' ' GLN . 0.7 OUTLIER 76.56 72.46 0.07 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.546 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 26.7 mt -139.22 62.08 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.203 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 64.67 67.87 0.54 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.827 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 29.6 p -126.41 149.49 67.64 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.378 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.24 164.45 35.69 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 122.775 2.316 . . . . 0.0 111.646 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.709 HD21 ' CD1' ' A' ' 276' ' ' TRP . 2.5 pp -60.0 146.45 82.4 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.66 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.48 133.77 35.93 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.232 1.955 . . . . 0.0 112.382 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.686 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 1.1 m-80 -45.87 135.52 7.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' A' ' 236' ' ' ASN . 7.1 tp 29.32 -135.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 O-C-N 124.142 0.901 . . . . 0.0 110.923 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 237' ' ' GLY . 74.1 mm-40 56.86 -73.89 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.773 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 234' ' ' LEU . 19.2 m-80 -72.62 43.69 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.379 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.57 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . 141.95 -173.52 23.6 Favored Glycine 1 CA--C 1.442 -4.488 0 CA-C-N 115.587 -0.733 . . . . 0.0 114.615 178.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.483 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 5.9 Cg_exo -46.0 105.77 0.03 OUTLIER 'Cis proline' 1 N--CA 1.536 4.024 0 O-C-N 123.755 1.397 . . . . 0.0 115.488 0.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.604 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.1 m-30 -120.57 -127.78 0.27 Allowed 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.768 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.624 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.8 OUTLIER -141.46 124.01 15.9 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.66 0.743 . . . . 0.0 110.198 -178.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.924 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -104.59 -163.0 0.93 Allowed 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.387 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 19.5 tpp180 -161.47 89.87 0.77 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.214 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 243' ' ' VAL . 5.3 p -64.7 121.08 13.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.505 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.98 12.32 8.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.517 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.554 ' HA ' HG22 ' A' ' 261' ' ' VAL . 2.0 mm-40 -169.01 120.39 0.74 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 110.565 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.839 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -163.04 -145.56 0.1 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.591 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.4 ptt85 -155.75 -142.38 0.11 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.654 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 248' ' ' VAL . 78.7 t -132.84 67.83 78.3 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.608 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 74.5 Cg_endo -91.62 172.7 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.135 2.557 . . . . 0.0 111.61 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.765 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.0 OUTLIER -143.98 140.83 29.85 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.914 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.32 -2.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.887 0.742 . . . . 0.0 112.184 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.765 ' N ' ' O ' ' A' ' 250' ' ' ASN . 2.5 m-85 -96.78 -54.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 123.591 0.756 . . . . 0.0 110.044 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -44.41 -65.84 0.47 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.03 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.555 ' C ' ' H ' ' A' ' 256' ' ' ALA . 25.8 mttt -149.05 33.3 0.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.757 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.408 ' O ' ' CA ' ' A' ' 285' ' ' GLY . 1.7 m 71.19 -16.53 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.822 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -48.81 161.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.22 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.826 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -105.29 150.53 25.08 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.846 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -91.57 119.44 31.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 258' ' ' ALA . 3.7 mt -140.48 -172.14 3.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.438 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 17.8 tt0 -147.23 146.13 29.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.065 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 245' ' ' GLN . 68.9 t -55.35 102.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.639 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 121.84 8.01 7.66 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 264' ' ' LEU . 64.8 mm-40 -90.57 -124.8 0.07 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.841 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.053 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.3 OUTLIER 161.61 136.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.053 ' N ' HD12 ' A' ' 264' ' ' LEU . 10.7 p -126.29 142.78 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.287 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 2.6 ttmt -100.63 83.36 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.188 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 75.2 t -51.96 151.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.449 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -151.7 -51.34 0.12 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.693 -178.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.524 ' O ' ' OE1' ' A' ' 277' ' ' GLU . 0.1 OUTLIER -70.52 104.13 2.68 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.076 -178.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.542 HG12 ' H ' ' A' ' 234' ' ' LEU . 1.7 mp -95.14 154.61 3.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.625 HD21 ' HA ' ' A' ' 276' ' ' TRP . 0.1 OUTLIER -171.63 -97.83 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.153 179.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.648 ' HE3' ' O ' ' A' ' 275' ' ' GLN . 19.3 mtm -59.0 134.91 57.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.831 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.9 p -66.97 25.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -152.12 -69.89 0.01 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.929 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.648 ' O ' ' HE3' ' A' ' 272' ' ' MET . 21.4 mp0 -92.19 112.52 24.49 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.148 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.709 ' CD1' HD21 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -116.18 -171.8 2.06 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.524 ' OE1' ' O ' ' A' ' 269' ' ' LYS . 54.8 mp0 -97.09 -160.49 0.8 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.492 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -173.76 117.71 0.66 Allowed Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.525 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.466 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.2 tt0 -99.49 127.82 45.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 110.34 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.729 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -144.39 78.97 1.59 Allowed 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 3.9 m-20 82.63 30.09 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 0.0 109.921 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 93.95 -32.64 5.72 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.405 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.571 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.4 OUTLIER -66.21 72.81 0.07 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.762 -178.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.554 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 90.5 mtt180 -72.82 168.04 19.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 123.886 0.741 . . . . 0.0 109.918 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 168.94 -158.07 30.48 Favored Glycine 0 C--O 1.206 -1.653 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.588 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 3.8 p80 -124.71 167.41 14.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.249 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 167.65 115.14 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.223 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.5 Cg_exo -51.68 145.13 31.53 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.963 1.775 . . . . 0.0 112.304 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.2 OUTLIER -64.25 -0.11 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 110.465 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 288' ' ' PRO . 76.2 p -56.27 3.85 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 O-C-N 121.81 -0.556 . . . . 0.0 112.33 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' A' ' 289' ' ' PHE . 3.9 p-80 -156.11 69.69 0.66 Allowed 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.574 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -165.86 154.33 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -129.35 76.19 1.7 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.24 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.6 mt -38.08 127.97 1.3 Allowed 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.438 0.637 . . . . 0.0 111.368 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.97 -99.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.767 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -159.02 -85.52 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.412 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.604 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 3.9 tp-100 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.474 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 137' ' ' TYR . 11.0 m . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 57.77 -75.18 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 123.34 0.4 . . . . 0.0 110.958 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.958 ' O ' HG22 ' A' ' 138' ' ' VAL . 13.1 p90 -70.74 -55.68 8.08 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 118.902 -0.57 . . . . 0.0 112.247 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.958 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.4 m 86.17 165.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 125.0 1.437 . . . . 0.0 111.646 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -128.15 138.29 52.44 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.346 0.593 . . . . 0.0 110.569 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -96.84 98.92 10.52 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.753 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.497 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -104.51 37.51 2.1 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.271 -179.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 53.5 m-85 -135.17 0.82 2.88 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.515 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER 60.55 139.51 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.765 0 O-C-N 123.887 0.742 . . . . 0.0 109.273 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.0 t80 -128.48 -38.68 1.72 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.079 0.399 . . . . 0.0 110.466 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t30 40.54 56.25 2.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.517 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -69.67 -132.3 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.631 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 0.8 OUTLIER 169.5 -89.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.663 -0.269 . . . . 0.0 110.355 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.58 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.7 m-20 -19.58 134.47 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.573 0.749 . . . . 0.0 112.225 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.2 -3.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.442 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 148' ' ' ASP . 12.5 pt-20 -108.12 16.76 23.03 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.631 ' CG ' ' H ' ' A' ' 147' ' ' ASN . 8.2 p30 -137.54 152.82 49.86 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 182' ' ' MET . 12.6 tp -107.72 90.35 6.16 Favored Pre-proline 0 C--O 1.215 -0.76 0 CA-C-N 118.181 0.446 . . . . 0.0 110.717 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 74.1 Cg_endo -66.97 146.47 77.62 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 C-N-CA 121.364 1.376 . . . . 0.0 114.082 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.571 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 11.8 p90 -169.97 162.84 9.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.82 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -152.76 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.885 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -97.93 129.44 44.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.879 0.847 . . . . 0.0 110.483 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . 88.89 12.39 64.0 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.991 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.45 ' C ' HD12 ' A' ' 159' ' ' ILE . 27.0 t0 -75.04 139.8 43.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.7 mp -97.56 114.76 35.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.459 HD11 ' CD2' ' A' ' 154' ' ' PHE . 10.8 mt -125.42 133.9 52.32 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.923 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -81.6 140.2 34.58 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.108 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.2 mp -66.37 -52.07 51.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.656 ' CZ ' HH21 ' A' ' 180' ' ' ARG . 54.1 ttt85 66.85 -48.18 0.46 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.306 0.379 . . . . 0.0 111.215 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 162' ' ' ILE . 41.0 t0 -152.93 133.5 13.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.432 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.44 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.9 pttp -133.94 78.67 59.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.752 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.64 -31.2 7.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.165 1.91 . . . . 0.0 112.539 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -101.81 -174.47 2.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 168' ' ' GLU . 1.5 pm0 -115.25 -13.97 11.71 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -109.47 -29.33 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.825 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 76.5 m95 -121.04 146.25 46.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.608 ' CD2' HG22 ' A' ' 185' ' ' VAL . 16.4 m0 -137.38 125.61 23.14 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 162' ' ' ILE . 18.9 t-20 -76.09 101.62 5.39 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.38 173.56 6.25 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.467 0.479 . . . . 0.0 111.079 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 21.4 tt0 -121.45 123.63 42.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.067 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.75 173.35 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.234 0.54 . . . . 0.0 110.211 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 96.1 mtp -72.84 -3.05 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.851 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 179' ' ' LYS . 89.5 m-20 -98.63 -20.23 17.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.361 0.601 . . . . 0.0 110.905 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 120.68 -28.89 6.03 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 177' ' ' ASP . 16.9 mttp -52.49 146.79 9.2 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.19 0.519 . . . . 0.0 110.813 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.656 HH21 ' CZ ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -114.67 130.62 56.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.344 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -159.84 157.12 28.37 Favored Glycine 0 C--N 1.313 -0.716 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.387 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.525 ' C ' HG22 ' A' ' 183' ' ' ILE . 1.8 tpt -68.4 163.28 23.55 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.037 -0.581 . . . . 0.0 111.169 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.879 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -161.32 147.79 11.38 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.554 178.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.07 115.84 4.47 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.107 1.205 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 188' ' ' VAL . 38.3 t -53.49 -52.05 70.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 122.041 -0.412 . . . . 0.0 111.541 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 13.2 Cg_endo -49.11 -27.7 12.81 Favored 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.487 2.125 . . . . 0.0 113.345 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.28 4.95 0.43 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.055 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 138' ' ' VAL . 1.8 m -130.43 168.92 22.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 123.109 0.256 . . . . 0.0 110.764 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.56 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.4 OUTLIER -100.09 -66.34 0.91 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.027 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 45.0 tptt 134.91 -4.27 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.993 1.433 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . . . . . . . . . 12.9 t 56.93 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.921 -0.487 . . . . 0.0 109.912 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 194' ' ' SER . 15.1 ptt180 -163.64 78.61 1.62 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.53 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.24 39.47 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.176 2.584 . . . . 0.0 112.377 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 192' ' ' ARG . 34.6 t -80.22 -6.62 58.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.625 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.6 p -152.59 172.34 16.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.49 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -171.24 -169.23 0.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.5 t 76.56 137.68 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.844 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.79 -43.3 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.0 m -56.11 143.04 34.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.41 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 4.8 p 59.25 109.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.254 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.501 HD21 ' HA3' ' A' ' 282' ' ' GLY . 0.2 OUTLIER 54.87 94.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.289 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 48.6 p -77.35 104.16 7.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.22 -29.01 13.19 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.09 -54.31 3.89 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 49.77 98.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.757 0.313 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -137.02 -174.75 3.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.489 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 55.52 35.87 26.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.6 m -91.68 115.68 28.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.45 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.3 m -152.9 148.03 26.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.372 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -40.63 111.64 0.8 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.595 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.05 162.38 37.09 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.655 1.57 . . . . 0.0 111.95 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -40.7 150.05 0.3 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -47.74 139.54 18.69 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.627 1.551 . . . . 0.0 112.353 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.14 10.79 40.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.491 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 177.82 157.19 18.12 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -65.31 -179.47 8.06 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.77 -43.16 53.19 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.323 2.015 . . . . 0.0 112.417 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 39.17 73.13 0.84 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.051 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -61.99 150.27 87.01 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.976 2.451 . . . . 0.0 112.053 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 156.61 -75.58 0.21 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.74 177.48 4.83 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.518 2.145 . . . . 0.0 112.227 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 224' ' ' GLN . 99.1 m-85 -58.97 163.15 3.66 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.216 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -40.78 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.904 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.746 ' NE2' ' H ' ' A' ' 228' ' ' ASN . 0.0 OUTLIER -143.38 146.12 34.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.784 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -48.56 -57.27 2.45 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.577 1.518 . . . . 0.0 112.912 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.674 ' C ' HE22 ' A' ' 224' ' ' GLN . 1.5 t 169.58 -12.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.046 0.451 . . . . 0.0 110.957 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.575 ' H ' ' CD1' ' A' ' 227' ' ' ILE . 0.1 OUTLIER -77.44 13.58 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.6 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.746 ' H ' ' NE2' ' A' ' 224' ' ' GLN . 2.9 m120 66.83 -133.9 0.14 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.057 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 69.2 p -113.31 116.62 46.37 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.771 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.26 -157.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 121.429 1.419 . . . . 0.0 112.26 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.707 HD21 ' CD1' ' A' ' 276' ' ' TRP . 0.1 OUTLIER -61.37 146.57 88.98 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.445 -178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.89 143.78 33.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.126 1.884 . . . . 0.0 111.681 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 235' ' ' GLN . 11.3 m120 37.76 -155.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.02 0.438 . . . . 0.0 111.153 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 234' ' ' LEU . 1.1 pt? -69.69 4.22 2.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.61 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.469 ' HG2' ' H ' ' A' ' 237' ' ' GLY . 3.5 tt0 66.02 129.84 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -40.66 -34.04 0.34 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.55 0.691 . . . . 0.0 110.39 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.476 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -61.37 -175.73 1.8 Allowed Glycine 1 CA--C 1.447 -4.164 0 CA-C-N 114.759 -1.109 . . . . 0.0 113.23 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.476 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 4.9 Cg_endo -53.21 122.97 0.4 Allowed 'Cis proline' 0 N--CA 1.525 3.367 0 N-CA-C 116.481 1.685 . . . . 0.0 116.481 -1.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.2 m-85 -154.67 -121.48 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.7 OUTLIER -145.18 135.09 23.69 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 118.976 0.807 . . . . 0.0 108.962 -179.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.541 ' O ' HD13 ' A' ' 295' ' ' LEU . . . -117.94 -148.51 0.42 Allowed 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.174 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 262' ' ' GLY . 21.6 tpp180 -161.93 95.15 0.96 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.627 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 263' ' ' GLU . 2.9 p -61.62 137.29 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.783 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.8 20.9 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 176.48 103.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 110.09 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -145.88 -143.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.959 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -155.51 -139.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.015 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 248' ' ' VAL . 70.8 t -133.91 68.65 75.11 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-O 121.215 0.531 . . . . 0.0 110.887 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.649 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 61.3 Cg_endo -91.63 175.63 2.17 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 122.816 2.344 . . . . 0.0 111.209 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.767 ' O ' ' N ' ' A' ' 252' ' ' TYR . 0.9 OUTLIER -142.89 140.0 31.02 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 255' ' ' THR . . . -37.1 -8.02 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.46 0.648 . . . . 0.0 111.983 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.767 ' N ' ' O ' ' A' ' 250' ' ' ASN . 4.8 m-85 -92.41 -48.77 6.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 250' ' ' ASN . 27.9 t0 -65.09 56.39 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.661 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 256' ' ' ALA . 33.0 mtmt 85.55 20.28 0.1 Allowed 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 124.642 1.214 . . . . 0.0 111.47 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.519 ' O ' ' O ' ' A' ' 284' ' ' ARG . 2.4 m 75.49 -19.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.021 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -39.74 107.52 0.07 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.522 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.949 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -47.03 157.3 0.17 Allowed 'General case' 0 CA--C 1.492 -1.259 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.777 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.83 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -110.17 124.43 51.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.954 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.83 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.3 mt -142.66 -179.08 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.069 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 6.7 tt0 -133.86 146.06 50.24 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.787 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 52.9 t -45.96 110.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.102 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.781 ' O ' ' O ' ' A' ' 263' ' ' GLU . . . 131.06 -70.56 0.52 Allowed Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.781 ' O ' ' O ' ' A' ' 262' ' ' GLY . 4.1 mm-40 -29.08 -163.4 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.444 0 O-C-N 125.764 1.508 . . . . 0.0 114.142 -172.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 264' ' ' LEU . 3.8 pp -155.57 166.04 34.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.281 1.038 . . . . 0.0 112.518 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.09 143.22 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.525 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 279' ' ' GLU . 0.0 OUTLIER -101.39 85.32 2.76 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.591 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.469 HG21 HE22 ' A' ' 235' ' ' GLN . 3.0 t -58.2 155.49 2.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.939 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.73 -56.24 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.038 0.446 . . . . 0.0 109.807 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.45 102.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.749 -0.781 . . . . 0.0 110.689 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.61 HG23 ' CE3' ' A' ' 276' ' ' TRP . 5.7 mt -115.17 106.46 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.871 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.702 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -111.45 -101.53 0.4 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.623 ' O ' ' CE3' ' A' ' 276' ' ' TRP . 38.6 mtm -51.26 148.33 4.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.003 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 p -72.17 16.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.507 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -140.86 -80.9 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.227 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -86.18 116.37 24.33 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 121.002 0.429 . . . . 0.0 111.358 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.707 ' CD1' HD21 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -134.58 -172.92 3.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.742 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -115.53 -171.79 2.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.92 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -159.89 -152.78 6.64 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.056 -1.068 . . . . 0.0 112.348 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 281' ' ' ASN . 0.5 OUTLIER -168.59 139.33 2.53 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.192 0.52 . . . . 0.0 112.168 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.706 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -148.05 76.25 1.37 Allowed 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.102 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE1' ' A' ' 279' ' ' GLU . 1.5 m120 84.35 36.52 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 -179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.501 ' HA3' HD21 ' A' ' 201' ' ' LEU . . . 89.81 -35.84 3.67 Favored Glycine 0 CA--C 1.509 -0.325 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.843 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -63.89 88.0 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.169 0.509 . . . . 0.0 110.257 -178.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.519 ' O ' ' O ' ' A' ' 255' ' ' THR . 43.9 mtt85 -86.45 168.1 14.07 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.278 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 168.11 -154.6 24.68 Favored Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.583 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 13.1 p80 -129.37 172.14 11.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 163.2 114.39 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.431 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.526 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 54.5 Cg_exo -48.4 129.53 19.67 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.222 1.281 . . . . 0.0 112.255 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -62.98 -1.92 1.06 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.275 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 288' ' ' PRO . 53.0 p -58.77 2.21 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.889 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' A' ' 288' ' ' PRO . 1.2 p-80 -142.82 50.88 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.739 0.304 . . . . 0.0 111.633 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.416 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.2 OUTLIER -145.89 166.3 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 294' ' ' LEU . 18.8 mtm180 -136.85 77.02 1.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.529 0.204 . . . . 0.0 110.878 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 35.1 mt -34.29 134.37 0.2 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.398 0.618 . . . . 0.0 111.274 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 241' ' ' ALA . 3.4 mp -79.08 -165.39 0.75 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.365 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 42.5 p-10 -77.43 -0.42 25.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.63 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 27.5 tt0 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.09 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -152.8 167.57 28.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.483 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.671 ' O ' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -162.02 -22.36 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.671 ' O ' ' O ' ' A' ' 137' ' ' TYR . 32.6 m 36.38 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 122.08 0.943 . . . . 0.0 112.635 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 188' ' ' VAL . 14.9 ttp180 -143.47 120.38 11.31 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.413 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -98.78 91.51 5.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 124.321 1.013 . . . . 0.0 111.812 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.727 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -99.78 18.97 16.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.285 -179.418 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.575 ' CE1' ' CZ ' ' A' ' 284' ' ' ARG . 46.8 m-85 -114.98 0.91 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 142' ' ' PHE . 0.7 OUTLIER 58.57 138.01 0.01 OUTLIER 'General case' 0 C--O 1.209 -1.035 0 O-C-N 124.407 1.067 . . . . 0.0 110.014 -179.194 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.433 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 17.2 t80 -130.06 -46.69 1.12 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.905 0.321 . . . . 0.0 110.44 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 144' ' ' PHE . 66.3 t30 36.04 58.6 0.95 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.484 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -61.6 -93.8 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 0.7 OUTLIER 170.31 15.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.966 0.888 . . . . 0.0 110.316 -179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 151' ' ' ASP . 1.3 p-10 33.66 -159.2 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.92 -1.491 . . . . 0.0 113.156 -177.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.511 ' N ' ' OD2' ' A' ' 148' ' ' ASP . 97.7 m-20 48.64 38.81 12.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 149' ' ' ASP . 3.6 mm-40 149.71 -10.2 0.0 OUTLIER 'General case' 0 C--N 1.345 0.386 0 O-C-N 124.701 1.251 . . . . 0.0 108.987 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 0.2 OUTLIER -157.45 -178.02 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.793 -178.06 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 175' ' ' ASP . 10.7 tp -118.04 87.67 29.27 Favored Pre-proline 0 C--O 1.206 -1.203 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.508 ' HD3' ' H ' ' A' ' 148' ' ' ASP . 71.6 Cg_endo -71.38 139.74 35.4 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 CA-C-N 120.03 1.046 . . . . 0.0 112.079 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.609 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.1 p90 -160.9 163.76 31.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -155.88 169.08 25.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.811 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 157' ' ' GLY . 3.5 ttmt 50.43 82.67 0.05 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.334 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 23.1 47.41 0.01 OUTLIER Glycine 0 N--CA 1.467 0.715 0 O-C-N 123.834 0.709 . . . . 0.0 113.008 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.502 ' C ' HD12 ' A' ' 159' ' ' ILE . 35.3 t0 -62.71 159.69 15.74 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.547 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.565 HG23 ' CB ' ' A' ' 137' ' ' TYR . 1.5 mp -109.2 106.85 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 154' ' ' PHE . 6.4 mt -109.47 106.84 16.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.458 -177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -64.73 129.12 38.6 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.64 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.964 HG22 ' H ' ' A' ' 163' ' ' ARG . 42.7 mm -66.44 -134.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.857 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.964 ' H ' HG22 ' A' ' 162' ' ' ILE . 77.4 ttt180 175.75 -48.78 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.518 0.675 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -149.63 -19.12 0.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.071 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.4 pttt 37.04 72.89 0.76 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 123.205 0.315 . . . . 0.0 111.202 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.28 -43.15 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.592 1.528 . . . . 0.0 112.059 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.59 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 76.4 mm-40 -99.29 157.06 16.65 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.909 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.427 ' O ' HG21 ' A' ' 185' ' ' VAL . 2.7 pt-20 -85.06 -36.46 21.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.381 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -82.59 -26.14 32.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.831 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 239' ' ' PHE . 85.2 m95 -127.32 150.98 49.34 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.666 ' CE3' HG22 ' A' ' 185' ' ' VAL . 13.0 m0 -145.07 136.03 24.73 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.874 0.368 . . . . 0.0 110.234 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -86.8 110.36 19.89 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.43 ' HB3' HG21 ' A' ' 183' ' ' ILE . . . -119.62 -178.58 3.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.633 . . . . 0.0 111.528 -178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 -123.68 125.35 44.61 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -56.8 172.5 0.26 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.94 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -78.61 2.67 18.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.059 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -104.99 -29.26 10.57 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.05 51.16 0.52 Allowed Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -135.81 140.51 44.29 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 113.882 -1.159 . . . . 0.0 109.644 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.06 121.43 44.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 111.343 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.446 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -155.28 153.29 24.67 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.191 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.5 mtp -65.9 152.41 44.55 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -138.49 143.36 38.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.069 -0.969 . . . . 0.0 113.023 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.57 114.58 4.05 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.314 1.343 . . . . 0.0 108.914 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.801 ' O ' HG22 ' A' ' 188' ' ' VAL . 47.4 t -52.85 -51.23 76.17 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.823 -0.548 . . . . 0.0 111.944 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 9.6 Cg_endo -48.56 -29.39 13.94 Favored 'Trans proline' 0 N--CA 1.504 2.137 0 C-N-CA 122.669 2.246 . . . . 0.0 113.014 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 5.8 m-85 -67.93 -0.92 4.8 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.712 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 185' ' ' VAL . 17.2 m -128.98 166.41 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.283 0.364 . . . . 0.0 110.633 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.727 ' CD ' HD21 ' A' ' 141' ' ' LEU . 2.5 pt-20 -146.72 50.58 1.12 Allowed 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 191' ' ' CYS . 3.8 tmtt? -161.96 105.24 1.19 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.524 ' SG ' ' CH2' ' A' ' 171' ' ' TRP . 0.0 OUTLIER 160.27 -27.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.081 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 193' ' ' PRO . 14.7 mtp180 -162.11 -62.84 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.481 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 192' ' ' ARG . 17.8 Cg_endo -56.49 -36.3 97.49 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.371 2.047 . . . . 0.0 112.109 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 p -39.56 110.06 0.13 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.973 0.415 . . . . 0.0 110.756 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 97.2 p -64.9 160.61 20.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.224 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.52 79.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.654 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 35.3 m -157.92 173.94 16.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.1 t 56.35 93.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.501 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -170.75 70.44 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.5 p -103.4 135.79 44.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.306 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -40.13 79.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.939 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 31.65 74.93 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.414 0.446 . . . . 0.0 111.428 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.27 93.94 2.06 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -165.55 -149.16 5.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 55.69 65.29 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.432 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 47.91 94.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.375 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 208' ' ' SER . 91.6 m-20 -88.38 110.06 20.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.139 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 207' ' ' ASP . 82.8 p 54.1 163.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.726 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.473 ' H ' ' CD2' ' A' ' 210' ' ' HIS . 4.3 t -165.09 -74.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 210' ' ' HIS . 0.2 OUTLIER 58.99 167.42 0.08 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.53 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.0 145.73 96.61 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.715 1.61 . . . . 0.0 111.748 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.433 ' OE1' ' OE1' ' A' ' 275' ' ' GLN . 1.0 OUTLIER -62.06 172.16 1.28 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 215' ' ' GLY . 50.5 Cg_exo -51.69 -35.93 59.55 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.287 1.992 . . . . 0.0 111.873 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 65.6 tp 49.89 -91.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.77 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 213' ' ' PRO . . . -71.67 -30.46 66.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -44.62 153.6 0.47 Allowed Glycine 0 CA--C 1.533 1.159 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.55 -19.47 42.44 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.607 2.205 . . . . 0.0 111.929 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.11 145.81 12.1 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.025 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.65 160.58 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.716 1.61 . . . . 0.0 112.274 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.558 ' H ' ' HD3' ' A' ' 221' ' ' PRO . . . 144.34 63.65 0.02 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.436 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.558 ' HD3' ' H ' ' A' ' 220' ' ' GLY . 69.7 Cg_endo -81.36 158.7 19.83 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.339 2.026 . . . . 0.0 112.264 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -83.88 167.9 16.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.409 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.4 121.17 1.58 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.331 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -143.68 162.67 40.43 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.689 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 226' ' ' SER . 52.6 Cg_exo -50.19 -42.63 46.21 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.169 1.913 . . . . 0.0 112.863 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 225' ' ' PRO . 0.8 OUTLIER -169.94 59.77 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 227' ' ' ILE . 3.5 mp -130.49 73.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 50.62 84.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.155 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.3 p -107.76 125.63 31.76 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.06 -165.89 0.33 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 121.278 1.319 . . . . 0.0 111.832 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 6.7 tp -124.81 91.46 49.38 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 233' ' ' ASN . 31.6 Cg_exo -58.38 -173.63 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.222 1.948 . . . . 0.0 111.752 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 232' ' ' PRO . 4.3 t-20 79.37 162.21 0.19 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.082 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.544 HD11 HD13 ' A' ' 270' ' ' ILE . 25.4 tp -60.81 -8.71 3.25 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 234' ' ' LEU . 40.7 tt0 73.48 154.15 0.15 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -62.0 -39.99 94.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.913 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.594 ' HA2' ' C ' ' A' ' 238' ' ' PRO . . . -59.83 -178.61 1.62 Allowed Glycine 1 CA--C 1.427 -5.427 0 CA-C-O 122.631 1.128 . . . . 0.0 115.464 -178.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.594 ' C ' ' HA2' ' A' ' 237' ' ' GLY . 3.3 Cg_exo -52.44 127.83 1.01 Allowed 'Cis proline' 1 N--CA 1.538 4.095 0 O-C-N 124.766 1.929 . . . . 0.0 115.698 -1.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 170' ' ' TRP . 9.6 m-85 -155.24 -122.87 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.72 123.85 14.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 120.389 1.45 . . . . 0.0 109.165 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.502 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -108.53 141.75 39.96 Favored 'General case' 0 C--O 1.19 -2.043 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.247 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -104.57 96.99 6.97 Favored 'General case' 0 CA--C 1.496 -1.113 0 CA-C-O 121.616 0.722 . . . . 0.0 110.664 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.824 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.9 p -69.1 112.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.616 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.589 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.2 pt -105.78 17.79 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.194 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.465 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.9 mm-40 -176.79 119.84 0.13 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.085 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.805 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.5 ttmt -161.24 -145.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.982 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 253' ' ' ASP . 2.9 ptt85 -156.25 -141.42 0.09 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.821 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 248' ' ' VAL . 69.3 t -134.6 69.39 72.4 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.572 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 59.7 Cg_endo -98.46 177.93 0.39 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.381 2.721 . . . . 0.0 111.915 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.665 ' C ' ' H ' ' A' ' 252' ' ' TYR . 1.5 p-10 -157.25 151.73 25.24 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.896 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -41.5 -4.85 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.665 ' H ' ' C ' ' A' ' 250' ' ' ASN . 38.2 m-85 -95.19 -53.11 3.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.294 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 247' ' ' ARG . 17.9 t0 -45.61 -57.84 3.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.899 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.524 ' CE ' HH21 ' A' ' 247' ' ' ARG . 13.1 pttt -169.82 39.66 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.157 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 56.92 46.09 20.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.469 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.453 ' HA ' ' H ' ' A' ' 286' ' ' HIS . . . -121.45 119.57 32.44 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.774 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -51.02 159.62 0.57 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 123.083 0.553 . . . . 0.0 112.329 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.812 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -106.38 114.35 28.41 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.812 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.0 OUTLIER -139.59 -178.37 5.37 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.871 0.843 . . . . 0.0 111.607 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 8.0 tt0 -144.67 143.96 31.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.906 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.589 HG13 ' HA ' ' A' ' 244' ' ' ILE . 84.6 t -47.7 99.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.637 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.24 7.39 10.13 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 12.1 mm-40 -86.85 -39.08 16.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.567 0.699 . . . . 0.0 112.641 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.008 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER 66.49 139.45 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 122.18 0.99 . . . . 0.0 109.416 -178.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.008 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.6 p -136.71 155.33 33.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.946 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -100.64 96.31 7.26 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.312 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.813 ' O ' ' N ' ' A' ' 269' ' ' LYS . 34.2 t -50.49 -37.22 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.519 HG23 ' N ' ' A' ' 269' ' ' LYS . 15.1 t 39.58 -64.25 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 O-C-N 124.3 1.0 . . . . 0.0 112.019 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' A' ' 267' ' ' VAL . 7.8 tppt? -76.13 114.25 14.58 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.996 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -119.82 107.88 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.028 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.739 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.2 OUTLIER -114.83 -93.38 0.49 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.631 0.729 . . . . 0.0 110.505 179.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.739 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 26.8 mtm -55.22 134.84 49.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.143 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.459 ' HA ' ' CH2' ' A' ' 276' ' ' TRP . 5.7 p -63.16 14.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.788 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -144.37 -61.6 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.204 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 276' ' ' TRP . 1.1 mp0 -60.34 -86.44 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.607 0.717 . . . . 0.0 110.353 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.596 ' HA ' HD21 ' A' ' 271' ' ' ASN . 47.6 m95 95.95 144.23 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.565 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 11.6 mt-10 -99.2 107.65 20.04 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 121.375 0.607 . . . . 0.0 112.187 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 267' ' ' VAL . . . -67.66 -178.94 13.66 Favored Glycine 0 N--CA 1.434 -1.443 0 C-N-CA 118.734 -1.698 . . . . 0.0 113.465 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.507 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 4.1 tt0 -168.35 107.53 0.5 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.649 -0.776 . . . . 0.0 110.368 177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.698 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.5 OUTLIER -129.58 75.75 1.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.988 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 37.0 t30 85.17 29.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.998 0.428 . . . . 0.0 110.346 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 99.17 -30.01 10.7 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.484 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -68.4 77.29 0.27 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.575 ' CZ ' ' CE1' ' A' ' 142' ' ' PHE . 87.0 mtt180 -79.18 175.84 10.22 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.428 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 169.05 -147.88 11.64 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 107.142 -2.383 . . . . 0.0 107.142 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 8.2 p80 -141.8 175.37 9.76 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 118.279 1.039 . . . . 0.0 109.378 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.657 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.3 m-85 161.62 152.84 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 O-C-N 123.687 0.617 . . . . 0.0 111.534 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.598 ' HB2' HG23 ' A' ' 290' ' ' THR . 51.2 Cg_endo -72.75 148.52 46.73 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 123.096 2.531 . . . . 0.0 112.983 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 29.4 t80 -74.58 -2.15 24.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.158 0.504 . . . . 0.0 109.77 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.598 HG23 ' HB2' ' A' ' 288' ' ' PRO . 23.5 p -61.39 -8.33 3.9 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.049 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.517 ' CE1' ' CE ' ' A' ' 246' ' ' LYS . 7.0 p80 -136.79 53.9 1.89 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -152.9 150.58 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 294' ' ' LEU . 30.5 mmm-85 -131.91 77.1 1.74 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.667 0.27 . . . . 0.0 110.952 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 293' ' ' ARG . 45.1 mt -34.13 122.22 0.48 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 122.487 1.137 . . . . 0.0 112.187 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 297' ' ' GLN . 4.1 mp -61.01 -173.56 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 112.998 -1.91 . . . . 0.0 110.082 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 296' ' ' ASP . 26.7 p-10 -74.94 18.42 0.18 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.061 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.478 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 65.5 tt0 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.528 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 136' ' ' GLU . 35.3 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.64 ' O ' ' CG ' ' A' ' 137' ' ' TYR . 12.1 tp10 -160.2 166.6 29.35 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 136' ' ' GLU . 25.7 m-85 -173.32 135.93 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.29 0.369 . . . . 0.0 110.324 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.1 m -148.33 164.93 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.739 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -128.42 132.24 48.47 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.702 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -101.57 96.87 7.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.651 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.636 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -99.95 18.69 17.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.46 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.597 ' CE1' ' NH1' ' A' ' 284' ' ' ARG . 51.1 m-85 -115.69 5.01 14.16 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.5 p30 56.86 149.12 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.947 0 O-C-N 124.44 1.087 . . . . 0.0 109.903 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 10.3 t80 -140.79 -46.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.167 0.439 . . . . 0.0 110.761 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 42.12 63.55 1.33 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.228 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.514 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.45 -126.12 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.542 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.2 p30 165.2 -40.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.026 0.413 . . . . 0.0 112.111 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 20.0 m-20 -73.65 160.23 31.89 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.211 0.529 . . . . 0.0 111.217 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.3 -17.59 63.74 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.503 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 150' ' ' GLU . 55.2 mp0 -98.36 31.28 2.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 38.0 p30 -145.55 164.18 32.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.029 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.459 ' CB ' HG22 ' A' ' 183' ' ' ILE . 11.9 tp -122.01 84.5 45.09 Favored Pre-proline 0 C--O 1.213 -0.835 0 CA-C-O 120.39 0.138 . . . . 0.0 111.149 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.514 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 24.5 Cg_exo -59.98 140.15 91.35 Favored 'Trans proline' 0 C--N 1.284 -2.831 0 C-N-CA 122.442 2.094 . . . . 0.0 113.528 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.702 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 11.6 p90 -162.32 158.47 24.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.344 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.92 -54.02 0.65 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.447 0.641 . . . . 0.0 112.059 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 158' ' ' ASP . 15.4 mmtt -88.6 90.54 8.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.614 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 14.56 53.65 0.01 OUTLIER Glycine 0 C--N 1.343 0.971 0 O-C-N 124.115 0.884 . . . . 0.0 111.844 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 156' ' ' LYS . 34.5 t0 -66.12 139.59 58.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.404 0.621 . . . . 0.0 109.82 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.4 mp -86.41 100.06 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.35 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.404 HD11 ' CD2' ' A' ' 154' ' ' PHE . 4.8 mt -106.52 106.56 17.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.749 -177.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.61 141.4 48.36 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.606 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.5 mp -81.04 139.49 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.59 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -114.18 -47.62 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.532 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -140.95 113.81 8.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.151 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.442 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 29.6 pttt -112.37 75.16 1.65 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.324 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.81 -25.07 24.15 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.229 1.953 . . . . 0.0 112.122 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -118.79 166.83 12.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.635 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -95.87 -28.82 14.52 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.767 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.414 ' NE2' ' CE1' ' A' ' 240' ' ' TYR . 78.8 mt-30 -85.16 -19.65 31.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.548 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 65.7 m95 -131.17 154.61 48.2 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.552 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.7 m0 -144.67 135.32 24.65 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.272 0.558 . . . . 0.0 111.231 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.72 115.23 24.03 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -127.62 -178.5 4.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.746 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -125.89 137.77 53.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 177' ' ' ASP . 0.4 OUTLIER -85.1 135.36 34.02 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.222 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -45.74 -8.19 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.568 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.6 ' H ' ' C ' ' A' ' 175' ' ' ASP . 56.5 m-20 -78.03 -31.48 50.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 110.759 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.59 45.26 0.92 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.695 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -143.79 143.28 31.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.612 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.55 129.89 53.72 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.131 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.448 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -158.65 155.09 26.14 Favored Glycine 0 C--N 1.318 -0.448 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.534 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.03 152.56 44.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.982 0.42 . . . . 0.0 110.42 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.459 HG22 ' CB ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -141.17 142.24 26.52 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.53 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.406 ' HG2' ' CG ' ' A' ' 187' ' ' TYR . 20.5 Cg_endo -69.49 118.99 6.01 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.096 1.198 . . . . 0.0 109.048 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 24.1 t -53.96 -52.1 71.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 121.874 -0.516 . . . . 0.0 111.779 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 18.6 Cg_endo -53.02 -24.64 25.6 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.317 2.011 . . . . 0.0 113.618 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.529 ' OH ' ' O ' ' A' ' 268' ' ' THR . 5.5 m-85 -68.59 0.38 4.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.812 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.2 m -132.06 166.24 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.535 0.207 . . . . 0.0 110.476 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.636 ' CD ' HD21 ' A' ' 141' ' ' LEU . 1.9 pt-20 -130.29 58.6 1.67 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.846 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 190' ' ' LYS . 13.1 mptt 37.44 25.2 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' GLU . 18.4 t 39.66 78.44 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -64.14 150.14 92.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.479 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.4 -32.59 60.37 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.339 2.026 . . . . 0.0 112.116 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 36.6 m -157.66 85.22 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.352 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 70.6 m -56.77 -46.21 81.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.22 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 61.73 179.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.53 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 13.2 t -121.2 35.6 4.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 199' ' ' SER . 33.3 m -64.52 -41.24 91.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.541 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 198' ' ' VAL . 31.8 t -151.19 -179.89 7.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.364 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 41.2 p -94.32 102.4 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.298 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.4 tp -173.33 51.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.93 -38.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 205' ' ' ASN . . . 174.64 -87.43 0.08 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 69.48 -8.64 2.9 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 203' ' ' GLY . 34.3 m120 54.38 47.81 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.311 . . . . 0.0 110.508 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -50.0 116.8 1.98 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.303 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 209' ' ' SER . 97.4 m-20 -76.69 -86.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.439 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.3 t 43.38 -87.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.958 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 207' ' ' ASP . 29.7 t -126.15 121.17 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.179 0.514 . . . . 0.0 110.056 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.476 ' N ' ' HD2' ' A' ' 211' ' ' PRO . 0.2 OUTLIER 164.44 -57.54 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.669 -178.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 210' ' ' HIS . 47.4 Cg_endo -65.53 -165.03 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.823 1.682 . . . . 0.0 112.036 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 211' ' ' PRO . 0.0 OUTLIER -46.85 177.36 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.288 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.94 143.58 99.53 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.334 2.023 . . . . 0.0 111.85 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 215' ' ' GLY . 81.1 mt -89.66 -86.85 0.18 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 214' ' ' LEU . . . -55.45 -156.8 0.01 OUTLIER Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.601 ' H ' ' CD ' ' A' ' 217' ' ' PRO . . . -107.37 -45.98 1.11 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.601 ' CD ' ' H ' ' A' ' 216' ' ' GLY . 31.4 Cg_exo -57.93 138.96 88.64 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.542 2.161 . . . . 0.0 111.963 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -155.14 78.35 4.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.879 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.35 144.04 84.11 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.709 2.272 . . . . 0.0 112.205 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 46.98 -117.05 2.81 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.483 ' O ' ' CD1' ' A' ' 222' ' ' TYR . 59.7 Cg_endo -74.28 -61.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.466 1.633 . . . . 0.0 112.456 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.483 ' CD1' ' O ' ' A' ' 221' ' ' PRO . 68.7 m-85 -153.63 168.44 26.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.432 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.57 97.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.15 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 226' ' ' SER . 0.2 OUTLIER -137.02 123.93 13.88 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.557 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 226' ' ' SER . 36.5 Cg_exo -59.23 40.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.201 0 C-N-CA 122.423 2.082 . . . . 0.0 112.266 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 228' ' ' ASN . 1.8 m 160.89 130.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 227' ' ' ILE . 9.7 tp -60.87 74.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.193 0.52 . . . . 0.0 110.175 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.551 HD22 ' C ' ' A' ' 228' ' ' ASN . 0.2 OUTLIER -178.12 168.45 1.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.088 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 230' ' ' PRO . 2.1 p -111.54 90.8 13.0 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.437 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 231' ' ' LEU . 50.5 Cg_exo -42.86 -103.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.105 1.87 . . . . 0.0 113.177 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.613 HD12 ' CD1' ' A' ' 276' ' ' TRP . 71.6 mt -51.62 137.13 33.23 Favored Pre-proline 0 N--CA 1.447 -0.611 0 O-C-N 122.263 -0.273 . . . . 0.0 111.152 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.48 -93.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.94 1.76 . . . . 0.0 111.94 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.45 ' CG ' ' H ' ' A' ' 234' ' ' LEU . 54.2 t30 -126.58 -169.17 1.98 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.213 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.45 ' H ' ' CG ' ' A' ' 233' ' ' ASN . 31.9 tp -40.06 100.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.31 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.582 ' C ' ' H ' ' A' ' 237' ' ' GLY . 12.8 mm100 -53.16 159.8 1.2 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.924 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 70.2 m-20 -54.36 -2.41 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.593 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 235' ' ' GLN . . . -94.04 -167.91 37.54 Favored Glycine 1 CA--C 1.445 -4.3 0 CA-C-O 121.773 0.652 . . . . 0.0 113.965 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.4 Cg_endo -47.55 98.32 0.03 OUTLIER 'Cis proline' 0 N--CA 1.532 3.752 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 0.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.609 ' CZ ' ' NE2' ' A' ' 297' ' ' GLN . 4.0 m-30 -117.06 -130.7 0.31 Allowed 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.414 ' CE1' ' NE2' ' A' ' 169' ' ' GLN . 2.3 m-30 -137.11 119.51 15.81 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.765 0.793 . . . . 0.0 109.169 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 264' ' ' LEU . . . -111.75 142.35 44.2 Favored 'General case' 0 C--O 1.188 -2.159 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.047 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 292' ' ' VAL . 15.6 tpp180 -103.96 110.44 22.59 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.873 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.5 p -82.58 74.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 123.702 0.626 . . . . 0.0 111.936 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.825 ' HA ' ' O ' ' A' ' 261' ' ' VAL . 1.4 pt -60.81 24.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.617 ' H ' ' C ' ' A' ' 243' ' ' VAL . 1.6 mm-40 173.46 130.88 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.492 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.864 ' HD2' HD12 ' A' ' 259' ' ' LEU . 0.6 OUTLIER -165.68 -144.81 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.444 176.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 4.3 ptt85 -156.91 -140.34 0.08 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.381 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 248' ' ' VAL . 76.7 t -138.3 68.59 47.35 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.69 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 55.7 Cg_endo -96.07 179.65 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.422 2.748 . . . . 0.0 111.75 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.751 ' C ' ' H ' ' A' ' 252' ' ' TYR . 10.7 p-10 -148.66 145.64 27.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.362 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -44.88 4.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.751 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.0 m-85 -98.82 -55.4 2.73 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.952 0.901 . . . . 0.0 110.58 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -44.6 -67.41 0.29 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.846 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.523 ' O ' ' CE1' ' A' ' 286' ' ' HIS . 27.1 mtmt -149.11 36.05 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.453 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 60.45 38.63 19.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' A' ' 287' ' ' PHE . . . -109.0 170.55 7.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.901 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.755 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -112.32 152.64 28.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.122 0.569 . . . . 0.0 110.807 -178.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.744 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -97.89 119.35 36.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.464 0.649 . . . . 0.0 111.684 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 246' ' ' LYS . 0.4 OUTLIER -144.78 -163.03 1.61 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.52 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.672 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -132.58 -176.98 4.28 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 244' ' ' ILE . 2.3 t -61.11 -34.35 59.86 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.666 0 CA-C-O 121.575 0.703 . . . . 0.0 112.379 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.574 ' H ' ' HG2' ' A' ' 260' ' ' GLU . . . -128.41 38.46 2.06 Favored Glycine 0 C--N 1.277 -2.701 0 O-C-N 120.539 -1.351 . . . . 0.0 111.581 -176.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 260' ' ' GLU . 13.0 mm-40 -86.29 -35.68 19.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.279 0.561 . . . . 0.0 111.389 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.992 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 64.27 139.1 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.061 -178.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.992 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.4 p -128.51 150.74 34.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.473 -1.239 . . . . 0.0 108.375 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -100.92 86.92 3.16 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.989 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 40.9 t -50.97 153.09 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.482 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.529 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.5 OUTLIER -153.33 -53.46 0.11 Allowed 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.125 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 142' ' ' PHE . 1.9 tpmt? -67.6 146.16 54.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.279 0.562 . . . . 0.0 111.298 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.589 HG23 ' CZ3' ' A' ' 276' ' ' TRP . 3.0 mt -126.48 162.65 30.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.62 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.843 HD21 ' HA ' ' A' ' 276' ' ' TRP . 0.1 OUTLIER 171.74 -101.89 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.639 ' SD ' ' ND2' ' A' ' 271' ' ' ASN . 0.0 OUTLIER -73.66 163.04 28.52 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.551 ' HA ' ' HE1' ' A' ' 276' ' ' TRP . 2.1 p -98.74 29.79 3.59 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.427 ' C ' ' NE2' ' A' ' 275' ' ' GLN . . . -139.65 -39.72 0.09 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.531 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.455 ' OE1' ' OE1' ' A' ' 224' ' ' GLN . 1.0 OUTLIER -96.05 -79.72 0.44 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.218 0.532 . . . . 0.0 111.182 -179.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.843 ' HA ' HD21 ' A' ' 271' ' ' ASN . 17.0 m95 77.6 166.49 0.23 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.194 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 90.3 mt-10 -132.27 148.51 52.45 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -129.09 -141.81 5.19 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.597 -0.811 . . . . 0.0 115.094 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.413 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 1.3 tt0 -173.03 129.79 0.48 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.522 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.71 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.4 OUTLIER -144.32 75.21 1.45 Allowed 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.825 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 280' ' ' CYS . 13.8 t-20 84.69 27.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.434 0.635 . . . . 0.0 110.001 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 95.78 -32.05 6.68 Favored Glycine 0 N--CA 1.459 0.198 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.49 72.6 0.08 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 -178.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.597 ' NH1' ' CE1' ' A' ' 142' ' ' PHE . 77.2 mtt180 -71.49 168.91 16.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.249 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 277' ' ' GLU . . . 170.57 -159.1 31.24 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.632 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 0.0 OUTLIER -135.76 176.15 8.94 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.872 0.469 . . . . 0.0 110.069 179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.632 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 2.8 m-85 170.54 154.89 0.2 Allowed Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 123.944 0.778 . . . . 0.0 111.158 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.631 ' HB2' HG23 ' A' ' 290' ' ' THR . 56.2 Cg_endo -74.83 155.59 43.74 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.022 2.481 . . . . 0.0 112.071 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 292' ' ' VAL . 64.0 t80 -74.77 0.48 15.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.554 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.631 HG23 ' HB2' ' A' ' 288' ' ' PRO . 41.4 p -62.68 0.46 0.5 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.507 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.42 62.38 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.611 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 242' ' ' ARG . 0.0 OUTLIER -158.05 143.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -127.66 81.15 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 19.4 mt -40.68 131.24 2.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.857 0.837 . . . . 0.0 111.334 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.43 -171.61 3.56 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.272 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -101.2 33.73 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.609 ' NE2' ' CZ ' ' A' ' 239' ' ' PHE . 56.0 tt0 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.432 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 178.04 -174.2 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 O-C-N 124.113 0.883 . . . . 0.0 110.436 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.031 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -128.6 -89.34 0.52 Allowed 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.168 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 1.031 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.8 m 90.36 168.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 O-C-N 124.241 0.963 . . . . 0.0 111.922 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.4 ptt85 -140.63 156.34 46.29 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 155' ' ' LYS . . . -56.73 168.62 0.58 Allowed 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.67 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -136.02 -36.56 0.74 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.643 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.549 ' CE2' ' CZ ' ' A' ' 284' ' ' ARG . 92.5 m-85 -130.51 6.6 4.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.567 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER 78.02 136.71 0.06 Allowed 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 5.8 t80 -108.27 -49.26 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 110.879 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.461 ' OD1' ' NZ ' ' A' ' 155' ' ' LYS . 4.0 m120 41.28 66.92 0.6 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 153' ' ' PRO . . . -63.26 -122.61 0.01 OUTLIER Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 146' ' ' GLY . 1.7 p30 168.21 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.576 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.594 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 9.0 m-20 -80.66 154.01 27.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.73 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.0 -16.83 64.62 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.036 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.15 24.74 4.15 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.594 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 7.5 p30 -144.82 162.44 36.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.038 178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 182' ' ' MET . 13.4 tp -112.31 89.71 12.82 Favored Pre-proline 0 C--O 1.215 -0.737 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 59.6 Cg_endo -69.17 127.18 14.68 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 121.692 1.595 . . . . 0.0 112.859 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CG ' HD11 ' A' ' 160' ' ' LEU . 16.7 p90 -147.75 166.94 25.97 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.588 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 143' ' ' ASP . 1.4 tptp -106.65 -141.11 0.37 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 158' ' ' ASP . 24.7 pttm -91.24 174.13 7.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 36.29 20.14 0.01 OUTLIER Glycine 0 CA--C 1.526 0.724 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.042 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 156' ' ' LYS . 14.5 t0 -79.27 132.66 36.55 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.26 111.88 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.095 0.474 . . . . 0.0 110.858 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.44 HD11 ' CG ' ' A' ' 154' ' ' PHE . 7.9 mt -120.57 128.63 53.24 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.6 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 7.8 ttpm? -83.27 135.17 34.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.558 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' ' O ' ' A' ' 172' ' ' ASN . 1.7 mp -66.3 -51.53 57.68 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.485 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.601 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 54.2 ttt85 65.94 -49.44 0.41 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.713 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 162' ' ' ILE . 68.2 t0 -149.96 128.43 12.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.115 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.528 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 3.5 ptmm? -121.44 81.74 39.05 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.866 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 -44.01 53.74 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.61 2.207 . . . . 0.0 112.372 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -119.37 176.93 5.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.438 ' O ' HG21 ' A' ' 185' ' ' VAL . 3.5 mm-40 -93.36 -41.82 9.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.01 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.484 ' NE2' ' CE2' ' A' ' 240' ' ' TYR . 86.4 mt-30 -72.44 -32.75 66.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.366 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.4 m95 -119.92 153.75 35.43 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.647 ' CD2' HG22 ' A' ' 185' ' ' VAL . 14.0 m0 -143.64 135.69 26.67 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 120.992 0.425 . . . . 0.0 110.739 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.694 ' O ' ' O ' ' A' ' 162' ' ' ILE . 46.4 t30 -86.59 107.78 18.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -115.68 -179.09 3.55 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.546 0.529 . . . . 0.0 110.379 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 179' ' ' LYS . 74.0 tt0 -126.13 136.09 52.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.514 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.91 171.39 3.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.651 0.739 . . . . 0.0 110.636 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 1.28 23.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.608 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -105.46 -28.94 10.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 118.16 50.48 0.34 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 174' ' ' GLU . 36.2 mttt -134.24 138.76 45.29 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.35 -0.925 . . . . 0.0 111.212 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.601 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.1 OUTLIER -108.92 122.12 46.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.569 0.7 . . . . 0.0 111.76 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.87 153.0 24.41 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.771 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -68.08 162.06 25.45 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.187 0.517 . . . . 0.0 110.409 -179.121 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.789 ' O ' HD13 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -157.62 152.16 20.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.954 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.04 113.44 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 121.199 1.266 . . . . 0.0 110.554 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.647 HG22 ' CD2' ' A' ' 171' ' ' TRP . 42.4 t -50.48 -50.96 68.7 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.953 -0.467 . . . . 0.0 111.275 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 6.0 Cg_endo -45.87 -34.66 12.65 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.933 1.755 . . . . 0.0 112.84 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 268' ' ' THR . 7.2 m-85 -63.81 -8.23 10.17 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.975 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.987 HG21 HG21 ' A' ' 138' ' ' VAL . 1.3 m -135.22 166.2 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.812 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 190' ' ' LYS . 0.6 OUTLIER -150.43 -51.18 0.13 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.644 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.746 ' O ' HG12 ' A' ' 138' ' ' VAL . 13.9 mmtp -26.9 136.12 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.639 0.587 . . . . 0.0 111.485 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.458 ' O ' HG12 ' A' ' 138' ' ' VAL . 42.7 t 55.48 102.06 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.066 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.508 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 0.0 OUTLIER 177.38 -48.3 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.255 -179.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 71.2 Cg_endo -84.07 67.51 6.87 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.405 2.07 . . . . 0.0 111.763 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.9 m 63.86 47.6 3.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.446 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.5 t 61.69 136.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.622 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -169.65 46.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.593 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 78.0 p -61.81 -35.1 77.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.515 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 198' ' ' VAL . 4.3 m -98.01 75.59 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.5 t -170.64 21.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.669 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.8 t -55.62 147.7 17.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.326 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 201' ' ' LEU . 10.1 mp -65.65 -75.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.661 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 6.7 p 55.33 55.85 7.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -154.71 -65.51 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -135.81 30.25 2.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -79.57 66.58 5.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.373 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -163.87 101.16 0.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.591 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -151.21 70.02 0.97 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.474 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 70.8 m -61.73 -97.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.606 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 41.1 t -157.87 151.83 24.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.56 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -166.27 71.77 1.18 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.42 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.41 144.73 99.52 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.735 2.29 . . . . 0.0 111.975 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.632 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 2.5 tt0 -81.97 -41.07 0.99 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.17 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 26.8 Cg_exo -60.4 148.56 90.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.628 2.219 . . . . 0.0 111.971 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.47 112.4 4.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.164 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -75.9 140.56 26.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.452 ' N ' ' CD ' ' A' ' 217' ' ' PRO . . . 156.07 -52.63 0.43 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 216' ' ' GLY . 31.5 Cg_exo -57.08 140.2 92.02 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.727 2.284 . . . . 0.0 111.85 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.01 147.7 70.47 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.339 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.71 115.3 0.33 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.275 1.983 . . . . 0.0 112.472 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -118.96 56.31 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.4 -153.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.847 2.364 . . . . 0.0 111.89 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 224' ' ' GLN . 97.6 m-85 -57.3 149.84 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -41.18 89.65 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 222' ' ' TYR . 53.9 mt-30 -148.39 147.8 26.74 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.371 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 226' ' ' SER . 50.5 Cg_endo -71.34 23.22 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.559 2.173 . . . . 0.0 111.435 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 224' ' ' GLN . 0.7 OUTLIER 78.93 28.45 0.4 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.28 -179.485 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.9 tt -84.75 -5.57 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.542 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.522 ' ND2' ' CD ' ' A' ' 224' ' ' GLN . 0.0 OUTLIER -144.35 46.56 1.41 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.037 0.446 . . . . 0.0 110.003 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 17.4 p -57.45 152.17 34.95 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.55 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.498 ' HB2' ' HE1' ' A' ' 276' ' ' TRP . 65.1 Cg_exo -37.05 -82.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 122.552 2.168 . . . . 0.0 112.651 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.55 ' O ' ' CH2' ' A' ' 276' ' ' TRP . 0.2 OUTLIER -131.04 92.87 32.23 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 233' ' ' ASN . 51.6 Cg_exo -53.81 74.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.452 2.101 . . . . 0.0 112.265 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 231' ' ' LEU . 65.6 m-80 48.73 179.85 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.444 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 236' ' ' ASN . 31.4 tp -53.22 -106.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.211 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 61.66 -67.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 234' ' ' LEU . 97.3 m-20 -68.04 -110.81 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.696 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.49 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -55.83 -168.97 0.07 OUTLIER Glycine 1 CA--C 1.439 -4.698 0 CA-C-O 122.314 0.952 . . . . 0.0 114.096 -179.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.45 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.7 Cg_exo -47.61 110.82 0.08 OUTLIER 'Cis proline' 1 N--CA 1.544 4.45 0 O-C-N 123.917 1.482 . . . . 0.0 115.253 0.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.631 ' CE1' ' NE2' ' A' ' 297' ' ' GLN . 9.0 m-30 -126.7 -136.45 0.25 Allowed 'General case' 0 C--O 1.212 -0.887 0 O-C-N 124.242 0.964 . . . . 0.0 109.128 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.484 ' CE2' ' NE2' ' A' ' 169' ' ' GLN . 2.7 m-30 -134.86 114.58 12.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.903 0.859 . . . . 0.0 109.754 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -107.41 140.79 39.8 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.695 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 263' ' ' GLU . 10.7 tpp85 -104.32 100.77 10.49 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.396 -0.815 . . . . 0.0 109.792 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 243' ' ' VAL . 4.9 p -71.92 121.74 22.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.178 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.997 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.2 OUTLIER -121.62 20.67 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.624 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -172.9 108.33 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.418 0.628 . . . . 0.0 109.695 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 259' ' ' LEU . 1.9 ttmt -154.49 -140.63 0.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.53 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -158.21 -142.12 0.09 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 248' ' ' VAL . 66.0 t -134.47 70.49 72.4 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.761 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.513 ' HG2' ' O ' ' A' ' 257' ' ' LEU . 44.8 Cg_endo -90.16 168.91 4.34 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.954 2.436 . . . . 0.0 111.475 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.734 ' C ' ' H ' ' A' ' 252' ' ' TYR . 0.6 OUTLIER -131.57 130.2 41.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.831 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.33 -4.87 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.832 0.708 . . . . 0.0 111.994 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.734 ' H ' ' C ' ' A' ' 250' ' ' ASN . 45.4 m-85 -93.39 -54.67 3.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.848 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 250' ' ' ASN . 41.9 t0 -41.35 -62.57 0.83 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.553 -177.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 256' ' ' ALA . 22.6 mtmt -151.34 26.29 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.999 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 284' ' ' ARG . 1.2 m 75.21 -21.48 0.3 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.628 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 254' ' ' LYS . . . -42.24 107.44 0.08 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.224 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.96 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -44.92 157.77 0.07 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.363 178.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.809 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -108.23 121.42 44.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.752 0.658 . . . . 0.0 110.723 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.4 mt -140.42 -173.95 3.82 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.928 0.394 . . . . 0.0 111.243 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 16.2 tt0 -144.95 152.28 39.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.955 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.85 106.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.621 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 119.94 8.72 8.64 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 46.7 mm-40 -96.8 -135.93 0.24 Allowed 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.1 OUTLIER 172.1 136.8 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.999 ' N ' HD12 ' A' ' 264' ' ' LEU . 14.8 p -127.09 153.76 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.014 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 265' ' ' VAL . 1.8 ttmm -105.48 95.15 5.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 268' ' ' THR . 18.2 t -63.03 161.46 2.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.058 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 187' ' ' TYR . 0.2 OUTLIER -152.66 -62.38 0.16 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.657 -178.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -71.69 132.14 44.15 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.425 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.745 ' H ' HD13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -148.05 145.39 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.375 -179.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.655 ' C ' HD22 ' A' ' 271' ' ' ASN . 0.1 OUTLIER 174.49 -136.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.876 179.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.597 ' CE ' HD21 ' A' ' 271' ' ' ASN . 47.6 mtm 54.51 -122.47 1.96 Allowed 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.259 0.552 . . . . 0.0 111.163 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.4 p -143.96 -16.63 0.6 Allowed 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.035 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.525 ' O ' ' NE1' ' A' ' 276' ' ' TRP . . . -168.13 -15.14 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 118.94 -1.6 . . . . 0.0 112.232 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.589 ' C ' ' CG ' ' A' ' 276' ' ' TRP . 4.0 mp0 -97.06 159.58 14.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.632 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.589 ' CG ' ' C ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -167.57 161.02 13.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.556 -178.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 286' ' ' HIS . 8.7 mt-10 -93.84 -168.04 1.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.255 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -151.29 179.36 28.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.507 ' OE1' ' NH2' ' A' ' 284' ' ' ARG . 5.2 tt0 -168.8 113.82 0.59 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.118 0.485 . . . . 0.0 110.686 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.628 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -109.45 -99.85 0.39 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -91.64 48.68 1.48 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.33 -29.62 6.51 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' CG ' ' SG ' ' A' ' 280' ' ' CYS . 0.2 OUTLIER -66.7 92.5 0.22 Allowed 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.303 -177.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.549 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 78.3 mtt180 -87.11 172.35 10.01 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.159 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 166.04 -152.44 21.63 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.564 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 11.3 p80 -126.23 166.87 16.29 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.15 0.5 . . . . 0.0 109.783 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.564 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.7 OUTLIER 164.75 110.72 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.798 177.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.561 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 36.3 Cg_exo -54.91 141.37 78.08 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.978 1.786 . . . . 0.0 112.598 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.656 ' CD2' HG23 ' A' ' 292' ' ' VAL . 0.5 OUTLIER -61.24 -1.43 0.49 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 288' ' ' PRO . 39.9 p -46.9 -7.39 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.092 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 289' ' ' PHE . 0.9 OUTLIER -150.27 80.2 1.35 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.016 -178.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.656 HG23 ' CD2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -168.92 151.71 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.567 ' HG2' HD12 ' A' ' 244' ' ' ILE . 0.2 OUTLIER -123.45 74.31 1.24 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.64 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 293' ' ' ARG . 68.2 mt -36.49 131.64 0.65 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.1 mp -78.85 -171.97 2.82 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -91.8 17.14 9.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.45 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.631 ' NE2' ' CE1' ' A' ' 239' ' ' PHE . 62.4 tt0 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.307 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.483 ' C ' ' CD1' ' A' ' 137' ' ' TYR . 42.4 tp10 -164.94 152.41 11.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.973 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.7 OUTLIER -142.47 -68.22 0.37 Allowed 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.268 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.973 HG22 ' O ' ' A' ' 137' ' ' TYR . 1.2 m 81.75 162.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 O-C-N 125.183 1.552 . . . . 0.0 111.928 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.447 ' HE ' ' HA ' ' A' ' 191' ' ' CYS . 9.8 ptp180 -132.31 142.33 49.31 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.598 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . . . -99.83 102.94 14.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.626 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.631 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -101.4 20.56 15.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.717 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' CE2' ' CD1' ' A' ' 141' ' ' LEU . 51.9 m-85 -121.14 1.92 10.34 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.884 -0.144 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.504 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER 60.56 139.13 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.797 0 O-C-N 123.999 0.812 . . . . 0.0 109.968 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 154' ' ' PHE . 13.1 t80 -128.86 -50.57 1.23 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.569 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 144' ' ' PHE . 47.5 t30 37.36 58.07 1.29 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.517 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 147' ' ' ASN . . . -65.77 -150.3 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.609 HD22 ' N ' ' A' ' 148' ' ' ASP . 0.1 OUTLIER 165.6 -15.05 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.855 -0.672 . . . . 0.0 111.207 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.609 ' N ' HD22 ' A' ' 147' ' ' ASN . 63.2 m-20 -49.66 -166.71 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' A' ' 148' ' ' ASP . 98.9 m-20 -16.44 -68.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.311 0.382 . . . . 0.0 110.949 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 151' ' ' ASP . 17.3 pt-20 -171.07 40.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.027 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 150' ' ' GLU . 1.4 m-20 -53.74 -157.56 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.076 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.491 ' O ' ' CD2' ' A' ' 154' ' ' PHE . 13.5 tp -123.92 84.4 54.58 Favored Pre-proline 0 C--O 1.217 -0.622 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.688 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.401 ' HA ' ' H ' ' A' ' 146' ' ' GLY . 56.1 Cg_endo -68.17 121.25 8.23 Favored 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 121.669 1.58 . . . . 0.0 112.438 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CE1' ' CB ' ' A' ' 140' ' ' ALA . 7.7 p90 -140.2 -177.59 5.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 5.8 mttp 179.69 121.84 0.06 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 118.576 -0.725 . . . . 0.0 109.128 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER 105.93 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 124.635 1.209 . . . . 0.0 110.96 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 19.86 52.48 0.01 OUTLIER Glycine 0 N--CA 1.472 1.038 0 O-C-N 123.564 0.54 . . . . 0.0 111.919 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 156' ' ' LYS . 8.1 t70 -74.46 142.26 44.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.083 0.468 . . . . 0.0 110.329 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.05 96.44 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.56 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 mt -102.34 103.67 14.13 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.805 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 88.1 tttt -53.21 132.91 39.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.737 -177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 172' ' ' ASN . 40.1 mm -71.3 -55.15 14.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.965 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.113 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.699 HH12 HH11 ' A' ' 180' ' ' ARG . 32.1 ttm180 78.56 -52.03 0.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.551 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 165' ' ' LYS . 50.0 p-10 -120.3 -120.34 0.3 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.21 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.503 ' H ' ' CG ' ' A' ' 164' ' ' ASP . 2.7 pttp 141.87 62.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 124.438 1.086 . . . . 0.0 109.963 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.25 -65.97 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.567 2.178 . . . . 0.0 112.697 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 96.7 mt-10 -108.33 168.85 9.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.548 ' O ' HG21 ' A' ' 185' ' ' VAL . 2.7 pt-20 -82.13 -37.95 25.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.652 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -79.73 -23.46 42.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.264 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.526 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 77.8 m95 -126.88 152.47 47.01 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.723 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.8 m0 -147.16 138.5 23.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.001 0.429 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.682 ' O ' ' O ' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -90.23 121.63 32.42 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.11 -178.14 4.42 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 123.66 0.6 . . . . 0.0 110.002 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.495 ' CD ' ' NH2' ' A' ' 163' ' ' ARG . 49.1 tt0 -124.62 130.02 51.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.287 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.487 ' HB2' HD11 ' A' ' 152' ' ' LEU . 9.2 t70 -56.29 177.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.397 0.618 . . . . 0.0 110.879 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -80.04 -4.95 54.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.383 177.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -104.91 -27.64 11.58 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.78 48.46 0.33 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.2 mttt -129.29 129.04 44.39 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.856 -0.672 . . . . 0.0 111.376 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.699 HH11 HH12 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -97.65 121.19 39.26 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.79 0.805 . . . . 0.0 111.467 -178.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -152.76 149.43 21.05 Favored Glycine 0 N--CA 1.471 0.984 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.217 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.52 153.46 41.39 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.122 0.487 . . . . 0.0 110.09 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.94 143.56 28.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.472 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.4 ' HB3' ' CG ' ' A' ' 238' ' ' PRO . 37.1 Cg_endo -74.58 114.57 4.06 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.437 1.424 . . . . 0.0 109.978 175.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.723 HG22 ' CE3' ' A' ' 171' ' ' TRP . 54.2 t -52.15 -48.86 87.51 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.079 -0.388 . . . . 0.0 110.941 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 12.2 Cg_endo -50.49 -27.73 19.63 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.912 1.742 . . . . 0.0 113.314 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.528 ' OH ' ' O ' ' A' ' 268' ' ' THR . 7.8 m-85 -72.24 -5.54 36.62 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.509 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 185' ' ' VAL . 21.1 m -128.1 168.14 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.259 0.349 . . . . 0.0 110.759 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.631 ' CD ' HD21 ' A' ' 141' ' ' LEU . 2.5 pt-20 -134.59 67.53 1.5 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.517 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER 21.61 49.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.922 0.764 . . . . 0.0 111.327 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.475 ' N ' ' O ' ' A' ' 189' ' ' GLU . 29.4 t 41.45 69.04 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.022 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -76.35 129.42 80.1 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.649 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -46.99 137.95 16.25 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.211 1.94 . . . . 0.0 112.394 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.3 p -159.79 -98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.404 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.3 p 56.41 52.03 10.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.588 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 53.56 72.63 0.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 198' ' ' VAL . 80.9 p -149.98 -99.77 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.566 HG13 ' N ' ' A' ' 199' ' ' SER . 7.9 p -60.96 -46.78 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.544 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.566 ' N ' HG13 ' A' ' 198' ' ' VAL . 5.2 p -91.38 139.38 30.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.501 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 201' ' ' LEU . 60.4 p -66.38 131.35 45.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.271 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 200' ' ' THR . 2.9 tp 55.37 164.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.402 ' H ' ' HG ' ' A' ' 201' ' ' LEU . 72.2 p -76.31 171.63 14.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.81 82.16 0.02 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -58.92 133.93 52.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -157.83 179.01 9.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.313 . . . . 0.0 110.338 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -99.45 160.37 14.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 207' ' ' ASP . 35.7 p-10 -67.59 115.76 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.458 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 56.0 m -153.65 -124.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.362 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.2 t -133.19 -34.29 1.09 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.427 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 53.43 64.34 7.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.307 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.08 -179.05 4.3 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.708 2.272 . . . . 0.0 111.818 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -139.62 72.81 36.04 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -61.33 143.32 97.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.915 2.41 . . . . 0.0 112.011 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 215' ' ' GLY . 2.5 tt -164.2 111.12 1.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.294 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.523 ' N ' HD23 ' A' ' 214' ' ' LEU . . . -168.82 -63.44 0.03 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.458 ' H ' ' HD3' ' A' ' 217' ' ' PRO . . . 111.11 73.75 0.72 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.458 ' HD3' ' H ' ' A' ' 216' ' ' GLY . 24.9 Cg_exo -61.57 147.35 95.61 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.954 2.436 . . . . 0.0 111.803 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.462 ' H ' ' HD2' ' A' ' 219' ' ' PRO . 5.0 mt-10 -155.65 -64.14 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.656 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.462 ' HD2' ' H ' ' A' ' 218' ' ' GLU . 30.8 Cg_endo -61.39 143.13 97.51 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.066 1.844 . . . . 0.0 111.963 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.96 -145.79 0.45 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -80.97 -177.49 3.76 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.39 2.06 . . . . 0.0 111.885 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -59.76 137.61 58.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.326 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.48 94.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.318 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.432 ' NE2' HG21 ' A' ' 229' ' ' THR . 12.1 mt-30 -144.06 155.73 58.53 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.432 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.16 -0.54 4.23 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.731 2.287 . . . . 0.0 111.8 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 228' ' ' ASN . 49.6 m -108.86 -6.51 15.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.826 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 39.0 mm 53.14 -87.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.524 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 226' ' ' SER . 87.0 m-20 -76.94 81.87 3.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.07 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.432 HG21 ' NE2' ' A' ' 224' ' ' GLN . 2.9 p -69.87 150.78 96.43 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.791 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -37.62 -80.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 122.849 2.366 . . . . 0.0 112.491 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 37.0 tp -128.71 94.2 35.5 Favored Pre-proline 0 C--O 1.232 0.137 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -79.18 169.01 19.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.364 2.043 . . . . 0.0 111.872 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 74.92 145.7 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.427 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.548 HD21 ' O ' ' A' ' 237' ' ' GLY . 5.2 tp -54.88 128.11 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.877 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.531 ' N ' ' OE1' ' A' ' 235' ' ' GLN . 0.9 OUTLIER -70.51 39.95 0.05 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.467 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.601 ' O ' ' CD1' ' A' ' 239' ' ' PHE . 83.4 m-20 56.29 4.86 0.15 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.17 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.548 ' O ' HD21 ' A' ' 234' ' ' LEU . . . -103.61 -169.48 25.55 Favored Glycine 1 CA--C 1.435 -4.908 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.98 -179.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.424 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 5.4 Cg_exo -48.12 101.54 0.03 OUTLIER 'Cis proline' 0 N--CA 1.533 3.851 0 O-C-N 123.442 1.233 . . . . 0.0 114.799 0.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 236' ' ' ASN . 2.3 m-30 -120.66 -135.94 0.32 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 295' ' ' LEU . 1.8 m-30 -138.79 118.97 13.52 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.584 0.707 . . . . 0.0 109.592 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.874 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -98.4 -162.86 0.99 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -157.43 86.94 0.95 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.654 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 264' ' ' LEU . 8.2 p -63.21 112.57 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.598 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.575 HD13 ' HE ' ' A' ' 293' ' ' ARG . 1.1 pt -103.83 16.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.533 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.2 mm-40 -176.2 124.51 0.19 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.202 0.525 . . . . 0.0 111.131 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.5 ttmt -165.08 -157.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.217 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 1.6 ptt85 -145.82 -134.22 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.466 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.439 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 4.6 t -139.38 60.44 16.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.962 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.72 ' O ' ' O ' ' A' ' 250' ' ' ASN . 95.9 Cg_endo -94.68 44.04 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.812 2.341 . . . . 0.0 113.322 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.726 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.3 p-10 -21.23 153.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 O-C-N 124.014 0.821 . . . . 0.0 111.465 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.2 -5.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.688 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.828 ' O ' ' N ' ' A' ' 254' ' ' LYS . 31.9 m-85 -79.28 -64.52 1.17 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 35.2 t70 -45.98 63.42 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 125.142 1.526 . . . . 0.0 110.319 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.828 ' N ' ' O ' ' A' ' 252' ' ' TYR . 33.7 mtmt 81.34 -48.47 0.25 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.618 1.199 . . . . 0.0 110.364 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.1 OUTLIER 159.65 -25.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.849 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.668 ' O ' ' O ' ' A' ' 249' ' ' PRO . . . -41.34 108.56 0.09 Allowed 'General case' 0 C--O 1.216 -0.664 0 CA-C-O 120.951 0.405 . . . . 0.0 111.48 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.846 HD23 ' H ' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -43.07 159.98 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.431 0 O-C-N 122.11 -0.369 . . . . 0.0 110.963 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.814 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -112.17 122.51 47.94 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.814 HD23 ' O ' ' A' ' 258' ' ' ALA . 0.8 OUTLIER -140.68 -174.07 3.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.086 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.435 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 9.1 tt0 -145.84 145.33 30.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.159 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 245' ' ' GLN . 66.4 t -46.82 100.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.39 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 115.01 11.84 10.6 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 56.3 mm-40 -88.3 -36.32 16.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.281 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.082 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 135.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.614 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.082 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.3 p -133.45 159.37 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.39 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.565 ' N ' HG22 ' A' ' 265' ' ' VAL . 6.1 ttmt -103.33 94.9 5.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.927 ' O ' ' N ' ' A' ' 269' ' ' LYS . 2.6 t -46.03 -42.4 4.41 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.527 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.651 HG23 ' N ' ' A' ' 269' ' ' LYS . 7.9 t 35.16 -60.07 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.927 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER -73.77 110.49 8.1 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.9 mt -136.6 101.97 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.598 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.935 HD22 ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -93.05 -31.64 14.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 179.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.935 ' H ' HD22 ' A' ' 271' ' ' ASN . 29.1 mtm -131.28 172.49 12.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.999 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 1.9 p -91.22 5.62 48.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.479 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.489 ' O ' ' CD1' ' A' ' 276' ' ' TRP . . . -124.33 -90.69 0.89 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.791 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.48 69.2 10.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 0.0 110.722 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.547 ' HA ' HD21 ' A' ' 271' ' ' ASN . 0.4 OUTLIER -77.78 178.48 7.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.623 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 285' ' ' GLY . 3.4 mt-10 -104.19 -167.41 1.36 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 267' ' ' VAL . . . -157.76 -171.39 23.67 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 2.0 tt0 -170.44 109.54 0.36 Allowed 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.765 0.317 . . . . 0.0 111.516 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.67 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -100.84 -101.69 0.25 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -90.6 47.64 1.45 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.14 -28.31 9.0 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.41 ' HG3' ' SG ' ' A' ' 280' ' ' CYS . 0.0 OUTLIER -66.86 91.55 0.2 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.122 -178.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.469 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 84.5 mtt180 -85.54 173.31 10.29 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.099 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 257' ' ' LEU . . . 161.79 -151.12 21.15 Favored Glycine 0 C--O 1.215 -1.052 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.543 ' H ' ' HA ' ' A' ' 256' ' ' ALA . 14.3 p-80 -130.4 169.3 15.67 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.453 0.644 . . . . 0.0 110.474 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 0.5 OUTLIER 169.66 116.04 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.547 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.733 ' HB2' HG23 ' A' ' 290' ' ' THR . 22.6 Cg_endo -62.72 162.48 24.83 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.106 1.87 . . . . 0.0 112.912 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.654 ' CD1' HG23 ' A' ' 292' ' ' VAL . 82.8 t80 -65.48 1.92 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.682 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 288' ' ' PRO . 71.7 p -51.2 -2.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.536 ' O ' HG13 ' A' ' 292' ' ' VAL . 1.7 p80 -172.29 85.98 0.07 Allowed 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.391 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.654 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -174.27 148.29 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.575 ' HE ' HD13 ' A' ' 244' ' ' ILE . 24.3 mmt180 -130.15 81.96 2.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.935 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 36.9 mt -43.69 133.96 4.44 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 121.381 0.61 . . . . 0.0 111.066 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.0 mp -88.11 -169.95 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -100.55 14.97 29.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.582 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.468 ' CD ' ' CZ ' ' A' ' 239' ' ' PHE . 34.2 tt0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.365 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -139.87 162.24 35.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.923 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 p90 175.03 144.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.88 167.19 16.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -119.72 126.23 50.57 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.073 0.464 . . . . 0.0 110.038 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.735 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -92.0 89.28 6.91 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.97 -178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' CD1' ' CE2' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -100.38 31.47 3.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.385 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 143' ' ' ASP . 50.4 m-85 -132.56 2.98 3.84 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.392 -0.193 . . . . 0.0 110.811 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.562 ' O ' ' O ' ' A' ' 142' ' ' PHE . 4.3 p30 52.7 137.63 0.0 OUTLIER 'General case' 0 C--O 1.208 -1.109 0 O-C-N 124.924 1.39 . . . . 0.0 110.11 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . 6.3 t80 -122.76 -42.77 2.29 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.735 0.302 . . . . 0.0 110.636 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 42.77 59.14 2.92 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.512 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.491 ' C ' ' ND2' ' A' ' 147' ' ' ASN . . . -65.43 -145.36 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.3 p30 168.39 82.89 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.931 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.506 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 5.2 m-20 174.94 179.06 0.13 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 110.349 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -87.94 -21.07 25.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.203 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -103.48 26.12 8.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 56.4 p30 -141.18 158.75 43.48 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 152' ' ' LEU . 10.5 tp -118.51 89.45 36.76 Favored Pre-proline 0 C--O 1.215 -0.748 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.14 139.93 52.2 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 CA-C-N 120.314 1.148 . . . . 0.0 112.542 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.735 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 16.0 p90 -158.79 161.72 36.98 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.576 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.519 ' HZ2' ' HB3' ' A' ' 155' ' ' LYS . 0.4 OUTLIER 176.84 125.68 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.507 0.504 . . . . 0.0 110.101 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 11.3 ptpt 136.0 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.521 1.138 . . . . 0.0 109.796 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.76 51.17 0.38 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -83.86 158.7 21.55 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.134 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.6 mm -109.14 112.88 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.381 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -112.94 126.0 55.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.821 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 162' ' ' ILE . 62.4 tttm -81.01 143.75 32.28 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 111.145 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.7 mp -94.98 156.28 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.588 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.518 HH21 ' CD ' ' A' ' 174' ' ' GLU . 21.5 ttm105 -135.8 -33.65 0.85 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.473 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.77 128.56 11.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 13.1 pttm -121.67 79.26 39.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.118 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.21 -42.2 69.35 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.181 1.921 . . . . 0.0 111.989 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -117.37 178.17 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.493 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.58 -29.73 13.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.006 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.59 ' NE2' ' CD1' ' A' ' 240' ' ' TYR . 78.9 mt-30 -80.8 -27.34 36.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.864 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.466 ' NE1' ' HE1' ' A' ' 239' ' ' PHE . 71.7 m95 -123.3 151.96 41.88 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.516 ' CD2' HG22 ' A' ' 185' ' ' VAL . 13.5 m0 -143.22 135.65 27.3 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-O 120.84 0.352 . . . . 0.0 110.748 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.52 108.34 12.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.8 163.09 13.22 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.81 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 16.0 tt0 -122.77 128.36 50.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.196 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.09 177.76 0.76 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.68 0.752 . . . . 0.0 110.228 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 98.1 mmm -74.82 -2.25 25.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.609 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -99.41 -20.67 16.35 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.464 0.649 . . . . 0.0 110.843 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.82 -28.52 6.39 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 179' ' ' LYS . 41.3 mttt -53.01 146.05 11.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.073 0.463 . . . . 0.0 110.532 -177.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.14 132.54 56.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.658 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -155.51 151.61 23.16 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.222 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 84.1 mmm -67.34 159.25 29.72 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.318 0.58 . . . . 0.0 110.387 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 6.7 pt -151.26 142.7 15.53 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.952 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.53 115.62 4.28 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.447 1.431 . . . . 0.0 110.015 176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 36.3 t -50.24 -52.94 49.45 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 19.7 Cg_endo -51.58 -25.99 21.24 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 122.383 2.055 . . . . 0.0 113.291 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' A' ' 268' ' ' THR . 6.6 m-85 -69.89 0.92 5.02 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.413 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.1 m -132.39 161.68 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -93.98 -62.42 1.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.729 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 17.3 tptm 132.81 -5.22 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.81 1.319 . . . . 0.0 109.757 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 190' ' ' LYS . 36.7 t 57.71 110.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.466 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 18.1 ttm180 69.94 51.22 0.4 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.394 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 69.8 Cg_endo -71.44 49.95 1.2 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.906 2.404 . . . . 0.0 111.927 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m 69.38 -46.92 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 196' ' ' ALA . 39.5 p -167.93 165.56 13.71 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 195' ' ' SER . . . 69.28 73.05 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.023 0.44 . . . . 0.0 111.256 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.4 p -161.46 7.86 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 199' ' ' SER . 14.5 p -62.63 -42.71 97.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.352 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.519 ' N ' HG13 ' A' ' 198' ' ' VAL . 26.8 p -151.3 148.67 28.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.481 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.6 t -162.34 170.47 18.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.737 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.733 ' C ' HD22 ' A' ' 201' ' ' LEU . 0.0 OUTLIER -170.27 166.13 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.6 p -142.94 155.1 44.64 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -130.42 88.83 0.3 Allowed Glycine 0 N--CA 1.467 0.753 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 167.8 133.75 1.6 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -97.17 176.16 6.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.339 . . . . 0.0 110.565 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.649 ' NE2' ' H ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -77.63 -172.99 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.489 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.461 ' OD1' ' CG2' ' A' ' 270' ' ' ILE . 99.4 m-20 -60.71 92.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.362 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.5 p -165.66 -13.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.563 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 31.0 t -105.6 118.16 35.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.602 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -139.11 75.35 34.8 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.161 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 -30.21 53.13 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.921 2.414 . . . . 0.0 111.92 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.608 ' H ' ' CD ' ' A' ' 213' ' ' PRO . 1.8 tm0? -173.15 -43.16 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.249 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.608 ' CD ' ' H ' ' A' ' 212' ' ' GLN . 32.9 Cg_exo -60.9 145.62 98.78 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.345 2.03 . . . . 0.0 112.155 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.43 ' O ' ' OD1' ' A' ' 228' ' ' ASN . 2.0 pp -144.02 141.39 30.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.58 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -44.59 -52.33 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.6 57.91 4.78 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.3 -39.73 9.55 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.514 2.143 . . . . 0.0 112.342 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.8 OUTLIER -101.61 -45.97 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.269 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 32.3 Cg_exo -55.25 -63.06 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.281 1.987 . . . . 0.0 112.117 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 40.94 71.75 0.29 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.561 ' CG ' HD22 ' A' ' 228' ' ' ASN . 73.0 Cg_endo -76.32 -90.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.2 1.933 . . . . 0.0 111.984 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -144.79 151.53 38.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.32 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.62 95.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.473 ' NE2' ' CG1' ' A' ' 227' ' ' ILE . 21.2 mt-30 -122.57 138.97 30.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.464 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.446 ' C ' HG22 ' A' ' 229' ' ' THR . 61.3 Cg_endo -71.93 12.5 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.041 1.828 . . . . 0.0 112.147 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.16 -73.63 0.59 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.936 0.398 . . . . 0.0 111.754 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.473 ' CG1' ' NE2' ' A' ' 224' ' ' GLN . 28.7 mm -56.19 -55.39 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.856 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.561 HD22 ' CG ' ' A' ' 221' ' ' PRO . 70.3 m-80 -136.89 84.2 2.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.399 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.446 HG22 ' C ' ' A' ' 225' ' ' PRO . 1.9 p -67.84 151.66 97.0 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.879 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.21 135.7 48.13 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.289 1.993 . . . . 0.0 112.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 231' ' ' LEU . 1.2 pt? -132.16 148.08 68.37 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.057 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.26 9.12 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.139 1.892 . . . . 0.0 111.712 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' LEU . 27.9 m120 51.75 56.79 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.901 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 236' ' ' ASN . 29.8 tp -58.89 -115.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.018 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.437 ' N ' ' HG ' ' A' ' 234' ' ' LEU . 67.8 mt-30 61.03 -62.69 0.08 Allowed 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 123.493 0.495 . . . . 0.0 110.783 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.568 ' N ' ' O ' ' A' ' 234' ' ' LEU . 36.7 p-10 -58.49 -40.2 82.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.331 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.579 ' HA2' ' CD1' ' A' ' 239' ' ' PHE . . . -89.23 -165.55 41.24 Favored Glycine 1 CA--C 1.436 -4.85 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.749 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.419 ' C ' ' CA ' ' A' ' 237' ' ' GLY . 2.7 Cg_endo -45.05 100.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.536 3.994 0 N-CA-C 116.843 1.824 . . . . 0.0 116.843 1.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.579 ' CD1' ' HA2' ' A' ' 237' ' ' GLY . 8.4 m-30 -114.55 -130.66 0.31 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD1' ' NE2' ' A' ' 169' ' ' GLN . 0.7 OUTLIER -142.29 127.6 18.75 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 119.67 1.123 . . . . 0.0 109.227 -178.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.788 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -104.51 -165.09 1.11 Allowed 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.222 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -156.48 94.77 1.51 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.72 HG12 ' H ' ' A' ' 264' ' ' LEU . 7.6 p -73.71 116.9 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.0 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.753 HD13 ' H ' ' A' ' 244' ' ' ILE . 0.0 OUTLIER -110.21 18.03 7.18 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.993 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 244' ' ' ILE . 2.3 mm-40 -174.38 121.06 0.26 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.778 ' CD ' HD12 ' A' ' 259' ' ' LEU . 0.8 OUTLIER -168.55 -156.47 0.17 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.551 178.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.661 HH21 ' NZ ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -154.57 -134.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.634 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.421 ' O ' ' OD2' ' A' ' 253' ' ' ASP . 3.4 t -137.84 62.89 36.39 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.607 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.71 ' O ' ' O ' ' A' ' 250' ' ' ASN . 11.6 Cg_endo -98.62 31.04 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.959 1.773 . . . . 0.0 114.417 -177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.71 ' O ' ' O ' ' A' ' 249' ' ' PRO . 13.5 p30 -24.93 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.463 1.102 . . . . 0.0 112.588 -177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -56.26 -22.32 29.15 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.442 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.405 ' C ' ' OD1' ' A' ' 250' ' ' ASN . 32.9 m-85 -111.34 47.71 0.99 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 249' ' ' PRO . 1.2 m-20 -151.42 15.98 0.7 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.661 ' NZ ' HH21 ' A' ' 247' ' ' ARG . 28.1 mtmt 147.22 -65.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 254' ' ' LYS . 41.7 m 166.77 -16.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 O-C-N 124.199 0.937 . . . . 0.0 110.428 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ASN . . . -82.02 170.24 15.79 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.294 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.005 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.5 OUTLIER -87.26 151.18 23.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.68 0.392 . . . . 0.0 110.623 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.854 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -96.45 121.71 38.57 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.124 0.42 . . . . 0.0 111.118 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.854 HD23 ' O ' ' A' ' 258' ' ' ALA . 1.5 mt -142.33 -171.78 3.47 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.646 0.736 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.453 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 12.1 tt0 -144.79 148.44 34.07 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.272 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.57 HG13 ' HA ' ' A' ' 244' ' ' ILE . 81.1 t -53.11 100.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.509 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 117.62 9.71 9.94 Favored Glycine 0 CA--C 1.51 -0.233 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 260' ' ' GLU . 12.5 mm-40 -86.99 -36.23 18.38 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.066 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.08 136.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.116 0.96 . . . . 0.0 109.12 -178.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.066 ' N ' HD12 ' A' ' 264' ' ' LEU . 12.5 p -131.63 150.67 34.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -107.33 91.94 3.86 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.67 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.682 HG22 ' HA2' ' A' ' 278' ' ' GLY . 55.6 t -62.34 159.63 2.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.846 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.491 ' O ' ' OH ' ' A' ' 187' ' ' TYR . 0.4 OUTLIER -157.76 -44.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.415 ' HE3' ' H ' ' A' ' 270' ' ' ILE . 0.1 OUTLIER -62.63 142.84 57.86 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.225 -177.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.461 ' CG2' ' OD1' ' A' ' 207' ' ' ASP . 74.0 mt -132.34 156.08 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.618 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.66 ' ND2' ' H ' ' A' ' 272' ' ' MET . 0.1 OUTLIER 172.32 -91.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.801 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.66 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 3.9 mtm -69.03 135.72 51.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.137 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.3 p -74.71 20.49 0.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 272' ' ' MET . . . -148.03 -50.46 0.02 OUTLIER Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.151 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.56 ' O ' ' HE3' ' A' ' 272' ' ' MET . 1.0 OUTLIER -105.33 98.34 8.06 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.572 ' HE1' ' HB3' ' A' ' 231' ' ' LEU . 1.6 m95 -101.49 173.74 6.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -115.83 127.25 54.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.023 0.439 . . . . 0.0 110.614 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' A' ' 267' ' ' VAL . . . -79.58 -164.37 28.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.256 -177.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.469 ' HG3' ' HE ' ' A' ' 284' ' ' ARG . 3.3 tt0 -172.7 112.26 0.25 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.848 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.731 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.1 OUTLIER -107.96 -98.08 0.37 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -93.07 40.34 1.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.17 -21.46 42.1 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.628 ' O ' ' HB3' ' A' ' 257' ' ' LEU . 0.0 OUTLIER -68.63 75.26 0.28 Allowed 'General case' 0 C--O 1.209 -1.036 0 CA-C-N 114.576 -0.812 . . . . 0.0 110.369 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.469 ' HE ' ' HG3' ' A' ' 279' ' ' GLU . 89.9 mtt180 -74.54 166.12 24.06 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.256 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.795 ' O ' ' CD2' ' A' ' 257' ' ' LEU . . . 157.74 129.23 1.09 Allowed Glycine 0 C--O 1.198 -2.14 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.519 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -59.02 174.99 0.32 Allowed 'General case' 0 C--N 1.292 -1.931 0 O-C-N 117.963 -3.081 . . . . 0.0 110.329 -175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.557 ' CZ ' ' NH1' ' A' ' 247' ' ' ARG . 0.1 OUTLIER -179.66 115.95 0.22 Allowed Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.114 -178.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.534 ' O ' ' CE1' ' A' ' 291' ' ' HIS . 85.0 Cg_exo -44.33 130.38 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 CA-C-N 120.055 1.055 . . . . 0.0 112.783 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.631 ' C ' ' H ' ' A' ' 291' ' ' HIS . 0.0 OUTLIER -62.6 -3.3 1.41 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.903 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 82.4 p -52.02 4.47 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.73 ' O ' HG13 ' A' ' 292' ' ' VAL . 5.7 p80 -156.5 74.71 0.83 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 291' ' ' HIS . 1.3 m -166.58 150.96 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -108.82 -44.39 4.03 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 3.0 mt 74.31 118.41 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.503 1.144 . . . . 0.0 111.578 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 8.9 mp -88.46 -175.42 4.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.855 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -70.33 -52.35 23.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.441 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.403 ' OXT' ' OE1' ' A' ' 169' ' ' GLN . 55.5 tt0 . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.706 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.569 ' N ' ' HH ' ' A' ' 137' ' ' TYR . 15.8 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.947 ' O ' HG13 ' A' ' 138' ' ' VAL . 18.2 pt-20 -151.59 -31.43 0.16 Allowed 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.066 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.569 ' HH ' ' N ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -42.66 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.947 HG13 ' O ' ' A' ' 136' ' ' GLU . 31.5 m 42.9 -179.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 124.06 0.85 . . . . 0.0 110.303 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -133.08 121.72 23.07 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.736 ' HB1' ' CE1' ' A' ' 154' ' ' PHE . . . -95.3 100.01 11.86 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.057 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.611 HD21 ' CD ' ' A' ' 189' ' ' GLU . 0.3 OUTLIER -111.29 32.29 5.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.921 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 143' ' ' ASP . 43.7 m-85 -127.63 2.9 6.14 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.88 -0.145 . . . . 0.0 110.72 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 142' ' ' PHE . 1.1 p30 58.88 138.03 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 124.464 1.102 . . . . 0.0 109.811 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 154' ' ' PHE . 7.6 t80 -130.11 -49.78 1.11 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.04 0.382 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 40.13 65.78 0.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.77 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.43 -138.55 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.639 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 1.3 p30 172.86 101.08 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.323 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.608 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 9.8 m-20 151.1 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.363 1.039 . . . . 0.0 110.697 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.42 -15.81 26.71 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -105.36 24.8 11.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.855 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.639 ' OD2' ' N ' ' A' ' 147' ' ' ASN . 7.9 p-10 -137.48 152.64 49.75 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.553 HD11 ' CG ' ' A' ' 175' ' ' ASP . 11.3 tp -116.33 87.89 21.54 Favored Pre-proline 0 C--O 1.214 -0.792 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.542 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.98 122.76 9.65 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.347 1.364 . . . . 0.0 112.201 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.736 ' CE1' ' HB1' ' A' ' 140' ' ' ALA . 14.5 p90 -139.21 169.27 18.08 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -171.04 122.01 0.56 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.553 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 1.1 mtpp 98.64 74.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.675 1.234 . . . . 0.0 111.589 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' LYS . . . 30.82 55.26 0.26 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.068 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 159' ' ' ILE . 31.2 t0 -73.58 150.52 41.38 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 120.9 0.381 . . . . 0.0 110.708 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.444 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.6 mp -102.51 108.76 24.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 mt -121.71 106.22 11.12 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.235 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -61.31 133.51 55.94 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.802 0.689 . . . . 0.0 112.785 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -78.64 132.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.717 178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.63 ' NE ' ' NH2' ' A' ' 180' ' ' ARG . 12.8 tpt180 -106.38 -48.17 3.62 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.529 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -147.18 121.28 9.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.437 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.455 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 10.6 ptmt -112.7 75.2 1.8 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.817 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.84 -35.74 11.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.981 1.788 . . . . 0.0 112.122 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -103.66 168.7 8.97 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.149 0.5 . . . . 0.0 110.607 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -93.71 -38.38 11.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.867 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.37 -22.29 32.83 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.514 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 69.6 m95 -120.8 151.67 39.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.709 ' CE3' HG22 ' A' ' 185' ' ' VAL . 12.4 m0 -145.43 135.98 24.25 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.085 0.469 . . . . 0.0 110.738 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -80.12 107.97 13.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.34 164.95 11.46 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.978 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 178' ' ' GLY . 14.4 tt0 -127.34 136.96 52.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.609 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.553 ' CG ' HD11 ' A' ' 152' ' ' LEU . 46.4 m-20 -71.68 -175.28 1.32 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.492 0.663 . . . . 0.0 110.461 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 87.2 mmm -76.28 -15.45 60.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.955 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.52 -22.27 22.51 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.275 0.56 . . . . 0.0 111.011 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 174' ' ' GLU . . . 119.67 -19.98 9.55 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -52.73 143.61 15.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.63 ' NH2' ' NE ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -115.85 124.76 51.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.503 0.668 . . . . 0.0 111.225 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.18 145.54 14.65 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.705 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mtp -64.59 160.19 20.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.566 0.698 . . . . 0.0 110.458 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 171' ' ' TRP . 5.1 pt -151.75 144.32 16.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.881 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.71 110.01 2.98 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.025 1.15 . . . . 0.0 110.657 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.709 HG22 ' CE3' ' A' ' 171' ' ' TRP . 55.6 t -44.22 -52.69 15.67 Favored Pre-proline 0 C--O 1.218 -0.604 0 O-C-N 121.882 -0.511 . . . . 0.0 111.821 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 10.9 Cg_endo -48.39 -24.54 6.27 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.887 1.724 . . . . 0.0 113.509 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.29 5.52 4.45 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.311 -0.555 . . . . 0.0 112.004 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 185' ' ' VAL . 2.4 m -133.64 162.79 38.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.419 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.611 ' CD ' HD21 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -121.74 -67.18 0.98 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.044 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.591 ' O ' HG12 ' A' ' 138' ' ' VAL . 21.9 tptm -37.81 93.2 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.507 ' HB2' HG12 ' A' ' 138' ' ' VAL . 0.1 OUTLIER 160.56 105.26 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.204 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 40.87 59.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.842 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 195' ' ' SER . 25.9 Cg_endo -60.54 -32.38 93.47 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.504 2.136 . . . . 0.0 111.968 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.0 t 56.38 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.667 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 193' ' ' PRO . 84.1 p -81.83 -136.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -150.32 142.79 24.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 66.4 m -123.29 113.0 18.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.419 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 199' ' ' SER . 3.0 m -139.26 -109.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.242 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.458 ' H ' HG23 ' A' ' 198' ' ' VAL . 1.4 m 57.85 -170.05 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.3 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 58.4 m -142.97 128.62 19.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.602 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.919 ' H ' HD23 ' A' ' 201' ' ' LEU . 1.4 pt? -131.44 142.57 50.03 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 54.0 m -99.21 140.77 32.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.758 0.313 . . . . 0.0 110.182 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -69.42 -124.07 0.04 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.35 129.83 1.06 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -88.79 118.15 28.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 275' ' ' GLN . 25.9 pt20 -56.62 159.6 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.519 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 208' ' ' SER . 38.8 t70 -154.08 168.69 25.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.498 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 207' ' ' ASP . 9.1 t 59.33 135.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.564 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.8 t -161.43 -6.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.535 ' O ' ' ND1' ' A' ' 210' ' ' HIS . 17.7 t-80 -147.22 52.98 1.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.521 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 40.2 Cg_endo -66.55 -44.78 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.7 2.267 . . . . 0.0 111.847 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.521 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 12.0 pt20 -175.04 49.02 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.462 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 33.0 Cg_endo -63.24 144.13 91.04 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.593 2.196 . . . . 0.0 111.865 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 214' ' ' LEU . 3.8 mm? 43.26 -166.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.736 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -78.91 -132.89 0.82 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -63.95 165.85 29.22 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.55 -21.26 30.08 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.941 2.427 . . . . 0.0 111.882 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.446 ' CB ' ' CD ' ' A' ' 219' ' ' PRO . 0.4 OUTLIER -50.85 -63.79 1.7 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.164 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 218' ' ' GLU . 33.6 Cg_endo -61.52 143.92 97.51 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.317 2.011 . . . . 0.0 112.039 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -179.75 172.39 44.08 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.68 -80.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.729 2.286 . . . . 0.0 112.032 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -100.28 143.14 30.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -60.08 98.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.382 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -137.98 152.9 72.98 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.636 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.73 -9.73 22.09 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.519 2.146 . . . . 0.0 111.466 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 54.8 m -146.03 160.79 41.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 227' ' ' ILE . 1.4 mp -87.15 90.66 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.068 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 227' ' ' ILE . 12.8 m120 34.72 69.2 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.44 ' H ' HG23 ' A' ' 229' ' ' THR . 0.2 OUTLIER -57.78 175.09 0.29 Allowed Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 -177.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.8 163.75 37.14 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.902 1.734 . . . . 0.0 111.51 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.761 ' C ' HD22 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -71.77 158.97 86.78 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.369 -179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 233' ' ' ASN . 72.9 Cg_endo -85.03 85.12 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.92 1.747 . . . . 0.0 112.319 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 234' ' ' LEU . 9.0 t30 45.98 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 117.863 0.301 . . . . 0.0 110.68 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.702 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 15.3 tp -36.28 -98.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.059 0.456 . . . . 0.0 110.38 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 297' ' ' GLN . 65.1 mm-40 55.46 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.791 178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 234' ' ' LEU . 19.0 m120 -76.21 32.73 0.12 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.814 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 235' ' ' GLN . . . -168.05 160.74 34.4 Favored Glycine 1 CA--C 1.448 -4.15 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.405 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.418 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 9.0 Cg_exo -72.48 131.94 24.1 Favored 'Cis proline' 0 C--N 1.285 -2.766 0 O-C-N 122.257 0.609 . . . . 0.0 110.931 -6.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 240' ' ' TYR . 37.4 m-85 -159.74 -123.17 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -145.2 121.74 11.07 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.337 0.517 . . . . 0.0 111.103 -178.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.857 ' O ' HD13 ' A' ' 264' ' ' LEU . . . -101.55 -158.49 0.67 Allowed 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.592 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -159.47 94.95 1.2 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.74 HG12 ' H ' ' A' ' 264' ' ' LEU . 9.8 p -73.61 110.66 7.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.431 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.502 ' HA ' HG13 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -108.72 22.69 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.731 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 177.81 110.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.819 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.7 ttmt -153.62 -145.94 0.18 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.404 0.621 . . . . 0.0 110.284 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.474 ' H ' ' CG ' ' A' ' 246' ' ' LYS . 6.0 ptt85 -155.41 -144.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.621 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 248' ' ' VAL . 8.7 p -131.96 66.38 77.55 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.485 0.66 . . . . 0.0 110.186 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.527 ' HD2' ' HA ' ' A' ' 258' ' ' ALA . 60.1 Cg_endo -83.38 157.72 14.68 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.81 2.34 . . . . 0.0 113.574 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -90.9 -172.44 3.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.286 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -103.68 -3.63 24.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.661 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 254' ' ' LYS . 25.5 m-85 -89.05 -27.67 20.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 254' ' ' LYS . 32.9 t70 -70.03 43.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.198 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.752 ' O ' HG23 ' A' ' 255' ' ' THR . 38.5 mtmt 99.04 -45.55 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 C-N-CA 124.424 1.09 . . . . 0.0 108.945 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 254' ' ' LYS . 0.9 OUTLIER 149.18 5.99 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.907 0 O-C-N 125.132 1.52 . . . . 0.0 110.364 179.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 249' ' ' PRO . . . -35.71 115.87 0.34 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.206 0.527 . . . . 0.0 111.774 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 257' ' ' LEU . 0.7 OUTLIER -68.68 117.64 10.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.858 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -71.23 125.29 26.55 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.323 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 258' ' ' ALA . 2.6 mt -142.14 -175.67 4.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.712 0.768 . . . . 0.0 111.238 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.41 ' H ' ' HG3' ' A' ' 263' ' ' GLU . 10.2 tt0 -145.61 138.94 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.33 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.502 HG13 ' HA ' ' A' ' 244' ' ' ILE . 53.1 t -44.01 105.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.147 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 111.54 7.13 24.57 Favored Glycine 0 CA--C 1.507 -0.455 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.362 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 264' ' ' LEU . 43.8 mm-40 -83.7 -37.34 22.85 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 1.073 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.2 OUTLIER 62.5 135.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 1.073 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.7 p -131.14 152.51 37.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.302 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 279' ' ' GLU . 0.9 OUTLIER -103.86 108.67 20.09 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.377 -179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' A' ' 276' ' ' TRP . 97.9 t -72.43 157.05 6.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.501 HG22 ' C ' ' A' ' 267' ' ' VAL . 0.0 OUTLIER 177.83 43.82 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.346 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.703 ' C ' HD12 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -157.51 98.74 1.7 Allowed 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 120.827 -1.171 . . . . 0.0 109.15 178.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.703 HD12 ' C ' ' A' ' 269' ' ' LYS . 1.6 mp -113.33 133.31 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.38 0.61 . . . . 0.0 111.233 -177.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.78 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -112.81 -29.62 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.98 178.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.706 ' H ' HD22 ' A' ' 271' ' ' ASN . 0.0 OUTLIER -134.54 -164.4 1.51 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.536 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 2.5 p -109.66 19.33 19.31 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.181 -0.325 . . . . 0.0 110.705 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.502 ' N ' ' SD ' ' A' ' 272' ' ' MET . . . -130.81 -100.3 0.85 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.704 ' N ' ' SD ' ' A' ' 272' ' ' MET . 50.6 mm-40 -76.24 105.29 7.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.138 0.494 . . . . 0.0 111.987 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.802 ' CE3' HG11 ' A' ' 267' ' ' VAL . 0.4 OUTLIER -98.05 178.45 5.1 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.623 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.477 ' OE2' ' OD1' ' A' ' 271' ' ' ASN . 24.8 mp0 -95.39 -152.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.751 -178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 277' ' ' GLU . . . -161.32 -177.88 34.79 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 266' ' ' LYS . 2.4 tm-20 -169.75 117.06 0.58 Allowed 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 117.226 0.513 . . . . 0.0 110.768 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 259' ' ' LEU . 0.0 OUTLIER -107.08 -56.56 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.357 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -136.92 38.22 2.58 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 284' ' ' ARG . . . 93.28 -21.31 41.1 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.942 ' O ' ' O ' ' A' ' 284' ' ' ARG . 0.0 OUTLIER -57.54 -6.73 0.51 Allowed 'General case' 0 CA--C 1.485 -1.531 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.386 -176.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.942 ' O ' ' O ' ' A' ' 283' ' ' LYS . 13.9 mtt85 15.86 -177.21 0.0 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 O-C-N 126.023 2.077 . . . . 0.0 113.104 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 255' ' ' THR . . . 150.02 -145.38 13.42 Favored Glycine 0 C--N 1.287 -2.182 0 O-C-N 120.652 -1.28 . . . . 0.0 110.549 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 287' ' ' PHE . 10.2 p80 -145.37 177.86 8.52 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 114.351 -0.924 . . . . 0.0 109.206 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.619 ' CD2' ' O ' ' A' ' 286' ' ' HIS . 1.4 m-85 159.06 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.631 0 O-C-N 123.877 0.736 . . . . 0.0 109.143 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 290' ' ' THR . 50.0 Cg_exo -51.54 153.96 9.74 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.93 1.753 . . . . 0.0 113.214 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 289' ' ' PHE . 46.9 t80 -65.13 2.86 0.69 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.633 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.457 ' H ' ' C ' ' A' ' 288' ' ' PRO . 32.3 p -51.77 -38.31 54.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.51 72.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -163.58 144.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -123.55 75.5 1.34 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.065 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 8.3 mt -43.61 125.95 4.27 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.575 0.702 . . . . 0.0 111.01 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 240' ' ' TYR . 7.9 mp -71.15 -173.29 0.82 Allowed 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.015 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -83.18 39.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.843 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.502 ' NE2' ' CE2' ' A' ' 239' ' ' PHE . 82.2 mt-30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.195 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -157.73 -173.54 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.027 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 1.034 ' O ' HG22 ' A' ' 138' ' ' VAL . 5.8 p90 -132.7 -73.09 0.51 Allowed 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.828 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 1.034 HG22 ' O ' ' A' ' 137' ' ' TYR . 2.8 m 93.78 152.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 125.686 1.866 . . . . 0.0 111.984 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.416 ' NH1' HD23 ' A' ' 141' ' ' LEU . 15.9 ttp85 -120.81 133.21 55.32 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.331 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . . . -94.08 93.71 7.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.007 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.65 ' H ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.35 20.03 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.034 -178.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.454 ' O ' ' OD2' ' A' ' 143' ' ' ASP . 47.6 m-85 -115.93 -9.36 11.8 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.481 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER 72.3 136.32 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.048 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.436 ' CB ' ' CE1' ' A' ' 154' ' ' PHE . 9.1 t80 -128.83 -43.22 1.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.854 0.359 . . . . 0.0 110.125 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 146' ' ' GLY . 21.9 t-20 41.62 62.49 1.54 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 145' ' ' ASN . . . -62.57 -122.43 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 1.0 OUTLIER 169.56 -65.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.879 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.525 ' N ' ' OD2' ' A' ' 151' ' ' ASP . 18.2 m-20 -53.81 142.65 23.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.079 0.466 . . . . 0.0 110.783 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 149' ' ' ASP . 31.2 p-10 -61.47 -1.2 0.5 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 148' ' ' ASP . 47.5 mt-10 -105.68 13.76 29.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.269 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 148' ' ' ASP . 20.5 p30 -130.78 163.26 27.71 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.645 HD13 ' N ' ' A' ' 181' ' ' GLY . 3.8 tp -104.35 91.71 4.17 Favored Pre-proline 0 C--O 1.211 -0.966 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.303 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.467 ' O ' ' OD2' ' A' ' 175' ' ' ASP . 72.7 Cg_endo -70.49 139.13 37.03 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 CA-C-N 120.825 1.33 . . . . 0.0 112.804 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.685 ' CD2' HD11 ' A' ' 160' ' ' LEU . 12.5 p90 -167.42 157.05 10.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 157' ' ' GLY . 0.7 OUTLIER -174.35 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.436 0.636 . . . . 0.0 111.349 179.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -61.02 -3.28 0.75 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.265 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 155' ' ' LYS . . . 92.85 56.94 1.45 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.471 ' C ' HD12 ' A' ' 159' ' ' ILE . 27.0 t0 -81.74 157.85 24.39 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.502 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 159' ' ' ILE . 1.6 mp -98.63 98.12 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.685 HD11 ' CD2' ' A' ' 154' ' ' PHE . 96.3 mt -91.83 94.13 9.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.128 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 52.8 tttp -68.87 132.44 46.74 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.518 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.22 142.81 15.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -124.27 -48.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.64 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -153.24 64.05 0.76 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.641 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.403 ' CB ' ' CD1' ' A' ' 171' ' ' TRP . 11.8 pttp -49.54 106.48 0.63 Allowed Pre-proline 0 CA--C 1.545 0.759 0 CA-C-O 119.402 -0.332 . . . . 0.0 110.787 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.79 -48.13 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.443 1.428 . . . . 0.0 112.438 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.02 172.75 6.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.775 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 168' ' ' GLU . 5.0 pt-20 -85.51 -34.47 21.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.914 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -84.4 -15.57 45.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.468 ' CE3' ' C ' ' A' ' 183' ' ' ILE . 48.1 m95 -131.46 151.53 51.48 Favored 'General case' 0 C--O 1.228 -0.074 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.589 ' CD2' HG22 ' A' ' 185' ' ' VAL . 12.9 m0 -139.78 134.44 31.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.907 0.86 . . . . 0.0 112.496 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -91.55 101.03 13.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.578 0.704 . . . . 0.0 109.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.27 -179.26 3.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.51 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.88 112.72 13.83 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.642 ' H ' HD11 ' A' ' 152' ' ' LEU . 0.4 OUTLIER -63.81 140.58 58.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.951 -179.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 95.2 mtp -47.85 -8.14 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 123.426 0.454 . . . . 0.0 110.591 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 175' ' ' ASP . 96.6 m-20 -72.98 -21.78 60.79 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.667 0.746 . . . . 0.0 110.048 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.49 44.06 3.54 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.631 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.478 ' O ' HD11 ' A' ' 152' ' ' LEU . 11.4 ptpt -142.46 143.92 32.81 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.161 -0.519 . . . . 0.0 109.76 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.05 127.95 53.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.534 0.683 . . . . 0.0 110.964 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.645 ' N ' HD13 ' A' ' 152' ' ' LEU . . . -156.07 153.1 24.48 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.361 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.1 mtp -66.54 152.79 44.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.0 111.1 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.468 ' C ' ' CE3' ' A' ' 170' ' ' TRP . 1.3 pt -143.4 146.58 36.53 Favored Pre-proline 0 N--CA 1.455 -0.191 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.46 140.46 63.41 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.481 -1.392 . . . . 0.0 108.481 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.624 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 38.5 t -79.93 -37.9 1.14 Allowed Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.661 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 185' ' ' VAL . 36.4 Cg_endo -68.88 -21.0 38.43 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.271 1.981 . . . . 0.0 112.914 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.481 ' CE2' ' O ' ' A' ' 143' ' ' ASP . 8.1 m-85 -77.88 4.51 11.77 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.976 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 185' ' ' VAL . 26.5 m -136.01 161.17 38.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.424 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.644 ' CG ' HD21 ' A' ' 141' ' ' LEU . 1.1 pp20? -146.35 153.58 40.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 189' ' ' GLU . 13.4 tptm 103.76 85.52 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.276 1.03 . . . . 0.0 111.808 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.664 ' HB3' HG12 ' A' ' 138' ' ' VAL . 0.8 OUTLIER -171.23 -11.9 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.31 -179.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 193' ' ' PRO . 4.2 mtt-85 175.56 -49.14 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 192' ' ' ARG . 73.2 Cg_endo -81.55 -175.48 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.032 1.821 . . . . 0.0 111.576 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 77.4 p -147.07 -151.24 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.107 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 52.0 p -145.99 -55.88 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.569 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -39.45 -76.44 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.726 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 68.0 m -64.49 148.95 49.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.274 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 198' ' ' VAL . 7.5 p -59.82 100.34 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.725 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.4 t -166.55 136.05 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.746 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 201' ' ' LEU . 2.8 m 55.39 -133.0 1.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.567 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 200' ' ' THR . 63.2 mt -60.71 130.54 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.104 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 42.1 m -158.69 97.9 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.567 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 134.08 86.6 0.27 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -141.15 45.14 0.98 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -78.77 127.81 32.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 110.439 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -145.06 158.09 43.92 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.434 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.449 ' O ' ' OG ' ' A' ' 208' ' ' SER . 63.0 t0 -62.64 -55.02 30.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 207' ' ' ASP . 1.6 m -170.54 -54.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.9 t -94.27 122.48 36.85 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.574 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.6 ' N ' ' CD ' ' A' ' 211' ' ' PRO . 0.1 OUTLIER -76.36 -42.37 3.22 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.397 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 210' ' ' HIS . 35.7 Cg_exo -60.09 144.54 99.47 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.757 2.305 . . . . 0.0 112.318 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.631 ' N ' ' CD ' ' A' ' 213' ' ' PRO . 2.6 tp-100 -69.18 -38.91 11.65 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.499 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 212' ' ' GLN . 37.5 Cg_exo -60.16 140.4 92.09 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.16 1.906 . . . . 0.0 111.826 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.33 -63.57 1.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.095 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -101.74 -66.36 0.78 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 174.78 60.5 0.05 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.9 -176.46 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.705 2.27 . . . . 0.0 111.938 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 1.2 tt0 -177.18 -43.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.151 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 218' ' ' GLU . 28.0 Cg_exo -61.36 9.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.511 2.141 . . . . 0.0 112.344 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 218' ' ' GLU . . . 105.86 164.74 23.24 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.33 -177.74 3.49 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.601 2.201 . . . . 0.0 111.791 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 223' ' ' ALA . 93.0 t80 -72.58 162.38 29.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.476 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 222' ' ' TYR . . . -44.46 114.66 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.352 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 226' ' ' SER . 14.9 mt-30 -143.33 164.29 32.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.524 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.489 ' O ' ' OG ' ' A' ' 226' ' ' SER . 30.8 Cg_exo -61.33 57.1 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.444 2.096 . . . . 0.0 112.168 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 228' ' ' ASN . 1.5 m 165.1 -4.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.655 ' N ' HD12 ' A' ' 227' ' ' ILE . 1.5 mp 61.34 -24.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.816 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.621 ' H ' ' C ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -172.92 174.64 3.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.771 ' H ' ' NE2' ' A' ' 275' ' ' GLN . 41.5 p -129.49 83.58 64.49 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -85.34 125.59 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.365 2.71 . . . . 0.0 112.924 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.76 ' H ' HD13 ' A' ' 231' ' ' LEU . 0.0 OUTLIER -134.63 162.77 55.71 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.719 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 233' ' ' ASN . 66.6 Cg_exo -51.77 -71.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 121.511 1.474 . . . . 0.0 113.163 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.528 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 5.3 t-20 153.38 174.52 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.736 ' O ' ' N ' ' A' ' 236' ' ' ASN . 29.2 tp -22.42 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.727 0.642 . . . . 0.0 110.006 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLN . . . . . 0.593 ' O ' ' CE1' ' A' ' 239' ' ' PHE . 18.7 mm-40 22.3 -73.34 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 O-C-N 125.184 1.552 . . . . 0.0 111.254 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 234' ' ' LEU . 31.3 m120 -77.35 39.88 0.27 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.191 176.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 234' ' ' LEU . . . -165.11 134.41 3.31 Favored Glycine 1 CA--C 1.445 -4.322 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.061 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.411 ' HD2' ' CZ2' ' A' ' 170' ' ' TRP . 4.0 Cg_exo -71.56 97.49 0.15 OUTLIER 'Cis proline' 0 N--CA 1.529 3.615 0 CA-C-N 118.171 0.985 . . . . 0.0 112.134 -6.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.593 ' CE1' ' O ' ' A' ' 235' ' ' GLN . 4.3 m-85 -117.09 -134.34 0.34 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 239' ' ' PHE . 0.9 OUTLIER -146.19 137.54 24.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 118.986 0.812 . . . . 0.0 109.768 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.592 ' H ' HD13 ' A' ' 264' ' ' LEU . . . -122.93 140.26 53.18 Favored 'General case' 0 C--O 1.195 -1.768 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.147 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -104.17 111.04 23.48 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.366 0.603 . . . . 0.0 110.704 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.1 p -79.63 127.46 39.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.141 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.44 15.74 7.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 261' ' ' VAL . 1.0 OUTLIER -174.08 112.21 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.633 -179.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.897 ' HD2' HD12 ' A' ' 259' ' ' LEU . 2.5 ttmt -165.13 -156.24 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.266 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.92 -138.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.134 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.697 ' O ' HG12 ' A' ' 248' ' ' VAL . 73.4 t -132.83 60.89 53.08 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 120.677 0.275 . . . . 0.0 111.194 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 258' ' ' ALA . 18.0 Cg_endo -96.72 -170.82 0.16 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.479 2.119 . . . . 0.0 111.394 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.635 ' O ' ' N ' ' A' ' 252' ' ' TYR . 7.1 p-10 -157.9 153.34 26.11 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.142 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 256' ' ' ALA . . . -41.16 -11.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 254' ' ' LYS . 33.4 m-85 -73.83 -53.12 10.94 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 250' ' ' ASN . 35.9 t70 -53.58 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 125.813 1.946 . . . . 0.0 111.702 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' A' ' 252' ' ' TYR . 29.7 mtmt 82.33 -43.11 0.14 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.302 -1.772 . . . . 0.0 110.269 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.558 ' O ' ' ND1' ' A' ' 286' ' ' HIS . 0.1 OUTLIER 158.37 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.405 0.621 . . . . 0.0 110.029 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -109.95 165.01 12.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.864 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.834 ' CD1' HD11 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -114.77 151.78 33.2 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -178.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.963 ' O ' HD23 ' A' ' 259' ' ' LEU . . . -88.64 113.66 24.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 258' ' ' ALA . 0.4 OUTLIER -143.28 174.57 10.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.798 177.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -142.95 148.84 37.55 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.386 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.488 HG22 ' HA ' ' A' ' 245' ' ' GLN . 73.3 t -52.65 99.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.957 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 127.79 -2.94 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.39 -163.25 1.03 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.072 0.463 . . . . 0.0 110.621 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.96 HD12 ' N ' ' A' ' 265' ' ' VAL . 0.0 OUTLIER -159.11 149.37 19.35 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.755 0.788 . . . . 0.0 111.117 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.96 ' N ' HD12 ' A' ' 264' ' ' LEU . 7.0 p -133.48 141.48 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -74.26 176.01 7.06 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.915 ' O ' ' N ' ' A' ' 269' ' ' LYS . 18.4 t -119.29 -36.36 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.144 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 269' ' ' LYS . 0.0 OUTLIER 20.64 -55.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 O-C-N 124.904 1.378 . . . . 0.0 114.178 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.915 ' N ' ' O ' ' A' ' 267' ' ' VAL . 0.1 OUTLIER -84.7 116.11 23.05 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.388 0.613 . . . . 0.0 111.853 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 270' ' ' ILE . 0.6 OUTLIER -136.92 154.1 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.501 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 272' ' ' MET . 0.1 OUTLIER -174.69 158.37 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.99 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.534 ' O ' ' O ' ' A' ' 271' ' ' ASN . 3.9 mtm 52.52 162.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.462 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 p -88.98 27.94 1.26 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 229' ' ' THR . . . -149.07 -85.5 0.06 OUTLIER Glycine 0 C--O 1.209 -1.464 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.325 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.771 ' NE2' ' H ' ' A' ' 229' ' ' THR . 1.8 mp0 -61.99 168.78 3.0 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.58 ' CD1' HD12 ' A' ' 231' ' ' LEU . 16.2 p-90 178.1 -174.17 0.15 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.28 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -144.64 147.5 33.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.494 -1.685 . . . . 0.0 113.598 -176.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -131.16 131.92 6.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.037 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.522 ' OE2' ' N ' ' A' ' 281' ' ' ASN . 6.2 tm-20 -103.45 125.14 49.86 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.627 -0.786 . . . . 0.0 112.541 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' CYS . . . . . 0.623 ' O ' ' CG ' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -125.88 84.37 2.27 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.099 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.522 ' N ' ' OE2' ' A' ' 279' ' ' GLU . 2.4 m120 76.36 21.49 1.39 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.086 -1.009 . . . . 0.0 110.654 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 284' ' ' ARG . . . 104.21 -32.83 7.11 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.475 -0.329 . . . . 0.0 112.65 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.623 ' CG ' ' O ' ' A' ' 280' ' ' CYS . 0.8 OUTLIER -63.06 60.85 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.954 0.407 . . . . 0.0 110.754 -178.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 282' ' ' GLY . 52.8 mtt180 -60.86 162.25 7.08 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.527 0.68 . . . . 0.0 109.939 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.98 -170.68 43.46 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.634 ' CG ' ' O ' ' A' ' 286' ' ' HIS . 1.7 p-80 -140.39 95.3 2.85 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.866 1.333 . . . . 0.0 112.654 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.533 ' HE2' ' HB1' ' A' ' 256' ' ' ALA . 0.7 OUTLIER -101.23 129.38 27.15 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 113.714 -1.585 . . . . 0.0 109.646 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.48 ' CA ' HG22 ' A' ' 229' ' ' THR . 22.5 Cg_exo -50.55 153.91 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.367 1.378 . . . . 0.0 112.528 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.536 ' C ' ' H ' ' A' ' 291' ' ' HIS . 90.3 t80 -72.01 -3.55 23.46 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.431 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 67.8 p -55.63 10.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.676 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.536 ' H ' ' C ' ' A' ' 289' ' ' PHE . 1.2 p80 -176.19 68.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.625 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.534 HG23 ' CD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -155.07 153.73 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 294' ' ' LEU . 27.8 mmm-85 -130.98 66.32 1.54 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.401 0.143 . . . . 0.0 111.357 -178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 241' ' ' ALA . 11.3 mt -31.32 129.05 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.107 0.956 . . . . 0.0 112.499 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.17 -106.53 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.23 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 297' ' ' GLN . 34.5 t0 -173.82 44.45 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.476 ' CB ' ' O ' ' A' ' 296' ' ' ASP . 7.6 tt0 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.136 179.969 . . . . . . . . 1 1 . 1 stop_ save_